data_2opu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2opu _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 67.58 -68.2 0.16 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.116 0.966 . . . . 0.0 112.854 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.0 mt 70.89 -87.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.95 0.9 . . . . 0.0 111.231 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 99.41 0.25 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.177 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.2 -17.47 24.46 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.017 2.478 . . . . 0.0 112.131 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.812 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.1 tp -100.21 147.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.719 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 35.9 m-70 -90.77 -19.14 0.24 Allowed Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -36.21 163.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.447 2.765 . . . . 0.0 114.397 169.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -42.61 161.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.87 3.047 . . . . 0.0 114.06 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.722 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 18.1 Cg_endo -60.37 3.62 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.824 3.016 . . . . 0.0 114.523 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -59.32 -19.9 50.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.312 0.577 . . . . 0.0 109.519 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -151.11 -19.81 0.21 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.654 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 t -80.04 -2.53 44.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.067 0.46 . . . . 0.0 111.004 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.55 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.7 mmt -134.1 39.64 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.904 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 29.1 m -78.96 112.76 16.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.637 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.1 tp10 -114.16 117.31 30.86 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -99.49 104.52 16.35 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.46 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -90.19 116.28 28.06 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.841 -168.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.501 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 65.4 mtm180 -81.0 96.09 7.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.008 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -120.11 126.55 26.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.449 -173.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.35 135.74 46.81 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.193 2.595 . . . . 0.0 111.245 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 3.6 p-10 -60.49 -30.68 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.663 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.71 -31.06 63.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.802 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.705 ' HE2' HG23 ' A' ' 86' ' ' ILE . 95.9 mmm -78.04 -15.16 59.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 34' ' ' ILE . 91.4 t -76.02 -35.88 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.16 -28.73 64.52 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.128 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD11 ' SD ' ' A' ' 30' ' ' MET . 82.5 mt -89.17 -27.83 20.42 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.1 tp -69.24 -28.06 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.613 0.72 . . . . 0.0 109.648 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.9 pt -83.35 -15.0 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.598 174.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.06 -89.87 0.03 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.818 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 6.4 ptm180 -74.6 9.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.032 0.533 . . . . 0.0 111.623 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.26 9.51 27.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.953 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.681 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.74 -39.47 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.026 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 32.2 tt0 -64.49 -28.88 69.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -171.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.18 -51.98 67.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.274 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.42 -37.65 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.175 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -61.45 -43.97 97.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.7 mttm -54.06 -53.39 53.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.433 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.73 -42.92 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.102 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -29.28 64.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.124 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -81.38 -32.45 32.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.183 0.516 . . . . 0.0 110.116 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.93 -46.82 56.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.7 p -67.56 -38.04 83.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.237 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.92 7.94 55.98 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 43.6 t -85.78 144.81 27.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.369 0.604 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -88.06 70.49 9.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.599 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.72 110.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -114.55 123.27 48.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.637 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.5 mm -79.78 124.53 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 37.2 t -112.68 109.85 52.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.619 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 74.1 Cg_endo -75.12 -16.13 20.1 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.983 2.456 . . . . 0.0 111.4 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.41 -33.25 42.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.623 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.629 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 9.6 t 70.45 -74.47 0.08 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.621 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.49 -61.52 0.51 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.409 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.93 -8.59 6.09 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.793 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 2.5 mm? -107.53 152.18 41.28 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.9 -28.07 3.49 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.292 1.995 . . . . 0.0 111.539 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.42 -169.6 2.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.131 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 24.4 mmt180 -79.81 153.1 29.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.629 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 99.1 p -124.28 117.93 25.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG23 HG11 ' A' ' 26' ' ' VAL . 59.1 t -97.75 124.2 50.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -95.63 127.51 41.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.57 0.7 . . . . 0.0 111.408 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.805 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -108.48 124.66 50.77 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.902 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.34 156.28 39.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.88 -128.0 2.15 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 119.838 -1.172 . . . . 0.0 113.121 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.722 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -111.53 165.41 12.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.693 ' HD2' ' HB2' ' A' ' 72' ' ' ALA . 14.1 Cg_endo -55.66 -40.83 83.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.182 1.921 . . . . 0.0 113.06 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -31.89 22.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.462 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 p -71.03 -46.4 62.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -64.99 -23.79 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.864 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.61 -55.28 7.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.131 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -55.48 -45.46 76.97 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.615 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.41 -51.22 70.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.609 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.805 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mtmt -75.71 -20.03 58.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.53 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 tpt -59.81 -49.89 75.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.522 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.0 mmt -66.06 -38.59 88.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 110.874 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.34 -44.82 95.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.35 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.53 -46.01 84.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.106 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.67 -59.6 4.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.842 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.705 HG23 ' HE2' ' A' ' 30' ' ' MET . 2.0 mp -72.69 -41.23 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' A' ' 24' ' ' TYR . 93.1 t -70.38 -25.32 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.683 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.6 t -72.95 -40.81 65.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.677 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.2 ptp180 -77.9 -6.89 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.686 0.279 . . . . 0.0 111.17 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.1 -46.81 0.8 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.483 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 O-C-N 122.518 -0.401 . . . . 0.0 111.291 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 35.2 t . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -161.42 106.35 1.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 0.0 110.093 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.463 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 24.4 tp -91.41 96.6 10.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.4 70.92 0.33 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.03 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 6.7 Cg_exo -73.96 -38.37 2.29 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.561 2.174 . . . . 0.0 111.332 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.58 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 12.4 pt -121.81 152.42 25.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.699 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.65 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 72.7 t60 -89.08 -26.22 0.32 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.0 Cg_exo -39.15 159.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.79 2.327 . . . . 0.0 114.049 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 17' ' ' ARG . 4.6 Cg_exo -38.16 144.38 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.127 3.218 . . . . 0.0 113.828 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 46.3 Cg_endo -66.77 31.32 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.539 3.493 . . . . 0.0 114.493 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.803 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 ppt_? -82.63 0.06 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 0.0 110.176 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.803 HG22 ' HD2' ' A' ' 17' ' ' ARG . 11.9 t -179.46 -17.76 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.489 ' HB3' HG13 ' A' ' 12' ' ' ILE . 3.7 m -78.32 -80.92 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.583 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.613 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.6 ptp -76.24 76.61 3.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.9 m -81.82 114.01 20.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.2 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 15.3 tt0 -94.04 118.01 30.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -99.29 104.98 16.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.676 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -90.82 118.78 30.5 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.684 -168.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -81.86 99.1 8.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.685 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.627 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -116.63 123.52 30.4 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.763 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HG2' ' HG2' ' A' ' 30' ' ' MET . 31.9 Cg_endo -66.36 152.55 80.71 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.482 2.121 . . . . 0.0 111.832 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -52.72 -42.02 64.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.88 93.21 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.482 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.536 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 88.4 mmm -78.84 -23.49 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.431 -0.452 . . . . 0.0 111.354 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 34' ' ' ILE . 2.8 p -74.26 -30.55 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.672 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -28.82 69.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.925 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.29 -23.92 22.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.7 tp -70.3 -25.55 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.691 0.758 . . . . 0.0 109.597 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.81 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 9.4 pt -85.33 -14.73 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.434 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.17 -91.18 0.02 OUTLIER Glycine 0 C--N 1.336 0.574 0 O-C-N 124.209 0.943 . . . . 0.0 113.191 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 1.011 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.5 ptm180 -76.99 44.9 0.41 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.166 0.587 . . . . 0.0 111.501 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.06 13.78 80.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 114.354 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.81 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 135.51 -36.09 2.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.623 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.011 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 71.8 tt0 -57.75 -33.9 68.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -59.91 -52.42 65.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.712 0.291 . . . . 0.0 111.361 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.658 HD11 HG12 ' A' ' 53' ' ' VAL . 10.0 tp -63.8 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.106 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -58.33 -40.66 82.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 13.7 mmmm -60.32 -59.96 4.58 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.86 -41.54 93.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -33.2 72.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.015 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 47' ' ' GLN . 1.0 OUTLIER -77.95 -37.88 46.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.469 0.652 . . . . 0.0 109.539 176.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.45 -26.07 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.198 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 34.1 p -99.65 -44.85 5.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.95 8.96 21.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.06 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 21.0 t -92.77 136.97 32.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 110.855 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -79.77 79.05 6.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.922 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.658 HG12 HD11 ' A' ' 42' ' ' ILE . 40.6 t -82.64 109.52 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 14.5 mm-40 -101.03 116.05 31.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.531 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.5 mm -89.7 96.95 6.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.743 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 m -88.36 105.39 9.36 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.812 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.588 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 2.8 Cg_exo -75.43 -22.09 14.42 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.321 2.681 . . . . 0.0 111.641 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -79.62 -38.08 34.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.001 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.62 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.3 t 71.41 -54.09 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.556 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.94 -71.79 2.9 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.646 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.78 -9.44 61.13 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.958 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.617 ' HB2' ' OG ' ' A' ' 59' ' ' SER . 2.1 mm? -121.49 154.48 59.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -85.5 -4.3 9.25 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 111.985 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 6.3 pt-20 -111.03 -141.05 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.817 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.627 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.0 tpp180 -107.4 140.15 40.78 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 67.2 p -116.94 111.64 19.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.348 0.594 . . . . 0.0 109.944 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 55' ' ' ILE . 84.7 t -100.83 119.53 49.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.776 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 29.7 m -88.68 128.24 35.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.329 0.585 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.861 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.9 mm? -107.31 108.09 19.32 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.805 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 18' ' ' THR . 0.7 OUTLIER -151.2 119.45 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.005 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -158.88 -107.34 0.24 Allowed Glycine 0 C--O 1.225 -0.455 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.734 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -129.35 163.63 44.97 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.6 -51.22 8.37 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.463 2.109 . . . . 0.0 112.859 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -72.65 -46.86 51.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.362 0.601 . . . . 0.0 110.698 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.7 m -62.47 -45.5 92.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.818 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.541 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.1 p -71.23 -27.87 30.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 -174.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -40.2 49.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.32 . . . . 0.0 110.385 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.721 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.8 tpmt? -64.26 -46.59 83.04 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.659 0.742 . . . . 0.0 109.818 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.24 -46.5 76.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.294 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.861 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 37.7 mtmt -73.5 -22.45 60.13 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.721 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.5 -31.09 68.05 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.458 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.0 mmt -69.02 -46.7 67.3 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.677 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.403 ' HG ' HD23 ' A' ' 69' ' ' LEU . 4.4 mm? -61.51 -48.59 80.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.87 -40.5 69.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.266 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.8 -57.62 12.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.947 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.687 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -72.13 -41.52 67.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.758 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.676 HG22 ' CD1' ' A' ' 24' ' ' TYR . 85.8 t -64.57 -32.42 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.336 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 t -73.25 -37.77 66.21 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.455 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.687 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.5 ptp180 -78.41 -7.6 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.929 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -107.41 -64.89 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.344 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -177.645 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.537 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 62.6 m . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.523 0.201 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.616 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 68.5 mm-40 53.78 -162.3 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.48 0.712 . . . . 0.0 111.621 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 28.8 tp 173.05 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 121.76 92.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.952 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.09 -26.13 26.32 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.998 2.466 . . . . 0.0 111.385 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.639 HG22 ' HD2' ' A' ' 14' ' ' PRO . 4.1 mt -77.17 108.45 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.658 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 23.3 m170 -89.72 7.12 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -168.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 20.5 Cg_exo -46.1 -176.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.82 1.68 . . . . 0.0 112.863 158.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 17' ' ' ARG . 67.5 Cg_exo -42.14 158.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.983 2.455 . . . . 0.0 113.557 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 26.8 Cg_endo -64.4 17.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.79 2.993 . . . . 0.0 114.207 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -74.43 -6.55 48.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.0 109.961 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.3 t -158.71 -25.96 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.609 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.0 t -79.31 8.12 6.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.812 0.339 . . . . 0.0 111.083 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.756 ' HA ' ' HE1' ' A' ' 20' ' ' MET . 1.5 mmt -145.58 32.67 1.06 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.397 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 40.1 m -79.51 110.99 15.33 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.21 118.97 34.28 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.616 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.9 tt0 -84.91 104.12 14.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.85 109.46 20.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.259 -174.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 96.7 mtt180 -87.37 98.83 11.57 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.21 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -112.65 128.87 25.01 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.936 -173.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 20.0 Cg_exo -60.7 143.51 99.41 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 123.276 2.651 . . . . 0.0 111.773 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.82 -50.62 56.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -170.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.87 -29.8 75.24 Favored Glycine 0 C--O 1.237 0.333 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.413 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.771 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 80.3 mmm -77.45 -21.0 53.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.657 ' O ' HG12 ' A' ' 35' ' ' ILE . 41.4 t -66.19 -37.98 80.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -63.17 -29.38 74.28 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.708 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.81 -25.17 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.607 HG21 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -75.77 -29.48 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.3 0.572 . . . . 0.0 109.815 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 31' ' ' VAL . 8.8 pt -83.32 -13.51 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.181 172.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.15 -91.02 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.087 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.957 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 16.9 ptm180 -71.18 -9.52 58.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.712 0.405 . . . . 0.0 111.451 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.84 3.38 7.66 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.294 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.606 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -58.93 0.25 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.314 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 18.8 tp10 -55.17 -21.96 15.45 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -65.7 -48.45 71.99 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.02 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 39' ' ' GLY . 9.9 tp -63.98 -37.87 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -53.78 -49.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.629 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 22.1 mmtm -66.95 -41.76 86.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.299 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.19 -41.17 86.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -22.87 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.017 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -78.24 -42.57 30.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.335 0.588 . . . . 0.0 110.047 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.61 -43.77 93.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.01 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 23.1 p -83.69 -43.06 15.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.291 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.8 10.49 26.54 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.559 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 t -79.71 141.73 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 0.0 110.475 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 50.9 mmtt -94.22 67.34 3.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.438 0.637 . . . . 0.0 109.615 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.435 HG21 HD13 ' A' ' 69' ' ' LEU . 2.2 p -82.5 142.88 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.127 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -136.53 114.86 11.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.518 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.459 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 36.9 mm -79.63 104.65 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.39 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 6.2 t -92.35 105.43 14.14 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 3.2 Cg_exo -75.93 -30.79 5.57 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.45 2.767 . . . . 0.0 112.724 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.53 -29.67 46.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.535 ' HA ' ' HG ' ' A' ' 66' ' ' SER . 7.4 t 73.19 -67.53 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.821 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.99 76.83 0.88 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.823 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.08 -57.69 0.68 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.815 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 25' ' ' ARG . 1.3 mm? -87.57 144.15 35.02 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.05 -23.92 8.73 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.435 2.09 . . . . 0.0 110.225 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 6.6 pt-20 -88.99 -168.67 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.556 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.732 ' HB3' HG11 ' A' ' 26' ' ' VAL . 4.0 tpp180 -87.08 139.46 30.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.146 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.535 ' HG ' ' HA ' ' A' ' 59' ' ' SER . 15.9 p -117.28 111.34 19.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.43 HG12 HD13 ' A' ' 55' ' ' ILE . 49.1 t -109.32 131.74 59.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.694 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.6 m -91.79 125.59 36.56 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.022 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 21' ' ' THR . 4.0 mm? -104.57 111.45 24.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.025 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 m -152.29 147.98 26.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.654 0.206 . . . . 0.0 111.036 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.74 -156.72 28.8 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.018 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -78.3 161.62 69.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.595 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.8 Cg_endo -48.53 -54.96 4.56 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.008 2.472 . . . . 0.0 113.417 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.48 -37.07 77.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.088 0.47 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.667 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 9.0 m -66.6 -51.66 53.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.425 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 p -67.62 -26.48 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.267 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -71.74 -45.26 62.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.388 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 81' ' ' MET . 1.3 tmtp? -68.6 -39.23 80.98 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.362 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.444 ' O ' HD22 ' A' ' 83' ' ' LEU . . . -62.07 -40.85 97.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.977 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 45.8 mtmt -80.96 -21.32 40.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.1 tpt -57.15 -50.7 72.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.357 173.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 92.9 mmm -68.96 -39.8 79.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 111.038 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.444 HD22 ' O ' ' A' ' 79' ' ' ALA . 3.7 mm? -62.67 -47.84 81.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.96 -45.67 78.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.042 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.0 -54.23 47.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.669 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.575 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.7 mp -75.24 -41.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.7 -23.65 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.291 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -75.2 -41.42 57.88 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.799 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.575 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.9 ptm180 -76.74 -6.96 54.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.771 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -105.72 -52.44 0.8 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.982 -0.627 . . . . 0.0 113.597 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.311 0.577 . . . . 0.0 112.33 -175.744 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 23' ' ' GLU . 62.2 m . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -176.01 163.03 2.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.201 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.444 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 75.1 mt -138.78 107.32 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.669 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -126.32 57.66 0.69 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.627 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 92.0 Cg_endo -93.88 -2.68 3.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.002 2.468 . . . . 0.0 112.387 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.571 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 30.9 pt -126.51 149.17 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.813 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.586 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 22.1 m80 -91.18 -19.56 0.24 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 93.2 Cg_exo -38.81 162.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.671 2.247 . . . . 0.0 114.324 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.62 152.64 8.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.847 2.364 . . . . 0.0 112.077 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 42.4 Cg_endo -65.99 7.56 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.423 2.748 . . . . 0.0 113.788 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.87 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.18 0.514 . . . . 0.0 110.284 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -159.29 7.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.14 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.431 ' HA ' HD11 ' A' ' 12' ' ' ILE . 30.8 t -93.28 -104.64 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.297 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.463 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptm -63.95 74.22 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.045 0.926 . . . . 0.0 111.712 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.62 HG22 ' HG1' ' A' ' 70' ' ' THR . 62.5 m -90.04 139.02 31.02 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.622 ' CG ' ' HD3' ' A' ' 80' ' ' LYS . 10.9 mm-40 -95.33 148.87 21.97 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.299 168.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HB3' ' H ' ' A' ' 7' ' ' SER . 54.5 tp10 -120.34 98.76 6.2 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 160.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.505 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.36 124.57 37.43 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.266 -161.453 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.939 ' HG2' HD21 ' A' ' 62' ' ' LEU . 32.6 mtm180 -81.78 111.38 17.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.473 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -130.31 126.59 22.25 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.893 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 35.0 Cg_exo -60.07 151.38 72.96 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.488 2.792 . . . . 0.0 112.658 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 31' ' ' VAL . 35.5 t70 -55.17 -51.91 65.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.03 75.05 Favored Glycine 0 C--O 1.236 0.253 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.935 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.549 ' HE3' ' CA ' ' A' ' 90' ' ' GLY . 28.0 tpp -79.53 -32.05 42.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.473 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 34' ' ' ILE . 12.7 p -72.69 -24.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.2 74.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.06 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.45 -24.55 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.56 HD11 ' HB ' ' A' ' 86' ' ' ILE . 10.7 tp -72.93 -27.93 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 109.663 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 11.9 pt -85.05 -13.59 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.348 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.33 -93.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 O-C-N 124.164 0.915 . . . . 0.0 113.066 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.931 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -72.99 48.68 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.179 0.592 . . . . 0.0 111.027 177.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.15 20.8 58.62 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.113 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.605 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.05 -50.91 0.58 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.809 -1.186 . . . . 0.0 113.602 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.931 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 22.2 tt0 -54.62 -33.49 60.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.508 ' O ' HG12 ' A' ' 45' ' ' ILE . 24.5 tt0 -60.03 -48.4 81.85 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.473 -171.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 53' ' ' VAL . 9.8 tp -60.59 -38.48 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.214 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 60.2 m-20 -65.32 -44.69 87.02 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.58 -31.94 69.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.534 0.207 . . . . 0.0 111.035 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 41' ' ' GLN . 26.4 mm -76.32 -50.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.989 0.423 . . . . 0.0 111.357 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.45 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -75.72 -24.64 56.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.408 -174.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -82.95 -34.48 26.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.684 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.81 -46.02 76.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.869 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.603 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 25.8 p -73.04 -48.04 39.57 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.209 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 13.47 25.7 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.4 t -92.84 143.36 26.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.954 0.407 . . . . 0.0 110.706 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 41.4 mtmt -81.6 72.09 8.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.73 HG12 HD13 ' A' ' 42' ' ' ILE . 57.9 t -82.4 110.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.397 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 15.7 mm-40 -110.99 122.44 47.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.123 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.574 HD13 HG12 ' A' ' 42' ' ' ILE . 42.7 mm -88.9 99.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.79 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.5 t -81.08 115.14 54.18 Favored Pre-proline 0 C--O 1.243 0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HA ' HH11 ' A' ' 65' ' ' ARG . 97.4 Cg_endo -79.65 -27.54 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.367 2.712 . . . . 0.0 112.061 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.65 -40.32 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.457 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 11.0 t 70.72 -69.11 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.236 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.57 -96.54 0.54 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.061 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.06 -12.47 79.36 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.654 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.939 HD21 ' HG2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -94.78 139.93 22.38 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.796 0.332 . . . . 0.0 110.817 -176.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.09 -2.46 9.52 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.8 2.333 . . . . 0.0 111.434 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' CD ' HH21 ' A' ' 91' ' ' ARG . 2.5 pt-20 -110.64 -104.06 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.31 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.576 HH11 ' HA ' ' A' ' 57' ' ' PRO . 6.7 tpp180 -144.57 155.4 43.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 78.0 p -136.94 146.97 46.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.373 173.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.454 HG11 HD12 ' A' ' 55' ' ' ILE . 52.2 t -123.3 131.06 73.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -91.48 131.23 37.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.2 0.524 . . . . 0.0 110.768 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 22' ' ' GLU . 3.6 mm? -114.09 104.03 11.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.62 ' HG1' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -147.2 124.19 11.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.389 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.76 -158.03 19.2 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.333 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.11 161.88 69.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -45.67 -52.24 7.09 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.79 2.326 . . . . 0.0 112.945 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.5 -43.33 81.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.6 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.603 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.3 m -64.94 -49.62 69.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.618 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.55 -23.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.162 -175.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.535 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.2 tt0 -72.55 -52.37 15.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.886 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -55.04 -43.47 73.8 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.191 0.52 . . . . 0.0 110.588 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.94 63.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.725 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.622 ' HD3' ' CG ' ' A' ' 22' ' ' GLU . 11.2 mtmm -66.91 -23.06 65.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.616 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.7 mmt -59.77 -52.72 64.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.422 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 20.4 mmt -68.37 -37.71 80.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.5 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.3 mm? -60.48 -54.99 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.183 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.3 -34.86 74.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 110.559 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.39 -55.98 17.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.56 ' HB ' HD11 ' A' ' 34' ' ' ILE . 1.9 mp -74.09 -41.48 52.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.365 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 24' ' ' TYR . 87.9 t -64.18 -28.1 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.23 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 t -75.73 -31.63 59.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.342 -0.224 . . . . 0.0 110.91 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 17.4 ptp180 -77.74 -12.44 59.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.549 ' CA ' ' HE3' ' A' ' 30' ' ' MET . . . -106.33 -50.07 0.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.957 176.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.427 HH21 ' CD ' ' A' ' 64' ' ' GLU . 26.3 mmt180 . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 122.293 0.237 . . . . 0.0 111.6 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.984 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 34.1 m . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -158.2 121.46 3.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.022 0.439 . . . . 0.0 110.34 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.26 104.08 15.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.085 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.57 69.38 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.891 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -84.95 -27.29 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.656 2.238 . . . . 0.0 112.991 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.68 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 6.0 mm -120.49 147.32 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.611 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 24.7 t60 -93.53 12.03 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.718 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -170.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.68 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 29.8 Cg_endo -61.06 -166.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 122.33 2.02 . . . . 0.0 113.958 171.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 67.3 Cg_exo -56.63 167.08 3.08 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.358 2.039 . . . . 0.0 112.517 168.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.1 33.63 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 124.189 3.259 . . . . 0.0 114.708 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' O ' ' HB ' ' A' ' 18' ' ' THR . 4.7 ptp180 -96.92 13.17 29.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 15.0 t 174.53 -15.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.289 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -79.97 -6.42 57.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.629 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.42 58.14 0.4 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.22 0.533 . . . . 0.0 110.354 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -78.21 110.83 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 7' ' ' SER . 12.7 tt0 -98.9 119.57 37.9 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -172.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.984 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 4.6 tp10 -92.34 102.01 14.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -90.96 126.24 36.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.112 0.482 . . . . 0.0 110.739 -171.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -91.09 98.12 11.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.083 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 HH21 ' A' ' 65' ' ' ARG . 1.3 p -120.37 114.33 33.27 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.528 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.594 ' HA ' ' CB ' ' A' ' 64' ' ' GLU . 50.3 Cg_exo -57.5 164.25 7.5 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 124.454 3.436 . . . . 0.0 114.38 -169.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.91 -45.34 74.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 0.0 111.845 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' HD23 ' A' ' 33' ' ' LEU . . . -63.76 -34.04 88.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.806 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.567 ' HA ' ' HE3' ' A' ' 30' ' ' MET . 31.4 mmt -80.25 -25.81 39.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -175.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -70.77 -33.89 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.934 172.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.37 77.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.708 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 29' ' ' GLY . 4.2 mm? -87.01 -24.02 24.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.963 HG22 HH22 ' A' ' 65' ' ' ARG . 10.8 tp -71.43 -30.49 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 109.249 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.62 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.0 pt -86.99 -14.05 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.731 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.76 -90.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.918 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.05 -6.91 9.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.998 -0.601 . . . . 0.0 111.946 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.9 4.42 9.5 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.824 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.62 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.17 -44.91 0.5 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.182 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.4 -26.31 66.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.59 -45.29 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.94 -174.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -65.39 -34.0 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.973 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -61.47 -38.67 88.11 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -37.63 64.81 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 41' ' ' GLN . 98.1 mt -64.13 -52.74 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 111.258 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -21.87 59.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -84.14 -35.56 23.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.508 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.17 -39.49 78.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.666 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 p -84.07 -39.78 19.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.477 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.57 3.45 59.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.687 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 54.0 t -80.31 146.15 31.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.949 0.404 . . . . 0.0 110.533 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.711 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 10.9 mmpt? -84.98 81.01 9.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -81.92 107.16 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.7 mm-40 -95.93 106.68 18.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.933 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.547 HG22 HH11 ' A' ' 65' ' ' ARG . 33.2 mm -81.12 110.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.637 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -97.38 98.57 5.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 39.5 Cg_exo -60.05 -41.36 53.17 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 112.419 -173.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -115.36 102.99 10.35 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.5 t -68.92 -26.0 64.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.751 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.07 -82.01 1.39 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.191 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.27 -31.04 77.88 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.782 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.31 138.52 20.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.979 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.86 -19.52 23.51 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.783 2.322 . . . . 0.0 110.784 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.594 ' CB ' ' HA ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -96.69 -174.35 2.99 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.183 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.963 HH22 HG22 ' A' ' 34' ' ' ILE . 5.7 tmm_? -94.84 141.3 28.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 79.5 p -115.26 150.82 35.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.382 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 82.6 t -129.96 114.34 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.701 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.3 m -85.87 129.95 34.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.399 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.997 HD13 ' HG2' ' A' ' 80' ' ' LYS . 5.4 mt -114.94 121.75 44.14 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.8 m -151.33 141.29 22.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.247 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.89 -136.94 4.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.482 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.575 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -96.13 163.11 21.64 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 5.7 Cg_endo -48.05 -48.35 16.72 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.798 2.332 . . . . 0.0 112.854 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.36 -39.67 53.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 p -70.94 -47.69 57.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.104 0.478 . . . . 0.0 110.441 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.73 -29.2 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.228 -177.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.68 -50.99 46.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 81' ' ' MET . 50.8 tptt -63.13 -40.56 97.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.758 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 51' ' ' CYS . . . -58.81 -41.71 87.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.138 0.494 . . . . 0.0 111.082 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.997 ' HG2' HD13 ' A' ' 69' ' ' LEU . 48.5 mtmt -81.18 -21.89 39.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.957 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 7.8 tpt -59.1 -50.58 73.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.357 174.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mmm -70.25 -37.53 74.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.593 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.4 mm? -60.37 -55.09 37.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.418 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -55.18 -34.92 64.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.766 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.72 -56.57 19.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.575 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -70.13 -40.21 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.336 0.588 . . . . 0.0 110.77 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 83' ' ' LEU . 74.4 t -62.41 -28.47 44.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.293 0.568 . . . . 0.0 110.106 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -75.4 -31.13 60.32 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.164 -0.335 . . . . 0.0 110.759 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.603 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.5 ptm180 -78.31 -15.74 58.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.616 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.424 ' HA3' ' SD ' ' A' ' 30' ' ' MET . . . -158.21 44.94 0.47 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.009 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 87' ' ' VAL . 7.6 tpm_? . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 117.551 0.676 . . . . 0.0 110.084 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 120.918 0.389 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -56.84 120.0 7.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 20' ' ' MET . 53.2 tp -100.19 102.61 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.791 168.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.499 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -132.69 57.33 0.72 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.774 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.692 ' HD2' HD12 ' A' ' 12' ' ' ILE . 5.8 Cg_exo -78.51 -46.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.48 2.12 . . . . 0.0 111.368 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.785 ' H ' HD12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.28 147.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.837 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.668 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 53.5 m80 -91.12 -19.21 0.24 Allowed Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.6 Cg_endo -53.67 164.8 2.04 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.31 2.007 . . . . 0.0 113.482 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 17' ' ' ARG . 85.0 Cg_exo -46.65 149.25 3.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.201 2.601 . . . . 0.0 112.791 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 39.7 Cg_endo -65.53 26.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.567 3.511 . . . . 0.0 114.437 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.765 ' HG3' HG23 ' A' ' 18' ' ' THR . 13.3 ptp180 -82.23 -20.96 36.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.151 0.5 . . . . 0.0 110.004 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.765 HG23 ' HG3' ' A' ' 17' ' ' ARG . 9.8 t -168.62 34.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.691 0.758 . . . . 0.0 110.458 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.9 p -126.12 -80.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.1 ptm -74.55 79.13 1.96 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.0 m -79.48 118.78 21.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.867 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 68' ' ' SER . 6.2 tp10 -92.83 118.24 30.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -100.4 103.42 14.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.43 123.62 36.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.207 0.527 . . . . 0.0 111.9 -172.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -81.65 110.35 16.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.939 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.3 p -132.76 127.04 20.21 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.294 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.436 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.0 Cg_exo -54.62 136.51 70.94 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.268 2.645 . . . . 0.0 111.038 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.4 -29.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.352 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.34 -28.95 57.03 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.626 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.609 ' SD ' HD13 ' A' ' 33' ' ' LEU . 32.8 tpp -77.5 -20.68 53.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.674 ' HA ' HG23 ' A' ' 34' ' ' ILE . 80.1 t -69.15 -39.21 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.377 169.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.54 -28.45 56.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.65 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.609 HD13 ' SD ' ' A' ' 30' ' ' MET . 81.1 mt -85.78 -29.99 23.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.674 HG23 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -72.1 -29.52 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.267 0.556 . . . . 0.0 109.969 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.726 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 17.9 pt -80.38 -13.24 12.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.512 174.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 -97.19 0.19 Allowed Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.459 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 1.087 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 19.5 ptp180 -60.0 -24.86 64.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.003 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.04 30.79 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.486 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.726 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.84 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.306 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.087 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 9.5 mp0 -60.86 -21.63 63.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -168.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 45' ' ' ILE . 9.1 tt0 -60.1 -50.67 72.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.367 0.53 . . . . 0.0 110.765 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.489 HG12 HD11 ' A' ' 55' ' ' ILE . 8.9 tp -64.45 -39.18 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.29 -46.3 76.21 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.407 0.622 . . . . 0.0 110.037 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -65.57 -37.65 87.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.246 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 41' ' ' GLN . 22.9 mm -68.19 -51.17 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 111.267 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.32 -31.3 65.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.675 -173.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -78.84 -31.48 45.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.823 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.14 -45.48 56.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.344 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 p -68.12 -45.21 74.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.76 -0.28 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.542 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.742 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 47.3 t -83.36 135.95 34.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.775 0.321 . . . . 0.0 110.286 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -80.62 72.86 7.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 69' ' ' LEU . 43.3 t -82.52 111.32 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -111.26 118.03 34.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.176 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 42' ' ' ILE . 34.2 mm -79.75 115.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -99.71 104.81 30.28 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.555 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.866 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 60.1 Cg_endo -73.62 -21.95 18.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.989 2.46 . . . . 0.0 111.88 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.87 -32.39 23.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.878 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.541 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 21.4 t 65.39 -77.32 0.04 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.804 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.09 -86.16 0.36 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.084 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.88 -3.07 60.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.86 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.491 ' HB2' ' OG ' ' A' ' 59' ' ' SER . 2.0 mm? -112.92 147.68 37.74 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.279 . . . . 0.0 110.494 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.98 -10.15 11.62 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.124 2.549 . . . . 0.0 111.556 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 4.2 pt-20 -104.27 -147.54 0.39 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.524 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.866 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 19.3 mmt180 -106.53 139.88 40.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.1 p -110.75 108.11 17.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.496 0.665 . . . . 0.0 109.347 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 55' ' ' ILE . 64.7 t -97.08 108.16 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.249 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -86.88 134.7 33.51 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.954 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 53' ' ' VAL . 2.3 mp -123.5 121.87 36.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.163 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -151.92 121.46 6.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.026 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.04 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.177 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . . . -160.85 165.45 17.25 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 72' ' ' ALA . 8.6 Cg_endo -49.93 -47.0 25.27 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 113.284 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.19 -38.94 23.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.431 0.634 . . . . 0.0 110.152 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -65.69 -46.17 80.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.789 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 p -73.06 -23.6 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 0.0 110.332 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.502 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.7 tp60 -76.47 -47.84 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.966 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 81' ' ' MET . 17.2 tppt? -60.64 -45.23 94.88 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.778 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.32 79.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.471 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 47.5 mtmt -69.1 -21.04 64.07 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.908 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.1 mmt -61.25 -48.04 83.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.211 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.24 -41.24 97.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.704 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -64.12 -57.33 9.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.361 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.56 -35.89 61.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.317 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.01 -61.44 2.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.013 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.542 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.1 mp -70.41 -38.77 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.052 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 83' ' ' LEU . 77.9 t -61.45 -36.69 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.333 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t -71.17 -22.67 62.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.835 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -59.83 -49.2 78.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.471 ' CA ' ' HE2' ' A' ' 30' ' ' MET . . . -81.31 -54.9 3.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.385 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.458 HH21 ' CD ' ' A' ' 64' ' ' GLU . 39.3 mmt180 . . . . . 0 C--N 1.32 -0.71 0 C-N-CA 123.354 0.662 . . . . 0.0 110.372 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.482 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 8.1 m . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HB3' ' O ' ' A' ' 21' ' ' THR . 60.0 tp60 170.83 -31.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.068 0.855 . . . . 0.0 108.964 171.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 67.55 -90.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.663 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 148.06 94.94 0.15 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.134 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.36 -12.96 30.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.806 2.337 . . . . 0.0 111.854 176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.771 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -99.69 161.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.651 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 31.5 t-80 -92.5 -37.95 0.35 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 51.8 Cg_exo -32.58 144.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.874 3.049 . . . . 0.0 114.387 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 17' ' ' ARG . 73.1 Cg_exo -40.58 140.76 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.376 2.717 . . . . 0.0 112.29 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 9.5 Cg_endo -51.79 60.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.132 1 C-N-CA 125.652 4.234 . . . . 0.0 116.884 -168.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 15' ' ' PRO . 11.9 ptp180 -114.84 15.11 17.45 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -178.87 -25.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.513 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.482 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 12.8 m -86.2 10.86 13.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.438 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.625 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 90.1 mmm -147.38 31.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.466 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 88.4 m -79.88 115.75 19.64 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 9.3 tt0 -123.89 118.04 26.18 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.3 109.29 20.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.599 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -92.1 128.22 37.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.003 -170.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.534 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 87.8 mtm180 -88.14 101.72 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.518 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -120.4 120.4 29.91 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.079 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' A' ' 91' ' ' ARG . 85.4 Cg_exo -50.11 145.71 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.878 3.052 . . . . 0.0 112.207 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -60.5 -37.04 79.81 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.587 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.76 -25.3 53.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.791 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.626 ' HE2' ' HA2' ' A' ' 90' ' ' GLY . 35.5 tpp -79.54 -26.67 41.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.203 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 34' ' ' ILE . 7.5 p -75.81 -30.18 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -28.3 62.25 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.16 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -88.87 -24.24 22.57 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 31' ' ' VAL . 9.8 tp -70.8 -27.47 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.313 0.578 . . . . 0.0 109.892 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.618 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 pt -81.15 -14.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.431 173.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 61.09 -90.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 O-C-N 124.187 0.929 . . . . 0.0 113.155 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.06 28.15 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.15 0.58 . . . . 0.0 111.991 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 96.0 -10.38 67.99 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.271 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.618 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -51.87 0.27 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.872 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 5.0 mm-40 -59.12 -22.41 60.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -53.24 52.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.763 0.71 . . . . 0.0 111.34 -172.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.91 -44.44 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.48 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -59.68 -42.95 94.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.0 109.68 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 4.5 ttmm -63.25 -35.73 81.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.569 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.01 -50.67 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.79 84.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.808 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -73.97 -37.49 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.76 -45.03 91.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -73.19 -46.54 49.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.81 8.63 9.63 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.789 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 22.9 t -84.21 139.55 32.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.625 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -94.36 71.82 3.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.742 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.66 120.93 35.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.236 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.5 mm-40 -117.03 119.53 35.57 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.213 0.53 . . . . 0.0 111.032 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 67' ' ' VAL . 32.6 mm -85.16 109.06 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.522 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.803 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 10.0 m -91.12 109.76 37.63 Favored Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 120.695 0.283 . . . . 0.0 110.641 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.59 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 32.8 Cg_endo -64.81 -50.96 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.987 2.458 . . . . 0.0 111.941 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.95 94.08 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.859 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.3 p -74.6 -29.74 61.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.329 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.71 -86.56 1.34 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.712 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.401 ' C ' HD11 ' A' ' 62' ' ' LEU . . . -75.98 -12.03 84.29 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.506 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.859 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.9 mp -110.0 144.47 30.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.73 -37.67 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.453 2.102 . . . . 0.0 111.931 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.69 -154.26 0.36 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.322 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 17.0 tpp180 -85.78 154.97 21.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.803 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 73.8 p -120.74 117.36 27.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 26' ' ' VAL . 97.1 t -104.51 120.95 55.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.061 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -86.97 128.51 35.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.431 0.634 . . . . 0.0 111.16 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.585 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.2 mm? -104.67 112.18 25.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.231 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 25.5 m -151.81 155.08 37.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.18 -101.76 0.18 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.415 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . . . -143.78 164.04 32.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.647 ' HD2' ' HB2' ' A' ' 72' ' ' ALA . 7.8 Cg_endo -49.05 -53.17 7.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.959 2.439 . . . . 0.0 113.54 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -84.54 -30.11 25.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.091 0.472 . . . . 0.0 111.143 -177.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.5 m -72.97 -43.19 62.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.204 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.615 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.6 p -67.74 -24.81 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.963 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.554 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.7 tt0 -74.81 -42.62 57.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.893 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 81' ' ' MET . 21.1 tptp -61.12 -44.64 97.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.461 0.648 . . . . 0.0 110.283 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.38 -48.21 82.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.627 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.585 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 8.4 mtmp? -69.22 -20.69 63.96 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.393 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 24.2 mmt -58.35 -46.84 85.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 81.9 mtp -63.68 -49.97 71.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 110.743 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.528 ' HG ' HD23 ' A' ' 69' ' ' LEU . 4.1 mm? -59.68 -50.88 72.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.629 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.59 -41.66 95.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.842 0.353 . . . . 0.0 110.339 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.33 -56.71 18.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.396 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.86 -35.28 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.123 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 24' ' ' TYR . 55.3 t -72.11 -28.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 121.608 -0.683 . . . . 0.0 111.0 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -69.37 -40.41 77.45 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.652 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 16.9 ptm180 -73.92 -21.54 60.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.879 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.626 ' HA2' ' HE2' ' A' ' 30' ' ' MET . . . -94.02 -58.94 1.2 Allowed Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.139 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.536 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 14.3 mmm180 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 110.749 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.931 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 20.3 t . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.689 0.28 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.51 156.04 7.88 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.077 0.551 . . . . 0.0 110.864 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 20' ' ' MET . 80.2 mt -137.92 106.43 5.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.27 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.18 61.58 0.64 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.93 -27.42 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.405 2.07 . . . . 0.0 112.76 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.602 HG13 ' HB3' ' A' ' 19' ' ' SER . 15.7 pt -111.11 144.56 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.573 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 41.2 m80 -90.22 -20.48 0.25 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 92.9 Cg_exo -40.58 154.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.216 1.944 . . . . 0.0 112.83 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 17' ' ' ARG . 80.9 Cg_exo -46.58 152.99 1.34 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 123.29 2.66 . . . . 0.0 113.119 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 38.4 Cg_endo -65.51 24.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.294 3.329 . . . . 0.0 114.064 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.775 ' HG3' HG23 ' A' ' 18' ' ' THR . 12.0 ptp180 -71.69 -24.66 61.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.124 0.487 . . . . 0.0 109.942 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.775 HG23 ' HG3' ' A' ' 17' ' ' ARG . 7.2 t -163.25 10.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.916 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.602 ' HB3' HG13 ' A' ' 12' ' ' ILE . 15.2 m -105.22 -86.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.8 ptp -69.13 85.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.508 0.67 . . . . 0.0 110.949 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 m -88.92 114.03 25.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.223 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 14.5 tt0 -95.95 118.88 33.43 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.931 ' HB3' ' HB3' ' A' ' 7' ' ' SER . 4.9 tp10 -90.92 106.86 18.81 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.562 ' HD2' HG23 ' A' ' 87' ' ' VAL . 1.9 m-85 -90.54 108.47 19.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.379 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HD2' ' CG ' ' A' ' 62' ' ' LEU . 12.4 mtm180 -89.51 99.58 12.55 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.694 HG12 ' HB3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -114.71 133.03 22.62 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -170.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.7 Cg_exo -58.55 133.62 55.64 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.018 2.479 . . . . 0.0 110.421 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.8 -32.25 67.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.01 -31.41 79.39 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.712 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.59 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.1 mmm -78.29 -15.86 58.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.61 ' HA ' HG21 ' A' ' 34' ' ' ILE . 37.8 t -72.59 -39.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.51 -27.9 70.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.534 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.79 -29.98 23.38 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.61 HG21 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -72.68 -26.25 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.494 0.664 . . . . 0.0 110.067 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.744 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 20.3 pt -83.2 -13.91 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.829 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.4 -100.54 0.31 Allowed Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.578 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HD3' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -60.28 -14.84 20.18 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.748 0.419 . . . . 0.0 111.503 178.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.39 27.84 1.57 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.451 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.744 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.61 -51.61 0.6 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.995 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.5 ' N ' ' HD3' ' A' ' 37' ' ' ARG . 15.1 tt0 -62.03 -51.71 66.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.122 0.419 . . . . 0.0 111.083 -173.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.57 HD11 HG13 ' A' ' 53' ' ' VAL . 8.1 tp -62.27 -40.92 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -52.35 -52.52 52.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 123.628 0.58 . . . . 0.0 110.05 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -56.89 -50.76 71.53 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.5 mm -60.56 -50.8 78.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -39.7 73.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.298 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -75.96 -34.12 59.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.25 -44.75 95.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.1 p -80.31 -36.75 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.161 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.92 5.03 31.29 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.499 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 49.7 t -79.9 141.59 35.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.392 0.615 . . . . 0.0 110.378 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -96.54 74.27 2.79 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.613 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.57 HG13 HD11 ' A' ' 42' ' ' ILE . 41.7 t -82.22 107.85 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.177 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -103.92 111.12 23.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.759 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.458 HD13 HG13 ' A' ' 67' ' ' VAL . 28.7 mm -79.21 90.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.961 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 66' ' ' SER . 57.7 m -79.78 116.25 59.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 95.1 Cg_endo -84.89 1.8 8.33 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.0 2.467 . . . . 0.0 110.934 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.49 ' C ' ' HG ' ' A' ' 59' ' ' SER . 15.4 t70 -78.32 -33.36 49.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.515 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.49 ' HG ' ' C ' ' A' ' 58' ' ' ASP . 58.5 p 55.05 -78.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 113.035 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.43 -104.97 2.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.015 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 3.38 86.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.612 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 25' ' ' ARG . 2.9 mm? -110.08 141.67 24.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.0 0.67 6.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.987 2.458 . . . . 0.0 110.577 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -113.54 -170.27 1.66 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.552 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.694 ' HB3' HG12 ' A' ' 26' ' ' VAL . 7.4 tpp180 -85.58 133.67 34.05 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 56' ' ' SER . 52.9 p -108.31 99.62 9.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 0.0 109.896 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.458 HG13 HD13 ' A' ' 55' ' ' ILE . 57.9 t -101.03 110.36 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -85.73 130.12 34.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.406 0.622 . . . . 0.0 110.956 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.583 HD22 ' HG ' ' A' ' 83' ' ' LEU . 4.4 mm? -105.58 111.3 23.94 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.457 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.41 127.53 11.23 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . -155.12 -89.92 0.07 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.653 -1.26 . . . . 0.0 113.583 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -160.96 165.86 16.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 89.9 Cg_exo -44.9 -53.22 5.4 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.521 2.147 . . . . 0.0 112.969 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.56 -40.13 23.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 110.907 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.1 m -65.59 -44.05 87.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.65 -172.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.548 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.6 p -71.64 -30.48 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.037 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.8 tt0 -70.95 -43.62 67.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -52.35 65.79 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.357 0.598 . . . . 0.0 110.102 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.22 74.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.29 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 43.9 mtmt -69.47 -20.9 63.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.605 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.4 mmt -62.73 -42.1 99.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.115 172.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.9 mmt -67.01 -43.11 83.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.99 0.424 . . . . 0.0 111.046 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.583 ' HG ' HD22 ' A' ' 69' ' ' LEU . 4.1 mm? -64.29 -53.15 53.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.966 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.66 -33.66 66.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.47 . . . . 0.0 110.435 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.6 -60.98 2.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.082 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.694 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.3 mp -75.93 -37.09 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.921 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.562 HG23 ' HD2' ' A' ' 24' ' ' TYR . 77.5 t -66.09 -32.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.943 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.694 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.7 ptm180 -75.09 -12.94 60.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.752 0.31 . . . . 0.0 111.129 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.59 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -108.97 -62.15 0.54 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.155 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 91' ' ' ARG . 5.1 tmm_? . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.597 0.237 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.56 134.22 56.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.594 0.712 . . . . 0.0 112.508 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' MET . 75.1 mt -120.09 145.55 46.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.923 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.47 66.8 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.361 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.04 -49.72 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.829 2.353 . . . . 0.0 112.101 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.459 HD11 HG23 ' A' ' 18' ' ' THR . 18.7 pt -117.98 163.74 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.649 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 92.0 m-70 -91.25 -29.57 0.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 38.8 Cg_exo -41.27 167.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.168 2.579 . . . . 0.0 114.904 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 17' ' ' ARG . 68.0 Cg_exo -42.3 156.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.62 2.88 . . . . 0.0 113.758 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 28.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 124.031 3.154 . . . . 0.0 114.563 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.49 -11.08 43.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.083 0.468 . . . . 0.0 110.01 173.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.459 HG23 HD11 ' A' ' 12' ' ' ILE . 6.2 t -163.88 8.18 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.865 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 41.0 t -92.9 -94.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.339 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.7 ptp -70.63 85.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 0.0 110.537 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.7 m -94.24 114.81 26.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.196 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.7 tp10 -95.45 118.38 32.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -96.46 100.68 12.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.515 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -94.07 116.92 29.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.141 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.412 ' O ' ' HD3' ' A' ' 91' ' ' ARG . 31.5 mtm180 -84.39 113.68 21.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.31 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 87' ' ' VAL . 2.2 p -117.71 131.55 24.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 111.048 -176.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG21 ' A' ' 31' ' ' VAL . 26.9 Cg_exo -58.74 139.28 90.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.168 2.579 . . . . 0.0 110.764 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 2.7 p-10 -59.18 -32.17 69.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.136 -172.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -39.55 87.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.246 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.462 ' HE3' ' CA ' ' A' ' 90' ' ' GLY . 1.5 mpp? -79.5 -7.2 58.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.192 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 35' ' ' ILE . 75.6 t -70.69 -43.18 77.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.99 -31.38 72.32 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.57 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.0 mt -83.41 -32.11 26.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.688 HG23 HH22 ' A' ' 65' ' ' ARG . 10.2 tp -70.8 -28.36 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.619 0.723 . . . . 0.0 109.921 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.675 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 14.2 pt -85.4 -13.26 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.59 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 57.46 -87.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 113.493 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.75 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 2.5 ptm85 -77.26 42.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.074 0.55 . . . . 0.0 110.784 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 66.43 19.76 69.0 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.03 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.675 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.75 -51.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.311 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.75 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 32.0 tt0 -60.42 -21.39 62.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.479 ' O ' HD12 ' A' ' 45' ' ' ILE . 29.0 tt0 -63.56 -38.9 92.88 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.341 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.542 HD13 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -66.03 -36.94 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 1.3 m-20 -59.39 -43.2 92.99 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -59.54 -57.13 14.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.548 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -58.81 -53.01 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.484 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -29.72 61.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.252 -172.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.764 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -77.79 -39.92 42.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 178.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -66.08 -32.46 73.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.488 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 29.8 p -91.29 -36.01 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.738 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.38 7.25 57.16 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.59 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 49.1 t -78.99 142.75 36.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.624 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -83.6 72.62 10.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.542 HG11 HD13 ' A' ' 42' ' ' ILE . 49.1 t -86.04 107.47 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.054 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 6.8 tp60 -98.84 122.66 42.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.5 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.7 mm -100.54 117.14 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.954 0.406 . . . . 0.0 111.666 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.419 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 44.9 m -112.7 93.97 26.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.644 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 76.6 Cg_exo -51.89 -55.92 3.45 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.434 3.422 . . . . 0.0 114.342 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.3 -2.02 58.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.646 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 p 49.93 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.55 1.14 . . . . 0.0 113.035 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.52 -65.85 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.74 2.44 87.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.206 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 66' ' ' SER . 58.2 mt -126.02 151.73 72.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.22 -14.11 8.5 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 110.104 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 7.1 pt-20 -105.27 -164.75 1.06 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.305 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.688 HH22 HG23 ' A' ' 34' ' ' ILE . 6.3 tmm_? -101.1 137.92 38.83 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.723 ' HB3' HD13 ' A' ' 62' ' ' LEU . 77.9 p -105.24 142.6 34.74 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.944 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.0 t -130.31 111.96 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.426 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.7 m -81.15 121.45 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.311 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.999 HD11 ' HG2' ' A' ' 80' ' ' LYS . 96.6 mt -109.72 108.45 18.83 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.14 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 149.79 30.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.65 -95.98 0.11 Allowed Glycine 0 C--O 1.226 -0.362 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.809 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.415 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . . . -147.66 163.7 26.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 72' ' ' ALA . 83.6 Cg_exo -45.44 -55.26 3.64 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.003 2.469 . . . . 0.0 113.432 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.34 -32.81 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 110.912 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.0 m -67.6 -48.06 67.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.899 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 1.4 p -71.84 -24.32 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.765 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -71.88 -43.34 65.6 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.253 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 81' ' ' MET . 20.9 tptm -66.02 -45.59 80.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.457 0.646 . . . . 0.0 110.128 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.411 ' O ' HD22 ' A' ' 83' ' ' LEU . . . -54.99 -49.33 71.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.072 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.999 ' HG2' HD11 ' A' ' 69' ' ' LEU . 43.1 mtmt -71.79 -22.75 61.53 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.755 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.646 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 21.9 ptm -69.32 -38.05 78.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.783 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.47 ' HG3' ' CG1' ' A' ' 45' ' ' ILE . 20.9 mmt -75.11 -39.28 60.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.731 ' HG ' HD12 ' A' ' 69' ' ' LEU . 3.3 mm? -61.78 -59.57 4.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.56 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.58 -34.11 66.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.736 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 24.6 t70 -69.45 -61.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.857 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.72 -40.27 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 111.282 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.489 HG23 HG22 ' A' ' 26' ' ' VAL . 58.3 t -70.92 -21.97 22.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.592 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -72.56 -30.25 64.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 15.1 mmm-85 -67.99 -29.94 69.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.12 0.486 . . . . 0.0 110.0 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.462 ' CA ' ' HE3' ' A' ' 30' ' ' MET . . . -96.21 -41.63 3.68 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.973 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 4.5 ptm180 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 122.557 -0.378 . . . . 0.0 110.755 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.358 0.123 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.458 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 19.1 mm-40 57.78 -161.8 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.955 0.502 . . . . 0.0 111.721 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 2.6 tt 171.66 -72.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 111.24 114.32 3.46 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.615 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.44 -5.08 14.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.746 2.297 . . . . 0.0 112.179 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.559 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.8 mt -98.62 121.28 49.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.691 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 m80 -82.55 -26.59 0.41 Allowed Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.3 Cg_exo -31.45 130.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 123.583 2.855 . . . . 0.0 114.07 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.5 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.8 Cg_exo -33.89 127.08 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 125.079 3.853 . . . . 0.0 112.456 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 10.0 Cg_exo -19.62 53.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.571 5.514 . . . . 0.0 117.572 -157.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 76.4 mtp180 -99.06 -4.48 32.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.551 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -178.62 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.41 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -79.15 -23.25 44.08 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.598 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.49 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.6 mtt -117.68 52.69 0.97 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -79.11 112.28 16.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.5 tp10 -111.27 118.95 37.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.458 ' HB2' ' CG ' ' A' ' 8' ' ' GLN . 36.7 tp10 -98.38 103.53 15.49 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.83 128.0 37.5 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.043 -169.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' A' ' 62' ' ' LEU . 19.9 mtp180 -87.4 110.14 20.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.997 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.744 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -125.56 127.95 24.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -177.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.752 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 31.9 Cg_exo -57.73 147.89 77.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.621 2.214 . . . . 0.0 111.963 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.658 ' O ' HG11 ' A' ' 31' ' ' VAL . 20.0 t70 -53.21 -51.07 63.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.81 76.25 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.193 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.785 ' HE3' ' HA3' ' A' ' 90' ' ' GLY . 9.5 tpp -79.53 -28.53 41.31 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.699 -0.295 . . . . 0.0 110.373 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.658 HG11 ' O ' ' A' ' 28' ' ' ASP . 13.3 p -74.74 -30.09 24.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.59 67.32 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.795 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.542 HD13 ' SD ' ' A' ' 30' ' ' MET . 95.7 mt -87.55 -25.59 23.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.627 HG21 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -68.7 -31.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.435 0.636 . . . . 0.0 109.541 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.603 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.1 pt -82.73 -14.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 173.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 57.37 -88.28 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 124.213 0.945 . . . . 0.0 112.968 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.482 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 8.0 ptp180 -77.7 38.93 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.216 0.606 . . . . 0.0 111.561 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 76.96 3.27 80.51 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.978 -0.556 . . . . 0.0 114.324 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.603 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 160.33 -50.53 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.158 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 12.6 tp10 -54.08 -25.01 19.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.49 -46.95 77.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.719 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.703 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 10.6 tp -65.94 -38.78 82.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -53.53 -42.88 67.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.33 -48.46 72.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.876 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 41' ' ' GLN . 95.4 mt -58.91 -57.97 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.703 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 7.9 pt20 -73.24 -20.97 60.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.523 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.835 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -78.36 -38.7 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.434 0.635 . . . . 0.0 110.022 172.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -63.18 -39.59 95.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.811 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.415 ' CB ' ' HB3' ' A' ' 78' ' ' LYS . 23.3 p -80.36 -46.78 15.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.349 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.9 56.2 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 54.1 t -82.44 143.15 31.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.17 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 33.4 mtmt -80.47 76.78 7.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 42' ' ' ILE . 79.9 t -82.74 110.41 17.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.776 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -109.67 115.93 30.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.508 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 67' ' ' VAL . 33.3 mm -89.24 106.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.333 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.6 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 46.8 m -87.24 107.46 14.83 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.809 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.0 Cg_exo -75.26 -38.28 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.818 3.012 . . . . 0.0 113.289 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.6 116.09 19.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.033 0.444 . . . . 0.0 110.259 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 16.4 p -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.713 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 -85.22 1.84 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.096 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.27 -13.35 83.4 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 59' ' ' SER . 6.3 mp -112.59 149.73 41.59 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.406 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -87.69 3.39 6.3 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.702 2.268 . . . . 0.0 110.252 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 3.4 pt-20 -125.96 -173.59 2.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.564 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.809 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 8.1 tpp85 -83.83 145.22 28.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.6 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 54.6 p -121.5 122.31 39.44 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.096 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.579 HG12 HD13 ' A' ' 55' ' ' ILE . 69.1 t -116.22 131.44 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -94.15 125.41 38.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.045 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.794 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 mm? -108.34 104.45 13.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.238 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.6 m -152.28 130.81 12.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -162.57 -82.25 0.04 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.926 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.65 168.33 12.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.57 ' N ' ' HG2' ' A' ' 16' ' ' PRO . 97.4 Cg_exo -45.43 -57.74 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.864 2.376 . . . . 0.0 113.675 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -76.66 -35.64 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.495 0.664 . . . . 0.0 110.067 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 49' ' ' SER . 33.7 m -68.63 -42.37 78.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.981 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.15 -31.77 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.848 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -74.11 -37.72 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 81' ' ' MET . 22.9 tptp -70.8 -36.24 72.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 110.413 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 51' ' ' CYS . . . -63.76 -40.81 97.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.638 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.3 mtmt -81.92 -20.55 38.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.246 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 14.3 tpt -58.7 -55.71 31.57 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.751 175.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mmm -69.74 -38.42 76.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.979 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' HG22 ' A' ' 87' ' ' VAL . 1.3 mm? -56.69 -58.09 9.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.336 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.04 -41.88 65.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.105 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 37.7 t70 -55.37 -59.2 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.41 ' HB ' HD12 ' A' ' 34' ' ' ILE . 2.4 mp -72.17 -37.15 58.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.1 0.476 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 83' ' ' LEU . 94.9 t -65.11 -31.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.2 m -71.87 -29.8 64.75 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.678 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 24.4 mmm180 -56.53 -49.38 74.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.966 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.785 ' HA3' ' HE3' ' A' ' 30' ' ' MET . . . -99.94 -53.02 1.13 Allowed Glycine 0 C--O 1.228 -0.248 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.551 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.752 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 7.4 tpt85 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.152 0.501 . . . . 0.0 110.106 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -145.5 167.34 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.391 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.612 HD13 ' HD3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -155.66 135.68 12.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.993 178.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.71 81.46 0.21 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.593 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.612 ' HD3' HD13 ' A' ' 9' ' ' LEU . 67.3 Cg_endo -75.81 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.454 2.103 . . . . 0.0 112.363 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.779 HD11 HG23 ' A' ' 18' ' ' THR . 27.4 pt -131.14 161.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.537 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.577 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.2 m80 -90.52 -26.81 0.3 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 66.2 Cg_exo -39.37 168.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.23 2.62 . . . . 0.0 114.923 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 14' ' ' PRO . 1.3 Cg_endo -42.56 153.65 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.139 3.226 . . . . 0.0 113.941 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 60.4 Cg_endo -69.51 27.95 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 124.092 3.195 . . . . 0.0 113.765 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HG3' HG21 ' A' ' 18' ' ' THR . 10.7 ptp180 -81.08 -20.82 40.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.401 0.619 . . . . 0.0 109.649 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.779 HG23 HD11 ' A' ' 12' ' ' ILE . 5.2 t -160.92 18.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.027 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 t -99.5 -98.85 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.7 ptp -64.83 88.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.641 0.734 . . . . 0.0 110.653 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.48 HG21 ' OG1' ' A' ' 70' ' ' THR . 29.2 m -92.66 113.46 25.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.808 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' CD ' ' HD2' ' A' ' 80' ' ' LYS . 19.2 tt0 -96.06 118.08 31.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -96.37 102.88 14.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.405 ' CE1' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -92.01 124.46 36.13 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.482 -169.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HB3' ' OE2' ' A' ' 64' ' ' GLU . 50.9 mtp180 -81.01 118.93 22.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.679 174.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -137.31 123.77 13.46 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 30' ' ' MET . 20.5 Cg_endo -61.97 141.67 90.16 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.577 2.185 . . . . 0.0 110.632 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HA ' HG12 ' A' ' 31' ' ' VAL . 30.5 t70 -59.05 -30.56 68.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.975 -167.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.94 -36.97 87.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.286 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.646 ' HE2' HG21 ' A' ' 86' ' ' ILE . 87.8 mmm -78.5 -27.91 46.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.66 -0.318 . . . . 0.0 111.002 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 34' ' ' ILE . 11.4 p -70.98 -28.63 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.411 174.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.81 71.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.038 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.17 -28.63 23.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 31' ' ' VAL . 11.0 tp -68.39 -29.95 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.862 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.649 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.7 pt -83.64 -14.04 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.201 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.66 -93.07 0.03 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 123.921 0.763 . . . . 0.0 113.496 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.437 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 12.8 ptp180 -64.15 -1.18 1.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.55 0.74 . . . . 0.0 112.493 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.59 11.1 18.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.276 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.649 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.9 -44.57 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.884 174.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.437 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 22.8 tt0 -55.72 -32.31 63.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -61.35 -47.83 84.08 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.436 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 53' ' ' VAL . 8.5 tp -61.59 -42.59 94.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.14 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.87 -38.91 83.51 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.77 -49.07 78.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.12 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.88 HD11 ' HG3' ' A' ' 82' ' ' MET . 72.1 mt -63.64 -52.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.708 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -72.59 -43.9 62.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.209 -172.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 47' ' ' GLN . 6.3 tp60 -73.8 -26.02 60.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 110.818 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.21 -53.92 7.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.324 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.685 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 41.8 p -64.5 -40.83 96.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.14 7.72 20.84 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.242 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.635 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 38.6 t -92.81 135.19 34.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.771 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -83.22 88.1 6.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.648 HG12 HD11 ' A' ' 42' ' ' ILE . 58.4 t -95.34 111.14 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -111.1 116.04 30.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.44 HD12 HG11 ' A' ' 67' ' ' VAL . 33.1 mm -80.69 100.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.7 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.607 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 17.7 m -85.53 114.45 56.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.57 -27.02 4.39 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.383 2.722 . . . . 0.0 112.698 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.28 -23.87 30.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.616 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.495 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 74.7 p 53.64 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.841 1.257 . . . . 0.0 113.187 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.93 -100.33 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.51 18.29 50.21 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.066 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.59 136.98 25.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.28 -8.69 11.71 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.905 2.403 . . . . 0.0 110.55 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.565 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 4.9 pt-20 -104.09 -162.01 0.87 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.784 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.68 ' HB3' HG11 ' A' ' 26' ' ' VAL . 2.2 tpp180 -95.81 148.26 22.78 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.607 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 65.4 p -122.38 125.2 45.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.44 HG11 HD12 ' A' ' 55' ' ' ILE . 64.4 t -111.26 112.14 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.733 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -80.28 126.41 31.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.275 0.559 . . . . 0.0 110.817 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 1.036 HD13 ' HG2' ' A' ' 80' ' ' LYS . 16.0 mt -118.14 110.91 18.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.48 ' OG1' HG21 ' A' ' 21' ' ' THR . 2.6 m -151.22 121.79 7.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.791 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.635 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.57 -90.47 0.08 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.937 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.78 167.09 14.72 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.762 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 73.5 Cg_exo -39.89 -59.48 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.356 2.704 . . . . 0.0 114.276 -176.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -82.65 -37.58 24.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.423 0.63 . . . . 0.0 110.15 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.685 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.3 m -61.51 -46.32 90.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.399 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.586 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.8 p -72.33 -32.27 41.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.54 -38.72 74.23 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.677 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -63.12 -46.96 84.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.493 0.663 . . . . 0.0 110.317 177.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.07 75.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.856 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 1.036 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.3 mtmt -74.92 -21.41 59.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.078 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.677 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 19.0 ptm -69.08 -37.35 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.667 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.88 ' HG3' HD11 ' A' ' 45' ' ' ILE . 89.8 mmm -67.89 -43.12 80.06 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.627 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.9 mm? -59.38 -56.89 16.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.69 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.54 -39.48 57.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.27 -57.58 12.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.561 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.717 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.4 mp -73.04 -40.58 58.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.519 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.405 HG12 ' CE1' ' A' ' 24' ' ' TYR . 81.7 t -61.43 -40.84 87.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.642 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -68.36 -36.41 79.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.453 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.717 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.2 ptm180 -79.89 -7.68 58.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.793 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -131.43 9.63 5.58 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.477 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.52 -179.032 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 8.6 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.752 0.31 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -67.67 109.43 3.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.664 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 53.0 mt -92.42 104.34 16.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.392 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -115.16 58.51 0.44 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.102 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.725 ' HD2' HD13 ' A' ' 12' ' ' ILE . 2.6 Cg_endo -82.28 -43.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.639 2.226 . . . . 0.0 112.12 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.8 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -87.72 138.49 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.298 0.571 . . . . 0.0 110.607 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 52.2 t-80 -78.31 -29.84 0.67 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 95.5 Cg_exo -35.9 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.751 2.967 . . . . 0.0 115.292 173.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.69 160.71 3.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.094 2.529 . . . . 0.0 111.58 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 38.5 Cg_endo -63.79 3.91 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.135 2.557 . . . . 0.0 114.021 -172.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HD3' ' HG2' ' A' ' 15' ' ' PRO . 2.7 ptt180 -58.31 -29.58 66.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.071 0.462 . . . . 0.0 110.319 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -148.14 3.88 0.71 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.228 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.624 ' HA ' HG12 ' A' ' 12' ' ' ILE . 35.9 t -84.52 -96.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.344 -175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.0 ptp -68.09 80.05 0.23 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.593 0.711 . . . . 0.0 111.277 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -79.49 116.17 19.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -91.8 117.87 30.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 43.0 tt0 -87.62 103.86 15.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.512 ' HD2' HG22 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -91.22 110.45 21.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.686 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.437 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 64.1 mtp180 -80.26 103.53 10.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.959 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.579 HG23 HG21 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.36 127.52 25.83 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.366 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 52.5 Cg_exo -56.59 139.17 87.29 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.864 2.376 . . . . 0.0 111.831 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.85 -55.56 6.5 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -24.09 72.92 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.557 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.63 ' HE1' ' HA3' ' A' ' 90' ' ' GLY . 27.8 tpp -78.81 -18.73 53.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.613 ' HA ' HG21 ' A' ' 34' ' ' ILE . 2.1 t -73.02 -33.13 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.87 -30.07 56.19 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.913 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -88.03 -23.23 23.83 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.613 HG21 ' HA ' ' A' ' 31' ' ' VAL . 6.8 tp -71.56 -28.32 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.992 0.814 . . . . 0.0 109.663 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.666 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.0 pt -85.59 -15.3 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.324 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 58.31 -89.24 0.02 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 124.086 0.866 . . . . 0.0 113.701 173.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.601 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 13.2 ptp180 -71.96 11.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.07 0.548 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 100.87 14.71 30.81 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.098 175.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.666 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.5 -46.39 0.78 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.412 173.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.601 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 9.4 tp10 -62.31 -22.22 65.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.521 ' O ' HG12 ' A' ' 45' ' ' ILE . 20.5 tt0 -64.63 -48.13 76.01 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.108 -0.37 . . . . 0.0 111.318 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 39' ' ' GLY . 7.1 tp -61.54 -42.44 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.46 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.3 m-20 -52.59 -52.54 54.74 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 123.66 0.6 . . . . 0.0 109.463 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -56.88 -48.8 77.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.104 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 41' ' ' GLN . 25.1 mm -62.27 -49.37 84.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.156 -175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -79.33 -28.2 42.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.365 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -71.13 -42.09 69.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.79 -47.72 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.485 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.559 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 14.5 p -80.52 -38.29 30.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.896 -175.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.02 9.38 42.6 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.607 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 52.3 t -78.72 139.7 38.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.34 0.59 . . . . 0.0 111.352 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -88.2 79.94 7.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.891 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG21 ' CD2' ' A' ' 69' ' ' LEU . 7.6 p -82.04 131.13 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.4 mm-40 -114.51 107.56 15.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.734 0.778 . . . . 0.0 110.703 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 ' NH1' ' A' ' 65' ' ' ARG . 18.5 mm -80.83 106.14 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.567 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.8 m -109.91 100.17 41.97 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.496 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -86.77 24.64 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.478 2.785 . . . . 0.0 111.05 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.43 -31.04 47.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.094 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 p 45.52 64.9 1.26 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.521 0.677 . . . . 0.0 111.075 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.16 116.24 4.9 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.948 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.83 -47.54 3.33 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -172.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 2.6 mp -88.39 128.01 54.71 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.62 -13.35 10.8 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 121.96 1.773 . . . . 0.0 111.117 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -99.34 -155.62 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.715 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.604 ' NH1' HG23 ' A' ' 55' ' ' ILE . 5.5 mmm-85 -89.76 138.37 31.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.627 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 p -110.1 129.17 55.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.131 0.491 . . . . 0.0 110.286 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.432 HG22 ' NH2' ' A' ' 65' ' ' ARG . 87.7 t -119.22 116.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.138 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 74.2 m -93.67 135.21 35.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.132 0.492 . . . . 0.0 110.597 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.732 HD12 ' HG ' ' A' ' 83' ' ' LEU . 74.2 mt -118.86 127.97 54.0 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.792 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -150.73 157.54 43.07 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.266 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 148.69 -152.73 24.73 Favored Glycine 0 C--O 1.217 -0.911 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.179 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.87 152.42 80.03 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.06 -46.36 19.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.675 2.25 . . . . 0.0 112.717 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.63 -32.29 60.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.972 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -71.15 -49.74 40.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.531 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 9.2 p -67.02 -27.08 38.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.506 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 81' ' ' MET . 28.8 tt0 -72.54 -41.96 65.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.43 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -64.82 -40.2 94.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.083 0.468 . . . . 0.0 110.419 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.33 88.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.92 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.637 ' HG2' HD11 ' A' ' 69' ' ' LEU . 55.6 mtmt -64.79 -23.33 67.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.642 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.6 mmm -60.44 -52.46 65.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.929 ' HA ' ' HE2' ' A' ' 82' ' ' MET . 10.1 mmt -70.84 -36.2 72.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.978 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.732 ' HG ' HD12 ' A' ' 69' ' ' LEU . 1.1 mm? -60.87 -60.48 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.29 -29.28 70.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 110.662 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.69 -60.26 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.26 0.553 . . . . 0.0 110.649 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.02 -37.0 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.07 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.512 HG22 ' HD2' ' A' ' 24' ' ' TYR . 65.6 t -62.53 -32.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.718 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -71.46 -39.99 70.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.253 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.9 ptp180 -72.97 -18.6 61.35 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.605 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.63 ' HA3' ' HE1' ' A' ' 30' ' ' MET . . . -103.93 -65.07 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.649 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.475 0.655 . . . . 0.0 110.298 -178.008 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.62 ' HB3' ' OE1' ' A' ' 22' ' ' GLU . 39.7 m . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.782 ' HB3' ' O ' ' A' ' 21' ' ' THR . 36.7 tt0 -175.4 -143.41 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.727 0.694 . . . . 0.0 110.074 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.641 ' HG ' ' H ' ' A' ' 10' ' ' GLY . 2.0 pt? -167.09 -61.15 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -175.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.641 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . 119.74 149.2 8.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.454 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 10' ' ' GLY . 6.2 Cg_exo -80.08 -52.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.146 2.564 . . . . 0.0 113.329 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.662 HG21 ' HD2' ' A' ' 14' ' ' PRO . 2.1 mt -93.47 128.59 44.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.682 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 45.5 m80 -92.61 3.57 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -168.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.752 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 19.0 Cg_endo -57.99 -162.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.559 2.173 . . . . 0.0 112.81 169.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.752 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 28.2 Cg_exo -38.59 155.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.874 2.383 . . . . 0.0 113.594 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 34.6 Cg_endo -64.68 23.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.231 3.287 . . . . 0.0 115.162 -171.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 15' ' ' PRO . 25.9 ptt180 -78.94 2.13 21.31 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.513 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -179.13 2.27 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.688 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.2 p -97.59 -8.87 28.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.403 ' HG2' ' HB3' ' A' ' 16' ' ' PRO . 15.8 ptp -146.43 52.9 1.12 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.871 0.844 . . . . 0.0 109.452 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.782 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 94.6 m -78.25 116.77 18.93 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.788 177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.62 ' OE1' ' HB3' ' A' ' 7' ' ' SER . 2.8 tp10 -101.78 125.16 48.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.343 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -98.57 104.38 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.473 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.13 116.79 29.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.635 -169.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.64 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 23.9 mtp180 -81.78 109.52 16.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.874 HG11 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -125.05 125.09 25.36 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 110.808 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.4 136.31 73.13 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.784 2.322 . . . . 0.0 110.885 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.413 ' HA ' HG22 ' A' ' 31' ' ' VAL . 28.1 t70 -58.61 -33.87 70.51 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.561 -168.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.42 -34.64 90.45 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.65 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.603 ' HE3' HG22 ' A' ' 86' ' ' ILE . 92.1 mmm -78.65 -9.92 59.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.707 ' HA ' HG23 ' A' ' 34' ' ' ILE . 44.2 t -75.83 -40.46 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.96 -30.41 69.9 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.284 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.16 -28.97 25.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.707 HG23 ' HA ' ' A' ' 31' ' ' VAL . 9.3 tp -71.82 -28.94 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.413 0.625 . . . . 0.0 110.114 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.634 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.5 pt -80.46 -13.74 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.677 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 60.39 -91.82 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.954 0.783 . . . . 0.0 113.302 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.537 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.2 ptm85 -77.5 37.89 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.503 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 72.13 19.75 78.68 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.683 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.634 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.04 -49.33 0.6 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.92 173.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.537 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 28.2 tt0 -58.71 -28.7 66.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -169.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -56.42 22.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.818 0.281 . . . . 0.0 111.166 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.556 HD12 HG13 ' A' ' 53' ' ' VAL . 6.1 tp -57.29 -49.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.826 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.21 -38.88 88.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.036 0.446 . . . . 0.0 110.637 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -60.17 -44.29 95.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.71 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.531 HG12 ' HE3' ' A' ' 82' ' ' MET . 1.7 mp -81.06 -41.85 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.856 -176.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -69.96 -37.38 75.8 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.07 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -71.36 -38.03 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.44 -51.77 66.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.072 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.776 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 32.9 p -70.56 -37.63 74.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.48 12.05 22.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.955 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 35.4 t -84.99 150.03 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.867 0.365 . . . . 0.0 110.149 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -104.99 82.66 1.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.526 0.679 . . . . 0.0 109.693 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 42' ' ' ILE . 40.8 t -93.02 113.59 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.165 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.435 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 14.3 mm-40 -107.29 129.7 54.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.783 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 67' ' ' VAL . 30.1 mm -102.42 89.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.445 -174.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 35.0 t -79.95 114.6 47.69 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.698 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 5.5 Cg_exo -78.88 -32.54 1.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.588 2.859 . . . . 0.0 112.393 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.31 -34.62 42.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.547 ' HG ' ' HB3' ' A' ' 66' ' ' SER . 40.4 t 71.02 -65.52 0.34 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.183 176.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.43 -55.92 0.59 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.098 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.75 -10.12 10.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.64 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.8 mt -112.91 144.59 31.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.798 0.332 . . . . 0.0 110.5 -173.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.42 -16.64 8.05 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.83 2.353 . . . . 0.0 110.336 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.51 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 4.3 pt-20 -92.98 -168.74 2.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.11 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.874 ' HB3' HG11 ' A' ' 26' ' ' VAL . 5.5 tpp180 -89.44 140.57 29.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.547 ' HB3' ' HG ' ' A' ' 59' ' ' SER . 67.7 p -114.56 105.17 12.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.546 0.689 . . . . 0.0 109.345 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.472 HG11 HD13 ' A' ' 55' ' ' ILE . 95.3 t -98.13 121.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.8 m -89.67 128.16 36.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.412 0.625 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.701 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -106.56 112.33 25.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.9 m -151.32 143.69 24.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.988 -0.096 . . . . 0.0 110.805 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.54 -154.9 25.06 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.402 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.45 ' HB2' ' OG ' ' A' ' 75' ' ' SER . . . -78.92 160.89 70.57 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -47.52 -53.07 6.99 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.796 2.33 . . . . 0.0 113.479 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -72.98 -40.33 65.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.975 0.417 . . . . 0.0 110.336 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.776 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.2 m -60.02 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.436 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.537 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 3.6 p -70.65 -30.01 40.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.01 -37.88 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 109.925 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.725 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.95 -47.06 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 177.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.11 -48.68 79.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.456 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.701 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 46.1 mtmt -68.52 -22.19 64.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.48 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.725 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 17.9 ptm -70.41 -36.47 74.05 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.497 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.531 ' HE3' HG12 ' A' ' 45' ' ' ILE . 24.3 mmt -70.62 -39.98 73.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.135 0.493 . . . . 0.0 110.097 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.0 mm? -64.55 -56.57 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.137 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.54 -35.14 67.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 110.557 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.76 -55.89 25.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.515 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.647 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -75.57 -37.19 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.979 0.419 . . . . 0.0 111.425 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 24' ' ' TYR . 72.6 t -68.13 -33.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.875 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.6 t -70.76 -38.63 73.49 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.821 -0.549 . . . . 0.0 110.304 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.647 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -78.39 -13.43 59.85 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.524 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -120.82 -20.58 3.42 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.016 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 117.16 0.48 . . . . 0.0 110.524 -177.705 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.451 ' O ' HD21 ' A' ' 9' ' ' LEU . 49.2 m . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -64.45 112.98 3.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.776 0.322 . . . . 0.0 111.781 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 7' ' ' SER . 1.9 mm? -92.15 108.68 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 167.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 73.2 0.29 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.442 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 4.6 Cg_exo -74.99 -57.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.764 2.31 . . . . 0.0 111.874 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 pp -104.19 151.38 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.416 176.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.61 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 7.0 t-160 -90.6 -11.88 0.18 Allowed Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -170.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 72.7 Cg_exo -39.27 161.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.477 2.118 . . . . 0.0 114.337 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 17' ' ' ARG . 80.5 Cg_exo -42.49 148.47 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.703 2.935 . . . . 0.0 113.462 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.35 31.05 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.793 2.995 . . . . 0.0 113.905 -172.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -92.89 -0.36 57.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.874 0.369 . . . . 0.0 110.331 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.529 HG22 ' HD3' ' A' ' 17' ' ' ARG . 12.7 t -174.33 1.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.762 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 p -93.74 -85.09 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.1 ptm -72.56 71.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.596 0.712 . . . . 0.0 111.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.6 m -79.19 120.91 24.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.645 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.893 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 9.0 tp10 -92.58 118.88 31.47 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.82 106.19 18.42 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.551 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -92.26 118.61 31.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.944 -172.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 95.6 mtt180 -81.98 95.46 7.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.254 174.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -114.73 121.02 36.41 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.028 -176.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 51.5 Cg_exo -54.93 154.93 19.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.311 2.674 . . . . 0.0 112.442 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.71 -39.06 79.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.4 . . . . 0.0 111.236 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.23 64.11 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.876 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.473 ' HA ' ' HE3' ' A' ' 30' ' ' MET . 0.0 OUTLIER -78.0 -29.64 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.756 -0.261 . . . . 0.0 111.08 -177.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.699 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.8 p -73.25 -30.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.758 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 35' ' ' ILE . . . -67.66 -22.32 73.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.364 170.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.462 HD21 HG23 ' A' ' 86' ' ' ILE . 62.0 tp -89.05 -30.13 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.699 HG21 ' HA ' ' A' ' 31' ' ' VAL . 10.8 tp -72.47 -26.18 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.401 0.619 . . . . 0.0 109.906 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.589 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.3 pt -81.24 -14.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -92.06 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 O-C-N 124.045 0.841 . . . . 0.0 113.281 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 11.1 ptp180 -71.13 3.78 3.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.016 0.526 . . . . 0.0 111.835 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.5 25.72 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.107 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.41 -50.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.45 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 28.9 tt0 -50.65 -36.16 34.19 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' O ' HG12 ' A' ' 45' ' ' ILE . 15.1 tt0 -59.81 -55.33 35.56 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.538 HD13 HG11 ' A' ' 53' ' ' VAL . 5.1 tp -58.55 -46.64 89.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.53 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -56.42 -43.66 79.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 123.453 0.471 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.4 -43.25 95.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.646 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 41' ' ' GLN . 24.0 mm -65.19 -50.89 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.769 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -70.54 -27.77 64.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.987 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -72.45 -44.78 61.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.0 -50.02 73.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.436 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.6 p -67.7 -45.31 75.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.319 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.67 10.98 27.79 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.67 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.42 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 53.9 t -94.17 138.64 31.98 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.094 0.473 . . . . 0.0 110.094 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -85.95 79.94 9.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.616 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 42' ' ' ILE . 43.9 t -89.07 107.42 17.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.212 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HB3' ' OG ' ' A' ' 68' ' ' SER . 12.1 tp60 -99.06 116.26 30.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -175.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 42' ' ' ILE . 44.5 mm -83.53 89.96 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.111 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 41.1 m -85.49 114.82 58.61 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 121.164 0.507 . . . . 0.0 111.036 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.504 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 12.1 Cg_exo -69.61 -36.6 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.324 2.683 . . . . 0.0 111.485 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.11 89.57 5.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.63 ' HA ' ' HG ' ' A' ' 66' ' ' SER . 3.9 m -72.38 -19.31 61.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.155 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 -99.86 1.04 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.296 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.59 -26.87 66.51 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.263 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.56 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.3 mm? -87.25 139.95 32.26 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -85.05 0.71 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.766 2.311 . . . . 0.0 111.421 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -108.45 -110.57 0.31 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.8 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.578 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -133.92 149.57 51.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.63 ' HG ' ' HA ' ' A' ' 59' ' ' SER . 82.7 p -119.77 111.4 17.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.734 0.778 . . . . 0.0 110.35 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.56 132.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.01 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 p -99.38 130.06 45.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.369 0.604 . . . . 0.0 111.485 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.893 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 2.9 mm? -110.49 105.78 14.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.233 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 69' ' ' LEU . 6.5 m -150.97 128.01 11.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.939 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -166.81 -97.29 0.11 Allowed Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.924 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.54 163.68 43.61 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.25 -43.41 37.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.441 2.094 . . . . 0.0 112.593 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -79.44 -38.0 35.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.231 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -77.18 -41.76 40.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.087 0.47 . . . . 0.0 110.654 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -23.92 30.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.278 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.563 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.2 tp-100 -77.86 -45.6 23.81 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 81' ' ' MET . 4.9 tppp? -60.7 -45.83 92.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.026 0.441 . . . . 0.0 110.561 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.408 ' O ' HD21 ' A' ' 83' ' ' LEU . . . -55.8 -49.73 72.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.393 176.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.524 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.3 mtmt -69.54 -21.05 63.67 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.023 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.6 mmt -60.66 -50.18 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.172 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.903 ' HA ' ' HE1' ' A' ' 82' ' ' MET . 6.8 mmt -66.11 -39.5 89.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.067 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 79' ' ' ALA . 4.1 mm? -66.27 -54.19 27.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.54 -30.68 67.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.27 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 15.2 t70 -66.03 -61.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 33' ' ' LEU . 2.0 mp -68.66 -38.42 78.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.141 0.496 . . . . 0.0 111.295 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.551 HG21 ' HD2' ' A' ' 24' ' ' TYR . 76.9 t -66.62 -29.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -78.15 -22.68 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.345 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 26.7 mmm180 -66.87 -32.51 73.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.069 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.83 -64.38 0.82 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.754 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.101 0.477 . . . . 0.0 110.962 -178.248 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 10.5 t . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.656 ' HG3' ' H ' ' A' ' 9' ' ' LEU . 23.8 tp60 48.51 -156.47 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 111.667 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.656 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 4.2 pp 174.33 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.261 1.024 . . . . 0.0 108.301 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' N ' HD11 ' A' ' 9' ' ' LEU . . . 150.98 126.15 1.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.541 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.47 -13.75 22.63 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.542 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.919 HG12 ' HD2' ' A' ' 14' ' ' PRO . 13.1 tt -147.49 148.52 16.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.696 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.5 m-70 -90.38 -10.89 0.16 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.919 ' HD2' HG12 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -38.05 164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.802 2.334 . . . . 0.0 113.226 162.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -26.98 146.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 125.022 3.814 . . . . 0.0 115.871 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.96 12.9 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.033 3.155 . . . . 0.0 114.213 -171.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HD3' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER -77.52 2.83 15.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 109.474 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 17' ' ' ARG . 8.4 t -159.83 -25.21 0.07 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.651 172.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 15.6 t -79.85 6.36 11.28 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.156 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 mmt -144.52 37.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.1 m -85.9 112.16 20.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 7' ' ' SER . 9.7 tt0 -123.56 119.49 30.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.228 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.74 102.19 14.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.641 ' CD2' HG23 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -92.37 136.76 32.93 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.725 -170.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 25' ' ' ARG . 7.5 mtm180 -101.85 129.38 48.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.87 HG11 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -135.03 124.11 16.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.801 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 91' ' ' ARG . 51.2 Cg_exo -55.8 140.99 85.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 111.731 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.63 -47.03 29.25 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.68 -31.11 79.81 Favored Glycine 0 C--O 1.238 0.349 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.697 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.503 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 84.2 mmm -77.99 -15.05 59.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.617 ' O ' HG12 ' A' ' 35' ' ' ILE . 17.4 t -72.43 -40.11 63.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.94 -29.94 68.85 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.342 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.69 -24.66 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.615 HG21 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -74.48 -26.34 20.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.507 0.67 . . . . 0.0 109.544 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.703 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 16.4 pt -88.1 -15.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.062 171.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.89 0.02 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.105 0.878 . . . . 0.0 113.72 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.667 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 4.2 ptp180 -81.02 14.07 2.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.014 0.525 . . . . 0.0 111.166 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 16.02 28.15 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.331 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.703 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.48 -49.74 0.58 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.303 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.667 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.0 tt0 -51.4 -33.56 30.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -173.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' O ' HD11 ' A' ' 45' ' ' ILE . 21.2 tt0 -60.59 -50.78 72.16 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.652 -173.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.562 HD11 HG13 ' A' ' 53' ' ' VAL . 8.1 tp -63.7 -43.59 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.514 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -62.06 -36.36 81.41 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -65.01 -52.62 55.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.141 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.443 HG13 ' HE3' ' A' ' 82' ' ' MET . 1.4 mp -60.08 -48.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.029 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -73.5 -34.42 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.693 0.282 . . . . 0.0 111.167 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.87 -39.34 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.137 0.494 . . . . 0.0 110.51 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.68 -38.21 89.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.935 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.3 p -81.11 -43.97 18.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.36 8.64 28.68 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 41.5 t -90.0 132.68 35.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.979 0.418 . . . . 0.0 110.14 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -79.82 79.25 6.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.288 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.562 HG13 HD11 ' A' ' 42' ' ' ILE . 47.6 t -87.31 107.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.064 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 10.6 mm-40 -97.9 110.05 22.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.613 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.445 HD11 HG12 ' A' ' 42' ' ' ILE . 49.7 mm -80.2 112.91 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.26 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.9 m -104.15 99.39 16.86 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.609 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 40.0 Cg_endo -68.95 -30.49 26.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.863 2.375 . . . . 0.0 110.943 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.42 79.62 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -72.62 -36.78 68.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.283 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.78 -69.56 3.2 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.844 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.18 -4.38 90.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.203 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' ' 66' ' ' SER . 56.6 mt -126.63 144.34 49.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.72 -19.54 9.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.687 2.258 . . . . 0.0 109.939 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 3.6 pt-20 -94.2 -161.9 0.89 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.034 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.87 ' HB3' HG11 ' A' ' 26' ' ' VAL . 2.7 tpp180 -99.62 146.27 26.65 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.759 ' HB3' HD13 ' A' ' 62' ' ' LEU . 83.8 p -118.43 134.23 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.905 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 55' ' ' ILE . 57.1 t -128.7 122.68 57.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.633 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 54.3 m -86.04 123.82 31.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.308 0.575 . . . . 0.0 111.27 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 21' ' ' THR . 4.3 mm? -105.51 114.76 29.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.607 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.9 m -152.87 141.68 21.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.12 -133.53 1.96 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.617 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.716 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -114.59 166.29 11.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 8.3 Cg_endo -50.04 -41.87 47.35 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.909 2.406 . . . . 0.0 113.39 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -84.28 -44.95 13.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 23.8 p -66.48 -46.91 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -67.5 -32.51 57.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.303 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 81' ' ' MET . 64.5 tt0 -74.55 -42.22 59.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 81' ' ' MET . 1.9 tpmt? -58.42 -51.65 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.935 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.85 72.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.995 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.5 mtmt -67.24 -22.62 65.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.543 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.571 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 61.7 mtt -62.96 -47.74 81.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.443 ' HE3' HG13 ' A' ' 45' ' ' ILE . 2.3 mpt? -65.25 -41.67 94.06 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.19 176.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.51 ' HG ' HD23 ' A' ' 69' ' ' LEU . 3.6 mm? -60.39 -57.13 14.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.59 -38.76 72.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.466 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.12 -51.68 68.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.386 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.632 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -80.4 -40.87 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.585 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.641 HG23 ' CD2' ' A' ' 24' ' ' TYR . 70.8 t -61.42 -41.98 92.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.852 0.358 . . . . 0.0 110.455 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -68.04 -40.3 82.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.632 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 8.1 ptp180 -69.9 -28.07 65.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.579 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.503 ' HA3' ' SD ' ' A' ' 30' ' ' MET . . . -118.08 10.6 13.45 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.477 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.462 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 2.0 tmt_? . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.04 0.447 . . . . 0.0 109.996 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 70.6 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.622 ' HB2' ' O ' ' A' ' 21' ' ' THR . 77.2 mm-40 -162.53 -36.93 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.773 0.829 . . . . 0.0 109.317 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.16 -126.96 0.09 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.783 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 140.74 119.7 1.61 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.594 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.84 -6.88 17.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.679 . . . . 0.0 112.061 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.766 HG21 ' HD2' ' A' ' 14' ' ' PRO . 13.9 mt -92.03 113.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.586 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 26.8 m-70 -82.19 -11.74 0.18 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -165.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.766 ' HD2' HG21 ' A' ' 12' ' ' ILE . 76.3 Cg_exo -35.01 127.84 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.133 1.889 . . . . 0.0 112.874 169.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' ARG . 45.1 Cg_exo -36.97 132.4 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 124.391 3.394 . . . . 0.0 112.812 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 2.7 Cg_exo -25.23 62.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 127.076 5.184 . . . . 0.0 117.079 -159.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HA ' ' CG2' ' A' ' 70' ' ' THR . 11.8 ptp180 -122.2 10.34 9.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 7.9 t 174.11 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.147 178.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.7 t -79.58 -24.06 42.31 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.2 0.524 . . . . 0.0 110.221 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.441 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 8.8 ptp -155.26 70.17 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 51.8 m -78.79 120.68 23.77 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.843 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.7 tp10 -102.59 118.5 36.98 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.888 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 5.3 tp10 -94.06 105.85 17.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.613 170.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 115.04 27.73 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.272 -173.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 1.01 ' HG2' HD13 ' A' ' 62' ' ' LEU . 39.0 mtm105 -81.48 98.77 8.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 172.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.758 HG12 ' HB3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -108.11 116.71 56.46 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.209 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.519 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 50.2 Cg_exo -50.63 139.08 39.6 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 123.291 2.66 . . . . 0.0 112.518 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -50.34 -48.5 55.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -28.36 73.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.29 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.765 ' HE3' HG21 ' A' ' 86' ' ' ILE . 91.0 mmm -78.78 -10.28 59.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 65' ' ' ARG . 39.5 t -77.12 -41.24 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.15 64.44 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.396 172.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.5 mt -89.01 -26.12 21.63 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.597 HG21 ' O ' ' A' ' 31' ' ' VAL . 10.5 tp -72.49 -27.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.477 0.656 . . . . 0.0 109.736 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.598 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 13.4 pt -84.27 -14.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.133 173.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.86 -90.8 0.07 OUTLIER Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.644 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.04 10.41 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.867 0.467 . . . . 0.0 111.698 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.13 35.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.111 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.598 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 154.1 -46.3 0.55 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.467 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 26.5 tt0 -48.18 -38.18 17.56 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -61.32 -45.57 93.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.524 HD13 HG12 ' A' ' 53' ' ' VAL . 5.7 tp -59.4 -49.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.424 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.11 -43.08 99.62 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.344 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -58.78 -39.25 80.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.364 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.414 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -81.27 -42.49 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.769 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -73.46 -26.83 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.61 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.99 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.41 -51.43 69.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.348 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 p -74.43 -37.29 63.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.772 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.53 2.43 60.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.533 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 51.4 t -79.67 139.98 37.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 110.56 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HE2' ' HA2' ' A' ' 71' ' ' GLY . 12.4 mttm -83.46 75.56 10.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.264 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.524 HG12 HD13 ' A' ' 42' ' ' ILE . 45.4 t -82.18 110.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.638 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.0 mm-40 -102.41 106.44 17.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.675 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.04 106.05 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.411 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.58 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 15.1 m -98.99 107.49 44.17 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-O 120.753 0.311 . . . . 0.0 110.656 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.681 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 21.6 Cg_endo -62.13 -37.18 65.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.528 2.819 . . . . 0.0 112.249 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.12 97.12 8.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.48 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 4.2 p -70.84 -37.45 73.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.372 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.7 -72.9 2.72 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.312 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.19 70.53 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.714 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 1.01 HD13 ' HG2' ' A' ' 25' ' ' ARG . 22.2 mt -115.36 153.18 47.53 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.63 -31.28 2.04 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.33 -161.66 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.572 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.758 ' HB3' HG12 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -81.35 151.06 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.679 ' HB3' HD12 ' A' ' 62' ' ' LEU . 88.5 p -118.11 114.24 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.036 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.5 t -106.0 122.63 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.828 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.6 m -88.83 125.58 34.97 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.628 0.728 . . . . 0.0 110.78 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.843 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.9 mm? -105.04 109.58 21.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.449 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.667 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 26.3 m -151.26 144.75 24.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 52' ' ' LYS . . . 173.28 -107.82 0.26 Allowed Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.935 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.606 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -131.61 164.17 44.55 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 5.3 Cg_endo -47.4 -50.02 12.06 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.193 2.596 . . . . 0.0 112.994 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.53 -30.24 25.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.1 m -71.56 -48.25 49.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -69.51 -23.9 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -177.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.75 -51.01 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.319 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 81' ' ' MET . 24.4 tptm -62.7 -41.07 98.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.23 90.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.689 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 48.0 mtmt -74.93 -21.35 59.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.37 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 6.1 tpp -60.23 -46.42 89.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.414 ' HG3' HG12 ' A' ' 45' ' ' ILE . 20.4 mmt -71.02 -39.67 72.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.418 ' HG ' HD22 ' A' ' 69' ' ' LEU . 4.0 mm? -61.43 -48.92 78.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.321 177.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.5 -46.74 83.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.141 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -46.88 -58.13 4.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.385 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.765 HG21 ' HE3' ' A' ' 30' ' ' MET . 1.9 mp -79.57 -44.57 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.388 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.68 -27.49 36.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.747 0.308 . . . . 0.0 111.131 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -77.93 -38.55 45.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.471 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 3.3 ptp180 -72.26 -21.32 61.39 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.38 -83.15 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.379 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.187 0.518 . . . . 0.0 111.256 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -53.24 112.41 0.87 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.1 tp -106.83 117.39 33.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.839 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.99 79.75 0.26 Allowed Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.926 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -87.78 -7.82 6.24 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.761 2.308 . . . . 0.0 112.734 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.789 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.9 tp -140.87 152.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.685 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 71.3 m80 -88.6 -27.08 0.34 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.789 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.6 Cg_exo -37.69 165.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.474 2.783 . . . . 0.0 114.16 165.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 17' ' ' ARG . 42.4 Cg_exo -58.3 169.44 2.97 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.139 2.559 . . . . 0.0 112.606 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 37.4 Cg_endo -64.29 21.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.066 3.177 . . . . 0.0 114.064 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 13.5 ptm180 -77.98 -18.12 56.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 70' ' ' THR . 9.9 t -164.5 6.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.366 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.543 ' HA ' HG21 ' A' ' 12' ' ' ILE . 33.6 t -92.36 -99.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.927 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 17.4 ptm -60.98 84.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.715 0.769 . . . . 0.0 111.407 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -84.89 114.96 22.5 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.613 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.8 tp10 -92.75 116.63 29.2 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.97 109.21 22.01 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.755 0.788 . . . . 0.0 109.25 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.8 ' HD2' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.56 125.14 36.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.664 -169.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 -84.35 99.12 10.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.185 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.592 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -119.63 121.93 29.57 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.838 -175.431 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.561 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 46.1 Cg_exo -59.11 150.11 75.6 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.543 2.829 . . . . 0.0 113.025 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' HG11 ' A' ' 31' ' ' VAL . 10.2 t70 -45.82 -59.28 2.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.59 -173.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.44 -24.64 73.76 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.666 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.638 ' HE2' HG23 ' A' ' 86' ' ' ILE . 78.1 mmm -78.97 -33.35 45.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.697 -0.296 . . . . 0.0 110.598 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 34' ' ' ILE . 11.7 p -73.14 -28.07 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.868 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.07 72.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.161 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.18 -27.48 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -69.66 -28.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.574 0.702 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.694 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.4 pt -85.75 -15.19 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.515 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 58.31 -93.81 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 123.908 0.755 . . . . 0.0 112.95 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.92 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.07 37.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.115 0.566 . . . . 0.0 111.187 176.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 77.76 9.47 86.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 113.864 174.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.694 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.27 -42.33 0.86 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.185 174.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.92 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 34.0 tt0 -51.67 -30.96 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -66.45 -47.89 71.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 39' ' ' GLY . 10.4 tp -69.37 -36.95 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.857 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.86 -34.32 77.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.339 0.59 . . . . 0.0 110.18 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.149 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.406 HG13 ' HG3' ' A' ' 82' ' ' MET . 30.9 mm -74.14 -38.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.34 -174.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.25 64.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -77.24 -43.29 34.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.472 . . . . 0.0 109.729 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -54.92 -41.64 71.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.449 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.1 p -86.02 -38.04 18.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.289 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.73 2.98 52.76 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 48.2 t -79.51 139.72 37.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.307 0.575 . . . . 0.0 110.771 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -86.24 74.46 10.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.195 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -81.67 109.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.103 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -105.0 112.27 25.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.449 HD13 HG13 ' A' ' 67' ' ' VAL . 39.2 mm -79.43 97.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 44.1 m -81.17 106.58 5.89 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.568 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.831 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 5.4 Cg_exo -77.86 -33.58 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.105 3.203 . . . . 0.0 113.157 -173.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.2 -25.87 42.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.991 0.425 . . . . 0.0 109.875 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.403 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.0 t 62.33 -154.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.901 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.39 108.16 0.22 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.22 -34.71 4.78 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.493 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.4 mm? -100.55 137.09 19.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 1.55 9.2 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.733 2.289 . . . . 0.0 111.912 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -111.11 -115.24 0.31 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.508 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.831 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 4.2 tpp180 -130.16 155.57 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.458 ' HB3' HD21 ' A' ' 62' ' ' LEU . 34.3 p -130.89 129.54 42.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.2 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.449 HG13 HD13 ' A' ' 55' ' ' ILE . 60.9 t -114.55 130.99 67.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.127 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 p -97.91 128.25 44.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.588 0.709 . . . . 0.0 111.03 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.2 mm? -108.29 112.37 24.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.801 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.442 HG22 ' HA ' ' A' ' 18' ' ' THR . 2.3 m -150.86 155.37 39.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . 162.88 -71.3 0.21 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.382 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.71 161.36 24.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.27 -53.56 6.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.244 1.962 . . . . 0.0 112.558 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -71.23 -37.31 72.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.316 0.579 . . . . 0.0 110.714 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 14.2 m -72.85 -43.55 62.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.591 -171.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.456 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.4 p -70.13 -24.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' A' ' 81' ' ' MET . 43.5 tp60 -82.01 -35.99 28.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.204 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 81' ' ' MET . 24.4 tptm -64.26 -45.92 86.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.69 0.757 . . . . 0.0 109.584 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.72 -48.21 75.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.284 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.538 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.1 mtmt -69.02 -21.51 64.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.993 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.924 ' HE3' ' HA ' ' A' ' 81' ' ' MET . 13.2 mmt -59.27 -47.56 84.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.9 0.381 . . . . 0.0 110.029 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.406 ' HG3' HG13 ' A' ' 45' ' ' ILE . 92.5 mmm -67.5 -45.77 74.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -59.42 -54.0 51.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.55 -35.13 78.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.483 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.31 -53.44 56.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.491 . . . . 0.0 110.793 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.638 HG23 ' HE2' ' A' ' 30' ' ' MET . 1.9 mp -76.66 -39.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.636 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.8 HG23 ' HD2' ' A' ' 24' ' ' TYR . 78.9 t -65.56 -31.86 55.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 t -78.02 -32.63 51.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.5 ptp180 -74.57 -16.37 60.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.889 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.01 -73.79 1.08 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.339 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.127 -179.47 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.53 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 47.9 m . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -36.42 117.37 0.48 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.57 1.148 . . . . 0.0 113.525 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' MET . 0.7 OUTLIER -121.27 137.33 54.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.596 170.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.48 71.75 0.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.793 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.77 -37.83 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.951 2.434 . . . . 0.0 112.819 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.703 HG21 ' HD2' ' A' ' 14' ' ' PRO . 8.9 mm -113.87 149.19 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.576 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 10.0 t60 -90.67 -41.72 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.703 ' HD2' HG21 ' A' ' 12' ' ' ILE . 25.1 Cg_exo -41.79 171.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.629 2.886 . . . . 0.0 114.397 172.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 17' ' ' ARG . 26.1 Cg_exo -33.99 150.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.361 3.374 . . . . 0.0 114.833 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 55.7 Cg_endo -66.26 27.25 0.1 Allowed 'Trans proline' 0 N--CA 1.48 0.729 0 C-N-CA 124.265 3.31 . . . . 0.0 114.899 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 15' ' ' PRO . 3.9 ptp180 -84.54 -8.16 59.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.412 0.625 . . . . 0.0 109.334 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -164.45 12.33 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.003 174.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 47.2 t -92.86 -99.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 15.7 ptp -68.71 78.07 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.644 0.735 . . . . 0.0 110.525 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -79.34 115.71 19.15 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.6 tp10 -95.16 118.77 32.52 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB3' ' N ' ' A' ' 7' ' ' SER . 10.0 tp10 -105.1 106.24 16.64 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.539 -0.865 . . . . 0.0 108.861 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.479 ' CD1' HG23 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -91.66 124.96 36.21 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.133 -167.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.649 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 19.2 mtp180 -90.3 99.44 12.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.202 174.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -116.1 122.27 32.55 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.559 -175.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.48 145.85 44.93 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.796 2.331 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.433 ' HA ' HG13 ' A' ' 31' ' ' VAL . 1.4 p-10 -61.95 -28.75 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.306 -169.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -28.95 61.23 Favored Glycine 0 C--O 1.238 0.399 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.507 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.578 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 20.4 mmt -78.67 -31.27 46.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.344 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 34' ' ' ILE . 9.0 p -69.99 -34.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.648 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.78 -30.36 69.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.556 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.9 mt -87.81 -23.86 23.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 31' ' ' VAL . 10.2 tp -71.49 -30.23 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.654 0.74 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.685 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.7 pt -83.13 -14.79 11.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 -91.83 0.11 Allowed Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.214 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.61 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 14.3 ptp180 -76.74 -0.02 22.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.0 111.275 -176.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.67 10.39 8.53 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.811 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.685 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 158.01 -55.54 0.37 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.578 173.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 26.4 mm-40 -59.3 -23.92 62.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -59.99 -52.86 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.081 0.855 . . . . 0.0 110.576 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.571 HD13 HG12 ' A' ' 53' ' ' VAL . 6.3 tp -62.02 -45.33 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.021 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -54.7 -37.13 65.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.439 0.462 . . . . 0.0 110.745 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HE2' ' HB3' ' A' ' 40' ' ' GLU . 68.0 mttm -72.28 -41.76 66.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.198 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.21 -48.69 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 111.664 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.32 -31.46 71.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.069 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.464 HE21 ' HB3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -74.09 -36.26 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.21 0.528 . . . . 0.0 109.879 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.38 -32.25 73.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.053 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.647 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 8.0 p -96.87 -40.35 8.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.839 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.99 27.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.712 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 32.0 t -79.99 136.68 36.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.117 0.484 . . . . 0.0 110.734 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -84.22 72.17 10.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.571 HG12 HD13 ' A' ' 42' ' ' ILE . 44.6 t -83.14 106.81 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.972 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.21 110.65 22.94 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.136 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.488 HD12 HG11 ' A' ' 67' ' ' VAL . 48.1 mm -79.78 112.62 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.679 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.475 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 2.6 m -94.82 102.05 8.25 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.084 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 86.7 Cg_endo -76.56 -21.36 13.1 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.982 2.455 . . . . 0.0 112.581 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.95 -41.77 25.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.025 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.609 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 9.0 t 73.78 -64.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.746 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 -76.5 2.2 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.143 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.77 -8.25 84.69 Favored Glycine 0 CA--C 1.511 -0.189 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.853 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.649 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.7 mt -121.16 146.82 45.32 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.65 -20.7 10.48 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.61 2.206 . . . . 0.0 110.242 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -93.05 -163.94 1.11 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.752 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.532 ' HG2' HG21 ' A' ' 31' ' ' VAL . 6.0 tpp180 -92.18 147.01 23.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.535 ' HB3' HD12 ' A' ' 62' ' ' LEU . 78.0 p -117.91 141.66 48.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.674 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 55' ' ' ILE . 87.7 t -137.68 120.94 20.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.382 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 p -92.46 125.5 37.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.604 0.716 . . . . 0.0 111.497 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.85 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.7 mm? -105.23 120.01 40.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.19 155.74 40.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.11 -121.21 1.01 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.198 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -119.45 164.01 24.01 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.72 -46.33 21.45 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.573 2.182 . . . . 0.0 112.695 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -75.47 -46.64 31.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.923 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.647 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 1.5 m -61.51 -48.65 80.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.281 -173.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.0 p -70.09 -24.26 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.381 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -74.76 -45.94 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -58.72 -48.69 80.3 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.36 0.6 . . . . 0.0 110.187 176.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.16 -52.09 67.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.886 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.759 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.0 mtmt -68.39 -21.97 64.66 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.253 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.567 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 10.6 ptm -72.08 -32.49 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.846 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.6 mmt -66.77 -47.62 71.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 110.011 171.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.29 -52.27 66.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.737 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.98 -38.38 70.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.837 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.52 -60.39 3.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.541 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.585 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.8 mp -72.61 -37.73 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 111.727 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 24' ' ' TYR . 69.7 t -67.68 -26.1 34.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.781 -0.574 . . . . 0.0 111.113 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t -75.67 -34.66 60.48 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.387 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.585 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -77.48 -12.87 60.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.077 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.84 -55.97 0.82 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.546 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 121.043 0.449 . . . . 0.0 110.562 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 21' ' ' THR . 26.1 mt-30 -147.92 -93.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp 172.97 -173.4 0.05 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.376 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.565 ' HA3' ' C ' ' A' ' 19' ' ' SER . . . -143.52 114.89 0.86 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.076 172.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 -24.79 26.01 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.874 2.383 . . . . 0.0 113.269 -174.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.604 HD11 ' HG2' ' A' ' 14' ' ' PRO . 17.0 pt -121.67 164.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.157 0.503 . . . . 0.0 111.098 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.657 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 63.4 m80 -90.09 -19.11 0.24 Allowed Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 73.2 Cg_exo -39.5 167.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.601 2.2 . . . . 0.0 114.077 168.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 17' ' ' ARG . 7.0 Cg_endo -49.29 165.61 0.22 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.371 2.714 . . . . 0.0 113.057 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.75 34.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.061 3.174 . . . . 0.0 114.723 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 15' ' ' PRO . 12.4 ptm180 -86.21 0.3 54.04 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.563 HG22 HD13 ' A' ' 12' ' ' ILE . 12.7 t -178.92 -12.77 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.011 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.565 ' C ' ' HA3' ' A' ' 10' ' ' GLY . 12.6 t -79.59 1.6 25.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -177.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.5 ptm -164.26 72.73 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.591 . . . . 0.0 110.732 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 48.4 m -79.13 122.22 25.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.572 ' HG2' ' HD2' ' A' ' 24' ' ' TYR . 1.6 tt0 -102.28 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.977 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -91.09 103.38 16.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.572 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -92.37 127.3 37.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.399 -172.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.582 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 63.9 mtp180 -81.59 111.46 17.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.294 0.568 . . . . 0.0 110.751 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.771 HG11 HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -128.65 121.64 21.24 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.792 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 33.9 Cg_endo -68.55 151.38 75.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.932 1.755 . . . . 0.0 110.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -37.75 64.86 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -166.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.42 80.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.478 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.595 ' HE2' HD11 ' A' ' 33' ' ' LEU . 32.0 mmt -78.42 -15.99 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 35' ' ' ILE . 40.3 t -70.01 -44.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.31 -31.73 80.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.089 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.595 HD11 ' HE2' ' A' ' 30' ' ' MET . 45.2 mt -88.37 -23.24 23.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -71.11 -29.75 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.357 0.599 . . . . 0.0 109.508 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.685 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -85.37 -15.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.284 170.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.35 -90.6 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.498 0 O-C-N 124.401 1.063 . . . . 0.0 112.429 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 ptt-85 -76.69 48.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.884 -0.658 . . . . 0.0 111.579 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.83 11.79 61.11 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.902 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.685 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.03 -42.0 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.292 -1.433 . . . . 0.0 113.534 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.59 -32.23 66.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.4 tt0 -61.72 -52.48 64.12 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.439 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.524 HG22 HG22 ' A' ' 35' ' ' ILE . 9.9 tp -62.0 -41.27 90.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.521 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -58.1 -48.17 80.99 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -60.13 -40.49 89.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.909 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.593 HD11 ' HG3' ' A' ' 82' ' ' MET . 87.8 mt -70.89 -50.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.448 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -26.96 62.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -175.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.827 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -78.46 -35.99 45.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.164 0.507 . . . . 0.0 110.218 176.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -42.74 99.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.857 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.743 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 11.9 p -84.88 -38.79 19.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.26 11.35 31.83 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.422 ' N ' ' HB3' ' A' ' 75' ' ' SER . 51.2 t -86.45 154.51 21.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.213 0.53 . . . . 0.0 110.28 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -105.58 71.58 0.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.054 0.93 . . . . 0.0 109.241 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.507 HG11 HD12 ' A' ' 42' ' ' ILE . 37.3 t -81.99 119.34 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.174 -175.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.405 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 14.4 mm-40 -113.69 120.4 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.4 mm -83.61 93.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 t -79.71 110.89 17.38 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.1 Cg_exo -80.85 -9.39 13.16 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.654 2.902 . . . . 0.0 111.157 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 -37.91 46.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.902 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.55 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 11.2 m 70.03 -59.64 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.161 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.56 -87.65 1.46 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.775 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.527 ' C ' HD11 ' A' ' 62' ' ' LEU . . . -87.66 3.25 86.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.63 HD23 ' HB3' ' A' ' 66' ' ' SER . 5.1 mp -124.19 139.55 32.97 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -170.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -87.19 -24.17 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.794 2.329 . . . . 0.0 111.972 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.792 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -88.44 -84.16 0.21 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.677 -175.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 5.4 tpp85 -160.61 153.92 21.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.63 ' HB3' HD23 ' A' ' 62' ' ' LEU . 88.3 p -124.55 130.24 52.08 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.235 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.771 HG22 HG11 ' A' ' 26' ' ' VAL . 85.8 t -105.11 115.7 47.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.2 m -79.76 120.32 23.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.366 0.603 . . . . 0.0 109.806 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.912 HD13 ' HG2' ' A' ' 80' ' ' LYS . 27.1 mt -113.27 105.01 12.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -150.12 145.12 26.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.218 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.33 -98.32 0.11 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 119.741 -1.219 . . . . 0.0 113.607 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -138.06 165.04 36.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 93.0 Cg_exo -45.06 -66.12 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.066 2.511 . . . . 0.0 113.46 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.75 -39.99 80.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.458 0.647 . . . . 0.0 110.235 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.743 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 7.1 m -59.64 -46.19 89.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.709 -173.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.643 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.2 p -73.74 -31.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.879 -173.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.79 -42.26 86.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.048 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 81' ' ' MET . 2.4 tmtp? -70.29 -42.26 72.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.688 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.26 93.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.0 111.414 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.912 ' HG2' HD13 ' A' ' 69' ' ' LEU . 5.1 mtmp? -81.19 -21.22 39.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.6 tpt -60.32 -47.49 85.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 173.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.593 ' HG3' HD11 ' A' ' 45' ' ' ILE . 18.9 mmt -68.17 -37.62 81.2 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 176.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.705 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.2 mm? -59.44 -49.84 76.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.28 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.15 -42.63 66.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.735 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.87 -56.5 20.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.661 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.58 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -71.27 -41.15 74.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.045 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.529 HG21 ' CD1' ' A' ' 24' ' ' TYR . 60.7 t -63.56 -23.87 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 O-C-N 121.886 -0.509 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.9 m -85.07 -26.01 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.58 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.4 ptp180 -77.04 -12.94 60.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.148 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.28 -39.92 1.45 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.693 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.569 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 0.0 110.945 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' THR . 26.8 mt-30 -64.98 109.5 2.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.304 0.573 . . . . 0.0 111.815 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -84.8 133.53 34.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.91 77.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.847 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.96 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.734 2.289 . . . . 0.0 112.207 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.669 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -109.03 157.89 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.553 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.624 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 54.6 t60 -91.02 -26.98 0.3 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 49.7 Cg_exo -37.12 166.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 123.441 2.76 . . . . 0.0 115.097 170.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 17' ' ' ARG . 83.6 Cg_exo -45.13 153.92 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.776 2.984 . . . . 0.0 113.879 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.54 12.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.416 3.411 . . . . 0.0 114.3 -174.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 15' ' ' PRO . 3.8 ptp180 -64.9 -24.5 67.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.225 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -154.1 -5.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.947 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.1 p -79.79 -90.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.061 -0.4 . . . . 0.0 111.433 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.5 ptm -70.45 76.15 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.629 0.728 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 HG22 ' A' ' 70' ' ' THR . 24.8 m -84.53 116.21 23.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.336 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.918 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 5.5 tp10 -92.66 118.2 30.79 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -97.26 101.92 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.427 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -95.09 121.08 36.35 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.726 -171.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -81.94 123.81 29.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.544 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.512 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -136.44 124.23 14.74 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.575 -175.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.662 ' HG2' ' HA ' ' A' ' 91' ' ' ARG . 35.8 Cg_exo -59.48 152.93 58.03 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.858 2.372 . . . . 0.0 113.338 -175.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.46 ' O ' HG11 ' A' ' 31' ' ' VAL . 24.2 t70 -50.11 -52.12 37.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.1 70.43 Favored Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.075 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.631 ' HE1' HH11 ' A' ' 89' ' ' ARG . 47.7 tpp -79.26 -27.61 42.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.639 -0.33 . . . . 0.0 110.695 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.606 ' O ' HG21 ' A' ' 34' ' ' ILE . 11.2 p -74.59 -25.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.49 -24.98 73.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.874 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.0 mt -87.76 -24.69 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.606 HG21 ' O ' ' A' ' 31' ' ' VAL . 11.2 tp -70.92 -32.71 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.586 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.3 pt -82.97 -14.6 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.15 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.16 -94.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.608 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.547 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 9.7 ptm180 -63.17 -10.32 14.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.589 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.08 4.96 5.84 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.08 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.578 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.79 -53.1 0.4 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.134 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 41.2 tt0 -55.43 -20.73 13.22 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.12 -53.16 61.54 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.865 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.541 HD11 HG12 ' A' ' 53' ' ' VAL . 11.2 tp -65.73 -36.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.918 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.47 -41.25 89.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.155 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -60.67 -56.78 17.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.843 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' CG1' ' HG2' ' A' ' 82' ' ' MET . 1.5 mp -54.61 -56.63 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.159 -176.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.476 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -70.03 -34.61 73.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -170.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.62 -35.49 39.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 110.327 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.99 -26.63 66.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.368 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 p -95.06 -40.58 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.743 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.31 18.23 9.34 Favored Glycine 0 CA--C 1.505 -0.567 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.809 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.95 160.96 14.2 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 0.0 111.978 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -101.3 76.25 1.69 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.16 173.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.541 HG12 HD11 ' A' ' 42' ' ' ILE . 41.8 t -90.4 109.05 20.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.697 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -113.02 137.8 50.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.65 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.3 116.29 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.291 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -95.01 107.1 29.37 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.227 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.958 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 81.9 Cg_endo -78.62 -30.15 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.89 2.393 . . . . 0.0 112.805 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.73 -44.44 23.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.8 t 68.65 -68.33 0.18 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.893 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.9 -86.69 0.46 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.595 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.24 -1.1 90.45 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.132 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 66' ' ' SER . 48.8 mt -119.2 135.81 24.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.96 -17.36 17.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.687 2.258 . . . . 0.0 110.459 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -94.26 -162.44 0.94 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.101 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.958 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -99.64 156.64 16.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.661 ' HB3' HD11 ' A' ' 62' ' ' LEU . 24.7 p -128.64 135.82 49.82 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.693 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.08 129.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.565 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.1 m -91.72 127.62 37.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.349 0.595 . . . . 0.0 111.146 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.918 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 4.2 mm? -108.1 117.63 34.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.325 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.458 HG22 HG22 ' A' ' 21' ' ' THR . 0.6 OUTLIER -150.34 156.6 41.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.021 176.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.17 -152.21 23.65 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.785 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -80.37 159.54 69.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 6.3 Cg_endo -49.08 -50.0 13.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.755 2.303 . . . . 0.0 112.368 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.33 -44.8 82.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.408 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.593 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 9.7 m -62.03 -54.61 39.07 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.034 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -25.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.302 -172.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' ' HG3' ' A' ' 81' ' ' MET . 51.1 tt0 -71.45 -50.58 30.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -57.7 -50.73 72.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.754 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.719 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . . . -54.17 -48.31 71.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.134 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 38.3 mtmt -67.09 -21.5 65.87 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.381 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.624 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 94.0 mtp -66.85 -41.45 87.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.459 ' HG2' ' CG1' ' A' ' 45' ' ' ILE . 2.6 mpt? -65.91 -47.43 74.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.711 0.291 . . . . 0.0 111.048 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.471 ' HG ' HD22 ' A' ' 69' ' ' LEU . 4.3 mm? -57.95 -55.56 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.943 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.7 -44.71 77.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.554 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.24 -53.32 55.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.517 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.747 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 2.0 mp -75.29 -45.25 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.713 -175.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 24' ' ' TYR . 84.7 t -61.82 -40.19 86.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.076 0.465 . . . . 0.0 110.717 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -72.83 -28.5 62.58 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.056 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.747 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -73.28 -21.93 60.49 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.836 -178.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.02 63.27 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.048 -1.549 . . . . 0.0 114.608 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.662 ' HA ' ' HG2' ' A' ' 27' ' ' PRO . 36.1 ttt180 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 117.697 0.748 . . . . 0.0 109.744 170.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.844 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 40.1 m . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 7' ' ' SER . 26.1 mt-30 -178.77 -103.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.339 1.055 . . . . 0.0 108.668 166.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 38.1 tp 158.83 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.399 1.062 . . . . 0.0 109.082 176.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 152.94 108.11 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.237 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.2 -8.54 23.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.824 2.349 . . . . 0.0 112.013 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.606 HD13 HG22 ' A' ' 18' ' ' THR . 1.0 OUTLIER -114.44 142.62 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.812 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.689 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 18.7 t-80 -92.55 -11.1 0.17 Allowed Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -172.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.4 Cg_endo -56.4 -175.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.515 2.144 . . . . 0.0 113.15 176.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 14' ' ' PRO . 1.8 Cg_endo -44.22 153.7 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.885 2.39 . . . . 0.0 112.962 174.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 36.7 Cg_endo -65.46 33.81 0.11 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 124.286 3.324 . . . . 0.0 115.254 -174.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 15' ' ' PRO . 66.6 mtt180 -84.56 7.2 20.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.626 0.726 . . . . 0.0 109.213 175.033 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.606 HG22 HD13 ' A' ' 12' ' ' ILE . 8.9 t -176.02 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.127 175.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.503 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 1.8 m -86.41 9.66 17.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.001 -178.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.625 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 18.5 mmt -146.47 31.23 0.99 Allowed 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.002 177.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 85.7 m -78.92 114.51 17.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.844 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 19.8 tt0 -121.64 118.86 30.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.818 176.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -87.63 110.65 20.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CD1' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.34 124.0 34.03 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.81 -166.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.862 ' HG2' HD22 ' A' ' 62' ' ' LEU . 48.9 mtm180 -81.86 103.73 11.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.302 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.3 124.59 26.81 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.508 -175.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.0 148.09 78.68 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.424 2.083 . . . . 0.0 111.644 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.683 ' O ' HG11 ' A' ' 31' ' ' VAL . 37.8 t70 -54.47 -51.43 65.07 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.85 -24.52 70.01 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.838 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.497 ' HE3' ' CA ' ' A' ' 90' ' ' GLY . 30.4 tpp -79.32 -29.64 42.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.477 -0.361 . . . . 0.0 110.828 -175.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.731 ' HA ' HG23 ' A' ' 34' ' ' ILE . 13.4 p -70.99 -26.32 27.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -30.12 75.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.421 169.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.472 HD22 ' SD ' ' A' ' 30' ' ' MET . 64.3 tp -84.15 -31.01 25.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 177.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.731 HG23 ' HA ' ' A' ' 31' ' ' VAL . 9.5 tp -70.39 -26.42 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.685 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 8.5 pt -81.42 -14.38 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.557 174.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 63.7 -92.19 0.1 Allowed Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.316 172.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.738 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -77.34 20.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.86 0.464 . . . . 0.0 111.393 -179.458 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 96.43 5.89 58.88 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.042 177.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.685 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 154.53 -45.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.388 176.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.738 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 49.6 tt0 -56.59 -29.09 61.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' HG12 ' A' ' 45' ' ' ILE . 25.4 tt0 -62.43 -53.24 57.8 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.442 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.585 HD11 HG12 ' A' ' 53' ' ' VAL . 8.6 tp -62.95 -38.71 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.261 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.97 -42.99 99.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.647 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -58.51 -43.2 89.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.602 176.064 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.6 mm -69.96 -50.93 44.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.912 -176.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.24 -31.92 68.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 -174.688 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -76.04 -38.36 57.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 110.17 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.467 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 11.9 t70 -62.82 -50.57 70.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.851 178.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 p -70.85 -45.52 64.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.73 -4.36 26.04 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.464 -176.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 41.6 t -79.12 135.16 36.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.11 0.481 . . . . 0.0 110.099 178.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -85.02 74.5 10.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.519 0.676 . . . . 0.0 110.104 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.585 HG12 HD11 ' A' ' 42' ' ' ILE . 44.9 t -82.49 115.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.789 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.6 mm-40 -119.48 129.95 54.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.856 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.423 HD12 HG12 ' A' ' 67' ' ' VAL . 42.7 mm -83.95 109.12 17.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.754 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.55 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 7.3 m -82.4 111.33 27.43 Favored Pre-proline 0 C--O 1.242 0.662 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.576 -178.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.773 ' HA ' HH11 ' A' ' 65' ' ' ARG . 60.8 Cg_endo -73.01 -27.73 13.76 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.949 2.433 . . . . 0.0 111.858 178.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.46 88.39 2.72 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.861 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 5.3 p -65.6 -39.2 91.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.238 -175.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.01 -61.51 4.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.729 174.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 62' ' ' LEU . . . -93.86 4.88 72.36 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.817 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.862 HD22 ' HG2' ' A' ' 25' ' ' ARG . 5.8 mp -127.71 151.38 75.3 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.36 -0.42 . . . . 0.0 109.941 -170.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -90.89 -4.4 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.696 2.264 . . . . 0.0 111.072 171.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.434 ' CD ' HH21 ' A' ' 91' ' ' ARG . 1.6 pt-20 -119.52 -153.27 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.962 -177.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.773 HH11 ' HA ' ' A' ' 57' ' ' PRO . 14.6 tpp180 -91.97 157.86 16.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.791 ' HB3' HD23 ' A' ' 62' ' ' LEU . 56.9 p -131.96 153.41 50.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.642 174.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.423 HG12 HD12 ' A' ' 55' ' ' ILE . 57.5 t -135.19 131.75 52.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.2 m -89.87 127.66 36.04 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.284 177.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.732 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -110.57 107.48 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 175.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -152.54 134.64 14.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.61 -147.39 7.84 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.846 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.6 160.2 70.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.558 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . 99.9 Cg_exo -45.06 -56.51 2.66 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.033 2.489 . . . . 0.0 114.237 -174.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -84.15 -30.98 25.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.956 -178.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 m -62.38 -43.33 99.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.007 0.432 . . . . 0.0 110.696 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.8 p -66.86 -27.77 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.4 tp-100 -73.52 -50.28 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.126 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -54.2 -43.89 71.14 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.207 0.527 . . . . 0.0 110.566 178.798 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.71 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.562 176.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.732 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 9.8 mtmp? -66.16 -21.23 66.32 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.854 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.4 mmm -67.7 -43.41 80.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.83 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.0 mmm -66.73 -34.55 78.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 175.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.37 -49.09 65.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -51.3 -44.59 61.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.614 177.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 10.5 t70 -64.08 -61.04 2.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.682 -178.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 34' ' ' ILE . 1.9 mp -66.68 -40.51 86.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.27 -174.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.478 HG23 ' CD1' ' A' ' 24' ' ' TYR . 77.3 t -67.82 -26.86 35.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.502 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.4 t -72.79 -26.25 61.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.815 0.341 . . . . 0.0 110.239 175.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 25.5 mmt180 -63.6 -41.91 98.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.21 0.529 . . . . 0.0 109.671 176.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.497 ' CA ' ' HE3' ' A' ' 30' ' ' MET . . . -87.45 -59.51 1.72 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.721 178.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.434 HH21 ' CD ' ' A' ' 64' ' ' GLU . 33.2 mmt180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.469 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.2 t . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.444 0.164 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -155.93 143.49 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.099 0.476 . . . . 0.0 110.889 -177.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -134.65 98.56 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 67.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 172.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.12 -11.86 14.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.917 2.411 . . . . 0.0 111.826 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.525 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 23.2 pt -124.97 154.9 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.678 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 49.4 t-80 -89.45 -22.1 0.27 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 23.8 Cg_exo -42.23 168.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.692 2.262 . . . . 0.0 114.474 174.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 17' ' ' ARG . 65.4 Cg_exo -41.25 157.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.758 2.972 . . . . 0.0 114.36 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 35.1 Cg_endo -66.83 28.6 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.901 3.067 . . . . 0.0 114.357 -175.171 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 15' ' ' PRO . 88.4 mtt180 -73.19 -26.69 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.476 HG22 HD11 ' A' ' 12' ' ' ILE . 2.7 t -158.36 10.16 0.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.353 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.5 t -101.07 -12.51 18.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.391 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.518 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 21.8 mmt -134.33 34.46 3.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 -176.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 87.3 m -79.68 112.19 16.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 14.4 tt0 -111.01 119.09 37.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -96.61 103.21 15.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -91.81 118.68 30.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.973 -166.853 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.548 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 32.4 mtm180 -81.78 114.74 20.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.776 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.553 HG12 ' HB3' ' A' ' 65' ' ' ARG . 1.1 p -135.45 131.87 19.62 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.065 -173.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 38.2 Cg_exo -61.8 146.28 96.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.905 2.403 . . . . 0.0 111.555 177.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -59.89 -30.32 68.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.405 -172.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.62 -33.24 56.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.177 176.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.729 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 83.7 mmm -78.82 -29.48 44.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.904 -0.174 . . . . 0.0 110.795 -176.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.0 p -69.72 -31.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.358 173.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.58 70.38 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.431 171.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.76 -23.65 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.9 tp -72.37 -27.32 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.457 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.6 pt -85.18 -14.75 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.155 171.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.42 -97.78 0.1 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.362 173.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 14.2 ptm180 -58.99 -22.39 60.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.097 0.559 . . . . 0.0 111.63 178.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -7.63 1.83 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.785 177.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.605 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 167.85 -48.36 0.24 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.256 176.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 28.3 tt0 -59.96 -21.64 61.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -171.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.26 -55.32 35.14 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.316 0.507 . . . . 0.0 110.582 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.84 -38.66 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.76 -36.83 79.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 28.1 tptp -63.04 -58.64 6.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.125 176.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.47 -41.37 87.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.259 -174.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.1 pp0? -71.85 -40.32 69.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.85 -176.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -73.76 -30.29 62.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.347 0.594 . . . . 0.0 110.537 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 13.0 t70 -69.12 -43.99 73.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.716 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 39.4 p -80.03 -35.36 37.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 7.19 30.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.626 -177.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 33.9 t -90.71 141.47 28.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -94.05 89.09 5.9 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.238 0.542 . . . . 0.0 109.657 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.37 106.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.745 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -106.0 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -175.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.43 HD11 HG12 ' A' ' 67' ' ' VAL . 43.1 mm -78.9 116.94 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.7 t -107.76 112.91 61.81 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 111.133 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.89 -37.49 19.78 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.357 2.705 . . . . 0.0 111.306 175.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -80.11 83.28 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.557 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.4 m -76.31 4.19 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.11 -169.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.16 -92.91 1.07 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.826 169.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.8 -11.26 58.08 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.553 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 59' ' ' SER . 3.0 mm? -103.78 142.87 25.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.1 -18.75 2.18 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.752 2.301 . . . . 0.0 112.502 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -83.41 -86.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.391 -175.253 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' HB3' HG12 ' A' ' 26' ' ' VAL . 1.3 tpp180 -160.27 154.31 23.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 176.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 22.1 t -139.35 143.8 37.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.43 HG12 HD11 ' A' ' 55' ' ' ILE . 46.3 t -129.84 134.95 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.189 -175.305 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.8 m -92.49 128.69 38.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.422 0.63 . . . . 0.0 111.557 177.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.647 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.6 mm? -110.48 112.91 25.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.579 177.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -151.5 148.22 27.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.042 176.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.65 -131.58 2.4 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.601 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.6 162.99 18.53 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.34 -48.58 19.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.823 2.349 . . . . 0.0 113.376 -174.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.48 -41.19 40.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.565 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 29.4 p -65.5 -41.56 93.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.454 0.645 . . . . 0.0 110.34 -174.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.605 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.15 -26.57 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.773 -176.781 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 81' ' ' MET . 47.6 mt-30 -82.62 -34.04 27.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.608 177.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -65.84 -43.79 87.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.671 0.748 . . . . 0.0 109.684 176.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.36 78.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.104 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.647 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.2 mtmt -77.05 -19.94 56.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.039 -174.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -57.05 -55.04 39.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.879 173.214 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.75 -35.87 82.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.2 mm? -65.99 -56.85 9.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -177.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -52.86 -40.86 63.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.571 179.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.543 ' HB3' HD12 ' A' ' 86' ' ' ILE . 7.4 t70 -53.52 -60.03 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.335 -178.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.703 HG21 ' HE1' ' A' ' 30' ' ' MET . 2.5 mp -76.25 -44.37 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.683 -175.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 83' ' ' LEU . 98.8 t -59.1 -39.8 79.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.52 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 t -70.2 -39.11 75.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.804 -179.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.585 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 11.4 ptt180 -77.33 -7.47 56.09 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.526 -176.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.729 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -121.85 0.74 10.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.681 174.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.562 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.552 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.8 t . . . . . 0 C--O 1.224 -0.283 0 CA-C-O 120.002 -0.047 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -149.01 136.46 20.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.282 0.563 . . . . 0.0 111.599 -177.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.829 ' HG ' ' HD3' ' A' ' 11' ' ' PRO . 57.1 tp -115.28 136.29 53.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.26 63.76 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.653 177.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.829 ' HD3' ' HG ' ' A' ' 9' ' ' LEU . 93.3 Cg_endo -86.47 -19.78 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.306 2.004 . . . . 0.0 112.124 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.587 HG23 ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -127.06 138.66 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.218 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.677 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 t-80 -91.71 -15.68 0.21 Allowed Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 22.6 Cg_endo -56.34 178.99 0.11 Allowed 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.201 1.934 . . . . 0.0 113.031 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 17' ' ' ARG . 59.5 Cg_exo -40.18 153.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.404 2.736 . . . . 0.0 114.188 179.077 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 73.8 Cg_endo -71.04 34.88 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.097 3.198 . . . . 0.0 113.283 -175.187 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 15' ' ' PRO . 92.8 mtt180 -84.87 -20.16 31.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -164.56 23.24 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.505 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 34.5 t -101.16 -90.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.749 -176.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptm -79.2 79.79 5.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.157 0.503 . . . . 0.0 110.909 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 9' ' ' LEU . 89.2 m -84.92 114.94 22.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 7' ' ' SER . 13.0 tt0 -94.4 117.95 30.89 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.82 106.25 18.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.529 0.681 . . . . 0.0 109.277 -179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.61 ' HD2' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.88 120.98 33.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.191 -172.733 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.802 ' HG2' HD22 ' A' ' 62' ' ' LEU . 70.5 mtm180 -86.26 101.31 12.94 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.589 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.766 HG12 ' HB3' ' A' ' 65' ' ' ARG . 1.4 p -116.44 129.24 25.4 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.8 Cg_exo -57.23 150.29 58.79 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.536 2.824 . . . . 0.0 112.338 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.35 -44.72 84.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -175.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.76 64.35 Favored Glycine 0 C--O 1.237 0.305 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.875 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.696 ' HE3' ' HA2' ' A' ' 90' ' ' GLY . 31.1 tpp -78.54 -28.65 46.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.828 -175.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.552 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -74.34 -25.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.96 -32.09 69.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.763 168.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.1 mt -82.05 -22.12 36.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 172.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' A' ' 31' ' ' VAL . 8.7 mm -61.36 -44.96 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 122.05 0.928 . . . . 0.0 108.674 174.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.621 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 4.8 pt -82.11 -14.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.787 175.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.18 -88.55 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.021 170.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.87 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 3.1 ptm180 -74.05 0.87 12.38 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.746 0.418 . . . . 0.0 110.998 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.18 -5.44 10.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.138 174.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.621 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 160.37 -41.46 0.44 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.722 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.87 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 1.5 tm-20 -58.83 -35.57 73.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.378 0.271 . . . . 0.0 111.199 -175.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.401 HE22 ' HE1' ' A' ' 82' ' ' MET . 1.2 tm0? -59.12 -47.1 86.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.496 0.189 . . . . 0.0 110.854 -171.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 tp -68.2 -36.32 74.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.224 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -62.46 -37.87 87.61 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -61.61 -54.49 42.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.499 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.53 -45.61 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.245 0.545 . . . . 0.0 111.594 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.873 HE21 ' HB ' ' A' ' 53' ' ' VAL . 97.1 mt-30 -58.33 -45.45 88.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.42 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -69.12 -42.55 75.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.023 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.7 -46.24 84.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.448 177.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.0 p -78.37 -47.48 17.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.583 -177.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.64 6.07 53.16 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 51.1 t -84.72 143.45 29.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.568 . . . . 0.0 110.631 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -89.98 77.66 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.317 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.873 ' HB ' HE21 ' A' ' 46' ' ' GLN . 26.1 t -82.13 107.73 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.123 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.579 HE21 ' CA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.69 106.58 18.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -176.969 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.473 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.8 mm -88.03 94.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.443 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 46.3 m -91.88 106.07 15.91 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.707 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.68 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 8.3 Cg_exo -72.59 -34.35 7.34 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -176.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.21 -12.14 59.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.695 178.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 11.9 p 47.58 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 176.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.08 -75.41 0.35 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.002 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.538 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -81.63 0.23 88.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.766 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.802 HD22 ' HG2' ' A' ' 25' ' ' ARG . 7.6 mp -127.48 145.7 55.59 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.943 -170.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.456 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 43.4 Cg_endo -86.57 -15.17 4.26 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.138 2.559 . . . . 0.0 112.749 176.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.747 ' OE1' ' HB3' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.86 -102.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.947 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.766 ' HB3' HG12 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -135.64 131.12 35.37 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.269 -0.27 . . . . 0.0 110.381 -176.253 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.625 ' HB3' HD23 ' A' ' 62' ' ' LEU . 85.8 p -108.72 112.95 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.44 HG11 HD11 ' A' ' 55' ' ' ILE . 92.9 t -103.16 119.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.112 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.5 m -88.95 126.4 35.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.314 0.578 . . . . 0.0 110.851 176.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.706 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.0 mm? -102.27 104.06 14.57 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.492 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' ' 69' ' ' LEU . 3.2 m -151.44 148.29 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.25 -93.96 0.1 OUTLIER Glycine 0 C--O 1.226 -0.347 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.134 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.02 161.97 45.78 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -46.44 -55.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.194 2.596 . . . . 0.0 113.535 -175.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.74 -33.02 25.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 110.272 -178.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -64.68 -45.06 88.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.293 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.7 p -70.06 -26.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.558 -175.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.96 -43.97 67.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.676 ' O ' ' HG3' ' A' ' 81' ' ' MET . 23.4 tptm -66.15 -44.07 85.18 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -54.18 -48.78 70.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.2 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.706 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 33.0 mtmt -71.13 -25.02 62.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.565 -177.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.676 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 4.2 ppp? -70.18 -30.56 67.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.868 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.401 ' HE1' HE22 ' A' ' 41' ' ' GLN . 86.7 mmm -77.43 -36.17 53.41 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.755 172.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.6 mm? -63.73 -49.1 74.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.89 -44.05 86.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.886 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.1 -59.36 4.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.458 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.524 HG22 ' SD ' ' A' ' 30' ' ' MET . 1.6 mp -72.45 -45.16 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.119 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.61 HG23 ' HD2' ' A' ' 24' ' ' TYR . 9.1 t -67.2 -28.69 43.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 122.043 -0.411 . . . . 0.0 111.322 -176.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.4 t -69.47 -41.34 76.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.023 174.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 12.2 ptp180 -73.7 -13.23 60.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 110.473 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.696 ' HA2' ' HE3' ' A' ' 30' ' ' MET . . . -95.98 -39.45 4.32 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.987 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.784 0.326 . . . . 0.0 111.398 -178.674 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.869 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 20.4 m . . . . . 0 C--O 1.225 -0.204 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.63 96.18 8.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.81 0.338 . . . . 0.0 111.75 -172.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 21' ' ' THR . 91.1 mt -123.38 92.55 3.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.89 73.3 0.39 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.204 178.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.57 -63.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.11 2.54 . . . . 0.0 112.541 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.917 HG12 ' HD2' ' A' ' 14' ' ' PRO . 10.1 tt -99.51 154.92 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.701 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 15.6 m-70 -91.83 -20.78 0.24 Allowed Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -172.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.917 ' HD2' HG12 ' A' ' 12' ' ' ILE . 23.9 Cg_exo -39.94 171.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.319 2.68 . . . . 0.0 114.833 170.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 17' ' ' ARG . 83.8 Cg_exo -49.02 156.6 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.224 2.616 . . . . 0.0 113.538 177.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 36.8 Cg_endo -65.21 11.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.226 3.284 . . . . 0.0 114.371 -175.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 15' ' ' PRO . 12.1 ptt180 -62.51 -24.05 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 110.293 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 t -157.75 -11.01 0.08 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.718 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 14.0 m -79.86 -83.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.838 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.538 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptp -74.56 73.05 1.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.493 0.663 . . . . 0.0 110.193 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 18.0 m -79.41 131.63 36.15 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.843 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.869 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -94.26 117.37 30.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.309 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' SER . 40.9 tt0 -98.97 96.7 8.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.14 116.28 28.88 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.429 -167.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.51 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 44.1 mtt85 -81.66 103.03 11.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.875 176.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.749 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -121.89 131.87 24.35 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.914 -174.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.616 ' HG3' HH11 ' A' ' 91' ' ' ARG . 25.7 Cg_exo -62.98 135.99 54.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.761 2.308 . . . . 0.0 110.568 175.424 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.86 -36.84 49.82 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.367 -169.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -34.09 87.64 Favored Glycine 0 C--O 1.236 0.227 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.214 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.42 ' HE3' HG22 ' A' ' 86' ' ' ILE . 87.1 mmm -78.15 -13.36 59.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 34' ' ' ILE . 37.1 t -74.16 -40.9 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.445 173.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -27.78 71.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.226 174.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.26 -24.81 25.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.626 HD12 ' HB ' ' A' ' 86' ' ' ILE . 8.9 tp -74.22 -25.31 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.564 0.697 . . . . 0.0 109.673 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.584 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -89.33 -15.82 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.864 171.289 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -86.29 0.07 OUTLIER Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.603 174.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 9.0 ptp180 -79.58 -1.29 37.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.949 0.404 . . . . 0.0 111.07 -177.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.33 2.72 10.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.69 173.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.584 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.73 -49.66 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.066 175.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.5 tt0 -44.74 -42.81 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' OE1' ' HE2' ' A' ' 82' ' ' MET . 0.7 OUTLIER -58.7 -46.62 86.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -167.119 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 53' ' ' VAL . 8.0 tp -65.47 -54.31 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.617 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 42' ' ' ILE . 39.5 m-80 -56.19 -42.17 76.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.439 -177.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.45 -47.48 83.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.684 -179.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.74 -45.24 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 2.1 pt20 -69.13 -43.18 74.92 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.575 -176.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.96 -36.58 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.407 -178.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.1 -50.07 74.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.958 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 p -72.78 -33.14 66.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.523 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.04 27.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.615 -178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.628 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 15.2 t -79.73 152.36 29.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.985 0.422 . . . . 0.0 110.133 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -108.84 86.61 2.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.584 HG11 HD11 ' A' ' 42' ' ' ILE . 44.7 t -103.9 111.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.085 0.469 . . . . 0.0 110.923 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.2 115.58 30.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.426 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.49 HD13 HG11 ' A' ' 67' ' ' VAL . 32.1 mm -81.85 94.47 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.731 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 42.1 m -79.25 114.79 47.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.951 0.405 . . . . 0.0 110.788 -178.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 4.3 Cg_exo -74.41 -40.62 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.668 2.912 . . . . 0.0 111.854 -177.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.43 78.77 2.71 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -61.69 -27.85 68.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.128 -175.73 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.97 -72.53 1.82 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.62 -14.03 74.9 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 177.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 2.5 mm? -123.89 138.88 31.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.2 -9.52 10.47 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.045 2.497 . . . . 0.0 111.257 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -101.16 -94.75 0.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.323 -173.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.749 ' HB3' HG13 ' A' ' 26' ' ' VAL . 3.6 tpp180 -150.03 148.25 28.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 175.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.731 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 68.4 p -122.85 112.47 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.119 0.485 . . . . 0.0 110.082 174.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.49 HG11 HD13 ' A' ' 55' ' ' ILE . 99.7 t -98.58 115.81 39.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.716 179.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.1 m -86.14 131.51 34.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.141 0.496 . . . . 0.0 110.548 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.998 HD12 ' HG2' ' A' ' 80' ' ' LYS . 62.6 mt -120.33 116.91 26.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -179.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.65 156.44 40.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.403 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 151.48 -150.9 22.9 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.493 176.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.12 152.25 76.45 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.45 -49.94 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.104 2.536 . . . . 0.0 113.526 -175.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.1 -33.37 50.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 0.0 110.845 -178.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -70.06 -41.27 74.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.641 -178.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.674 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.5 p -68.47 -32.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -177.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.36 81.7 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -55.91 -45.44 78.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.343 0.592 . . . . 0.0 110.793 178.746 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 51' ' ' CYS . . . -66.86 -36.74 83.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.376 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.998 ' HG2' HD12 ' A' ' 69' ' ' LEU . 44.6 mtmt -82.39 -22.02 35.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -173.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.458 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 17.1 tpt -60.82 -49.59 76.85 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.655 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.438 ' HE2' ' OE1' ' A' ' 41' ' ' GLN . 93.4 mmm -68.37 -39.61 81.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.751 176.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.839 ' HG ' HD13 ' A' ' 69' ' ' LEU . 1.4 mm? -62.29 -59.63 4.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.02 -40.58 63.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.024 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -55.5 34.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.132 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.626 ' HB ' HD12 ' A' ' 34' ' ' ILE . 2.3 mp -80.6 -38.91 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.659 0.266 . . . . 0.0 111.704 -175.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.02 -50.31 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.703 178.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -57.83 -48.6 79.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.682 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.605 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.2 ptp180 -61.49 -22.35 65.01 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.183 0.302 . . . . 0.0 111.587 -175.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.81 12.76 13.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.117 -1.04 . . . . 0.0 113.472 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.616 HH11 ' HG3' ' A' ' 27' ' ' PRO . 7.3 tpt180 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 117.309 0.554 . . . . 0.0 112.008 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.521 ' H ' ' HB3' ' A' ' 23' ' ' GLU . 13.6 m . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -52.18 113.81 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.73 125.51 52.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.159 170.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.45 75.36 0.42 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.574 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.92 -64.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.684 2.256 . . . . 0.0 111.565 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.779 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 pt -104.77 141.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 177.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.544 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 56.3 m80 -96.26 31.42 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.779 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 18.7 Cg_endo -57.85 -163.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.36 0 C-N-CA 122.47 2.113 . . . . 0.0 112.798 161.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 10.2 Cg_endo -56.44 164.48 5.44 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.219 1.946 . . . . 0.0 112.208 168.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HB3' ' HE3' ' A' ' 20' ' ' MET . 44.4 Cg_endo -67.76 33.69 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.816 3.01 . . . . 0.0 114.393 -175.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 18' ' ' THR . 10.6 ptp180 -92.69 14.59 16.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 9.4 t 171.47 -16.58 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.672 177.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.2 m -78.21 -11.48 59.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.527 ' HE1' HG13 ' A' ' 76' ' ' VAL . 11.7 ptt? -150.56 69.75 0.99 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.836 0.827 . . . . 0.0 109.19 167.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.2 m -78.53 115.3 18.14 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.248 177.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 68' ' ' SER . 8.1 tp10 -94.4 119.76 33.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -172.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HB3' ' H ' ' A' ' 7' ' ' SER . 6.0 tp10 -104.87 102.75 12.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -91.43 125.66 36.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.837 -169.536 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 59.7 mtm180 -82.65 102.48 11.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 175.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.725 HG12 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -125.14 126.72 25.17 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.778 -177.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 54.6 Cg_exo -54.82 148.24 47.06 Favored 'Trans proline' 0 CA--C 1.521 -0.169 0 C-N-CA 123.537 2.824 . . . . 0.0 111.815 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' A' ' 31' ' ' VAL . 28.8 t70 -59.63 -36.83 77.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.918 -175.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -34.34 61.9 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.384 175.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.508 ' HE2' ' CA ' ' A' ' 90' ' ' GLY . 28.6 tpp -78.95 -22.96 44.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.93 -175.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 34' ' ' ILE . 3.7 p -76.85 -29.96 18.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.78 -26.93 67.6 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.851 169.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.63 -24.26 20.57 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 175.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 31' ' ' VAL . 9.3 tp -68.92 -32.23 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.74 0.781 . . . . 0.0 109.693 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.584 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.3 pt -71.95 -12.12 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.367 174.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.84 -8.75 27.59 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.845 163.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.689 ' HD3' ' HB2' ' A' ' 40' ' ' GLU . 11.8 ptm180 -174.75 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.045 -174.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.85 -2.09 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.767 179.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.584 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.08 -37.23 0.61 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.82 -1.181 . . . . 0.0 112.653 174.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.689 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 3.5 mp0 -56.73 -40.93 76.62 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -59.48 -44.81 92.96 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -168.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.645 HD12 HG13 ' A' ' 53' ' ' VAL . 8.5 tp -64.03 -48.08 87.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.445 -177.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.563 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.3 m-20 -65.87 -33.39 75.74 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -60.55 -49.65 76.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.161 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.95 -40.71 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.798 -178.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.563 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -70.55 -27.21 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.638 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.75 -40.48 40.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.66 -40.11 90.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.889 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.6 p -80.86 -42.78 20.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.235 -179.433 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.99 1.19 36.11 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 44.5 t -79.9 139.25 37.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.242 178.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.21 79.33 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.357 0.599 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG13 HD12 ' A' ' 42' ' ' ILE . 44.9 t -89.73 123.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.348 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -118.51 133.78 55.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 -176.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.435 HD13 HG12 ' A' ' 67' ' ' VAL . 43.3 mm -91.98 98.44 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 14.8 m -81.02 108.43 10.25 Favored Pre-proline 0 C--O 1.238 0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 -177.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 2.1 Cg_endo -83.85 -21.42 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.513 2.809 . . . . 0.0 112.693 -176.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.44 -38.3 35.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 t 68.94 -80.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.867 177.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.23 48.3 5.74 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.828 179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.71 -30.8 0.56 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.57 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.8 mm? -113.47 143.22 28.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.84 8.39 4.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.666 2.244 . . . . 0.0 111.098 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 6.0 pt-20 -126.7 -154.21 0.61 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.435 -175.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.725 ' HB3' HG12 ' A' ' 26' ' ' VAL . 4.6 tpp180 -94.88 140.91 29.27 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.559 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 33.5 p -116.64 108.78 16.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG21 HG13 ' A' ' 26' ' ' VAL . 94.1 t -96.74 114.69 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.123 -176.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -92.0 134.86 34.42 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.101 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 80' ' ' LYS . 2.0 mp -125.8 128.73 48.13 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -152.09 146.98 25.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.41 -137.99 4.96 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.024 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.36 161.43 37.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.03 -56.89 2.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.501 2.134 . . . . 0.0 113.041 -175.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.05 -37.71 81.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.486 -178.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -68.03 -48.42 65.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.414 -176.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.552 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 5.5 p -69.12 -33.75 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.138 -174.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.56 -35.41 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.652 0.263 . . . . 0.0 110.442 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -45.8 92.43 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.407 0.623 . . . . 0.0 109.846 176.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 53' ' ' VAL . . . -64.29 -35.96 82.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.348 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 50.0 mtmt -81.13 -22.91 38.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.246 0.546 . . . . 0.0 109.764 -176.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.2 ttt -65.11 -44.47 88.64 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.459 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.427 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 4.0 ppp? -73.2 -28.02 61.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.956 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -66.18 -55.37 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.585 177.396 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.53 -30.35 65.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.465 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.83 -60.79 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.192 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -73.0 -36.61 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -175.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.7 -21.68 28.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.186 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.2 t -72.34 -40.45 67.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 174.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 7.2 ptp180 -72.3 -17.35 61.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.754 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.508 ' CA ' ' HE2' ' A' ' 30' ' ' MET . . . -100.15 -49.27 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.347 -178.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 -177.183 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.503 ' HB2' ' HD3' ' A' ' 25' ' ' ARG . 12.1 p -153.8 156.52 37.85 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.132 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.3 m 72.9 -35.66 0.33 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.504 0.722 . . . . 0.0 112.229 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 6' ' ' SER . 19.3 mm-40 67.58 -68.2 0.16 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.116 0.966 . . . . 0.0 112.854 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.0 mt 70.89 -87.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.95 0.9 . . . . 0.0 111.231 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 99.41 0.25 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.177 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.2 -17.47 24.46 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.017 2.478 . . . . 0.0 112.131 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.812 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.1 tp -100.21 147.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.719 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 35.9 m-70 -90.77 -19.14 0.24 Allowed Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -36.21 163.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.447 2.765 . . . . 0.0 114.397 169.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -42.61 161.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.87 3.047 . . . . 0.0 114.06 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.722 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 18.1 Cg_endo -60.37 3.62 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.824 3.016 . . . . 0.0 114.523 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -59.32 -19.9 50.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.312 0.577 . . . . 0.0 109.519 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -151.11 -19.81 0.21 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.654 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 t -80.04 -2.53 44.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.067 0.46 . . . . 0.0 111.004 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.55 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.7 mmt -134.1 39.64 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.904 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 29.1 m -78.96 112.76 16.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.637 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.1 tp10 -114.16 117.31 30.86 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -99.49 104.52 16.35 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.46 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -90.19 116.28 28.06 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.841 -168.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 6' ' ' SER . 65.4 mtm180 -81.0 96.09 7.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.008 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -120.11 126.55 26.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.449 -173.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.35 135.74 46.81 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.193 2.595 . . . . 0.0 111.245 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 3.6 p-10 -60.49 -30.68 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.663 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.71 -31.06 63.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.802 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.705 ' HE2' HG23 ' A' ' 86' ' ' ILE . 95.9 mmm -78.04 -15.16 59.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 34' ' ' ILE . 91.4 t -76.02 -35.88 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.16 -28.73 64.52 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.128 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD11 ' SD ' ' A' ' 30' ' ' MET . 82.5 mt -89.17 -27.83 20.42 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.1 tp -69.24 -28.06 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.613 0.72 . . . . 0.0 109.648 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.681 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.9 pt -83.35 -15.0 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.598 174.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.06 -89.87 0.03 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.818 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.423 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 6.4 ptm180 -74.6 9.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.032 0.533 . . . . 0.0 111.623 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.26 9.51 27.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.953 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.681 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.74 -39.47 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.026 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 32.2 tt0 -64.49 -28.88 69.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -171.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.18 -51.98 67.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.274 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.42 -37.65 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.175 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -61.45 -43.97 97.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.7 mttm -54.06 -53.39 53.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.433 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.73 -42.92 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.102 -173.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -29.28 64.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.124 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -81.38 -32.45 32.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.183 0.516 . . . . 0.0 110.116 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.93 -46.82 56.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.7 p -67.56 -38.04 83.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.237 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.92 7.94 55.98 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 43.6 t -85.78 144.81 27.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.369 0.604 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -88.06 70.49 9.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.599 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.3 t -86.72 110.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -114.55 123.27 48.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.637 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.5 mm -79.78 124.53 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 37.2 t -112.68 109.85 52.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.619 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 74.1 Cg_endo -75.12 -16.13 20.1 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.983 2.456 . . . . 0.0 111.4 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.41 -33.25 42.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.623 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.629 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 9.6 t 70.45 -74.47 0.08 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.621 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.49 -61.52 0.51 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.409 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.93 -8.59 6.09 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.793 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 2.5 mm? -107.53 152.18 41.28 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.9 -28.07 3.49 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.292 1.995 . . . . 0.0 111.539 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.42 -169.6 2.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.131 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.619 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 24.4 mmt180 -79.81 153.1 29.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.629 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 99.1 p -124.28 117.93 25.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG23 HG11 ' A' ' 26' ' ' VAL . 59.1 t -97.75 124.2 50.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -95.63 127.51 41.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.57 0.7 . . . . 0.0 111.408 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.805 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -108.48 124.66 50.77 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.902 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.34 156.28 39.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.88 -128.0 2.15 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 119.838 -1.172 . . . . 0.0 113.121 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.722 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -111.53 165.41 12.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.693 ' HD2' ' HB2' ' A' ' 72' ' ' ALA . 14.1 Cg_endo -55.66 -40.83 83.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.182 1.921 . . . . 0.0 113.06 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.33 -31.89 22.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.462 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 53.6 p -71.03 -46.4 62.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -64.99 -23.79 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.864 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.61 -55.28 7.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.131 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -55.48 -45.46 76.97 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.615 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.41 -51.22 70.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.609 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.805 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mtmt -75.71 -20.03 58.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.53 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 tpt -59.81 -49.89 75.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.522 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.0 mmt -66.06 -38.59 88.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 110.874 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.34 -44.82 95.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.35 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.53 -46.01 84.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.106 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.67 -59.6 4.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.842 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.705 HG23 ' HE2' ' A' ' 30' ' ' MET . 2.0 mp -72.69 -41.23 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.46 HG21 ' CD1' ' A' ' 24' ' ' TYR . 93.1 t -70.38 -25.32 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.683 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.6 t -72.95 -40.81 65.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.677 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.2 ptp180 -77.9 -6.89 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.686 0.279 . . . . 0.0 111.17 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.1 -46.81 0.8 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.483 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -4.16 25.0 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.518 -0.401 . . . . 0.0 111.291 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.77 -68.68 3.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.164 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.922 -0.932 . . . . 0.0 111.525 -179.499 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.766 HD12 ' H1 ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.757 0.313 . . . . 0.0 111.776 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 23' ' ' GLU . 11.2 p -89.28 177.12 6.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.302 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 35.2 t 74.11 -69.71 0.18 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.259 0.624 . . . . 0.0 110.122 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -161.42 106.35 1.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 0.0 110.093 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.545 HD11 ' HA ' ' A' ' 5' ' ' ILE . 24.4 tp -91.41 96.6 10.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.4 70.92 0.33 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.03 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 6.7 Cg_exo -73.96 -38.37 2.29 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.561 2.174 . . . . 0.0 111.332 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.58 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 12.4 pt -121.81 152.42 25.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.699 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.65 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 72.7 t60 -89.08 -26.22 0.32 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.65 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.0 Cg_exo -39.15 159.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.79 2.327 . . . . 0.0 114.049 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 17' ' ' ARG . 4.6 Cg_exo -38.16 144.38 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.127 3.218 . . . . 0.0 113.828 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.613 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 46.3 Cg_endo -66.77 31.32 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.539 3.493 . . . . 0.0 114.493 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.803 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 ppt_? -82.63 0.06 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 0.0 110.176 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.803 HG22 ' HD2' ' A' ' 17' ' ' ARG . 11.9 t -179.46 -17.76 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.489 ' HB3' HG13 ' A' ' 12' ' ' ILE . 3.7 m -78.32 -80.92 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.583 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.613 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.6 ptp -76.24 76.61 3.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.9 m -81.82 114.01 20.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.2 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.492 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 15.3 tt0 -94.04 118.01 30.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 6.9 tp10 -99.29 104.98 16.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.676 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -90.82 118.78 30.5 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.684 -168.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -81.86 99.1 8.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.685 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.627 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -116.63 123.52 30.4 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.763 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.491 ' HG2' ' HG2' ' A' ' 30' ' ' MET . 31.9 Cg_endo -66.36 152.55 80.71 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.482 2.121 . . . . 0.0 111.832 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -52.72 -42.02 64.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.88 93.21 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.482 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.536 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 88.4 mmm -78.84 -23.49 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.431 -0.452 . . . . 0.0 111.354 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 34' ' ' ILE . 2.8 p -74.26 -30.55 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.672 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -28.82 69.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.925 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.29 -23.92 22.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.7 tp -70.3 -25.55 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.691 0.758 . . . . 0.0 109.597 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.81 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 9.4 pt -85.33 -14.73 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.434 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.17 -91.18 0.02 OUTLIER Glycine 0 C--N 1.336 0.574 0 O-C-N 124.209 0.943 . . . . 0.0 113.191 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 1.011 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.5 ptm180 -76.99 44.9 0.41 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.166 0.587 . . . . 0.0 111.501 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.06 13.78 80.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 114.354 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.81 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 135.51 -36.09 2.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.623 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.011 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 71.8 tt0 -57.75 -33.9 68.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -59.91 -52.42 65.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.712 0.291 . . . . 0.0 111.361 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.658 HD11 HG12 ' A' ' 53' ' ' VAL . 10.0 tp -63.8 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.106 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -58.33 -40.66 82.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 13.7 mmmm -60.32 -59.96 4.58 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.86 -41.54 93.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -33.2 72.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.015 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 47' ' ' GLN . 1.0 OUTLIER -77.95 -37.88 46.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.469 0.652 . . . . 0.0 109.539 176.07 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.45 -26.07 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.198 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 34.1 p -99.65 -44.85 5.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.95 8.96 21.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.06 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 21.0 t -92.77 136.97 32.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 110.855 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -79.77 79.05 6.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.922 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.658 HG12 HD11 ' A' ' 42' ' ' ILE . 40.6 t -82.64 109.52 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 14.5 mm-40 -101.03 116.05 31.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.531 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.5 mm -89.7 96.95 6.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.743 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 m -88.36 105.39 9.36 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.812 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.588 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 2.8 Cg_exo -75.43 -22.09 14.42 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.321 2.681 . . . . 0.0 111.641 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -79.62 -38.08 34.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.001 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.62 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.3 t 71.41 -54.09 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.556 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.94 -71.79 2.9 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.646 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.78 -9.44 61.13 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.958 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.617 ' HB2' ' OG ' ' A' ' 59' ' ' SER . 2.1 mm? -121.49 154.48 59.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -85.5 -4.3 9.25 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 111.985 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 6.3 pt-20 -111.03 -141.05 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.817 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.627 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.0 tpp180 -107.4 140.15 40.78 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 67.2 p -116.94 111.64 19.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.348 0.594 . . . . 0.0 109.944 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 55' ' ' ILE . 84.7 t -100.83 119.53 49.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.776 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.458 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 29.7 m -88.68 128.24 35.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.329 0.585 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.861 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.9 mm? -107.31 108.09 19.32 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.805 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 18' ' ' THR . 0.7 OUTLIER -151.2 119.45 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.005 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -158.88 -107.34 0.24 Allowed Glycine 0 C--O 1.225 -0.455 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.734 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -129.35 163.63 44.97 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.6 -51.22 8.37 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.463 2.109 . . . . 0.0 112.859 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -72.65 -46.86 51.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.362 0.601 . . . . 0.0 110.698 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.7 m -62.47 -45.5 92.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.818 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.541 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.1 p -71.23 -27.87 30.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 -174.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -40.2 49.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.32 . . . . 0.0 110.385 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.721 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.8 tpmt? -64.26 -46.59 83.04 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.659 0.742 . . . . 0.0 109.818 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.24 -46.5 76.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.294 176.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.861 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 37.7 mtmt -73.5 -22.45 60.13 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.721 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.5 -31.09 68.05 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.458 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.0 mmt -69.02 -46.7 67.3 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.677 172.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.403 ' HG ' HD23 ' A' ' 69' ' ' LEU . 4.4 mm? -61.51 -48.59 80.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.87 -40.5 69.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.266 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.8 -57.62 12.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.947 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.687 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -72.13 -41.52 67.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.758 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.676 HG22 ' CD1' ' A' ' 24' ' ' TYR . 85.8 t -64.57 -32.42 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.336 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 t -73.25 -37.77 66.21 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.455 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.687 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.5 ptp180 -78.41 -7.6 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.929 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -107.41 -64.89 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.344 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -81.79 -33.8 30.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.61 -6.39 83.49 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.111 -179.003 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.524 HD12 ' H1 ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.273 0.559 . . . . 0.0 109.895 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m -98.0 91.0 5.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.297 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.537 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 62.6 m -77.52 178.04 7.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.861 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.616 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 68.5 mm-40 53.78 -162.3 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.48 0.712 . . . . 0.0 111.621 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 28.8 tp 173.05 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 121.76 92.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.952 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.09 -26.13 26.32 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.998 2.466 . . . . 0.0 111.385 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.639 HG22 ' HD2' ' A' ' 14' ' ' PRO . 4.1 mt -77.17 108.45 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.658 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 23.3 m170 -89.72 7.12 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -168.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.658 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 20.5 Cg_exo -46.1 -176.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.82 1.68 . . . . 0.0 112.863 158.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' C ' ' H ' ' A' ' 17' ' ' ARG . 67.5 Cg_exo -42.14 158.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.983 2.455 . . . . 0.0 113.557 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 26.8 Cg_endo -64.4 17.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.79 2.993 . . . . 0.0 114.207 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.465 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -74.43 -6.55 48.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.0 109.961 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.416 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.3 t -158.71 -25.96 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.609 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.0 t -79.31 8.12 6.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.812 0.339 . . . . 0.0 111.083 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.756 ' HA ' ' HE1' ' A' ' 20' ' ' MET . 1.5 mmt -145.58 32.67 1.06 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.397 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 40.1 m -79.51 110.99 15.33 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.21 118.97 34.28 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.616 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.9 tt0 -84.91 104.12 14.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.85 109.46 20.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.259 -174.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 96.7 mtt180 -87.37 98.83 11.57 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.21 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -112.65 128.87 25.01 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.936 -173.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 20.0 Cg_exo -60.7 143.51 99.41 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 123.276 2.651 . . . . 0.0 111.773 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.82 -50.62 56.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -170.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.87 -29.8 75.24 Favored Glycine 0 C--O 1.237 0.333 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.413 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.771 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 80.3 mmm -77.45 -21.0 53.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.657 ' O ' HG12 ' A' ' 35' ' ' ILE . 41.4 t -66.19 -37.98 80.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -63.17 -29.38 74.28 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.708 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.81 -25.17 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.607 HG21 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -75.77 -29.48 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.3 0.572 . . . . 0.0 109.815 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.657 HG12 ' O ' ' A' ' 31' ' ' VAL . 8.8 pt -83.32 -13.51 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.181 172.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.15 -91.02 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.087 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.957 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 16.9 ptm180 -71.18 -9.52 58.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.712 0.405 . . . . 0.0 111.451 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.84 3.38 7.66 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.294 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.606 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -58.93 0.25 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.314 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 18.8 tp10 -55.17 -21.96 15.45 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -65.7 -48.45 71.99 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.02 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 39' ' ' GLY . 9.9 tp -63.98 -37.87 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -53.78 -49.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.629 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 22.1 mmtm -66.95 -41.76 86.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.299 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.19 -41.17 86.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -22.87 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.017 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -78.24 -42.57 30.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.335 0.588 . . . . 0.0 110.047 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.61 -43.77 93.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.01 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 23.1 p -83.69 -43.06 15.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.291 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.8 10.49 26.54 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.559 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 t -79.71 141.73 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 0.0 110.475 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 50.9 mmtt -94.22 67.34 3.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.438 0.637 . . . . 0.0 109.615 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.435 HG21 HD13 ' A' ' 69' ' ' LEU . 2.2 p -82.5 142.88 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.127 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -136.53 114.86 11.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.518 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.459 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 36.9 mm -79.63 104.65 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.39 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 6.2 t -92.35 105.43 14.14 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 3.2 Cg_exo -75.93 -30.79 5.57 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.45 2.767 . . . . 0.0 112.724 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.53 -29.67 46.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.535 ' HA ' ' HG ' ' A' ' 66' ' ' SER . 7.4 t 73.19 -67.53 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.821 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.99 76.83 0.88 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.823 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.08 -57.69 0.68 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.815 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.447 HD11 ' CZ ' ' A' ' 25' ' ' ARG . 1.3 mm? -87.57 144.15 35.02 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.05 -23.92 8.73 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.435 2.09 . . . . 0.0 110.225 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 6.6 pt-20 -88.99 -168.67 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.556 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.732 ' HB3' HG11 ' A' ' 26' ' ' VAL . 4.0 tpp180 -87.08 139.46 30.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.146 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.535 ' HG ' ' HA ' ' A' ' 59' ' ' SER . 15.9 p -117.28 111.34 19.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.43 HG12 HD13 ' A' ' 55' ' ' ILE . 49.1 t -109.32 131.74 59.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.694 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.6 m -91.79 125.59 36.56 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.022 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 21' ' ' THR . 4.0 mm? -104.57 111.45 24.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.025 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 m -152.29 147.98 26.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.654 0.206 . . . . 0.0 111.036 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.74 -156.72 28.8 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.018 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.595 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -78.3 161.62 69.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.595 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.8 Cg_endo -48.53 -54.96 4.56 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.008 2.472 . . . . 0.0 113.417 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.48 -37.07 77.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.088 0.47 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.667 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 9.0 m -66.6 -51.66 53.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.425 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 p -67.62 -26.48 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.267 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -71.74 -45.26 62.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.388 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 81' ' ' MET . 1.3 tmtp? -68.6 -39.23 80.98 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.362 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.444 ' O ' HD22 ' A' ' 83' ' ' LEU . . . -62.07 -40.85 97.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.977 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 45.8 mtmt -80.96 -21.32 40.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.1 tpt -57.15 -50.7 72.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.357 173.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 92.9 mmm -68.96 -39.8 79.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 111.038 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.444 HD22 ' O ' ' A' ' 79' ' ' ALA . 3.7 mm? -62.67 -47.84 81.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.96 -45.67 78.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.042 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.0 -54.23 47.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.669 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.575 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.7 mp -75.24 -41.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.7 -23.65 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.291 -174.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -75.2 -41.42 57.88 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.799 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.575 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.9 ptm180 -76.74 -6.96 54.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.771 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -105.72 -52.44 0.8 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.982 -0.627 . . . . 0.0 113.597 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -84.56 95.28 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.311 0.577 . . . . 0.0 112.33 -175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.68 52.73 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.519 -1.156 . . . . 0.0 110.917 176.318 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.385 0.612 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -73.0 88.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.12 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 23' ' ' GLU . 62.2 m -173.31 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.991 0.917 . . . . 0.0 109.41 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -176.01 163.03 2.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.201 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 75.1 mt -138.78 107.32 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.669 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -126.32 57.66 0.69 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.627 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.444 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 92.0 Cg_endo -93.88 -2.68 3.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.002 2.468 . . . . 0.0 112.387 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.571 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 30.9 pt -126.51 149.17 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.813 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.586 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 22.1 m80 -91.18 -19.56 0.24 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 93.2 Cg_exo -38.81 162.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.671 2.247 . . . . 0.0 114.324 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.62 152.64 8.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.847 2.364 . . . . 0.0 112.077 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 42.4 Cg_endo -65.99 7.56 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.423 2.748 . . . . 0.0 113.788 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.87 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.18 0.514 . . . . 0.0 110.284 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -159.29 7.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.14 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.431 ' HA ' HD11 ' A' ' 12' ' ' ILE . 30.8 t -93.28 -104.64 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.297 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.463 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptm -63.95 74.22 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.045 0.926 . . . . 0.0 111.712 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.62 HG22 ' HG1' ' A' ' 70' ' ' THR . 62.5 m -90.04 139.02 31.02 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.622 ' CG ' ' HD3' ' A' ' 80' ' ' LYS . 10.9 mm-40 -95.33 148.87 21.97 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.299 168.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' HB3' ' H ' ' A' ' 7' ' ' SER . 54.5 tp10 -120.34 98.76 6.2 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 160.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.505 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.36 124.57 37.43 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.266 -161.453 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.939 ' HG2' HD21 ' A' ' 62' ' ' LEU . 32.6 mtm180 -81.78 111.38 17.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.473 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -130.31 126.59 22.25 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.893 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 35.0 Cg_exo -60.07 151.38 72.96 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.488 2.792 . . . . 0.0 112.658 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' O ' HG13 ' A' ' 31' ' ' VAL . 35.5 t70 -55.17 -51.91 65.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.03 75.05 Favored Glycine 0 C--O 1.236 0.253 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.935 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.549 ' HE3' ' CA ' ' A' ' 90' ' ' GLY . 28.0 tpp -79.53 -32.05 42.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.473 -175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.559 ' O ' HG22 ' A' ' 34' ' ' ILE . 12.7 p -72.69 -24.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.2 74.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.06 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.45 -24.55 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.56 HD11 ' HB ' ' A' ' 86' ' ' ILE . 10.7 tp -72.93 -27.93 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 109.663 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 11.9 pt -85.05 -13.59 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.348 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.33 -93.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 O-C-N 124.164 0.915 . . . . 0.0 113.066 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.931 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -72.99 48.68 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.179 0.592 . . . . 0.0 111.027 177.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.15 20.8 58.62 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.113 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.605 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.05 -50.91 0.58 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.809 -1.186 . . . . 0.0 113.602 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.931 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 22.2 tt0 -54.62 -33.49 60.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.508 ' O ' HG12 ' A' ' 45' ' ' ILE . 24.5 tt0 -60.03 -48.4 81.85 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.473 -171.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 53' ' ' VAL . 9.8 tp -60.59 -38.48 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.214 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 60.2 m-20 -65.32 -44.69 87.02 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.58 -31.94 69.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.534 0.207 . . . . 0.0 111.035 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 41' ' ' GLN . 26.4 mm -76.32 -50.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.989 0.423 . . . . 0.0 111.357 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.45 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -75.72 -24.64 56.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.408 -174.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -82.95 -34.48 26.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.684 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.81 -46.02 76.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.869 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.603 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 25.8 p -73.04 -48.04 39.57 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.209 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 13.47 25.7 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.4 t -92.84 143.36 26.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.954 0.407 . . . . 0.0 110.706 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 41.4 mtmt -81.6 72.09 8.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.73 HG12 HD13 ' A' ' 42' ' ' ILE . 57.9 t -82.4 110.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.397 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.412 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 15.7 mm-40 -110.99 122.44 47.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.123 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.574 HD13 HG12 ' A' ' 42' ' ' ILE . 42.7 mm -88.9 99.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.79 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.5 t -81.08 115.14 54.18 Favored Pre-proline 0 C--O 1.243 0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.576 ' HA ' HH11 ' A' ' 65' ' ' ARG . 97.4 Cg_endo -79.65 -27.54 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.367 2.712 . . . . 0.0 112.061 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.65 -40.32 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.457 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.54 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 11.0 t 70.72 -69.11 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.236 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.57 -96.54 0.54 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.061 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.06 -12.47 79.36 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.654 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.939 HD21 ' HG2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -94.78 139.93 22.38 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.796 0.332 . . . . 0.0 110.817 -176.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.09 -2.46 9.52 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.8 2.333 . . . . 0.0 111.434 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' CD ' HH21 ' A' ' 91' ' ' ARG . 2.5 pt-20 -110.64 -104.06 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.31 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.576 HH11 ' HA ' ' A' ' 57' ' ' PRO . 6.7 tpp180 -144.57 155.4 43.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 78.0 p -136.94 146.97 46.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.373 173.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.454 HG11 HD12 ' A' ' 55' ' ' ILE . 52.2 t -123.3 131.06 73.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -91.48 131.23 37.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.2 0.524 . . . . 0.0 110.768 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 22' ' ' GLU . 3.6 mm? -114.09 104.03 11.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.62 ' HG1' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER -147.2 124.19 11.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.389 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.76 -158.03 19.2 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.333 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.11 161.88 69.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -45.67 -52.24 7.09 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.79 2.326 . . . . 0.0 112.945 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.5 -43.33 81.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.6 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.603 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.3 m -64.94 -49.62 69.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.618 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.55 -23.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.162 -175.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.535 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.2 tt0 -72.55 -52.37 15.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.886 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.4 tppp? -55.04 -43.47 73.8 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.191 0.52 . . . . 0.0 110.588 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.94 63.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.725 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.622 ' HD3' ' CG ' ' A' ' 22' ' ' GLU . 11.2 mtmm -66.91 -23.06 65.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.616 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.7 mmt -59.77 -52.72 64.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.422 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 20.4 mmt -68.37 -37.71 80.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.5 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.3 mm? -60.48 -54.99 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.183 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -60.3 -34.86 74.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 110.559 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.39 -55.98 17.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.56 ' HB ' HD11 ' A' ' 34' ' ' ILE . 1.9 mp -74.09 -41.48 52.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.365 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG22 ' CD1' ' A' ' 24' ' ' TYR . 87.9 t -64.18 -28.1 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.23 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 t -75.73 -31.63 59.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.342 -0.224 . . . . 0.0 110.91 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 17.4 ptp180 -77.74 -12.44 59.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.549 ' CA ' ' HE3' ' A' ' 30' ' ' MET . . . -106.33 -50.07 0.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.957 176.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.427 HH21 ' CD ' ' A' ' 64' ' ' GLU . 26.3 mmt180 -92.22 -77.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.293 0.237 . . . . 0.0 111.6 -177.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.73 69.68 3.25 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.652 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.803 -0.998 . . . . 0.0 111.804 -179.346 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -144.07 134.39 24.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.275 0.56 . . . . 0.0 111.904 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.984 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 34.1 m -92.69 163.45 13.76 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -158.2 121.46 3.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.022 0.439 . . . . 0.0 110.34 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.26 104.08 15.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.085 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.57 69.38 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.891 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -84.95 -27.29 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.656 2.238 . . . . 0.0 112.991 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.68 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 6.0 mm -120.49 147.32 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.611 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 24.7 t60 -93.53 12.03 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.718 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -170.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.68 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 29.8 Cg_endo -61.06 -166.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 122.33 2.02 . . . . 0.0 113.958 171.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.511 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 67.3 Cg_exo -56.63 167.08 3.08 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.358 2.039 . . . . 0.0 112.517 168.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.1 33.63 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 124.189 3.259 . . . . 0.0 114.708 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' O ' ' HB ' ' A' ' 18' ' ' THR . 4.7 ptp180 -96.92 13.17 29.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 15.0 t 174.53 -15.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.289 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -79.97 -6.42 57.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.629 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.42 58.14 0.4 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.22 0.533 . . . . 0.0 110.354 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -78.21 110.83 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 7' ' ' SER . 12.7 tt0 -98.9 119.57 37.9 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -172.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.984 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 4.6 tp10 -92.34 102.01 14.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -90.96 126.24 36.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.112 0.482 . . . . 0.0 110.739 -171.604 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -91.09 98.12 11.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.083 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG12 HH21 ' A' ' 65' ' ' ARG . 1.3 p -120.37 114.33 33.27 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.528 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.594 ' HA ' ' CB ' ' A' ' 64' ' ' GLU . 50.3 Cg_exo -57.5 164.25 7.5 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 124.454 3.436 . . . . 0.0 114.38 -169.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.91 -45.34 74.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 0.0 111.845 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.417 ' O ' HD23 ' A' ' 33' ' ' LEU . . . -63.76 -34.04 88.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.806 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.567 ' HA ' ' HE3' ' A' ' 30' ' ' MET . 31.4 mmt -80.25 -25.81 39.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -175.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -70.77 -33.89 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.934 172.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.37 77.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.708 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 29' ' ' GLY . 4.2 mm? -87.01 -24.02 24.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.963 HG22 HH22 ' A' ' 65' ' ' ARG . 10.8 tp -71.43 -30.49 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 109.249 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.62 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.0 pt -86.99 -14.05 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.731 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.76 -90.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.918 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.05 -6.91 9.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.998 -0.601 . . . . 0.0 111.946 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.9 4.42 9.5 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.824 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.62 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.17 -44.91 0.5 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.182 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.4 -26.31 66.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.59 -45.29 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.94 -174.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -65.39 -34.0 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.973 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -61.47 -38.67 88.11 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -37.63 64.81 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 41' ' ' GLN . 98.1 mt -64.13 -52.74 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 111.258 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -21.87 59.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -84.14 -35.56 23.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.508 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.17 -39.49 78.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.666 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 p -84.07 -39.78 19.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.477 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.57 3.45 59.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.687 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' ALA . 54.0 t -80.31 146.15 31.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.949 0.404 . . . . 0.0 110.533 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.711 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 10.9 mmpt? -84.98 81.01 9.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -81.92 107.16 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.429 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.7 mm-40 -95.93 106.68 18.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.933 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.547 HG22 HH11 ' A' ' 65' ' ' ARG . 33.2 mm -81.12 110.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.637 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -97.38 98.57 5.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 39.5 Cg_exo -60.05 -41.36 53.17 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 112.419 -173.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -115.36 102.99 10.35 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.5 t -68.92 -26.0 64.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.751 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.07 -82.01 1.39 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.191 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.27 -31.04 77.88 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.782 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.31 138.52 20.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.979 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.86 -19.52 23.51 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.783 2.322 . . . . 0.0 110.784 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.594 ' CB ' ' HA ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -96.69 -174.35 2.99 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.183 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.963 HH22 HG22 ' A' ' 34' ' ' ILE . 5.7 tmm_? -94.84 141.3 28.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.529 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 79.5 p -115.26 150.82 35.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.382 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 82.6 t -129.96 114.34 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.701 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.3 m -85.87 129.95 34.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.399 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.997 HD13 ' HG2' ' A' ' 80' ' ' LYS . 5.4 mt -114.94 121.75 44.14 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.8 m -151.33 141.29 22.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.247 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.89 -136.94 4.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.482 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.575 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -96.13 163.11 21.64 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.575 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 5.7 Cg_endo -48.05 -48.35 16.72 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.798 2.332 . . . . 0.0 112.854 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.36 -39.67 53.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 p -70.94 -47.69 57.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.104 0.478 . . . . 0.0 110.441 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.73 -29.2 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.228 -177.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.68 -50.99 46.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 81' ' ' MET . 50.8 tptt -63.13 -40.56 97.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.758 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 51' ' ' CYS . . . -58.81 -41.71 87.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.138 0.494 . . . . 0.0 111.082 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.997 ' HG2' HD13 ' A' ' 69' ' ' LEU . 48.5 mtmt -81.18 -21.89 39.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.957 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 7.8 tpt -59.1 -50.58 73.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.357 174.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mmm -70.25 -37.53 74.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.593 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.4 mm? -60.37 -55.09 37.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.418 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -55.18 -34.92 64.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.766 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.72 -56.57 19.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.575 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -70.13 -40.21 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.336 0.588 . . . . 0.0 110.77 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 83' ' ' LEU . 74.4 t -62.41 -28.47 44.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.293 0.568 . . . . 0.0 110.106 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -75.4 -31.13 60.32 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.164 -0.335 . . . . 0.0 110.759 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.603 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.5 ptm180 -78.31 -15.74 58.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.616 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.424 ' HA3' ' SD ' ' A' ' 30' ' ' MET . . . -158.21 44.94 0.47 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.009 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 87' ' ' VAL . 7.6 tpm_? -160.44 -50.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.551 0.676 . . . . 0.0 110.084 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.03 -158.27 34.15 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.938 -0.923 . . . . 0.0 111.588 179.473 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 9' ' ' LEU . 14.4 tt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -100.74 141.3 33.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 m 70.53 -163.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.663 0.602 . . . . 0.0 111.517 178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -56.84 120.0 7.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 20' ' ' MET . 53.2 tp -100.19 102.61 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.791 168.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.499 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -132.69 57.33 0.72 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.774 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.692 ' HD2' HD12 ' A' ' 12' ' ' ILE . 5.8 Cg_exo -78.51 -46.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.48 2.12 . . . . 0.0 111.368 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.785 ' H ' HD12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.28 147.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.837 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.668 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 53.5 m80 -91.12 -19.21 0.24 Allowed Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.6 Cg_endo -53.67 164.8 2.04 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.31 2.007 . . . . 0.0 113.482 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 17' ' ' ARG . 85.0 Cg_exo -46.65 149.25 3.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.201 2.601 . . . . 0.0 112.791 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 39.7 Cg_endo -65.53 26.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.567 3.511 . . . . 0.0 114.437 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.765 ' HG3' HG23 ' A' ' 18' ' ' THR . 13.3 ptp180 -82.23 -20.96 36.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.151 0.5 . . . . 0.0 110.004 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.765 HG23 ' HG3' ' A' ' 17' ' ' ARG . 9.8 t -168.62 34.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.691 0.758 . . . . 0.0 110.458 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.9 p -126.12 -80.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.611 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.1 ptm -74.55 79.13 1.96 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.0 m -79.48 118.78 21.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.867 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.564 ' O ' ' HA ' ' A' ' 68' ' ' SER . 6.2 tp10 -92.83 118.24 30.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -100.4 103.42 14.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.43 123.62 36.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.207 0.527 . . . . 0.0 111.9 -172.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -81.65 110.35 16.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.939 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 1.3 p -132.76 127.04 20.21 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.294 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.436 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.0 Cg_exo -54.62 136.51 70.94 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.268 2.645 . . . . 0.0 111.038 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.4 -29.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.352 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.34 -28.95 57.03 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.626 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.609 ' SD ' HD13 ' A' ' 33' ' ' LEU . 32.8 tpp -77.5 -20.68 53.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.674 ' HA ' HG23 ' A' ' 34' ' ' ILE . 80.1 t -69.15 -39.21 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.377 169.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.54 -28.45 56.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.65 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.609 HD13 ' SD ' ' A' ' 30' ' ' MET . 81.1 mt -85.78 -29.99 23.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.674 HG23 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -72.1 -29.52 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.267 0.556 . . . . 0.0 109.969 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.726 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 17.9 pt -80.38 -13.24 12.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.512 174.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 -97.19 0.19 Allowed Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.459 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 1.087 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 19.5 ptp180 -60.0 -24.86 64.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.003 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.04 30.79 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.486 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.726 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.84 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.306 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.087 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 9.5 mp0 -60.86 -21.63 63.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -168.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' O ' HG12 ' A' ' 45' ' ' ILE . 9.1 tt0 -60.1 -50.67 72.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.367 0.53 . . . . 0.0 110.765 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.489 HG12 HD11 ' A' ' 55' ' ' ILE . 8.9 tp -64.45 -39.18 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.29 -46.3 76.21 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.407 0.622 . . . . 0.0 110.037 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -65.57 -37.65 87.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.246 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 41' ' ' GLN . 22.9 mm -68.19 -51.17 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 111.267 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.32 -31.3 65.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.675 -173.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -78.84 -31.48 45.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.823 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.14 -45.48 56.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.344 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 p -68.12 -45.21 74.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.76 -0.28 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.542 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.742 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 47.3 t -83.36 135.95 34.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.775 0.321 . . . . 0.0 110.286 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -80.62 72.86 7.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.54 HG21 HD21 ' A' ' 69' ' ' LEU . 43.3 t -82.52 111.32 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -111.26 118.03 34.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.176 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 42' ' ' ILE . 34.2 mm -79.75 115.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -99.71 104.81 30.28 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.555 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.866 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 60.1 Cg_endo -73.62 -21.95 18.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.989 2.46 . . . . 0.0 111.88 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.87 -32.39 23.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.878 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.541 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 21.4 t 65.39 -77.32 0.04 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.804 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.09 -86.16 0.36 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.084 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.88 -3.07 60.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.86 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.491 ' HB2' ' OG ' ' A' ' 59' ' ' SER . 2.0 mm? -112.92 147.68 37.74 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.279 . . . . 0.0 110.494 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.98 -10.15 11.62 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.124 2.549 . . . . 0.0 111.556 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 4.2 pt-20 -104.27 -147.54 0.39 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.524 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.866 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 19.3 mmt180 -106.53 139.88 40.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.1 p -110.75 108.11 17.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.496 0.665 . . . . 0.0 109.347 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 55' ' ' ILE . 64.7 t -97.08 108.16 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.249 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -86.88 134.7 33.51 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.954 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.54 HD21 HG21 ' A' ' 53' ' ' VAL . 2.3 mp -123.5 121.87 36.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.163 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -151.92 121.46 6.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.026 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.742 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.04 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.177 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.667 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . . . -160.85 165.45 17.25 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.667 ' HD2' ' HB2' ' A' ' 72' ' ' ALA . 8.6 Cg_endo -49.93 -47.0 25.27 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 113.284 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.19 -38.94 23.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.431 0.634 . . . . 0.0 110.152 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -65.69 -46.17 80.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.789 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 p -73.06 -23.6 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 0.0 110.332 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.502 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.7 tp60 -76.47 -47.84 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.966 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 81' ' ' MET . 17.2 tppt? -60.64 -45.23 94.88 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.778 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.32 79.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.471 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 47.5 mtmt -69.1 -21.04 64.07 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.908 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.1 mmt -61.25 -48.04 83.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.211 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.24 -41.24 97.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.704 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -64.12 -57.33 9.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.361 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.56 -35.89 61.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.317 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.01 -61.44 2.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.013 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.542 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.1 mp -70.41 -38.77 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.052 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 83' ' ' LEU . 77.9 t -61.45 -36.69 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.333 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t -71.17 -22.67 62.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.835 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -59.83 -49.2 78.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.471 ' CA ' ' HE2' ' A' ' 30' ' ' MET . . . -81.31 -54.9 3.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.385 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.458 HH21 ' CD ' ' A' ' 64' ' ' GLU . 39.3 mmt180 -85.41 95.41 9.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.354 0.662 . . . . 0.0 110.372 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.6 31.95 4.08 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.911 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.796 179.094 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 HD13 ' HA3' ' A' ' 61' ' ' GLY . 8.5 tp . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 121.544 0.687 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 p -124.97 155.96 38.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.299 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.482 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 8.1 m 62.91 -153.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.469 0.481 . . . . 0.0 109.751 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.567 ' HB3' ' O ' ' A' ' 21' ' ' THR . 60.0 tp60 170.83 -31.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.068 0.855 . . . . 0.0 108.964 171.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 67.55 -90.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.663 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 148.06 94.94 0.15 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.134 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.36 -12.96 30.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.806 2.337 . . . . 0.0 111.854 176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.771 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -99.69 161.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.651 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 31.5 t-80 -92.5 -37.95 0.35 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 51.8 Cg_exo -32.58 144.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.874 3.049 . . . . 0.0 114.387 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.486 ' O ' ' N ' ' A' ' 17' ' ' ARG . 73.1 Cg_exo -40.58 140.76 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.376 2.717 . . . . 0.0 112.29 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 9.5 Cg_endo -51.79 60.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.132 1 C-N-CA 125.652 4.234 . . . . 0.0 116.884 -168.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 15' ' ' PRO . 11.9 ptp180 -114.84 15.11 17.45 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -178.87 -25.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.513 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.482 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 12.8 m -86.2 10.86 13.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.438 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.625 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 90.1 mmm -147.38 31.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.466 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 88.4 m -79.88 115.75 19.64 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.482 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 9.3 tt0 -123.89 118.04 26.18 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.3 109.29 20.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.599 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -92.1 128.22 37.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.003 -170.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.534 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 87.8 mtm180 -88.14 101.72 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.518 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -120.4 120.4 29.91 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.079 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.536 ' HD3' ' HG2' ' A' ' 91' ' ' ARG . 85.4 Cg_exo -50.11 145.71 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.878 3.052 . . . . 0.0 112.207 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -60.5 -37.04 79.81 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.587 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.76 -25.3 53.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.791 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.626 ' HE2' ' HA2' ' A' ' 90' ' ' GLY . 35.5 tpp -79.54 -26.67 41.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.203 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 34' ' ' ILE . 7.5 p -75.81 -30.18 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -28.3 62.25 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.16 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -88.87 -24.24 22.57 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.619 HG23 ' O ' ' A' ' 31' ' ' VAL . 9.8 tp -70.8 -27.47 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.313 0.578 . . . . 0.0 109.892 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.618 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 pt -81.15 -14.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.431 173.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 61.09 -90.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 O-C-N 124.187 0.929 . . . . 0.0 113.155 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.06 28.15 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.15 0.58 . . . . 0.0 111.991 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 96.0 -10.38 67.99 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.271 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.618 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -51.87 0.27 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.872 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 5.0 mm-40 -59.12 -22.41 60.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -53.24 52.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.763 0.71 . . . . 0.0 111.34 -172.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.91 -44.44 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.48 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -59.68 -42.95 94.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.0 109.68 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 4.5 ttmm -63.25 -35.73 81.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.569 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.01 -50.67 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.79 84.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.808 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -73.97 -37.49 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.76 -45.03 91.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -73.19 -46.54 49.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.81 8.63 9.63 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.789 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 22.9 t -84.21 139.55 32.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.625 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -94.36 71.82 3.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.742 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.66 120.93 35.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.236 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.5 mm-40 -117.03 119.53 35.57 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.213 0.53 . . . . 0.0 111.032 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.48 HD12 HG12 ' A' ' 67' ' ' VAL . 32.6 mm -85.16 109.06 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.522 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.803 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 10.0 m -91.12 109.76 37.63 Favored Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 120.695 0.283 . . . . 0.0 110.641 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.59 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 32.8 Cg_endo -64.81 -50.96 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.987 2.458 . . . . 0.0 111.941 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.95 94.08 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.859 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.3 p -74.6 -29.74 61.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.329 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.71 -86.56 1.34 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.712 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.487 ' HA3' HD13 ' A' ' 5' ' ' ILE . . . -75.98 -12.03 84.29 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.506 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.859 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.9 mp -110.0 144.47 30.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.73 -37.67 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.453 2.102 . . . . 0.0 111.931 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.69 -154.26 0.36 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.322 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 17.0 tpp180 -85.78 154.97 21.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.803 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 73.8 p -120.74 117.36 27.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 26' ' ' VAL . 97.1 t -104.51 120.95 55.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.061 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -86.97 128.51 35.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.431 0.634 . . . . 0.0 111.16 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.585 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.2 mm? -104.67 112.18 25.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.231 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.427 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 25.5 m -151.81 155.08 37.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.18 -101.76 0.18 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.415 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.647 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . . . -143.78 164.04 32.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.647 ' HD2' ' HB2' ' A' ' 72' ' ' ALA . 7.8 Cg_endo -49.05 -53.17 7.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.959 2.439 . . . . 0.0 113.54 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -84.54 -30.11 25.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.091 0.472 . . . . 0.0 111.143 -177.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.5 m -72.97 -43.19 62.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.204 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.615 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.6 p -67.74 -24.81 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.963 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.554 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.7 tt0 -74.81 -42.62 57.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.893 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 81' ' ' MET . 21.1 tptp -61.12 -44.64 97.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.461 0.648 . . . . 0.0 110.283 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.38 -48.21 82.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.627 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.585 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 8.4 mtmp? -69.22 -20.69 63.96 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.393 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.554 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 24.2 mmt -58.35 -46.84 85.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 81.9 mtp -63.68 -49.97 71.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 110.743 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.528 ' HG ' HD23 ' A' ' 69' ' ' LEU . 4.1 mm? -59.68 -50.88 72.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.629 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.59 -41.66 95.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.842 0.353 . . . . 0.0 110.339 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.33 -56.71 18.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.396 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.503 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.86 -35.28 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.123 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 24' ' ' TYR . 55.3 t -72.11 -28.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 121.608 -0.683 . . . . 0.0 111.0 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -69.37 -40.41 77.45 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.652 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 16.9 ptm180 -73.92 -21.54 60.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.879 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.626 ' HA2' ' HE2' ' A' ' 30' ' ' MET . . . -94.02 -58.94 1.2 Allowed Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.139 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.536 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 14.3 mmm180 -75.53 -20.71 58.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 110.749 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 -61.4 3.67 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.44 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m 65.74 -145.29 0.2 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.931 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 20.3 t -130.59 162.82 28.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 0.0 110.283 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.51 156.04 7.88 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.077 0.551 . . . . 0.0 110.864 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 20' ' ' MET . 80.2 mt -137.92 106.43 5.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.27 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.18 61.58 0.64 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.93 -27.42 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.405 2.07 . . . . 0.0 112.76 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.602 HG13 ' HB3' ' A' ' 19' ' ' SER . 15.7 pt -111.11 144.56 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.573 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 41.2 m80 -90.22 -20.48 0.25 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 92.9 Cg_exo -40.58 154.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.216 1.944 . . . . 0.0 112.83 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.499 ' C ' ' H ' ' A' ' 17' ' ' ARG . 80.9 Cg_exo -46.58 152.99 1.34 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 123.29 2.66 . . . . 0.0 113.119 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.575 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 38.4 Cg_endo -65.51 24.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.294 3.329 . . . . 0.0 114.064 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.775 ' HG3' HG23 ' A' ' 18' ' ' THR . 12.0 ptp180 -71.69 -24.66 61.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.124 0.487 . . . . 0.0 109.942 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.775 HG23 ' HG3' ' A' ' 17' ' ' ARG . 7.2 t -163.25 10.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.916 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.602 ' HB3' HG13 ' A' ' 12' ' ' ILE . 15.2 m -105.22 -86.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.575 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.8 ptp -69.13 85.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.508 0.67 . . . . 0.0 110.949 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 m -88.92 114.03 25.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.223 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 14.5 tt0 -95.95 118.88 33.43 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.931 ' HB3' ' HB3' ' A' ' 7' ' ' SER . 4.9 tp10 -90.92 106.86 18.81 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.562 ' HD2' HG23 ' A' ' 87' ' ' VAL . 1.9 m-85 -90.54 108.47 19.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.379 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HD2' ' CG ' ' A' ' 62' ' ' LEU . 12.4 mtm180 -89.51 99.58 12.55 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.694 HG12 ' HB3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -114.71 133.03 22.62 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -170.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.7 Cg_exo -58.55 133.62 55.64 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.018 2.479 . . . . 0.0 110.421 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.8 -32.25 67.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.01 -31.41 79.39 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.712 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.59 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.1 mmm -78.29 -15.86 58.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.61 ' HA ' HG21 ' A' ' 34' ' ' ILE . 37.8 t -72.59 -39.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.51 -27.9 70.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.534 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.79 -29.98 23.38 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.61 HG21 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -72.68 -26.25 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.494 0.664 . . . . 0.0 110.067 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.744 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 20.3 pt -83.2 -13.91 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.829 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.4 -100.54 0.31 Allowed Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.578 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' HD3' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -60.28 -14.84 20.18 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.748 0.419 . . . . 0.0 111.503 178.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.39 27.84 1.57 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.451 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.744 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.61 -51.61 0.6 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.995 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.5 ' N ' ' HD3' ' A' ' 37' ' ' ARG . 15.1 tt0 -62.03 -51.71 66.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.122 0.419 . . . . 0.0 111.083 -173.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.57 HD11 HG13 ' A' ' 53' ' ' VAL . 8.1 tp -62.27 -40.92 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -52.35 -52.52 52.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 123.628 0.58 . . . . 0.0 110.05 176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -56.89 -50.76 71.53 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.5 mm -60.56 -50.8 78.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -39.7 73.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.298 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -75.96 -34.12 59.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.25 -44.75 95.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.1 p -80.31 -36.75 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.161 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.92 5.03 31.29 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.499 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 49.7 t -79.9 141.59 35.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.392 0.615 . . . . 0.0 110.378 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -96.54 74.27 2.79 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.613 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.57 HG13 HD11 ' A' ' 42' ' ' ILE . 41.7 t -82.22 107.85 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.177 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -103.92 111.12 23.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.759 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.458 HD13 HG13 ' A' ' 67' ' ' VAL . 28.7 mm -79.21 90.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.961 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 66' ' ' SER . 57.7 m -79.78 116.25 59.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 95.1 Cg_endo -84.89 1.8 8.33 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.0 2.467 . . . . 0.0 110.934 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.49 ' C ' ' HG ' ' A' ' 59' ' ' SER . 15.4 t70 -78.32 -33.36 49.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.515 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.49 ' HG ' ' C ' ' A' ' 58' ' ' ASP . 58.5 p 55.05 -78.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 113.035 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.43 -104.97 2.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.015 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 3.38 86.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.612 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 25' ' ' ARG . 2.9 mm? -110.08 141.67 24.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.0 0.67 6.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.987 2.458 . . . . 0.0 110.577 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -113.54 -170.27 1.66 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.552 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.694 ' HB3' HG12 ' A' ' 26' ' ' VAL . 7.4 tpp180 -85.58 133.67 34.05 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 56' ' ' SER . 52.9 p -108.31 99.62 9.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 0.0 109.896 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.458 HG13 HD13 ' A' ' 55' ' ' ILE . 57.9 t -101.03 110.36 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -85.73 130.12 34.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.406 0.622 . . . . 0.0 110.956 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.583 HD22 ' HG ' ' A' ' 83' ' ' LEU . 4.4 mm? -105.58 111.3 23.94 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.457 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.41 127.53 11.23 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . -155.12 -89.92 0.07 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.653 -1.26 . . . . 0.0 113.583 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -160.96 165.86 16.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 89.9 Cg_exo -44.9 -53.22 5.4 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.521 2.147 . . . . 0.0 112.969 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.56 -40.13 23.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 110.907 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.1 m -65.59 -44.05 87.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.65 -172.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.548 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.6 p -71.64 -30.48 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.037 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.8 tt0 -70.95 -43.62 67.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -52.35 65.79 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.357 0.598 . . . . 0.0 110.102 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.22 74.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.29 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 43.9 mtmt -69.47 -20.9 63.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.605 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.4 mmt -62.73 -42.1 99.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.115 172.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.9 mmt -67.01 -43.11 83.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.99 0.424 . . . . 0.0 111.046 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.583 ' HG ' HD22 ' A' ' 69' ' ' LEU . 4.1 mm? -64.29 -53.15 53.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.966 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.66 -33.66 66.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.47 . . . . 0.0 110.435 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.6 -60.98 2.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.082 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.694 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.3 mp -75.93 -37.09 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.921 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.562 HG23 ' HD2' ' A' ' 24' ' ' TYR . 77.5 t -66.09 -32.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.943 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.694 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.7 ptm180 -75.09 -12.94 60.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.752 0.31 . . . . 0.0 111.129 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.59 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -108.97 -62.15 0.54 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.155 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 91' ' ' ARG . 5.1 tmm_? -76.15 92.52 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.56 -1.77 24.85 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.58 -1.122 . . . . 0.0 111.206 178.226 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -143.74 122.35 12.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.889 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.7 m 62.98 -162.58 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.807 0.692 . . . . 0.0 111.637 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.56 134.22 56.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.594 0.712 . . . . 0.0 112.508 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' MET . 75.1 mt -120.09 145.55 46.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.923 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.47 66.8 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.361 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.04 -49.72 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.829 2.353 . . . . 0.0 112.101 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.459 HD11 HG23 ' A' ' 18' ' ' THR . 18.7 pt -117.98 163.74 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.649 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 92.0 m-70 -91.25 -29.57 0.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 38.8 Cg_exo -41.27 167.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.168 2.579 . . . . 0.0 114.904 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 17' ' ' ARG . 68.0 Cg_exo -42.3 156.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.62 2.88 . . . . 0.0 113.758 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 28.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 124.031 3.154 . . . . 0.0 114.563 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.429 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.49 -11.08 43.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.083 0.468 . . . . 0.0 110.01 173.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.459 HG23 HD11 ' A' ' 12' ' ' ILE . 6.2 t -163.88 8.18 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.865 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 41.0 t -92.9 -94.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.339 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.7 ptp -70.63 85.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 0.0 110.537 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.7 m -94.24 114.81 26.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.196 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.7 tp10 -95.45 118.38 32.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -96.46 100.68 12.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.515 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -94.07 116.92 29.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.141 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.412 ' O ' ' HD3' ' A' ' 91' ' ' ARG . 31.5 mtm180 -84.39 113.68 21.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.31 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.489 HG22 HG23 ' A' ' 87' ' ' VAL . 2.2 p -117.71 131.55 24.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 111.048 -176.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' O ' HG21 ' A' ' 31' ' ' VAL . 26.9 Cg_exo -58.74 139.28 90.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.168 2.579 . . . . 0.0 110.764 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 2.7 p-10 -59.18 -32.17 69.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.136 -172.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -39.55 87.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.246 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.462 ' HE3' ' CA ' ' A' ' 90' ' ' GLY . 1.5 mpp? -79.5 -7.2 58.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.192 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.627 ' O ' HG12 ' A' ' 35' ' ' ILE . 75.6 t -70.69 -43.18 77.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.99 -31.38 72.32 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.57 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.0 mt -83.41 -32.11 26.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.688 HG23 HH22 ' A' ' 65' ' ' ARG . 10.2 tp -70.8 -28.36 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.619 0.723 . . . . 0.0 109.921 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.675 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 14.2 pt -85.4 -13.26 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.59 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 57.46 -87.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 113.493 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.75 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 2.5 ptm85 -77.26 42.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.074 0.55 . . . . 0.0 110.784 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 66.43 19.76 69.0 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.03 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.675 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.75 -51.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.311 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.75 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 32.0 tt0 -60.42 -21.39 62.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.479 ' O ' HD12 ' A' ' 45' ' ' ILE . 29.0 tt0 -63.56 -38.9 92.88 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.341 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.542 HD13 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -66.03 -36.94 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 1.3 m-20 -59.39 -43.2 92.99 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -59.54 -57.13 14.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.548 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -58.81 -53.01 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.484 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -29.72 61.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.252 -172.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.764 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -77.79 -39.92 42.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 178.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -66.08 -32.46 73.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.488 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 29.8 p -91.29 -36.01 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.738 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.38 7.25 57.16 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.59 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 49.1 t -78.99 142.75 36.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.624 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -83.6 72.62 10.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.542 HG11 HD13 ' A' ' 42' ' ' ILE . 49.1 t -86.04 107.47 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.054 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 6.8 tp60 -98.84 122.66 42.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.5 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 24.7 mm -100.54 117.14 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.954 0.406 . . . . 0.0 111.666 -177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.419 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 44.9 m -112.7 93.97 26.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.644 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 76.6 Cg_exo -51.89 -55.92 3.45 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.434 3.422 . . . . 0.0 114.342 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.3 -2.02 58.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.646 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 p 49.93 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.55 1.14 . . . . 0.0 113.035 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.52 -65.85 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.74 2.44 87.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.206 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 66' ' ' SER . 58.2 mt -126.02 151.73 72.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.22 -14.11 8.5 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 110.104 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 7.1 pt-20 -105.27 -164.75 1.06 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.305 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.688 HH22 HG23 ' A' ' 34' ' ' ILE . 6.3 tmm_? -101.1 137.92 38.83 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.723 ' HB3' HD13 ' A' ' 62' ' ' LEU . 77.9 p -105.24 142.6 34.74 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.944 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.0 t -130.31 111.96 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.426 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.7 m -81.15 121.45 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.311 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.999 HD11 ' HG2' ' A' ' 80' ' ' LYS . 96.6 mt -109.72 108.45 18.83 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.14 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 149.79 30.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.65 -95.98 0.11 Allowed Glycine 0 C--O 1.226 -0.362 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.809 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.415 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . . . -147.66 163.7 26.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 72' ' ' ALA . 83.6 Cg_exo -45.44 -55.26 3.64 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.003 2.469 . . . . 0.0 113.432 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.34 -32.81 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 110.912 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.0 m -67.6 -48.06 67.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.899 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 1.4 p -71.84 -24.32 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.765 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -71.88 -43.34 65.6 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.253 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 81' ' ' MET . 20.9 tptm -66.02 -45.59 80.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.457 0.646 . . . . 0.0 110.128 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.411 ' O ' HD22 ' A' ' 83' ' ' LEU . . . -54.99 -49.33 71.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.072 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.999 ' HG2' HD11 ' A' ' 69' ' ' LEU . 43.1 mtmt -71.79 -22.75 61.53 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.755 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.646 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 21.9 ptm -69.32 -38.05 78.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.783 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.47 ' HG3' ' CG1' ' A' ' 45' ' ' ILE . 20.9 mmt -75.11 -39.28 60.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.731 ' HG ' HD12 ' A' ' 69' ' ' LEU . 3.3 mm? -61.78 -59.57 4.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.56 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.58 -34.11 66.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.736 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.519 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 24.6 t70 -69.45 -61.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.857 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.72 -40.27 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 111.282 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.489 HG23 HG22 ' A' ' 26' ' ' VAL . 58.3 t -70.92 -21.97 22.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.592 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -72.56 -30.25 64.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 15.1 mmm-85 -67.99 -29.94 69.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.12 0.486 . . . . 0.0 110.0 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.462 ' CA ' ' HE3' ' A' ' 30' ' ' MET . . . -96.21 -41.63 3.68 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.973 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 4.5 ptm180 -147.05 -161.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.557 -0.378 . . . . 0.0 110.755 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.26 76.78 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -173.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.19 0 CA-C-O 118.126 -1.374 . . . . 0.0 111.036 -178.246 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.4 t 71.56 135.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.808 0.692 . . . . 0.0 110.479 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 m 70.75 -61.22 0.48 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.219 0.607 . . . . 0.0 110.703 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.458 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 19.1 mm-40 57.78 -161.8 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.955 0.502 . . . . 0.0 111.721 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 2.6 tt 171.66 -72.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 111.24 114.32 3.46 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.615 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.44 -5.08 14.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.746 2.297 . . . . 0.0 112.179 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.559 HG23 ' HD2' ' A' ' 14' ' ' PRO . 6.8 mt -98.62 121.28 49.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.691 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 m80 -82.55 -26.59 0.41 Allowed Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.3 Cg_exo -31.45 130.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 123.583 2.855 . . . . 0.0 114.07 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.5 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.8 Cg_exo -33.89 127.08 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 125.079 3.853 . . . . 0.0 112.456 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 10.0 Cg_exo -19.62 53.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.571 5.514 . . . . 0.0 117.572 -157.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 76.4 mtp180 -99.06 -4.48 32.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.551 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -178.62 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.41 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -79.15 -23.25 44.08 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.598 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.49 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.6 mtt -117.68 52.69 0.97 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -79.11 112.28 16.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.5 tp10 -111.27 118.95 37.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.458 ' HB2' ' CG ' ' A' ' 8' ' ' GLN . 36.7 tp10 -98.38 103.53 15.49 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.83 128.0 37.5 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.043 -169.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.533 ' HG2' HD22 ' A' ' 62' ' ' LEU . 19.9 mtp180 -87.4 110.14 20.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.997 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.744 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -125.56 127.95 24.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -177.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.752 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 31.9 Cg_exo -57.73 147.89 77.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.621 2.214 . . . . 0.0 111.963 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.658 ' O ' HG11 ' A' ' 31' ' ' VAL . 20.0 t70 -53.21 -51.07 63.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.81 76.25 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.193 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.785 ' HE3' ' HA3' ' A' ' 90' ' ' GLY . 9.5 tpp -79.53 -28.53 41.31 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.699 -0.295 . . . . 0.0 110.373 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.658 HG11 ' O ' ' A' ' 28' ' ' ASP . 13.3 p -74.74 -30.09 24.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.59 67.32 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.795 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.542 HD13 ' SD ' ' A' ' 30' ' ' MET . 95.7 mt -87.55 -25.59 23.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.627 HG21 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -68.7 -31.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.435 0.636 . . . . 0.0 109.541 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.603 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.1 pt -82.73 -14.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 173.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 57.37 -88.28 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 124.213 0.945 . . . . 0.0 112.968 176.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.482 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 8.0 ptp180 -77.7 38.93 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.216 0.606 . . . . 0.0 111.561 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 76.96 3.27 80.51 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.978 -0.556 . . . . 0.0 114.324 174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.603 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 160.33 -50.53 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.158 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 12.6 tp10 -54.08 -25.01 19.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.479 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.49 -46.95 77.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.719 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.703 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 10.6 tp -65.94 -38.78 82.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -53.53 -42.88 67.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.33 -48.46 72.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.876 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 41' ' ' GLN . 95.4 mt -58.91 -57.97 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.703 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 7.9 pt20 -73.24 -20.97 60.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.523 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.835 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -78.36 -38.7 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.434 0.635 . . . . 0.0 110.022 172.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -63.18 -39.59 95.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.811 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.415 ' CB ' ' HB3' ' A' ' 78' ' ' LYS . 23.3 p -80.36 -46.78 15.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.349 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.9 56.2 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 54.1 t -82.44 143.15 31.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.17 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 33.4 mtmt -80.47 76.78 7.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 42' ' ' ILE . 79.9 t -82.74 110.41 17.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.776 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -109.67 115.93 30.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.508 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.579 HD13 HG12 ' A' ' 67' ' ' VAL . 33.3 mm -89.24 106.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.333 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.6 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 46.8 m -87.24 107.46 14.83 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.809 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.0 Cg_exo -75.26 -38.28 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.818 3.012 . . . . 0.0 113.289 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.6 116.09 19.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.033 0.444 . . . . 0.0 110.259 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 16.4 p -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.713 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 -85.22 1.84 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.096 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.27 -13.35 83.4 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.605 ' O ' ' HB2' ' A' ' 59' ' ' SER . 6.3 mp -112.59 149.73 41.59 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.406 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -87.69 3.39 6.3 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.702 2.268 . . . . 0.0 110.252 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 3.4 pt-20 -125.96 -173.59 2.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.564 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.809 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 8.1 tpp85 -83.83 145.22 28.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.6 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 54.6 p -121.5 122.31 39.44 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.096 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.579 HG12 HD13 ' A' ' 55' ' ' ILE . 69.1 t -116.22 131.44 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -94.15 125.41 38.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.045 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.794 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 mm? -108.34 104.45 13.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.238 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.6 m -152.28 130.81 12.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -162.57 -82.25 0.04 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.926 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.65 168.33 12.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.57 ' N ' ' HG2' ' A' ' 16' ' ' PRO . 97.4 Cg_exo -45.43 -57.74 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.864 2.376 . . . . 0.0 113.675 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -76.66 -35.64 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.495 0.664 . . . . 0.0 110.067 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 49' ' ' SER . 33.7 m -68.63 -42.37 78.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.981 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.15 -31.77 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.848 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -74.11 -37.72 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 81' ' ' MET . 22.9 tptp -70.8 -36.24 72.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 110.413 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 51' ' ' CYS . . . -63.76 -40.81 97.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.638 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.3 mtmt -81.92 -20.55 38.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.246 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 14.3 tpt -58.7 -55.71 31.57 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.751 175.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mmm -69.74 -38.42 76.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.979 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.497 ' O ' HG22 ' A' ' 87' ' ' VAL . 1.3 mm? -56.69 -58.09 9.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.336 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.04 -41.88 65.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.105 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 37.7 t70 -55.37 -59.2 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.41 ' HB ' HD12 ' A' ' 34' ' ' ILE . 2.4 mp -72.17 -37.15 58.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.1 0.476 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 83' ' ' LEU . 94.9 t -65.11 -31.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.2 m -71.87 -29.8 64.75 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.678 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 24.4 mmm180 -56.53 -49.38 74.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.966 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.785 ' HA3' ' HE3' ' A' ' 30' ' ' MET . . . -99.94 -53.02 1.13 Allowed Glycine 0 C--O 1.228 -0.248 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.551 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.752 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 7.4 tpt85 -91.58 36.25 0.95 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.152 0.501 . . . . 0.0 110.106 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.74 72.11 0.49 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.27 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.439 -1.2 . . . . 0.0 111.457 177.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.7 pt . . . . . 0 C--O 1.236 0.349 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.0 t -155.57 144.66 20.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m 73.62 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.84 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -145.5 167.34 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.391 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.612 HD13 ' HD3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -155.66 135.68 12.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.993 178.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.71 81.46 0.21 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.593 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.612 ' HD3' HD13 ' A' ' 9' ' ' LEU . 67.3 Cg_endo -75.81 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.454 2.103 . . . . 0.0 112.363 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.779 HD11 HG23 ' A' ' 18' ' ' THR . 27.4 pt -131.14 161.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.537 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.577 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.2 m80 -90.52 -26.81 0.3 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.622 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 66.2 Cg_exo -39.37 168.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.23 2.62 . . . . 0.0 114.923 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 14' ' ' PRO . 1.3 Cg_endo -42.56 153.65 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.139 3.226 . . . . 0.0 113.941 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 60.4 Cg_endo -69.51 27.95 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 124.092 3.195 . . . . 0.0 113.765 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HG3' HG21 ' A' ' 18' ' ' THR . 10.7 ptp180 -81.08 -20.82 40.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.401 0.619 . . . . 0.0 109.649 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.779 HG23 HD11 ' A' ' 12' ' ' ILE . 5.2 t -160.92 18.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.027 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 t -99.5 -98.85 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.7 ptp -64.83 88.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.641 0.734 . . . . 0.0 110.653 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.48 HG21 ' OG1' ' A' ' 70' ' ' THR . 29.2 m -92.66 113.46 25.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.808 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' CD ' ' HD2' ' A' ' 80' ' ' LYS . 19.2 tt0 -96.06 118.08 31.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -96.37 102.88 14.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.405 ' CE1' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -92.01 124.46 36.13 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.482 -169.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HB3' ' OE2' ' A' ' 64' ' ' GLU . 50.9 mtp180 -81.01 118.93 22.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.679 174.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -137.31 123.77 13.46 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 30' ' ' MET . 20.5 Cg_endo -61.97 141.67 90.16 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.577 2.185 . . . . 0.0 110.632 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HA ' HG12 ' A' ' 31' ' ' VAL . 30.5 t70 -59.05 -30.56 68.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.975 -167.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.94 -36.97 87.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.286 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.646 ' HE2' HG21 ' A' ' 86' ' ' ILE . 87.8 mmm -78.5 -27.91 46.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.66 -0.318 . . . . 0.0 111.002 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.624 ' O ' HG23 ' A' ' 34' ' ' ILE . 11.4 p -70.98 -28.63 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.411 174.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.81 71.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.038 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.17 -28.63 23.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 31' ' ' VAL . 11.0 tp -68.39 -29.95 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.862 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.649 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.7 pt -83.64 -14.04 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.201 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.66 -93.07 0.03 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 123.921 0.763 . . . . 0.0 113.496 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 12.8 ptp180 -64.15 -1.18 1.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.55 0.74 . . . . 0.0 112.493 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.59 11.1 18.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.276 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.649 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.9 -44.57 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.884 174.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.437 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 22.8 tt0 -55.72 -32.31 63.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -61.35 -47.83 84.08 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.436 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.648 HD11 HG12 ' A' ' 53' ' ' VAL . 8.5 tp -61.59 -42.59 94.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.14 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.87 -38.91 83.51 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.77 -49.07 78.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.12 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.88 HD11 ' HG3' ' A' ' 82' ' ' MET . 72.1 mt -63.64 -52.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.708 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -72.59 -43.9 62.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.209 -172.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' OE1' ' A' ' 47' ' ' GLN . 6.3 tp60 -73.8 -26.02 60.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 110.818 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.21 -53.92 7.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.324 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.685 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 41.8 p -64.5 -40.83 96.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.14 7.72 20.84 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.242 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.635 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 38.6 t -92.81 135.19 34.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.771 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -83.22 88.1 6.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.648 HG12 HD11 ' A' ' 42' ' ' ILE . 58.4 t -95.34 111.14 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -111.1 116.04 30.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.44 HD12 HG11 ' A' ' 67' ' ' VAL . 33.1 mm -80.69 100.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.7 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.607 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 17.7 m -85.53 114.45 56.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.57 -27.02 4.39 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.383 2.722 . . . . 0.0 112.698 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.28 -23.87 30.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.616 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.495 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 74.7 p 53.64 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.841 1.257 . . . . 0.0 113.187 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.93 -100.33 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.51 18.29 50.21 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.066 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -119.59 136.98 25.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.28 -8.69 11.71 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.905 2.403 . . . . 0.0 110.55 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.565 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 4.9 pt-20 -104.09 -162.01 0.87 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.784 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.68 ' HB3' HG11 ' A' ' 26' ' ' VAL . 2.2 tpp180 -95.81 148.26 22.78 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.607 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 65.4 p -122.38 125.2 45.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.44 HG11 HD12 ' A' ' 55' ' ' ILE . 64.4 t -111.26 112.14 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.733 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -80.28 126.41 31.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.275 0.559 . . . . 0.0 110.817 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 1.036 HD13 ' HG2' ' A' ' 80' ' ' LYS . 16.0 mt -118.14 110.91 18.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.48 ' OG1' HG21 ' A' ' 21' ' ' THR . 2.6 m -151.22 121.79 7.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.791 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.57 -90.47 0.08 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.937 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.568 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.78 167.09 14.72 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.762 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 73.5 Cg_exo -39.89 -59.48 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.356 2.704 . . . . 0.0 114.276 -176.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -82.65 -37.58 24.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.423 0.63 . . . . 0.0 110.15 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.685 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.3 m -61.51 -46.32 90.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.399 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.586 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.8 p -72.33 -32.27 41.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.54 -38.72 74.23 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.677 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -63.12 -46.96 84.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.493 0.663 . . . . 0.0 110.317 177.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.07 75.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.856 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 1.036 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.3 mtmt -74.92 -21.41 59.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.078 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.677 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 19.0 ptm -69.08 -37.35 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.667 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.88 ' HG3' HD11 ' A' ' 45' ' ' ILE . 89.8 mmm -67.89 -43.12 80.06 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.627 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.9 mm? -59.38 -56.89 16.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.69 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.54 -39.48 57.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.27 -57.58 12.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.561 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.717 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.4 mp -73.04 -40.58 58.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.519 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.405 HG12 ' CE1' ' A' ' 24' ' ' TYR . 81.7 t -61.43 -40.84 87.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.642 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.472 ' HA ' ' HA2' ' A' ' 92' ' ' GLY . 72.3 m -68.36 -36.41 79.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.453 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.717 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.2 ptm180 -79.89 -7.68 58.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.793 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -131.43 9.63 5.58 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.477 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -162.37 -51.54 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.52 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 88' ' ' SER . . . 102.91 -54.79 0.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.622 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.231 -1.316 . . . . 0.0 111.031 178.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p 61.51 137.91 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.692 1.197 . . . . 0.0 112.388 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 8.6 m -121.62 81.15 1.77 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.102 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -67.67 109.43 3.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.664 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 53.0 mt -92.42 104.34 16.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.392 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -115.16 58.51 0.44 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.102 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.725 ' HD2' HD13 ' A' ' 12' ' ' ILE . 2.6 Cg_endo -82.28 -43.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.639 2.226 . . . . 0.0 112.12 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.8 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -87.72 138.49 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.298 0.571 . . . . 0.0 110.607 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 52.2 t-80 -78.31 -29.84 0.67 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 95.5 Cg_exo -35.9 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.751 2.967 . . . . 0.0 115.292 173.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.69 160.71 3.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.094 2.529 . . . . 0.0 111.58 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 38.5 Cg_endo -63.79 3.91 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.135 2.557 . . . . 0.0 114.021 -172.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.472 ' HD3' ' HG2' ' A' ' 15' ' ' PRO . 2.7 ptt180 -58.31 -29.58 66.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.071 0.462 . . . . 0.0 110.319 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -148.14 3.88 0.71 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.228 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.624 ' HA ' HG12 ' A' ' 12' ' ' ILE . 35.9 t -84.52 -96.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.344 -175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.445 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.0 ptp -68.09 80.05 0.23 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.593 0.711 . . . . 0.0 111.277 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -79.49 116.17 19.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -91.8 117.87 30.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 43.0 tt0 -87.62 103.86 15.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.512 ' HD2' HG22 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -91.22 110.45 21.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.686 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.437 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 64.1 mtp180 -80.26 103.53 10.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.959 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.579 HG23 HG21 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.36 127.52 25.83 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.366 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 52.5 Cg_exo -56.59 139.17 87.29 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.864 2.376 . . . . 0.0 111.831 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.85 -55.56 6.5 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -24.09 72.92 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.557 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.63 ' HE1' ' HA3' ' A' ' 90' ' ' GLY . 27.8 tpp -78.81 -18.73 53.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.613 ' HA ' HG21 ' A' ' 34' ' ' ILE . 2.1 t -73.02 -33.13 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.87 -30.07 56.19 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.913 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -88.03 -23.23 23.83 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.613 HG21 ' HA ' ' A' ' 31' ' ' VAL . 6.8 tp -71.56 -28.32 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.992 0.814 . . . . 0.0 109.663 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.666 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.0 pt -85.59 -15.3 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.324 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 58.31 -89.24 0.02 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 124.086 0.866 . . . . 0.0 113.701 173.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.601 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 13.2 ptp180 -71.96 11.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.07 0.548 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 100.87 14.71 30.81 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.098 175.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.666 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.5 -46.39 0.78 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.412 173.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.601 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 9.4 tp10 -62.31 -22.22 65.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.521 ' O ' HG12 ' A' ' 45' ' ' ILE . 20.5 tt0 -64.63 -48.13 76.01 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.108 -0.37 . . . . 0.0 111.318 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG21 ' O ' ' A' ' 39' ' ' GLY . 7.1 tp -61.54 -42.44 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.46 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.3 m-20 -52.59 -52.54 54.74 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 123.66 0.6 . . . . 0.0 109.463 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -56.88 -48.8 77.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.104 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 41' ' ' GLN . 25.1 mm -62.27 -49.37 84.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.156 -175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -79.33 -28.2 42.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.365 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -71.13 -42.09 69.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.79 -47.72 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.485 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.559 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 14.5 p -80.52 -38.29 30.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.896 -175.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.02 9.38 42.6 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.607 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 52.3 t -78.72 139.7 38.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.34 0.59 . . . . 0.0 111.352 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -88.2 79.94 7.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.891 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG21 ' CD2' ' A' ' 69' ' ' LEU . 7.6 p -82.04 131.13 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.4 mm-40 -114.51 107.56 15.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.734 0.778 . . . . 0.0 110.703 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.604 HG23 ' NH1' ' A' ' 65' ' ' ARG . 18.5 mm -80.83 106.14 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.567 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.8 m -109.91 100.17 41.97 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.496 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -86.77 24.64 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.478 2.785 . . . . 0.0 111.05 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.43 -31.04 47.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.094 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 p 45.52 64.9 1.26 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.521 0.677 . . . . 0.0 111.075 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.16 116.24 4.9 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.948 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.83 -47.54 3.33 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -172.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 2.6 mp -88.39 128.01 54.71 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.62 -13.35 10.8 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 121.96 1.773 . . . . 0.0 111.117 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -99.34 -155.62 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.715 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.604 ' NH1' HG23 ' A' ' 55' ' ' ILE . 5.5 mmm-85 -89.76 138.37 31.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.627 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 p -110.1 129.17 55.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.131 0.491 . . . . 0.0 110.286 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.432 HG22 ' NH2' ' A' ' 65' ' ' ARG . 87.7 t -119.22 116.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.138 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 74.2 m -93.67 135.21 35.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.132 0.492 . . . . 0.0 110.597 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.732 HD12 ' HG ' ' A' ' 83' ' ' LEU . 74.2 mt -118.86 127.97 54.0 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.792 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -150.73 157.54 43.07 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.266 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 148.69 -152.73 24.73 Favored Glycine 0 C--O 1.217 -0.911 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.179 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.87 152.42 80.03 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.06 -46.36 19.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.675 2.25 . . . . 0.0 112.717 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.63 -32.29 60.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.972 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -71.15 -49.74 40.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.531 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 9.2 p -67.02 -27.08 38.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.506 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 81' ' ' MET . 28.8 tt0 -72.54 -41.96 65.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.43 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -64.82 -40.2 94.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.083 0.468 . . . . 0.0 110.419 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.33 88.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.92 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.637 ' HG2' HD11 ' A' ' 69' ' ' LEU . 55.6 mtmt -64.79 -23.33 67.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.642 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.6 mmm -60.44 -52.46 65.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.929 ' HA ' ' HE2' ' A' ' 82' ' ' MET . 10.1 mmt -70.84 -36.2 72.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.978 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.732 ' HG ' HD12 ' A' ' 69' ' ' LEU . 1.1 mm? -60.87 -60.48 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.29 -29.28 70.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 110.662 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.69 -60.26 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.26 0.553 . . . . 0.0 110.649 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.544 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.02 -37.0 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.07 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.512 HG22 ' HD2' ' A' ' 24' ' ' TYR . 65.6 t -62.53 -32.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.718 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -71.46 -39.99 70.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.253 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.9 ptp180 -72.97 -18.6 61.35 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.605 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.63 ' HA3' ' HE1' ' A' ' 30' ' ' MET . . . -103.93 -65.07 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.649 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -80.93 -56.26 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.475 0.655 . . . . 0.0 110.298 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.2 -158.95 15.27 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 CA-C-O 117.749 -1.584 . . . . 0.0 111.189 178.18 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.725 0.298 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.4 p -87.4 122.77 31.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.62 ' HB3' ' OE1' ' A' ' 22' ' ' GLU . 39.7 m 68.39 -147.24 0.13 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.782 ' HB3' ' O ' ' A' ' 21' ' ' THR . 36.7 tt0 -175.4 -143.41 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.727 0.694 . . . . 0.0 110.074 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.641 ' HG ' ' H ' ' A' ' 10' ' ' GLY . 2.0 pt? -167.09 -61.15 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -175.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.641 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . 119.74 149.2 8.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.454 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 10' ' ' GLY . 6.2 Cg_exo -80.08 -52.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.146 2.564 . . . . 0.0 113.329 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.662 HG21 ' HD2' ' A' ' 14' ' ' PRO . 2.1 mt -93.47 128.59 44.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.682 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 45.5 m80 -92.61 3.57 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -168.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.752 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 19.0 Cg_endo -57.99 -162.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.559 2.173 . . . . 0.0 112.81 169.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.752 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 28.2 Cg_exo -38.59 155.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.874 2.383 . . . . 0.0 113.594 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 34.6 Cg_endo -64.68 23.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.231 3.287 . . . . 0.0 115.162 -171.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 15' ' ' PRO . 25.9 ptt180 -78.94 2.13 21.31 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.513 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -179.13 2.27 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.688 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.2 p -97.59 -8.87 28.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -174.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.403 ' HG2' ' HB3' ' A' ' 16' ' ' PRO . 15.8 ptp -146.43 52.9 1.12 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.871 0.844 . . . . 0.0 109.452 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.782 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 94.6 m -78.25 116.77 18.93 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.788 177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.62 ' OE1' ' HB3' ' A' ' 7' ' ' SER . 2.8 tp10 -101.78 125.16 48.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.343 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -98.57 104.38 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.473 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.13 116.79 29.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.635 -169.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.64 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 23.9 mtp180 -81.78 109.52 16.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.874 HG11 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -125.05 125.09 25.36 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 110.808 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.4 136.31 73.13 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.784 2.322 . . . . 0.0 110.885 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.413 ' HA ' HG22 ' A' ' 31' ' ' VAL . 28.1 t70 -58.61 -33.87 70.51 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.561 -168.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.42 -34.64 90.45 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.65 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.603 ' HE3' HG22 ' A' ' 86' ' ' ILE . 92.1 mmm -78.65 -9.92 59.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.707 ' HA ' HG23 ' A' ' 34' ' ' ILE . 44.2 t -75.83 -40.46 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.96 -30.41 69.9 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.284 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.16 -28.97 25.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.707 HG23 ' HA ' ' A' ' 31' ' ' VAL . 9.3 tp -71.82 -28.94 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.413 0.625 . . . . 0.0 110.114 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.634 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.5 pt -80.46 -13.74 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.677 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 60.39 -91.82 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.954 0.783 . . . . 0.0 113.302 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.537 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.2 ptm85 -77.5 37.89 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.503 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 72.13 19.75 78.68 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.683 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.634 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.04 -49.33 0.6 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.92 173.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 28.2 tt0 -58.71 -28.7 66.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -169.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -56.42 22.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.818 0.281 . . . . 0.0 111.166 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.556 HD12 HG13 ' A' ' 53' ' ' VAL . 6.1 tp -57.29 -49.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.826 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.21 -38.88 88.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.036 0.446 . . . . 0.0 110.637 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -60.17 -44.29 95.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.71 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.531 HG12 ' HE3' ' A' ' 82' ' ' MET . 1.7 mp -81.06 -41.85 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.856 -176.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -69.96 -37.38 75.8 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.07 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -71.36 -38.03 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.44 -51.77 66.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.072 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.776 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 32.9 p -70.56 -37.63 74.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.48 12.05 22.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.955 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.537 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 35.4 t -84.99 150.03 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.867 0.365 . . . . 0.0 110.149 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -104.99 82.66 1.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.526 0.679 . . . . 0.0 109.693 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 42' ' ' ILE . 40.8 t -93.02 113.59 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.165 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.435 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 14.3 mm-40 -107.29 129.7 54.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.783 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.472 HD13 HG11 ' A' ' 67' ' ' VAL . 30.1 mm -102.42 89.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.445 -174.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 35.0 t -79.95 114.6 47.69 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.698 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 5.5 Cg_exo -78.88 -32.54 1.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.588 2.859 . . . . 0.0 112.393 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.31 -34.62 42.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.547 ' HG ' ' HB3' ' A' ' 66' ' ' SER . 40.4 t 71.02 -65.52 0.34 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.183 176.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.43 -55.92 0.59 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.098 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.75 -10.12 10.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.64 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.8 mt -112.91 144.59 31.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.798 0.332 . . . . 0.0 110.5 -173.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.42 -16.64 8.05 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.83 2.353 . . . . 0.0 110.336 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.51 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 4.3 pt-20 -92.98 -168.74 2.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.11 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.874 ' HB3' HG11 ' A' ' 26' ' ' VAL . 5.5 tpp180 -89.44 140.57 29.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.547 ' HB3' ' HG ' ' A' ' 59' ' ' SER . 67.7 p -114.56 105.17 12.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.546 0.689 . . . . 0.0 109.345 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.472 HG11 HD13 ' A' ' 55' ' ' ILE . 95.3 t -98.13 121.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.8 m -89.67 128.16 36.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.412 0.625 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.701 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -106.56 112.33 25.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.9 m -151.32 143.69 24.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.988 -0.096 . . . . 0.0 110.805 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.54 -154.9 25.06 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.402 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.45 ' HB2' ' OG ' ' A' ' 75' ' ' SER . . . -78.92 160.89 70.57 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -47.52 -53.07 6.99 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.796 2.33 . . . . 0.0 113.479 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -72.98 -40.33 65.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.975 0.417 . . . . 0.0 110.336 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.776 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.2 m -60.02 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.436 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.537 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 3.6 p -70.65 -30.01 40.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.01 -37.88 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 109.925 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.725 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.95 -47.06 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 177.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.11 -48.68 79.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.456 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.701 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 46.1 mtmt -68.52 -22.19 64.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.48 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.725 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 17.9 ptm -70.41 -36.47 74.05 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.497 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.531 ' HE3' HG12 ' A' ' 45' ' ' ILE . 24.3 mmt -70.62 -39.98 73.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.135 0.493 . . . . 0.0 110.097 175.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.0 mm? -64.55 -56.57 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.137 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.54 -35.14 67.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 110.557 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.76 -55.89 25.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.515 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.647 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -75.57 -37.19 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.979 0.419 . . . . 0.0 111.425 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.473 HG21 ' CD1' ' A' ' 24' ' ' TYR . 72.6 t -68.13 -33.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.875 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.6 t -70.76 -38.63 73.49 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.821 -0.549 . . . . 0.0 110.304 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.647 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -78.39 -13.43 59.85 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.524 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -120.82 -20.58 3.42 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.016 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -116.11 -25.9 7.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.16 0.48 . . . . 0.0 110.524 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 -93.46 1.59 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.226 -1.319 . . . . 0.0 111.278 177.789 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.579 ' H1 ' HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.267 0.556 . . . . 0.0 110.057 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.9 m -95.94 -166.72 1.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.186 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.451 ' O ' HD21 ' A' ' 9' ' ' LEU . 49.2 m 68.78 -166.45 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.527 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -64.45 112.98 3.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.776 0.322 . . . . 0.0 111.781 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 7' ' ' SER . 1.9 mm? -92.15 108.68 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 167.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 73.2 0.29 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.442 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 4.6 Cg_exo -74.99 -57.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.764 2.31 . . . . 0.0 111.874 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 pp -104.19 151.38 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.416 176.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.61 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 7.0 t-160 -90.6 -11.88 0.18 Allowed Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -170.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 72.7 Cg_exo -39.27 161.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.477 2.118 . . . . 0.0 114.337 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 17' ' ' ARG . 80.5 Cg_exo -42.49 148.47 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.703 2.935 . . . . 0.0 113.462 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.35 31.05 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.793 2.995 . . . . 0.0 113.905 -172.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -92.89 -0.36 57.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.874 0.369 . . . . 0.0 110.331 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.529 HG22 ' HD3' ' A' ' 17' ' ' ARG . 12.7 t -174.33 1.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.762 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 p -93.74 -85.09 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.1 ptm -72.56 71.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.596 0.712 . . . . 0.0 111.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.6 m -79.19 120.91 24.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.645 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.893 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 9.0 tp10 -92.58 118.88 31.47 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.82 106.19 18.42 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.551 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -92.26 118.61 31.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.944 -172.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 95.6 mtt180 -81.98 95.46 7.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.254 174.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.578 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -114.73 121.02 36.41 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.028 -176.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 51.5 Cg_exo -54.93 154.93 19.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.311 2.674 . . . . 0.0 112.442 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.71 -39.06 79.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.4 . . . . 0.0 111.236 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.23 64.11 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.876 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.473 ' HA ' ' HE3' ' A' ' 30' ' ' MET . 0.0 OUTLIER -78.0 -29.64 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.756 -0.261 . . . . 0.0 111.08 -177.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.699 ' HA ' HG21 ' A' ' 34' ' ' ILE . 5.8 p -73.25 -30.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.758 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 35' ' ' ILE . . . -67.66 -22.32 73.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.364 170.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.462 HD21 HG23 ' A' ' 86' ' ' ILE . 62.0 tp -89.05 -30.13 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.699 HG21 ' HA ' ' A' ' 31' ' ' VAL . 10.8 tp -72.47 -26.18 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.401 0.619 . . . . 0.0 109.906 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.589 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.3 pt -81.24 -14.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -92.06 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 O-C-N 124.045 0.841 . . . . 0.0 113.281 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 11.1 ptp180 -71.13 3.78 3.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.016 0.526 . . . . 0.0 111.835 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.5 25.72 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.107 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.41 -50.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.45 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 28.9 tt0 -50.65 -36.16 34.19 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' O ' HG12 ' A' ' 45' ' ' ILE . 15.1 tt0 -59.81 -55.33 35.56 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.538 HD13 HG11 ' A' ' 53' ' ' VAL . 5.1 tp -58.55 -46.64 89.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.53 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -56.42 -43.66 79.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 123.453 0.471 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.4 -43.25 95.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.646 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 41' ' ' GLN . 24.0 mm -65.19 -50.89 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.769 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -70.54 -27.77 64.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.987 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -72.45 -44.78 61.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.0 -50.02 73.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.436 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.6 p -67.7 -45.31 75.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.319 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.67 10.98 27.79 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.67 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.42 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 53.9 t -94.17 138.64 31.98 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.094 0.473 . . . . 0.0 110.094 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -85.95 79.94 9.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.616 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 42' ' ' ILE . 43.9 t -89.07 107.42 17.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.212 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' HB3' ' OG ' ' A' ' 68' ' ' SER . 12.1 tp60 -99.06 116.26 30.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -175.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.44 HD12 HG12 ' A' ' 42' ' ' ILE . 44.5 mm -83.53 89.96 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.111 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 41.1 m -85.49 114.82 58.61 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 121.164 0.507 . . . . 0.0 111.036 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.504 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 12.1 Cg_exo -69.61 -36.6 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.324 2.683 . . . . 0.0 111.485 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.11 89.57 5.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.63 ' HA ' ' HG ' ' A' ' 66' ' ' SER . 3.9 m -72.38 -19.31 61.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.155 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 -99.86 1.04 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.296 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.59 -26.87 66.51 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.263 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.56 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.3 mm? -87.25 139.95 32.26 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -85.05 0.71 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.766 2.311 . . . . 0.0 111.421 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -108.45 -110.57 0.31 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.8 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.578 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -133.92 149.57 51.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.63 ' HG ' ' HA ' ' A' ' 59' ' ' SER . 82.7 p -119.77 111.4 17.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.734 0.778 . . . . 0.0 110.35 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.56 132.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.01 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 p -99.38 130.06 45.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.369 0.604 . . . . 0.0 111.485 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.893 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 2.9 mm? -110.49 105.78 14.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.233 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 69' ' ' LEU . 6.5 m -150.97 128.01 11.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.939 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -166.81 -97.29 0.11 Allowed Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.924 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.54 163.68 43.61 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.25 -43.41 37.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.441 2.094 . . . . 0.0 112.593 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -79.44 -38.0 35.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.231 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -77.18 -41.76 40.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.087 0.47 . . . . 0.0 110.654 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -23.92 30.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.278 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.563 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.2 tp-100 -77.86 -45.6 23.81 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 81' ' ' MET . 4.9 tppp? -60.7 -45.83 92.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.026 0.441 . . . . 0.0 110.561 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.408 ' O ' HD21 ' A' ' 83' ' ' LEU . . . -55.8 -49.73 72.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.393 176.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.524 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.3 mtmt -69.54 -21.05 63.67 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.023 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.563 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.6 mmt -60.66 -50.18 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.172 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.903 ' HA ' ' HE1' ' A' ' 82' ' ' MET . 6.8 mmt -66.11 -39.5 89.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.067 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 79' ' ' ALA . 4.1 mm? -66.27 -54.19 27.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.54 -30.68 67.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.27 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 15.2 t70 -66.03 -61.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 33' ' ' LEU . 2.0 mp -68.66 -38.42 78.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.141 0.496 . . . . 0.0 111.295 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.551 HG21 ' HD2' ' A' ' 24' ' ' TYR . 76.9 t -66.62 -29.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -78.15 -22.68 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.345 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 26.7 mmm180 -66.87 -32.51 73.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.069 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.83 -64.38 0.82 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.754 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -87.91 157.36 18.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.101 0.477 . . . . 0.0 110.962 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.31 96.3 1.66 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 172.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.776 -1.014 . . . . 0.0 112.465 -177.51 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.5 tt . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.842 0.353 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m 67.54 178.38 0.24 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 10.5 t 68.49 -69.15 0.16 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.35 0.66 . . . . 0.0 110.176 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.656 ' HG3' ' H ' ' A' ' 9' ' ' LEU . 23.8 tp60 48.51 -156.47 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 111.667 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.656 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 4.2 pp 174.33 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.261 1.024 . . . . 0.0 108.301 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' N ' HD11 ' A' ' 9' ' ' LEU . . . 150.98 126.15 1.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.541 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.47 -13.75 22.63 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.542 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.919 HG12 ' HD2' ' A' ' 14' ' ' PRO . 13.1 tt -147.49 148.52 16.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.696 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.5 m-70 -90.38 -10.89 0.16 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.919 ' HD2' HG12 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -38.05 164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.802 2.334 . . . . 0.0 113.226 162.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -26.98 146.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 125.022 3.814 . . . . 0.0 115.871 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.96 12.9 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.033 3.155 . . . . 0.0 114.213 -171.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HD3' HG23 ' A' ' 18' ' ' THR . 0.0 OUTLIER -77.52 2.83 15.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 109.474 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 17' ' ' ARG . 8.4 t -159.83 -25.21 0.07 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.651 172.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 15.6 t -79.85 6.36 11.28 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.156 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 mmt -144.52 37.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.1 m -85.9 112.16 20.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 7' ' ' SER . 9.7 tt0 -123.56 119.49 30.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.228 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.74 102.19 14.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.641 ' CD2' HG23 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -92.37 136.76 32.93 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.725 -170.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 25' ' ' ARG . 7.5 mtm180 -101.85 129.38 48.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.87 HG11 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -135.03 124.11 16.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.801 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 91' ' ' ARG . 51.2 Cg_exo -55.8 140.99 85.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 111.731 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.63 -47.03 29.25 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.68 -31.11 79.81 Favored Glycine 0 C--O 1.238 0.349 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.697 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.503 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 84.2 mmm -77.99 -15.05 59.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.617 ' O ' HG12 ' A' ' 35' ' ' ILE . 17.4 t -72.43 -40.11 63.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.94 -29.94 68.85 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.342 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.69 -24.66 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.615 HG21 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -74.48 -26.34 20.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.507 0.67 . . . . 0.0 109.544 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.703 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 16.4 pt -88.1 -15.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.062 171.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.89 0.02 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.105 0.878 . . . . 0.0 113.72 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.667 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 4.2 ptp180 -81.02 14.07 2.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.014 0.525 . . . . 0.0 111.166 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 16.02 28.15 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.331 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.703 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.48 -49.74 0.58 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.303 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.667 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.0 tt0 -51.4 -33.56 30.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -173.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' O ' HD11 ' A' ' 45' ' ' ILE . 21.2 tt0 -60.59 -50.78 72.16 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.652 -173.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.562 HD11 HG13 ' A' ' 53' ' ' VAL . 8.1 tp -63.7 -43.59 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.514 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -62.06 -36.36 81.41 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -65.01 -52.62 55.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.141 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.443 HG13 ' HE3' ' A' ' 82' ' ' MET . 1.4 mp -60.08 -48.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.029 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -73.5 -34.42 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.693 0.282 . . . . 0.0 111.167 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.87 -39.34 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.137 0.494 . . . . 0.0 110.51 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.68 -38.21 89.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.935 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.495 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.3 p -81.11 -43.97 18.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.36 8.64 28.68 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 41.5 t -90.0 132.68 35.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.979 0.418 . . . . 0.0 110.14 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -79.82 79.25 6.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.288 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.562 HG13 HD11 ' A' ' 42' ' ' ILE . 47.6 t -87.31 107.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.064 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 10.6 mm-40 -97.9 110.05 22.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.613 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.445 HD11 HG12 ' A' ' 42' ' ' ILE . 49.7 mm -80.2 112.91 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.26 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.9 m -104.15 99.39 16.86 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.609 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 40.0 Cg_endo -68.95 -30.49 26.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.863 2.375 . . . . 0.0 110.943 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.42 79.62 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -72.62 -36.78 68.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.283 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.78 -69.56 3.2 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.844 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.18 -4.38 90.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.203 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.759 HD13 ' HB3' ' A' ' 66' ' ' SER . 56.6 mt -126.63 144.34 49.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.72 -19.54 9.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.687 2.258 . . . . 0.0 109.939 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 3.6 pt-20 -94.2 -161.9 0.89 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.034 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.87 ' HB3' HG11 ' A' ' 26' ' ' VAL . 2.7 tpp180 -99.62 146.27 26.65 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.759 ' HB3' HD13 ' A' ' 62' ' ' LEU . 83.8 p -118.43 134.23 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.905 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 55' ' ' ILE . 57.1 t -128.7 122.68 57.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.633 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 54.3 m -86.04 123.82 31.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.308 0.575 . . . . 0.0 111.27 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 21' ' ' THR . 4.3 mm? -105.51 114.76 29.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.607 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.9 m -152.87 141.68 21.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.12 -133.53 1.96 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.617 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.716 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -114.59 166.29 11.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 8.3 Cg_endo -50.04 -41.87 47.35 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.909 2.406 . . . . 0.0 113.39 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -84.28 -44.95 13.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.495 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 23.8 p -66.48 -46.91 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -67.5 -32.51 57.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.303 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 81' ' ' MET . 64.5 tt0 -74.55 -42.22 59.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 81' ' ' MET . 1.9 tpmt? -58.42 -51.65 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.935 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.85 72.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.995 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.555 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.5 mtmt -67.24 -22.62 65.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.543 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.571 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 61.7 mtt -62.96 -47.74 81.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.443 ' HE3' HG13 ' A' ' 45' ' ' ILE . 2.3 mpt? -65.25 -41.67 94.06 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.19 176.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.51 ' HG ' HD23 ' A' ' 69' ' ' LEU . 3.6 mm? -60.39 -57.13 14.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.59 -38.76 72.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.466 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.12 -51.68 68.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.386 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.632 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -80.4 -40.87 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.585 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.641 HG23 ' CD2' ' A' ' 24' ' ' TYR . 70.8 t -61.42 -41.98 92.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.852 0.358 . . . . 0.0 110.455 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -68.04 -40.3 82.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.632 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 8.1 ptp180 -69.9 -28.07 65.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.579 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.503 ' HA3' ' SD ' ' A' ' 30' ' ' MET . . . -118.08 10.6 13.45 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.477 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.462 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 2.0 tmt_? -156.19 -56.45 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.04 0.447 . . . . 0.0 109.996 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.01 -165.27 12.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.368 -1.24 . . . . 0.0 111.228 -179.297 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 121.649 0.738 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -123.26 162.01 23.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.902 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 70.6 m 68.51 -163.46 0.2 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.414 0.446 . . . . 0.0 110.582 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.622 ' HB2' ' O ' ' A' ' 21' ' ' THR . 77.2 mm-40 -162.53 -36.93 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.773 0.829 . . . . 0.0 109.317 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.16 -126.96 0.09 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.783 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 140.74 119.7 1.61 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.594 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.84 -6.88 17.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.679 . . . . 0.0 112.061 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.766 HG21 ' HD2' ' A' ' 14' ' ' PRO . 13.9 mt -92.03 113.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.586 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 26.8 m-70 -82.19 -11.74 0.18 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -165.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.766 ' HD2' HG21 ' A' ' 12' ' ' ILE . 76.3 Cg_exo -35.01 127.84 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.133 1.889 . . . . 0.0 112.874 169.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' ARG . 45.1 Cg_exo -36.97 132.4 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 124.391 3.394 . . . . 0.0 112.812 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 2.7 Cg_exo -25.23 62.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 127.076 5.184 . . . . 0.0 117.079 -159.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HA ' ' CG2' ' A' ' 70' ' ' THR . 11.8 ptp180 -122.2 10.34 9.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.559 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 7.9 t 174.11 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.147 178.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.7 t -79.58 -24.06 42.31 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.2 0.524 . . . . 0.0 110.221 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.441 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 8.8 ptp -155.26 70.17 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 51.8 m -78.79 120.68 23.77 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.843 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.7 tp10 -102.59 118.5 36.98 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.888 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 5.3 tp10 -94.06 105.85 17.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.613 170.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 115.04 27.73 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.272 -173.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 1.01 ' HG2' HD13 ' A' ' 62' ' ' LEU . 39.0 mtm105 -81.48 98.77 8.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 172.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.758 HG12 ' HB3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -108.11 116.71 56.46 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.209 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.519 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 50.2 Cg_exo -50.63 139.08 39.6 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 123.291 2.66 . . . . 0.0 112.518 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -50.34 -48.5 55.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -28.36 73.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.29 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.765 ' HE3' HG21 ' A' ' 86' ' ' ILE . 91.0 mmm -78.78 -10.28 59.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.621 HG22 ' HB2' ' A' ' 65' ' ' ARG . 39.5 t -77.12 -41.24 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.15 64.44 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.396 172.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.5 mt -89.01 -26.12 21.63 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.597 HG21 ' O ' ' A' ' 31' ' ' VAL . 10.5 tp -72.49 -27.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.477 0.656 . . . . 0.0 109.736 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.598 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 13.4 pt -84.27 -14.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.133 173.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.86 -90.8 0.07 OUTLIER Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.644 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.04 10.41 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.867 0.467 . . . . 0.0 111.698 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.13 35.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.111 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.598 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 154.1 -46.3 0.55 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.467 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 26.5 tt0 -48.18 -38.18 17.56 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -61.32 -45.57 93.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.524 HD13 HG12 ' A' ' 53' ' ' VAL . 5.7 tp -59.4 -49.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.424 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.11 -43.08 99.62 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.344 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -58.78 -39.25 80.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.364 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.414 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -81.27 -42.49 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.769 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -73.46 -26.83 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.61 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.99 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.41 -51.43 69.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.348 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 p -74.43 -37.29 63.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.772 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.53 2.43 60.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.533 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 51.4 t -79.67 139.98 37.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 110.56 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' HE2' ' HA2' ' A' ' 71' ' ' GLY . 12.4 mttm -83.46 75.56 10.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.264 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.524 HG12 HD13 ' A' ' 42' ' ' ILE . 45.4 t -82.18 110.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.638 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.0 mm-40 -102.41 106.44 17.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.675 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.04 106.05 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.411 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.58 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 15.1 m -98.99 107.49 44.17 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-O 120.753 0.311 . . . . 0.0 110.656 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.681 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 21.6 Cg_endo -62.13 -37.18 65.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.528 2.819 . . . . 0.0 112.249 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.12 97.12 8.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.48 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 4.2 p -70.84 -37.45 73.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.372 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.7 -72.9 2.72 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.312 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.19 70.53 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.714 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 1.01 HD13 ' HG2' ' A' ' 25' ' ' ARG . 22.2 mt -115.36 153.18 47.53 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.63 -31.28 2.04 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.33 -161.66 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.572 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.758 ' HB3' HG12 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -81.35 151.06 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.679 ' HB3' HD12 ' A' ' 62' ' ' LEU . 88.5 p -118.11 114.24 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.036 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 91.5 t -106.0 122.63 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.828 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.6 m -88.83 125.58 34.97 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.628 0.728 . . . . 0.0 110.78 177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.843 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.9 mm? -105.04 109.58 21.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.449 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.667 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 26.3 m -151.26 144.75 24.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' A' ' 52' ' ' LYS . . . 173.28 -107.82 0.26 Allowed Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.935 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.606 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -131.61 164.17 44.55 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 5.3 Cg_endo -47.4 -50.02 12.06 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.193 2.596 . . . . 0.0 112.994 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.53 -30.24 25.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.1 m -71.56 -48.25 49.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -69.51 -23.9 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -177.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.75 -51.01 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.319 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 81' ' ' MET . 24.4 tptm -62.7 -41.07 98.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.23 90.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.689 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 48.0 mtmt -74.93 -21.35 59.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.37 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.412 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 6.1 tpp -60.23 -46.42 89.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.414 ' HG3' HG12 ' A' ' 45' ' ' ILE . 20.4 mmt -71.02 -39.67 72.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.418 ' HG ' HD22 ' A' ' 69' ' ' LEU . 4.0 mm? -61.43 -48.92 78.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.321 177.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.5 -46.74 83.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.141 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -46.88 -58.13 4.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.385 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.765 HG21 ' HE3' ' A' ' 30' ' ' MET . 1.9 mp -79.57 -44.57 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.388 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.68 -27.49 36.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.747 0.308 . . . . 0.0 111.131 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -77.93 -38.55 45.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.471 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 3.3 ptp180 -72.26 -21.32 61.39 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.38 -83.15 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.379 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.85 60.72 4.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.187 0.518 . . . . 0.0 111.256 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.97 120.41 5.14 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.341 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.821 -179.403 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.687 HD12 ' HA3' ' A' ' 61' ' ' GLY . 41.4 pt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.206 0.526 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -115.94 -160.35 0.75 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.525 -174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 m 68.21 -170.96 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.704 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.419 ' H ' ' HG2' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -53.24 112.41 0.87 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.1 tp -106.83 117.39 33.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.839 172.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.99 79.75 0.26 Allowed Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.926 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -87.78 -7.82 6.24 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.761 2.308 . . . . 0.0 112.734 -176.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.789 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.9 tp -140.87 152.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.685 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 71.3 m80 -88.6 -27.08 0.34 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.789 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.6 Cg_exo -37.69 165.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.474 2.783 . . . . 0.0 114.16 165.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 17' ' ' ARG . 42.4 Cg_exo -58.3 169.44 2.97 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.139 2.559 . . . . 0.0 112.606 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 37.4 Cg_endo -64.29 21.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.066 3.177 . . . . 0.0 114.064 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 13.5 ptm180 -77.98 -18.12 56.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 70' ' ' THR . 9.9 t -164.5 6.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.366 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.543 ' HA ' HG21 ' A' ' 12' ' ' ILE . 33.6 t -92.36 -99.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.927 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 17.4 ptm -60.98 84.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.715 0.769 . . . . 0.0 111.407 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -84.89 114.96 22.5 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.613 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.8 tp10 -92.75 116.63 29.2 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.97 109.21 22.01 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.755 0.788 . . . . 0.0 109.25 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.8 ' HD2' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.56 125.14 36.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.664 -169.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 -84.35 99.12 10.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.185 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.592 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -119.63 121.93 29.57 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.838 -175.431 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.561 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 46.1 Cg_exo -59.11 150.11 75.6 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.543 2.829 . . . . 0.0 113.025 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' HG11 ' A' ' 31' ' ' VAL . 10.2 t70 -45.82 -59.28 2.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.59 -173.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.44 -24.64 73.76 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.666 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.638 ' HE2' HG23 ' A' ' 86' ' ' ILE . 78.1 mmm -78.97 -33.35 45.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.697 -0.296 . . . . 0.0 110.598 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 34' ' ' ILE . 11.7 p -73.14 -28.07 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.868 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.07 72.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.161 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.18 -27.48 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -69.66 -28.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.574 0.702 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.694 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.4 pt -85.75 -15.19 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.515 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 58.31 -93.81 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 123.908 0.755 . . . . 0.0 112.95 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.92 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.07 37.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.115 0.566 . . . . 0.0 111.187 176.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 77.76 9.47 86.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 113.864 174.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.694 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.27 -42.33 0.86 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.185 174.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.92 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 34.0 tt0 -51.67 -30.96 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -66.45 -47.89 71.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 39' ' ' GLY . 10.4 tp -69.37 -36.95 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.857 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.86 -34.32 77.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.339 0.59 . . . . 0.0 110.18 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.149 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.406 HG13 ' HG3' ' A' ' 82' ' ' MET . 30.9 mm -74.14 -38.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.34 -174.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.25 64.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -77.24 -43.29 34.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.472 . . . . 0.0 109.729 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -54.92 -41.64 71.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.449 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.1 p -86.02 -38.04 18.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.289 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.73 2.98 52.76 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.456 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 48.2 t -79.51 139.72 37.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.307 0.575 . . . . 0.0 110.771 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -86.24 74.46 10.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.195 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -81.67 109.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.103 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -105.0 112.27 25.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.449 HD13 HG13 ' A' ' 67' ' ' VAL . 39.2 mm -79.43 97.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 44.1 m -81.17 106.58 5.89 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.568 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.831 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 5.4 Cg_exo -77.86 -33.58 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.105 3.203 . . . . 0.0 113.157 -173.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.2 -25.87 42.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.991 0.425 . . . . 0.0 109.875 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.403 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.0 t 62.33 -154.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.901 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.39 108.16 0.22 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.687 ' HA3' HD12 ' A' ' 5' ' ' ILE . . . 96.22 -34.71 4.78 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.493 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.4 mm? -100.55 137.09 19.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 1.55 9.2 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.733 2.289 . . . . 0.0 111.912 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -111.11 -115.24 0.31 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.508 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.831 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 4.2 tpp180 -130.16 155.57 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.458 ' HB3' HD21 ' A' ' 62' ' ' LEU . 34.3 p -130.89 129.54 42.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.2 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.449 HG13 HD13 ' A' ' 55' ' ' ILE . 60.9 t -114.55 130.99 67.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.127 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 p -97.91 128.25 44.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.588 0.709 . . . . 0.0 111.03 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.2 mm? -108.29 112.37 24.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.801 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.442 HG22 ' HA ' ' A' ' 18' ' ' THR . 2.3 m -150.86 155.37 39.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . 162.88 -71.3 0.21 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.382 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.71 161.36 24.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.27 -53.56 6.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.244 1.962 . . . . 0.0 112.558 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -71.23 -37.31 72.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.316 0.579 . . . . 0.0 110.714 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.422 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 14.2 m -72.85 -43.55 62.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.591 -171.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.456 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.4 p -70.13 -24.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' A' ' 81' ' ' MET . 43.5 tp60 -82.01 -35.99 28.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.204 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 81' ' ' MET . 24.4 tptm -64.26 -45.92 86.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.69 0.757 . . . . 0.0 109.584 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.72 -48.21 75.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.284 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.538 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.1 mtmt -69.02 -21.51 64.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.993 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.924 ' HE3' ' HA ' ' A' ' 81' ' ' MET . 13.2 mmt -59.27 -47.56 84.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.9 0.381 . . . . 0.0 110.029 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.406 ' HG3' HG13 ' A' ' 45' ' ' ILE . 92.5 mmm -67.5 -45.77 74.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -59.42 -54.0 51.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.55 -35.13 78.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.483 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.31 -53.44 56.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.491 . . . . 0.0 110.793 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.638 HG23 ' HE2' ' A' ' 30' ' ' MET . 1.9 mp -76.66 -39.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.636 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.8 HG23 ' HD2' ' A' ' 24' ' ' TYR . 78.9 t -65.56 -31.86 55.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.493 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 13.4 t -78.02 -32.63 51.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.49 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.5 ptp180 -74.57 -16.37 60.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.889 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.01 -73.79 1.08 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.339 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.97 -37.16 55.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.127 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 88' ' ' SER . . . 94.19 -77.64 0.99 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.888 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.151 -179.153 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 tt . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.7 p -149.46 -173.7 4.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.838 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.53 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 47.9 m 70.57 -169.78 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.71 0.631 . . . . 0.0 111.739 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -36.42 117.37 0.48 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.57 1.148 . . . . 0.0 113.525 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' MET . 0.7 OUTLIER -121.27 137.33 54.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.596 170.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.48 71.75 0.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.793 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.77 -37.83 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.951 2.434 . . . . 0.0 112.819 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.703 HG21 ' HD2' ' A' ' 14' ' ' PRO . 8.9 mm -113.87 149.19 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.576 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 10.0 t60 -90.67 -41.72 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.703 ' HD2' HG21 ' A' ' 12' ' ' ILE . 25.1 Cg_exo -41.79 171.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.629 2.886 . . . . 0.0 114.397 172.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 17' ' ' ARG . 26.1 Cg_exo -33.99 150.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.361 3.374 . . . . 0.0 114.833 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 55.7 Cg_endo -66.26 27.25 0.1 Allowed 'Trans proline' 0 N--CA 1.48 0.729 0 C-N-CA 124.265 3.31 . . . . 0.0 114.899 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 15' ' ' PRO . 3.9 ptp180 -84.54 -8.16 59.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.412 0.625 . . . . 0.0 109.334 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -164.45 12.33 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.003 174.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.53 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 47.2 t -92.86 -99.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 15.7 ptp -68.71 78.07 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.644 0.735 . . . . 0.0 110.525 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -79.34 115.71 19.15 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.6 tp10 -95.16 118.77 32.52 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB3' ' N ' ' A' ' 7' ' ' SER . 10.0 tp10 -105.1 106.24 16.64 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.539 -0.865 . . . . 0.0 108.861 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.479 ' CD1' HG23 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -91.66 124.96 36.21 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.133 -167.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.649 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 19.2 mtp180 -90.3 99.44 12.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.202 174.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -116.1 122.27 32.55 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.559 -175.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.48 145.85 44.93 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.796 2.331 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' HA ' HG13 ' A' ' 31' ' ' VAL . 1.4 p-10 -61.95 -28.75 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.306 -169.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -28.95 61.23 Favored Glycine 0 C--O 1.238 0.399 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.507 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.578 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 20.4 mmt -78.67 -31.27 46.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.344 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 34' ' ' ILE . 9.0 p -69.99 -34.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.648 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.78 -30.36 69.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.556 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.9 mt -87.81 -23.86 23.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 31' ' ' VAL . 10.2 tp -71.49 -30.23 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.654 0.74 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.685 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.7 pt -83.13 -14.79 11.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 -91.83 0.11 Allowed Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.214 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.61 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 14.3 ptp180 -76.74 -0.02 22.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.0 111.275 -176.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.67 10.39 8.53 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.811 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.685 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 158.01 -55.54 0.37 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.578 173.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.61 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 26.4 mm-40 -59.3 -23.92 62.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -59.99 -52.86 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.081 0.855 . . . . 0.0 110.576 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.571 HD13 HG12 ' A' ' 53' ' ' VAL . 6.3 tp -62.02 -45.33 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.021 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -54.7 -37.13 65.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.439 0.462 . . . . 0.0 110.745 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HE2' ' HB3' ' A' ' 40' ' ' GLU . 68.0 mttm -72.28 -41.76 66.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.198 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.21 -48.69 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 111.664 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.32 -31.46 71.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.069 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.464 HE21 ' HB3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -74.09 -36.26 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.21 0.528 . . . . 0.0 109.879 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.38 -32.25 73.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.053 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.647 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 8.0 p -96.87 -40.35 8.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.839 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.99 27.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.712 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 32.0 t -79.99 136.68 36.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.117 0.484 . . . . 0.0 110.734 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -84.22 72.17 10.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.571 HG12 HD13 ' A' ' 42' ' ' ILE . 44.6 t -83.14 106.81 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.972 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.21 110.65 22.94 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.136 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.488 HD12 HG11 ' A' ' 67' ' ' VAL . 48.1 mm -79.78 112.62 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.679 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.475 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 2.6 m -94.82 102.05 8.25 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.084 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 86.7 Cg_endo -76.56 -21.36 13.1 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.982 2.455 . . . . 0.0 112.581 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.95 -41.77 25.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.025 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.609 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 9.0 t 73.78 -64.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.746 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 -76.5 2.2 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.143 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.77 -8.25 84.69 Favored Glycine 0 CA--C 1.511 -0.189 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.853 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.649 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.7 mt -121.16 146.82 45.32 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.65 -20.7 10.48 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.61 2.206 . . . . 0.0 110.242 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -93.05 -163.94 1.11 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.752 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.532 ' HG2' HG21 ' A' ' 31' ' ' VAL . 6.0 tpp180 -92.18 147.01 23.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.535 ' HB3' HD12 ' A' ' 62' ' ' LEU . 78.0 p -117.91 141.66 48.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.674 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.488 HG11 HD12 ' A' ' 55' ' ' ILE . 87.7 t -137.68 120.94 20.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.382 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 p -92.46 125.5 37.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.604 0.716 . . . . 0.0 111.497 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.85 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.7 mm? -105.23 120.01 40.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.19 155.74 40.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.11 -121.21 1.01 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.198 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -119.45 164.01 24.01 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.72 -46.33 21.45 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.573 2.182 . . . . 0.0 112.695 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -75.47 -46.64 31.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.923 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.647 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 1.5 m -61.51 -48.65 80.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.281 -173.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.551 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.0 p -70.09 -24.26 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.381 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -74.76 -45.94 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -58.72 -48.69 80.3 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.36 0.6 . . . . 0.0 110.187 176.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.16 -52.09 67.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.886 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.759 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.0 mtmt -68.39 -21.97 64.66 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.253 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.567 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 10.6 ptm -72.08 -32.49 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.846 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.6 mmt -66.77 -47.62 71.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 110.011 171.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.29 -52.27 66.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.737 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.98 -38.38 70.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.837 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.52 -60.39 3.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.541 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.585 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.8 mp -72.61 -37.73 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 111.727 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 24' ' ' TYR . 69.7 t -67.68 -26.1 34.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.781 -0.574 . . . . 0.0 111.113 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t -75.67 -34.66 60.48 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.387 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.585 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -77.48 -12.87 60.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.077 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.84 -55.97 0.82 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.546 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.41 39.26 0.94 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.043 0.449 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.76 82.96 1.55 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.63 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.709 -1.051 . . . . 0.0 111.169 -177.367 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.424 ' H1 ' HG13 ' A' ' 5' ' ' ILE . 2.7 pp . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.561 0.22 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.4 t -153.19 155.19 36.2 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m 62.26 -161.41 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.748 0.655 . . . . 0.0 110.807 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 21' ' ' THR . 26.1 mt-30 -147.92 -93.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp 172.97 -173.4 0.05 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.376 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.565 ' HA3' ' C ' ' A' ' 19' ' ' SER . . . -143.52 114.89 0.86 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.076 172.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 -24.79 26.01 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.874 2.383 . . . . 0.0 113.269 -174.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.604 HD11 ' HG2' ' A' ' 14' ' ' PRO . 17.0 pt -121.67 164.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.157 0.503 . . . . 0.0 111.098 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.657 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 63.4 m80 -90.09 -19.11 0.24 Allowed Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.657 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 73.2 Cg_exo -39.5 167.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.601 2.2 . . . . 0.0 114.077 168.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 17' ' ' ARG . 7.0 Cg_endo -49.29 165.61 0.22 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.371 2.714 . . . . 0.0 113.057 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.75 34.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.061 3.174 . . . . 0.0 114.723 -178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' A' ' 15' ' ' PRO . 12.4 ptm180 -86.21 0.3 54.04 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.563 HG22 HD13 ' A' ' 12' ' ' ILE . 12.7 t -178.92 -12.77 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.011 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.565 ' C ' ' HA3' ' A' ' 10' ' ' GLY . 12.6 t -79.59 1.6 25.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -177.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.5 ptm -164.26 72.73 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.591 . . . . 0.0 110.732 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.617 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 48.4 m -79.13 122.22 25.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.572 ' HG2' ' HD2' ' A' ' 24' ' ' TYR . 1.6 tt0 -102.28 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.977 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -91.09 103.38 16.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.572 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -92.37 127.3 37.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.399 -172.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.582 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 63.9 mtp180 -81.59 111.46 17.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.294 0.568 . . . . 0.0 110.751 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.771 HG11 HG22 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -128.65 121.64 21.24 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.792 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 33.9 Cg_endo -68.55 151.38 75.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.932 1.755 . . . . 0.0 110.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -37.75 64.86 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -166.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.42 80.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.478 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.595 ' HE2' HD11 ' A' ' 33' ' ' LEU . 32.0 mmt -78.42 -15.99 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 35' ' ' ILE . 40.3 t -70.01 -44.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.31 -31.73 80.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.089 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.595 HD11 ' HE2' ' A' ' 30' ' ' MET . 45.2 mt -88.37 -23.24 23.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -71.11 -29.75 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.357 0.599 . . . . 0.0 109.508 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.685 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -85.37 -15.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.284 170.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.35 -90.6 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.498 0 O-C-N 124.401 1.063 . . . . 0.0 112.429 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.2 ptt-85 -76.69 48.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.884 -0.658 . . . . 0.0 111.579 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.83 11.79 61.11 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.902 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.685 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.03 -42.0 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.292 -1.433 . . . . 0.0 113.534 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.59 -32.23 66.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.4 tt0 -61.72 -52.48 64.12 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.439 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.524 HG22 HG22 ' A' ' 35' ' ' ILE . 9.9 tp -62.0 -41.27 90.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.521 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -58.1 -48.17 80.99 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -60.13 -40.49 89.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.909 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.593 HD11 ' HG3' ' A' ' 82' ' ' MET . 87.8 mt -70.89 -50.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.448 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -26.96 62.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -175.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.827 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -78.46 -35.99 45.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.164 0.507 . . . . 0.0 110.218 176.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -42.74 99.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.857 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.743 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 11.9 p -84.88 -38.79 19.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.26 11.35 31.83 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.422 ' N ' ' HB3' ' A' ' 75' ' ' SER . 51.2 t -86.45 154.51 21.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.213 0.53 . . . . 0.0 110.28 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -105.58 71.58 0.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.054 0.93 . . . . 0.0 109.241 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.507 HG11 HD12 ' A' ' 42' ' ' ILE . 37.3 t -81.99 119.34 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.174 -175.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 14.4 mm-40 -113.69 120.4 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.4 mm -83.61 93.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.428 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 t -79.71 110.89 17.38 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.1 Cg_exo -80.85 -9.39 13.16 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.654 2.902 . . . . 0.0 111.157 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 -37.91 46.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.902 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.55 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 11.2 m 70.03 -59.64 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.161 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.56 -87.65 1.46 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.775 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.527 ' C ' HD11 ' A' ' 62' ' ' LEU . . . -87.66 3.25 86.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.63 HD23 ' HB3' ' A' ' 66' ' ' SER . 5.1 mp -124.19 139.55 32.97 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -170.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -87.19 -24.17 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.794 2.329 . . . . 0.0 111.972 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.792 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -88.44 -84.16 0.21 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.677 -175.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 5.4 tpp85 -160.61 153.92 21.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.63 ' HB3' HD23 ' A' ' 62' ' ' LEU . 88.3 p -124.55 130.24 52.08 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.235 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.771 HG22 HG11 ' A' ' 26' ' ' VAL . 85.8 t -105.11 115.7 47.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 72.2 m -79.76 120.32 23.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.366 0.603 . . . . 0.0 109.806 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.912 HD13 ' HG2' ' A' ' 80' ' ' LYS . 27.1 mt -113.27 105.01 12.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -150.12 145.12 26.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.218 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.33 -98.32 0.11 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 119.741 -1.219 . . . . 0.0 113.607 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.5 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -138.06 165.04 36.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.466 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 93.0 Cg_exo -45.06 -66.12 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.066 2.511 . . . . 0.0 113.46 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.75 -39.99 80.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.458 0.647 . . . . 0.0 110.235 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.743 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 7.1 m -59.64 -46.19 89.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.709 -173.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.643 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.2 p -73.74 -31.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.879 -173.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.79 -42.26 86.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.048 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 81' ' ' MET . 2.4 tmtp? -70.29 -42.26 72.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.688 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.26 93.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.0 111.414 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.912 ' HG2' HD13 ' A' ' 69' ' ' LEU . 5.1 mtmp? -81.19 -21.22 39.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.526 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.6 tpt -60.32 -47.49 85.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 173.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.593 ' HG3' HD11 ' A' ' 45' ' ' ILE . 18.9 mmt -68.17 -37.62 81.2 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 176.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.705 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.2 mm? -59.44 -49.84 76.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.28 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.15 -42.63 66.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.735 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.87 -56.5 20.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.661 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.58 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -71.27 -41.15 74.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.045 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.529 HG21 ' CD1' ' A' ' 24' ' ' TYR . 60.7 t -63.56 -23.87 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 O-C-N 121.886 -0.509 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.9 m -85.07 -26.01 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.58 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.4 ptp180 -77.04 -12.94 60.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.148 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.28 -39.92 1.45 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.693 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.569 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -115.74 47.71 1.31 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 0.0 110.945 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.29 36.82 3.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.319 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.18 -1.345 . . . . 0.0 110.981 -177.569 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p 56.09 -162.37 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.873 0.869 . . . . 0.0 111.586 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m 62.37 -168.66 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.662 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' THR . 26.8 mt-30 -64.98 109.5 2.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.304 0.573 . . . . 0.0 111.815 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -84.8 133.53 34.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.91 77.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.847 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.96 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.734 2.289 . . . . 0.0 112.207 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.669 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -109.03 157.89 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.553 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.624 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 54.6 t60 -91.02 -26.98 0.3 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 49.7 Cg_exo -37.12 166.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 123.441 2.76 . . . . 0.0 115.097 170.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 17' ' ' ARG . 83.6 Cg_exo -45.13 153.92 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.776 2.984 . . . . 0.0 113.879 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.54 12.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.416 3.411 . . . . 0.0 114.3 -174.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 15' ' ' PRO . 3.8 ptp180 -64.9 -24.5 67.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.225 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -154.1 -5.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.947 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.1 p -79.79 -90.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.061 -0.4 . . . . 0.0 111.433 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.5 ptm -70.45 76.15 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.629 0.728 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 HG22 ' A' ' 70' ' ' THR . 24.8 m -84.53 116.21 23.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.336 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.918 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 5.5 tp10 -92.66 118.2 30.79 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -97.26 101.92 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.427 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -95.09 121.08 36.35 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.726 -171.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -81.94 123.81 29.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.544 179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.512 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -136.44 124.23 14.74 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.575 -175.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.662 ' HG2' ' HA ' ' A' ' 91' ' ' ARG . 35.8 Cg_exo -59.48 152.93 58.03 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.858 2.372 . . . . 0.0 113.338 -175.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.46 ' O ' HG11 ' A' ' 31' ' ' VAL . 24.2 t70 -50.11 -52.12 37.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.1 70.43 Favored Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.075 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.631 ' HE1' HH11 ' A' ' 89' ' ' ARG . 47.7 tpp -79.26 -27.61 42.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.639 -0.33 . . . . 0.0 110.695 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.606 ' O ' HG21 ' A' ' 34' ' ' ILE . 11.2 p -74.59 -25.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.49 -24.98 73.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.874 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.0 mt -87.76 -24.69 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.606 HG21 ' O ' ' A' ' 31' ' ' VAL . 11.2 tp -70.92 -32.71 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.586 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.3 pt -82.97 -14.6 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.15 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.16 -94.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.608 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.547 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 9.7 ptm180 -63.17 -10.32 14.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.589 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.08 4.96 5.84 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.08 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.578 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.79 -53.1 0.4 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.134 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 41.2 tt0 -55.43 -20.73 13.22 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.586 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.12 -53.16 61.54 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.865 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.541 HD11 HG12 ' A' ' 53' ' ' VAL . 11.2 tp -65.73 -36.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.918 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.47 -41.25 89.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.155 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -60.67 -56.78 17.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.843 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' CG1' ' HG2' ' A' ' 82' ' ' MET . 1.5 mp -54.61 -56.63 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.159 -176.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.476 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -70.03 -34.61 73.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -170.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.62 -35.49 39.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 110.327 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.99 -26.63 66.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.368 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 p -95.06 -40.58 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.743 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.31 18.23 9.34 Favored Glycine 0 CA--C 1.505 -0.567 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.809 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.95 160.96 14.2 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 0.0 111.978 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -101.3 76.25 1.69 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.16 173.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.541 HG12 HD11 ' A' ' 42' ' ' ILE . 41.8 t -90.4 109.05 20.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.697 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -113.02 137.8 50.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.65 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.3 116.29 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.291 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -95.01 107.1 29.37 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.227 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.958 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 81.9 Cg_endo -78.62 -30.15 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.89 2.393 . . . . 0.0 112.805 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.73 -44.44 23.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.8 t 68.65 -68.33 0.18 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.893 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.9 -86.69 0.46 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.595 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.24 -1.1 90.45 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.132 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 66' ' ' SER . 48.8 mt -119.2 135.81 24.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.96 -17.36 17.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.687 2.258 . . . . 0.0 110.459 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -94.26 -162.44 0.94 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.101 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.958 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -99.64 156.64 16.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.661 ' HB3' HD11 ' A' ' 62' ' ' LEU . 24.7 p -128.64 135.82 49.82 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.693 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.08 129.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.565 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.1 m -91.72 127.62 37.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.349 0.595 . . . . 0.0 111.146 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.918 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 4.2 mm? -108.1 117.63 34.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.325 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.458 HG22 HG22 ' A' ' 21' ' ' THR . 0.6 OUTLIER -150.34 156.6 41.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.021 176.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.17 -152.21 23.65 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.785 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . . . -80.37 159.54 69.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 72' ' ' ALA . 6.3 Cg_endo -49.08 -50.0 13.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.755 2.303 . . . . 0.0 112.368 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.33 -44.8 82.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.408 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.593 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 9.7 m -62.03 -54.61 39.07 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.034 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -25.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.302 -172.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.624 ' O ' ' HG3' ' A' ' 81' ' ' MET . 51.1 tt0 -71.45 -50.58 30.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -57.7 -50.73 72.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.754 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.719 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . . . -54.17 -48.31 71.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.134 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.704 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 38.3 mtmt -67.09 -21.5 65.87 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.381 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.624 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 94.0 mtp -66.85 -41.45 87.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.459 ' HG2' ' CG1' ' A' ' 45' ' ' ILE . 2.6 mpt? -65.91 -47.43 74.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.711 0.291 . . . . 0.0 111.048 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.471 ' HG ' HD22 ' A' ' 69' ' ' LEU . 4.3 mm? -57.95 -55.56 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.943 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.7 -44.71 77.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.554 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.24 -53.32 55.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.517 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.747 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 2.0 mp -75.29 -45.25 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.713 -175.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG22 ' CD1' ' A' ' 24' ' ' TYR . 84.7 t -61.82 -40.19 86.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.076 0.465 . . . . 0.0 110.717 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -72.83 -28.5 62.58 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.056 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.747 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -73.28 -21.93 60.49 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.836 -178.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.02 63.27 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.048 -1.549 . . . . 0.0 114.608 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.662 ' HA ' ' HG2' ' A' ' 27' ' ' PRO . 36.1 ttt180 -84.68 77.51 10.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.697 0.748 . . . . 0.0 109.744 170.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.77 105.28 0.26 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.862 179.493 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.546 0.212 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t 67.9 92.7 0.08 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.762 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.844 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 40.1 m 63.19 -152.2 0.33 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.931 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 7' ' ' SER . 26.1 mt-30 -178.77 -103.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.339 1.055 . . . . 0.0 108.668 166.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.545 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 38.1 tp 158.83 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.399 1.062 . . . . 0.0 109.082 176.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 152.94 108.11 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.237 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.2 -8.54 23.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.824 2.349 . . . . 0.0 112.013 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.606 HD13 HG22 ' A' ' 18' ' ' THR . 1.0 OUTLIER -114.44 142.62 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.812 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.689 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 18.7 t-80 -92.55 -11.1 0.17 Allowed Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -172.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.689 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.4 Cg_endo -56.4 -175.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.515 2.144 . . . . 0.0 113.15 176.582 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 14' ' ' PRO . 1.8 Cg_endo -44.22 153.7 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.885 2.39 . . . . 0.0 112.962 174.804 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.625 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 36.7 Cg_endo -65.46 33.81 0.11 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 124.286 3.324 . . . . 0.0 115.254 -174.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 15' ' ' PRO . 66.6 mtt180 -84.56 7.2 20.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.626 0.726 . . . . 0.0 109.213 175.033 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.606 HG22 HD13 ' A' ' 12' ' ' ILE . 8.9 t -176.02 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.127 175.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.503 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 1.8 m -86.41 9.66 17.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.001 -178.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.625 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 18.5 mmt -146.47 31.23 0.99 Allowed 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.002 177.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 85.7 m -78.92 114.51 17.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.844 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 19.8 tt0 -121.64 118.86 30.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.818 176.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -87.63 110.65 20.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.478 ' CD1' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.34 124.0 34.03 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.81 -166.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.862 ' HG2' HD22 ' A' ' 62' ' ' LEU . 48.9 mtm180 -81.86 103.73 11.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.302 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.402 HG12 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.3 124.59 26.81 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.508 -175.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.0 148.09 78.68 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.424 2.083 . . . . 0.0 111.644 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.683 ' O ' HG11 ' A' ' 31' ' ' VAL . 37.8 t70 -54.47 -51.43 65.07 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.85 -24.52 70.01 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.838 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.497 ' HE3' ' CA ' ' A' ' 90' ' ' GLY . 30.4 tpp -79.32 -29.64 42.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.477 -0.361 . . . . 0.0 110.828 -175.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.731 ' HA ' HG23 ' A' ' 34' ' ' ILE . 13.4 p -70.99 -26.32 27.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -30.12 75.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.421 169.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.472 HD22 ' SD ' ' A' ' 30' ' ' MET . 64.3 tp -84.15 -31.01 25.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 177.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.731 HG23 ' HA ' ' A' ' 31' ' ' VAL . 9.5 tp -70.39 -26.42 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.685 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 8.5 pt -81.42 -14.38 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.557 174.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 63.7 -92.19 0.1 Allowed Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.316 172.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.738 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -77.34 20.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.86 0.464 . . . . 0.0 111.393 -179.458 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 96.43 5.89 58.88 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.042 177.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.685 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 154.53 -45.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.388 176.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.738 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 49.6 tt0 -56.59 -29.09 61.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' O ' HG12 ' A' ' 45' ' ' ILE . 25.4 tt0 -62.43 -53.24 57.8 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.442 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.585 HD11 HG12 ' A' ' 53' ' ' VAL . 8.6 tp -62.95 -38.71 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.261 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.97 -42.99 99.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.647 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -58.51 -43.2 89.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.602 176.064 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.6 mm -69.96 -50.93 44.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.912 -176.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.405 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.24 -31.92 68.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 -174.688 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -76.04 -38.36 57.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 110.17 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.467 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 11.9 t70 -62.82 -50.57 70.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.851 178.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 p -70.85 -45.52 64.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.73 -4.36 26.04 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.464 -176.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 41.6 t -79.12 135.16 36.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.11 0.481 . . . . 0.0 110.099 178.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -85.02 74.5 10.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.519 0.676 . . . . 0.0 110.104 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.585 HG12 HD11 ' A' ' 42' ' ' ILE . 44.9 t -82.49 115.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.789 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.6 mm-40 -119.48 129.95 54.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.856 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.423 HD12 HG12 ' A' ' 67' ' ' VAL . 42.7 mm -83.95 109.12 17.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.754 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.55 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 7.3 m -82.4 111.33 27.43 Favored Pre-proline 0 C--O 1.242 0.662 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.576 -178.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.773 ' HA ' HH11 ' A' ' 65' ' ' ARG . 60.8 Cg_endo -73.01 -27.73 13.76 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.949 2.433 . . . . 0.0 111.858 178.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.46 88.39 2.72 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.861 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 5.3 p -65.6 -39.2 91.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.238 -175.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.01 -61.51 4.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.729 174.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.598 ' C ' HD13 ' A' ' 62' ' ' LEU . . . -93.86 4.88 72.36 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.817 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.862 HD22 ' HG2' ' A' ' 25' ' ' ARG . 5.8 mp -127.71 151.38 75.3 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.36 -0.42 . . . . 0.0 109.941 -170.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -90.89 -4.4 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.696 2.264 . . . . 0.0 111.072 171.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.434 ' CD ' HH21 ' A' ' 91' ' ' ARG . 1.6 pt-20 -119.52 -153.27 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.962 -177.335 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.773 HH11 ' HA ' ' A' ' 57' ' ' PRO . 14.6 tpp180 -91.97 157.86 16.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.791 ' HB3' HD23 ' A' ' 62' ' ' LEU . 56.9 p -131.96 153.41 50.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.642 174.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.423 HG12 HD12 ' A' ' 55' ' ' ILE . 57.5 t -135.19 131.75 52.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.2 m -89.87 127.66 36.04 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.284 177.49 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.732 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -110.57 107.48 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 175.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -152.54 134.64 14.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.61 -147.39 7.84 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.846 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.6 160.2 70.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.558 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . 99.9 Cg_exo -45.06 -56.51 2.66 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.033 2.489 . . . . 0.0 114.237 -174.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -84.15 -30.98 25.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.956 -178.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 m -62.38 -43.33 99.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.007 0.432 . . . . 0.0 110.696 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.8 p -66.86 -27.77 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.4 tp-100 -73.52 -50.28 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.126 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -54.2 -43.89 71.14 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.207 0.527 . . . . 0.0 110.566 178.798 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.71 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.562 176.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.732 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 9.8 mtmp? -66.16 -21.23 66.32 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.854 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.4 mmm -67.7 -43.41 80.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.83 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.0 mmm -66.73 -34.55 78.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 175.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.37 -49.09 65.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -51.3 -44.59 61.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.614 177.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 10.5 t70 -64.08 -61.04 2.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.682 -178.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.443 ' HB ' HD13 ' A' ' 34' ' ' ILE . 1.9 mp -66.68 -40.51 86.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.27 -174.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.478 HG23 ' CD1' ' A' ' 24' ' ' TYR . 77.3 t -67.82 -26.86 35.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.502 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.4 t -72.79 -26.25 61.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.815 0.341 . . . . 0.0 110.239 175.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 25.5 mmt180 -63.6 -41.91 98.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.21 0.529 . . . . 0.0 109.671 176.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.497 ' CA ' ' HE3' ' A' ' 30' ' ' MET . . . -87.45 -59.51 1.72 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.721 178.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.434 HH21 ' CD ' ' A' ' 64' ' ' GLU . 33.2 mmt180 -88.35 57.85 4.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.469 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.14 -126.16 1.15 Allowed Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.644 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.634 -1.092 . . . . 0.0 111.77 178.989 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.697 0.761 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 p -153.47 -169.7 3.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.2 t 73.42 -69.67 0.18 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.678 0.611 . . . . 0.0 111.024 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -155.93 143.49 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.099 0.476 . . . . 0.0 110.889 -177.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -134.65 98.56 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 67.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 172.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.12 -11.86 14.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.917 2.411 . . . . 0.0 111.826 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.525 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 23.2 pt -124.97 154.9 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.678 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 49.4 t-80 -89.45 -22.1 0.27 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 23.8 Cg_exo -42.23 168.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.692 2.262 . . . . 0.0 114.474 174.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 17' ' ' ARG . 65.4 Cg_exo -41.25 157.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.758 2.972 . . . . 0.0 114.36 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.518 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 35.1 Cg_endo -66.83 28.6 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.901 3.067 . . . . 0.0 114.357 -175.171 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.468 ' H ' ' C ' ' A' ' 15' ' ' PRO . 88.4 mtt180 -73.19 -26.69 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.476 HG22 HD11 ' A' ' 12' ' ' ILE . 2.7 t -158.36 10.16 0.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.353 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.5 t -101.07 -12.51 18.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.391 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.518 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 21.8 mmt -134.33 34.46 3.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 -176.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 87.3 m -79.68 112.19 16.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 14.4 tt0 -111.01 119.09 37.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -96.61 103.21 15.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -91.81 118.68 30.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.973 -166.853 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.548 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 32.4 mtm180 -81.78 114.74 20.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.776 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.553 HG12 ' HB3' ' A' ' 65' ' ' ARG . 1.1 p -135.45 131.87 19.62 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.065 -173.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 38.2 Cg_exo -61.8 146.28 96.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.905 2.403 . . . . 0.0 111.555 177.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -59.89 -30.32 68.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.405 -172.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.62 -33.24 56.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.177 176.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.729 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 83.7 mmm -78.82 -29.48 44.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.904 -0.174 . . . . 0.0 110.795 -176.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.0 p -69.72 -31.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.358 173.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.58 70.38 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.431 171.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.76 -23.65 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.9 tp -72.37 -27.32 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.457 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.6 pt -85.18 -14.75 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.155 171.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.42 -97.78 0.1 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.362 173.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 14.2 ptm180 -58.99 -22.39 60.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.097 0.559 . . . . 0.0 111.63 178.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -7.63 1.83 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.785 177.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.605 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 167.85 -48.36 0.24 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.256 176.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 28.3 tt0 -59.96 -21.64 61.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -171.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.26 -55.32 35.14 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.316 0.507 . . . . 0.0 110.582 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.84 -38.66 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.76 -36.83 79.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 28.1 tptp -63.04 -58.64 6.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.125 176.501 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.47 -41.37 87.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.259 -174.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.1 pp0? -71.85 -40.32 69.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.85 -176.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -73.76 -30.29 62.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.347 0.594 . . . . 0.0 110.537 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 13.0 t70 -69.12 -43.99 73.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.716 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 39.4 p -80.03 -35.36 37.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 7.19 30.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.626 -177.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 33.9 t -90.71 141.47 28.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -94.05 89.09 5.9 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.238 0.542 . . . . 0.0 109.657 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.37 106.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.745 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -106.0 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -175.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.43 HD11 HG12 ' A' ' 67' ' ' VAL . 43.1 mm -78.9 116.94 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.7 t -107.76 112.91 61.81 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 111.133 -177.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.89 -37.49 19.78 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.357 2.705 . . . . 0.0 111.306 175.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -80.11 83.28 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.557 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.4 m -76.31 4.19 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.11 -169.289 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.16 -92.91 1.07 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.826 169.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.8 -11.26 58.08 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.553 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 59' ' ' SER . 3.0 mm? -103.78 142.87 25.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.1 -18.75 2.18 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.752 2.301 . . . . 0.0 112.502 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -83.41 -86.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.391 -175.253 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' HB3' HG12 ' A' ' 26' ' ' VAL . 1.3 tpp180 -160.27 154.31 23.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 176.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 22.1 t -139.35 143.8 37.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.43 HG12 HD11 ' A' ' 55' ' ' ILE . 46.3 t -129.84 134.95 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.189 -175.305 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.8 m -92.49 128.69 38.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.422 0.63 . . . . 0.0 111.557 177.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.647 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.6 mm? -110.48 112.91 25.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.579 177.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -151.5 148.22 27.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.042 176.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.65 -131.58 2.4 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.601 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.6 162.99 18.53 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.34 -48.58 19.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.823 2.349 . . . . 0.0 113.376 -174.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.48 -41.19 40.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.565 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 29.4 p -65.5 -41.56 93.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.454 0.645 . . . . 0.0 110.34 -174.208 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.605 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.15 -26.57 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.773 -176.781 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' A' ' 81' ' ' MET . 47.6 mt-30 -82.62 -34.04 27.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.608 177.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -65.84 -43.79 87.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.671 0.748 . . . . 0.0 109.684 176.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.36 78.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.104 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.647 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.2 mtmt -77.05 -19.94 56.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.039 -174.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.484 ' HB2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -57.05 -55.04 39.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.879 173.214 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.75 -35.87 82.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.2 mm? -65.99 -56.85 9.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -177.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -52.86 -40.86 63.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.571 179.225 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.543 ' HB3' HD12 ' A' ' 86' ' ' ILE . 7.4 t70 -53.52 -60.03 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.335 -178.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.703 HG21 ' HE1' ' A' ' 30' ' ' MET . 2.5 mp -76.25 -44.37 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.683 -175.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 83' ' ' LEU . 98.8 t -59.1 -39.8 79.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.52 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 t -70.2 -39.11 75.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.804 -179.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.585 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 11.4 ptt180 -77.33 -7.47 56.09 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.526 -176.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.729 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -121.85 0.74 10.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.681 174.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -164.03 100.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.24 68.68 1.43 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.903 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.707 -1.052 . . . . 0.0 111.256 -179.959 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.9 m -80.21 166.39 21.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.481 178.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.552 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.8 t 75.19 -68.61 0.2 Allowed 'General case' 0 C--O 1.224 -0.283 0 O-C-N 123.767 0.667 . . . . 0.0 110.976 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -149.01 136.46 20.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.282 0.563 . . . . 0.0 111.599 -177.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.829 ' HG ' ' HD3' ' A' ' 11' ' ' PRO . 57.1 tp -115.28 136.29 53.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.26 63.76 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.653 177.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.829 ' HD3' ' HG ' ' A' ' 9' ' ' LEU . 93.3 Cg_endo -86.47 -19.78 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.306 2.004 . . . . 0.0 112.124 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.587 HG23 ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -127.06 138.66 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.218 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.677 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 t-80 -91.71 -15.68 0.21 Allowed Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 22.6 Cg_endo -56.34 178.99 0.11 Allowed 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.201 1.934 . . . . 0.0 113.031 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 17' ' ' ARG . 59.5 Cg_exo -40.18 153.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.404 2.736 . . . . 0.0 114.188 179.077 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 73.8 Cg_endo -71.04 34.88 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.097 3.198 . . . . 0.0 113.283 -175.187 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 15' ' ' PRO . 92.8 mtt180 -84.87 -20.16 31.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -164.56 23.24 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.505 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.417 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 34.5 t -101.16 -90.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.749 -176.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptm -79.2 79.79 5.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.157 0.503 . . . . 0.0 110.909 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 9' ' ' LEU . 89.2 m -84.92 114.94 22.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 7' ' ' SER . 13.0 tt0 -94.4 117.95 30.89 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.82 106.25 18.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.529 0.681 . . . . 0.0 109.277 -179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.61 ' HD2' HG23 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.88 120.98 33.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.191 -172.733 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.802 ' HG2' HD22 ' A' ' 62' ' ' LEU . 70.5 mtm180 -86.26 101.31 12.94 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.589 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.766 HG12 ' HB3' ' A' ' 65' ' ' ARG . 1.4 p -116.44 129.24 25.4 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.8 Cg_exo -57.23 150.29 58.79 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.536 2.824 . . . . 0.0 112.338 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.35 -44.72 84.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -175.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.76 64.35 Favored Glycine 0 C--O 1.237 0.305 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.875 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.696 ' HE3' ' HA2' ' A' ' 90' ' ' GLY . 31.1 tpp -78.54 -28.65 46.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.828 -175.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -74.34 -25.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.96 -32.09 69.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.763 168.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.1 mt -82.05 -22.12 36.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 172.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' A' ' 31' ' ' VAL . 8.7 mm -61.36 -44.96 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 122.05 0.928 . . . . 0.0 108.674 174.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.621 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 4.8 pt -82.11 -14.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.787 175.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.18 -88.55 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.021 170.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.87 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 3.1 ptm180 -74.05 0.87 12.38 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.746 0.418 . . . . 0.0 110.998 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.18 -5.44 10.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.138 174.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.621 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 160.37 -41.46 0.44 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.722 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.87 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 1.5 tm-20 -58.83 -35.57 73.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.378 0.271 . . . . 0.0 111.199 -175.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.401 HE22 ' HE1' ' A' ' 82' ' ' MET . 1.2 tm0? -59.12 -47.1 86.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.496 0.189 . . . . 0.0 110.854 -171.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 tp -68.2 -36.32 74.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.224 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -62.46 -37.87 87.61 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -61.61 -54.49 42.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.499 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.53 -45.61 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.245 0.545 . . . . 0.0 111.594 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.873 HE21 ' HB ' ' A' ' 53' ' ' VAL . 97.1 mt-30 -58.33 -45.45 88.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.42 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -69.12 -42.55 75.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.023 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.7 -46.24 84.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.448 177.509 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.0 p -78.37 -47.48 17.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.583 -177.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.64 6.07 53.16 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 51.1 t -84.72 143.45 29.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.568 . . . . 0.0 110.631 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -89.98 77.66 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.317 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.873 ' HB ' HE21 ' A' ' 46' ' ' GLN . 26.1 t -82.13 107.73 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.123 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.579 HE21 ' CA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.69 106.58 18.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -176.969 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.473 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.8 mm -88.03 94.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.443 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 46.3 m -91.88 106.07 15.91 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.707 -179.236 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.68 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 8.3 Cg_exo -72.59 -34.35 7.34 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -176.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.21 -12.14 59.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.695 178.263 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.625 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 11.9 p 47.58 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 176.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.08 -75.41 0.35 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.002 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.538 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -81.63 0.23 88.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.766 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.802 HD22 ' HG2' ' A' ' 25' ' ' ARG . 7.6 mp -127.48 145.7 55.59 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.943 -170.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.456 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 43.4 Cg_endo -86.57 -15.17 4.26 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.138 2.559 . . . . 0.0 112.749 176.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.747 ' OE1' ' HB3' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.86 -102.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.947 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.766 ' HB3' HG12 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -135.64 131.12 35.37 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.269 -0.27 . . . . 0.0 110.381 -176.253 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.625 ' HB3' HD23 ' A' ' 62' ' ' LEU . 85.8 p -108.72 112.95 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.44 HG11 HD11 ' A' ' 55' ' ' ILE . 92.9 t -103.16 119.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.112 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.5 m -88.95 126.4 35.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.314 0.578 . . . . 0.0 110.851 176.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.706 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.0 mm? -102.27 104.06 14.57 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.492 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' ' 69' ' ' LEU . 3.2 m -151.44 148.29 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.766 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.25 -93.96 0.1 OUTLIER Glycine 0 C--O 1.226 -0.347 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.134 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -143.02 161.97 45.78 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -46.44 -55.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.194 2.596 . . . . 0.0 113.535 -175.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.74 -33.02 25.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 110.272 -178.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -64.68 -45.06 88.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.293 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.7 p -70.06 -26.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.558 -175.332 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.96 -43.97 67.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.676 ' O ' ' HG3' ' A' ' 81' ' ' MET . 23.4 tptm -66.15 -44.07 85.18 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -54.18 -48.78 70.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.2 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.706 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 33.0 mtmt -71.13 -25.02 62.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.565 -177.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.676 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 4.2 ppp? -70.18 -30.56 67.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.868 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.401 ' HE1' HE22 ' A' ' 41' ' ' GLN . 86.7 mmm -77.43 -36.17 53.41 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.755 172.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.43 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.6 mm? -63.73 -49.1 74.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.89 -44.05 86.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.886 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.1 -59.36 4.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.458 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.524 HG22 ' SD ' ' A' ' 30' ' ' MET . 1.6 mp -72.45 -45.16 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.119 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.61 HG23 ' HD2' ' A' ' 24' ' ' TYR . 9.1 t -67.2 -28.69 43.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 122.043 -0.411 . . . . 0.0 111.322 -176.397 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.442 ' HA ' ' HA2' ' A' ' 92' ' ' GLY . 21.4 t -69.47 -41.34 76.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.023 174.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 12.2 ptp180 -73.7 -13.23 60.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 110.473 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.696 ' HA2' ' HE3' ' A' ' 30' ' ' MET . . . -95.98 -39.45 4.32 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.987 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 92' ' ' GLY . 8.1 ptp180 -157.4 -48.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.784 0.326 . . . . 0.0 111.398 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 88' ' ' SER . . . 118.1 -39.15 2.68 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.666 -175.003 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 177.604 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.3 mt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.638 0.733 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -133.95 126.78 31.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.584 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.869 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 20.4 m 74.03 -4.27 2.32 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.088 0.867 . . . . 0.0 111.755 177.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.63 96.18 8.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.81 0.338 . . . . 0.0 111.75 -172.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 21' ' ' THR . 91.1 mt -123.38 92.55 3.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.466 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.89 73.3 0.39 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.204 178.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.57 -63.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.11 2.54 . . . . 0.0 112.541 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.917 HG12 ' HD2' ' A' ' 14' ' ' PRO . 10.1 tt -99.51 154.92 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.701 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 15.6 m-70 -91.83 -20.78 0.24 Allowed Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -172.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.917 ' HD2' HG12 ' A' ' 12' ' ' ILE . 23.9 Cg_exo -39.94 171.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.319 2.68 . . . . 0.0 114.833 170.235 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 17' ' ' ARG . 83.8 Cg_exo -49.02 156.6 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.224 2.616 . . . . 0.0 113.538 177.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 36.8 Cg_endo -65.21 11.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.226 3.284 . . . . 0.0 114.371 -175.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 15' ' ' PRO . 12.1 ptt180 -62.51 -24.05 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 110.293 179.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 t -157.75 -11.01 0.08 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.718 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 14.0 m -79.86 -83.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.838 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.538 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptp -74.56 73.05 1.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.493 0.663 . . . . 0.0 110.193 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 18.0 m -79.41 131.63 36.15 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.843 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.869 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -94.26 117.37 30.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.309 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 7' ' ' SER . 40.9 tt0 -98.97 96.7 8.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.14 116.28 28.88 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.429 -167.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.51 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 44.1 mtt85 -81.66 103.03 11.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.875 176.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.749 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -121.89 131.87 24.35 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.914 -174.863 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.616 ' HG3' HH11 ' A' ' 91' ' ' ARG . 25.7 Cg_exo -62.98 135.99 54.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.761 2.308 . . . . 0.0 110.568 175.424 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.86 -36.84 49.82 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.367 -169.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -34.09 87.64 Favored Glycine 0 C--O 1.236 0.227 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.214 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.42 ' HE3' HG22 ' A' ' 86' ' ' ILE . 87.1 mmm -78.15 -13.36 59.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.323 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 34' ' ' ILE . 37.1 t -74.16 -40.9 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.445 173.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -27.78 71.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.226 174.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.26 -24.81 25.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.626 HD12 ' HB ' ' A' ' 86' ' ' ILE . 8.9 tp -74.22 -25.31 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.564 0.697 . . . . 0.0 109.673 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.584 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -89.33 -15.82 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.864 171.289 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -86.29 0.07 OUTLIER Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.603 174.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 9.0 ptp180 -79.58 -1.29 37.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.949 0.404 . . . . 0.0 111.07 -177.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.33 2.72 10.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.69 173.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.584 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.73 -49.66 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.066 175.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.5 tt0 -44.74 -42.81 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.052 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' OE1' ' HE2' ' A' ' 82' ' ' MET . 0.7 OUTLIER -58.7 -46.62 86.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -167.119 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.584 HD11 HG11 ' A' ' 53' ' ' VAL . 8.0 tp -65.47 -54.31 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.617 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 42' ' ' ILE . 39.5 m-80 -56.19 -42.17 76.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.439 -177.264 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.45 -47.48 83.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.684 -179.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.74 -45.24 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 2.1 pt20 -69.13 -43.18 74.92 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.575 -176.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.96 -36.58 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.407 -178.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.1 -50.07 74.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.958 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 p -72.78 -33.14 66.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.523 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.04 27.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.615 -178.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.628 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 15.2 t -79.73 152.36 29.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.985 0.422 . . . . 0.0 110.133 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -108.84 86.61 2.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.584 HG11 HD11 ' A' ' 42' ' ' ILE . 44.7 t -103.9 111.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.085 0.469 . . . . 0.0 110.923 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.2 115.58 30.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.426 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.49 HD13 HG11 ' A' ' 67' ' ' VAL . 32.1 mm -81.85 94.47 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.731 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 42.1 m -79.25 114.79 47.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.951 0.405 . . . . 0.0 110.788 -178.547 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 4.3 Cg_exo -74.41 -40.62 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.668 2.912 . . . . 0.0 111.854 -177.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.43 78.77 2.71 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -61.69 -27.85 68.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.128 -175.73 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.97 -72.53 1.82 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.62 -14.03 74.9 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 177.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.612 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 2.5 mm? -123.89 138.88 31.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.2 -9.52 10.47 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.045 2.497 . . . . 0.0 111.257 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -101.16 -94.75 0.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.323 -173.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.749 ' HB3' HG13 ' A' ' 26' ' ' VAL . 3.6 tpp180 -150.03 148.25 28.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 175.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.731 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 68.4 p -122.85 112.47 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.119 0.485 . . . . 0.0 110.082 174.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.49 HG11 HD13 ' A' ' 55' ' ' ILE . 99.7 t -98.58 115.81 39.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.716 179.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.1 m -86.14 131.51 34.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.141 0.496 . . . . 0.0 110.548 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.998 HD12 ' HG2' ' A' ' 80' ' ' LYS . 62.6 mt -120.33 116.91 26.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -179.331 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.65 156.44 40.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.403 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.427 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 151.48 -150.9 22.9 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.493 176.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.12 152.25 76.45 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.45 -49.94 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.104 2.536 . . . . 0.0 113.526 -175.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.1 -33.37 50.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 0.0 110.845 -178.404 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -70.06 -41.27 74.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.641 -178.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.674 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.5 p -68.47 -32.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -177.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.36 81.7 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -55.91 -45.44 78.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.343 0.592 . . . . 0.0 110.793 178.746 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' A' ' 51' ' ' CYS . . . -66.86 -36.74 83.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.376 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.998 ' HG2' HD12 ' A' ' 69' ' ' LEU . 44.6 mtmt -82.39 -22.02 35.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -173.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.458 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 17.1 tpt -60.82 -49.59 76.85 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.655 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.438 ' HE2' ' OE1' ' A' ' 41' ' ' GLN . 93.4 mmm -68.37 -39.61 81.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.751 176.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.839 ' HG ' HD13 ' A' ' 69' ' ' LEU . 1.4 mm? -62.29 -59.63 4.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.02 -40.58 63.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.024 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -55.5 34.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.132 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.626 ' HB ' HD12 ' A' ' 34' ' ' ILE . 2.3 mp -80.6 -38.91 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.659 0.266 . . . . 0.0 111.704 -175.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.02 -50.31 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.703 178.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -57.83 -48.6 79.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.682 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.605 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.2 ptp180 -61.49 -22.35 65.01 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.183 0.302 . . . . 0.0 111.587 -175.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.81 12.76 13.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.117 -1.04 . . . . 0.0 113.472 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.616 HH11 ' HG3' ' A' ' 27' ' ' PRO . 7.3 tpt180 -129.0 -47.26 1.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.309 0.554 . . . . 0.0 112.008 -178.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.3 -37.67 0.19 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.75 -173.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.77 -1.017 . . . . 0.0 111.473 -177.593 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.44 ' H1 ' HG13 ' A' ' 5' ' ' ILE . 2.1 pp . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.8 p -148.32 -169.98 3.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.344 -177.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.521 ' H ' ' HB3' ' A' ' 23' ' ' GLU . 13.6 m 64.47 -155.26 0.3 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 123.664 0.602 . . . . 0.0 110.318 -179.083 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -52.18 113.81 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.73 125.51 52.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.159 170.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.45 75.36 0.42 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.574 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.92 -64.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.684 2.256 . . . . 0.0 111.565 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.779 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 pt -104.77 141.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 177.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.544 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 56.3 m80 -96.26 31.42 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.496 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.779 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 18.7 Cg_endo -57.85 -163.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.36 0 C-N-CA 122.47 2.113 . . . . 0.0 112.798 161.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.634 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 10.2 Cg_endo -56.44 164.48 5.44 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.219 1.946 . . . . 0.0 112.208 168.848 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HB3' ' HE3' ' A' ' 20' ' ' MET . 44.4 Cg_endo -67.76 33.69 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.816 3.01 . . . . 0.0 114.393 -175.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' O ' ' HB ' ' A' ' 18' ' ' THR . 10.6 ptp180 -92.69 14.59 16.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 9.4 t 171.47 -16.58 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.672 177.304 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.2 m -78.21 -11.48 59.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.527 ' HE1' HG13 ' A' ' 76' ' ' VAL . 11.7 ptt? -150.56 69.75 0.99 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.836 0.827 . . . . 0.0 109.19 167.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.2 m -78.53 115.3 18.14 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.248 177.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 68' ' ' SER . 8.1 tp10 -94.4 119.76 33.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -172.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HB3' ' H ' ' A' ' 7' ' ' SER . 6.0 tp10 -104.87 102.75 12.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -91.43 125.66 36.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.837 -169.536 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 59.7 mtm180 -82.65 102.48 11.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 175.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.725 HG12 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -125.14 126.72 25.17 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.778 -177.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 54.6 Cg_exo -54.82 148.24 47.06 Favored 'Trans proline' 0 CA--C 1.521 -0.169 0 C-N-CA 123.537 2.824 . . . . 0.0 111.815 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' HG12 ' A' ' 31' ' ' VAL . 28.8 t70 -59.63 -36.83 77.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.918 -175.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -34.34 61.9 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.384 175.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.508 ' HE2' ' CA ' ' A' ' 90' ' ' GLY . 28.6 tpp -78.95 -22.96 44.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.93 -175.125 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 34' ' ' ILE . 3.7 p -76.85 -29.96 18.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.78 -26.93 67.6 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.851 169.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.63 -24.26 20.57 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 175.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.651 HG23 ' O ' ' A' ' 31' ' ' VAL . 9.3 tp -68.92 -32.23 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.74 0.781 . . . . 0.0 109.693 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.584 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.3 pt -71.95 -12.12 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.367 174.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.84 -8.75 27.59 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.845 163.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.689 ' HD3' ' HB2' ' A' ' 40' ' ' GLU . 11.8 ptm180 -174.75 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.045 -174.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.85 -2.09 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.767 179.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.584 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.08 -37.23 0.61 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.82 -1.181 . . . . 0.0 112.653 174.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.689 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 3.5 mp0 -56.73 -40.93 76.62 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.624 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -59.48 -44.81 92.96 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -168.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.645 HD12 HG13 ' A' ' 53' ' ' VAL . 8.5 tp -64.03 -48.08 87.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.445 -177.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.563 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.3 m-20 -65.87 -33.39 75.74 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -60.55 -49.65 76.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.161 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.95 -40.71 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.798 -178.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.563 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -70.55 -27.21 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.638 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.75 -40.48 40.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.66 -40.11 90.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.889 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.6 p -80.86 -42.78 20.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.235 -179.433 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.99 1.19 36.11 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.552 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 44.5 t -79.9 139.25 37.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.242 178.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.21 79.33 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.357 0.599 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG13 HD12 ' A' ' 42' ' ' ILE . 44.9 t -89.73 123.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.348 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -118.51 133.78 55.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 -176.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.435 HD13 HG12 ' A' ' 67' ' ' VAL . 43.3 mm -91.98 98.44 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HG ' ' A' ' 66' ' ' SER . 14.8 m -81.02 108.43 10.25 Favored Pre-proline 0 C--O 1.238 0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 -177.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 2.1 Cg_endo -83.85 -21.42 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.513 2.809 . . . . 0.0 112.693 -176.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.44 -38.3 35.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 t 68.94 -80.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.867 177.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.23 48.3 5.74 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.828 179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.71 -30.8 0.56 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.57 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.8 mm? -113.47 143.22 28.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.84 8.39 4.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.666 2.244 . . . . 0.0 111.098 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 6.0 pt-20 -126.7 -154.21 0.61 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.435 -175.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.725 ' HB3' HG12 ' A' ' 26' ' ' VAL . 4.6 tpp180 -94.88 140.91 29.27 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.559 ' HG ' ' HB2' ' A' ' 56' ' ' SER . 33.5 p -116.64 108.78 16.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG21 HG13 ' A' ' 26' ' ' VAL . 94.1 t -96.74 114.69 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.123 -176.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -92.0 134.86 34.42 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.101 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD11 ' HG2' ' A' ' 80' ' ' LYS . 2.0 mp -125.8 128.73 48.13 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -152.09 146.98 25.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.41 -137.99 4.96 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.024 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.36 161.43 37.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.03 -56.89 2.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.501 2.134 . . . . 0.0 113.041 -175.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.05 -37.71 81.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.486 -178.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -68.03 -48.42 65.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.414 -176.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.552 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 5.5 p -69.12 -33.75 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.138 -174.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.56 -35.41 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.652 0.263 . . . . 0.0 110.442 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.49 -45.8 92.43 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.407 0.623 . . . . 0.0 109.846 176.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.502 ' HB3' HG23 ' A' ' 53' ' ' VAL . . . -64.29 -35.96 82.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.348 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 50.0 mtmt -81.13 -22.91 38.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.246 0.546 . . . . 0.0 109.764 -176.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.2 ttt -65.11 -44.47 88.64 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.459 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.427 ' HG3' ' O ' ' A' ' 79' ' ' ALA . 4.0 ppp? -73.2 -28.02 61.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.956 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -66.18 -55.37 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.585 177.396 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.53 -30.35 65.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.465 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.83 -60.79 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.192 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.488 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -73.0 -36.61 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -175.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.7 -21.68 28.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.186 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.2 t -72.34 -40.45 67.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 174.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 7.2 ptp180 -72.3 -17.35 61.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.754 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.508 ' CA ' ' HE2' ' A' ' 30' ' ' MET . . . -100.15 -49.27 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.347 -178.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -105.9 29.79 6.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 -177.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.14 57.3 5.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.09 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.954 0 CA-C-O 118.268 -1.296 . . . . 0.0 110.932 179.031 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 19.3 mm-40 67.58 -68.2 0.16 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.116 0.966 . . . . 0.0 112.854 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.0 mt 70.89 -87.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.95 0.9 . . . . 0.0 111.231 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 99.41 0.25 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.177 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.2 -17.47 24.46 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.017 2.478 . . . . 0.0 112.131 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.84 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.1 tp -100.21 147.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.73 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 35.9 m-70 -90.77 -19.14 0.24 Allowed Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.84 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -36.21 163.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.447 2.765 . . . . 0.0 114.397 169.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -42.61 161.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.87 3.047 . . . . 0.0 114.06 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.74 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 18.1 Cg_endo -60.37 3.62 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.824 3.016 . . . . 0.0 114.523 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -59.32 -19.9 50.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.312 0.577 . . . . 0.0 109.519 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -151.11 -19.81 0.21 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.654 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 t -80.04 -2.53 44.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.067 0.46 . . . . 0.0 111.004 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.575 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.7 mmt -134.1 39.64 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.904 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 29.1 m -78.96 112.76 16.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.1 tp10 -114.16 117.31 30.86 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.2 tt0 -99.49 104.52 16.35 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -90.19 116.28 28.06 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.841 -168.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 65.4 mtm180 -81.0 96.09 7.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.008 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.474 HG11 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -120.11 126.55 26.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.449 -173.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.35 135.74 46.81 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.193 2.595 . . . . 0.0 111.245 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 3.6 p-10 -60.49 -30.68 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.663 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.71 -31.06 63.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.802 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.529 ' HE1' ' HG3' ' A' ' 89' ' ' ARG . 95.9 mmm -78.04 -15.16 59.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' HG22 ' A' ' 34' ' ' ILE . 91.4 t -76.02 -35.88 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.16 -28.73 64.52 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.128 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD12 ' SD ' ' A' ' 30' ' ' MET . 82.5 mt -89.17 -27.83 20.42 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.1 tp -69.24 -28.06 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.613 0.72 . . . . 0.0 109.648 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.687 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.9 pt -83.35 -15.0 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.598 174.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.06 -89.87 0.03 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.818 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 6.4 ptm180 -74.6 9.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.032 0.533 . . . . 0.0 111.623 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.26 9.51 27.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.953 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.687 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.74 -39.47 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.026 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 32.2 tt0 -64.49 -28.88 69.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -171.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.18 -51.98 67.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.274 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.42 -37.65 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.175 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -61.45 -43.97 97.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.7 mttm -54.06 -53.39 53.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.433 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.428 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -70.73 -42.92 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.102 -173.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -29.28 64.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.124 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -81.38 -32.45 32.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.183 0.516 . . . . 0.0 110.116 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.93 -46.82 56.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 30.7 p -67.56 -38.04 83.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.237 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.92 7.94 55.98 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 43.6 t -85.78 144.81 27.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.369 0.604 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -88.06 70.49 9.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.599 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.408 HG22 HD13 ' A' ' 69' ' ' LEU . 47.3 t -86.72 110.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -114.55 123.27 48.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.637 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.5 mm -79.78 124.53 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 37.2 t -112.68 109.85 52.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.642 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 74.1 Cg_endo -75.12 -16.13 20.1 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.983 2.456 . . . . 0.0 111.4 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.41 -33.25 42.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.623 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.638 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 9.6 t 70.45 -74.47 0.08 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.621 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.49 -61.52 0.51 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.409 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.93 -8.59 6.09 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.793 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 2.5 mm? -107.53 152.18 41.28 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.9 -28.07 3.49 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.292 1.995 . . . . 0.0 111.539 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.42 -169.6 2.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.131 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.642 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 24.4 mmt180 -79.81 153.1 29.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.638 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 99.1 p -124.28 117.93 25.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG23 HG11 ' A' ' 26' ' ' VAL . 59.1 t -97.75 124.2 50.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -95.63 127.51 41.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.57 0.7 . . . . 0.0 111.408 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.823 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -108.48 124.66 50.77 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.902 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.34 156.28 39.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.88 -128.0 2.15 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 119.838 -1.172 . . . . 0.0 113.121 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.74 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -111.53 165.41 12.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 14.1 Cg_endo -55.66 -40.83 83.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.182 1.921 . . . . 0.0 113.06 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -85.33 -31.89 22.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.462 -177.072 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 53.6 p -71.03 -46.4 62.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -64.99 -23.79 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.864 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.61 -55.28 7.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.131 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 49' ' ' SER . 4.5 tppp? -55.48 -45.46 76.97 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.615 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.41 -51.22 70.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.609 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.823 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mtmt -75.71 -20.03 58.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.53 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 tpt -59.81 -49.89 75.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.522 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.428 ' HG3' HG12 ' A' ' 45' ' ' ILE . 16.0 mmt -66.06 -38.59 88.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 110.874 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.34 -44.82 95.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.35 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.53 -46.01 84.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.106 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.67 -59.6 4.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.842 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.683 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.69 -41.23 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 24' ' ' TYR . 93.1 t -70.38 -25.32 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.683 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.6 t -72.95 -40.81 65.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.2 ptp180 -77.9 -6.89 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.686 0.279 . . . . 0.0 111.17 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.1 -46.81 0.8 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.483 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 O-C-N 122.518 -0.401 . . . . 0.0 111.291 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 35.2 t . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -161.42 106.35 1.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 0.0 110.093 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 24.4 tp -91.41 96.6 10.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.4 70.92 0.33 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.03 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 6.7 Cg_exo -73.96 -38.37 2.29 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.561 2.174 . . . . 0.0 111.332 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.584 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 12.4 pt -121.81 152.42 25.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.699 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.662 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 72.7 t60 -89.08 -26.22 0.32 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.0 Cg_exo -39.15 159.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.79 2.327 . . . . 0.0 114.049 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -38.16 144.38 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.127 3.218 . . . . 0.0 113.828 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.609 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 46.3 Cg_endo -66.77 31.32 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.539 3.493 . . . . 0.0 114.493 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.847 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 ppt_? -82.63 0.06 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 0.0 110.176 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.847 HG22 ' HD2' ' A' ' 17' ' ' ARG . 11.9 t -179.46 -17.76 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 12' ' ' ILE . 3.7 m -78.32 -80.92 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.583 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.609 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.6 ptp -76.24 76.61 3.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.9 m -81.82 114.01 20.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.2 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 15.3 tt0 -94.04 118.01 30.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -99.29 104.98 16.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.673 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -90.82 118.78 30.5 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.684 -168.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -81.86 99.1 8.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.685 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -116.63 123.52 30.4 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.763 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' A' ' 30' ' ' MET . 31.9 Cg_endo -66.36 152.55 80.71 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.482 2.121 . . . . 0.0 111.832 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -52.72 -42.02 64.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.88 93.21 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.482 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.557 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 88.4 mmm -78.84 -23.49 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.431 -0.452 . . . . 0.0 111.354 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 ' HG2' ' A' ' 65' ' ' ARG . 2.8 p -74.26 -30.55 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.672 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -28.82 69.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.925 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.29 -23.92 22.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.7 tp -70.3 -25.55 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.691 0.758 . . . . 0.0 109.597 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.789 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 9.4 pt -85.33 -14.73 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.434 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.17 -91.18 0.02 OUTLIER Glycine 0 C--N 1.336 0.574 0 O-C-N 124.209 0.943 . . . . 0.0 113.191 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 1.005 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.5 ptm180 -76.99 44.9 0.41 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.166 0.587 . . . . 0.0 111.501 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.06 13.78 80.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 114.354 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.789 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 135.51 -36.09 2.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.623 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.005 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 71.8 tt0 -57.75 -33.9 68.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -59.91 -52.42 65.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.712 0.291 . . . . 0.0 111.361 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.69 HD11 HG11 ' A' ' 53' ' ' VAL . 10.0 tp -63.8 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.106 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -58.33 -40.66 82.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 13.7 mmmm -60.32 -59.96 4.58 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.425 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -62.86 -41.54 93.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -33.2 72.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.015 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -77.95 -37.88 46.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.469 0.652 . . . . 0.0 109.539 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.45 -26.07 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.198 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 34.1 p -99.65 -44.85 5.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.95 8.96 21.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.06 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.549 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 21.0 t -92.77 136.97 32.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 110.855 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -79.77 79.05 6.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.922 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.69 HG11 HD11 ' A' ' 42' ' ' ILE . 40.6 t -82.64 109.52 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 15.5 mm100 -101.03 116.05 31.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.521 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.5 mm -89.7 96.95 6.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.743 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 m -88.36 105.39 9.36 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.812 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 2.8 Cg_exo -75.43 -22.09 14.42 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.321 2.681 . . . . 0.0 111.641 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -79.62 -38.08 34.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.001 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.632 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.3 t 71.41 -54.09 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.556 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.94 -71.79 2.9 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.646 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.78 -9.44 61.13 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.958 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.627 ' HB2' ' OG ' ' A' ' 59' ' ' SER . 2.1 mm? -121.49 154.48 59.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -85.5 -4.3 9.25 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 111.985 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 6.3 pt-20 -111.03 -141.05 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.817 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.726 ' HG2' HG21 ' A' ' 31' ' ' VAL . 2.0 tpp180 -107.4 140.15 40.78 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.632 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 67.2 p -116.94 111.64 19.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.348 0.594 . . . . 0.0 109.944 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 55' ' ' ILE . 84.7 t -100.83 119.53 49.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.776 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 29.7 m -88.68 128.24 35.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.329 0.585 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.897 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.9 mm? -107.31 108.09 19.32 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.805 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 18' ' ' THR . 0.7 OUTLIER -151.2 119.45 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.005 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -158.88 -107.34 0.24 Allowed Glycine 0 C--O 1.225 -0.455 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.734 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.565 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -129.35 163.63 44.97 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.6 -51.22 8.37 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.463 2.109 . . . . 0.0 112.859 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -72.65 -46.86 51.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.362 0.601 . . . . 0.0 110.698 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' A' ' 72' ' ' ALA . 6.7 m -62.47 -45.5 92.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.818 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.1 p -71.23 -27.87 30.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 -174.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -40.2 49.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.32 . . . . 0.0 110.385 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.733 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.8 tpmt? -64.26 -46.59 83.04 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.659 0.742 . . . . 0.0 109.818 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.412 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -55.24 -46.5 76.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.294 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.897 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 37.7 mtmt -73.5 -22.45 60.13 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.733 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.5 -31.09 68.05 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.458 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.425 ' HG3' HG12 ' A' ' 45' ' ' ILE . 15.0 mmt -69.02 -46.7 67.3 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.677 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.416 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.4 mm? -61.51 -48.59 80.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.87 -40.5 69.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.266 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.8 -57.62 12.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.947 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.682 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -72.13 -41.52 67.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.758 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 24' ' ' TYR . 85.8 t -64.57 -32.42 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.336 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 t -73.25 -37.77 66.21 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.455 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.682 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.5 ptp180 -78.41 -7.6 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.929 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -107.41 -64.89 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.344 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 91' ' ' ARG . 22.2 mtp180 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.572 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 62.6 m . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.523 0.201 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.664 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 68.5 mm-40 53.78 -162.3 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.48 0.712 . . . . 0.0 111.621 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 28.8 tp 173.05 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 121.76 92.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.952 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.09 -26.13 26.32 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.998 2.466 . . . . 0.0 111.385 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.586 HG22 ' HD2' ' A' ' 14' ' ' PRO . 4.1 mt -77.17 108.45 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.671 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 23.3 m170 -89.72 7.12 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -168.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 20.5 Cg_exo -46.1 -176.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.82 1.68 . . . . 0.0 112.863 158.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' ARG . 67.5 Cg_exo -42.14 158.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.983 2.455 . . . . 0.0 113.557 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 26.8 Cg_endo -64.4 17.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.79 2.993 . . . . 0.0 114.207 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -74.43 -6.55 48.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.0 109.961 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.3 t -158.71 -25.96 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.609 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.0 t -79.31 8.12 6.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.812 0.339 . . . . 0.0 111.083 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 1.5 mmt -145.58 32.67 1.06 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.397 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 40.1 m -79.51 110.99 15.33 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.21 118.97 34.28 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.664 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.9 tt0 -84.91 104.12 14.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.85 109.46 20.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.259 -174.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.454 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 96.7 mtt180 -87.37 98.83 11.57 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.21 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -112.65 128.87 25.01 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.936 -173.042 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 20.0 Cg_exo -60.7 143.51 99.41 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 123.276 2.651 . . . . 0.0 111.773 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.82 -50.62 56.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -170.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.87 -29.8 75.24 Favored Glycine 0 C--O 1.237 0.333 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.413 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.779 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 80.3 mmm -77.45 -21.0 53.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 35' ' ' ILE . 41.4 t -66.19 -37.98 80.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -63.17 -29.38 74.28 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.708 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.81 -25.17 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -75.77 -29.48 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.3 0.572 . . . . 0.0 109.815 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 31' ' ' VAL . 8.8 pt -83.32 -13.51 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.181 172.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.15 -91.02 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.087 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.968 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 16.9 ptm180 -71.18 -9.52 58.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.712 0.405 . . . . 0.0 111.451 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.84 3.38 7.66 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.294 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.622 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -58.93 0.25 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.314 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.968 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 18.8 tp10 -55.17 -21.96 15.45 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' O ' HD13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.7 -48.45 71.99 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.02 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 39' ' ' GLY . 9.9 tp -63.98 -37.87 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -53.78 -49.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.629 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 22.1 mmtm -66.95 -41.76 86.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.299 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.418 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.4 mp -67.19 -41.17 86.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -22.87 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.017 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -78.24 -42.57 30.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.335 0.588 . . . . 0.0 110.047 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.61 -43.77 93.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.01 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.693 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 23.1 p -83.69 -43.06 15.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.291 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.8 10.49 26.54 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.559 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 t -79.71 141.73 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 0.0 110.475 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 50.9 mmtt -94.22 67.34 3.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.438 0.637 . . . . 0.0 109.615 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.42 HG23 HD13 ' A' ' 69' ' ' LEU . 2.2 p -82.5 142.88 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.127 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -136.53 114.86 11.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.518 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.451 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 36.9 mm -79.63 104.65 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.39 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 6.2 t -92.35 105.43 14.14 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 3.2 Cg_exo -75.93 -30.79 5.57 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.45 2.767 . . . . 0.0 112.724 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.53 -29.67 46.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 7.4 t 73.19 -67.53 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.821 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.99 76.83 0.88 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.823 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.08 -57.69 0.68 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.815 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 25' ' ' ARG . 1.3 mm? -87.57 144.15 35.02 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.05 -23.92 8.73 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.435 2.09 . . . . 0.0 110.225 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 6.6 pt-20 -88.99 -168.67 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.556 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.754 ' HB3' HG13 ' A' ' 26' ' ' VAL . 4.0 tpp180 -87.08 139.46 30.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.146 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.9 p -117.28 111.34 19.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG13 HD13 ' A' ' 55' ' ' ILE . 49.1 t -109.32 131.74 59.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.694 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.6 m -91.79 125.59 36.56 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.022 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 21' ' ' THR . 4.0 mm? -104.57 111.45 24.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.025 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 m -152.29 147.98 26.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.654 0.206 . . . . 0.0 111.036 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.74 -156.72 28.8 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.018 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -78.3 161.62 69.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.8 Cg_endo -48.53 -54.96 4.56 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.008 2.472 . . . . 0.0 113.417 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.48 -37.07 77.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.088 0.47 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.693 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 9.0 m -66.6 -51.66 53.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.425 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 p -67.62 -26.48 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.267 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -71.74 -45.26 62.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.388 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 81' ' ' MET . 1.3 tmtp? -68.6 -39.23 80.98 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.362 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -62.07 -40.85 97.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.977 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 45.8 mtmt -80.96 -21.32 40.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.1 tpt -57.15 -50.7 72.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.357 173.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.418 ' HG3' HG12 ' A' ' 45' ' ' ILE . 92.9 mmm -68.96 -39.8 79.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 111.038 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 79' ' ' ALA . 3.7 mm? -62.67 -47.84 81.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.96 -45.67 78.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.042 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.0 -54.23 47.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.669 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.7 mp -75.24 -41.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 26' ' ' VAL . 67.8 t -72.7 -23.65 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.291 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -75.2 -41.42 57.88 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.799 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.9 ptm180 -76.74 -6.96 54.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.779 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -105.72 -52.44 0.8 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.982 -0.627 . . . . 0.0 113.597 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.424 ' HG2' ' HG3' ' A' ' 27' ' ' PRO . 17.5 mtp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.311 0.577 . . . . 0.0 112.33 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -176.01 163.03 2.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.201 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.461 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 75.1 mt -138.78 107.32 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.669 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -126.32 57.66 0.69 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.627 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 92.0 Cg_endo -93.88 -2.68 3.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.002 2.468 . . . . 0.0 112.387 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 30.9 pt -126.51 149.17 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.813 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.6 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 22.1 m80 -91.18 -19.56 0.24 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 93.2 Cg_exo -38.81 162.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.671 2.247 . . . . 0.0 114.324 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.62 152.64 8.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.847 2.364 . . . . 0.0 112.077 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 42.4 Cg_endo -65.99 7.56 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.423 2.748 . . . . 0.0 113.788 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.87 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.18 0.514 . . . . 0.0 110.284 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -159.29 7.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.14 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 30.8 t -93.28 -104.64 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.297 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.468 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptm -63.95 74.22 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.045 0.926 . . . . 0.0 111.712 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 62.5 m -90.04 139.02 31.02 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.635 ' HB2' HD23 ' A' ' 69' ' ' LEU . 10.9 mm-40 -95.33 148.87 21.97 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.299 168.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -120.34 98.76 6.2 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 160.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.506 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.36 124.57 37.43 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.266 -161.453 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.955 ' HG2' HD21 ' A' ' 62' ' ' LEU . 32.6 mtm180 -81.78 111.38 17.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.489 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -130.31 126.59 22.25 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.893 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 35.0 Cg_exo -60.07 151.38 72.96 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.488 2.792 . . . . 0.0 112.658 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 31' ' ' VAL . 35.5 t70 -55.17 -51.91 65.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.03 75.05 Favored Glycine 0 C--O 1.236 0.253 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.935 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 tpp -79.53 -32.05 42.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.473 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 34' ' ' ILE . 12.7 p -72.69 -24.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.2 74.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.06 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.45 -24.55 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD13 ' HB ' ' A' ' 86' ' ' ILE . 10.7 tp -72.93 -27.93 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 109.663 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.617 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 11.9 pt -85.05 -13.59 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.348 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.33 -93.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 O-C-N 124.164 0.915 . . . . 0.0 113.066 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.957 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -72.99 48.68 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.179 0.592 . . . . 0.0 111.027 177.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.15 20.8 58.62 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.113 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.617 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.05 -50.91 0.58 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.809 -1.186 . . . . 0.0 113.602 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 22.2 tt0 -54.62 -33.49 60.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' HG12 ' A' ' 45' ' ' ILE . 24.5 tt0 -60.03 -48.4 81.85 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.473 -171.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.76 HD11 HG11 ' A' ' 53' ' ' VAL . 9.8 tp -60.59 -38.48 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.214 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.43 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 60.2 m-20 -65.32 -44.69 87.02 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.58 -31.94 69.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.534 0.207 . . . . 0.0 111.035 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 41' ' ' GLN . 26.4 mm -76.32 -50.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.989 0.423 . . . . 0.0 111.357 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.43 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -75.72 -24.64 56.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.408 -174.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -82.95 -34.48 26.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.684 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.81 -46.02 76.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.869 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 25.8 p -73.04 -48.04 39.57 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.209 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 13.47 25.7 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.4 t -92.84 143.36 26.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.954 0.407 . . . . 0.0 110.706 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 41.4 mtmt -81.6 72.09 8.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.76 HG11 HD11 ' A' ' 42' ' ' ILE . 57.9 t -82.4 110.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.397 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -110.99 122.44 47.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.123 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 HG12 ' A' ' 42' ' ' ILE . 42.7 mm -88.9 99.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.79 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.5 t -81.08 115.14 54.18 Favored Pre-proline 0 C--O 1.243 0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HA ' HH11 ' A' ' 65' ' ' ARG . 97.4 Cg_endo -79.65 -27.54 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.367 2.712 . . . . 0.0 112.061 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.65 -40.32 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.457 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 11.0 t 70.72 -69.11 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.236 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.57 -96.54 0.54 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.061 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.06 -12.47 79.36 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.654 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.955 HD21 ' HG2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -94.78 139.93 22.38 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.796 0.332 . . . . 0.0 110.817 -176.542 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.09 -2.46 9.52 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.8 2.333 . . . . 0.0 111.434 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 91' ' ' ARG . 2.5 pt-20 -110.64 -104.06 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.31 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.543 HH11 ' HA ' ' A' ' 57' ' ' PRO . 6.7 tpp180 -144.57 155.4 43.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 78.0 p -136.94 146.97 46.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.373 173.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 55' ' ' ILE . 52.2 t -123.3 131.06 73.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -91.48 131.23 37.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.2 0.524 . . . . 0.0 110.768 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 22' ' ' GLU . 3.6 mm? -114.09 104.03 11.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.2 124.19 11.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.389 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.76 -158.03 19.2 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.333 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.11 161.88 69.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -45.67 -52.24 7.09 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.79 2.326 . . . . 0.0 112.945 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.5 -43.33 81.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.6 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.635 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.3 m -64.94 -49.62 69.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.618 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.55 -23.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.162 -175.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.54 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.2 tt0 -72.55 -52.37 15.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.886 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 49' ' ' SER . 5.4 tppp? -55.04 -43.47 73.8 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.191 0.52 . . . . 0.0 110.588 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.94 63.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.725 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.62 ' HD3' ' CG ' ' A' ' 22' ' ' GLU . 11.2 mtmm -66.91 -23.06 65.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.616 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.7 mmt -59.77 -52.72 64.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.422 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 20.4 mmt -68.37 -37.71 80.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.5 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.3 mm? -60.48 -54.99 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.183 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' SER . 24.6 t70 -60.3 -34.86 74.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.39 -55.98 17.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.09 -41.48 52.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.365 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 24' ' ' TYR . 87.9 t -64.18 -28.1 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.23 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 16.1 t -75.73 -31.63 59.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.342 -0.224 . . . . 0.0 110.91 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 17.4 ptp180 -77.74 -12.44 59.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.33 -50.07 0.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.957 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 64' ' ' GLU . 26.3 mmt180 . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 122.293 0.237 . . . . 0.0 111.6 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 1.006 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 34.1 m . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -158.2 121.46 3.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.022 0.439 . . . . 0.0 110.34 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.26 104.08 15.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.085 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.57 69.38 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.891 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -84.95 -27.29 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.656 2.238 . . . . 0.0 112.991 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.696 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 6.0 mm -120.49 147.32 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 24.7 t60 -93.53 12.03 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.718 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -170.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.696 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 29.8 Cg_endo -61.06 -166.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 122.33 2.02 . . . . 0.0 113.958 171.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 67.3 Cg_exo -56.63 167.08 3.08 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.358 2.039 . . . . 0.0 112.517 168.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.1 33.63 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 124.189 3.259 . . . . 0.0 114.708 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' O ' ' HB ' ' A' ' 18' ' ' THR . 4.7 ptp180 -96.92 13.17 29.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 15.0 t 174.53 -15.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.289 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -79.97 -6.42 57.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.629 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.42 58.14 0.4 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.22 0.533 . . . . 0.0 110.354 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -78.21 110.83 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 7' ' ' SER . 12.7 tt0 -98.9 119.57 37.9 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -172.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 1.006 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 4.6 tp10 -92.34 102.01 14.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -90.96 126.24 36.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.112 0.482 . . . . 0.0 110.739 -171.604 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -91.09 98.12 11.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.083 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG11 HH21 ' A' ' 65' ' ' ARG . 1.3 p -120.37 114.33 33.27 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.528 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.644 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 50.3 Cg_exo -57.5 164.25 7.5 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 124.454 3.436 . . . . 0.0 114.38 -169.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.91 -45.34 74.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 0.0 111.845 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 33' ' ' LEU . . . -63.76 -34.04 88.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.806 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.419 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 31.4 mmt -80.25 -25.81 39.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -175.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -70.77 -33.89 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.934 172.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.37 77.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.708 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 29' ' ' GLY . 4.2 mm? -87.01 -24.02 24.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.986 HG21 HH22 ' A' ' 65' ' ' ARG . 10.8 tp -71.43 -30.49 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 109.249 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.626 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.0 pt -86.99 -14.05 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.731 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.76 -90.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.918 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.05 -6.91 9.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.998 -0.601 . . . . 0.0 111.946 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.9 4.42 9.5 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.824 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.626 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.17 -44.91 0.5 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.182 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.4 -26.31 66.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.59 -45.29 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.94 -174.003 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -65.39 -34.0 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.973 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 74.3 m-20 -61.47 -38.67 88.11 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -37.63 64.81 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 41' ' ' GLN . 98.1 mt -64.13 -52.74 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 111.258 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -21.87 59.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 6.5 tp-100 -84.14 -35.56 23.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.508 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.17 -39.49 78.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.666 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 p -84.07 -39.78 19.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.477 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.57 3.45 59.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.687 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 54.0 t -80.31 146.15 31.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.949 0.404 . . . . 0.0 110.533 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.724 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 10.9 mmpt? -84.98 81.01 9.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -81.92 107.16 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -95.93 106.68 18.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.933 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 HH11 ' A' ' 65' ' ' ARG . 33.2 mm -81.12 110.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.637 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -97.38 98.57 5.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 39.5 Cg_exo -60.05 -41.36 53.17 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 112.419 -173.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -115.36 102.99 10.35 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 34.5 t -68.92 -26.0 64.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.751 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.07 -82.01 1.39 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.191 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.27 -31.04 77.88 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.782 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 51.7 mt -98.31 138.52 20.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.979 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.86 -19.52 23.51 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.783 2.322 . . . . 0.0 110.784 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.644 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -96.69 -174.35 2.99 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.183 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.986 HH22 HG21 ' A' ' 34' ' ' ILE . 5.7 tmm_? -94.84 141.3 28.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 79.5 p -115.26 150.82 35.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.382 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 82.6 t -129.96 114.34 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.701 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.3 m -85.87 129.95 34.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.399 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.003 HD13 ' HG2' ' A' ' 80' ' ' LYS . 5.4 mt -114.94 121.75 44.14 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.8 m -151.33 141.29 22.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.247 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.89 -136.94 4.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.482 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -96.13 163.11 21.64 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.7 Cg_endo -48.05 -48.35 16.72 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.798 2.332 . . . . 0.0 112.854 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.36 -39.67 53.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 p -70.94 -47.69 57.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.104 0.478 . . . . 0.0 110.441 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.73 -29.2 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.228 -177.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -68.68 -50.99 46.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 81' ' ' MET . 50.8 tptt -63.13 -40.56 97.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.758 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -58.81 -41.71 87.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.138 0.494 . . . . 0.0 111.082 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.003 ' HG2' HD13 ' A' ' 69' ' ' LEU . 48.5 mtmt -81.18 -21.89 39.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.957 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 7.8 tpt -59.1 -50.58 73.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.357 174.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mmm -70.25 -37.53 74.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.4 mm? -60.37 -55.09 37.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.418 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -55.18 -34.92 64.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.766 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.72 -56.57 19.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.575 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.608 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -70.13 -40.21 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.336 0.588 . . . . 0.0 110.77 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 74.4 t -62.41 -28.47 44.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.293 0.568 . . . . 0.0 110.106 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -75.4 -31.13 60.32 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.164 -0.335 . . . . 0.0 110.759 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.5 ptm180 -78.31 -15.74 58.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.616 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -158.21 44.94 0.47 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.009 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.527 ' HD2' ' HG3' ' A' ' 27' ' ' PRO . 7.6 tpm_? . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 117.551 0.676 . . . . 0.0 110.084 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.405 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 20.9 m . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 120.918 0.389 . . . . 0.0 111.517 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.84 120.0 7.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' MET . 53.2 tp -100.19 102.61 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.791 168.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -132.69 57.33 0.72 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.774 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.702 ' HD2' HD13 ' A' ' 12' ' ' ILE . 5.8 Cg_exo -78.51 -46.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.48 2.12 . . . . 0.0 111.368 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.28 147.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.837 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.688 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 53.5 m80 -91.12 -19.21 0.24 Allowed Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.6 Cg_endo -53.67 164.8 2.04 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.31 2.007 . . . . 0.0 113.482 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' ARG . 85.0 Cg_exo -46.65 149.25 3.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.201 2.601 . . . . 0.0 112.791 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 39.7 Cg_endo -65.53 26.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.567 3.511 . . . . 0.0 114.437 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.774 ' HG3' HG22 ' A' ' 18' ' ' THR . 13.3 ptp180 -82.23 -20.96 36.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.151 0.5 . . . . 0.0 110.004 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.774 HG22 ' HG3' ' A' ' 17' ' ' ARG . 9.8 t -168.62 34.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.691 0.758 . . . . 0.0 110.458 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.9 p -126.12 -80.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.614 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.1 ptm -74.55 79.13 1.96 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.403 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 99.0 m -79.48 118.78 21.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.867 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 68' ' ' SER . 6.2 tp10 -92.83 118.24 30.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB3' ' N ' ' A' ' 7' ' ' SER . 6.4 tp10 -100.4 103.42 14.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.43 123.62 36.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.207 0.527 . . . . 0.0 111.9 -172.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -81.65 110.35 16.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.939 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 87' ' ' VAL . 1.3 p -132.76 127.04 20.21 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.294 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.0 Cg_exo -54.62 136.51 70.94 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.268 2.645 . . . . 0.0 111.038 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.4 -29.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.352 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.34 -28.95 57.03 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.626 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.621 ' SD ' HD12 ' A' ' 33' ' ' LEU . 32.8 tpp -77.5 -20.68 53.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' HG22 ' A' ' 34' ' ' ILE . 80.1 t -69.15 -39.21 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.377 169.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.54 -28.45 56.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.65 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.621 HD12 ' SD ' ' A' ' 30' ' ' MET . 81.1 mt -85.78 -29.99 23.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -72.1 -29.52 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.267 0.556 . . . . 0.0 109.969 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.738 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 17.9 pt -80.38 -13.24 12.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.512 174.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 -97.19 0.19 Allowed Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.459 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 1.078 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 19.5 ptp180 -60.0 -24.86 64.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.003 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.04 30.79 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.486 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.738 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.84 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.306 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.078 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 9.5 mp0 -60.86 -21.63 63.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -168.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.496 ' O ' HG12 ' A' ' 45' ' ' ILE . 9.1 tt0 -60.1 -50.67 72.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.367 0.53 . . . . 0.0 110.765 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.5 HG12 HD11 ' A' ' 55' ' ' ILE . 8.9 tp -64.45 -39.18 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.29 -46.3 76.21 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.407 0.622 . . . . 0.0 110.037 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -65.57 -37.65 87.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.246 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 41' ' ' GLN . 22.9 mm -68.19 -51.17 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 111.267 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.45 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.32 -31.3 65.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.675 -173.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -78.84 -31.48 45.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.823 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.14 -45.48 56.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.344 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 p -68.12 -45.21 74.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.76 -0.28 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.542 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.772 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 47.3 t -83.36 135.95 34.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.775 0.321 . . . . 0.0 110.286 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -80.62 72.86 7.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.549 HG22 HD23 ' A' ' 69' ' ' LEU . 43.3 t -82.52 111.32 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -111.26 118.03 34.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.176 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 67' ' ' VAL . 34.2 mm -79.75 115.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -99.71 104.81 30.28 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.555 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.889 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 60.1 Cg_endo -73.62 -21.95 18.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.989 2.46 . . . . 0.0 111.88 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.87 -32.39 23.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.878 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.543 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 21.4 t 65.39 -77.32 0.04 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.804 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.09 -86.16 0.36 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.084 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.88 -3.07 60.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.86 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 64' ' ' GLU . 2.0 mm? -112.92 147.68 37.74 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.279 . . . . 0.0 110.494 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.98 -10.15 11.62 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.124 2.549 . . . . 0.0 111.556 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 4.2 pt-20 -104.27 -147.54 0.39 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.524 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.889 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 19.3 mmt180 -106.53 139.88 40.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.1 p -110.75 108.11 17.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.496 0.665 . . . . 0.0 109.347 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG13 HD13 ' A' ' 55' ' ' ILE . 64.7 t -97.08 108.16 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.249 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -86.88 134.7 33.51 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.954 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD23 HG22 ' A' ' 53' ' ' VAL . 2.3 mp -123.5 121.87 36.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.163 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 21' ' ' THR . 26.2 m -151.92 121.46 6.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.026 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.772 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.04 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.177 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -160.85 165.45 17.25 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 8.6 Cg_endo -49.93 -47.0 25.27 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 113.284 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.19 -38.94 23.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.431 0.634 . . . . 0.0 110.152 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -65.69 -46.17 80.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.789 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 p -73.06 -23.6 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 0.0 110.332 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.7 tp60 -76.47 -47.84 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.966 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 81' ' ' MET . 17.2 tppt? -60.64 -45.23 94.88 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.778 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.32 79.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.471 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 47.5 mtmt -69.1 -21.04 64.07 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.908 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.1 mmt -61.25 -48.04 83.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.211 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.24 -41.24 97.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.704 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -64.12 -57.33 9.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.361 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.56 -35.89 61.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.317 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.01 -61.44 2.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.013 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.548 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.1 mp -70.41 -38.77 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.052 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 26' ' ' VAL . 77.9 t -61.45 -36.69 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.333 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t -71.17 -22.67 62.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.835 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -59.83 -49.2 78.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.31 -54.9 3.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.385 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 64' ' ' GLU . 39.3 mmt180 . . . . . 0 C--N 1.32 -0.71 0 C-N-CA 123.354 0.662 . . . . 0.0 110.372 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 8.1 m . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 21' ' ' THR . 60.0 tp60 170.83 -31.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.068 0.855 . . . . 0.0 108.964 171.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 67.55 -90.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.663 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 148.06 94.94 0.15 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.134 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.36 -12.96 30.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.806 2.337 . . . . 0.0 111.854 176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.84 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -99.69 161.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.661 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 31.5 t-80 -92.5 -37.95 0.35 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 51.8 Cg_exo -32.58 144.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.874 3.049 . . . . 0.0 114.387 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 73.1 Cg_exo -40.58 140.76 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.376 2.717 . . . . 0.0 112.29 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 9.5 Cg_endo -51.79 60.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.132 1 C-N-CA 125.652 4.234 . . . . 0.0 116.884 -168.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 11.9 ptp180 -114.84 15.11 17.45 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -178.87 -25.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.513 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.521 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 12.8 m -86.2 10.86 13.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.438 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.655 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 90.1 mmm -147.38 31.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.466 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.578 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 88.4 m -79.88 115.75 19.64 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 9.3 tt0 -123.89 118.04 26.18 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.3 109.29 20.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -92.1 128.22 37.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.003 -170.022 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 87.8 mtm180 -88.14 101.72 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.518 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -120.4 120.4 29.91 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.079 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.565 ' HD3' ' HG2' ' A' ' 91' ' ' ARG . 85.4 Cg_exo -50.11 145.71 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.878 3.052 . . . . 0.0 112.207 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -60.5 -37.04 79.81 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.587 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.76 -25.3 53.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.791 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.616 ' HG2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 tpp -79.54 -26.67 41.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.203 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 34' ' ' ILE . 7.5 p -75.81 -30.18 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -28.3 62.25 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.16 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -88.87 -24.24 22.57 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.8 tp -70.8 -27.47 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.313 0.578 . . . . 0.0 109.892 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 pt -81.15 -14.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.431 173.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.09 -90.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 O-C-N 124.187 0.929 . . . . 0.0 113.155 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.06 28.15 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.15 0.58 . . . . 0.0 111.991 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.38 67.99 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.271 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -51.87 0.27 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.872 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 5.0 mm-40 -59.12 -22.41 60.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -53.24 52.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.763 0.71 . . . . 0.0 111.34 -172.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.91 -44.44 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.48 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -59.68 -42.95 94.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.0 109.68 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 4.5 ttmm -63.25 -35.73 81.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.569 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.01 -50.67 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.79 84.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.808 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -73.97 -37.49 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.76 -45.03 91.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -73.19 -46.54 49.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.81 8.63 9.63 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.789 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 22.9 t -84.21 139.55 32.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.625 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -94.36 71.82 3.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.742 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.66 120.93 35.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.236 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.5 mm-40 -117.03 119.53 35.57 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.213 0.53 . . . . 0.0 111.032 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.501 HD13 HG13 ' A' ' 67' ' ' VAL . 32.6 mm -85.16 109.06 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.522 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.479 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 10.0 m -91.12 109.76 37.63 Favored Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 120.695 0.283 . . . . 0.0 110.641 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.625 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 32.8 Cg_endo -64.81 -50.96 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.987 2.458 . . . . 0.0 111.941 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.95 94.08 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.884 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.3 p -74.6 -29.74 61.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.329 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.71 -86.56 1.34 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.712 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.98 -12.03 84.29 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.506 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.884 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.9 mp -110.0 144.47 30.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.73 -37.67 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.453 2.102 . . . . 0.0 111.931 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.69 -154.26 0.36 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.322 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.625 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 17.0 tpp180 -85.78 154.97 21.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.642 ' HB3' HD22 ' A' ' 62' ' ' LEU . 73.8 p -120.74 117.36 27.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.537 HG23 HG11 ' A' ' 26' ' ' VAL . 97.1 t -104.51 120.95 55.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.061 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -86.97 128.51 35.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.431 0.634 . . . . 0.0 111.16 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.605 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.2 mm? -104.67 112.18 25.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.231 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.432 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 25.5 m -151.81 155.08 37.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.18 -101.76 0.18 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.415 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -143.78 164.04 32.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 7.8 Cg_endo -49.05 -53.17 7.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.959 2.439 . . . . 0.0 113.54 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -84.54 -30.11 25.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.091 0.472 . . . . 0.0 111.143 -177.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.5 m -72.97 -43.19 62.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.204 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.627 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.6 p -67.74 -24.81 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.963 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.559 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.7 tt0 -74.81 -42.62 57.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.893 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 81' ' ' MET . 21.1 tptp -61.12 -44.64 97.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.461 0.648 . . . . 0.0 110.283 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.38 -48.21 82.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.627 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 8.4 mtmp? -69.22 -20.69 63.96 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.393 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 24.2 mmt -58.35 -46.84 85.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 81.9 mtp -63.68 -49.97 71.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 110.743 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.1 mm? -59.68 -50.88 72.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.629 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.59 -41.66 95.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.842 0.353 . . . . 0.0 110.339 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.33 -56.71 18.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.396 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.86 -35.28 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.123 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 24' ' ' TYR . 55.3 t -72.11 -28.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 121.608 -0.683 . . . . 0.0 111.0 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -69.37 -40.41 77.45 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.652 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 16.9 ptm180 -73.92 -21.54 60.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.879 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.616 ' HA3' ' HG2' ' A' ' 30' ' ' MET . . . -94.02 -58.94 1.2 Allowed Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.139 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.565 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 14.3 mmm180 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 110.749 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.936 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 20.3 t . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.689 0.28 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.51 156.04 7.88 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.077 0.551 . . . . 0.0 110.864 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' MET . 80.2 mt -137.92 106.43 5.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.27 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.18 61.58 0.64 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.93 -27.42 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.405 2.07 . . . . 0.0 112.76 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.597 HG13 ' HB3' ' A' ' 19' ' ' SER . 15.7 pt -111.11 144.56 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.585 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 41.2 m80 -90.22 -20.48 0.25 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 92.9 Cg_exo -40.58 154.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.216 1.944 . . . . 0.0 112.83 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 17' ' ' ARG . 80.9 Cg_exo -46.58 152.99 1.34 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 123.29 2.66 . . . . 0.0 113.119 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 38.4 Cg_endo -65.51 24.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.294 3.329 . . . . 0.0 114.064 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.791 ' HG3' HG22 ' A' ' 18' ' ' THR . 12.0 ptp180 -71.69 -24.66 61.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.124 0.487 . . . . 0.0 109.942 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.791 HG22 ' HG3' ' A' ' 17' ' ' ARG . 7.2 t -163.25 10.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.916 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.597 ' HB3' HG13 ' A' ' 12' ' ' ILE . 15.2 m -105.22 -86.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.573 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.8 ptp -69.13 85.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.508 0.67 . . . . 0.0 110.949 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 m -88.92 114.03 25.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.223 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.485 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 14.5 tt0 -95.95 118.88 33.43 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.936 ' HB3' ' HB3' ' A' ' 7' ' ' SER . 4.9 tp10 -90.92 106.86 18.81 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.564 ' CD2' HG21 ' A' ' 87' ' ' VAL . 1.9 m-85 -90.54 108.47 19.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.379 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' HD2' ' CG ' ' A' ' 62' ' ' LEU . 12.4 mtm180 -89.51 99.58 12.55 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -114.71 133.03 22.62 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -170.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.7 Cg_exo -58.55 133.62 55.64 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.018 2.479 . . . . 0.0 110.421 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.8 -32.25 67.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.01 -31.41 79.39 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.712 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.596 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.1 mmm -78.29 -15.86 58.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 34' ' ' ILE . 37.8 t -72.59 -39.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.51 -27.9 70.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.534 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.79 -29.98 23.38 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -72.68 -26.25 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.494 0.664 . . . . 0.0 110.067 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.764 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 20.3 pt -83.2 -13.91 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.829 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.4 -100.54 0.31 Allowed Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.578 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.515 ' HD3' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -60.28 -14.84 20.18 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.748 0.419 . . . . 0.0 111.503 178.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.39 27.84 1.57 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.451 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.764 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.61 -51.61 0.6 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.995 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.403 ' HA ' HD22 ' A' ' 43' ' ' ASN . 5.7 tp10 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' HD3' ' A' ' 37' ' ' ARG . 15.1 tt0 -62.03 -51.71 66.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.122 0.419 . . . . 0.0 111.083 -173.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.525 HD11 HG11 ' A' ' 53' ' ' VAL . 8.1 tp -62.27 -40.92 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 40' ' ' GLU . 95.6 m-20 -52.35 -52.52 52.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 123.628 0.58 . . . . 0.0 110.05 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -56.89 -50.76 71.53 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.5 mm -60.56 -50.8 78.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -39.7 73.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.298 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -75.96 -34.12 59.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.25 -44.75 95.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.688 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.1 p -80.31 -36.75 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.161 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.92 5.03 31.29 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 49.7 t -79.9 141.59 35.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.392 0.615 . . . . 0.0 110.378 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -96.54 74.27 2.79 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.613 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 42' ' ' ILE . 41.7 t -82.22 107.85 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.177 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -103.92 111.12 23.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.759 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.482 HD13 HG13 ' A' ' 67' ' ' VAL . 28.7 mm -79.21 90.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.961 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 66' ' ' SER . 57.7 m -79.78 116.25 59.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 95.1 Cg_endo -84.89 1.8 8.33 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.0 2.467 . . . . 0.0 110.934 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.32 -33.36 49.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.515 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 58.5 p 55.05 -78.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 113.035 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.43 -104.97 2.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.015 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 3.38 86.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.612 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CG ' ' HD2' ' A' ' 25' ' ' ARG . 2.9 mm? -110.08 141.67 24.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.0 0.67 6.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.987 2.458 . . . . 0.0 110.577 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.4 pt-20 -113.54 -170.27 1.66 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.552 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.709 ' HB3' HG13 ' A' ' 26' ' ' VAL . 7.4 tpp180 -85.58 133.67 34.05 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 56' ' ' SER . 52.9 p -108.31 99.62 9.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 0.0 109.896 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 55' ' ' ILE . 57.9 t -101.03 110.36 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -85.73 130.12 34.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.406 0.622 . . . . 0.0 110.956 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.594 HD21 ' HG ' ' A' ' 83' ' ' LEU . 4.4 mm? -105.58 111.3 23.94 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.457 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -150.41 127.53 11.23 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . -155.12 -89.92 0.07 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.653 -1.26 . . . . 0.0 113.583 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -160.96 165.86 16.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 89.9 Cg_exo -44.9 -53.22 5.4 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.521 2.147 . . . . 0.0 112.969 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.56 -40.13 23.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 110.907 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.688 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.1 m -65.59 -44.05 87.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.65 -172.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.6 p -71.64 -30.48 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.037 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.8 tt0 -70.95 -43.62 67.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -52.35 65.79 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.357 0.598 . . . . 0.0 110.102 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.22 74.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.29 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 43.9 mtmt -69.47 -20.9 63.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.605 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.4 mmt -62.73 -42.1 99.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.115 172.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.9 mmt -67.01 -43.11 83.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.99 0.424 . . . . 0.0 111.046 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.1 mm? -64.29 -53.15 53.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.966 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.66 -33.66 66.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.47 . . . . 0.0 110.435 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.6 -60.98 2.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.082 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.697 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.3 mp -75.93 -37.09 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.921 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 24' ' ' TYR . 77.5 t -66.09 -32.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.943 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.697 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.7 ptm180 -75.09 -12.94 60.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.752 0.31 . . . . 0.0 111.129 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.596 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -108.97 -62.15 0.54 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.155 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 91' ' ' ARG . 5.1 tmm_? . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.597 0.237 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.56 134.22 56.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.594 0.712 . . . . 0.0 112.508 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' MET . 75.1 mt -120.09 145.55 46.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.923 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.47 66.8 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.361 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.04 -49.72 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.829 2.353 . . . . 0.0 112.101 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.498 HD11 HG23 ' A' ' 18' ' ' THR . 18.7 pt -117.98 163.74 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.66 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 92.0 m-70 -91.25 -29.57 0.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 38.8 Cg_exo -41.27 167.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.168 2.579 . . . . 0.0 114.904 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 17' ' ' ARG . 68.0 Cg_exo -42.3 156.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.62 2.88 . . . . 0.0 113.758 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 28.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 124.031 3.154 . . . . 0.0 114.563 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.49 -11.08 43.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.083 0.468 . . . . 0.0 110.01 173.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 12' ' ' ILE . 6.2 t -163.88 8.18 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.865 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 41.0 t -92.9 -94.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.339 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.7 ptp -70.63 85.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 0.0 110.537 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.7 m -94.24 114.81 26.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.196 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.7 tp10 -95.45 118.38 32.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -96.46 100.68 12.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.538 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -94.07 116.92 29.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.141 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 91' ' ' ARG . 31.5 mtm180 -84.39 113.68 21.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.31 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.505 HG23 HG22 ' A' ' 87' ' ' VAL . 2.2 p -117.71 131.55 24.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 111.048 -176.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.52 ' O ' HG23 ' A' ' 31' ' ' VAL . 26.9 Cg_exo -58.74 139.28 90.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.168 2.579 . . . . 0.0 110.764 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 2.7 p-10 -59.18 -32.17 69.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.136 -172.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -39.55 87.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.246 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.405 ' SD ' HD12 ' A' ' 33' ' ' LEU . 1.5 mpp? -79.5 -7.2 58.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.192 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 35' ' ' ILE . 75.6 t -70.69 -43.18 77.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.99 -31.38 72.32 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.57 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' SD ' ' A' ' 30' ' ' MET . 60.0 mt -83.41 -32.11 26.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 HH22 ' A' ' 65' ' ' ARG . 10.2 tp -70.8 -28.36 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.619 0.723 . . . . 0.0 109.921 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.68 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 14.2 pt -85.4 -13.26 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.59 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.46 -87.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 113.493 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.778 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 2.5 ptm85 -77.26 42.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.074 0.55 . . . . 0.0 110.784 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.43 19.76 69.0 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.03 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.68 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.75 -51.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.311 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 32.0 tt0 -60.42 -21.39 62.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' HD13 ' A' ' 45' ' ' ILE . 29.0 tt0 -63.56 -38.9 92.88 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.341 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -66.03 -36.94 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 1.3 m-20 -59.39 -43.2 92.99 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -59.54 -57.13 14.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.548 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.489 HD13 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -58.81 -53.01 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.484 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -29.72 61.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.252 -172.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 43' ' ' ASN . 6.5 tp60 -77.79 -39.92 42.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -66.08 -32.46 73.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 29.8 p -91.29 -36.01 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.738 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.38 7.25 57.16 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.59 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 49.1 t -78.99 142.75 36.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.624 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -83.6 72.62 10.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 42' ' ' ILE . 49.1 t -86.04 107.47 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.054 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.453 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 6.8 tp60 -98.84 122.66 42.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.5 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.402 HG23 ' HD3' ' A' ' 65' ' ' ARG . 24.7 mm -100.54 117.14 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.954 0.406 . . . . 0.0 111.666 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 44.9 m -112.7 93.97 26.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.772 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 76.6 Cg_exo -51.89 -55.92 3.45 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.434 3.422 . . . . 0.0 114.342 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.3 -2.02 58.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.646 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 p 49.93 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.55 1.14 . . . . 0.0 113.035 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.52 -65.85 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.74 2.44 87.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.206 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.728 HD12 ' HB3' ' A' ' 66' ' ' SER . 58.2 mt -126.02 151.73 72.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.22 -14.11 8.5 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 110.104 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 7.1 pt-20 -105.27 -164.75 1.06 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.305 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.772 ' HG2' ' HA ' ' A' ' 57' ' ' PRO . 6.3 tmm_? -101.1 137.92 38.83 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.728 ' HB3' HD12 ' A' ' 62' ' ' LEU . 77.9 p -105.24 142.6 34.74 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.944 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.0 t -130.31 111.96 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.426 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.7 m -81.15 121.45 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.311 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.999 HD13 ' HG2' ' A' ' 80' ' ' LYS . 96.6 mt -109.72 108.45 18.83 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.14 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 149.79 30.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.65 -95.98 0.11 Allowed Glycine 0 C--O 1.226 -0.362 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.809 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -147.66 163.7 26.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 83.6 Cg_exo -45.44 -55.26 3.64 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.003 2.469 . . . . 0.0 113.432 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.34 -32.81 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 110.912 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.0 m -67.6 -48.06 67.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.899 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.515 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 1.4 p -71.84 -24.32 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.765 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -71.88 -43.34 65.6 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.253 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 81' ' ' MET . 20.9 tptm -66.02 -45.59 80.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.457 0.646 . . . . 0.0 110.128 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.422 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -54.99 -49.33 71.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.072 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.999 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.1 mtmt -71.79 -22.75 61.53 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.755 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 21.9 ptm -69.32 -38.05 78.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.783 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.485 ' HG3' ' CG1' ' A' ' 45' ' ' ILE . 20.9 mmt -75.11 -39.28 60.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.744 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.3 mm? -61.78 -59.57 4.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.56 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.58 -34.11 66.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.736 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 24.6 t70 -69.45 -61.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.857 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.72 -40.27 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 111.282 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 26' ' ' VAL . 58.3 t -70.92 -21.97 22.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.592 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -72.56 -30.25 64.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 15.1 mmm-85 -67.99 -29.94 69.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.12 0.486 . . . . 0.0 110.0 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.21 -41.63 3.68 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.973 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 4.5 ptm180 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 122.557 -0.378 . . . . 0.0 110.755 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.358 0.123 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.476 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 19.1 mm-40 57.78 -161.8 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.955 0.502 . . . . 0.0 111.721 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 2.6 tt 171.66 -72.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 111.24 114.32 3.46 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.615 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.44 -5.08 14.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.746 2.297 . . . . 0.0 112.179 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.56 ' HB ' ' CG2' ' A' ' 18' ' ' THR . 6.8 mt -98.62 121.28 49.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.7 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 m80 -82.55 -26.59 0.41 Allowed Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.3 Cg_exo -31.45 130.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 123.583 2.855 . . . . 0.0 114.07 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.8 Cg_exo -33.89 127.08 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 125.079 3.853 . . . . 0.0 112.456 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 10.0 Cg_exo -19.62 53.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.571 5.514 . . . . 0.0 117.572 -157.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 76.4 mtp180 -99.06 -4.48 32.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.56 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -178.62 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.41 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -79.15 -23.25 44.08 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.598 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.438 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.6 mtt -117.68 52.69 0.97 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -79.11 112.28 16.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.821 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.5 tp10 -111.27 118.95 37.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' HB2' ' CG ' ' A' ' 8' ' ' GLN . 36.7 tp10 -98.38 103.53 15.49 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.427 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.83 128.0 37.5 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.043 -169.19 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HG2' HD21 ' A' ' 62' ' ' LEU . 19.9 mtp180 -87.4 110.14 20.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.997 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.753 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -125.56 127.95 24.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -177.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 31.9 Cg_exo -57.73 147.89 77.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.621 2.214 . . . . 0.0 111.963 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 31' ' ' VAL . 20.0 t70 -53.21 -51.07 63.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.81 76.25 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.193 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.544 ' SD ' HD12 ' A' ' 33' ' ' LEU . 9.5 tpp -79.53 -28.53 41.31 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.699 -0.295 . . . . 0.0 110.373 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 28' ' ' ASP . 13.3 p -74.74 -30.09 24.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.59 67.32 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.795 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.544 HD12 ' SD ' ' A' ' 30' ' ' MET . 95.7 mt -87.55 -25.59 23.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -68.7 -31.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.435 0.636 . . . . 0.0 109.541 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.617 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.1 pt -82.73 -14.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 173.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.37 -88.28 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 124.213 0.945 . . . . 0.0 112.968 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 8.0 ptp180 -77.7 38.93 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.216 0.606 . . . . 0.0 111.561 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.96 3.27 80.51 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.978 -0.556 . . . . 0.0 114.324 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.617 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 160.33 -50.53 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.158 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 12.6 tp10 -54.08 -25.01 19.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.49 -46.95 77.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.719 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.732 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 10.6 tp -65.94 -38.78 82.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -53.53 -42.88 67.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.33 -48.46 72.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.876 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.501 ' HB ' HD12 ' A' ' 42' ' ' ILE . 95.4 mt -58.91 -57.97 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.732 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 7.9 pt20 -73.24 -20.97 60.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.523 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -78.36 -38.7 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.434 0.635 . . . . 0.0 110.022 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -63.18 -39.59 95.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.811 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' SER . 23.3 p -80.36 -46.78 15.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.349 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.9 56.2 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.583 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 54.1 t -82.44 143.15 31.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.17 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.453 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 33.4 mtmt -80.47 76.78 7.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.442 HG11 HD11 ' A' ' 42' ' ' ILE . 79.9 t -82.74 110.41 17.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.776 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -109.67 115.93 30.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.508 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.574 HD13 HG13 ' A' ' 67' ' ' VAL . 33.3 mm -89.24 106.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.333 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 46.8 m -87.24 107.46 14.83 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.862 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.0 Cg_exo -75.26 -38.28 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.818 3.012 . . . . 0.0 113.289 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.6 116.09 19.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.033 0.444 . . . . 0.0 110.259 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.612 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 16.4 p -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.713 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 -85.22 1.84 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.096 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.27 -13.35 83.4 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 59' ' ' SER . 6.3 mp -112.59 149.73 41.59 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.406 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -87.69 3.39 6.3 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.702 2.268 . . . . 0.0 110.252 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 3.4 pt-20 -125.96 -173.59 2.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.564 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.862 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 8.1 tpp85 -83.83 145.22 28.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.498 ' HB3' HD22 ' A' ' 62' ' ' LEU . 54.6 p -121.5 122.31 39.44 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.096 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.574 HG13 HD13 ' A' ' 55' ' ' ILE . 69.1 t -116.22 131.44 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -94.15 125.41 38.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.045 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 mm? -108.34 104.45 13.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.238 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.6 m -152.28 130.81 12.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -162.57 -82.25 0.04 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.926 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.65 168.33 12.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.586 ' N ' ' HG2' ' A' ' 16' ' ' PRO . 97.4 Cg_exo -45.43 -57.74 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.864 2.376 . . . . 0.0 113.675 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -76.66 -35.64 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.495 0.664 . . . . 0.0 110.067 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' SER . 33.7 m -68.63 -42.37 78.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.981 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.15 -31.77 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.848 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.11 -37.72 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 81' ' ' MET . 22.9 tptp -70.8 -36.24 72.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 110.413 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -63.76 -40.81 97.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.681 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.3 mtmt -81.92 -20.55 38.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.246 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.586 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 14.3 tpt -58.7 -55.71 31.57 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.751 175.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mmm -69.74 -38.42 76.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.979 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 87' ' ' VAL . 1.3 mm? -56.69 -58.09 9.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.336 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.04 -41.88 65.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.105 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 37.7 t70 -55.37 -59.2 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.4 mp -72.17 -37.15 58.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.1 0.476 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 83' ' ' LEU . 94.9 t -65.11 -31.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.2 m -71.87 -29.8 64.75 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.678 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 24.4 mmm180 -56.53 -49.38 74.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.966 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.94 -53.02 1.13 Allowed Glycine 0 C--O 1.228 -0.248 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.551 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.761 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 7.4 tpt85 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.152 0.501 . . . . 0.0 110.106 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -145.5 167.34 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.391 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD12 ' HD3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -155.66 135.68 12.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.993 178.366 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.71 81.46 0.21 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.593 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD3' HD12 ' A' ' 9' ' ' LEU . 67.3 Cg_endo -75.81 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.454 2.103 . . . . 0.0 112.363 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.783 HD11 HG23 ' A' ' 18' ' ' THR . 27.4 pt -131.14 161.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.537 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.587 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.2 m80 -90.52 -26.81 0.3 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 66.2 Cg_exo -39.37 168.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.23 2.62 . . . . 0.0 114.923 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 14' ' ' PRO . 1.3 Cg_endo -42.56 153.65 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.139 3.226 . . . . 0.0 113.941 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 60.4 Cg_endo -69.51 27.95 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 124.092 3.195 . . . . 0.0 113.765 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' HG3' HG22 ' A' ' 18' ' ' THR . 10.7 ptp180 -81.08 -20.82 40.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.401 0.619 . . . . 0.0 109.649 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.783 HG23 HD11 ' A' ' 12' ' ' ILE . 5.2 t -160.92 18.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.027 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 t -99.5 -98.85 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.7 ptp -64.83 88.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.641 0.734 . . . . 0.0 110.653 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.487 HG23 ' OG1' ' A' ' 70' ' ' THR . 29.2 m -92.66 113.46 25.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.808 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.463 ' CD ' ' HD2' ' A' ' 80' ' ' LYS . 19.2 tt0 -96.06 118.08 31.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -96.37 102.88 14.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -92.01 124.46 36.13 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.482 -169.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' OE2' ' A' ' 64' ' ' GLU . 50.9 mtp180 -81.01 118.93 22.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.679 174.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -137.31 123.77 13.46 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HG2' ' CG ' ' A' ' 30' ' ' MET . 20.5 Cg_endo -61.97 141.67 90.16 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.577 2.185 . . . . 0.0 110.632 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' HG12 ' A' ' 31' ' ' VAL . 30.5 t70 -59.05 -30.56 68.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.975 -167.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.94 -36.97 87.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.286 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.576 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.8 mmm -78.5 -27.91 46.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.66 -0.318 . . . . 0.0 111.002 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.4 p -70.98 -28.63 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.411 174.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.81 71.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.038 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.17 -28.63 23.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.0 tp -68.39 -29.95 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.862 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.664 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.7 pt -83.64 -14.04 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.201 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.66 -93.07 0.03 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 123.921 0.763 . . . . 0.0 113.496 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 12.8 ptp180 -64.15 -1.18 1.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.55 0.74 . . . . 0.0 112.493 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.59 11.1 18.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.276 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.664 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.9 -44.57 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.884 174.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 22.8 tt0 -55.72 -32.31 63.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -61.35 -47.83 84.08 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.436 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 53' ' ' VAL . 8.5 tp -61.59 -42.59 94.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.14 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.87 -38.91 83.51 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.77 -49.07 78.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.12 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 82' ' ' MET . 72.1 mt -63.64 -52.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.708 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -72.59 -43.9 62.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.209 -172.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 47' ' ' GLN . 6.3 tp60 -73.8 -26.02 60.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 110.818 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.21 -53.92 7.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.324 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.709 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 41.8 p -64.5 -40.83 96.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.14 7.72 20.84 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.242 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.659 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 38.6 t -92.81 135.19 34.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.771 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 41.2 mtmt -83.22 88.1 6.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 42' ' ' ILE . 58.4 t -95.34 111.14 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -111.1 116.04 30.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 67' ' ' VAL . 33.1 mm -80.69 100.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.7 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.52 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 17.7 m -85.53 114.45 56.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 6.0 Cg_exo -79.57 -27.02 4.39 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.383 2.722 . . . . 0.0 112.698 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.28 -23.87 30.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.616 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.499 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 74.7 p 53.64 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.841 1.257 . . . . 0.0 113.187 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.93 -100.33 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.51 18.29 50.21 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.066 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 64' ' ' GLU . 2.6 mm? -119.59 136.98 25.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.28 -8.69 11.71 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.905 2.403 . . . . 0.0 110.55 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.57 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 4.9 pt-20 -104.09 -162.01 0.87 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.784 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.711 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -95.81 148.26 22.78 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.499 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 65.4 p -122.38 125.2 45.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 55' ' ' ILE . 64.4 t -111.26 112.14 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.733 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -80.28 126.41 31.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.275 0.559 . . . . 0.0 110.817 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.041 HD13 ' HG2' ' A' ' 80' ' ' LYS . 16.0 mt -118.14 110.91 18.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.487 ' OG1' HG23 ' A' ' 21' ' ' THR . 2.6 m -151.22 121.79 7.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.791 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.57 -90.47 0.08 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.937 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.78 167.09 14.72 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.762 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 73.5 Cg_exo -39.89 -59.48 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.356 2.704 . . . . 0.0 114.276 -176.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -82.65 -37.58 24.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.423 0.63 . . . . 0.0 110.15 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.3 m -61.51 -46.32 90.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.399 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.585 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.8 p -72.33 -32.27 41.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.54 -38.72 74.23 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -63.12 -46.96 84.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.493 0.663 . . . . 0.0 110.317 177.327 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.07 75.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.856 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.041 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.3 mtmt -74.92 -21.41 59.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.078 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.687 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 19.0 ptm -69.08 -37.35 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.667 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.875 ' HG3' HD13 ' A' ' 45' ' ' ILE . 89.8 mmm -67.89 -43.12 80.06 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.639 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.9 mm? -59.38 -56.89 16.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.69 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.54 -39.48 57.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.27 -57.58 12.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.561 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.723 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.4 mp -73.04 -40.58 58.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.519 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 24' ' ' TYR . 81.7 t -61.43 -40.84 87.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.642 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -68.36 -36.41 79.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.453 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.723 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.2 ptm180 -79.89 -7.68 58.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.793 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.576 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -131.43 9.63 5.58 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.477 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.52 -179.032 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 8.6 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.752 0.31 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -67.67 109.43 3.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.677 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 53.0 mt -92.42 104.34 16.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.392 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -115.16 58.51 0.44 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.102 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.709 ' HD2' HD13 ' A' ' 12' ' ' ILE . 2.6 Cg_endo -82.28 -43.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.639 2.226 . . . . 0.0 112.12 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.873 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -87.72 138.49 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.298 0.571 . . . . 0.0 110.607 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.639 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 52.2 t-80 -78.31 -29.84 0.67 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 95.5 Cg_exo -35.9 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.751 2.967 . . . . 0.0 115.292 173.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.486 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.69 160.71 3.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.094 2.529 . . . . 0.0 111.58 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 38.5 Cg_endo -63.79 3.91 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.135 2.557 . . . . 0.0 114.021 -172.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD3' ' HG2' ' A' ' 15' ' ' PRO . 2.7 ptt180 -58.31 -29.58 66.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.071 0.462 . . . . 0.0 110.319 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -148.14 3.88 0.71 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.228 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.629 ' HA ' HG12 ' A' ' 12' ' ' ILE . 35.9 t -84.52 -96.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.344 -175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.0 ptp -68.09 80.05 0.23 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.593 0.711 . . . . 0.0 111.277 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -79.49 116.17 19.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -91.8 117.87 30.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 43.0 tt0 -87.62 103.86 15.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -91.22 110.45 21.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.686 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.441 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 64.1 mtp180 -80.26 103.53 10.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.959 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.36 127.52 25.83 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.366 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 52.5 Cg_exo -56.59 139.17 87.29 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.864 2.376 . . . . 0.0 111.831 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.85 -55.56 6.5 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -24.09 72.92 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.557 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.8 tpp -78.81 -18.73 53.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.618 ' HA ' HG22 ' A' ' 34' ' ' ILE . 2.1 t -73.02 -33.13 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.87 -30.07 56.19 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.913 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -88.03 -23.23 23.83 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 31' ' ' VAL . 6.8 tp -71.56 -28.32 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.992 0.814 . . . . 0.0 109.663 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.684 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.0 pt -85.59 -15.3 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.324 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.31 -89.24 0.02 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 124.086 0.866 . . . . 0.0 113.701 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.623 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 13.2 ptp180 -71.96 11.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.07 0.548 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 14.71 30.81 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.098 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.684 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.5 -46.39 0.78 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.412 173.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.623 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 9.4 tp10 -62.31 -22.22 65.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 45' ' ' ILE . 20.5 tt0 -64.63 -48.13 76.01 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.108 -0.37 . . . . 0.0 111.318 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 39' ' ' GLY . 7.1 tp -61.54 -42.44 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.46 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.3 m-20 -52.59 -52.54 54.74 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 123.66 0.6 . . . . 0.0 109.463 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -56.88 -48.8 77.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.104 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 41' ' ' GLN . 25.1 mm -62.27 -49.37 84.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.156 -175.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -79.33 -28.2 42.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.365 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -71.13 -42.09 69.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.79 -47.72 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.485 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.558 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 14.5 p -80.52 -38.29 30.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.896 -175.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.02 9.38 42.6 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.607 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 52.3 t -78.72 139.7 38.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.34 0.59 . . . . 0.0 111.352 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -88.2 79.94 7.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.891 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 69' ' ' LEU . 7.6 p -82.04 131.13 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.4 mm-40 -114.51 107.56 15.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.734 0.778 . . . . 0.0 110.703 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.61 HG23 ' NH1' ' A' ' 65' ' ' ARG . 18.5 mm -80.83 106.14 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.567 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.8 m -109.91 100.17 41.97 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.496 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -86.77 24.64 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.478 2.785 . . . . 0.0 111.05 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.43 -31.04 47.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.094 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 p 45.52 64.9 1.26 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.521 0.677 . . . . 0.0 111.075 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.16 116.24 4.9 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.948 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.83 -47.54 3.33 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -172.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 25' ' ' ARG . 2.6 mp -88.39 128.01 54.71 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.62 -13.35 10.8 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 121.96 1.773 . . . . 0.0 111.117 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.4 pt-20 -99.34 -155.62 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.715 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.61 ' NH1' HG23 ' A' ' 55' ' ' ILE . 5.5 mmm-85 -89.76 138.37 31.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.627 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 p -110.1 129.17 55.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.131 0.491 . . . . 0.0 110.286 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG22 ' NH2' ' A' ' 65' ' ' ARG . 87.7 t -119.22 116.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.138 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 74.2 m -93.67 135.21 35.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.132 0.492 . . . . 0.0 110.597 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.749 HD11 ' HG ' ' A' ' 83' ' ' LEU . 74.2 mt -118.86 127.97 54.0 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.792 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -150.73 157.54 43.07 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.266 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 148.69 -152.73 24.73 Favored Glycine 0 C--O 1.217 -0.911 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.179 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.87 152.42 80.03 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.06 -46.36 19.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.675 2.25 . . . . 0.0 112.717 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.63 -32.29 60.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.972 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -71.15 -49.74 40.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.541 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 9.2 p -67.02 -27.08 38.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.506 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 81' ' ' MET . 28.8 tt0 -72.54 -41.96 65.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.43 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HD2' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -64.82 -40.2 94.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.083 0.468 . . . . 0.0 110.419 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.33 88.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.92 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.674 ' HG2' HD13 ' A' ' 69' ' ' LEU . 55.6 mtmt -64.79 -23.33 67.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.642 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.6 mmm -60.44 -52.46 65.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.603 ' HA ' ' CE ' ' A' ' 82' ' ' MET . 10.1 mmt -70.84 -36.2 72.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.978 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.749 ' HG ' HD11 ' A' ' 69' ' ' LEU . 1.1 mm? -60.87 -60.48 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.29 -29.28 70.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 110.662 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.69 -60.26 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.26 0.553 . . . . 0.0 110.649 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.557 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.02 -37.0 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.07 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.524 HG21 ' HD2' ' A' ' 24' ' ' TYR . 65.6 t -62.53 -32.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.718 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -71.46 -39.99 70.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.253 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.9 ptp180 -72.97 -18.6 61.35 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.605 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.93 -65.07 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.649 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.475 0.655 . . . . 0.0 110.298 -178.008 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.634 ' HB3' ' OE1' ' A' ' 22' ' ' GLU . 39.7 m . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.788 ' HB3' ' O ' ' A' ' 21' ' ' THR . 36.7 tt0 -175.4 -143.41 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.727 0.694 . . . . 0.0 110.074 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.645 ' H ' ' HG2' ' A' ' 8' ' ' GLN . 2.0 pt? -167.09 -61.15 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -175.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.633 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . 119.74 149.2 8.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.454 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HD3' ' HA2' ' A' ' 10' ' ' GLY . 6.2 Cg_exo -80.08 -52.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.146 2.564 . . . . 0.0 113.329 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.684 HG22 ' HD2' ' A' ' 14' ' ' PRO . 2.1 mt -93.47 128.59 44.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.699 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 45.5 m80 -92.61 3.57 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -168.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.758 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 19.0 Cg_endo -57.99 -162.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.559 2.173 . . . . 0.0 112.81 169.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 28.2 Cg_exo -38.59 155.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.874 2.383 . . . . 0.0 113.594 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 34.6 Cg_endo -64.68 23.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.231 3.287 . . . . 0.0 115.162 -171.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -78.94 2.13 21.31 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.527 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -179.13 2.27 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.688 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 16' ' ' PRO . 49.2 p -97.59 -8.87 28.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 16' ' ' PRO . 15.8 ptp -146.43 52.9 1.12 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.871 0.844 . . . . 0.0 109.452 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.788 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 94.6 m -78.25 116.77 18.93 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.788 177.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 7' ' ' SER . 2.8 tp10 -101.78 125.16 48.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.343 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -98.57 104.38 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.13 116.79 29.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.635 -169.503 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.638 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 23.9 mtp180 -81.78 109.52 16.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.883 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -125.05 125.09 25.36 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 110.808 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 51.4 Cg_exo -55.4 136.31 73.13 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.784 2.322 . . . . 0.0 110.885 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.455 ' HA ' HG23 ' A' ' 31' ' ' VAL . 28.1 t70 -58.61 -33.87 70.51 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.561 -168.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.42 -34.64 90.45 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.65 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.535 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 92.1 mmm -78.65 -9.92 59.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 34' ' ' ILE . 44.2 t -75.83 -40.46 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.96 -30.41 69.9 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.284 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.16 -28.97 25.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.3 tp -71.82 -28.94 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.413 0.625 . . . . 0.0 110.114 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.652 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.5 pt -80.46 -13.74 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.677 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.39 -91.82 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.954 0.783 . . . . 0.0 113.302 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.2 ptm85 -77.5 37.89 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.503 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.13 19.75 78.68 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.683 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.652 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.04 -49.33 0.6 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.92 173.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 28.2 tt0 -58.71 -28.7 66.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -169.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -56.42 22.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.818 0.281 . . . . 0.0 111.166 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.57 HD11 HG11 ' A' ' 53' ' ' VAL . 6.1 tp -57.29 -49.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.826 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.21 -38.88 88.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.036 0.446 . . . . 0.0 110.637 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -60.17 -44.29 95.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.71 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.06 -41.85 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.856 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -69.96 -37.38 75.8 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.07 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -71.36 -38.03 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.44 -51.77 66.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.072 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.79 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 32.9 p -70.56 -37.63 74.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.48 12.05 22.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.955 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 35.4 t -84.99 150.03 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.867 0.365 . . . . 0.0 110.149 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 67.2 mmtt -104.99 82.66 1.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.526 0.679 . . . . 0.0 109.693 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.57 HG11 HD11 ' A' ' 42' ' ' ILE . 40.8 t -93.02 113.59 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.165 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -107.29 129.7 54.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.783 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.485 HD13 HG13 ' A' ' 67' ' ' VAL . 30.1 mm -102.42 89.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.445 -174.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 35.0 t -79.95 114.6 47.69 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.698 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 5.5 Cg_exo -78.88 -32.54 1.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.588 2.859 . . . . 0.0 112.393 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.31 -34.62 42.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.503 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 40.4 t 71.02 -65.52 0.34 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.183 176.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.43 -55.92 0.59 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.098 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.75 -10.12 10.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.638 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.8 mt -112.91 144.59 31.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.798 0.332 . . . . 0.0 110.5 -173.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.42 -16.64 8.05 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.83 2.353 . . . . 0.0 110.336 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 4.3 pt-20 -92.98 -168.74 2.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.11 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.883 ' HB3' HG13 ' A' ' 26' ' ' VAL . 5.5 tpp180 -89.44 140.57 29.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.536 ' HB3' HD12 ' A' ' 62' ' ' LEU . 67.7 p -114.56 105.17 12.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.546 0.689 . . . . 0.0 109.345 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.485 HG13 HD13 ' A' ' 55' ' ' ILE . 95.3 t -98.13 121.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.8 m -89.67 128.16 36.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.412 0.625 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.731 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -106.56 112.33 25.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.9 m -151.32 143.69 24.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.988 -0.096 . . . . 0.0 110.805 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.54 -154.9 25.06 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.402 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -78.92 160.89 70.57 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -47.52 -53.07 6.99 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.796 2.33 . . . . 0.0 113.479 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -72.98 -40.33 65.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.975 0.417 . . . . 0.0 110.336 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.79 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.2 m -60.02 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.436 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.544 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 3.6 p -70.65 -30.01 40.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.01 -37.88 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 109.925 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.739 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.95 -47.06 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 177.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.11 -48.68 79.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.456 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.731 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 46.1 mtmt -68.52 -22.19 64.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.48 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.739 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 17.9 ptm -70.41 -36.47 74.05 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.497 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.62 -39.98 73.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.135 0.493 . . . . 0.0 110.097 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.0 mm? -64.55 -56.57 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.137 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.54 -35.14 67.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 110.557 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.76 -55.89 25.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.515 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.659 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -75.57 -37.19 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.979 0.419 . . . . 0.0 111.425 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 24' ' ' TYR . 72.6 t -68.13 -33.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.875 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.6 t -70.76 -38.63 73.49 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.821 -0.549 . . . . 0.0 110.304 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.659 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -78.39 -13.43 59.85 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.535 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -120.82 -20.58 3.42 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.016 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 117.16 0.48 . . . . 0.0 110.524 -177.705 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' HD22 ' A' ' 9' ' ' LEU . 49.2 m . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 45.9 tt0 -64.45 112.98 3.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.776 0.322 . . . . 0.0 111.781 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 7' ' ' SER . 1.9 mm? -92.15 108.68 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 167.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 73.2 0.29 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.442 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 4.6 Cg_exo -74.99 -57.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.764 2.31 . . . . 0.0 111.874 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.649 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 pp -104.19 151.38 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.416 176.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 7.0 t-160 -90.6 -11.88 0.18 Allowed Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -170.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 72.7 Cg_exo -39.27 161.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.477 2.118 . . . . 0.0 114.337 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.49 148.47 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.703 2.935 . . . . 0.0 113.462 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.35 31.05 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.793 2.995 . . . . 0.0 113.905 -172.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -92.89 -0.36 57.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.874 0.369 . . . . 0.0 110.331 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.579 HG22 ' HD3' ' A' ' 17' ' ' ARG . 12.7 t -174.33 1.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.762 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 p -93.74 -85.09 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.1 ptm -72.56 71.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.596 0.712 . . . . 0.0 111.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.6 m -79.19 120.91 24.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.645 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.904 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 9.0 tp10 -92.58 118.88 31.47 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.82 106.19 18.42 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.556 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -92.26 118.61 31.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.944 -172.049 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.557 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 95.6 mtt180 -81.98 95.46 7.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.254 174.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -114.73 121.02 36.41 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.028 -176.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.622 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 51.5 Cg_exo -54.93 154.93 19.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.311 2.674 . . . . 0.0 112.442 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.71 -39.06 79.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.4 . . . . 0.0 111.236 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.23 64.11 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.876 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.41 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -78.0 -29.64 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.756 -0.261 . . . . 0.0 111.08 -177.01 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.67 ' HA ' HG22 ' A' ' 34' ' ' ILE . 5.8 p -73.25 -30.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.758 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -67.66 -22.32 73.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.364 170.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD23 HG23 ' A' ' 86' ' ' ILE . 62.0 tp -89.05 -30.13 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.67 HG22 ' HA ' ' A' ' 31' ' ' VAL . 10.8 tp -72.47 -26.18 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.401 0.619 . . . . 0.0 109.906 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.604 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.3 pt -81.24 -14.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -92.06 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 O-C-N 124.045 0.841 . . . . 0.0 113.281 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 11.1 ptp180 -71.13 3.78 3.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.016 0.526 . . . . 0.0 111.835 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.5 25.72 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.107 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.41 -50.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.45 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 28.9 tt0 -50.65 -36.16 34.19 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 45' ' ' ILE . 15.1 tt0 -59.81 -55.33 35.56 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 53' ' ' VAL . 5.1 tp -58.55 -46.64 89.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.53 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -56.42 -43.66 79.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 123.453 0.471 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.4 -43.25 95.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.646 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 41' ' ' GLN . 24.0 mm -65.19 -50.89 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.769 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -70.54 -27.77 64.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.987 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -72.45 -44.78 61.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.0 -50.02 73.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.436 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.4 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 24.6 p -67.7 -45.31 75.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.319 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.67 10.98 27.79 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.67 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.448 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 53.9 t -94.17 138.64 31.98 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.094 0.473 . . . . 0.0 110.094 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -85.95 79.94 9.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.616 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 42' ' ' ILE . 43.9 t -89.07 107.42 17.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.212 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB3' ' OG ' ' A' ' 68' ' ' SER . 12.1 tp60 -99.06 116.26 30.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -175.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 42' ' ' ILE . 44.5 mm -83.53 89.96 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.111 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 41.1 m -85.49 114.82 58.61 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 121.164 0.507 . . . . 0.0 111.036 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 12.1 Cg_exo -69.61 -36.6 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.324 2.683 . . . . 0.0 111.485 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.11 89.57 5.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.576 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 3.9 m -72.38 -19.31 61.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.155 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 -99.86 1.04 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.296 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.59 -26.87 66.51 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.263 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.3 mm? -87.25 139.95 32.26 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -85.05 0.71 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.766 2.311 . . . . 0.0 111.421 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -108.45 -110.57 0.31 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.8 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.609 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -133.92 149.57 51.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.576 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 82.7 p -119.77 111.4 17.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.734 0.778 . . . . 0.0 110.35 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.56 132.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.01 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 p -99.38 130.06 45.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.369 0.604 . . . . 0.0 111.485 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.904 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 2.9 mm? -110.49 105.78 14.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.233 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 18' ' ' THR . 6.5 m -150.97 128.01 11.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.939 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -166.81 -97.29 0.11 Allowed Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.924 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.54 163.68 43.61 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.25 -43.41 37.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.441 2.094 . . . . 0.0 112.593 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -79.44 -38.0 35.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.231 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -77.18 -41.76 40.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.087 0.47 . . . . 0.0 110.654 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -23.92 30.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.278 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.2 tp-100 -77.86 -45.6 23.81 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 81' ' ' MET . 4.9 tppp? -60.7 -45.83 92.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.026 0.441 . . . . 0.0 110.561 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.411 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -55.8 -49.73 72.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.393 176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.558 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.3 mtmt -69.54 -21.05 63.67 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.023 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.6 mmt -60.66 -50.18 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.172 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.635 ' HA ' ' CE ' ' A' ' 82' ' ' MET . 6.8 mmt -66.11 -39.5 89.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.067 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.1 mm? -66.27 -54.19 27.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.54 -30.68 67.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.27 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 15.2 t70 -66.03 -61.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.469 HG23 HD23 ' A' ' 33' ' ' LEU . 2.0 mp -68.66 -38.42 78.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.141 0.496 . . . . 0.0 111.295 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.556 HG21 ' HD2' ' A' ' 24' ' ' TYR . 76.9 t -66.62 -29.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -78.15 -22.68 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.345 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 26.7 mmm180 -66.87 -32.51 73.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.069 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.83 -64.38 0.82 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.754 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.101 0.477 . . . . 0.0 110.962 -178.248 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 10.5 t . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.679 ' HG3' ' H ' ' A' ' 9' ' ' LEU . 23.8 tp60 48.51 -156.47 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 111.667 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.679 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 4.2 pp 174.33 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.261 1.024 . . . . 0.0 108.301 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 9' ' ' LEU . . . 150.98 126.15 1.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.541 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.47 -13.75 22.63 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.542 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.94 HG12 ' HD2' ' A' ' 14' ' ' PRO . 13.1 tt -147.49 148.52 16.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.701 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.5 m-70 -90.38 -10.89 0.16 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.94 ' HD2' HG12 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -38.05 164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.802 2.334 . . . . 0.0 113.226 162.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -26.98 146.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 125.022 3.814 . . . . 0.0 115.871 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 47.5 Cg_endo -65.96 12.9 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.033 3.155 . . . . 0.0 114.213 -171.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -77.52 2.83 15.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 109.474 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 17' ' ' ARG . 8.4 t -159.83 -25.21 0.07 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.651 172.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 15.6 t -79.85 6.36 11.28 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.156 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 mmt -144.52 37.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.1 m -85.9 112.16 20.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 7' ' ' SER . 9.7 tt0 -123.56 119.49 30.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.228 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.74 102.19 14.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.645 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -92.37 136.76 32.93 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.725 -170.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 25' ' ' ARG . 7.5 mtm180 -101.85 129.38 48.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -135.03 124.11 16.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.801 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 91' ' ' ARG . 51.2 Cg_exo -55.8 140.99 85.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 111.731 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.63 -47.03 29.25 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.68 -31.11 79.81 Favored Glycine 0 C--O 1.238 0.349 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.697 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.515 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 84.2 mmm -77.99 -15.05 59.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 65' ' ' ARG . 17.4 t -72.43 -40.11 63.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.94 -29.94 68.85 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.342 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.69 -24.66 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -74.48 -26.34 20.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.507 0.67 . . . . 0.0 109.544 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.72 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 16.4 pt -88.1 -15.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.062 171.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.89 0.02 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.105 0.878 . . . . 0.0 113.72 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.667 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 4.2 ptp180 -81.02 14.07 2.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.014 0.525 . . . . 0.0 111.166 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 16.02 28.15 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.331 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.72 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.48 -49.74 0.58 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.303 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.667 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.0 tt0 -51.4 -33.56 30.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -173.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 45' ' ' ILE . 21.2 tt0 -60.59 -50.78 72.16 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.652 -173.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.547 HD11 HG11 ' A' ' 53' ' ' VAL . 8.1 tp -63.7 -43.59 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.514 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -62.06 -36.36 81.41 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -65.01 -52.62 55.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.141 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -60.08 -48.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.029 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.2 pp0? -73.5 -34.42 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.693 0.282 . . . . 0.0 111.167 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.87 -39.34 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.137 0.494 . . . . 0.0 110.51 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.68 -38.21 89.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.935 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.3 p -81.11 -43.97 18.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.36 8.64 28.68 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 41.5 t -90.0 132.68 35.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.979 0.418 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -79.82 79.25 6.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.288 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.547 HG11 HD11 ' A' ' 42' ' ' ILE . 47.6 t -87.31 107.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.064 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 10.8 mm100 -97.9 110.05 22.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.613 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 42' ' ' ILE . 49.7 mm -80.2 112.91 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.26 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.9 m -104.15 99.39 16.86 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.624 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 40.0 Cg_endo -68.95 -30.49 26.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.863 2.375 . . . . 0.0 110.943 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.42 79.62 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -72.62 -36.78 68.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.283 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.78 -69.56 3.2 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.844 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.18 -4.38 90.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.203 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.77 HD12 ' HB3' ' A' ' 66' ' ' SER . 56.6 mt -126.63 144.34 49.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.72 -19.54 9.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.687 2.258 . . . . 0.0 109.939 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 3.6 pt-20 -94.2 -161.9 0.89 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.034 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.89 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.7 tpp180 -99.62 146.27 26.65 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.77 ' HB3' HD12 ' A' ' 62' ' ' LEU . 83.8 p -118.43 134.23 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.905 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG13 HD13 ' A' ' 55' ' ' ILE . 57.1 t -128.7 122.68 57.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.633 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 54.3 m -86.04 123.82 31.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.308 0.575 . . . . 0.0 111.27 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.581 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.3 mm? -105.51 114.76 29.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.607 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.9 m -152.87 141.68 21.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.12 -133.53 1.96 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.617 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.732 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -114.59 166.29 11.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.732 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 8.3 Cg_endo -50.04 -41.87 47.35 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.909 2.406 . . . . 0.0 113.39 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -84.28 -44.95 13.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 23.8 p -66.48 -46.91 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -67.5 -32.51 57.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.303 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG3' ' A' ' 81' ' ' MET . 64.5 tt0 -74.55 -42.22 59.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' MET . 1.9 tpmt? -58.42 -51.65 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.935 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.85 72.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.995 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.581 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.5 mtmt -67.24 -22.62 65.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.543 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 61.7 mtt -62.96 -47.74 81.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.406 ' HG2' HG12 ' A' ' 45' ' ' ILE . 2.3 mpt? -65.25 -41.67 94.06 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.19 176.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' A' ' 69' ' ' LEU . 3.6 mm? -60.39 -57.13 14.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.59 -38.76 72.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.466 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' MET . 15.2 t70 -57.12 -51.68 68.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.386 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -80.4 -40.87 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.585 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.645 HG21 ' CD2' ' A' ' 24' ' ' TYR . 70.8 t -61.42 -41.98 92.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.852 0.358 . . . . 0.0 110.455 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -68.04 -40.3 82.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.621 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 8.1 ptp180 -69.9 -28.07 65.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.579 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.515 ' HA3' ' SD ' ' A' ' 30' ' ' MET . . . -118.08 10.6 13.45 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.477 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.488 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 2.0 tmt_? . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.04 0.447 . . . . 0.0 109.996 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 70.6 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 21' ' ' THR . 77.2 mm-40 -162.53 -36.93 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.773 0.829 . . . . 0.0 109.317 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.16 -126.96 0.09 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.783 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 140.74 119.7 1.61 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.594 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.84 -6.88 17.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.679 . . . . 0.0 112.061 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.731 HG22 ' HD2' ' A' ' 14' ' ' PRO . 13.9 mt -92.03 113.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.596 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 26.8 m-70 -82.19 -11.74 0.18 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -165.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.731 ' HD2' HG22 ' A' ' 12' ' ' ILE . 76.3 Cg_exo -35.01 127.84 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.133 1.889 . . . . 0.0 112.874 169.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' ARG . 45.1 Cg_exo -36.97 132.4 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 124.391 3.394 . . . . 0.0 112.812 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 2.7 Cg_exo -25.23 62.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 127.076 5.184 . . . . 0.0 117.079 -159.587 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HA ' ' CG2' ' A' ' 70' ' ' THR . 11.8 ptp180 -122.2 10.34 9.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.57 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 7.9 t 174.11 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.147 178.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 18' ' ' THR . 32.7 t -79.58 -24.06 42.31 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.2 0.524 . . . . 0.0 110.221 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.439 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 8.8 ptp -155.26 70.17 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 51.8 m -78.79 120.68 23.77 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.868 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.7 tp10 -102.59 118.5 36.98 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.888 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 5.3 tp10 -94.06 105.85 17.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.613 170.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 115.04 27.73 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.272 -173.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 1.044 ' HG2' HD13 ' A' ' 62' ' ' LEU . 39.0 mtm105 -81.48 98.77 8.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 172.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -108.11 116.71 56.46 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.209 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.551 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 50.2 Cg_exo -50.63 139.08 39.6 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 123.291 2.66 . . . . 0.0 112.518 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -50.34 -48.5 55.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -28.36 73.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.29 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.551 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 91.0 mmm -78.78 -10.28 59.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 65' ' ' ARG . 39.5 t -77.12 -41.24 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.15 64.44 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.396 172.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.5 mt -89.01 -26.12 21.63 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 31' ' ' VAL . 10.5 tp -72.49 -27.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.477 0.656 . . . . 0.0 109.736 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.604 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.4 pt -84.27 -14.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.133 173.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.86 -90.8 0.07 OUTLIER Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.644 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.597 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.04 10.41 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.867 0.467 . . . . 0.0 111.698 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.13 35.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.111 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 154.1 -46.3 0.55 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.467 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.597 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 26.5 tt0 -48.18 -38.18 17.56 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -61.32 -45.57 93.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.521 HD11 HG11 ' A' ' 53' ' ' VAL . 5.7 tp -59.4 -49.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.424 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.11 -43.08 99.62 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.344 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -58.78 -39.25 80.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.364 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -81.27 -42.49 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.769 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -73.46 -26.83 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.61 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.99 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.41 -51.43 69.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.348 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 p -74.43 -37.29 63.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.772 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.53 2.43 60.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.533 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.411 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 51.4 t -79.67 139.98 37.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 110.56 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HE2' ' HA2' ' A' ' 71' ' ' GLY . 12.4 mttm -83.46 75.56 10.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.264 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.521 HG11 HD11 ' A' ' 42' ' ' ILE . 45.4 t -82.18 110.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.638 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 15.2 mm100 -102.41 106.44 17.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.675 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 67' ' ' VAL . 44.9 mm -81.04 106.05 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.411 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 15.1 m -98.99 107.49 44.17 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-O 120.753 0.311 . . . . 0.0 110.656 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.718 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 21.6 Cg_endo -62.13 -37.18 65.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.528 2.819 . . . . 0.0 112.249 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.12 97.12 8.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.481 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 4.2 p -70.84 -37.45 73.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.372 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.7 -72.9 2.72 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.312 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.19 70.53 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.714 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.044 HD13 ' HG2' ' A' ' 25' ' ' ARG . 22.2 mt -115.36 153.18 47.53 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.63 -31.28 2.04 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -94.33 -161.66 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.572 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.776 ' HB3' HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -81.35 151.06 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.713 ' HB3' HD12 ' A' ' 62' ' ' LEU . 88.5 p -118.11 114.24 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.036 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 55' ' ' ILE . 91.5 t -106.0 122.63 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.828 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 69.6 m -88.83 125.58 34.97 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.628 0.728 . . . . 0.0 110.78 177.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.868 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.9 mm? -105.04 109.58 21.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.449 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 26.3 m -151.26 144.75 24.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HE2' ' A' ' 52' ' ' LYS . . . 173.28 -107.82 0.26 Allowed Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.935 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -131.61 164.17 44.55 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.3 Cg_endo -47.4 -50.02 12.06 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.193 2.596 . . . . 0.0 112.994 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.53 -30.24 25.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' A' ' 72' ' ' ALA . 18.1 m -71.56 -48.25 49.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.411 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -69.51 -23.9 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -177.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.75 -51.01 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.319 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 81' ' ' MET . 24.4 tptm -62.7 -41.07 98.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.23 90.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.719 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 48.0 mtmt -74.93 -21.35 59.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.37 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 6.1 tpp -60.23 -46.42 89.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.451 ' HG3' HG12 ' A' ' 45' ' ' ILE . 20.4 mmt -71.02 -39.67 72.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.0 mm? -61.43 -48.92 78.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.321 177.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.5 -46.74 83.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.141 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -46.88 -58.13 4.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.385 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -79.57 -44.57 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.388 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.68 -27.49 36.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.747 0.308 . . . . 0.0 111.131 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -77.93 -38.55 45.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.471 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 3.3 ptp180 -72.26 -21.32 61.39 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.38 -83.15 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.379 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.187 0.518 . . . . 0.0 111.256 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -53.24 112.41 0.87 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 16.1 tp -106.83 117.39 33.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.839 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.99 79.75 0.26 Allowed Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.926 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 9' ' ' LEU . 92.4 Cg_endo -87.78 -7.82 6.24 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.761 2.308 . . . . 0.0 112.734 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.812 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.9 tp -140.87 152.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.686 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 71.3 m80 -88.6 -27.08 0.34 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.6 Cg_exo -37.69 165.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.474 2.783 . . . . 0.0 114.16 165.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 17' ' ' ARG . 42.4 Cg_exo -58.3 169.44 2.97 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.139 2.559 . . . . 0.0 112.606 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 37.4 Cg_endo -64.29 21.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.066 3.177 . . . . 0.0 114.064 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 13.5 ptm180 -77.98 -18.12 56.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 70' ' ' THR . 9.9 t -164.5 6.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.366 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.57 ' HA ' HG22 ' A' ' 12' ' ' ILE . 33.6 t -92.36 -99.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.927 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.541 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 17.4 ptm -60.98 84.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.715 0.769 . . . . 0.0 111.407 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -84.89 114.96 22.5 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.613 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.8 tp10 -92.75 116.63 29.2 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.97 109.21 22.01 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.755 0.788 . . . . 0.0 109.25 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.798 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.56 125.14 36.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.664 -169.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 -84.35 99.12 10.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.185 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -119.63 121.93 29.57 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.838 -175.431 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.59 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 46.1 Cg_exo -59.11 150.11 75.6 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.543 2.829 . . . . 0.0 113.025 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.2 t70 -45.82 -59.28 2.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.59 -173.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.44 -24.64 73.76 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.666 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.59 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 78.1 mmm -78.97 -33.35 45.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.697 -0.296 . . . . 0.0 110.598 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.654 HG21 ' HG2' ' A' ' 65' ' ' ARG . 11.7 p -73.14 -28.07 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.868 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.07 72.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.161 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.18 -27.48 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -69.66 -28.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.574 0.702 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.712 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.4 pt -85.75 -15.19 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.515 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 58.31 -93.81 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 123.908 0.755 . . . . 0.0 112.95 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.948 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.07 37.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.115 0.566 . . . . 0.0 111.187 176.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 77.76 9.47 86.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 113.864 174.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.712 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.27 -42.33 0.86 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.185 174.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.948 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 34.0 tt0 -51.67 -30.96 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -66.45 -47.89 71.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 39' ' ' GLY . 10.4 tp -69.37 -36.95 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.857 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.86 -34.32 77.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.339 0.59 . . . . 0.0 110.18 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.149 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.432 HG13 ' HG3' ' A' ' 82' ' ' MET . 30.9 mm -74.14 -38.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.34 -174.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.25 64.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -77.24 -43.29 34.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.472 . . . . 0.0 109.729 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -54.92 -41.64 71.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.449 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.1 p -86.02 -38.04 18.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.289 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.73 2.98 52.76 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 48.2 t -79.51 139.72 37.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.307 0.575 . . . . 0.0 110.771 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -86.24 74.46 10.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.195 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -81.67 109.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.103 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -105.0 112.27 25.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 67' ' ' VAL . 39.2 mm -79.43 97.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 44.1 m -81.17 106.58 5.89 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.568 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.899 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 5.4 Cg_exo -77.86 -33.58 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.105 3.203 . . . . 0.0 113.157 -173.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.2 -25.87 42.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.991 0.425 . . . . 0.0 109.875 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.419 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.0 t 62.33 -154.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.901 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.39 108.16 0.22 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.22 -34.71 4.78 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.493 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 66' ' ' SER . 1.4 mm? -100.55 137.09 19.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 1.55 9.2 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.733 2.289 . . . . 0.0 111.912 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -111.11 -115.24 0.31 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.508 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.899 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 4.2 tpp180 -130.16 155.57 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.486 ' HB3' HD23 ' A' ' 62' ' ' LEU . 34.3 p -130.89 129.54 42.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.2 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 55' ' ' ILE . 60.9 t -114.55 130.99 67.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.127 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 p -97.91 128.25 44.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.588 0.709 . . . . 0.0 111.03 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.2 mm? -108.29 112.37 24.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.801 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.467 HG21 ' HA ' ' A' ' 18' ' ' THR . 2.3 m -150.86 155.37 39.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . 162.88 -71.3 0.21 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.382 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.71 161.36 24.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.27 -53.56 6.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.244 1.962 . . . . 0.0 112.558 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -71.23 -37.31 72.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.316 0.579 . . . . 0.0 110.714 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 14.2 m -72.85 -43.55 62.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.591 -171.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.467 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.4 p -70.13 -24.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 81' ' ' MET . 43.5 tp60 -82.01 -35.99 28.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.204 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' MET . 24.4 tptm -64.26 -45.92 86.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.69 0.757 . . . . 0.0 109.584 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.72 -48.21 75.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.284 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.576 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.1 mtmt -69.02 -21.51 64.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.993 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.602 ' HA ' ' CE ' ' A' ' 81' ' ' MET . 13.2 mmt -59.27 -47.56 84.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.9 0.381 . . . . 0.0 110.029 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.432 ' HG3' HG13 ' A' ' 45' ' ' ILE . 92.5 mmm -67.5 -45.77 74.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -59.42 -54.0 51.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.55 -35.13 78.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.483 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.31 -53.44 56.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.491 . . . . 0.0 110.793 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -76.66 -39.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.636 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.798 HG21 ' HD2' ' A' ' 24' ' ' TYR . 78.9 t -65.56 -31.86 55.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 t -78.02 -32.63 51.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.5 ptp180 -74.57 -16.37 60.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.889 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.01 -73.79 1.08 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.339 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.127 -179.47 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 47.9 m . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -36.42 117.37 0.48 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.57 1.148 . . . . 0.0 113.525 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' MET . 0.7 OUTLIER -121.27 137.33 54.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.596 170.101 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.48 71.75 0.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.793 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.77 -37.83 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.951 2.434 . . . . 0.0 112.819 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.664 HG22 ' HD2' ' A' ' 14' ' ' PRO . 8.9 mm -113.87 149.19 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.582 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 10.0 t60 -90.67 -41.72 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 12' ' ' ILE . 25.1 Cg_exo -41.79 171.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.629 2.886 . . . . 0.0 114.397 172.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -33.99 150.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.361 3.374 . . . . 0.0 114.833 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 55.7 Cg_endo -66.26 27.25 0.1 Allowed 'Trans proline' 0 N--CA 1.48 0.729 0 C-N-CA 124.265 3.31 . . . . 0.0 114.899 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -84.54 -8.16 59.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.412 0.625 . . . . 0.0 109.334 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -164.45 12.33 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.003 174.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 47.2 t -92.86 -99.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 15.7 ptp -68.71 78.07 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.644 0.735 . . . . 0.0 110.525 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -79.34 115.71 19.15 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.87 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.6 tp10 -95.16 118.77 32.52 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HB3' ' N ' ' A' ' 7' ' ' SER . 10.0 tp10 -105.1 106.24 16.64 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.539 -0.865 . . . . 0.0 108.861 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.503 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -91.66 124.96 36.21 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.133 -167.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.65 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 19.2 mtp180 -90.3 99.44 12.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.202 174.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -116.1 122.27 32.55 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.559 -175.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.48 145.85 44.93 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.796 2.331 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' HG12 ' A' ' 31' ' ' VAL . 1.4 p-10 -61.95 -28.75 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.306 -169.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -28.95 61.23 Favored Glycine 0 C--O 1.238 0.399 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.507 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.561 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 20.4 mmt -78.67 -31.27 46.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.344 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.674 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -69.99 -34.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.648 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.78 -30.36 69.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.556 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.44 HD12 ' HE2' ' A' ' 30' ' ' MET . 49.9 mt -87.81 -23.86 23.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 31' ' ' VAL . 10.2 tp -71.49 -30.23 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.654 0.74 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.701 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.7 pt -83.13 -14.79 11.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 -91.83 0.11 Allowed Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.214 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 14.3 ptp180 -76.74 -0.02 22.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.0 111.275 -176.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.67 10.39 8.53 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.811 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.701 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 158.01 -55.54 0.37 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.578 173.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 26.4 mm-40 -59.3 -23.92 62.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -59.99 -52.86 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.081 0.855 . . . . 0.0 110.576 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.596 HD11 HG11 ' A' ' 53' ' ' VAL . 6.3 tp -62.02 -45.33 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.021 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -54.7 -37.13 65.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.439 0.462 . . . . 0.0 110.745 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 40' ' ' GLU . 68.0 mttm -72.28 -41.76 66.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.198 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.21 -48.69 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 111.664 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.32 -31.46 71.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.069 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -74.09 -36.26 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.21 0.528 . . . . 0.0 109.879 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.38 -32.25 73.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.053 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 8.0 p -96.87 -40.35 8.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.839 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.99 27.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.712 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 32.0 t -79.99 136.68 36.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.117 0.484 . . . . 0.0 110.734 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -84.22 72.17 10.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 42' ' ' ILE . 44.6 t -83.14 106.81 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.972 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -104.21 110.65 22.94 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.136 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.502 HD13 HG13 ' A' ' 67' ' ' VAL . 48.1 mm -79.78 112.62 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.679 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.489 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 2.6 m -94.82 102.05 8.25 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.084 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 86.7 Cg_endo -76.56 -21.36 13.1 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.982 2.455 . . . . 0.0 112.581 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.95 -41.77 25.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.025 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.613 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 9.0 t 73.78 -64.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.746 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 -76.5 2.2 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.143 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.77 -8.25 84.69 Favored Glycine 0 CA--C 1.511 -0.189 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.853 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.65 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.7 mt -121.16 146.82 45.32 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.65 -20.7 10.48 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.61 2.206 . . . . 0.0 110.242 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -93.05 -163.94 1.11 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.752 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.674 ' HG2' HG21 ' A' ' 31' ' ' VAL . 6.0 tpp180 -92.18 147.01 23.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.561 ' HB3' HD12 ' A' ' 62' ' ' LEU . 78.0 p -117.91 141.66 48.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.674 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.502 HG13 HD13 ' A' ' 55' ' ' ILE . 87.7 t -137.68 120.94 20.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.382 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 p -92.46 125.5 37.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.604 0.716 . . . . 0.0 111.497 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.7 mm? -105.23 120.01 40.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.19 155.74 40.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.11 -121.21 1.01 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.198 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.528 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -119.45 164.01 24.01 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 89.3 Cg_exo -47.72 -46.33 21.45 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.573 2.182 . . . . 0.0 112.695 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -75.47 -46.64 31.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.923 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.667 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 1.5 m -61.51 -48.65 80.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.281 -173.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.0 p -70.09 -24.26 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.381 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.76 -45.94 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -58.72 -48.69 80.3 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.36 0.6 . . . . 0.0 110.187 176.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.16 -52.09 67.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.886 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.789 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.0 mtmt -68.39 -21.97 64.66 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.253 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 10.6 ptm -72.08 -32.49 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.846 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.6 mmt -66.77 -47.62 71.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 110.011 171.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.29 -52.27 66.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.737 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.98 -38.38 70.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.837 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.52 -60.39 3.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.541 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.598 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.8 mp -72.61 -37.73 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 111.727 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 24' ' ' TYR . 69.7 t -67.68 -26.1 34.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.781 -0.574 . . . . 0.0 111.113 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t -75.67 -34.66 60.48 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.387 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.598 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -77.48 -12.87 60.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.077 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.84 -55.97 0.82 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.546 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 121.043 0.449 . . . . 0.0 110.562 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 21' ' ' THR . 26.1 mt-30 -147.92 -93.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp 172.97 -173.4 0.05 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.376 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' C ' ' A' ' 19' ' ' SER . . . -143.52 114.89 0.86 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.076 172.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 -24.79 26.01 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.874 2.383 . . . . 0.0 113.269 -174.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.6 HD12 ' HG2' ' A' ' 14' ' ' PRO . 17.0 pt -121.67 164.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.157 0.503 . . . . 0.0 111.098 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.664 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 63.4 m80 -90.09 -19.11 0.24 Allowed Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 73.2 Cg_exo -39.5 167.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.601 2.2 . . . . 0.0 114.077 168.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 17' ' ' ARG . 7.0 Cg_endo -49.29 165.61 0.22 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.371 2.714 . . . . 0.0 113.057 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' A' ' 73' ' ' PRO . 31.3 Cg_endo -63.75 34.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.061 3.174 . . . . 0.0 114.723 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 15' ' ' PRO . 12.4 ptm180 -86.21 0.3 54.04 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 12' ' ' ILE . 12.7 t -178.92 -12.77 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.011 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.582 ' C ' ' HA3' ' A' ' 10' ' ' GLY . 12.6 t -79.59 1.6 25.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.5 ptm -164.26 72.73 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.591 . . . . 0.0 110.732 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 48.4 m -79.13 122.22 25.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.586 ' HG2' ' HD2' ' A' ' 24' ' ' TYR . 1.6 tt0 -102.28 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.977 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -91.09 103.38 16.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.586 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -92.37 127.3 37.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.399 -172.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 63.9 mtp180 -81.59 111.46 17.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.294 0.568 . . . . 0.0 110.751 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.793 HG11 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -128.65 121.64 21.24 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.855 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 33.9 Cg_endo -68.55 151.38 75.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.932 1.755 . . . . 0.0 110.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -37.75 64.86 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -166.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.42 80.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.478 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.515 ' HB2' HG23 ' A' ' 26' ' ' VAL . 32.0 mmt -78.42 -15.99 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 34' ' ' ILE . 40.3 t -70.01 -44.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.31 -31.73 80.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.089 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.505 HD12 ' CE ' ' A' ' 30' ' ' MET . 45.2 mt -88.37 -23.24 23.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -71.11 -29.75 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.357 0.599 . . . . 0.0 109.508 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -85.37 -15.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.284 170.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.35 -90.6 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.498 0 O-C-N 124.401 1.063 . . . . 0.0 112.429 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 16.2 ptt-85 -76.69 48.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.884 -0.658 . . . . 0.0 111.579 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.83 11.79 61.11 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.902 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.702 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.03 -42.0 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.292 -1.433 . . . . 0.0 113.534 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.59 -32.23 66.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.4 tt0 -61.72 -52.48 64.12 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.439 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.539 HD11 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -62.0 -41.27 90.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.521 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -58.1 -48.17 80.99 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -60.13 -40.49 89.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.909 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.636 HD13 ' HG3' ' A' ' 82' ' ' MET . 87.8 mt -70.89 -50.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.448 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -26.96 62.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -175.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -78.46 -35.99 45.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.164 0.507 . . . . 0.0 110.218 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -42.74 99.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.857 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.768 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 11.9 p -84.88 -38.79 19.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.26 11.35 31.83 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.435 ' N ' ' HB3' ' A' ' 75' ' ' SER . 51.2 t -86.45 154.51 21.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.213 0.53 . . . . 0.0 110.28 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -105.58 71.58 0.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.054 0.93 . . . . 0.0 109.241 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.539 HG11 HD11 ' A' ' 42' ' ' ILE . 37.3 t -81.99 119.34 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.174 -175.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 14.4 mm-40 -113.69 120.4 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.4 mm -83.61 93.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 t -79.71 110.89 17.38 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.1 Cg_exo -80.85 -9.39 13.16 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.654 2.902 . . . . 0.0 111.157 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 -37.91 46.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.902 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.556 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 11.2 m 70.03 -59.64 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.161 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.56 -87.65 1.46 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.775 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -87.66 3.25 86.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 66' ' ' SER . 5.1 mp -124.19 139.55 32.97 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -170.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -87.19 -24.17 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.794 2.329 . . . . 0.0 111.972 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.855 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -88.44 -84.16 0.21 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.677 -175.13 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 5.4 tpp85 -160.61 153.92 21.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.662 ' HB3' HD22 ' A' ' 62' ' ' LEU . 88.3 p -124.55 130.24 52.08 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.235 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.793 HG23 HG11 ' A' ' 26' ' ' VAL . 85.8 t -105.11 115.7 47.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 72.2 m -79.76 120.32 23.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.366 0.603 . . . . 0.0 109.806 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.9 HD13 ' HG2' ' A' ' 80' ' ' LYS . 27.1 mt -113.27 105.01 12.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -150.12 145.12 26.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.218 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.33 -98.32 0.11 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 119.741 -1.219 . . . . 0.0 113.607 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -138.06 165.04 36.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 93.0 Cg_exo -45.06 -66.12 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.066 2.511 . . . . 0.0 113.46 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.75 -39.99 80.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.458 0.647 . . . . 0.0 110.235 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.768 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 7.1 m -59.64 -46.19 89.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.709 -173.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.638 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.2 p -73.74 -31.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.879 -173.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.79 -42.26 86.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.048 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 81' ' ' MET . 2.4 tmtp? -70.29 -42.26 72.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.688 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.26 93.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.0 111.414 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.9 ' HG2' HD13 ' A' ' 69' ' ' LEU . 5.1 mtmp? -81.19 -21.22 39.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.6 tpt -60.32 -47.49 85.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 173.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.636 ' HG3' HD13 ' A' ' 45' ' ' ILE . 18.9 mmt -68.17 -37.62 81.2 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 176.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.737 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.2 mm? -59.44 -49.84 76.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.28 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.15 -42.63 66.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.735 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.87 -56.5 20.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.661 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.6 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -71.27 -41.15 74.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.045 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 24' ' ' TYR . 60.7 t -63.56 -23.87 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 O-C-N 121.886 -0.509 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.9 m -85.07 -26.01 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 15.4 ptp180 -77.04 -12.94 60.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.148 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.28 -39.92 1.45 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.693 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.611 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 0.0 110.945 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 21' ' ' THR . 26.8 mt-30 -64.98 109.5 2.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.304 0.573 . . . . 0.0 111.815 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -84.8 133.53 34.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.91 77.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.847 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.96 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.734 2.289 . . . . 0.0 112.207 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -109.03 157.89 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.553 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 54.6 t60 -91.02 -26.98 0.3 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 49.7 Cg_exo -37.12 166.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 123.441 2.76 . . . . 0.0 115.097 170.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.13 153.92 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.776 2.984 . . . . 0.0 113.879 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 38.6 Cg_endo -64.54 12.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.416 3.411 . . . . 0.0 114.3 -174.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 17' ' ' ARG . 3.8 ptp180 -64.9 -24.5 67.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.225 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -154.1 -5.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.947 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.408 ' OG ' ' HA ' ' A' ' 16' ' ' PRO . 27.1 p -79.79 -90.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.061 -0.4 . . . . 0.0 111.433 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.5 ptm -70.45 76.15 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.629 0.728 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 HG23 ' A' ' 70' ' ' THR . 24.8 m -84.53 116.21 23.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.336 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.93 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 5.5 tp10 -92.66 118.2 30.79 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -97.26 101.92 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -95.09 121.08 36.35 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.726 -171.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.422 ' HD3' HD22 ' A' ' 62' ' ' LEU . 82.9 mtt180 -81.94 123.81 29.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.544 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -136.44 124.23 14.74 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.575 -175.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.679 ' HG2' ' HA ' ' A' ' 91' ' ' ARG . 35.8 Cg_exo -59.48 152.93 58.03 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.858 2.372 . . . . 0.0 113.338 -175.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' VAL . 24.2 t70 -50.11 -52.12 37.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.1 70.43 Favored Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.075 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.49 ' SD ' HG23 ' A' ' 86' ' ' ILE . 47.7 tpp -79.26 -27.61 42.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.639 -0.33 . . . . 0.0 110.695 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.2 p -74.59 -25.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.49 -24.98 73.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.874 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.0 mt -87.76 -24.69 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.2 tp -70.92 -32.71 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.596 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.3 pt -82.97 -14.6 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.15 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.16 -94.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.608 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 9.7 ptm180 -63.17 -10.32 14.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.589 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.08 4.96 5.84 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.08 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.79 -53.1 0.4 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.134 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 41.2 tt0 -55.43 -20.73 13.22 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.12 -53.16 61.54 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.865 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.537 HD11 HG11 ' A' ' 53' ' ' VAL . 11.2 tp -65.73 -36.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.918 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.47 -41.25 89.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.155 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -60.67 -56.78 17.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.843 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' CG1' ' HG2' ' A' ' 82' ' ' MET . 1.5 mp -54.61 -56.63 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.159 -176.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -70.03 -34.61 73.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -170.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -79.62 -35.49 39.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 110.327 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.99 -26.63 66.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.368 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 p -95.06 -40.58 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.743 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.31 18.23 9.34 Favored Glycine 0 CA--C 1.505 -0.567 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.809 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.95 160.96 14.2 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 0.0 111.978 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 46.3 mtmt -101.3 76.25 1.69 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.16 173.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 42' ' ' ILE . 41.8 t -90.4 109.05 20.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.697 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -113.02 137.8 50.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.65 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.3 116.29 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.291 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -95.01 107.1 29.37 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.227 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 1.002 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 81.9 Cg_endo -78.62 -30.15 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.89 2.393 . . . . 0.0 112.805 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.73 -44.44 23.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.8 t 68.65 -68.33 0.18 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.893 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.9 -86.69 0.46 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.595 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.24 -1.1 90.45 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.132 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 66' ' ' SER . 48.8 mt -119.2 135.81 24.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.96 -17.36 17.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.687 2.258 . . . . 0.0 110.459 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.7 pt-20 -94.26 -162.44 0.94 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.101 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 1.002 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -99.64 156.64 16.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.682 ' HB3' HD12 ' A' ' 62' ' ' LEU . 24.7 p -128.64 135.82 49.82 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.693 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.08 129.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.565 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.1 m -91.72 127.62 37.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.349 0.595 . . . . 0.0 111.146 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 4.2 mm? -108.1 117.63 34.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.325 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.429 HG23 HG23 ' A' ' 21' ' ' THR . 0.6 OUTLIER -150.34 156.6 41.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.021 176.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.17 -152.21 23.65 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.785 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -80.37 159.54 69.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 6.3 Cg_endo -49.08 -50.0 13.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.755 2.303 . . . . 0.0 112.368 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.33 -44.8 82.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.408 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.611 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 9.7 m -62.03 -54.61 39.07 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.034 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -25.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.302 -172.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 81' ' ' MET . 51.1 tt0 -71.45 -50.58 30.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -57.7 -50.73 72.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.754 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . . . -54.17 -48.31 71.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.134 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.735 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 38.3 mtmt -67.09 -21.5 65.87 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.381 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 94.0 mtp -66.85 -41.45 87.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.459 ' HG2' ' CG1' ' A' ' 45' ' ' ILE . 2.6 mpt? -65.91 -47.43 74.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.711 0.291 . . . . 0.0 111.048 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.479 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.3 mm? -57.95 -55.56 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.943 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.7 -44.71 77.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.554 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.24 -53.32 55.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.517 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.751 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 2.0 mp -75.29 -45.25 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.713 -175.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 24' ' ' TYR . 84.7 t -61.82 -40.19 86.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.076 0.465 . . . . 0.0 110.717 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -72.83 -28.5 62.58 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.056 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.751 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -73.28 -21.93 60.49 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.836 -178.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.02 63.27 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.048 -1.549 . . . . 0.0 114.608 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HA ' ' HG2' ' A' ' 27' ' ' PRO . 36.1 ttt180 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 117.697 0.748 . . . . 0.0 109.744 170.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.874 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 40.1 m . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 7' ' ' SER . 26.1 mt-30 -178.77 -103.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.339 1.055 . . . . 0.0 108.668 166.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 38.1 tp 158.83 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.399 1.062 . . . . 0.0 109.082 176.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 152.94 108.11 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.237 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.2 -8.54 23.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.824 2.349 . . . . 0.0 112.013 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.618 HD12 HG21 ' A' ' 18' ' ' THR . 1.0 OUTLIER -114.44 142.62 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.812 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.704 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 18.7 t-80 -92.55 -11.1 0.17 Allowed Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -172.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.4 Cg_endo -56.4 -175.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.515 2.144 . . . . 0.0 113.15 176.582 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 14' ' ' PRO . 1.8 Cg_endo -44.22 153.7 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.885 2.39 . . . . 0.0 112.962 174.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 36.7 Cg_endo -65.46 33.81 0.11 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 124.286 3.324 . . . . 0.0 115.254 -174.422 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -84.56 7.2 20.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.626 0.726 . . . . 0.0 109.213 175.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 12' ' ' ILE . 8.9 t -176.02 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.127 175.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.555 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 1.8 m -86.41 9.66 17.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.001 -178.062 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.672 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 18.5 mmt -146.47 31.23 0.99 Allowed 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.002 177.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 85.7 m -78.92 114.51 17.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.874 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 19.8 tt0 -121.64 118.86 30.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.818 176.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -87.63 110.65 20.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.486 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.34 124.0 34.03 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.81 -166.251 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.839 ' HG2' HD21 ' A' ' 62' ' ' LEU . 48.9 mtm180 -81.86 103.73 11.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.302 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.3 124.59 26.81 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.508 -175.993 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.0 148.09 78.68 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.424 2.083 . . . . 0.0 111.644 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 31' ' ' VAL . 37.8 t70 -54.47 -51.43 65.07 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.85 -24.52 70.01 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.838 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.457 ' SD ' HD23 ' A' ' 33' ' ' LEU . 30.4 tpp -79.32 -29.64 42.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.477 -0.361 . . . . 0.0 110.828 -175.324 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 34' ' ' ILE . 13.4 p -70.99 -26.32 27.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -30.12 75.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.421 169.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD23 ' SD ' ' A' ' 30' ' ' MET . 64.3 tp -84.15 -31.01 25.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 177.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.5 tp -70.39 -26.42 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.667 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 8.5 pt -81.42 -14.38 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.557 174.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.7 -92.19 0.1 Allowed Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.316 172.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.762 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -77.34 20.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.86 0.464 . . . . 0.0 111.393 -179.458 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.89 58.88 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.042 177.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.667 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 154.53 -45.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.388 176.094 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.762 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 49.6 tt0 -56.59 -29.09 61.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.024 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' HG12 ' A' ' 45' ' ' ILE . 25.4 tt0 -62.43 -53.24 57.8 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.442 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 53' ' ' VAL . 8.6 tp -62.95 -38.71 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.261 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.97 -42.99 99.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -58.51 -43.2 89.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.602 176.064 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.6 mm -69.96 -50.93 44.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.912 -176.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.24 -31.92 68.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 -174.688 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -76.04 -38.36 57.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 110.17 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 11.9 t70 -62.82 -50.57 70.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.851 178.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 p -70.85 -45.52 64.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.73 -4.36 26.04 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.464 -176.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 41.6 t -79.12 135.16 36.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.11 0.481 . . . . 0.0 110.099 178.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -85.02 74.5 10.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.519 0.676 . . . . 0.0 110.104 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 42' ' ' ILE . 44.9 t -82.49 115.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.789 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.6 mm-40 -119.48 129.95 54.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.856 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.425 HD13 HG13 ' A' ' 67' ' ' VAL . 42.7 mm -83.95 109.12 17.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.754 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.525 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 7.3 m -82.4 111.33 27.43 Favored Pre-proline 0 C--O 1.242 0.662 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.576 -178.137 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.801 ' HA ' HH11 ' A' ' 65' ' ' ARG . 60.8 Cg_endo -73.01 -27.73 13.76 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.949 2.433 . . . . 0.0 111.858 178.094 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.46 88.39 2.72 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.855 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 5.3 p -65.6 -39.2 91.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.238 -175.024 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.01 -61.51 4.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.729 174.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.613 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -93.86 4.88 72.36 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.817 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.855 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.8 mp -127.71 151.38 75.3 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.36 -0.42 . . . . 0.0 109.941 -170.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -90.89 -4.4 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.696 2.264 . . . . 0.0 111.072 171.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 91' ' ' ARG . 1.6 pt-20 -119.52 -153.27 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.962 -177.335 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.801 HH11 ' HA ' ' A' ' 57' ' ' PRO . 14.6 tpp180 -91.97 157.86 16.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.772 ' HB3' HD22 ' A' ' 62' ' ' LEU . 56.9 p -131.96 153.41 50.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.642 174.161 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 HD13 ' A' ' 55' ' ' ILE . 57.5 t -135.19 131.75 52.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.2 m -89.87 127.66 36.04 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.284 177.49 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.751 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -110.57 107.48 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 175.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -152.54 134.64 14.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.61 -147.39 7.84 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.846 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.6 160.2 70.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . 99.9 Cg_exo -45.06 -56.51 2.66 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.033 2.489 . . . . 0.0 114.237 -174.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -84.15 -30.98 25.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.956 -178.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 m -62.38 -43.33 99.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.007 0.432 . . . . 0.0 110.696 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.8 p -66.86 -27.77 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.546 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.4 tp-100 -73.52 -50.28 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.126 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -54.2 -43.89 71.14 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.207 0.527 . . . . 0.0 110.566 178.798 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.71 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.562 176.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.751 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 9.8 mtmp? -66.16 -21.23 66.32 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.854 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.4 mmm -67.7 -43.41 80.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.83 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.0 mmm -66.73 -34.55 78.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 175.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.37 -49.09 65.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -51.3 -44.59 61.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.614 177.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 10.5 t70 -64.08 -61.04 2.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.682 -178.249 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.455 ' HB ' HD13 ' A' ' 34' ' ' ILE . 1.9 mp -66.68 -40.51 86.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.27 -174.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 24' ' ' TYR . 77.3 t -67.82 -26.86 35.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.502 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.4 t -72.79 -26.25 61.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.815 0.341 . . . . 0.0 110.239 175.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 25.5 mmt180 -63.6 -41.91 98.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.21 0.529 . . . . 0.0 109.671 176.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.45 -59.51 1.72 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.721 178.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.44 HH21 ' CD ' ' A' ' 64' ' ' GLU . 33.2 mmt180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.469 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.2 t . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.444 0.164 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -155.93 143.49 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.099 0.476 . . . . 0.0 110.889 -177.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -134.65 98.56 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 67.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 172.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.12 -11.86 14.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.917 2.411 . . . . 0.0 111.826 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.541 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 23.2 pt -124.97 154.9 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.692 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 49.4 t-80 -89.45 -22.1 0.27 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 23.8 Cg_exo -42.23 168.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.692 2.262 . . . . 0.0 114.474 174.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 17' ' ' ARG . 65.4 Cg_exo -41.25 157.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.758 2.972 . . . . 0.0 114.36 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 35.1 Cg_endo -66.83 28.6 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.901 3.067 . . . . 0.0 114.357 -175.171 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 15' ' ' PRO . 88.4 mtt180 -73.19 -26.69 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.496 HG23 HD11 ' A' ' 12' ' ' ILE . 2.7 t -158.36 10.16 0.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.353 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.5 t -101.07 -12.51 18.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.391 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 21.8 mmt -134.33 34.46 3.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 -176.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 87.3 m -79.68 112.19 16.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 14.4 tt0 -111.01 119.09 37.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -96.61 103.21 15.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -91.81 118.68 30.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.973 -166.853 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 32.4 mtm180 -81.78 114.74 20.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.776 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.1 p -135.45 131.87 19.62 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.065 -173.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.614 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 38.2 Cg_exo -61.8 146.28 96.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.905 2.403 . . . . 0.0 111.555 177.672 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.402 ' HA ' HG12 ' A' ' 31' ' ' VAL . 2.6 p-10 -59.89 -30.32 68.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.405 -172.086 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.62 -33.24 56.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.177 176.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.736 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 83.7 mmm -78.82 -29.48 44.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.904 -0.174 . . . . 0.0 110.795 -176.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.0 p -69.72 -31.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.358 173.051 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.58 70.38 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.431 171.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.76 -23.65 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.9 tp -72.37 -27.32 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.457 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.615 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.6 pt -85.18 -14.75 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.155 171.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.42 -97.78 0.1 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.362 173.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 14.2 ptm180 -58.99 -22.39 60.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.097 0.559 . . . . 0.0 111.63 178.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -7.63 1.83 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.785 177.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 167.85 -48.36 0.24 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.256 176.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 28.3 tt0 -59.96 -21.64 61.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -171.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -60.26 -55.32 35.14 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.316 0.507 . . . . 0.0 110.582 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.84 -38.66 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.76 -36.83 79.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 28.1 tptp -63.04 -58.64 6.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.125 176.501 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.47 -41.37 87.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.259 -174.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.1 pp0? -71.85 -40.32 69.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.85 -176.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -73.76 -30.29 62.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.347 0.594 . . . . 0.0 110.537 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 13.0 t70 -69.12 -43.99 73.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.716 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 39.4 p -80.03 -35.36 37.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 7.19 30.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.626 -177.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 33.9 t -90.71 141.47 28.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -94.05 89.09 5.9 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.238 0.542 . . . . 0.0 109.657 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.37 106.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.745 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -106.0 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -175.255 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.452 HD13 HG13 ' A' ' 67' ' ' VAL . 43.1 mm -78.9 116.94 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 t -107.76 112.91 61.81 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 111.133 -177.235 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 18.6 Cg_exo -66.89 -37.49 19.78 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.357 2.705 . . . . 0.0 111.306 175.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -80.11 83.28 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.4 m -76.31 4.19 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.11 -169.289 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.16 -92.91 1.07 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.826 169.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.8 -11.26 58.08 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.553 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 59' ' ' SER . 3.0 mm? -103.78 142.87 25.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.1 -18.75 2.18 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.752 2.301 . . . . 0.0 112.502 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -83.41 -86.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.391 -175.253 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HB3' HG13 ' A' ' 26' ' ' VAL . 1.3 tpp180 -160.27 154.31 23.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 176.752 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 22.1 t -139.35 143.8 37.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 55' ' ' ILE . 46.3 t -129.84 134.95 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.189 -175.305 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.8 m -92.49 128.69 38.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.422 0.63 . . . . 0.0 111.557 177.81 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.662 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.6 mm? -110.48 112.91 25.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.579 177.154 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -151.5 148.22 27.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.042 176.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.65 -131.58 2.4 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.601 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.6 162.99 18.53 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.34 -48.58 19.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.823 2.349 . . . . 0.0 113.376 -174.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.48 -41.19 40.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 29.4 p -65.5 -41.56 93.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.454 0.645 . . . . 0.0 110.34 -174.208 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.15 -26.57 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.773 -176.781 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 81' ' ' MET . 47.6 mt-30 -82.62 -34.04 27.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.608 177.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -65.84 -43.79 87.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.671 0.748 . . . . 0.0 109.684 176.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.36 78.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.104 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.2 mtmt -77.05 -19.94 56.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.039 -174.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -57.05 -55.04 39.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.879 173.214 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.75 -35.87 82.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.2 mm? -65.99 -56.85 9.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -177.563 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -52.86 -40.86 63.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.571 179.225 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.532 ' HB3' HD12 ' A' ' 86' ' ' ILE . 7.4 t70 -53.52 -60.03 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.335 -178.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 89' ' ' ARG . 2.5 mp -76.25 -44.37 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.683 -175.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 26' ' ' VAL . 98.8 t -59.1 -39.8 79.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.52 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 t -70.2 -39.11 75.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.804 -179.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 11.4 ptt180 -77.33 -7.47 56.09 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.526 -176.099 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.736 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -121.85 0.74 10.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.681 174.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.562 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.8 t . . . . . 0 C--O 1.224 -0.283 0 CA-C-O 120.002 -0.047 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -149.01 136.46 20.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.282 0.563 . . . . 0.0 111.599 -177.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.845 ' HG ' ' HD3' ' A' ' 11' ' ' PRO . 57.1 tp -115.28 136.29 53.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.088 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.26 63.76 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.653 177.918 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.845 ' HD3' ' HG ' ' A' ' 9' ' ' LEU . 93.3 Cg_endo -86.47 -19.78 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.306 2.004 . . . . 0.0 112.124 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.605 HG22 ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -127.06 138.66 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.218 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.698 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 t-80 -91.71 -15.68 0.21 Allowed Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 22.6 Cg_endo -56.34 178.99 0.11 Allowed 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.201 1.934 . . . . 0.0 113.031 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 59.5 Cg_exo -40.18 153.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.404 2.736 . . . . 0.0 114.188 179.077 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 73.8 Cg_endo -71.04 34.88 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.097 3.198 . . . . 0.0 113.283 -175.187 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -84.87 -20.16 31.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -164.56 23.24 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.505 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 34.5 t -101.16 -90.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.749 -176.477 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptm -79.2 79.79 5.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.157 0.503 . . . . 0.0 110.909 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 9' ' ' LEU . 89.2 m -84.92 114.94 22.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.305 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 7' ' ' SER . 13.0 tt0 -94.4 117.95 30.89 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.82 106.25 18.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.529 0.681 . . . . 0.0 109.277 -179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.624 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.88 120.98 33.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.191 -172.733 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.781 ' HG2' HD21 ' A' ' 62' ' ' LEU . 70.5 mtm180 -86.26 101.31 12.94 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.589 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.773 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.4 p -116.44 129.24 25.4 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.8 Cg_exo -57.23 150.29 58.79 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.536 2.824 . . . . 0.0 112.338 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.35 -44.72 84.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -175.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.76 64.35 Favored Glycine 0 C--O 1.237 0.305 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.875 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.553 ' HG2' ' HA3' ' A' ' 90' ' ' GLY . 31.1 tpp -78.54 -28.65 46.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.828 -175.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.598 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -74.34 -25.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.96 -32.09 69.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.763 168.058 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.1 mt -82.05 -22.12 36.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 172.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 31' ' ' VAL . 8.7 mm -61.36 -44.96 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 122.05 0.928 . . . . 0.0 108.674 174.223 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 4.8 pt -82.11 -14.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.787 175.086 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.18 -88.55 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.021 170.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.862 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 3.1 ptm180 -74.05 0.87 12.38 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.746 0.418 . . . . 0.0 110.998 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.18 -5.44 10.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.138 174.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 160.37 -41.46 0.44 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.722 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.862 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 1.5 tm-20 -58.83 -35.57 73.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.378 0.271 . . . . 0.0 111.199 -175.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.12 -47.1 86.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.496 0.189 . . . . 0.0 110.854 -171.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 tp -68.2 -36.32 74.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.224 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -62.46 -37.87 87.61 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -61.61 -54.49 42.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.499 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.53 -45.61 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.245 0.545 . . . . 0.0 111.594 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.509 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 23.4 mt-30 -58.33 -45.45 88.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.42 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -69.12 -42.55 75.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.023 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.7 -46.24 84.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.448 177.509 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.0 p -78.37 -47.48 17.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.583 -177.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.64 6.07 53.16 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 51.1 t -84.72 143.45 29.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.568 . . . . 0.0 110.631 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -89.98 77.66 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.317 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.509 ' HB ' ' OE1' ' A' ' 46' ' ' GLN . 26.1 t -82.13 107.73 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.123 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.69 106.58 18.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -176.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.467 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.8 mm -88.03 94.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.3 m -91.88 106.07 15.91 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.707 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.679 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 8.3 Cg_exo -72.59 -34.35 7.34 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -176.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.21 -12.14 59.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.695 178.263 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 11.9 p 47.58 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 176.142 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.08 -75.41 0.35 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.002 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.545 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -81.63 0.23 88.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.766 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.781 HD21 ' HG2' ' A' ' 25' ' ' ARG . 7.6 mp -127.48 145.7 55.59 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.943 -170.111 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 43.4 Cg_endo -86.57 -15.17 4.26 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.138 2.559 . . . . 0.0 112.749 176.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.753 ' OE1' ' HB3' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.86 -102.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.947 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.773 ' HB3' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -135.64 131.12 35.37 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.269 -0.27 . . . . 0.0 110.381 -176.253 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.622 ' HB3' HD22 ' A' ' 62' ' ' LEU . 85.8 p -108.72 112.95 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 55' ' ' ILE . 92.9 t -103.16 119.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.112 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.5 m -88.95 126.4 35.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.314 0.578 . . . . 0.0 110.851 176.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.742 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.0 mm? -102.27 104.06 14.57 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.492 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -151.44 148.29 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.766 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.25 -93.96 0.1 OUTLIER Glycine 0 C--O 1.226 -0.347 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.134 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -143.02 161.97 45.78 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 84.1 Cg_exo -46.44 -55.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.194 2.596 . . . . 0.0 113.535 -175.168 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.74 -33.02 25.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 110.272 -178.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -64.68 -45.06 88.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.293 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.7 p -70.06 -26.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.558 -175.332 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.96 -43.97 67.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 81' ' ' MET . 23.4 tptm -66.15 -44.07 85.18 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -54.18 -48.78 70.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.2 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.742 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 33.0 mtmt -71.13 -25.02 62.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.565 -177.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.694 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 4.2 ppp? -70.18 -30.56 67.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.868 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.7 mmm -77.43 -36.17 53.41 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.755 172.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.6 mm? -63.73 -49.1 74.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.89 -44.05 86.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.886 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.1 -59.36 4.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.458 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.534 HG23 ' SD ' ' A' ' 30' ' ' MET . 1.6 mp -72.45 -45.16 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.119 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.624 HG21 ' HD2' ' A' ' 24' ' ' TYR . 9.1 t -67.2 -28.69 43.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 122.043 -0.411 . . . . 0.0 111.322 -176.397 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.4 t -69.47 -41.34 76.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.023 174.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 12.2 ptp180 -73.7 -13.23 60.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 110.473 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.553 ' HA3' ' HG2' ' A' ' 30' ' ' MET . . . -95.98 -39.45 4.32 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.987 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 27' ' ' PRO . 8.1 ptp180 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.784 0.326 . . . . 0.0 111.398 -178.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.872 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 20.4 m . . . . . 0 C--O 1.225 -0.204 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.63 96.18 8.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.81 0.338 . . . . 0.0 111.75 -172.007 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 21' ' ' THR . 91.1 mt -123.38 92.55 3.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.466 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.89 73.3 0.39 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.204 178.05 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.57 -63.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.11 2.54 . . . . 0.0 112.541 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.943 HG12 ' HD2' ' A' ' 14' ' ' PRO . 10.1 tt -99.51 154.92 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.716 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 15.6 m-70 -91.83 -20.78 0.24 Allowed Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -172.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.943 ' HD2' HG12 ' A' ' 12' ' ' ILE . 23.9 Cg_exo -39.94 171.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.319 2.68 . . . . 0.0 114.833 170.235 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.02 156.6 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.224 2.616 . . . . 0.0 113.538 177.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 36.8 Cg_endo -65.21 11.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.226 3.284 . . . . 0.0 114.371 -175.015 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -62.51 -24.05 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 110.293 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 19' ' ' SER . 12.7 t -157.75 -11.01 0.08 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.718 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 14.0 m -79.86 -83.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.838 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptp -74.56 73.05 1.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.493 0.663 . . . . 0.0 110.193 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 18.0 m -79.41 131.63 36.15 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.843 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.872 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -94.26 117.37 30.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.309 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' SER . 40.9 tt0 -98.97 96.7 8.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.067 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.419 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.14 116.28 28.88 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.429 -167.669 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HG3' HH11 ' A' ' 25' ' ' ARG . 44.1 mtt85 -81.66 103.03 11.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.875 176.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.768 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -121.89 131.87 24.35 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.914 -174.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HG3' HH11 ' A' ' 91' ' ' ARG . 25.7 Cg_exo -62.98 135.99 54.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.761 2.308 . . . . 0.0 110.568 175.424 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.86 -36.84 49.82 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.367 -169.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -34.09 87.64 Favored Glycine 0 C--O 1.236 0.227 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.214 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 87.1 mmm -78.15 -13.36 59.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 34' ' ' ILE . 37.1 t -74.16 -40.9 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.445 173.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -27.78 71.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.226 174.215 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.26 -24.81 25.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.613 HD13 ' HB ' ' A' ' 86' ' ' ILE . 8.9 tp -74.22 -25.31 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.564 0.697 . . . . 0.0 109.673 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.597 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -89.33 -15.82 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.864 171.289 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -86.29 0.07 OUTLIER Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.603 174.265 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 9.0 ptp180 -79.58 -1.29 37.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.949 0.404 . . . . 0.0 111.07 -177.536 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.33 2.72 10.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.69 173.759 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.73 -49.66 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.066 175.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.5 tt0 -44.74 -42.81 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.052 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -58.7 -46.62 86.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -167.119 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.605 HD11 HG11 ' A' ' 53' ' ' VAL . 8.0 tp -65.47 -54.31 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.617 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.441 ' N ' HG23 ' A' ' 42' ' ' ILE . 39.5 m-80 -56.19 -42.17 76.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.439 -177.264 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.45 -47.48 83.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.684 -179.343 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.74 -45.24 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 2.1 pt20 -69.13 -43.18 74.92 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.575 -176.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.96 -36.58 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.407 -178.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.1 -50.07 74.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.958 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 p -72.78 -33.14 66.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.523 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.04 27.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.615 -178.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.641 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 15.2 t -79.73 152.36 29.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.985 0.422 . . . . 0.0 110.133 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -108.84 86.61 2.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 42' ' ' ILE . 44.7 t -103.9 111.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.085 0.469 . . . . 0.0 110.923 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.2 115.58 30.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.426 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.498 HD13 HG13 ' A' ' 67' ' ' VAL . 32.1 mm -81.85 94.47 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.524 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 42.1 m -79.25 114.79 47.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.951 0.405 . . . . 0.0 110.788 -178.547 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 4.3 Cg_exo -74.41 -40.62 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.668 2.912 . . . . 0.0 111.854 -177.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.43 78.77 2.71 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -61.69 -27.85 68.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.128 -175.73 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.97 -72.53 1.82 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -71.62 -14.03 74.9 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 177.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 2.5 mm? -123.89 138.88 31.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.2 -9.52 10.47 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.045 2.497 . . . . 0.0 111.257 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 2.2 pt-20 -101.16 -94.75 0.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.323 -173.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.768 ' HB3' HG13 ' A' ' 26' ' ' VAL . 3.6 tpp180 -150.03 148.25 28.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 175.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 59' ' ' SER . 68.4 p -122.85 112.47 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.119 0.485 . . . . 0.0 110.082 174.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 55' ' ' ILE . 99.7 t -98.58 115.81 39.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.716 179.1 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.1 m -86.14 131.51 34.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.141 0.496 . . . . 0.0 110.548 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 1.013 HD13 ' HG2' ' A' ' 80' ' ' LYS . 62.6 mt -120.33 116.91 26.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -179.331 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.65 156.44 40.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.403 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 151.48 -150.9 22.9 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.493 176.552 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.12 152.25 76.45 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.45 -49.94 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.104 2.536 . . . . 0.0 113.526 -175.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.1 -33.37 50.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 0.0 110.845 -178.404 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -70.06 -41.27 74.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.641 -178.047 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.676 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.5 p -68.47 -32.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -177.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.36 81.7 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -55.91 -45.44 78.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.343 0.592 . . . . 0.0 110.793 178.746 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.74 83.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.376 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 1.013 ' HG2' HD13 ' A' ' 69' ' ' LEU . 44.6 mtmt -82.39 -22.02 35.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -173.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.468 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 17.1 tpt -60.82 -49.59 76.85 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.655 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 93.4 mmm -68.37 -39.61 81.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.751 176.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.859 ' HG ' HD11 ' A' ' 69' ' ' LEU . 1.4 mm? -62.29 -59.63 4.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.02 -40.58 63.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.024 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -55.5 34.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.132 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.613 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.3 mp -80.6 -38.91 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.659 0.266 . . . . 0.0 111.704 -175.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 24' ' ' TYR . 92.2 t -60.02 -50.31 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.703 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -57.83 -48.6 79.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.682 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.2 ptp180 -61.49 -22.35 65.01 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.183 0.302 . . . . 0.0 111.587 -175.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.81 12.76 13.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.117 -1.04 . . . . 0.0 113.472 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.641 HH11 ' HG3' ' A' ' 27' ' ' PRO . 7.3 tpt180 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 117.309 0.554 . . . . 0.0 112.008 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -52.18 113.81 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.288 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.73 125.51 52.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.159 170.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.45 75.36 0.42 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.574 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.92 -64.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.684 2.256 . . . . 0.0 111.565 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.794 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 pt -104.77 141.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 177.601 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.563 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 56.3 m80 -96.26 31.42 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.496 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.794 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 18.7 Cg_endo -57.85 -163.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.36 0 C-N-CA 122.47 2.113 . . . . 0.0 112.798 161.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 10.2 Cg_endo -56.44 164.48 5.44 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.219 1.946 . . . . 0.0 112.208 168.848 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.76 33.69 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.816 3.01 . . . . 0.0 114.393 -175.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 18' ' ' THR . 10.6 ptp180 -92.69 14.59 16.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 9.4 t 171.47 -16.58 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.672 177.304 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.2 m -78.21 -11.48 59.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.471 ' HE3' HG11 ' A' ' 76' ' ' VAL . 11.7 ptt? -150.56 69.75 0.99 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.836 0.827 . . . . 0.0 109.19 167.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.2 m -78.53 115.3 18.14 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.248 177.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' SER . 8.1 tp10 -94.4 119.76 33.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -172.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -104.87 102.75 12.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -91.43 125.66 36.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.837 -169.536 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 59.7 mtm180 -82.65 102.48 11.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 175.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.737 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -125.14 126.72 25.17 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.778 -177.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 54.6 Cg_exo -54.82 148.24 47.06 Favored 'Trans proline' 0 CA--C 1.521 -0.169 0 C-N-CA 123.537 2.824 . . . . 0.0 111.815 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' HG12 ' A' ' 31' ' ' VAL . 28.8 t70 -59.63 -36.83 77.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.918 -175.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -34.34 61.9 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.384 175.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.6 tpp -78.95 -22.96 44.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.93 -175.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.74 HG21 ' HG2' ' A' ' 65' ' ' ARG . 3.7 p -76.85 -29.96 18.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.44 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.78 -26.93 67.6 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.851 169.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.63 -24.26 20.57 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 175.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.3 tp -68.92 -32.23 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.74 0.781 . . . . 0.0 109.693 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.598 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.3 pt -71.95 -12.12 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.367 174.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.84 -8.75 27.59 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.845 163.222 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.696 ' HD3' ' HB2' ' A' ' 40' ' ' GLU . 11.8 ptm180 -174.75 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.045 -174.284 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.85 -2.09 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.767 179.04 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.598 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.08 -37.23 0.61 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.82 -1.181 . . . . 0.0 112.653 174.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.696 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 3.5 mp0 -56.73 -40.93 76.62 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.624 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -59.48 -44.81 92.96 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -168.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.653 HD11 HG11 ' A' ' 53' ' ' VAL . 8.5 tp -64.03 -48.08 87.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.445 -177.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.3 m-20 -65.87 -33.39 75.74 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -60.55 -49.65 76.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.161 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.536 HG21 ' HG2' ' A' ' 82' ' ' MET . 1.8 mp -75.95 -40.71 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.798 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.56 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -70.55 -27.21 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.638 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.75 -40.48 40.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.66 -40.11 90.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.889 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 28.6 p -80.86 -42.78 20.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.235 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.99 1.19 36.11 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 44.5 t -79.9 139.25 37.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.242 178.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.21 79.33 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.357 0.599 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.653 HG11 HD11 ' A' ' 42' ' ' ILE . 44.9 t -89.73 123.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.348 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -118.51 133.78 55.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 -176.499 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 67' ' ' VAL . 43.3 mm -91.98 98.44 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 14.8 m -81.02 108.43 10.25 Favored Pre-proline 0 C--O 1.238 0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 -177.315 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 2.1 Cg_endo -83.85 -21.42 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.513 2.809 . . . . 0.0 112.693 -176.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.44 -38.3 35.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 t 68.94 -80.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.867 177.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.23 48.3 5.74 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.828 179.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.71 -30.8 0.56 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.569 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.8 mm? -113.47 143.22 28.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.84 8.39 4.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.666 2.244 . . . . 0.0 111.098 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 6.0 pt-20 -126.7 -154.21 0.61 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.435 -175.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.74 ' HG2' HG21 ' A' ' 31' ' ' VAL . 4.6 tpp180 -94.88 140.91 29.27 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 33.5 p -116.64 108.78 16.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 55' ' ' ILE . 94.1 t -96.74 114.69 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.123 -176.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -92.0 134.86 34.42 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.101 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.459 HD13 ' HG2' ' A' ' 80' ' ' LYS . 2.0 mp -125.8 128.73 48.13 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -152.09 146.98 25.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.41 -137.99 4.96 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.024 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.36 161.43 37.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.03 -56.89 2.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.501 2.134 . . . . 0.0 113.041 -175.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.05 -37.71 81.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.486 -178.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.3 m -68.03 -48.42 65.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.414 -176.25 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.561 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 5.5 p -69.12 -33.75 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.138 -174.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.56 -35.41 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.652 0.263 . . . . 0.0 110.442 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -60.49 -45.8 92.43 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.407 0.623 . . . . 0.0 109.846 176.361 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 53' ' ' VAL . . . -64.29 -35.96 82.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.348 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 50.0 mtmt -81.13 -22.91 38.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.246 0.546 . . . . 0.0 109.764 -176.237 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.2 ttt -65.11 -44.47 88.64 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.459 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.536 ' HG2' HG21 ' A' ' 45' ' ' ILE . 4.0 ppp? -73.2 -28.02 61.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.956 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -66.18 -55.37 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.585 177.396 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.53 -30.35 65.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.465 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.83 -60.79 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.192 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -73.0 -36.61 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -175.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.7 -21.68 28.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.186 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.2 t -72.34 -40.45 67.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 174.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 7.2 ptp180 -72.3 -17.35 61.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.754 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.15 -49.27 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.347 -178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 91' ' ' ARG . 15.6 mtp180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.516 ' HB2' ' HD3' ' A' ' 25' ' ' ARG . 12.1 p -153.8 156.52 37.85 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.132 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.3 m 72.9 -35.66 0.33 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.504 0.722 . . . . 0.0 112.229 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 19.3 mm-40 67.58 -68.2 0.16 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.116 0.966 . . . . 0.0 112.854 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.0 mt 70.89 -87.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.95 0.9 . . . . 0.0 111.231 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 99.41 0.25 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.177 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.2 -17.47 24.46 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.017 2.478 . . . . 0.0 112.131 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.84 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.1 tp -100.21 147.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.73 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 35.9 m-70 -90.77 -19.14 0.24 Allowed Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.84 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -36.21 163.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.447 2.765 . . . . 0.0 114.397 169.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -42.61 161.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.87 3.047 . . . . 0.0 114.06 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.74 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 18.1 Cg_endo -60.37 3.62 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.824 3.016 . . . . 0.0 114.523 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -59.32 -19.9 50.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.312 0.577 . . . . 0.0 109.519 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -151.11 -19.81 0.21 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.654 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 t -80.04 -2.53 44.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.067 0.46 . . . . 0.0 111.004 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.575 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.7 mmt -134.1 39.64 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.904 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 29.1 m -78.96 112.76 16.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.1 tp10 -114.16 117.31 30.86 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.2 tt0 -99.49 104.52 16.35 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -90.19 116.28 28.06 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.841 -168.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HD3' ' HB2' ' A' ' 6' ' ' SER . 65.4 mtm180 -81.0 96.09 7.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.008 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.474 HG11 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -120.11 126.55 26.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.449 -173.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.35 135.74 46.81 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.193 2.595 . . . . 0.0 111.245 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 3.6 p-10 -60.49 -30.68 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.663 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.71 -31.06 63.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.802 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.529 ' HE1' ' HG3' ' A' ' 89' ' ' ARG . 95.9 mmm -78.04 -15.16 59.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' HG22 ' A' ' 34' ' ' ILE . 91.4 t -76.02 -35.88 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.16 -28.73 64.52 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.128 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD12 ' SD ' ' A' ' 30' ' ' MET . 82.5 mt -89.17 -27.83 20.42 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.1 tp -69.24 -28.06 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.613 0.72 . . . . 0.0 109.648 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.687 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.9 pt -83.35 -15.0 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.598 174.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.06 -89.87 0.03 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.818 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 6.4 ptm180 -74.6 9.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.032 0.533 . . . . 0.0 111.623 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.26 9.51 27.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.953 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.687 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.74 -39.47 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.026 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 32.2 tt0 -64.49 -28.88 69.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -171.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.18 -51.98 67.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.274 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.42 -37.65 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.175 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -61.45 -43.97 97.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.7 mttm -54.06 -53.39 53.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.433 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.428 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -70.73 -42.92 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.102 -173.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -29.28 64.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.124 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -81.38 -32.45 32.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.183 0.516 . . . . 0.0 110.116 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.93 -46.82 56.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 30.7 p -67.56 -38.04 83.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.237 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.92 7.94 55.98 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 43.6 t -85.78 144.81 27.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.369 0.604 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -88.06 70.49 9.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.599 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.408 HG22 HD13 ' A' ' 69' ' ' LEU . 47.3 t -86.72 110.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -114.55 123.27 48.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.637 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.5 mm -79.78 124.53 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 37.2 t -112.68 109.85 52.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.642 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 74.1 Cg_endo -75.12 -16.13 20.1 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.983 2.456 . . . . 0.0 111.4 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.41 -33.25 42.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.623 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.638 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 9.6 t 70.45 -74.47 0.08 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.621 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.49 -61.52 0.51 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.409 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.93 -8.59 6.09 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.793 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 2.5 mm? -107.53 152.18 41.28 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.9 -28.07 3.49 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.292 1.995 . . . . 0.0 111.539 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.42 -169.6 2.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.131 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.642 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 24.4 mmt180 -79.81 153.1 29.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.638 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 99.1 p -124.28 117.93 25.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG23 HG11 ' A' ' 26' ' ' VAL . 59.1 t -97.75 124.2 50.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -95.63 127.51 41.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.57 0.7 . . . . 0.0 111.408 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.823 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -108.48 124.66 50.77 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.902 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.34 156.28 39.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.88 -128.0 2.15 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 119.838 -1.172 . . . . 0.0 113.121 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.74 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -111.53 165.41 12.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 14.1 Cg_endo -55.66 -40.83 83.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.182 1.921 . . . . 0.0 113.06 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -85.33 -31.89 22.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.462 -177.072 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 53.6 p -71.03 -46.4 62.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -64.99 -23.79 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.864 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.61 -55.28 7.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.131 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 49' ' ' SER . 4.5 tppp? -55.48 -45.46 76.97 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.615 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.41 -51.22 70.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.609 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.823 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mtmt -75.71 -20.03 58.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.53 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 tpt -59.81 -49.89 75.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.522 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.428 ' HG3' HG12 ' A' ' 45' ' ' ILE . 16.0 mmt -66.06 -38.59 88.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 110.874 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.34 -44.82 95.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.35 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.53 -46.01 84.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.106 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.67 -59.6 4.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.842 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.683 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.69 -41.23 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 24' ' ' TYR . 93.1 t -70.38 -25.32 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.683 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.6 t -72.95 -40.81 65.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.2 ptp180 -77.9 -6.89 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.686 0.279 . . . . 0.0 111.17 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.1 -46.81 0.8 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.483 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -4.16 25.0 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.518 -0.401 . . . . 0.0 111.291 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.77 -68.68 3.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.164 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.922 -0.932 . . . . 0.0 111.525 -179.499 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.537 ' HA ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.757 0.313 . . . . 0.0 111.776 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' A' ' 23' ' ' GLU . 11.2 p -89.28 177.12 6.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.302 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 35.2 t 74.11 -69.71 0.18 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.259 0.624 . . . . 0.0 110.122 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -161.42 106.35 1.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 0.0 110.093 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 5' ' ' ILE . 24.4 tp -91.41 96.6 10.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.4 70.92 0.33 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.03 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 6.7 Cg_exo -73.96 -38.37 2.29 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.561 2.174 . . . . 0.0 111.332 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.584 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 12.4 pt -121.81 152.42 25.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.699 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.662 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 72.7 t60 -89.08 -26.22 0.32 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.0 Cg_exo -39.15 159.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.79 2.327 . . . . 0.0 114.049 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -38.16 144.38 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.127 3.218 . . . . 0.0 113.828 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.609 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 46.3 Cg_endo -66.77 31.32 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.539 3.493 . . . . 0.0 114.493 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.847 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 ppt_? -82.63 0.06 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 0.0 110.176 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.847 HG22 ' HD2' ' A' ' 17' ' ' ARG . 11.9 t -179.46 -17.76 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 12' ' ' ILE . 3.7 m -78.32 -80.92 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.583 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.609 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.6 ptp -76.24 76.61 3.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.9 m -81.82 114.01 20.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.2 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 15.3 tt0 -94.04 118.01 30.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 6.9 tp10 -99.29 104.98 16.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.673 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -90.82 118.78 30.5 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.684 -168.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -81.86 99.1 8.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.685 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -116.63 123.52 30.4 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.763 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' A' ' 30' ' ' MET . 31.9 Cg_endo -66.36 152.55 80.71 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.482 2.121 . . . . 0.0 111.832 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -52.72 -42.02 64.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.88 93.21 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.482 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.557 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 88.4 mmm -78.84 -23.49 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.431 -0.452 . . . . 0.0 111.354 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 ' HG2' ' A' ' 65' ' ' ARG . 2.8 p -74.26 -30.55 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.672 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -28.82 69.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.925 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.29 -23.92 22.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.7 tp -70.3 -25.55 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.691 0.758 . . . . 0.0 109.597 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.789 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 9.4 pt -85.33 -14.73 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.434 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.17 -91.18 0.02 OUTLIER Glycine 0 C--N 1.336 0.574 0 O-C-N 124.209 0.943 . . . . 0.0 113.191 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 1.005 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.5 ptm180 -76.99 44.9 0.41 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.166 0.587 . . . . 0.0 111.501 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.06 13.78 80.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 114.354 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.789 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 135.51 -36.09 2.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.623 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.005 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 71.8 tt0 -57.75 -33.9 68.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -59.91 -52.42 65.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.712 0.291 . . . . 0.0 111.361 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.69 HD11 HG11 ' A' ' 53' ' ' VAL . 10.0 tp -63.8 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.106 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -58.33 -40.66 82.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 13.7 mmmm -60.32 -59.96 4.58 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.425 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -62.86 -41.54 93.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -33.2 72.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.015 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.5 tm0? -77.95 -37.88 46.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.469 0.652 . . . . 0.0 109.539 176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.45 -26.07 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.198 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 34.1 p -99.65 -44.85 5.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.95 8.96 21.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.06 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.549 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 21.0 t -92.77 136.97 32.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 110.855 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -79.77 79.05 6.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.922 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.69 HG11 HD11 ' A' ' 42' ' ' ILE . 40.6 t -82.64 109.52 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 15.5 mm100 -101.03 116.05 31.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.521 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.5 mm -89.7 96.95 6.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.743 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 m -88.36 105.39 9.36 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.812 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 2.8 Cg_exo -75.43 -22.09 14.42 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.321 2.681 . . . . 0.0 111.641 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -79.62 -38.08 34.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.001 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.632 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.3 t 71.41 -54.09 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.556 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.94 -71.79 2.9 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.646 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.78 -9.44 61.13 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.958 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.627 ' HB2' ' OG ' ' A' ' 59' ' ' SER . 2.1 mm? -121.49 154.48 59.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -85.5 -4.3 9.25 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 111.985 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 6.3 pt-20 -111.03 -141.05 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.817 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.726 ' HG2' HG21 ' A' ' 31' ' ' VAL . 2.0 tpp180 -107.4 140.15 40.78 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.632 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 67.2 p -116.94 111.64 19.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.348 0.594 . . . . 0.0 109.944 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 55' ' ' ILE . 84.7 t -100.83 119.53 49.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.776 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 29.7 m -88.68 128.24 35.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.329 0.585 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.897 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.9 mm? -107.31 108.09 19.32 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.805 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 18' ' ' THR . 0.7 OUTLIER -151.2 119.45 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.005 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -158.88 -107.34 0.24 Allowed Glycine 0 C--O 1.225 -0.455 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.734 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.565 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -129.35 163.63 44.97 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.6 -51.22 8.37 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.463 2.109 . . . . 0.0 112.859 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -72.65 -46.86 51.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.362 0.601 . . . . 0.0 110.698 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' A' ' 72' ' ' ALA . 6.7 m -62.47 -45.5 92.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.818 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.1 p -71.23 -27.87 30.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 -174.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -40.2 49.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.32 . . . . 0.0 110.385 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.733 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.8 tpmt? -64.26 -46.59 83.04 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.659 0.742 . . . . 0.0 109.818 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.412 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -55.24 -46.5 76.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.294 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.897 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 37.7 mtmt -73.5 -22.45 60.13 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.733 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.5 -31.09 68.05 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.458 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.425 ' HG3' HG12 ' A' ' 45' ' ' ILE . 15.0 mmt -69.02 -46.7 67.3 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.677 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.416 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.4 mm? -61.51 -48.59 80.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.87 -40.5 69.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.266 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.8 -57.62 12.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.947 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.682 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -72.13 -41.52 67.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.758 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 24' ' ' TYR . 85.8 t -64.57 -32.42 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.336 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 t -73.25 -37.77 66.21 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.455 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.682 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.5 ptp180 -78.41 -7.6 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.929 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -107.41 -64.89 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.344 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 91' ' ' ARG . 22.2 mtp180 -81.79 -33.8 30.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.61 -6.39 83.49 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.111 -179.003 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.273 0.559 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m -98.0 91.0 5.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.297 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.572 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 62.6 m -77.52 178.04 7.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.861 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.664 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 68.5 mm-40 53.78 -162.3 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.48 0.712 . . . . 0.0 111.621 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 28.8 tp 173.05 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 121.76 92.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.952 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.09 -26.13 26.32 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.998 2.466 . . . . 0.0 111.385 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.586 HG22 ' HD2' ' A' ' 14' ' ' PRO . 4.1 mt -77.17 108.45 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.671 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 23.3 m170 -89.72 7.12 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -168.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 20.5 Cg_exo -46.1 -176.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.82 1.68 . . . . 0.0 112.863 158.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' ARG . 67.5 Cg_exo -42.14 158.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.983 2.455 . . . . 0.0 113.557 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 26.8 Cg_endo -64.4 17.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.79 2.993 . . . . 0.0 114.207 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -74.43 -6.55 48.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.0 109.961 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.3 t -158.71 -25.96 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.609 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.0 t -79.31 8.12 6.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.812 0.339 . . . . 0.0 111.083 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 1.5 mmt -145.58 32.67 1.06 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.397 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 40.1 m -79.51 110.99 15.33 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.21 118.97 34.28 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.664 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.9 tt0 -84.91 104.12 14.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.85 109.46 20.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.259 -174.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.454 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 96.7 mtt180 -87.37 98.83 11.57 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.21 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -112.65 128.87 25.01 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.936 -173.042 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 20.0 Cg_exo -60.7 143.51 99.41 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 123.276 2.651 . . . . 0.0 111.773 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.82 -50.62 56.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -170.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.87 -29.8 75.24 Favored Glycine 0 C--O 1.237 0.333 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.413 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.779 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 80.3 mmm -77.45 -21.0 53.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 35' ' ' ILE . 41.4 t -66.19 -37.98 80.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -63.17 -29.38 74.28 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.708 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.81 -25.17 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -75.77 -29.48 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.3 0.572 . . . . 0.0 109.815 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 31' ' ' VAL . 8.8 pt -83.32 -13.51 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.181 172.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.15 -91.02 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.087 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.968 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 16.9 ptm180 -71.18 -9.52 58.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.712 0.405 . . . . 0.0 111.451 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.84 3.38 7.66 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.294 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.622 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -58.93 0.25 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.314 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.968 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 18.8 tp10 -55.17 -21.96 15.45 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' O ' HD13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.7 -48.45 71.99 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.02 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 39' ' ' GLY . 9.9 tp -63.98 -37.87 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -53.78 -49.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.629 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 22.1 mmtm -66.95 -41.76 86.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.299 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.418 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.4 mp -67.19 -41.17 86.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -22.87 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.017 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -78.24 -42.57 30.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.335 0.588 . . . . 0.0 110.047 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.61 -43.77 93.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.01 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.693 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 23.1 p -83.69 -43.06 15.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.291 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.8 10.49 26.54 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.559 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 t -79.71 141.73 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 0.0 110.475 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 50.9 mmtt -94.22 67.34 3.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.438 0.637 . . . . 0.0 109.615 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.42 HG23 HD13 ' A' ' 69' ' ' LEU . 2.2 p -82.5 142.88 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.127 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -136.53 114.86 11.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.518 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.451 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 36.9 mm -79.63 104.65 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.39 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 6.2 t -92.35 105.43 14.14 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 3.2 Cg_exo -75.93 -30.79 5.57 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.45 2.767 . . . . 0.0 112.724 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.53 -29.67 46.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 7.4 t 73.19 -67.53 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.821 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.99 76.83 0.88 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.823 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.08 -57.69 0.68 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.815 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 25' ' ' ARG . 1.3 mm? -87.57 144.15 35.02 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.05 -23.92 8.73 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.435 2.09 . . . . 0.0 110.225 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 6.6 pt-20 -88.99 -168.67 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.556 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.754 ' HB3' HG13 ' A' ' 26' ' ' VAL . 4.0 tpp180 -87.08 139.46 30.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.146 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.9 p -117.28 111.34 19.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG13 HD13 ' A' ' 55' ' ' ILE . 49.1 t -109.32 131.74 59.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.694 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.6 m -91.79 125.59 36.56 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.022 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 21' ' ' THR . 4.0 mm? -104.57 111.45 24.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.025 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 m -152.29 147.98 26.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.654 0.206 . . . . 0.0 111.036 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.74 -156.72 28.8 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.018 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -78.3 161.62 69.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.8 Cg_endo -48.53 -54.96 4.56 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.008 2.472 . . . . 0.0 113.417 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.48 -37.07 77.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.088 0.47 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.693 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 9.0 m -66.6 -51.66 53.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.425 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 p -67.62 -26.48 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.267 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -71.74 -45.26 62.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.388 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 81' ' ' MET . 1.3 tmtp? -68.6 -39.23 80.98 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.362 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -62.07 -40.85 97.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.977 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 45.8 mtmt -80.96 -21.32 40.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.1 tpt -57.15 -50.7 72.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.357 173.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.418 ' HG3' HG12 ' A' ' 45' ' ' ILE . 92.9 mmm -68.96 -39.8 79.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 111.038 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 79' ' ' ALA . 3.7 mm? -62.67 -47.84 81.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.96 -45.67 78.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.042 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.0 -54.23 47.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.669 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.7 mp -75.24 -41.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 26' ' ' VAL . 67.8 t -72.7 -23.65 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.291 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -75.2 -41.42 57.88 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.799 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.9 ptm180 -76.74 -6.96 54.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.779 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -105.72 -52.44 0.8 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.982 -0.627 . . . . 0.0 113.597 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' HG2' ' HG3' ' A' ' 27' ' ' PRO . 17.5 mtp180 -84.56 95.28 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.311 0.577 . . . . 0.0 112.33 -175.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.68 52.73 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.519 -1.156 . . . . 0.0 110.917 176.318 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.385 0.612 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -73.0 88.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.12 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 23' ' ' GLU . 62.2 m -173.31 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.991 0.917 . . . . 0.0 109.41 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -176.01 163.03 2.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.201 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.461 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 75.1 mt -138.78 107.32 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.669 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -126.32 57.66 0.69 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.627 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 92.0 Cg_endo -93.88 -2.68 3.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.002 2.468 . . . . 0.0 112.387 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 30.9 pt -126.51 149.17 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.813 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.6 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 22.1 m80 -91.18 -19.56 0.24 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 93.2 Cg_exo -38.81 162.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.671 2.247 . . . . 0.0 114.324 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.62 152.64 8.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.847 2.364 . . . . 0.0 112.077 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 42.4 Cg_endo -65.99 7.56 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.423 2.748 . . . . 0.0 113.788 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.87 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.18 0.514 . . . . 0.0 110.284 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -159.29 7.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.14 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 30.8 t -93.28 -104.64 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.297 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.468 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptm -63.95 74.22 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.045 0.926 . . . . 0.0 111.712 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 62.5 m -90.04 139.02 31.02 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.635 ' HB2' HD23 ' A' ' 69' ' ' LEU . 10.9 mm-40 -95.33 148.87 21.97 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.299 168.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' HB3' ' H ' ' A' ' 7' ' ' SER . 54.5 tp10 -120.34 98.76 6.2 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 160.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.506 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.36 124.57 37.43 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.266 -161.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.955 ' HG2' HD21 ' A' ' 62' ' ' LEU . 32.6 mtm180 -81.78 111.38 17.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.489 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -130.31 126.59 22.25 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.893 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 35.0 Cg_exo -60.07 151.38 72.96 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.488 2.792 . . . . 0.0 112.658 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 31' ' ' VAL . 35.5 t70 -55.17 -51.91 65.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.03 75.05 Favored Glycine 0 C--O 1.236 0.253 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.935 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 tpp -79.53 -32.05 42.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.473 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 34' ' ' ILE . 12.7 p -72.69 -24.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.2 74.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.06 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.45 -24.55 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD13 ' HB ' ' A' ' 86' ' ' ILE . 10.7 tp -72.93 -27.93 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 109.663 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.617 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 11.9 pt -85.05 -13.59 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.348 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.33 -93.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 O-C-N 124.164 0.915 . . . . 0.0 113.066 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.957 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -72.99 48.68 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.179 0.592 . . . . 0.0 111.027 177.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.15 20.8 58.62 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.113 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.617 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.05 -50.91 0.58 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.809 -1.186 . . . . 0.0 113.602 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 22.2 tt0 -54.62 -33.49 60.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' HG12 ' A' ' 45' ' ' ILE . 24.5 tt0 -60.03 -48.4 81.85 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.473 -171.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.76 HD11 HG11 ' A' ' 53' ' ' VAL . 9.8 tp -60.59 -38.48 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.214 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.43 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 60.2 m-20 -65.32 -44.69 87.02 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.58 -31.94 69.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.534 0.207 . . . . 0.0 111.035 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 41' ' ' GLN . 26.4 mm -76.32 -50.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.989 0.423 . . . . 0.0 111.357 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.43 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -75.72 -24.64 56.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.408 -174.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -82.95 -34.48 26.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.684 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.81 -46.02 76.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.869 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 25.8 p -73.04 -48.04 39.57 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.209 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 13.47 25.7 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.4 t -92.84 143.36 26.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.954 0.407 . . . . 0.0 110.706 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 41.4 mtmt -81.6 72.09 8.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.76 HG11 HD11 ' A' ' 42' ' ' ILE . 57.9 t -82.4 110.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.397 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -110.99 122.44 47.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.123 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 HG12 ' A' ' 42' ' ' ILE . 42.7 mm -88.9 99.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.79 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.5 t -81.08 115.14 54.18 Favored Pre-proline 0 C--O 1.243 0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HA ' HH11 ' A' ' 65' ' ' ARG . 97.4 Cg_endo -79.65 -27.54 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.367 2.712 . . . . 0.0 112.061 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.65 -40.32 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.457 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 11.0 t 70.72 -69.11 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.236 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.57 -96.54 0.54 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.061 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.06 -12.47 79.36 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.654 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.955 HD21 ' HG2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -94.78 139.93 22.38 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.796 0.332 . . . . 0.0 110.817 -176.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.09 -2.46 9.52 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.8 2.333 . . . . 0.0 111.434 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 91' ' ' ARG . 2.5 pt-20 -110.64 -104.06 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.31 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.543 HH11 ' HA ' ' A' ' 57' ' ' PRO . 6.7 tpp180 -144.57 155.4 43.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 78.0 p -136.94 146.97 46.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.373 173.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 55' ' ' ILE . 52.2 t -123.3 131.06 73.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -91.48 131.23 37.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.2 0.524 . . . . 0.0 110.768 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 22' ' ' GLU . 3.6 mm? -114.09 104.03 11.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.2 124.19 11.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.389 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.76 -158.03 19.2 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.333 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.11 161.88 69.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -45.67 -52.24 7.09 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.79 2.326 . . . . 0.0 112.945 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.5 -43.33 81.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.6 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.635 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.3 m -64.94 -49.62 69.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.618 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.55 -23.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.162 -175.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.54 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.2 tt0 -72.55 -52.37 15.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.886 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 49' ' ' SER . 5.4 tppp? -55.04 -43.47 73.8 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.191 0.52 . . . . 0.0 110.588 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.94 63.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.725 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.62 ' HD3' ' CG ' ' A' ' 22' ' ' GLU . 11.2 mtmm -66.91 -23.06 65.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.616 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.7 mmt -59.77 -52.72 64.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.422 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 20.4 mmt -68.37 -37.71 80.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.5 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.3 mm? -60.48 -54.99 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.183 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' SER . 24.6 t70 -60.3 -34.86 74.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.39 -55.98 17.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.09 -41.48 52.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.365 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 24' ' ' TYR . 87.9 t -64.18 -28.1 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.23 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 16.1 t -75.73 -31.63 59.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.342 -0.224 . . . . 0.0 110.91 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 17.4 ptp180 -77.74 -12.44 59.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.33 -50.07 0.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.957 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 64' ' ' GLU . 26.3 mmt180 -92.22 -77.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.293 0.237 . . . . 0.0 111.6 -177.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.73 69.68 3.25 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.652 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.803 -0.998 . . . . 0.0 111.804 -179.346 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -144.07 134.39 24.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.275 0.56 . . . . 0.0 111.904 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 1.006 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 34.1 m -92.69 163.45 13.76 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -158.2 121.46 3.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.022 0.439 . . . . 0.0 110.34 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.26 104.08 15.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.085 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.57 69.38 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.891 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -84.95 -27.29 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.656 2.238 . . . . 0.0 112.991 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.696 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 6.0 mm -120.49 147.32 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 24.7 t60 -93.53 12.03 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.718 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -170.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.696 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 29.8 Cg_endo -61.06 -166.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 122.33 2.02 . . . . 0.0 113.958 171.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 67.3 Cg_exo -56.63 167.08 3.08 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.358 2.039 . . . . 0.0 112.517 168.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.1 33.63 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 124.189 3.259 . . . . 0.0 114.708 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' O ' ' HB ' ' A' ' 18' ' ' THR . 4.7 ptp180 -96.92 13.17 29.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 15.0 t 174.53 -15.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.289 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -79.97 -6.42 57.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.629 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.42 58.14 0.4 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.22 0.533 . . . . 0.0 110.354 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -78.21 110.83 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 7' ' ' SER . 12.7 tt0 -98.9 119.57 37.9 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -172.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 1.006 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 4.6 tp10 -92.34 102.01 14.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -90.96 126.24 36.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.112 0.482 . . . . 0.0 110.739 -171.604 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -91.09 98.12 11.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.083 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG11 HH21 ' A' ' 65' ' ' ARG . 1.3 p -120.37 114.33 33.27 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.528 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.644 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 50.3 Cg_exo -57.5 164.25 7.5 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 124.454 3.436 . . . . 0.0 114.38 -169.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.91 -45.34 74.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 0.0 111.845 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 33' ' ' LEU . . . -63.76 -34.04 88.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.806 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.419 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 31.4 mmt -80.25 -25.81 39.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -175.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -70.77 -33.89 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.934 172.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.37 77.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.708 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 29' ' ' GLY . 4.2 mm? -87.01 -24.02 24.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.986 HG21 HH22 ' A' ' 65' ' ' ARG . 10.8 tp -71.43 -30.49 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 109.249 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.626 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.0 pt -86.99 -14.05 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.731 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.76 -90.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.918 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.05 -6.91 9.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.998 -0.601 . . . . 0.0 111.946 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.9 4.42 9.5 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.824 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.626 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.17 -44.91 0.5 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.182 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.4 -26.31 66.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.59 -45.29 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.94 -174.003 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -65.39 -34.0 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.973 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 74.3 m-20 -61.47 -38.67 88.11 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -37.63 64.81 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 41' ' ' GLN . 98.1 mt -64.13 -52.74 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 111.258 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -21.87 59.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 6.5 tp-100 -84.14 -35.56 23.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.508 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.17 -39.49 78.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.666 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 p -84.07 -39.78 19.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.477 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.57 3.45 59.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.687 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 54.0 t -80.31 146.15 31.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.949 0.404 . . . . 0.0 110.533 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.724 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 10.9 mmpt? -84.98 81.01 9.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -81.92 107.16 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -95.93 106.68 18.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.933 -173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 HH11 ' A' ' 65' ' ' ARG . 33.2 mm -81.12 110.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.637 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -97.38 98.57 5.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 39.5 Cg_exo -60.05 -41.36 53.17 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 112.419 -173.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -115.36 102.99 10.35 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 34.5 t -68.92 -26.0 64.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.751 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.07 -82.01 1.39 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.191 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.27 -31.04 77.88 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.782 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 51.7 mt -98.31 138.52 20.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.979 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.86 -19.52 23.51 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.783 2.322 . . . . 0.0 110.784 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.644 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -96.69 -174.35 2.99 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.183 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.986 HH22 HG21 ' A' ' 34' ' ' ILE . 5.7 tmm_? -94.84 141.3 28.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 79.5 p -115.26 150.82 35.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.382 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 82.6 t -129.96 114.34 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.701 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.3 m -85.87 129.95 34.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.399 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.003 HD13 ' HG2' ' A' ' 80' ' ' LYS . 5.4 mt -114.94 121.75 44.14 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.8 m -151.33 141.29 22.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.247 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.89 -136.94 4.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.482 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -96.13 163.11 21.64 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.7 Cg_endo -48.05 -48.35 16.72 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.798 2.332 . . . . 0.0 112.854 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.36 -39.67 53.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 p -70.94 -47.69 57.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.104 0.478 . . . . 0.0 110.441 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.73 -29.2 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.228 -177.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -68.68 -50.99 46.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 81' ' ' MET . 50.8 tptt -63.13 -40.56 97.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.758 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -58.81 -41.71 87.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.138 0.494 . . . . 0.0 111.082 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.003 ' HG2' HD13 ' A' ' 69' ' ' LEU . 48.5 mtmt -81.18 -21.89 39.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.957 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 7.8 tpt -59.1 -50.58 73.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.357 174.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mmm -70.25 -37.53 74.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.4 mm? -60.37 -55.09 37.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.418 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -55.18 -34.92 64.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.766 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.72 -56.57 19.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.575 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.608 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -70.13 -40.21 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.336 0.588 . . . . 0.0 110.77 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 74.4 t -62.41 -28.47 44.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.293 0.568 . . . . 0.0 110.106 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -75.4 -31.13 60.32 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.164 -0.335 . . . . 0.0 110.759 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.5 ptm180 -78.31 -15.74 58.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.616 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -158.21 44.94 0.47 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.009 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.527 ' HD2' ' HG3' ' A' ' 27' ' ' PRO . 7.6 tpm_? -160.44 -50.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.551 0.676 . . . . 0.0 110.084 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.03 -158.27 34.15 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.938 -0.923 . . . . 0.0 111.588 179.473 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 9' ' ' LEU . 14.4 tt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -100.74 141.3 33.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.405 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 20.9 m 70.53 -163.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.663 0.602 . . . . 0.0 111.517 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.84 120.0 7.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' MET . 53.2 tp -100.19 102.61 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.791 168.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -132.69 57.33 0.72 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.774 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.702 ' HD2' HD13 ' A' ' 12' ' ' ILE . 5.8 Cg_exo -78.51 -46.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.48 2.12 . . . . 0.0 111.368 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.28 147.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.837 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.688 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 53.5 m80 -91.12 -19.21 0.24 Allowed Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.6 Cg_endo -53.67 164.8 2.04 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.31 2.007 . . . . 0.0 113.482 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' ARG . 85.0 Cg_exo -46.65 149.25 3.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.201 2.601 . . . . 0.0 112.791 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 39.7 Cg_endo -65.53 26.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.567 3.511 . . . . 0.0 114.437 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.774 ' HG3' HG22 ' A' ' 18' ' ' THR . 13.3 ptp180 -82.23 -20.96 36.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.151 0.5 . . . . 0.0 110.004 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.774 HG22 ' HG3' ' A' ' 17' ' ' ARG . 9.8 t -168.62 34.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.691 0.758 . . . . 0.0 110.458 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.9 p -126.12 -80.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.614 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.1 ptm -74.55 79.13 1.96 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.403 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 99.0 m -79.48 118.78 21.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.867 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 68' ' ' SER . 6.2 tp10 -92.83 118.24 30.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB3' ' N ' ' A' ' 7' ' ' SER . 6.4 tp10 -100.4 103.42 14.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.43 123.62 36.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.207 0.527 . . . . 0.0 111.9 -172.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -81.65 110.35 16.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.939 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 87' ' ' VAL . 1.3 p -132.76 127.04 20.21 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.294 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.0 Cg_exo -54.62 136.51 70.94 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.268 2.645 . . . . 0.0 111.038 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.4 -29.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.352 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.34 -28.95 57.03 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.626 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.621 ' SD ' HD12 ' A' ' 33' ' ' LEU . 32.8 tpp -77.5 -20.68 53.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' HG22 ' A' ' 34' ' ' ILE . 80.1 t -69.15 -39.21 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.377 169.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.54 -28.45 56.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.65 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.621 HD12 ' SD ' ' A' ' 30' ' ' MET . 81.1 mt -85.78 -29.99 23.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -72.1 -29.52 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.267 0.556 . . . . 0.0 109.969 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.738 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 17.9 pt -80.38 -13.24 12.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.512 174.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 -97.19 0.19 Allowed Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.459 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 1.078 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 19.5 ptp180 -60.0 -24.86 64.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.003 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.04 30.79 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.486 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.738 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.84 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.306 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.078 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 9.5 mp0 -60.86 -21.63 63.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -168.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.496 ' O ' HG12 ' A' ' 45' ' ' ILE . 9.1 tt0 -60.1 -50.67 72.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.367 0.53 . . . . 0.0 110.765 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.5 HG12 HD11 ' A' ' 55' ' ' ILE . 8.9 tp -64.45 -39.18 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.29 -46.3 76.21 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.407 0.622 . . . . 0.0 110.037 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -65.57 -37.65 87.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.246 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 41' ' ' GLN . 22.9 mm -68.19 -51.17 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 111.267 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.45 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.32 -31.3 65.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.675 -173.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -78.84 -31.48 45.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.823 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.14 -45.48 56.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.344 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 p -68.12 -45.21 74.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.76 -0.28 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.542 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.772 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 47.3 t -83.36 135.95 34.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.775 0.321 . . . . 0.0 110.286 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -80.62 72.86 7.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.549 HG22 HD23 ' A' ' 69' ' ' LEU . 43.3 t -82.52 111.32 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -111.26 118.03 34.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.176 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 67' ' ' VAL . 34.2 mm -79.75 115.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -99.71 104.81 30.28 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.555 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.889 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 60.1 Cg_endo -73.62 -21.95 18.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.989 2.46 . . . . 0.0 111.88 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.87 -32.39 23.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.878 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.543 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 21.4 t 65.39 -77.32 0.04 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.804 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.09 -86.16 0.36 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.084 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.88 -3.07 60.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.86 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 64' ' ' GLU . 2.0 mm? -112.92 147.68 37.74 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.279 . . . . 0.0 110.494 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.98 -10.15 11.62 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.124 2.549 . . . . 0.0 111.556 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 4.2 pt-20 -104.27 -147.54 0.39 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.524 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.889 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 19.3 mmt180 -106.53 139.88 40.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.1 p -110.75 108.11 17.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.496 0.665 . . . . 0.0 109.347 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG13 HD13 ' A' ' 55' ' ' ILE . 64.7 t -97.08 108.16 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.249 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -86.88 134.7 33.51 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.954 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD23 HG22 ' A' ' 53' ' ' VAL . 2.3 mp -123.5 121.87 36.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.163 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 21' ' ' THR . 26.2 m -151.92 121.46 6.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.026 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.772 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.04 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.177 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -160.85 165.45 17.25 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 8.6 Cg_endo -49.93 -47.0 25.27 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 113.284 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.19 -38.94 23.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.431 0.634 . . . . 0.0 110.152 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -65.69 -46.17 80.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.789 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 p -73.06 -23.6 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 0.0 110.332 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.7 tp60 -76.47 -47.84 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.966 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 81' ' ' MET . 17.2 tppt? -60.64 -45.23 94.88 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.778 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.32 79.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.471 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 47.5 mtmt -69.1 -21.04 64.07 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.908 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.1 mmt -61.25 -48.04 83.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.211 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.24 -41.24 97.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.704 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -64.12 -57.33 9.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.361 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.56 -35.89 61.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.317 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.01 -61.44 2.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.013 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.548 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.1 mp -70.41 -38.77 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.052 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 26' ' ' VAL . 77.9 t -61.45 -36.69 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.333 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t -71.17 -22.67 62.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.835 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -59.83 -49.2 78.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.31 -54.9 3.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.385 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 64' ' ' GLU . 39.3 mmt180 -85.41 95.41 9.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.354 0.662 . . . . 0.0 110.372 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.6 31.95 4.08 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.911 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.796 179.094 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.498 HD11 ' HA3' ' A' ' 61' ' ' GLY . 8.5 tp . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 121.544 0.687 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 p -124.97 155.96 38.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.299 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 8.1 m 62.91 -153.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.469 0.481 . . . . 0.0 109.751 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 21' ' ' THR . 60.0 tp60 170.83 -31.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.068 0.855 . . . . 0.0 108.964 171.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 67.55 -90.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.663 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 148.06 94.94 0.15 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.134 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.36 -12.96 30.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.806 2.337 . . . . 0.0 111.854 176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.84 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -99.69 161.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.661 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 31.5 t-80 -92.5 -37.95 0.35 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 51.8 Cg_exo -32.58 144.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.874 3.049 . . . . 0.0 114.387 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 73.1 Cg_exo -40.58 140.76 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.376 2.717 . . . . 0.0 112.29 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 9.5 Cg_endo -51.79 60.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.132 1 C-N-CA 125.652 4.234 . . . . 0.0 116.884 -168.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 11.9 ptp180 -114.84 15.11 17.45 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -178.87 -25.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.513 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.521 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 12.8 m -86.2 10.86 13.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.438 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.655 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 90.1 mmm -147.38 31.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.466 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.578 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 88.4 m -79.88 115.75 19.64 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 9.3 tt0 -123.89 118.04 26.18 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.3 109.29 20.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -92.1 128.22 37.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.003 -170.022 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 87.8 mtm180 -88.14 101.72 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.518 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -120.4 120.4 29.91 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.079 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.565 ' HD3' ' HG2' ' A' ' 91' ' ' ARG . 85.4 Cg_exo -50.11 145.71 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.878 3.052 . . . . 0.0 112.207 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -60.5 -37.04 79.81 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.587 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.76 -25.3 53.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.791 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.616 ' HG2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 tpp -79.54 -26.67 41.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.203 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 34' ' ' ILE . 7.5 p -75.81 -30.18 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -28.3 62.25 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.16 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -88.87 -24.24 22.57 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.8 tp -70.8 -27.47 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.313 0.578 . . . . 0.0 109.892 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 pt -81.15 -14.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.431 173.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.09 -90.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 O-C-N 124.187 0.929 . . . . 0.0 113.155 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.06 28.15 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.15 0.58 . . . . 0.0 111.991 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.38 67.99 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.271 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -51.87 0.27 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.872 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 5.0 mm-40 -59.12 -22.41 60.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -53.24 52.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.763 0.71 . . . . 0.0 111.34 -172.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.91 -44.44 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.48 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -59.68 -42.95 94.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.0 109.68 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 4.5 ttmm -63.25 -35.73 81.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.569 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.01 -50.67 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.79 84.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.808 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -73.97 -37.49 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.76 -45.03 91.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -73.19 -46.54 49.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.81 8.63 9.63 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.789 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 22.9 t -84.21 139.55 32.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.625 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -94.36 71.82 3.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.742 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.66 120.93 35.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.236 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.5 mm-40 -117.03 119.53 35.57 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.213 0.53 . . . . 0.0 111.032 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.501 HD13 HG13 ' A' ' 67' ' ' VAL . 32.6 mm -85.16 109.06 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.522 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.479 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 10.0 m -91.12 109.76 37.63 Favored Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 120.695 0.283 . . . . 0.0 110.641 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.625 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 32.8 Cg_endo -64.81 -50.96 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.987 2.458 . . . . 0.0 111.941 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.95 94.08 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.884 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.3 p -74.6 -29.74 61.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.329 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.71 -86.56 1.34 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.712 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.498 ' HA3' HD11 ' A' ' 5' ' ' ILE . . . -75.98 -12.03 84.29 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.506 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.884 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.9 mp -110.0 144.47 30.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.73 -37.67 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.453 2.102 . . . . 0.0 111.931 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.69 -154.26 0.36 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.322 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.625 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 17.0 tpp180 -85.78 154.97 21.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.642 ' HB3' HD22 ' A' ' 62' ' ' LEU . 73.8 p -120.74 117.36 27.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.537 HG23 HG11 ' A' ' 26' ' ' VAL . 97.1 t -104.51 120.95 55.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.061 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -86.97 128.51 35.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.431 0.634 . . . . 0.0 111.16 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.605 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.2 mm? -104.67 112.18 25.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.231 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.432 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 25.5 m -151.81 155.08 37.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.18 -101.76 0.18 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.415 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -143.78 164.04 32.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 7.8 Cg_endo -49.05 -53.17 7.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.959 2.439 . . . . 0.0 113.54 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -84.54 -30.11 25.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.091 0.472 . . . . 0.0 111.143 -177.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.5 m -72.97 -43.19 62.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.204 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.627 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.6 p -67.74 -24.81 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.963 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.559 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.7 tt0 -74.81 -42.62 57.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.893 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 81' ' ' MET . 21.1 tptp -61.12 -44.64 97.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.461 0.648 . . . . 0.0 110.283 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.38 -48.21 82.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.627 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 8.4 mtmp? -69.22 -20.69 63.96 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.393 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 24.2 mmt -58.35 -46.84 85.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 81.9 mtp -63.68 -49.97 71.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 110.743 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.1 mm? -59.68 -50.88 72.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.629 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.59 -41.66 95.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.842 0.353 . . . . 0.0 110.339 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.33 -56.71 18.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.396 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.86 -35.28 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.123 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 24' ' ' TYR . 55.3 t -72.11 -28.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 121.608 -0.683 . . . . 0.0 111.0 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -69.37 -40.41 77.45 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.652 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 16.9 ptm180 -73.92 -21.54 60.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.879 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.616 ' HA3' ' HG2' ' A' ' 30' ' ' MET . . . -94.02 -58.94 1.2 Allowed Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.139 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.565 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 14.3 mmm180 -75.53 -20.71 58.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 110.749 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 -61.4 3.67 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.44 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m 65.74 -145.29 0.2 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.936 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 20.3 t -130.59 162.82 28.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 0.0 110.283 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.51 156.04 7.88 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.077 0.551 . . . . 0.0 110.864 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' MET . 80.2 mt -137.92 106.43 5.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.27 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.18 61.58 0.64 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.93 -27.42 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.405 2.07 . . . . 0.0 112.76 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.597 HG13 ' HB3' ' A' ' 19' ' ' SER . 15.7 pt -111.11 144.56 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.585 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 41.2 m80 -90.22 -20.48 0.25 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 92.9 Cg_exo -40.58 154.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.216 1.944 . . . . 0.0 112.83 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 17' ' ' ARG . 80.9 Cg_exo -46.58 152.99 1.34 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 123.29 2.66 . . . . 0.0 113.119 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 38.4 Cg_endo -65.51 24.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.294 3.329 . . . . 0.0 114.064 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.791 ' HG3' HG22 ' A' ' 18' ' ' THR . 12.0 ptp180 -71.69 -24.66 61.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.124 0.487 . . . . 0.0 109.942 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.791 HG22 ' HG3' ' A' ' 17' ' ' ARG . 7.2 t -163.25 10.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.916 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.597 ' HB3' HG13 ' A' ' 12' ' ' ILE . 15.2 m -105.22 -86.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.573 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.8 ptp -69.13 85.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.508 0.67 . . . . 0.0 110.949 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 m -88.92 114.03 25.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.223 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.485 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 14.5 tt0 -95.95 118.88 33.43 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.936 ' HB3' ' HB3' ' A' ' 7' ' ' SER . 4.9 tp10 -90.92 106.86 18.81 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.564 ' CD2' HG21 ' A' ' 87' ' ' VAL . 1.9 m-85 -90.54 108.47 19.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.379 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' HD2' ' CG ' ' A' ' 62' ' ' LEU . 12.4 mtm180 -89.51 99.58 12.55 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -114.71 133.03 22.62 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -170.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.7 Cg_exo -58.55 133.62 55.64 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.018 2.479 . . . . 0.0 110.421 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.8 -32.25 67.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.01 -31.41 79.39 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.712 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.596 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.1 mmm -78.29 -15.86 58.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 34' ' ' ILE . 37.8 t -72.59 -39.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.51 -27.9 70.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.534 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.79 -29.98 23.38 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -72.68 -26.25 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.494 0.664 . . . . 0.0 110.067 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.764 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 20.3 pt -83.2 -13.91 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.829 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.4 -100.54 0.31 Allowed Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.578 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.515 ' HD3' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -60.28 -14.84 20.18 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.748 0.419 . . . . 0.0 111.503 178.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.39 27.84 1.57 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.451 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.764 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.61 -51.61 0.6 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.995 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.403 ' HA ' HD22 ' A' ' 43' ' ' ASN . 5.7 tp10 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' HD3' ' A' ' 37' ' ' ARG . 15.1 tt0 -62.03 -51.71 66.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.122 0.419 . . . . 0.0 111.083 -173.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.525 HD11 HG11 ' A' ' 53' ' ' VAL . 8.1 tp -62.27 -40.92 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 40' ' ' GLU . 95.6 m-20 -52.35 -52.52 52.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 123.628 0.58 . . . . 0.0 110.05 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -56.89 -50.76 71.53 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.5 mm -60.56 -50.8 78.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -39.7 73.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.298 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -75.96 -34.12 59.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.25 -44.75 95.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.688 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.1 p -80.31 -36.75 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.161 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.92 5.03 31.29 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 49.7 t -79.9 141.59 35.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.392 0.615 . . . . 0.0 110.378 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -96.54 74.27 2.79 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.613 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 42' ' ' ILE . 41.7 t -82.22 107.85 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.177 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -103.92 111.12 23.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.759 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.482 HD13 HG13 ' A' ' 67' ' ' VAL . 28.7 mm -79.21 90.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.961 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 66' ' ' SER . 57.7 m -79.78 116.25 59.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 95.1 Cg_endo -84.89 1.8 8.33 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.0 2.467 . . . . 0.0 110.934 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.32 -33.36 49.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.515 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 58.5 p 55.05 -78.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 113.035 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.43 -104.97 2.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.015 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 3.38 86.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.612 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CG ' ' HD2' ' A' ' 25' ' ' ARG . 2.9 mm? -110.08 141.67 24.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.0 0.67 6.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.987 2.458 . . . . 0.0 110.577 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.4 pt-20 -113.54 -170.27 1.66 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.552 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.709 ' HB3' HG13 ' A' ' 26' ' ' VAL . 7.4 tpp180 -85.58 133.67 34.05 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 56' ' ' SER . 52.9 p -108.31 99.62 9.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 0.0 109.896 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 55' ' ' ILE . 57.9 t -101.03 110.36 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -85.73 130.12 34.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.406 0.622 . . . . 0.0 110.956 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.594 HD21 ' HG ' ' A' ' 83' ' ' LEU . 4.4 mm? -105.58 111.3 23.94 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.457 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -150.41 127.53 11.23 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . -155.12 -89.92 0.07 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.653 -1.26 . . . . 0.0 113.583 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -160.96 165.86 16.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 89.9 Cg_exo -44.9 -53.22 5.4 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.521 2.147 . . . . 0.0 112.969 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.56 -40.13 23.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 110.907 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.688 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.1 m -65.59 -44.05 87.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.65 -172.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.6 p -71.64 -30.48 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.037 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.8 tt0 -70.95 -43.62 67.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -52.35 65.79 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.357 0.598 . . . . 0.0 110.102 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.22 74.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.29 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 43.9 mtmt -69.47 -20.9 63.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.605 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.4 mmt -62.73 -42.1 99.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.115 172.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.9 mmt -67.01 -43.11 83.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.99 0.424 . . . . 0.0 111.046 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.1 mm? -64.29 -53.15 53.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.966 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.66 -33.66 66.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.47 . . . . 0.0 110.435 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.6 -60.98 2.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.082 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.697 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.3 mp -75.93 -37.09 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.921 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 24' ' ' TYR . 77.5 t -66.09 -32.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.943 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.697 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.7 ptm180 -75.09 -12.94 60.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.752 0.31 . . . . 0.0 111.129 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.596 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -108.97 -62.15 0.54 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.155 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 91' ' ' ARG . 5.1 tmm_? -76.15 92.52 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.56 -1.77 24.85 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.58 -1.122 . . . . 0.0 111.206 178.226 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -143.74 122.35 12.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.889 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.7 m 62.98 -162.58 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.807 0.692 . . . . 0.0 111.637 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.56 134.22 56.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.594 0.712 . . . . 0.0 112.508 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' MET . 75.1 mt -120.09 145.55 46.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.923 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.47 66.8 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.361 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.04 -49.72 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.829 2.353 . . . . 0.0 112.101 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.498 HD11 HG23 ' A' ' 18' ' ' THR . 18.7 pt -117.98 163.74 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.66 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 92.0 m-70 -91.25 -29.57 0.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 38.8 Cg_exo -41.27 167.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.168 2.579 . . . . 0.0 114.904 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 17' ' ' ARG . 68.0 Cg_exo -42.3 156.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.62 2.88 . . . . 0.0 113.758 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 28.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 124.031 3.154 . . . . 0.0 114.563 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.49 -11.08 43.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.083 0.468 . . . . 0.0 110.01 173.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 12' ' ' ILE . 6.2 t -163.88 8.18 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.865 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 41.0 t -92.9 -94.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.339 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.7 ptp -70.63 85.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 0.0 110.537 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.7 m -94.24 114.81 26.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.196 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.7 tp10 -95.45 118.38 32.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -96.46 100.68 12.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.538 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -94.07 116.92 29.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.141 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 91' ' ' ARG . 31.5 mtm180 -84.39 113.68 21.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.31 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.505 HG23 HG22 ' A' ' 87' ' ' VAL . 2.2 p -117.71 131.55 24.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 111.048 -176.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.52 ' O ' HG23 ' A' ' 31' ' ' VAL . 26.9 Cg_exo -58.74 139.28 90.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.168 2.579 . . . . 0.0 110.764 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 2.7 p-10 -59.18 -32.17 69.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.136 -172.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -39.55 87.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.246 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.405 ' SD ' HD12 ' A' ' 33' ' ' LEU . 1.5 mpp? -79.5 -7.2 58.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.192 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 35' ' ' ILE . 75.6 t -70.69 -43.18 77.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.99 -31.38 72.32 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.57 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' SD ' ' A' ' 30' ' ' MET . 60.0 mt -83.41 -32.11 26.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 HH22 ' A' ' 65' ' ' ARG . 10.2 tp -70.8 -28.36 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.619 0.723 . . . . 0.0 109.921 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.68 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 14.2 pt -85.4 -13.26 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.59 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.46 -87.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 113.493 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.778 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 2.5 ptm85 -77.26 42.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.074 0.55 . . . . 0.0 110.784 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.43 19.76 69.0 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.03 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.68 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.75 -51.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.311 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 32.0 tt0 -60.42 -21.39 62.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' HD13 ' A' ' 45' ' ' ILE . 29.0 tt0 -63.56 -38.9 92.88 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.341 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -66.03 -36.94 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 1.3 m-20 -59.39 -43.2 92.99 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -59.54 -57.13 14.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.548 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.489 HD13 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -58.81 -53.01 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.484 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -29.72 61.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.252 -172.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.425 ' HB3' ' O ' ' A' ' 43' ' ' ASN . 6.5 tp60 -77.79 -39.92 42.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -66.08 -32.46 73.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 29.8 p -91.29 -36.01 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.738 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.38 7.25 57.16 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.59 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 49.1 t -78.99 142.75 36.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.624 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -83.6 72.62 10.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 42' ' ' ILE . 49.1 t -86.04 107.47 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.054 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 6.8 tp60 -98.84 122.66 42.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.5 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.402 HG23 ' HD3' ' A' ' 65' ' ' ARG . 24.7 mm -100.54 117.14 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.954 0.406 . . . . 0.0 111.666 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 44.9 m -112.7 93.97 26.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.772 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 76.6 Cg_exo -51.89 -55.92 3.45 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.434 3.422 . . . . 0.0 114.342 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.3 -2.02 58.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.646 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 p 49.93 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.55 1.14 . . . . 0.0 113.035 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.52 -65.85 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.74 2.44 87.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.206 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.728 HD12 ' HB3' ' A' ' 66' ' ' SER . 58.2 mt -126.02 151.73 72.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.22 -14.11 8.5 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 110.104 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 7.1 pt-20 -105.27 -164.75 1.06 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.305 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.772 ' HG2' ' HA ' ' A' ' 57' ' ' PRO . 6.3 tmm_? -101.1 137.92 38.83 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.728 ' HB3' HD12 ' A' ' 62' ' ' LEU . 77.9 p -105.24 142.6 34.74 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.944 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.0 t -130.31 111.96 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.426 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.7 m -81.15 121.45 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.311 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.999 HD13 ' HG2' ' A' ' 80' ' ' LYS . 96.6 mt -109.72 108.45 18.83 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.14 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 149.79 30.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.65 -95.98 0.11 Allowed Glycine 0 C--O 1.226 -0.362 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.809 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -147.66 163.7 26.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 83.6 Cg_exo -45.44 -55.26 3.64 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.003 2.469 . . . . 0.0 113.432 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.34 -32.81 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 110.912 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.0 m -67.6 -48.06 67.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.899 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.515 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 1.4 p -71.84 -24.32 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.765 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -71.88 -43.34 65.6 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.253 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 81' ' ' MET . 20.9 tptm -66.02 -45.59 80.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.457 0.646 . . . . 0.0 110.128 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.422 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -54.99 -49.33 71.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.072 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.999 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.1 mtmt -71.79 -22.75 61.53 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.755 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 21.9 ptm -69.32 -38.05 78.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.783 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.485 ' HG3' ' CG1' ' A' ' 45' ' ' ILE . 20.9 mmt -75.11 -39.28 60.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.744 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.3 mm? -61.78 -59.57 4.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.56 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.58 -34.11 66.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.736 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 24.6 t70 -69.45 -61.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.857 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.72 -40.27 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 111.282 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 26' ' ' VAL . 58.3 t -70.92 -21.97 22.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.592 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -72.56 -30.25 64.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 15.1 mmm-85 -67.99 -29.94 69.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.12 0.486 . . . . 0.0 110.0 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.21 -41.63 3.68 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.973 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 4.5 ptm180 -147.05 -161.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.557 -0.378 . . . . 0.0 110.755 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.26 76.78 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -173.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.19 0 CA-C-O 118.126 -1.374 . . . . 0.0 111.036 -178.246 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.405 ' HB2' HD11 ' A' ' 62' ' ' LEU . 34.4 t 71.56 135.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.808 0.692 . . . . 0.0 110.479 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 m 70.75 -61.22 0.48 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.219 0.607 . . . . 0.0 110.703 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.476 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 19.1 mm-40 57.78 -161.8 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.955 0.502 . . . . 0.0 111.721 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 2.6 tt 171.66 -72.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 111.24 114.32 3.46 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.615 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.44 -5.08 14.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.746 2.297 . . . . 0.0 112.179 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.56 ' HB ' ' CG2' ' A' ' 18' ' ' THR . 6.8 mt -98.62 121.28 49.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.7 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 m80 -82.55 -26.59 0.41 Allowed Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.3 Cg_exo -31.45 130.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 123.583 2.855 . . . . 0.0 114.07 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.8 Cg_exo -33.89 127.08 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 125.079 3.853 . . . . 0.0 112.456 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 10.0 Cg_exo -19.62 53.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.571 5.514 . . . . 0.0 117.572 -157.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 76.4 mtp180 -99.06 -4.48 32.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.56 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -178.62 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.41 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -79.15 -23.25 44.08 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.598 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.438 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.6 mtt -117.68 52.69 0.97 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -79.11 112.28 16.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.821 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.5 tp10 -111.27 118.95 37.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' HB2' ' CG ' ' A' ' 8' ' ' GLN . 36.7 tp10 -98.38 103.53 15.49 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.427 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.83 128.0 37.5 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.043 -169.19 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HG2' HD21 ' A' ' 62' ' ' LEU . 19.9 mtp180 -87.4 110.14 20.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.997 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.753 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -125.56 127.95 24.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -177.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 31.9 Cg_exo -57.73 147.89 77.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.621 2.214 . . . . 0.0 111.963 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 31' ' ' VAL . 20.0 t70 -53.21 -51.07 63.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.81 76.25 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.193 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.544 ' SD ' HD12 ' A' ' 33' ' ' LEU . 9.5 tpp -79.53 -28.53 41.31 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.699 -0.295 . . . . 0.0 110.373 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 28' ' ' ASP . 13.3 p -74.74 -30.09 24.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.59 67.32 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.795 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.544 HD12 ' SD ' ' A' ' 30' ' ' MET . 95.7 mt -87.55 -25.59 23.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -68.7 -31.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.435 0.636 . . . . 0.0 109.541 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.617 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.1 pt -82.73 -14.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 173.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.37 -88.28 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 124.213 0.945 . . . . 0.0 112.968 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 8.0 ptp180 -77.7 38.93 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.216 0.606 . . . . 0.0 111.561 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.96 3.27 80.51 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.978 -0.556 . . . . 0.0 114.324 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.617 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 160.33 -50.53 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.158 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 12.6 tp10 -54.08 -25.01 19.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.49 -46.95 77.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.719 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.732 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 10.6 tp -65.94 -38.78 82.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -53.53 -42.88 67.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.33 -48.46 72.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.876 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.501 ' HB ' HD12 ' A' ' 42' ' ' ILE . 95.4 mt -58.91 -57.97 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.732 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 7.9 pt20 -73.24 -20.97 60.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.523 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -78.36 -38.7 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.434 0.635 . . . . 0.0 110.022 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -63.18 -39.59 95.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.811 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' SER . 23.3 p -80.36 -46.78 15.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.349 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.9 56.2 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.583 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 54.1 t -82.44 143.15 31.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.17 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.453 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 33.4 mtmt -80.47 76.78 7.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG11 HD11 ' A' ' 42' ' ' ILE . 79.9 t -82.74 110.41 17.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.776 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -109.67 115.93 30.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.508 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.574 HD13 HG13 ' A' ' 67' ' ' VAL . 33.3 mm -89.24 106.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.333 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 46.8 m -87.24 107.46 14.83 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.862 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.0 Cg_exo -75.26 -38.28 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.818 3.012 . . . . 0.0 113.289 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.6 116.09 19.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.033 0.444 . . . . 0.0 110.259 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.612 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 16.4 p -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.713 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 -85.22 1.84 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.096 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.27 -13.35 83.4 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 59' ' ' SER . 6.3 mp -112.59 149.73 41.59 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.406 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -87.69 3.39 6.3 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.702 2.268 . . . . 0.0 110.252 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 3.4 pt-20 -125.96 -173.59 2.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.564 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.862 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 8.1 tpp85 -83.83 145.22 28.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.498 ' HB3' HD22 ' A' ' 62' ' ' LEU . 54.6 p -121.5 122.31 39.44 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.096 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.574 HG13 HD13 ' A' ' 55' ' ' ILE . 69.1 t -116.22 131.44 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -94.15 125.41 38.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.045 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 mm? -108.34 104.45 13.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.238 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.6 m -152.28 130.81 12.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -162.57 -82.25 0.04 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.926 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.65 168.33 12.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.586 ' N ' ' HG2' ' A' ' 16' ' ' PRO . 97.4 Cg_exo -45.43 -57.74 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.864 2.376 . . . . 0.0 113.675 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -76.66 -35.64 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.495 0.664 . . . . 0.0 110.067 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' SER . 33.7 m -68.63 -42.37 78.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.981 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.15 -31.77 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.848 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -74.11 -37.72 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 81' ' ' MET . 22.9 tptp -70.8 -36.24 72.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 110.413 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -63.76 -40.81 97.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.681 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.3 mtmt -81.92 -20.55 38.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.246 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.586 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 14.3 tpt -58.7 -55.71 31.57 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.751 175.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mmm -69.74 -38.42 76.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.979 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 87' ' ' VAL . 1.3 mm? -56.69 -58.09 9.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.336 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.04 -41.88 65.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.105 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 37.7 t70 -55.37 -59.2 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.4 mp -72.17 -37.15 58.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.1 0.476 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 83' ' ' LEU . 94.9 t -65.11 -31.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.2 m -71.87 -29.8 64.75 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.678 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 24.4 mmm180 -56.53 -49.38 74.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.966 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.94 -53.02 1.13 Allowed Glycine 0 C--O 1.228 -0.248 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.551 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.761 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 7.4 tpt85 -91.58 36.25 0.95 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.152 0.501 . . . . 0.0 110.106 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.74 72.11 0.49 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.27 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.439 -1.2 . . . . 0.0 111.457 177.947 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.7 pt . . . . . 0 C--O 1.236 0.349 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.0 t -155.57 144.66 20.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m 73.62 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.84 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -145.5 167.34 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.391 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD12 ' HD3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -155.66 135.68 12.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.993 178.366 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.71 81.46 0.21 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.593 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD3' HD12 ' A' ' 9' ' ' LEU . 67.3 Cg_endo -75.81 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.454 2.103 . . . . 0.0 112.363 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.783 HD11 HG23 ' A' ' 18' ' ' THR . 27.4 pt -131.14 161.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.537 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.587 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.2 m80 -90.52 -26.81 0.3 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 66.2 Cg_exo -39.37 168.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.23 2.62 . . . . 0.0 114.923 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 14' ' ' PRO . 1.3 Cg_endo -42.56 153.65 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.139 3.226 . . . . 0.0 113.941 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 60.4 Cg_endo -69.51 27.95 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 124.092 3.195 . . . . 0.0 113.765 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' HG3' HG22 ' A' ' 18' ' ' THR . 10.7 ptp180 -81.08 -20.82 40.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.401 0.619 . . . . 0.0 109.649 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.783 HG23 HD11 ' A' ' 12' ' ' ILE . 5.2 t -160.92 18.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.027 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 t -99.5 -98.85 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.7 ptp -64.83 88.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.641 0.734 . . . . 0.0 110.653 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.487 HG23 ' OG1' ' A' ' 70' ' ' THR . 29.2 m -92.66 113.46 25.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.808 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.463 ' CD ' ' HD2' ' A' ' 80' ' ' LYS . 19.2 tt0 -96.06 118.08 31.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -96.37 102.88 14.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -92.01 124.46 36.13 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.482 -169.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' OE2' ' A' ' 64' ' ' GLU . 50.9 mtp180 -81.01 118.93 22.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.679 174.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -137.31 123.77 13.46 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HG2' ' CG ' ' A' ' 30' ' ' MET . 20.5 Cg_endo -61.97 141.67 90.16 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.577 2.185 . . . . 0.0 110.632 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' HG12 ' A' ' 31' ' ' VAL . 30.5 t70 -59.05 -30.56 68.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.975 -167.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.94 -36.97 87.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.286 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.576 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.8 mmm -78.5 -27.91 46.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.66 -0.318 . . . . 0.0 111.002 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.4 p -70.98 -28.63 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.411 174.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.81 71.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.038 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.17 -28.63 23.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.0 tp -68.39 -29.95 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.862 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.664 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.7 pt -83.64 -14.04 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.201 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.66 -93.07 0.03 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 123.921 0.763 . . . . 0.0 113.496 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 12.8 ptp180 -64.15 -1.18 1.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.55 0.74 . . . . 0.0 112.493 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.59 11.1 18.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.276 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.664 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.9 -44.57 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.884 174.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 22.8 tt0 -55.72 -32.31 63.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -61.35 -47.83 84.08 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.436 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 53' ' ' VAL . 8.5 tp -61.59 -42.59 94.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.14 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.87 -38.91 83.51 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.77 -49.07 78.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.12 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 82' ' ' MET . 72.1 mt -63.64 -52.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.708 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -72.59 -43.9 62.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.209 -172.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 47' ' ' GLN . 6.3 tp60 -73.8 -26.02 60.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 110.818 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.21 -53.92 7.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.324 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.709 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 41.8 p -64.5 -40.83 96.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.14 7.72 20.84 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.242 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.659 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 38.6 t -92.81 135.19 34.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.771 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 41.2 mtmt -83.22 88.1 6.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 42' ' ' ILE . 58.4 t -95.34 111.14 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -111.1 116.04 30.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 67' ' ' VAL . 33.1 mm -80.69 100.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.7 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.52 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 17.7 m -85.53 114.45 56.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 6.0 Cg_exo -79.57 -27.02 4.39 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.383 2.722 . . . . 0.0 112.698 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.28 -23.87 30.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.616 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.499 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 74.7 p 53.64 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.841 1.257 . . . . 0.0 113.187 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.93 -100.33 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.51 18.29 50.21 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.066 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 64' ' ' GLU . 2.6 mm? -119.59 136.98 25.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.28 -8.69 11.71 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.905 2.403 . . . . 0.0 110.55 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.57 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 4.9 pt-20 -104.09 -162.01 0.87 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.784 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.711 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -95.81 148.26 22.78 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.499 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 65.4 p -122.38 125.2 45.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 55' ' ' ILE . 64.4 t -111.26 112.14 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.733 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -80.28 126.41 31.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.275 0.559 . . . . 0.0 110.817 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.041 HD13 ' HG2' ' A' ' 80' ' ' LYS . 16.0 mt -118.14 110.91 18.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.487 ' OG1' HG23 ' A' ' 21' ' ' THR . 2.6 m -151.22 121.79 7.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.791 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.57 -90.47 0.08 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.937 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.78 167.09 14.72 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.762 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 73.5 Cg_exo -39.89 -59.48 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.356 2.704 . . . . 0.0 114.276 -176.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -82.65 -37.58 24.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.423 0.63 . . . . 0.0 110.15 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.3 m -61.51 -46.32 90.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.399 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.585 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.8 p -72.33 -32.27 41.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.54 -38.72 74.23 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -63.12 -46.96 84.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.493 0.663 . . . . 0.0 110.317 177.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.07 75.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.856 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.041 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.3 mtmt -74.92 -21.41 59.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.078 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.687 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 19.0 ptm -69.08 -37.35 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.667 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.875 ' HG3' HD13 ' A' ' 45' ' ' ILE . 89.8 mmm -67.89 -43.12 80.06 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.639 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.9 mm? -59.38 -56.89 16.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.69 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.54 -39.48 57.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.27 -57.58 12.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.561 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.723 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.4 mp -73.04 -40.58 58.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.519 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 24' ' ' TYR . 81.7 t -61.43 -40.84 87.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.642 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HA2' ' A' ' 92' ' ' GLY . 72.3 m -68.36 -36.41 79.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.453 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.723 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.2 ptm180 -79.89 -7.68 58.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.793 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.576 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -131.43 9.63 5.58 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.477 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -162.37 -51.54 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.52 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 88' ' ' SER . . . 102.91 -54.79 0.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.622 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.231 -1.316 . . . . 0.0 111.031 178.977 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p 61.51 137.91 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.692 1.197 . . . . 0.0 112.388 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 8.6 m -121.62 81.15 1.77 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.102 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -67.67 109.43 3.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.677 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 53.0 mt -92.42 104.34 16.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.392 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -115.16 58.51 0.44 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.102 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.709 ' HD2' HD13 ' A' ' 12' ' ' ILE . 2.6 Cg_endo -82.28 -43.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.639 2.226 . . . . 0.0 112.12 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.873 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -87.72 138.49 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.298 0.571 . . . . 0.0 110.607 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.639 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 52.2 t-80 -78.31 -29.84 0.67 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 95.5 Cg_exo -35.9 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.751 2.967 . . . . 0.0 115.292 173.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.486 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.69 160.71 3.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.094 2.529 . . . . 0.0 111.58 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 38.5 Cg_endo -63.79 3.91 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.135 2.557 . . . . 0.0 114.021 -172.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD3' ' HG2' ' A' ' 15' ' ' PRO . 2.7 ptt180 -58.31 -29.58 66.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.071 0.462 . . . . 0.0 110.319 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -148.14 3.88 0.71 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.228 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.629 ' HA ' HG12 ' A' ' 12' ' ' ILE . 35.9 t -84.52 -96.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.344 -175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.0 ptp -68.09 80.05 0.23 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.593 0.711 . . . . 0.0 111.277 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -79.49 116.17 19.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -91.8 117.87 30.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 43.0 tt0 -87.62 103.86 15.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -91.22 110.45 21.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.686 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.441 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 64.1 mtp180 -80.26 103.53 10.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.959 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.36 127.52 25.83 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.366 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 52.5 Cg_exo -56.59 139.17 87.29 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.864 2.376 . . . . 0.0 111.831 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.85 -55.56 6.5 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -24.09 72.92 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.557 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.8 tpp -78.81 -18.73 53.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 ' HA ' HG22 ' A' ' 34' ' ' ILE . 2.1 t -73.02 -33.13 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.87 -30.07 56.19 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.913 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -88.03 -23.23 23.83 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 31' ' ' VAL . 6.8 tp -71.56 -28.32 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.992 0.814 . . . . 0.0 109.663 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.684 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.0 pt -85.59 -15.3 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.324 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.31 -89.24 0.02 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 124.086 0.866 . . . . 0.0 113.701 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.623 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 13.2 ptp180 -71.96 11.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.07 0.548 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 14.71 30.81 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.098 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.684 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.5 -46.39 0.78 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.412 173.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.623 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 9.4 tp10 -62.31 -22.22 65.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 45' ' ' ILE . 20.5 tt0 -64.63 -48.13 76.01 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.108 -0.37 . . . . 0.0 111.318 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 39' ' ' GLY . 7.1 tp -61.54 -42.44 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.46 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.3 m-20 -52.59 -52.54 54.74 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 123.66 0.6 . . . . 0.0 109.463 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -56.88 -48.8 77.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.104 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 41' ' ' GLN . 25.1 mm -62.27 -49.37 84.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.156 -175.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -79.33 -28.2 42.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.365 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -71.13 -42.09 69.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.79 -47.72 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.485 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.558 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 14.5 p -80.52 -38.29 30.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.896 -175.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.02 9.38 42.6 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.607 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 52.3 t -78.72 139.7 38.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.34 0.59 . . . . 0.0 111.352 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -88.2 79.94 7.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.891 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 69' ' ' LEU . 7.6 p -82.04 131.13 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.4 mm-40 -114.51 107.56 15.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.734 0.778 . . . . 0.0 110.703 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.61 HG23 ' NH1' ' A' ' 65' ' ' ARG . 18.5 mm -80.83 106.14 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.567 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.8 m -109.91 100.17 41.97 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.496 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -86.77 24.64 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.478 2.785 . . . . 0.0 111.05 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.43 -31.04 47.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.094 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 p 45.52 64.9 1.26 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.521 0.677 . . . . 0.0 111.075 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.16 116.24 4.9 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.948 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.83 -47.54 3.33 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -172.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 25' ' ' ARG . 2.6 mp -88.39 128.01 54.71 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.62 -13.35 10.8 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 121.96 1.773 . . . . 0.0 111.117 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.4 pt-20 -99.34 -155.62 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.715 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.61 ' NH1' HG23 ' A' ' 55' ' ' ILE . 5.5 mmm-85 -89.76 138.37 31.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.627 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 p -110.1 129.17 55.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.131 0.491 . . . . 0.0 110.286 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG22 ' NH2' ' A' ' 65' ' ' ARG . 87.7 t -119.22 116.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.138 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 74.2 m -93.67 135.21 35.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.132 0.492 . . . . 0.0 110.597 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.749 HD11 ' HG ' ' A' ' 83' ' ' LEU . 74.2 mt -118.86 127.97 54.0 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.792 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -150.73 157.54 43.07 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.266 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 148.69 -152.73 24.73 Favored Glycine 0 C--O 1.217 -0.911 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.179 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.87 152.42 80.03 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.06 -46.36 19.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.675 2.25 . . . . 0.0 112.717 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.63 -32.29 60.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.972 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -71.15 -49.74 40.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.541 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 9.2 p -67.02 -27.08 38.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.506 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 81' ' ' MET . 28.8 tt0 -72.54 -41.96 65.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.43 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HD2' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -64.82 -40.2 94.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.083 0.468 . . . . 0.0 110.419 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.33 88.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.92 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.674 ' HG2' HD13 ' A' ' 69' ' ' LEU . 55.6 mtmt -64.79 -23.33 67.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.642 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.6 mmm -60.44 -52.46 65.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.603 ' HA ' ' CE ' ' A' ' 82' ' ' MET . 10.1 mmt -70.84 -36.2 72.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.978 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.749 ' HG ' HD11 ' A' ' 69' ' ' LEU . 1.1 mm? -60.87 -60.48 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.29 -29.28 70.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 110.662 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.69 -60.26 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.26 0.553 . . . . 0.0 110.649 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.557 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.02 -37.0 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.07 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG21 ' HD2' ' A' ' 24' ' ' TYR . 65.6 t -62.53 -32.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.718 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -71.46 -39.99 70.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.253 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.9 ptp180 -72.97 -18.6 61.35 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.605 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.93 -65.07 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.649 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -80.93 -56.26 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.475 0.655 . . . . 0.0 110.298 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.2 -158.95 15.27 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 CA-C-O 117.749 -1.584 . . . . 0.0 111.189 178.18 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.725 0.298 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.4 p -87.4 122.77 31.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.634 ' HB3' ' OE1' ' A' ' 22' ' ' GLU . 39.7 m 68.39 -147.24 0.13 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.788 ' HB3' ' O ' ' A' ' 21' ' ' THR . 36.7 tt0 -175.4 -143.41 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.727 0.694 . . . . 0.0 110.074 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.645 ' H ' ' HG2' ' A' ' 8' ' ' GLN . 2.0 pt? -167.09 -61.15 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -175.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.633 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . 119.74 149.2 8.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.454 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HD3' ' HA2' ' A' ' 10' ' ' GLY . 6.2 Cg_exo -80.08 -52.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.146 2.564 . . . . 0.0 113.329 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.684 HG22 ' HD2' ' A' ' 14' ' ' PRO . 2.1 mt -93.47 128.59 44.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.699 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 45.5 m80 -92.61 3.57 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -168.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.758 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 19.0 Cg_endo -57.99 -162.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.559 2.173 . . . . 0.0 112.81 169.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 28.2 Cg_exo -38.59 155.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.874 2.383 . . . . 0.0 113.594 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 34.6 Cg_endo -64.68 23.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.231 3.287 . . . . 0.0 115.162 -171.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -78.94 2.13 21.31 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.527 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -179.13 2.27 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.688 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 16' ' ' PRO . 49.2 p -97.59 -8.87 28.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 16' ' ' PRO . 15.8 ptp -146.43 52.9 1.12 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.871 0.844 . . . . 0.0 109.452 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.788 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 94.6 m -78.25 116.77 18.93 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.788 177.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 7' ' ' SER . 2.8 tp10 -101.78 125.16 48.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.343 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -98.57 104.38 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.13 116.79 29.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.635 -169.503 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.638 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 23.9 mtp180 -81.78 109.52 16.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.883 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -125.05 125.09 25.36 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 110.808 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 51.4 Cg_exo -55.4 136.31 73.13 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.784 2.322 . . . . 0.0 110.885 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' HA ' HG23 ' A' ' 31' ' ' VAL . 28.1 t70 -58.61 -33.87 70.51 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.561 -168.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.42 -34.64 90.45 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.65 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.535 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 92.1 mmm -78.65 -9.92 59.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 34' ' ' ILE . 44.2 t -75.83 -40.46 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.96 -30.41 69.9 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.284 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.16 -28.97 25.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.3 tp -71.82 -28.94 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.413 0.625 . . . . 0.0 110.114 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.652 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.5 pt -80.46 -13.74 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.677 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.39 -91.82 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.954 0.783 . . . . 0.0 113.302 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.2 ptm85 -77.5 37.89 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.503 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.13 19.75 78.68 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.683 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.652 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.04 -49.33 0.6 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.92 173.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 28.2 tt0 -58.71 -28.7 66.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -169.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -56.42 22.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.818 0.281 . . . . 0.0 111.166 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.57 HD11 HG11 ' A' ' 53' ' ' VAL . 6.1 tp -57.29 -49.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.826 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.21 -38.88 88.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.036 0.446 . . . . 0.0 110.637 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -60.17 -44.29 95.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.71 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.06 -41.85 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.856 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -69.96 -37.38 75.8 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.07 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -71.36 -38.03 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.44 -51.77 66.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.072 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.79 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 32.9 p -70.56 -37.63 74.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.48 12.05 22.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.955 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 35.4 t -84.99 150.03 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.867 0.365 . . . . 0.0 110.149 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 67.2 mmtt -104.99 82.66 1.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.526 0.679 . . . . 0.0 109.693 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.57 HG11 HD11 ' A' ' 42' ' ' ILE . 40.8 t -93.02 113.59 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.165 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -107.29 129.7 54.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.783 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.485 HD13 HG13 ' A' ' 67' ' ' VAL . 30.1 mm -102.42 89.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.445 -174.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 35.0 t -79.95 114.6 47.69 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.698 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 5.5 Cg_exo -78.88 -32.54 1.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.588 2.859 . . . . 0.0 112.393 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.31 -34.62 42.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.503 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 40.4 t 71.02 -65.52 0.34 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.183 176.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.43 -55.92 0.59 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.098 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.75 -10.12 10.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.638 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.8 mt -112.91 144.59 31.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.798 0.332 . . . . 0.0 110.5 -173.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.42 -16.64 8.05 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.83 2.353 . . . . 0.0 110.336 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 4.3 pt-20 -92.98 -168.74 2.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.11 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.883 ' HB3' HG13 ' A' ' 26' ' ' VAL . 5.5 tpp180 -89.44 140.57 29.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.536 ' HB3' HD12 ' A' ' 62' ' ' LEU . 67.7 p -114.56 105.17 12.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.546 0.689 . . . . 0.0 109.345 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.485 HG13 HD13 ' A' ' 55' ' ' ILE . 95.3 t -98.13 121.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.8 m -89.67 128.16 36.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.412 0.625 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.731 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -106.56 112.33 25.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.9 m -151.32 143.69 24.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.988 -0.096 . . . . 0.0 110.805 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.54 -154.9 25.06 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.402 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -78.92 160.89 70.57 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -47.52 -53.07 6.99 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.796 2.33 . . . . 0.0 113.479 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -72.98 -40.33 65.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.975 0.417 . . . . 0.0 110.336 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.79 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.2 m -60.02 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.436 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.544 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 3.6 p -70.65 -30.01 40.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.01 -37.88 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 109.925 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.739 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.95 -47.06 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 177.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.11 -48.68 79.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.456 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.731 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 46.1 mtmt -68.52 -22.19 64.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.48 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.739 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 17.9 ptm -70.41 -36.47 74.05 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.497 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.62 -39.98 73.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.135 0.493 . . . . 0.0 110.097 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.0 mm? -64.55 -56.57 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.137 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.54 -35.14 67.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 110.557 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.76 -55.89 25.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.515 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.659 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -75.57 -37.19 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.979 0.419 . . . . 0.0 111.425 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 24' ' ' TYR . 72.6 t -68.13 -33.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.875 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.6 t -70.76 -38.63 73.49 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.821 -0.549 . . . . 0.0 110.304 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.659 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -78.39 -13.43 59.85 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.535 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -120.82 -20.58 3.42 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.016 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -116.11 -25.9 7.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.16 0.48 . . . . 0.0 110.524 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 -93.46 1.59 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.226 -1.319 . . . . 0.0 111.278 177.789 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.267 0.556 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.9 m -95.94 -166.72 1.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.186 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' HD22 ' A' ' 9' ' ' LEU . 49.2 m 68.78 -166.45 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.527 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 45.9 tt0 -64.45 112.98 3.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.776 0.322 . . . . 0.0 111.781 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 7' ' ' SER . 1.9 mm? -92.15 108.68 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 167.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 73.2 0.29 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.442 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 4.6 Cg_exo -74.99 -57.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.764 2.31 . . . . 0.0 111.874 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.649 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 pp -104.19 151.38 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.416 176.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 7.0 t-160 -90.6 -11.88 0.18 Allowed Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -170.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 72.7 Cg_exo -39.27 161.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.477 2.118 . . . . 0.0 114.337 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.49 148.47 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.703 2.935 . . . . 0.0 113.462 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.35 31.05 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.793 2.995 . . . . 0.0 113.905 -172.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -92.89 -0.36 57.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.874 0.369 . . . . 0.0 110.331 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.579 HG22 ' HD3' ' A' ' 17' ' ' ARG . 12.7 t -174.33 1.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.762 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 p -93.74 -85.09 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.1 ptm -72.56 71.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.596 0.712 . . . . 0.0 111.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.6 m -79.19 120.91 24.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.645 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.904 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 9.0 tp10 -92.58 118.88 31.47 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.82 106.19 18.42 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.556 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -92.26 118.61 31.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.944 -172.049 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.557 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 95.6 mtt180 -81.98 95.46 7.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.254 174.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -114.73 121.02 36.41 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.028 -176.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.622 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 51.5 Cg_exo -54.93 154.93 19.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.311 2.674 . . . . 0.0 112.442 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.71 -39.06 79.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.4 . . . . 0.0 111.236 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.23 64.11 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.876 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.41 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -78.0 -29.64 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.756 -0.261 . . . . 0.0 111.08 -177.01 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.67 ' HA ' HG22 ' A' ' 34' ' ' ILE . 5.8 p -73.25 -30.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.758 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -67.66 -22.32 73.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.364 170.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD23 HG23 ' A' ' 86' ' ' ILE . 62.0 tp -89.05 -30.13 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.67 HG22 ' HA ' ' A' ' 31' ' ' VAL . 10.8 tp -72.47 -26.18 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.401 0.619 . . . . 0.0 109.906 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.604 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.3 pt -81.24 -14.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -92.06 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 O-C-N 124.045 0.841 . . . . 0.0 113.281 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 11.1 ptp180 -71.13 3.78 3.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.016 0.526 . . . . 0.0 111.835 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.5 25.72 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.107 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.41 -50.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.45 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 28.9 tt0 -50.65 -36.16 34.19 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 45' ' ' ILE . 15.1 tt0 -59.81 -55.33 35.56 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 53' ' ' VAL . 5.1 tp -58.55 -46.64 89.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.53 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -56.42 -43.66 79.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 123.453 0.471 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.4 -43.25 95.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.646 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 41' ' ' GLN . 24.0 mm -65.19 -50.89 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.769 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -70.54 -27.77 64.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.987 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -72.45 -44.78 61.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.0 -50.02 73.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.436 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.4 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 24.6 p -67.7 -45.31 75.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.319 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.67 10.98 27.79 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.67 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.448 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 53.9 t -94.17 138.64 31.98 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.094 0.473 . . . . 0.0 110.094 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -85.95 79.94 9.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.616 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 42' ' ' ILE . 43.9 t -89.07 107.42 17.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.212 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB3' ' OG ' ' A' ' 68' ' ' SER . 12.1 tp60 -99.06 116.26 30.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -175.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 42' ' ' ILE . 44.5 mm -83.53 89.96 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.111 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 41.1 m -85.49 114.82 58.61 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 121.164 0.507 . . . . 0.0 111.036 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 12.1 Cg_exo -69.61 -36.6 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.324 2.683 . . . . 0.0 111.485 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.11 89.57 5.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.576 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 3.9 m -72.38 -19.31 61.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.155 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 -99.86 1.04 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.296 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.59 -26.87 66.51 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.263 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.3 mm? -87.25 139.95 32.26 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -85.05 0.71 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.766 2.311 . . . . 0.0 111.421 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -108.45 -110.57 0.31 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.8 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.609 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -133.92 149.57 51.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.576 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 82.7 p -119.77 111.4 17.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.734 0.778 . . . . 0.0 110.35 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.56 132.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.01 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 p -99.38 130.06 45.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.369 0.604 . . . . 0.0 111.485 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.904 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 2.9 mm? -110.49 105.78 14.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.233 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 18' ' ' THR . 6.5 m -150.97 128.01 11.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.939 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -166.81 -97.29 0.11 Allowed Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.924 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.54 163.68 43.61 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.25 -43.41 37.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.441 2.094 . . . . 0.0 112.593 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -79.44 -38.0 35.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.231 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -77.18 -41.76 40.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.087 0.47 . . . . 0.0 110.654 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -23.92 30.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.278 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.2 tp-100 -77.86 -45.6 23.81 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 81' ' ' MET . 4.9 tppp? -60.7 -45.83 92.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.026 0.441 . . . . 0.0 110.561 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.411 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -55.8 -49.73 72.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.393 176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.558 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.3 mtmt -69.54 -21.05 63.67 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.023 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.6 mmt -60.66 -50.18 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.172 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.635 ' HA ' ' CE ' ' A' ' 82' ' ' MET . 6.8 mmt -66.11 -39.5 89.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.067 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.1 mm? -66.27 -54.19 27.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.54 -30.68 67.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.27 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 15.2 t70 -66.03 -61.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.469 HG23 HD23 ' A' ' 33' ' ' LEU . 2.0 mp -68.66 -38.42 78.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.141 0.496 . . . . 0.0 111.295 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.556 HG21 ' HD2' ' A' ' 24' ' ' TYR . 76.9 t -66.62 -29.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -78.15 -22.68 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.345 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 26.7 mmm180 -66.87 -32.51 73.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.069 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.83 -64.38 0.82 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.754 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -87.91 157.36 18.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.101 0.477 . . . . 0.0 110.962 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.31 96.3 1.66 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 172.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.776 -1.014 . . . . 0.0 112.465 -177.51 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.5 tt . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.842 0.353 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m 67.54 178.38 0.24 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 10.5 t 68.49 -69.15 0.16 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.35 0.66 . . . . 0.0 110.176 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.679 ' HG3' ' H ' ' A' ' 9' ' ' LEU . 23.8 tp60 48.51 -156.47 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 111.667 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.679 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 4.2 pp 174.33 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.261 1.024 . . . . 0.0 108.301 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 9' ' ' LEU . . . 150.98 126.15 1.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.541 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.47 -13.75 22.63 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.542 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.94 HG12 ' HD2' ' A' ' 14' ' ' PRO . 13.1 tt -147.49 148.52 16.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.701 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.5 m-70 -90.38 -10.89 0.16 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.94 ' HD2' HG12 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -38.05 164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.802 2.334 . . . . 0.0 113.226 162.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -26.98 146.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 125.022 3.814 . . . . 0.0 115.871 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 47.5 Cg_endo -65.96 12.9 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.033 3.155 . . . . 0.0 114.213 -171.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -77.52 2.83 15.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 109.474 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 17' ' ' ARG . 8.4 t -159.83 -25.21 0.07 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.651 172.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 15.6 t -79.85 6.36 11.28 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.156 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 mmt -144.52 37.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.1 m -85.9 112.16 20.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 7' ' ' SER . 9.7 tt0 -123.56 119.49 30.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.228 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.74 102.19 14.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.645 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -92.37 136.76 32.93 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.725 -170.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 25' ' ' ARG . 7.5 mtm180 -101.85 129.38 48.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -135.03 124.11 16.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.801 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 91' ' ' ARG . 51.2 Cg_exo -55.8 140.99 85.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 111.731 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.63 -47.03 29.25 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.68 -31.11 79.81 Favored Glycine 0 C--O 1.238 0.349 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.697 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.515 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 84.2 mmm -77.99 -15.05 59.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 65' ' ' ARG . 17.4 t -72.43 -40.11 63.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.94 -29.94 68.85 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.342 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.69 -24.66 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -74.48 -26.34 20.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.507 0.67 . . . . 0.0 109.544 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.72 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 16.4 pt -88.1 -15.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.062 171.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.89 0.02 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.105 0.878 . . . . 0.0 113.72 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.667 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 4.2 ptp180 -81.02 14.07 2.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.014 0.525 . . . . 0.0 111.166 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 16.02 28.15 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.331 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.72 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.48 -49.74 0.58 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.303 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.667 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.0 tt0 -51.4 -33.56 30.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -173.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 45' ' ' ILE . 21.2 tt0 -60.59 -50.78 72.16 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.652 -173.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.547 HD11 HG11 ' A' ' 53' ' ' VAL . 8.1 tp -63.7 -43.59 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.514 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -62.06 -36.36 81.41 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -65.01 -52.62 55.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.141 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -60.08 -48.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.029 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.2 pp0? -73.5 -34.42 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.693 0.282 . . . . 0.0 111.167 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.87 -39.34 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.137 0.494 . . . . 0.0 110.51 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.68 -38.21 89.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.935 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.3 p -81.11 -43.97 18.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.36 8.64 28.68 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 41.5 t -90.0 132.68 35.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.979 0.418 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -79.82 79.25 6.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.288 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.547 HG11 HD11 ' A' ' 42' ' ' ILE . 47.6 t -87.31 107.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.064 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 10.8 mm100 -97.9 110.05 22.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.613 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 42' ' ' ILE . 49.7 mm -80.2 112.91 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.26 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.9 m -104.15 99.39 16.86 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.624 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 40.0 Cg_endo -68.95 -30.49 26.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.863 2.375 . . . . 0.0 110.943 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.42 79.62 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -72.62 -36.78 68.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.283 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.78 -69.56 3.2 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.844 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.18 -4.38 90.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.203 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.77 HD12 ' HB3' ' A' ' 66' ' ' SER . 56.6 mt -126.63 144.34 49.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.72 -19.54 9.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.687 2.258 . . . . 0.0 109.939 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 3.6 pt-20 -94.2 -161.9 0.89 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.034 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.89 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.7 tpp180 -99.62 146.27 26.65 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.77 ' HB3' HD12 ' A' ' 62' ' ' LEU . 83.8 p -118.43 134.23 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.905 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG13 HD13 ' A' ' 55' ' ' ILE . 57.1 t -128.7 122.68 57.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.633 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 54.3 m -86.04 123.82 31.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.308 0.575 . . . . 0.0 111.27 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.581 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.3 mm? -105.51 114.76 29.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.607 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.9 m -152.87 141.68 21.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.12 -133.53 1.96 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.617 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.732 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -114.59 166.29 11.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.732 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 8.3 Cg_endo -50.04 -41.87 47.35 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.909 2.406 . . . . 0.0 113.39 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -84.28 -44.95 13.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 23.8 p -66.48 -46.91 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -67.5 -32.51 57.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.303 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG3' ' A' ' 81' ' ' MET . 64.5 tt0 -74.55 -42.22 59.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' MET . 1.9 tpmt? -58.42 -51.65 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.935 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.85 72.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.995 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.581 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.5 mtmt -67.24 -22.62 65.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.543 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 61.7 mtt -62.96 -47.74 81.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.406 ' HG2' HG12 ' A' ' 45' ' ' ILE . 2.3 mpt? -65.25 -41.67 94.06 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.19 176.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' A' ' 69' ' ' LEU . 3.6 mm? -60.39 -57.13 14.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.59 -38.76 72.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.466 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' MET . 15.2 t70 -57.12 -51.68 68.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.386 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -80.4 -40.87 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.585 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.645 HG21 ' CD2' ' A' ' 24' ' ' TYR . 70.8 t -61.42 -41.98 92.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.852 0.358 . . . . 0.0 110.455 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -68.04 -40.3 82.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.621 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 8.1 ptp180 -69.9 -28.07 65.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.579 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.515 ' HA3' ' SD ' ' A' ' 30' ' ' MET . . . -118.08 10.6 13.45 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.477 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.488 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 2.0 tmt_? -156.19 -56.45 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.04 0.447 . . . . 0.0 109.996 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.01 -165.27 12.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.368 -1.24 . . . . 0.0 111.228 -179.297 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 121.649 0.738 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -123.26 162.01 23.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.902 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 70.6 m 68.51 -163.46 0.2 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.414 0.446 . . . . 0.0 110.582 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 21' ' ' THR . 77.2 mm-40 -162.53 -36.93 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.773 0.829 . . . . 0.0 109.317 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.16 -126.96 0.09 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.783 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 140.74 119.7 1.61 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.594 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.84 -6.88 17.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.679 . . . . 0.0 112.061 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.731 HG22 ' HD2' ' A' ' 14' ' ' PRO . 13.9 mt -92.03 113.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.596 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 26.8 m-70 -82.19 -11.74 0.18 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -165.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.731 ' HD2' HG22 ' A' ' 12' ' ' ILE . 76.3 Cg_exo -35.01 127.84 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.133 1.889 . . . . 0.0 112.874 169.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' ARG . 45.1 Cg_exo -36.97 132.4 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 124.391 3.394 . . . . 0.0 112.812 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 2.7 Cg_exo -25.23 62.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 127.076 5.184 . . . . 0.0 117.079 -159.587 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HA ' ' CG2' ' A' ' 70' ' ' THR . 11.8 ptp180 -122.2 10.34 9.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.57 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 7.9 t 174.11 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.147 178.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 18' ' ' THR . 32.7 t -79.58 -24.06 42.31 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.2 0.524 . . . . 0.0 110.221 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.439 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 8.8 ptp -155.26 70.17 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 51.8 m -78.79 120.68 23.77 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.868 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.7 tp10 -102.59 118.5 36.98 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.888 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 5.3 tp10 -94.06 105.85 17.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.613 170.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 115.04 27.73 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.272 -173.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 1.044 ' HG2' HD13 ' A' ' 62' ' ' LEU . 39.0 mtm105 -81.48 98.77 8.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 172.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -108.11 116.71 56.46 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.209 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.551 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 50.2 Cg_exo -50.63 139.08 39.6 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 123.291 2.66 . . . . 0.0 112.518 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -50.34 -48.5 55.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -28.36 73.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.29 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.551 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 91.0 mmm -78.78 -10.28 59.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 65' ' ' ARG . 39.5 t -77.12 -41.24 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.15 64.44 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.396 172.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.5 mt -89.01 -26.12 21.63 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 31' ' ' VAL . 10.5 tp -72.49 -27.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.477 0.656 . . . . 0.0 109.736 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.604 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.4 pt -84.27 -14.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.133 173.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.86 -90.8 0.07 OUTLIER Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.644 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.597 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.04 10.41 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.867 0.467 . . . . 0.0 111.698 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.13 35.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.111 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 154.1 -46.3 0.55 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.467 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.597 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 26.5 tt0 -48.18 -38.18 17.56 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -61.32 -45.57 93.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.521 HD11 HG11 ' A' ' 53' ' ' VAL . 5.7 tp -59.4 -49.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.424 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.11 -43.08 99.62 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.344 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -58.78 -39.25 80.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.364 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -81.27 -42.49 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.769 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -73.46 -26.83 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.61 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.99 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.41 -51.43 69.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.348 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 p -74.43 -37.29 63.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.772 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.53 2.43 60.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.533 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.411 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 51.4 t -79.67 139.98 37.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 110.56 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HE2' ' HA2' ' A' ' 71' ' ' GLY . 12.4 mttm -83.46 75.56 10.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.264 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.521 HG11 HD11 ' A' ' 42' ' ' ILE . 45.4 t -82.18 110.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.638 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 15.2 mm100 -102.41 106.44 17.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.675 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 67' ' ' VAL . 44.9 mm -81.04 106.05 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.411 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 15.1 m -98.99 107.49 44.17 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-O 120.753 0.311 . . . . 0.0 110.656 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.718 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 21.6 Cg_endo -62.13 -37.18 65.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.528 2.819 . . . . 0.0 112.249 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.12 97.12 8.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.481 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 4.2 p -70.84 -37.45 73.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.372 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.7 -72.9 2.72 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.312 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.19 70.53 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.714 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.044 HD13 ' HG2' ' A' ' 25' ' ' ARG . 22.2 mt -115.36 153.18 47.53 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.63 -31.28 2.04 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -94.33 -161.66 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.572 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.776 ' HB3' HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -81.35 151.06 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.713 ' HB3' HD12 ' A' ' 62' ' ' LEU . 88.5 p -118.11 114.24 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.036 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 55' ' ' ILE . 91.5 t -106.0 122.63 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.828 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 69.6 m -88.83 125.58 34.97 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.628 0.728 . . . . 0.0 110.78 177.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.868 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.9 mm? -105.04 109.58 21.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.449 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 26.3 m -151.26 144.75 24.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HE2' ' A' ' 52' ' ' LYS . . . 173.28 -107.82 0.26 Allowed Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.935 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -131.61 164.17 44.55 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.3 Cg_endo -47.4 -50.02 12.06 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.193 2.596 . . . . 0.0 112.994 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.53 -30.24 25.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' A' ' 72' ' ' ALA . 18.1 m -71.56 -48.25 49.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.411 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -69.51 -23.9 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -177.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.75 -51.01 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.319 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 81' ' ' MET . 24.4 tptm -62.7 -41.07 98.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.23 90.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.719 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 48.0 mtmt -74.93 -21.35 59.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.37 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 6.1 tpp -60.23 -46.42 89.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.451 ' HG3' HG12 ' A' ' 45' ' ' ILE . 20.4 mmt -71.02 -39.67 72.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.0 mm? -61.43 -48.92 78.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.321 177.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.5 -46.74 83.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.141 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -46.88 -58.13 4.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.385 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -79.57 -44.57 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.388 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.68 -27.49 36.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.747 0.308 . . . . 0.0 111.131 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -77.93 -38.55 45.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.471 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 3.3 ptp180 -72.26 -21.32 61.39 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.38 -83.15 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.379 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.85 60.72 4.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.187 0.518 . . . . 0.0 111.256 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.97 120.41 5.14 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.341 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.821 -179.403 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.704 HD11 ' HA3' ' A' ' 61' ' ' GLY . 41.4 pt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.206 0.526 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -115.94 -160.35 0.75 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.525 -174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 m 68.21 -170.96 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.704 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -53.24 112.41 0.87 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 16.1 tp -106.83 117.39 33.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.839 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.99 79.75 0.26 Allowed Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.926 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 9' ' ' LEU . 92.4 Cg_endo -87.78 -7.82 6.24 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.761 2.308 . . . . 0.0 112.734 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.812 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.9 tp -140.87 152.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.686 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 71.3 m80 -88.6 -27.08 0.34 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.6 Cg_exo -37.69 165.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.474 2.783 . . . . 0.0 114.16 165.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 17' ' ' ARG . 42.4 Cg_exo -58.3 169.44 2.97 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.139 2.559 . . . . 0.0 112.606 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 37.4 Cg_endo -64.29 21.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.066 3.177 . . . . 0.0 114.064 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 13.5 ptm180 -77.98 -18.12 56.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 70' ' ' THR . 9.9 t -164.5 6.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.366 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.57 ' HA ' HG22 ' A' ' 12' ' ' ILE . 33.6 t -92.36 -99.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.927 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.541 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 17.4 ptm -60.98 84.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.715 0.769 . . . . 0.0 111.407 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -84.89 114.96 22.5 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.613 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.8 tp10 -92.75 116.63 29.2 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.97 109.21 22.01 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.755 0.788 . . . . 0.0 109.25 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.798 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.56 125.14 36.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.664 -169.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 -84.35 99.12 10.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.185 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -119.63 121.93 29.57 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.838 -175.431 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.59 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 46.1 Cg_exo -59.11 150.11 75.6 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.543 2.829 . . . . 0.0 113.025 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.2 t70 -45.82 -59.28 2.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.59 -173.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.44 -24.64 73.76 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.666 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.59 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 78.1 mmm -78.97 -33.35 45.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.697 -0.296 . . . . 0.0 110.598 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.654 HG21 ' HG2' ' A' ' 65' ' ' ARG . 11.7 p -73.14 -28.07 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.868 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.07 72.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.161 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.18 -27.48 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -69.66 -28.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.574 0.702 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.712 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.4 pt -85.75 -15.19 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.515 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 58.31 -93.81 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 123.908 0.755 . . . . 0.0 112.95 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.948 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.07 37.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.115 0.566 . . . . 0.0 111.187 176.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 77.76 9.47 86.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 113.864 174.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.712 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.27 -42.33 0.86 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.185 174.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.948 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 34.0 tt0 -51.67 -30.96 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -66.45 -47.89 71.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 39' ' ' GLY . 10.4 tp -69.37 -36.95 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.857 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.86 -34.32 77.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.339 0.59 . . . . 0.0 110.18 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.149 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.432 HG13 ' HG3' ' A' ' 82' ' ' MET . 30.9 mm -74.14 -38.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.34 -174.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.25 64.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -77.24 -43.29 34.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.472 . . . . 0.0 109.729 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -54.92 -41.64 71.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.449 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.1 p -86.02 -38.04 18.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.289 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.73 2.98 52.76 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 48.2 t -79.51 139.72 37.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.307 0.575 . . . . 0.0 110.771 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -86.24 74.46 10.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.195 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -81.67 109.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.103 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -105.0 112.27 25.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 67' ' ' VAL . 39.2 mm -79.43 97.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 44.1 m -81.17 106.58 5.89 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.568 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.899 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 5.4 Cg_exo -77.86 -33.58 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.105 3.203 . . . . 0.0 113.157 -173.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.2 -25.87 42.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.991 0.425 . . . . 0.0 109.875 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.419 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.0 t 62.33 -154.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.901 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.39 108.16 0.22 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.704 ' HA3' HD11 ' A' ' 5' ' ' ILE . . . 96.22 -34.71 4.78 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.493 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 66' ' ' SER . 1.4 mm? -100.55 137.09 19.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 1.55 9.2 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.733 2.289 . . . . 0.0 111.912 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -111.11 -115.24 0.31 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.508 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.899 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 4.2 tpp180 -130.16 155.57 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.486 ' HB3' HD23 ' A' ' 62' ' ' LEU . 34.3 p -130.89 129.54 42.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.2 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 55' ' ' ILE . 60.9 t -114.55 130.99 67.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.127 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 p -97.91 128.25 44.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.588 0.709 . . . . 0.0 111.03 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.2 mm? -108.29 112.37 24.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.801 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.467 HG21 ' HA ' ' A' ' 18' ' ' THR . 2.3 m -150.86 155.37 39.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . 162.88 -71.3 0.21 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.382 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.71 161.36 24.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.27 -53.56 6.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.244 1.962 . . . . 0.0 112.558 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -71.23 -37.31 72.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.316 0.579 . . . . 0.0 110.714 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 14.2 m -72.85 -43.55 62.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.591 -171.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.467 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.4 p -70.13 -24.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 81' ' ' MET . 43.5 tp60 -82.01 -35.99 28.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.204 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' MET . 24.4 tptm -64.26 -45.92 86.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.69 0.757 . . . . 0.0 109.584 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.72 -48.21 75.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.284 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.576 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.1 mtmt -69.02 -21.51 64.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.993 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.602 ' HA ' ' CE ' ' A' ' 81' ' ' MET . 13.2 mmt -59.27 -47.56 84.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.9 0.381 . . . . 0.0 110.029 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.432 ' HG3' HG13 ' A' ' 45' ' ' ILE . 92.5 mmm -67.5 -45.77 74.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -59.42 -54.0 51.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.55 -35.13 78.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.483 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.31 -53.44 56.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.491 . . . . 0.0 110.793 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -76.66 -39.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.636 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.798 HG21 ' HD2' ' A' ' 24' ' ' TYR . 78.9 t -65.56 -31.86 55.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 13.4 t -78.02 -32.63 51.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.5 ptp180 -74.57 -16.37 60.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.889 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.01 -73.79 1.08 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.339 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.97 -37.16 55.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.127 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 88' ' ' SER . . . 94.19 -77.64 0.99 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.888 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.151 -179.153 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 tt . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.7 p -149.46 -173.7 4.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.838 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 47.9 m 70.57 -169.78 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.71 0.631 . . . . 0.0 111.739 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -36.42 117.37 0.48 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.57 1.148 . . . . 0.0 113.525 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' MET . 0.7 OUTLIER -121.27 137.33 54.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.596 170.101 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.48 71.75 0.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.793 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.77 -37.83 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.951 2.434 . . . . 0.0 112.819 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.664 HG22 ' HD2' ' A' ' 14' ' ' PRO . 8.9 mm -113.87 149.19 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.582 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 10.0 t60 -90.67 -41.72 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 12' ' ' ILE . 25.1 Cg_exo -41.79 171.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.629 2.886 . . . . 0.0 114.397 172.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -33.99 150.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.361 3.374 . . . . 0.0 114.833 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 55.7 Cg_endo -66.26 27.25 0.1 Allowed 'Trans proline' 0 N--CA 1.48 0.729 0 C-N-CA 124.265 3.31 . . . . 0.0 114.899 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -84.54 -8.16 59.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.412 0.625 . . . . 0.0 109.334 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -164.45 12.33 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.003 174.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 47.2 t -92.86 -99.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 15.7 ptp -68.71 78.07 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.644 0.735 . . . . 0.0 110.525 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -79.34 115.71 19.15 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.87 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.6 tp10 -95.16 118.77 32.52 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HB3' ' N ' ' A' ' 7' ' ' SER . 10.0 tp10 -105.1 106.24 16.64 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.539 -0.865 . . . . 0.0 108.861 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.503 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -91.66 124.96 36.21 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.133 -167.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.65 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 19.2 mtp180 -90.3 99.44 12.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.202 174.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -116.1 122.27 32.55 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.559 -175.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.48 145.85 44.93 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.796 2.331 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' HG12 ' A' ' 31' ' ' VAL . 1.4 p-10 -61.95 -28.75 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.306 -169.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -28.95 61.23 Favored Glycine 0 C--O 1.238 0.399 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.507 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.561 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 20.4 mmt -78.67 -31.27 46.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.344 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.674 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -69.99 -34.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.648 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.78 -30.36 69.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.556 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.44 HD12 ' HE2' ' A' ' 30' ' ' MET . 49.9 mt -87.81 -23.86 23.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 31' ' ' VAL . 10.2 tp -71.49 -30.23 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.654 0.74 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.701 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.7 pt -83.13 -14.79 11.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 -91.83 0.11 Allowed Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.214 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 14.3 ptp180 -76.74 -0.02 22.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.0 111.275 -176.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.67 10.39 8.53 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.811 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.701 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 158.01 -55.54 0.37 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.578 173.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 26.4 mm-40 -59.3 -23.92 62.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -59.99 -52.86 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.081 0.855 . . . . 0.0 110.576 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.596 HD11 HG11 ' A' ' 53' ' ' VAL . 6.3 tp -62.02 -45.33 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.021 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -54.7 -37.13 65.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.439 0.462 . . . . 0.0 110.745 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 40' ' ' GLU . 68.0 mttm -72.28 -41.76 66.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.198 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.21 -48.69 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 111.664 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.32 -31.46 71.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.069 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -74.09 -36.26 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.21 0.528 . . . . 0.0 109.879 176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.38 -32.25 73.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.053 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 8.0 p -96.87 -40.35 8.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.839 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.99 27.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.712 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 32.0 t -79.99 136.68 36.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.117 0.484 . . . . 0.0 110.734 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -84.22 72.17 10.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 42' ' ' ILE . 44.6 t -83.14 106.81 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.972 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -104.21 110.65 22.94 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.136 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.502 HD13 HG13 ' A' ' 67' ' ' VAL . 48.1 mm -79.78 112.62 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.679 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.489 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 2.6 m -94.82 102.05 8.25 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.084 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 86.7 Cg_endo -76.56 -21.36 13.1 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.982 2.455 . . . . 0.0 112.581 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.95 -41.77 25.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.025 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.613 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 9.0 t 73.78 -64.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.746 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 -76.5 2.2 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.143 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.77 -8.25 84.69 Favored Glycine 0 CA--C 1.511 -0.189 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.853 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.65 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.7 mt -121.16 146.82 45.32 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.65 -20.7 10.48 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.61 2.206 . . . . 0.0 110.242 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -93.05 -163.94 1.11 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.752 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.674 ' HG2' HG21 ' A' ' 31' ' ' VAL . 6.0 tpp180 -92.18 147.01 23.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.561 ' HB3' HD12 ' A' ' 62' ' ' LEU . 78.0 p -117.91 141.66 48.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.674 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.502 HG13 HD13 ' A' ' 55' ' ' ILE . 87.7 t -137.68 120.94 20.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.382 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 p -92.46 125.5 37.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.604 0.716 . . . . 0.0 111.497 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.7 mm? -105.23 120.01 40.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.19 155.74 40.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.11 -121.21 1.01 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.198 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.528 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -119.45 164.01 24.01 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 89.3 Cg_exo -47.72 -46.33 21.45 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.573 2.182 . . . . 0.0 112.695 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -75.47 -46.64 31.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.923 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.667 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 1.5 m -61.51 -48.65 80.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.281 -173.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.0 p -70.09 -24.26 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.381 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.76 -45.94 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -58.72 -48.69 80.3 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.36 0.6 . . . . 0.0 110.187 176.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.16 -52.09 67.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.886 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.789 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.0 mtmt -68.39 -21.97 64.66 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.253 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 10.6 ptm -72.08 -32.49 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.846 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.6 mmt -66.77 -47.62 71.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 110.011 171.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.29 -52.27 66.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.737 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.98 -38.38 70.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.837 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.52 -60.39 3.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.541 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.598 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.8 mp -72.61 -37.73 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 111.727 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 24' ' ' TYR . 69.7 t -67.68 -26.1 34.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.781 -0.574 . . . . 0.0 111.113 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t -75.67 -34.66 60.48 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.387 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.598 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -77.48 -12.87 60.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.077 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.84 -55.97 0.82 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.546 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.41 39.26 0.94 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.043 0.449 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.76 82.96 1.55 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.63 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.709 -1.051 . . . . 0.0 111.169 -177.367 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.561 0.22 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.4 t -153.19 155.19 36.2 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m 62.26 -161.41 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.748 0.655 . . . . 0.0 110.807 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 21' ' ' THR . 26.1 mt-30 -147.92 -93.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp 172.97 -173.4 0.05 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.376 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' C ' ' A' ' 19' ' ' SER . . . -143.52 114.89 0.86 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.076 172.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 -24.79 26.01 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.874 2.383 . . . . 0.0 113.269 -174.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.6 HD12 ' HG2' ' A' ' 14' ' ' PRO . 17.0 pt -121.67 164.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.157 0.503 . . . . 0.0 111.098 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.664 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 63.4 m80 -90.09 -19.11 0.24 Allowed Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 73.2 Cg_exo -39.5 167.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.601 2.2 . . . . 0.0 114.077 168.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 17' ' ' ARG . 7.0 Cg_endo -49.29 165.61 0.22 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.371 2.714 . . . . 0.0 113.057 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' A' ' 73' ' ' PRO . 31.3 Cg_endo -63.75 34.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.061 3.174 . . . . 0.0 114.723 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 15' ' ' PRO . 12.4 ptm180 -86.21 0.3 54.04 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 12' ' ' ILE . 12.7 t -178.92 -12.77 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.011 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.582 ' C ' ' HA3' ' A' ' 10' ' ' GLY . 12.6 t -79.59 1.6 25.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.5 ptm -164.26 72.73 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.591 . . . . 0.0 110.732 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 48.4 m -79.13 122.22 25.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.586 ' HG2' ' HD2' ' A' ' 24' ' ' TYR . 1.6 tt0 -102.28 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.977 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -91.09 103.38 16.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.586 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -92.37 127.3 37.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.399 -172.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 63.9 mtp180 -81.59 111.46 17.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.294 0.568 . . . . 0.0 110.751 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.793 HG11 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -128.65 121.64 21.24 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.855 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 33.9 Cg_endo -68.55 151.38 75.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.932 1.755 . . . . 0.0 110.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -37.75 64.86 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -166.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.42 80.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.478 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.515 ' HB2' HG23 ' A' ' 26' ' ' VAL . 32.0 mmt -78.42 -15.99 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 34' ' ' ILE . 40.3 t -70.01 -44.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.31 -31.73 80.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.089 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.505 HD12 ' CE ' ' A' ' 30' ' ' MET . 45.2 mt -88.37 -23.24 23.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -71.11 -29.75 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.357 0.599 . . . . 0.0 109.508 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -85.37 -15.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.284 170.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.35 -90.6 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.498 0 O-C-N 124.401 1.063 . . . . 0.0 112.429 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 16.2 ptt-85 -76.69 48.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.884 -0.658 . . . . 0.0 111.579 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.83 11.79 61.11 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.902 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.702 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.03 -42.0 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.292 -1.433 . . . . 0.0 113.534 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.59 -32.23 66.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.4 tt0 -61.72 -52.48 64.12 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.439 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.539 HD11 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -62.0 -41.27 90.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.521 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -58.1 -48.17 80.99 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -60.13 -40.49 89.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.909 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.636 HD13 ' HG3' ' A' ' 82' ' ' MET . 87.8 mt -70.89 -50.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.448 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -26.96 62.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -175.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -78.46 -35.99 45.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.164 0.507 . . . . 0.0 110.218 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -42.74 99.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.857 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.768 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 11.9 p -84.88 -38.79 19.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.26 11.35 31.83 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.435 ' N ' ' HB3' ' A' ' 75' ' ' SER . 51.2 t -86.45 154.51 21.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.213 0.53 . . . . 0.0 110.28 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -105.58 71.58 0.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.054 0.93 . . . . 0.0 109.241 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.539 HG11 HD11 ' A' ' 42' ' ' ILE . 37.3 t -81.99 119.34 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.174 -175.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 14.4 mm-40 -113.69 120.4 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.4 mm -83.61 93.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 t -79.71 110.89 17.38 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.1 Cg_exo -80.85 -9.39 13.16 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.654 2.902 . . . . 0.0 111.157 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 -37.91 46.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.902 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.556 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 11.2 m 70.03 -59.64 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.161 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.56 -87.65 1.46 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.775 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -87.66 3.25 86.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 66' ' ' SER . 5.1 mp -124.19 139.55 32.97 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -170.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -87.19 -24.17 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.794 2.329 . . . . 0.0 111.972 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.855 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -88.44 -84.16 0.21 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.677 -175.13 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 5.4 tpp85 -160.61 153.92 21.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.662 ' HB3' HD22 ' A' ' 62' ' ' LEU . 88.3 p -124.55 130.24 52.08 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.235 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.793 HG23 HG11 ' A' ' 26' ' ' VAL . 85.8 t -105.11 115.7 47.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 72.2 m -79.76 120.32 23.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.366 0.603 . . . . 0.0 109.806 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.9 HD13 ' HG2' ' A' ' 80' ' ' LYS . 27.1 mt -113.27 105.01 12.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -150.12 145.12 26.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.218 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.33 -98.32 0.11 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 119.741 -1.219 . . . . 0.0 113.607 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -138.06 165.04 36.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 93.0 Cg_exo -45.06 -66.12 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.066 2.511 . . . . 0.0 113.46 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.75 -39.99 80.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.458 0.647 . . . . 0.0 110.235 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.768 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 7.1 m -59.64 -46.19 89.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.709 -173.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.638 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.2 p -73.74 -31.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.879 -173.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.79 -42.26 86.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.048 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 81' ' ' MET . 2.4 tmtp? -70.29 -42.26 72.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.688 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.26 93.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.0 111.414 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.9 ' HG2' HD13 ' A' ' 69' ' ' LEU . 5.1 mtmp? -81.19 -21.22 39.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.6 tpt -60.32 -47.49 85.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 173.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.636 ' HG3' HD13 ' A' ' 45' ' ' ILE . 18.9 mmt -68.17 -37.62 81.2 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 176.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.737 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.2 mm? -59.44 -49.84 76.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.28 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.15 -42.63 66.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.735 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.87 -56.5 20.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.661 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.6 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -71.27 -41.15 74.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.045 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 24' ' ' TYR . 60.7 t -63.56 -23.87 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 O-C-N 121.886 -0.509 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.9 m -85.07 -26.01 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 15.4 ptp180 -77.04 -12.94 60.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.148 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.28 -39.92 1.45 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.693 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.611 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -115.74 47.71 1.31 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 0.0 110.945 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.29 36.82 3.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.319 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.18 -1.345 . . . . 0.0 110.981 -177.569 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p 56.09 -162.37 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.873 0.869 . . . . 0.0 111.586 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m 62.37 -168.66 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.662 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 21' ' ' THR . 26.8 mt-30 -64.98 109.5 2.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.304 0.573 . . . . 0.0 111.815 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -84.8 133.53 34.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.91 77.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.847 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.96 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.734 2.289 . . . . 0.0 112.207 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -109.03 157.89 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.553 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 54.6 t60 -91.02 -26.98 0.3 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 49.7 Cg_exo -37.12 166.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 123.441 2.76 . . . . 0.0 115.097 170.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.13 153.92 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.776 2.984 . . . . 0.0 113.879 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 38.6 Cg_endo -64.54 12.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.416 3.411 . . . . 0.0 114.3 -174.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 17' ' ' ARG . 3.8 ptp180 -64.9 -24.5 67.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.225 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -154.1 -5.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.947 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.408 ' OG ' ' HA ' ' A' ' 16' ' ' PRO . 27.1 p -79.79 -90.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.061 -0.4 . . . . 0.0 111.433 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.5 ptm -70.45 76.15 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.629 0.728 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 HG23 ' A' ' 70' ' ' THR . 24.8 m -84.53 116.21 23.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.336 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.93 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 5.5 tp10 -92.66 118.2 30.79 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -97.26 101.92 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -95.09 121.08 36.35 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.726 -171.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.422 ' HD3' HD22 ' A' ' 62' ' ' LEU . 82.9 mtt180 -81.94 123.81 29.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.544 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -136.44 124.23 14.74 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.575 -175.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.679 ' HG2' ' HA ' ' A' ' 91' ' ' ARG . 35.8 Cg_exo -59.48 152.93 58.03 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.858 2.372 . . . . 0.0 113.338 -175.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' VAL . 24.2 t70 -50.11 -52.12 37.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.1 70.43 Favored Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.075 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.49 ' SD ' HG23 ' A' ' 86' ' ' ILE . 47.7 tpp -79.26 -27.61 42.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.639 -0.33 . . . . 0.0 110.695 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.2 p -74.59 -25.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.49 -24.98 73.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.874 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.0 mt -87.76 -24.69 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.2 tp -70.92 -32.71 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.596 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.3 pt -82.97 -14.6 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.15 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.16 -94.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.608 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 9.7 ptm180 -63.17 -10.32 14.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.589 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.08 4.96 5.84 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.08 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.79 -53.1 0.4 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.134 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 41.2 tt0 -55.43 -20.73 13.22 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.12 -53.16 61.54 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.865 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.537 HD11 HG11 ' A' ' 53' ' ' VAL . 11.2 tp -65.73 -36.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.918 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.47 -41.25 89.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.155 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -60.67 -56.78 17.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.843 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' CG1' ' HG2' ' A' ' 82' ' ' MET . 1.5 mp -54.61 -56.63 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.159 -176.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -70.03 -34.61 73.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -170.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -79.62 -35.49 39.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 110.327 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.99 -26.63 66.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.368 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 p -95.06 -40.58 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.743 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.31 18.23 9.34 Favored Glycine 0 CA--C 1.505 -0.567 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.809 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.95 160.96 14.2 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 0.0 111.978 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 46.3 mtmt -101.3 76.25 1.69 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.16 173.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 42' ' ' ILE . 41.8 t -90.4 109.05 20.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.697 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -113.02 137.8 50.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.65 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.3 116.29 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.291 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -95.01 107.1 29.37 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.227 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 1.002 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 81.9 Cg_endo -78.62 -30.15 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.89 2.393 . . . . 0.0 112.805 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.73 -44.44 23.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.8 t 68.65 -68.33 0.18 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.893 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.9 -86.69 0.46 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.595 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.24 -1.1 90.45 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.132 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 66' ' ' SER . 48.8 mt -119.2 135.81 24.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.96 -17.36 17.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.687 2.258 . . . . 0.0 110.459 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.7 pt-20 -94.26 -162.44 0.94 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.101 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 1.002 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -99.64 156.64 16.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.682 ' HB3' HD12 ' A' ' 62' ' ' LEU . 24.7 p -128.64 135.82 49.82 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.693 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.08 129.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.565 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.1 m -91.72 127.62 37.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.349 0.595 . . . . 0.0 111.146 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 4.2 mm? -108.1 117.63 34.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.325 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.429 HG23 HG23 ' A' ' 21' ' ' THR . 0.6 OUTLIER -150.34 156.6 41.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.021 176.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.17 -152.21 23.65 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.785 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -80.37 159.54 69.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 6.3 Cg_endo -49.08 -50.0 13.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.755 2.303 . . . . 0.0 112.368 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.33 -44.8 82.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.408 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.611 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 9.7 m -62.03 -54.61 39.07 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.034 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -25.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.302 -172.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 81' ' ' MET . 51.1 tt0 -71.45 -50.58 30.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -57.7 -50.73 72.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.754 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . . . -54.17 -48.31 71.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.134 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.735 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 38.3 mtmt -67.09 -21.5 65.87 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.381 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 94.0 mtp -66.85 -41.45 87.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.459 ' HG2' ' CG1' ' A' ' 45' ' ' ILE . 2.6 mpt? -65.91 -47.43 74.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.711 0.291 . . . . 0.0 111.048 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.479 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.3 mm? -57.95 -55.56 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.943 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.7 -44.71 77.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.554 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.24 -53.32 55.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.517 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.751 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 2.0 mp -75.29 -45.25 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.713 -175.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 24' ' ' TYR . 84.7 t -61.82 -40.19 86.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.076 0.465 . . . . 0.0 110.717 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -72.83 -28.5 62.58 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.056 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.751 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -73.28 -21.93 60.49 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.836 -178.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.02 63.27 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.048 -1.549 . . . . 0.0 114.608 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HA ' ' HG2' ' A' ' 27' ' ' PRO . 36.1 ttt180 -84.68 77.51 10.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.697 0.748 . . . . 0.0 109.744 170.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.77 105.28 0.26 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.862 179.493 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.546 0.212 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t 67.9 92.7 0.08 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.762 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.874 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 40.1 m 63.19 -152.2 0.33 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.931 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 7' ' ' SER . 26.1 mt-30 -178.77 -103.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.339 1.055 . . . . 0.0 108.668 166.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 38.1 tp 158.83 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.399 1.062 . . . . 0.0 109.082 176.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 152.94 108.11 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.237 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.2 -8.54 23.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.824 2.349 . . . . 0.0 112.013 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.618 HD12 HG21 ' A' ' 18' ' ' THR . 1.0 OUTLIER -114.44 142.62 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.812 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.704 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 18.7 t-80 -92.55 -11.1 0.17 Allowed Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -172.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.4 Cg_endo -56.4 -175.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.515 2.144 . . . . 0.0 113.15 176.582 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 14' ' ' PRO . 1.8 Cg_endo -44.22 153.7 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.885 2.39 . . . . 0.0 112.962 174.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 36.7 Cg_endo -65.46 33.81 0.11 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 124.286 3.324 . . . . 0.0 115.254 -174.422 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -84.56 7.2 20.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.626 0.726 . . . . 0.0 109.213 175.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 12' ' ' ILE . 8.9 t -176.02 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.127 175.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.555 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 1.8 m -86.41 9.66 17.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.001 -178.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.672 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 18.5 mmt -146.47 31.23 0.99 Allowed 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.002 177.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 85.7 m -78.92 114.51 17.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.874 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 19.8 tt0 -121.64 118.86 30.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.818 176.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -87.63 110.65 20.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.486 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.34 124.0 34.03 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.81 -166.251 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.839 ' HG2' HD21 ' A' ' 62' ' ' LEU . 48.9 mtm180 -81.86 103.73 11.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.302 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.3 124.59 26.81 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.508 -175.993 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.0 148.09 78.68 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.424 2.083 . . . . 0.0 111.644 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 31' ' ' VAL . 37.8 t70 -54.47 -51.43 65.07 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.85 -24.52 70.01 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.838 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.457 ' SD ' HD23 ' A' ' 33' ' ' LEU . 30.4 tpp -79.32 -29.64 42.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.477 -0.361 . . . . 0.0 110.828 -175.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 34' ' ' ILE . 13.4 p -70.99 -26.32 27.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -30.12 75.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.421 169.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD23 ' SD ' ' A' ' 30' ' ' MET . 64.3 tp -84.15 -31.01 25.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 177.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.5 tp -70.39 -26.42 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.667 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 8.5 pt -81.42 -14.38 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.557 174.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.7 -92.19 0.1 Allowed Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.316 172.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.762 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -77.34 20.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.86 0.464 . . . . 0.0 111.393 -179.458 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.89 58.88 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.042 177.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.667 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 154.53 -45.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.388 176.094 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.762 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 49.6 tt0 -56.59 -29.09 61.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' HG12 ' A' ' 45' ' ' ILE . 25.4 tt0 -62.43 -53.24 57.8 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.442 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 53' ' ' VAL . 8.6 tp -62.95 -38.71 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.261 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.97 -42.99 99.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -58.51 -43.2 89.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.602 176.064 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.6 mm -69.96 -50.93 44.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.912 -176.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.24 -31.92 68.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 -174.688 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -76.04 -38.36 57.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 110.17 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 11.9 t70 -62.82 -50.57 70.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.851 178.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 p -70.85 -45.52 64.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.73 -4.36 26.04 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.464 -176.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 41.6 t -79.12 135.16 36.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.11 0.481 . . . . 0.0 110.099 178.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -85.02 74.5 10.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.519 0.676 . . . . 0.0 110.104 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 42' ' ' ILE . 44.9 t -82.49 115.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.789 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.6 mm-40 -119.48 129.95 54.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.856 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.425 HD13 HG13 ' A' ' 67' ' ' VAL . 42.7 mm -83.95 109.12 17.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.754 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.525 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 7.3 m -82.4 111.33 27.43 Favored Pre-proline 0 C--O 1.242 0.662 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.576 -178.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.801 ' HA ' HH11 ' A' ' 65' ' ' ARG . 60.8 Cg_endo -73.01 -27.73 13.76 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.949 2.433 . . . . 0.0 111.858 178.094 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.46 88.39 2.72 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.855 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 5.3 p -65.6 -39.2 91.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.238 -175.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.01 -61.51 4.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.729 174.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.613 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -93.86 4.88 72.36 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.817 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.855 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.8 mp -127.71 151.38 75.3 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.36 -0.42 . . . . 0.0 109.941 -170.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -90.89 -4.4 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.696 2.264 . . . . 0.0 111.072 171.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 91' ' ' ARG . 1.6 pt-20 -119.52 -153.27 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.962 -177.335 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.801 HH11 ' HA ' ' A' ' 57' ' ' PRO . 14.6 tpp180 -91.97 157.86 16.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.772 ' HB3' HD22 ' A' ' 62' ' ' LEU . 56.9 p -131.96 153.41 50.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.642 174.161 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 HD13 ' A' ' 55' ' ' ILE . 57.5 t -135.19 131.75 52.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.2 m -89.87 127.66 36.04 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.284 177.49 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.751 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -110.57 107.48 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 175.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -152.54 134.64 14.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.61 -147.39 7.84 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.846 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.6 160.2 70.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . 99.9 Cg_exo -45.06 -56.51 2.66 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.033 2.489 . . . . 0.0 114.237 -174.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -84.15 -30.98 25.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.956 -178.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 m -62.38 -43.33 99.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.007 0.432 . . . . 0.0 110.696 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.8 p -66.86 -27.77 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.546 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.4 tp-100 -73.52 -50.28 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.126 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -54.2 -43.89 71.14 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.207 0.527 . . . . 0.0 110.566 178.798 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.71 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.562 176.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.751 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 9.8 mtmp? -66.16 -21.23 66.32 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.854 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.4 mmm -67.7 -43.41 80.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.83 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.0 mmm -66.73 -34.55 78.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 175.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.37 -49.09 65.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -51.3 -44.59 61.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.614 177.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 10.5 t70 -64.08 -61.04 2.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.682 -178.249 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.455 ' HB ' HD13 ' A' ' 34' ' ' ILE . 1.9 mp -66.68 -40.51 86.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.27 -174.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 24' ' ' TYR . 77.3 t -67.82 -26.86 35.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.502 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.4 t -72.79 -26.25 61.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.815 0.341 . . . . 0.0 110.239 175.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 25.5 mmt180 -63.6 -41.91 98.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.21 0.529 . . . . 0.0 109.671 176.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.45 -59.51 1.72 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.721 178.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.44 HH21 ' CD ' ' A' ' 64' ' ' GLU . 33.2 mmt180 -88.35 57.85 4.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.469 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.14 -126.16 1.15 Allowed Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.644 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.634 -1.092 . . . . 0.0 111.77 178.989 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.697 0.761 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 p -153.47 -169.7 3.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.2 t 73.42 -69.67 0.18 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.678 0.611 . . . . 0.0 111.024 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -155.93 143.49 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.099 0.476 . . . . 0.0 110.889 -177.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -134.65 98.56 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 67.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 172.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.12 -11.86 14.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.917 2.411 . . . . 0.0 111.826 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.541 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 23.2 pt -124.97 154.9 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.692 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 49.4 t-80 -89.45 -22.1 0.27 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 23.8 Cg_exo -42.23 168.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.692 2.262 . . . . 0.0 114.474 174.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 17' ' ' ARG . 65.4 Cg_exo -41.25 157.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.758 2.972 . . . . 0.0 114.36 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 35.1 Cg_endo -66.83 28.6 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.901 3.067 . . . . 0.0 114.357 -175.171 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 15' ' ' PRO . 88.4 mtt180 -73.19 -26.69 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.496 HG23 HD11 ' A' ' 12' ' ' ILE . 2.7 t -158.36 10.16 0.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.353 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.5 t -101.07 -12.51 18.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.391 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 21.8 mmt -134.33 34.46 3.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 -176.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 87.3 m -79.68 112.19 16.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 14.4 tt0 -111.01 119.09 37.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -96.61 103.21 15.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -91.81 118.68 30.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.973 -166.853 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 32.4 mtm180 -81.78 114.74 20.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.776 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.1 p -135.45 131.87 19.62 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.065 -173.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.614 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 38.2 Cg_exo -61.8 146.28 96.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.905 2.403 . . . . 0.0 111.555 177.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' HA ' HG12 ' A' ' 31' ' ' VAL . 2.6 p-10 -59.89 -30.32 68.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.405 -172.086 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.62 -33.24 56.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.177 176.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.736 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 83.7 mmm -78.82 -29.48 44.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.904 -0.174 . . . . 0.0 110.795 -176.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.0 p -69.72 -31.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.358 173.051 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.58 70.38 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.431 171.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.76 -23.65 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.9 tp -72.37 -27.32 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.457 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.615 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.6 pt -85.18 -14.75 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.155 171.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.42 -97.78 0.1 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.362 173.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 14.2 ptm180 -58.99 -22.39 60.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.097 0.559 . . . . 0.0 111.63 178.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -7.63 1.83 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.785 177.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 167.85 -48.36 0.24 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.256 176.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 28.3 tt0 -59.96 -21.64 61.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -171.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 tm0? -60.26 -55.32 35.14 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.316 0.507 . . . . 0.0 110.582 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.84 -38.66 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.76 -36.83 79.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 28.1 tptp -63.04 -58.64 6.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.125 176.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.47 -41.37 87.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.259 -174.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.1 pp0? -71.85 -40.32 69.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.85 -176.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -73.76 -30.29 62.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.347 0.594 . . . . 0.0 110.537 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 13.0 t70 -69.12 -43.99 73.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.716 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 39.4 p -80.03 -35.36 37.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 7.19 30.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.626 -177.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 33.9 t -90.71 141.47 28.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -94.05 89.09 5.9 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.238 0.542 . . . . 0.0 109.657 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.37 106.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.745 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -106.0 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -175.255 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.452 HD13 HG13 ' A' ' 67' ' ' VAL . 43.1 mm -78.9 116.94 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 t -107.76 112.91 61.81 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 111.133 -177.235 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 18.6 Cg_exo -66.89 -37.49 19.78 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.357 2.705 . . . . 0.0 111.306 175.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -80.11 83.28 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.4 m -76.31 4.19 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.11 -169.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.16 -92.91 1.07 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.826 169.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.8 -11.26 58.08 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.553 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 59' ' ' SER . 3.0 mm? -103.78 142.87 25.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.1 -18.75 2.18 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.752 2.301 . . . . 0.0 112.502 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -83.41 -86.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.391 -175.253 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HB3' HG13 ' A' ' 26' ' ' VAL . 1.3 tpp180 -160.27 154.31 23.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 176.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 22.1 t -139.35 143.8 37.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 55' ' ' ILE . 46.3 t -129.84 134.95 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.189 -175.305 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.8 m -92.49 128.69 38.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.422 0.63 . . . . 0.0 111.557 177.81 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.662 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.6 mm? -110.48 112.91 25.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.579 177.154 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -151.5 148.22 27.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.042 176.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.65 -131.58 2.4 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.601 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.6 162.99 18.53 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.34 -48.58 19.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.823 2.349 . . . . 0.0 113.376 -174.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.48 -41.19 40.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 29.4 p -65.5 -41.56 93.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.454 0.645 . . . . 0.0 110.34 -174.208 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.15 -26.57 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.773 -176.781 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 81' ' ' MET . 47.6 mt-30 -82.62 -34.04 27.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.608 177.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -65.84 -43.79 87.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.671 0.748 . . . . 0.0 109.684 176.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.36 78.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.104 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.2 mtmt -77.05 -19.94 56.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.039 -174.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -57.05 -55.04 39.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.879 173.214 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.75 -35.87 82.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.2 mm? -65.99 -56.85 9.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -177.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -52.86 -40.86 63.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.571 179.225 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.532 ' HB3' HD12 ' A' ' 86' ' ' ILE . 7.4 t70 -53.52 -60.03 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.335 -178.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 89' ' ' ARG . 2.5 mp -76.25 -44.37 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.683 -175.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 26' ' ' VAL . 98.8 t -59.1 -39.8 79.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.52 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 t -70.2 -39.11 75.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.804 -179.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 11.4 ptt180 -77.33 -7.47 56.09 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.526 -176.099 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.736 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -121.85 0.74 10.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.681 174.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -164.03 100.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.24 68.68 1.43 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.903 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.707 -1.052 . . . . 0.0 111.256 -179.959 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 7' ' ' SER . 48.9 m -80.21 166.39 21.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.481 178.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.8 t 75.19 -68.61 0.2 Allowed 'General case' 0 C--O 1.224 -0.283 0 O-C-N 123.767 0.667 . . . . 0.0 110.976 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -149.01 136.46 20.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.282 0.563 . . . . 0.0 111.599 -177.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.845 ' HG ' ' HD3' ' A' ' 11' ' ' PRO . 57.1 tp -115.28 136.29 53.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.088 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.26 63.76 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.653 177.918 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.845 ' HD3' ' HG ' ' A' ' 9' ' ' LEU . 93.3 Cg_endo -86.47 -19.78 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.306 2.004 . . . . 0.0 112.124 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.605 HG22 ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -127.06 138.66 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.218 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.698 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 t-80 -91.71 -15.68 0.21 Allowed Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 22.6 Cg_endo -56.34 178.99 0.11 Allowed 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.201 1.934 . . . . 0.0 113.031 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 59.5 Cg_exo -40.18 153.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.404 2.736 . . . . 0.0 114.188 179.077 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 73.8 Cg_endo -71.04 34.88 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.097 3.198 . . . . 0.0 113.283 -175.187 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -84.87 -20.16 31.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -164.56 23.24 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.505 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 34.5 t -101.16 -90.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.749 -176.477 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptm -79.2 79.79 5.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.157 0.503 . . . . 0.0 110.909 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 9' ' ' LEU . 89.2 m -84.92 114.94 22.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 7' ' ' SER . 13.0 tt0 -94.4 117.95 30.89 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.82 106.25 18.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.529 0.681 . . . . 0.0 109.277 -179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.624 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.88 120.98 33.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.191 -172.733 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.781 ' HG2' HD21 ' A' ' 62' ' ' LEU . 70.5 mtm180 -86.26 101.31 12.94 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.589 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.773 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.4 p -116.44 129.24 25.4 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.8 Cg_exo -57.23 150.29 58.79 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.536 2.824 . . . . 0.0 112.338 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.35 -44.72 84.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -175.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.76 64.35 Favored Glycine 0 C--O 1.237 0.305 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.875 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.553 ' HG2' ' HA3' ' A' ' 90' ' ' GLY . 31.1 tpp -78.54 -28.65 46.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.828 -175.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.598 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -74.34 -25.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.96 -32.09 69.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.763 168.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.1 mt -82.05 -22.12 36.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 172.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 31' ' ' VAL . 8.7 mm -61.36 -44.96 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 122.05 0.928 . . . . 0.0 108.674 174.223 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 4.8 pt -82.11 -14.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.787 175.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.18 -88.55 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.021 170.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.862 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 3.1 ptm180 -74.05 0.87 12.38 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.746 0.418 . . . . 0.0 110.998 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.18 -5.44 10.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.138 174.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 160.37 -41.46 0.44 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.722 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.862 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 1.5 tm-20 -58.83 -35.57 73.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.378 0.271 . . . . 0.0 111.199 -175.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.12 -47.1 86.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.496 0.189 . . . . 0.0 110.854 -171.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 tp -68.2 -36.32 74.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.224 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -62.46 -37.87 87.61 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -61.61 -54.49 42.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.499 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.53 -45.61 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.245 0.545 . . . . 0.0 111.594 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.509 ' OE1' ' HB ' ' A' ' 53' ' ' VAL . 23.4 mt-30 -58.33 -45.45 88.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.42 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -69.12 -42.55 75.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.023 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.7 -46.24 84.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.448 177.509 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.0 p -78.37 -47.48 17.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.583 -177.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.64 6.07 53.16 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 51.1 t -84.72 143.45 29.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.568 . . . . 0.0 110.631 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -89.98 77.66 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.317 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.509 ' HB ' ' OE1' ' A' ' 46' ' ' GLN . 26.1 t -82.13 107.73 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.123 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -89.69 106.58 18.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -176.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.8 mm -88.03 94.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.3 m -91.88 106.07 15.91 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.707 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.679 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 8.3 Cg_exo -72.59 -34.35 7.34 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -176.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.21 -12.14 59.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.695 178.263 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 11.9 p 47.58 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 176.142 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.08 -75.41 0.35 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.002 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.545 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -81.63 0.23 88.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.766 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.781 HD21 ' HG2' ' A' ' 25' ' ' ARG . 7.6 mp -127.48 145.7 55.59 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.943 -170.111 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 43.4 Cg_endo -86.57 -15.17 4.26 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.138 2.559 . . . . 0.0 112.749 176.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.753 ' OE1' ' HB3' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.86 -102.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.947 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.773 ' HB3' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -135.64 131.12 35.37 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.269 -0.27 . . . . 0.0 110.381 -176.253 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.622 ' HB3' HD22 ' A' ' 62' ' ' LEU . 85.8 p -108.72 112.95 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 55' ' ' ILE . 92.9 t -103.16 119.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.112 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.5 m -88.95 126.4 35.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.314 0.578 . . . . 0.0 110.851 176.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.742 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.0 mm? -102.27 104.06 14.57 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.492 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -151.44 148.29 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.766 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.25 -93.96 0.1 OUTLIER Glycine 0 C--O 1.226 -0.347 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.134 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -143.02 161.97 45.78 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 84.1 Cg_exo -46.44 -55.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.194 2.596 . . . . 0.0 113.535 -175.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.74 -33.02 25.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 110.272 -178.109 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -64.68 -45.06 88.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.293 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.7 p -70.06 -26.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.558 -175.332 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.96 -43.97 67.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 81' ' ' MET . 23.4 tptm -66.15 -44.07 85.18 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -54.18 -48.78 70.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.2 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.742 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 33.0 mtmt -71.13 -25.02 62.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.565 -177.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.694 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 4.2 ppp? -70.18 -30.56 67.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.868 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.7 mmm -77.43 -36.17 53.41 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.755 172.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.6 mm? -63.73 -49.1 74.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.89 -44.05 86.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.886 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.1 -59.36 4.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.458 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.534 HG23 ' SD ' ' A' ' 30' ' ' MET . 1.6 mp -72.45 -45.16 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.119 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.624 HG21 ' HD2' ' A' ' 24' ' ' TYR . 9.1 t -67.2 -28.69 43.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 122.043 -0.411 . . . . 0.0 111.322 -176.397 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.452 ' HA ' ' HA2' ' A' ' 92' ' ' GLY . 21.4 t -69.47 -41.34 76.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.023 174.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 12.2 ptp180 -73.7 -13.23 60.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 110.473 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.553 ' HA3' ' HG2' ' A' ' 30' ' ' MET . . . -95.98 -39.45 4.32 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.987 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 27' ' ' PRO . 8.1 ptp180 -157.4 -48.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.784 0.326 . . . . 0.0 111.398 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 88' ' ' SER . . . 118.1 -39.15 2.68 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.666 -175.003 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 177.604 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.3 mt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.638 0.733 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -133.95 126.78 31.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.584 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.872 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 20.4 m 74.03 -4.27 2.32 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.088 0.867 . . . . 0.0 111.755 177.01 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.63 96.18 8.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.81 0.338 . . . . 0.0 111.75 -172.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 21' ' ' THR . 91.1 mt -123.38 92.55 3.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.466 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.89 73.3 0.39 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.204 178.05 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.57 -63.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.11 2.54 . . . . 0.0 112.541 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.943 HG12 ' HD2' ' A' ' 14' ' ' PRO . 10.1 tt -99.51 154.92 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.716 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 15.6 m-70 -91.83 -20.78 0.24 Allowed Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -172.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.943 ' HD2' HG12 ' A' ' 12' ' ' ILE . 23.9 Cg_exo -39.94 171.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.319 2.68 . . . . 0.0 114.833 170.235 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.02 156.6 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.224 2.616 . . . . 0.0 113.538 177.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 36.8 Cg_endo -65.21 11.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.226 3.284 . . . . 0.0 114.371 -175.015 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -62.51 -24.05 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 110.293 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 19' ' ' SER . 12.7 t -157.75 -11.01 0.08 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.718 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 14.0 m -79.86 -83.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.838 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptp -74.56 73.05 1.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.493 0.663 . . . . 0.0 110.193 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 18.0 m -79.41 131.63 36.15 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.843 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.872 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -94.26 117.37 30.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.309 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' SER . 40.9 tt0 -98.97 96.7 8.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.067 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.419 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.14 116.28 28.88 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.429 -167.669 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HG3' HH11 ' A' ' 25' ' ' ARG . 44.1 mtt85 -81.66 103.03 11.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.875 176.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.768 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -121.89 131.87 24.35 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.914 -174.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HG3' HH11 ' A' ' 91' ' ' ARG . 25.7 Cg_exo -62.98 135.99 54.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.761 2.308 . . . . 0.0 110.568 175.424 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.86 -36.84 49.82 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.367 -169.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -34.09 87.64 Favored Glycine 0 C--O 1.236 0.227 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.214 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 87.1 mmm -78.15 -13.36 59.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 34' ' ' ILE . 37.1 t -74.16 -40.9 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.445 173.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -27.78 71.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.226 174.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.26 -24.81 25.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD13 ' HB ' ' A' ' 86' ' ' ILE . 8.9 tp -74.22 -25.31 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.564 0.697 . . . . 0.0 109.673 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.597 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -89.33 -15.82 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.864 171.289 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -86.29 0.07 OUTLIER Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.603 174.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 9.0 ptp180 -79.58 -1.29 37.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.949 0.404 . . . . 0.0 111.07 -177.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.33 2.72 10.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.69 173.759 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.73 -49.66 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.066 175.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.5 tt0 -44.74 -42.81 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.052 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -58.7 -46.62 86.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -167.119 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.605 HD11 HG11 ' A' ' 53' ' ' VAL . 8.0 tp -65.47 -54.31 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.617 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.441 ' N ' HG23 ' A' ' 42' ' ' ILE . 39.5 m-80 -56.19 -42.17 76.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.439 -177.264 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.45 -47.48 83.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.684 -179.343 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.74 -45.24 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 2.1 pt20 -69.13 -43.18 74.92 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.575 -176.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.96 -36.58 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.407 -178.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.1 -50.07 74.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.958 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 p -72.78 -33.14 66.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.523 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.04 27.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.615 -178.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.641 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 15.2 t -79.73 152.36 29.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.985 0.422 . . . . 0.0 110.133 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -108.84 86.61 2.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 42' ' ' ILE . 44.7 t -103.9 111.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.085 0.469 . . . . 0.0 110.923 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.2 115.58 30.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.426 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.498 HD13 HG13 ' A' ' 67' ' ' VAL . 32.1 mm -81.85 94.47 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.524 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 42.1 m -79.25 114.79 47.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.951 0.405 . . . . 0.0 110.788 -178.547 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 4.3 Cg_exo -74.41 -40.62 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.668 2.912 . . . . 0.0 111.854 -177.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.43 78.77 2.71 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -61.69 -27.85 68.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.128 -175.73 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.97 -72.53 1.82 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -71.62 -14.03 74.9 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 177.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 2.5 mm? -123.89 138.88 31.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.2 -9.52 10.47 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.045 2.497 . . . . 0.0 111.257 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 2.2 pt-20 -101.16 -94.75 0.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.323 -173.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.768 ' HB3' HG13 ' A' ' 26' ' ' VAL . 3.6 tpp180 -150.03 148.25 28.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 175.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 59' ' ' SER . 68.4 p -122.85 112.47 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.119 0.485 . . . . 0.0 110.082 174.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 55' ' ' ILE . 99.7 t -98.58 115.81 39.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.716 179.1 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.1 m -86.14 131.51 34.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.141 0.496 . . . . 0.0 110.548 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 1.013 HD13 ' HG2' ' A' ' 80' ' ' LYS . 62.6 mt -120.33 116.91 26.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -179.331 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.65 156.44 40.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.403 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 151.48 -150.9 22.9 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.493 176.552 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.12 152.25 76.45 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.45 -49.94 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.104 2.536 . . . . 0.0 113.526 -175.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.1 -33.37 50.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 0.0 110.845 -178.404 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -70.06 -41.27 74.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.641 -178.047 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.676 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.5 p -68.47 -32.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -177.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.36 81.7 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -55.91 -45.44 78.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.343 0.592 . . . . 0.0 110.793 178.746 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.74 83.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.376 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 1.013 ' HG2' HD13 ' A' ' 69' ' ' LEU . 44.6 mtmt -82.39 -22.02 35.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -173.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.468 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 17.1 tpt -60.82 -49.59 76.85 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.655 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 93.4 mmm -68.37 -39.61 81.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.751 176.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.859 ' HG ' HD11 ' A' ' 69' ' ' LEU . 1.4 mm? -62.29 -59.63 4.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.02 -40.58 63.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.024 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -55.5 34.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.132 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.613 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.3 mp -80.6 -38.91 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.659 0.266 . . . . 0.0 111.704 -175.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 24' ' ' TYR . 92.2 t -60.02 -50.31 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.703 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -57.83 -48.6 79.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.682 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.2 ptp180 -61.49 -22.35 65.01 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.183 0.302 . . . . 0.0 111.587 -175.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.81 12.76 13.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.117 -1.04 . . . . 0.0 113.472 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.641 HH11 ' HG3' ' A' ' 27' ' ' PRO . 7.3 tpt180 -129.0 -47.26 1.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.309 0.554 . . . . 0.0 112.008 -178.092 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.3 -37.67 0.19 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.75 -173.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.77 -1.017 . . . . 0.0 111.473 -177.593 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 5' ' ' ILE . 2.1 pp . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.8 p -148.32 -169.98 3.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.344 -177.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.518 ' H ' ' HB3' ' A' ' 23' ' ' GLU . 13.6 m 64.47 -155.26 0.3 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 123.664 0.602 . . . . 0.0 110.318 -179.083 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -52.18 113.81 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.288 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.73 125.51 52.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.159 170.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.45 75.36 0.42 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.574 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.92 -64.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.684 2.256 . . . . 0.0 111.565 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.794 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 pt -104.77 141.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 177.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.563 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 56.3 m80 -96.26 31.42 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.496 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.794 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 18.7 Cg_endo -57.85 -163.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.36 0 C-N-CA 122.47 2.113 . . . . 0.0 112.798 161.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 10.2 Cg_endo -56.44 164.48 5.44 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.219 1.946 . . . . 0.0 112.208 168.848 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.76 33.69 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.816 3.01 . . . . 0.0 114.393 -175.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 18' ' ' THR . 10.6 ptp180 -92.69 14.59 16.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 9.4 t 171.47 -16.58 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.672 177.304 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.2 m -78.21 -11.48 59.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.471 ' HE3' HG11 ' A' ' 76' ' ' VAL . 11.7 ptt? -150.56 69.75 0.99 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.836 0.827 . . . . 0.0 109.19 167.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.2 m -78.53 115.3 18.14 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.248 177.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' SER . 8.1 tp10 -94.4 119.76 33.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -172.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HB3' ' H ' ' A' ' 7' ' ' SER . 6.0 tp10 -104.87 102.75 12.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -91.43 125.66 36.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.837 -169.536 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 59.7 mtm180 -82.65 102.48 11.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 175.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.737 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -125.14 126.72 25.17 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.778 -177.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 54.6 Cg_exo -54.82 148.24 47.06 Favored 'Trans proline' 0 CA--C 1.521 -0.169 0 C-N-CA 123.537 2.824 . . . . 0.0 111.815 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' HG12 ' A' ' 31' ' ' VAL . 28.8 t70 -59.63 -36.83 77.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.918 -175.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -34.34 61.9 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.384 175.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.6 tpp -78.95 -22.96 44.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.93 -175.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.74 HG21 ' HG2' ' A' ' 65' ' ' ARG . 3.7 p -76.85 -29.96 18.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.44 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.78 -26.93 67.6 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.851 169.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.63 -24.26 20.57 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 175.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.3 tp -68.92 -32.23 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.74 0.781 . . . . 0.0 109.693 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.598 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.3 pt -71.95 -12.12 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.367 174.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.84 -8.75 27.59 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.845 163.222 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.696 ' HD3' ' HB2' ' A' ' 40' ' ' GLU . 11.8 ptm180 -174.75 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.045 -174.284 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.85 -2.09 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.767 179.04 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.598 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.08 -37.23 0.61 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.82 -1.181 . . . . 0.0 112.653 174.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.696 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 3.5 mp0 -56.73 -40.93 76.62 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.624 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -59.48 -44.81 92.96 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -168.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.653 HD11 HG11 ' A' ' 53' ' ' VAL . 8.5 tp -64.03 -48.08 87.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.445 -177.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.3 m-20 -65.87 -33.39 75.74 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -60.55 -49.65 76.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.161 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.536 HG21 ' HG2' ' A' ' 82' ' ' MET . 1.8 mp -75.95 -40.71 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.798 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.56 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -70.55 -27.21 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.638 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.75 -40.48 40.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.66 -40.11 90.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.889 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 28.6 p -80.86 -42.78 20.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.235 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.99 1.19 36.11 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 44.5 t -79.9 139.25 37.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.242 178.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.21 79.33 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.357 0.599 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.653 HG11 HD11 ' A' ' 42' ' ' ILE . 44.9 t -89.73 123.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.348 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -118.51 133.78 55.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 -176.499 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 67' ' ' VAL . 43.3 mm -91.98 98.44 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 14.8 m -81.02 108.43 10.25 Favored Pre-proline 0 C--O 1.238 0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 -177.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 2.1 Cg_endo -83.85 -21.42 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.513 2.809 . . . . 0.0 112.693 -176.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.44 -38.3 35.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 t 68.94 -80.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.867 177.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.23 48.3 5.74 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.828 179.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.71 -30.8 0.56 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.569 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.8 mm? -113.47 143.22 28.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.84 8.39 4.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.666 2.244 . . . . 0.0 111.098 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 6.0 pt-20 -126.7 -154.21 0.61 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.435 -175.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.74 ' HG2' HG21 ' A' ' 31' ' ' VAL . 4.6 tpp180 -94.88 140.91 29.27 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 33.5 p -116.64 108.78 16.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 55' ' ' ILE . 94.1 t -96.74 114.69 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.123 -176.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -92.0 134.86 34.42 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.101 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.459 HD13 ' HG2' ' A' ' 80' ' ' LYS . 2.0 mp -125.8 128.73 48.13 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -152.09 146.98 25.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.41 -137.99 4.96 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.024 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.36 161.43 37.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.03 -56.89 2.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.501 2.134 . . . . 0.0 113.041 -175.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.05 -37.71 81.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.486 -178.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.3 m -68.03 -48.42 65.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.414 -176.25 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.561 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 5.5 p -69.12 -33.75 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.138 -174.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.56 -35.41 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.652 0.263 . . . . 0.0 110.442 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -60.49 -45.8 92.43 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.407 0.623 . . . . 0.0 109.846 176.361 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 53' ' ' VAL . . . -64.29 -35.96 82.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.348 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 50.0 mtmt -81.13 -22.91 38.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.246 0.546 . . . . 0.0 109.764 -176.237 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.2 ttt -65.11 -44.47 88.64 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.459 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.536 ' HG2' HG21 ' A' ' 45' ' ' ILE . 4.0 ppp? -73.2 -28.02 61.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.956 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -66.18 -55.37 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.585 177.396 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.53 -30.35 65.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.465 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.83 -60.79 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.192 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -73.0 -36.61 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -175.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.7 -21.68 28.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.186 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.2 t -72.34 -40.45 67.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 174.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 7.2 ptp180 -72.3 -17.35 61.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.754 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.15 -49.27 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.347 -178.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 91' ' ' ARG . 15.6 mtp180 -105.9 29.79 6.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 -177.183 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.14 57.3 5.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.09 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.954 0 CA-C-O 118.268 -1.296 . . . . 0.0 110.932 179.031 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.3 m . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 19.3 mm-40 67.58 -68.2 0.16 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.116 0.966 . . . . 0.0 112.854 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.0 mt 70.89 -87.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.95 0.9 . . . . 0.0 111.231 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 99.41 0.25 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.177 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.2 -17.47 24.46 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.017 2.478 . . . . 0.0 112.131 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.84 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.1 tp -100.21 147.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.73 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 35.9 m-70 -90.77 -19.14 0.24 Allowed Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.84 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -36.21 163.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.447 2.765 . . . . 0.0 114.397 169.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -42.61 161.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.87 3.047 . . . . 0.0 114.06 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.74 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 18.1 Cg_endo -60.37 3.62 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.824 3.016 . . . . 0.0 114.523 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -59.32 -19.9 50.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.312 0.577 . . . . 0.0 109.519 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -151.11 -19.81 0.21 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.654 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 t -80.04 -2.53 44.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.067 0.46 . . . . 0.0 111.004 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.575 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.7 mmt -134.1 39.64 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.904 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 29.1 m -78.96 112.76 16.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.1 tp10 -114.16 117.31 30.86 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.2 tt0 -99.49 104.52 16.35 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -90.19 116.28 28.06 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.841 -168.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 65.4 mtm180 -81.0 96.09 7.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.008 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.474 HG11 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -120.11 126.55 26.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.449 -173.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.35 135.74 46.81 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.193 2.595 . . . . 0.0 111.245 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 3.6 p-10 -60.49 -30.68 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.663 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.71 -31.06 63.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.802 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.529 ' HE1' ' HG3' ' A' ' 89' ' ' ARG . 95.9 mmm -78.04 -15.16 59.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' HG22 ' A' ' 34' ' ' ILE . 91.4 t -76.02 -35.88 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.16 -28.73 64.52 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.128 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD12 ' SD ' ' A' ' 30' ' ' MET . 82.5 mt -89.17 -27.83 20.42 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.1 tp -69.24 -28.06 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.613 0.72 . . . . 0.0 109.648 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.687 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.9 pt -83.35 -15.0 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.598 174.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.06 -89.87 0.03 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.818 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 6.4 ptm180 -74.6 9.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.032 0.533 . . . . 0.0 111.623 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.26 9.51 27.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.953 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.687 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.74 -39.47 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.026 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 32.2 tt0 -64.49 -28.88 69.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -171.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.18 -51.98 67.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.274 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.42 -37.65 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.175 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -61.45 -43.97 97.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.7 mttm -54.06 -53.39 53.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.433 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.428 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -70.73 -42.92 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.102 -173.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -29.28 64.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.124 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -81.38 -32.45 32.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.183 0.516 . . . . 0.0 110.116 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.93 -46.82 56.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 30.7 p -67.56 -38.04 83.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.237 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.92 7.94 55.98 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 43.6 t -85.78 144.81 27.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.369 0.604 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -88.06 70.49 9.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.599 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.408 HG22 HD13 ' A' ' 69' ' ' LEU . 47.3 t -86.72 110.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -114.55 123.27 48.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.637 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.5 mm -79.78 124.53 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 37.2 t -112.68 109.85 52.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.642 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 74.1 Cg_endo -75.12 -16.13 20.1 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.983 2.456 . . . . 0.0 111.4 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.41 -33.25 42.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.623 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.638 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 9.6 t 70.45 -74.47 0.08 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.621 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.49 -61.52 0.51 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.409 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.93 -8.59 6.09 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.793 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 2.5 mm? -107.53 152.18 41.28 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.9 -28.07 3.49 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.292 1.995 . . . . 0.0 111.539 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.42 -169.6 2.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.131 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.642 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 24.4 mmt180 -79.81 153.1 29.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.638 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 99.1 p -124.28 117.93 25.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.474 HG23 HG11 ' A' ' 26' ' ' VAL . 59.1 t -97.75 124.2 50.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -95.63 127.51 41.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.57 0.7 . . . . 0.0 111.408 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.823 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -108.48 124.66 50.77 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.902 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.34 156.28 39.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.88 -128.0 2.15 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 119.838 -1.172 . . . . 0.0 113.121 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.74 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -111.53 165.41 12.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 14.1 Cg_endo -55.66 -40.83 83.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.182 1.921 . . . . 0.0 113.06 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -85.33 -31.89 22.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.462 -177.072 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 53.6 p -71.03 -46.4 62.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -64.99 -23.79 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.864 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.61 -55.28 7.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.131 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 49' ' ' SER . 4.5 tppp? -55.48 -45.46 76.97 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.615 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.41 -51.22 70.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.609 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.823 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mtmt -75.71 -20.03 58.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.53 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 tpt -59.81 -49.89 75.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.522 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.428 ' HG3' HG12 ' A' ' 45' ' ' ILE . 16.0 mmt -66.06 -38.59 88.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 110.874 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.34 -44.82 95.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.35 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.53 -46.01 84.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.106 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.67 -59.6 4.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.842 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.683 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.69 -41.23 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 24' ' ' TYR . 93.1 t -70.38 -25.32 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.683 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.6 t -72.95 -40.81 65.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.2 ptp180 -77.9 -6.89 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.686 0.279 . . . . 0.0 111.17 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.1 -46.81 0.8 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.483 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 O-C-N 122.518 -0.401 . . . . 0.0 111.291 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 35.2 t . . . . . 0 N--CA 1.463 0.205 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -161.42 106.35 1.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 0.0 110.093 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 24.4 tp -91.41 96.6 10.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.4 70.92 0.33 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.03 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 6.7 Cg_exo -73.96 -38.37 2.29 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.561 2.174 . . . . 0.0 111.332 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.584 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 12.4 pt -121.81 152.42 25.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.699 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.662 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 72.7 t60 -89.08 -26.22 0.32 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.0 Cg_exo -39.15 159.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.79 2.327 . . . . 0.0 114.049 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -38.16 144.38 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.127 3.218 . . . . 0.0 113.828 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.609 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 46.3 Cg_endo -66.77 31.32 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.539 3.493 . . . . 0.0 114.493 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.847 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 ppt_? -82.63 0.06 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 0.0 110.176 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.847 HG22 ' HD2' ' A' ' 17' ' ' ARG . 11.9 t -179.46 -17.76 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 12' ' ' ILE . 3.7 m -78.32 -80.92 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.583 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.609 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.6 ptp -76.24 76.61 3.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.9 m -81.82 114.01 20.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.2 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 15.3 tt0 -94.04 118.01 30.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -99.29 104.98 16.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.673 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -90.82 118.78 30.5 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.684 -168.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -81.86 99.1 8.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.685 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -116.63 123.52 30.4 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.763 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' A' ' 30' ' ' MET . 31.9 Cg_endo -66.36 152.55 80.71 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.482 2.121 . . . . 0.0 111.832 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -52.72 -42.02 64.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.88 93.21 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.482 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.557 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 88.4 mmm -78.84 -23.49 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.431 -0.452 . . . . 0.0 111.354 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 ' HG2' ' A' ' 65' ' ' ARG . 2.8 p -74.26 -30.55 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.672 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -28.82 69.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.925 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.29 -23.92 22.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.7 tp -70.3 -25.55 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.691 0.758 . . . . 0.0 109.597 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.789 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 9.4 pt -85.33 -14.73 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.434 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.17 -91.18 0.02 OUTLIER Glycine 0 C--N 1.336 0.574 0 O-C-N 124.209 0.943 . . . . 0.0 113.191 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 1.005 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.5 ptm180 -76.99 44.9 0.41 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.166 0.587 . . . . 0.0 111.501 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.06 13.78 80.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 114.354 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.789 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 135.51 -36.09 2.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.623 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.005 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 71.8 tt0 -57.75 -33.9 68.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -59.91 -52.42 65.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.712 0.291 . . . . 0.0 111.361 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.69 HD11 HG11 ' A' ' 53' ' ' VAL . 10.0 tp -63.8 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.106 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -58.33 -40.66 82.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 13.7 mmmm -60.32 -59.96 4.58 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.425 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -62.86 -41.54 93.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -33.2 72.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.015 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 47' ' ' GLN . 1.0 OUTLIER -77.95 -37.88 46.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.469 0.652 . . . . 0.0 109.539 176.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.45 -26.07 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.198 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 34.1 p -99.65 -44.85 5.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.95 8.96 21.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.06 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.549 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 21.0 t -92.77 136.97 32.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 110.855 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -79.77 79.05 6.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.922 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.69 HG11 HD11 ' A' ' 42' ' ' ILE . 40.6 t -82.64 109.52 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 14.5 mm-40 -101.03 116.05 31.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.521 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.5 mm -89.7 96.95 6.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.743 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 m -88.36 105.39 9.36 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.812 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 2.8 Cg_exo -75.43 -22.09 14.42 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.321 2.681 . . . . 0.0 111.641 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -79.62 -38.08 34.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.001 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.632 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.3 t 71.41 -54.09 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.556 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.94 -71.79 2.9 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.646 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.78 -9.44 61.13 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.958 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.627 ' HB2' ' OG ' ' A' ' 59' ' ' SER . 2.1 mm? -121.49 154.48 59.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -85.5 -4.3 9.25 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 111.985 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 6.3 pt-20 -111.03 -141.05 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.817 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.726 ' HG2' HG21 ' A' ' 31' ' ' VAL . 2.0 tpp180 -107.4 140.15 40.78 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.632 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 67.2 p -116.94 111.64 19.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.348 0.594 . . . . 0.0 109.944 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 55' ' ' ILE . 84.7 t -100.83 119.53 49.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.776 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 29.7 m -88.68 128.24 35.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.329 0.585 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.897 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.9 mm? -107.31 108.09 19.32 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.805 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 18' ' ' THR . 0.7 OUTLIER -151.2 119.45 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.005 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -158.88 -107.34 0.24 Allowed Glycine 0 C--O 1.225 -0.455 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.734 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.565 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -129.35 163.63 44.97 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.6 -51.22 8.37 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.463 2.109 . . . . 0.0 112.859 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -72.65 -46.86 51.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.362 0.601 . . . . 0.0 110.698 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' A' ' 72' ' ' ALA . 6.7 m -62.47 -45.5 92.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.818 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.1 p -71.23 -27.87 30.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 -174.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -40.2 49.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.32 . . . . 0.0 110.385 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.733 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.8 tpmt? -64.26 -46.59 83.04 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.659 0.742 . . . . 0.0 109.818 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.412 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -55.24 -46.5 76.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.294 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.897 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 37.7 mtmt -73.5 -22.45 60.13 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.733 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.5 -31.09 68.05 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.458 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.425 ' HG3' HG12 ' A' ' 45' ' ' ILE . 15.0 mmt -69.02 -46.7 67.3 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.677 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.416 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.4 mm? -61.51 -48.59 80.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.87 -40.5 69.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.266 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.8 -57.62 12.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.947 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.682 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -72.13 -41.52 67.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.758 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 24' ' ' TYR . 85.8 t -64.57 -32.42 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.336 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 t -73.25 -37.77 66.21 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.455 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.682 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.5 ptp180 -78.41 -7.6 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.929 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -107.41 -64.89 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.344 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 91' ' ' ARG . 22.2 mtp180 . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.572 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 62.6 m . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.523 0.201 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.664 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 68.5 mm-40 53.78 -162.3 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.48 0.712 . . . . 0.0 111.621 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 28.8 tp 173.05 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 121.76 92.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.952 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.09 -26.13 26.32 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.998 2.466 . . . . 0.0 111.385 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.586 HG22 ' HD2' ' A' ' 14' ' ' PRO . 4.1 mt -77.17 108.45 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.671 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 23.3 m170 -89.72 7.12 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -168.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 20.5 Cg_exo -46.1 -176.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.82 1.68 . . . . 0.0 112.863 158.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' ARG . 67.5 Cg_exo -42.14 158.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.983 2.455 . . . . 0.0 113.557 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 26.8 Cg_endo -64.4 17.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.79 2.993 . . . . 0.0 114.207 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -74.43 -6.55 48.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.0 109.961 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.3 t -158.71 -25.96 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.609 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.0 t -79.31 8.12 6.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.812 0.339 . . . . 0.0 111.083 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 1.5 mmt -145.58 32.67 1.06 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.397 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 40.1 m -79.51 110.99 15.33 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.21 118.97 34.28 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.664 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.9 tt0 -84.91 104.12 14.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.85 109.46 20.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.259 -174.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.454 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 96.7 mtt180 -87.37 98.83 11.57 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.21 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -112.65 128.87 25.01 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.936 -173.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 20.0 Cg_exo -60.7 143.51 99.41 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 123.276 2.651 . . . . 0.0 111.773 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.82 -50.62 56.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -170.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.87 -29.8 75.24 Favored Glycine 0 C--O 1.237 0.333 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.413 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.779 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 80.3 mmm -77.45 -21.0 53.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 35' ' ' ILE . 41.4 t -66.19 -37.98 80.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -63.17 -29.38 74.28 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.708 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.81 -25.17 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -75.77 -29.48 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.3 0.572 . . . . 0.0 109.815 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 31' ' ' VAL . 8.8 pt -83.32 -13.51 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.181 172.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.15 -91.02 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.087 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.968 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 16.9 ptm180 -71.18 -9.52 58.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.712 0.405 . . . . 0.0 111.451 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.84 3.38 7.66 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.294 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.622 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -58.93 0.25 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.314 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.968 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 18.8 tp10 -55.17 -21.96 15.45 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' O ' HD13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.7 -48.45 71.99 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.02 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 39' ' ' GLY . 9.9 tp -63.98 -37.87 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -53.78 -49.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.629 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 22.1 mmtm -66.95 -41.76 86.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.299 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.418 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.4 mp -67.19 -41.17 86.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -22.87 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.017 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -78.24 -42.57 30.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.335 0.588 . . . . 0.0 110.047 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.61 -43.77 93.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.01 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.693 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 23.1 p -83.69 -43.06 15.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.291 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.8 10.49 26.54 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.559 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 t -79.71 141.73 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 0.0 110.475 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 50.9 mmtt -94.22 67.34 3.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.438 0.637 . . . . 0.0 109.615 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.42 HG23 HD13 ' A' ' 69' ' ' LEU . 2.2 p -82.5 142.88 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.127 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -136.53 114.86 11.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.518 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.451 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 36.9 mm -79.63 104.65 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.39 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 6.2 t -92.35 105.43 14.14 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 3.2 Cg_exo -75.93 -30.79 5.57 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.45 2.767 . . . . 0.0 112.724 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.53 -29.67 46.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 7.4 t 73.19 -67.53 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.821 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.99 76.83 0.88 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.823 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.08 -57.69 0.68 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.815 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 25' ' ' ARG . 1.3 mm? -87.57 144.15 35.02 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.05 -23.92 8.73 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.435 2.09 . . . . 0.0 110.225 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 6.6 pt-20 -88.99 -168.67 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.556 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.754 ' HB3' HG13 ' A' ' 26' ' ' VAL . 4.0 tpp180 -87.08 139.46 30.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.146 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.9 p -117.28 111.34 19.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.434 HG13 HD13 ' A' ' 55' ' ' ILE . 49.1 t -109.32 131.74 59.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.694 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.6 m -91.79 125.59 36.56 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.022 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 21' ' ' THR . 4.0 mm? -104.57 111.45 24.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.025 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 m -152.29 147.98 26.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.654 0.206 . . . . 0.0 111.036 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.74 -156.72 28.8 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.018 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -78.3 161.62 69.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.8 Cg_endo -48.53 -54.96 4.56 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.008 2.472 . . . . 0.0 113.417 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.48 -37.07 77.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.088 0.47 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.693 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 9.0 m -66.6 -51.66 53.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.425 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 p -67.62 -26.48 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.267 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -71.74 -45.26 62.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.388 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 81' ' ' MET . 1.3 tmtp? -68.6 -39.23 80.98 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.362 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -62.07 -40.85 97.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.977 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 45.8 mtmt -80.96 -21.32 40.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.1 tpt -57.15 -50.7 72.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.357 173.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.418 ' HG3' HG12 ' A' ' 45' ' ' ILE . 92.9 mmm -68.96 -39.8 79.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 111.038 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 79' ' ' ALA . 3.7 mm? -62.67 -47.84 81.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.96 -45.67 78.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.042 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.0 -54.23 47.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.669 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.7 mp -75.24 -41.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 26' ' ' VAL . 67.8 t -72.7 -23.65 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.291 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -75.2 -41.42 57.88 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.799 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.9 ptm180 -76.74 -6.96 54.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.779 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -105.72 -52.44 0.8 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.982 -0.627 . . . . 0.0 113.597 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.424 ' HG2' ' HG3' ' A' ' 27' ' ' PRO . 17.5 mtp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.311 0.577 . . . . 0.0 112.33 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 N--CA 1.462 0.149 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -176.01 163.03 2.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.201 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.461 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 75.1 mt -138.78 107.32 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.669 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -126.32 57.66 0.69 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.627 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 92.0 Cg_endo -93.88 -2.68 3.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.002 2.468 . . . . 0.0 112.387 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 30.9 pt -126.51 149.17 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.813 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.6 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 22.1 m80 -91.18 -19.56 0.24 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 93.2 Cg_exo -38.81 162.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.671 2.247 . . . . 0.0 114.324 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.62 152.64 8.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.847 2.364 . . . . 0.0 112.077 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 42.4 Cg_endo -65.99 7.56 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.423 2.748 . . . . 0.0 113.788 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.87 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.18 0.514 . . . . 0.0 110.284 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -159.29 7.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.14 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 30.8 t -93.28 -104.64 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.297 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.468 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptm -63.95 74.22 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.045 0.926 . . . . 0.0 111.712 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 62.5 m -90.04 139.02 31.02 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.635 ' HB2' HD23 ' A' ' 69' ' ' LEU . 10.9 mm-40 -95.33 148.87 21.97 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.299 168.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -120.34 98.76 6.2 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 160.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.506 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.36 124.57 37.43 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.266 -161.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.955 ' HG2' HD21 ' A' ' 62' ' ' LEU . 32.6 mtm180 -81.78 111.38 17.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.489 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -130.31 126.59 22.25 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.893 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 35.0 Cg_exo -60.07 151.38 72.96 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.488 2.792 . . . . 0.0 112.658 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 31' ' ' VAL . 35.5 t70 -55.17 -51.91 65.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.03 75.05 Favored Glycine 0 C--O 1.236 0.253 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.935 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 tpp -79.53 -32.05 42.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.473 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 34' ' ' ILE . 12.7 p -72.69 -24.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.2 74.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.06 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.45 -24.55 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD13 ' HB ' ' A' ' 86' ' ' ILE . 10.7 tp -72.93 -27.93 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 109.663 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.617 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 11.9 pt -85.05 -13.59 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.348 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.33 -93.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 O-C-N 124.164 0.915 . . . . 0.0 113.066 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.957 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -72.99 48.68 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.179 0.592 . . . . 0.0 111.027 177.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.15 20.8 58.62 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.113 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.617 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.05 -50.91 0.58 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.809 -1.186 . . . . 0.0 113.602 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 22.2 tt0 -54.62 -33.49 60.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' HG12 ' A' ' 45' ' ' ILE . 24.5 tt0 -60.03 -48.4 81.85 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.473 -171.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.76 HD11 HG11 ' A' ' 53' ' ' VAL . 9.8 tp -60.59 -38.48 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.214 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.43 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 60.2 m-20 -65.32 -44.69 87.02 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.58 -31.94 69.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.534 0.207 . . . . 0.0 111.035 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 41' ' ' GLN . 26.4 mm -76.32 -50.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.989 0.423 . . . . 0.0 111.357 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.43 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -75.72 -24.64 56.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.408 -174.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -82.95 -34.48 26.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.684 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.81 -46.02 76.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.869 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 25.8 p -73.04 -48.04 39.57 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.209 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 13.47 25.7 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.4 t -92.84 143.36 26.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.954 0.407 . . . . 0.0 110.706 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 41.4 mtmt -81.6 72.09 8.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.76 HG11 HD11 ' A' ' 42' ' ' ILE . 57.9 t -82.4 110.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.397 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 15.7 mm-40 -110.99 122.44 47.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.123 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 HG12 ' A' ' 42' ' ' ILE . 42.7 mm -88.9 99.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.79 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.5 t -81.08 115.14 54.18 Favored Pre-proline 0 C--O 1.243 0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HA ' HH11 ' A' ' 65' ' ' ARG . 97.4 Cg_endo -79.65 -27.54 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.367 2.712 . . . . 0.0 112.061 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.65 -40.32 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.457 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 11.0 t 70.72 -69.11 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.236 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.57 -96.54 0.54 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.061 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.06 -12.47 79.36 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.654 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.955 HD21 ' HG2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -94.78 139.93 22.38 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.796 0.332 . . . . 0.0 110.817 -176.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.09 -2.46 9.52 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.8 2.333 . . . . 0.0 111.434 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 91' ' ' ARG . 2.5 pt-20 -110.64 -104.06 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.31 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.543 HH11 ' HA ' ' A' ' 57' ' ' PRO . 6.7 tpp180 -144.57 155.4 43.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 78.0 p -136.94 146.97 46.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.373 173.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 55' ' ' ILE . 52.2 t -123.3 131.06 73.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -91.48 131.23 37.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.2 0.524 . . . . 0.0 110.768 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 22' ' ' GLU . 3.6 mm? -114.09 104.03 11.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.2 124.19 11.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.389 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.76 -158.03 19.2 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.333 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.11 161.88 69.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -45.67 -52.24 7.09 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.79 2.326 . . . . 0.0 112.945 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.5 -43.33 81.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.6 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.635 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.3 m -64.94 -49.62 69.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.618 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.55 -23.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.162 -175.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.54 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.2 tt0 -72.55 -52.37 15.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.886 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 49' ' ' SER . 5.4 tppp? -55.04 -43.47 73.8 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.191 0.52 . . . . 0.0 110.588 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.94 63.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.725 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.62 ' HD3' ' CG ' ' A' ' 22' ' ' GLU . 11.2 mtmm -66.91 -23.06 65.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.616 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.7 mmt -59.77 -52.72 64.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.422 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 20.4 mmt -68.37 -37.71 80.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.5 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.3 mm? -60.48 -54.99 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.183 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' SER . 24.6 t70 -60.3 -34.86 74.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.39 -55.98 17.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.09 -41.48 52.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.365 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 24' ' ' TYR . 87.9 t -64.18 -28.1 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.23 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 16.1 t -75.73 -31.63 59.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.342 -0.224 . . . . 0.0 110.91 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 17.4 ptp180 -77.74 -12.44 59.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.33 -50.07 0.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.957 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 64' ' ' GLU . 26.3 mmt180 . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 122.293 0.237 . . . . 0.0 111.6 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 1.006 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 34.1 m . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -158.2 121.46 3.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.022 0.439 . . . . 0.0 110.34 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.26 104.08 15.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.085 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.57 69.38 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.891 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -84.95 -27.29 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.656 2.238 . . . . 0.0 112.991 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.696 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 6.0 mm -120.49 147.32 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 24.7 t60 -93.53 12.03 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.718 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -170.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.696 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 29.8 Cg_endo -61.06 -166.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 122.33 2.02 . . . . 0.0 113.958 171.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 67.3 Cg_exo -56.63 167.08 3.08 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.358 2.039 . . . . 0.0 112.517 168.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.1 33.63 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 124.189 3.259 . . . . 0.0 114.708 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' O ' ' HB ' ' A' ' 18' ' ' THR . 4.7 ptp180 -96.92 13.17 29.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 15.0 t 174.53 -15.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.289 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -79.97 -6.42 57.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.629 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.42 58.14 0.4 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.22 0.533 . . . . 0.0 110.354 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -78.21 110.83 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 7' ' ' SER . 12.7 tt0 -98.9 119.57 37.9 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -172.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 1.006 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 4.6 tp10 -92.34 102.01 14.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -90.96 126.24 36.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.112 0.482 . . . . 0.0 110.739 -171.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -91.09 98.12 11.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.083 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG11 HH21 ' A' ' 65' ' ' ARG . 1.3 p -120.37 114.33 33.27 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.528 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.644 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 50.3 Cg_exo -57.5 164.25 7.5 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 124.454 3.436 . . . . 0.0 114.38 -169.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.91 -45.34 74.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 0.0 111.845 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 33' ' ' LEU . . . -63.76 -34.04 88.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.806 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.419 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 31.4 mmt -80.25 -25.81 39.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -175.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -70.77 -33.89 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.934 172.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.37 77.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.708 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 29' ' ' GLY . 4.2 mm? -87.01 -24.02 24.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.986 HG21 HH22 ' A' ' 65' ' ' ARG . 10.8 tp -71.43 -30.49 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 109.249 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.626 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.0 pt -86.99 -14.05 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.731 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.76 -90.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.918 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.05 -6.91 9.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.998 -0.601 . . . . 0.0 111.946 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.9 4.42 9.5 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.824 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.626 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.17 -44.91 0.5 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.182 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.4 -26.31 66.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.59 -45.29 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.94 -174.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -65.39 -34.0 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.973 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 74.3 m-20 -61.47 -38.67 88.11 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -37.63 64.81 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 41' ' ' GLN . 98.1 mt -64.13 -52.74 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 111.258 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -21.87 59.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 6.5 tp-100 -84.14 -35.56 23.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.508 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.17 -39.49 78.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.666 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 p -84.07 -39.78 19.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.477 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.57 3.45 59.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.687 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 54.0 t -80.31 146.15 31.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.949 0.404 . . . . 0.0 110.533 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.724 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 10.9 mmpt? -84.98 81.01 9.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -81.92 107.16 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.7 mm-40 -95.93 106.68 18.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.933 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 HH11 ' A' ' 65' ' ' ARG . 33.2 mm -81.12 110.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.637 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -97.38 98.57 5.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 39.5 Cg_exo -60.05 -41.36 53.17 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 112.419 -173.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -115.36 102.99 10.35 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 34.5 t -68.92 -26.0 64.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.751 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.07 -82.01 1.39 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.191 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.27 -31.04 77.88 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.782 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 51.7 mt -98.31 138.52 20.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.979 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.86 -19.52 23.51 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.783 2.322 . . . . 0.0 110.784 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.644 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -96.69 -174.35 2.99 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.183 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.986 HH22 HG21 ' A' ' 34' ' ' ILE . 5.7 tmm_? -94.84 141.3 28.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 79.5 p -115.26 150.82 35.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.382 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 82.6 t -129.96 114.34 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.701 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.3 m -85.87 129.95 34.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.399 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.003 HD13 ' HG2' ' A' ' 80' ' ' LYS . 5.4 mt -114.94 121.75 44.14 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.8 m -151.33 141.29 22.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.247 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.89 -136.94 4.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.482 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -96.13 163.11 21.64 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.7 Cg_endo -48.05 -48.35 16.72 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.798 2.332 . . . . 0.0 112.854 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.36 -39.67 53.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 p -70.94 -47.69 57.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.104 0.478 . . . . 0.0 110.441 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.73 -29.2 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.228 -177.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.68 -50.99 46.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 81' ' ' MET . 50.8 tptt -63.13 -40.56 97.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.758 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -58.81 -41.71 87.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.138 0.494 . . . . 0.0 111.082 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.003 ' HG2' HD13 ' A' ' 69' ' ' LEU . 48.5 mtmt -81.18 -21.89 39.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.957 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 7.8 tpt -59.1 -50.58 73.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.357 174.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mmm -70.25 -37.53 74.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.4 mm? -60.37 -55.09 37.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.418 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -55.18 -34.92 64.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.766 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.72 -56.57 19.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.575 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.608 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -70.13 -40.21 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.336 0.588 . . . . 0.0 110.77 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 74.4 t -62.41 -28.47 44.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.293 0.568 . . . . 0.0 110.106 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -75.4 -31.13 60.32 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.164 -0.335 . . . . 0.0 110.759 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.5 ptm180 -78.31 -15.74 58.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.616 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -158.21 44.94 0.47 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.009 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.527 ' HD2' ' HG3' ' A' ' 27' ' ' PRO . 7.6 tpm_? . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 117.551 0.676 . . . . 0.0 110.084 173.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.405 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 20.9 m . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 120.918 0.389 . . . . 0.0 111.517 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -56.84 120.0 7.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' MET . 53.2 tp -100.19 102.61 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.791 168.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -132.69 57.33 0.72 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.774 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.702 ' HD2' HD13 ' A' ' 12' ' ' ILE . 5.8 Cg_exo -78.51 -46.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.48 2.12 . . . . 0.0 111.368 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.28 147.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.837 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.688 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 53.5 m80 -91.12 -19.21 0.24 Allowed Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.6 Cg_endo -53.67 164.8 2.04 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.31 2.007 . . . . 0.0 113.482 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' ARG . 85.0 Cg_exo -46.65 149.25 3.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.201 2.601 . . . . 0.0 112.791 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 39.7 Cg_endo -65.53 26.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.567 3.511 . . . . 0.0 114.437 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.774 ' HG3' HG22 ' A' ' 18' ' ' THR . 13.3 ptp180 -82.23 -20.96 36.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.151 0.5 . . . . 0.0 110.004 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.774 HG22 ' HG3' ' A' ' 17' ' ' ARG . 9.8 t -168.62 34.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.691 0.758 . . . . 0.0 110.458 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.9 p -126.12 -80.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.614 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.1 ptm -74.55 79.13 1.96 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.403 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 99.0 m -79.48 118.78 21.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.867 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 68' ' ' SER . 6.2 tp10 -92.83 118.24 30.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB3' ' N ' ' A' ' 7' ' ' SER . 6.4 tp10 -100.4 103.42 14.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.43 123.62 36.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.207 0.527 . . . . 0.0 111.9 -172.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -81.65 110.35 16.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.939 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 87' ' ' VAL . 1.3 p -132.76 127.04 20.21 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.294 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.0 Cg_exo -54.62 136.51 70.94 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.268 2.645 . . . . 0.0 111.038 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.4 -29.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.352 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.34 -28.95 57.03 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.626 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.621 ' SD ' HD12 ' A' ' 33' ' ' LEU . 32.8 tpp -77.5 -20.68 53.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' HG22 ' A' ' 34' ' ' ILE . 80.1 t -69.15 -39.21 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.377 169.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.54 -28.45 56.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.65 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.621 HD12 ' SD ' ' A' ' 30' ' ' MET . 81.1 mt -85.78 -29.99 23.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -72.1 -29.52 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.267 0.556 . . . . 0.0 109.969 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.738 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 17.9 pt -80.38 -13.24 12.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.512 174.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 -97.19 0.19 Allowed Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.459 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 1.078 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 19.5 ptp180 -60.0 -24.86 64.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.003 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.04 30.79 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.486 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.738 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.84 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.306 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.078 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 9.5 mp0 -60.86 -21.63 63.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -168.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.496 ' O ' HG12 ' A' ' 45' ' ' ILE . 9.1 tt0 -60.1 -50.67 72.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.367 0.53 . . . . 0.0 110.765 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.5 HG12 HD11 ' A' ' 55' ' ' ILE . 8.9 tp -64.45 -39.18 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.29 -46.3 76.21 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.407 0.622 . . . . 0.0 110.037 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -65.57 -37.65 87.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.246 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 41' ' ' GLN . 22.9 mm -68.19 -51.17 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 111.267 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.45 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.32 -31.3 65.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.675 -173.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -78.84 -31.48 45.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.823 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.14 -45.48 56.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.344 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 p -68.12 -45.21 74.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.76 -0.28 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.542 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.772 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 47.3 t -83.36 135.95 34.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.775 0.321 . . . . 0.0 110.286 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -80.62 72.86 7.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.549 HG22 HD23 ' A' ' 69' ' ' LEU . 43.3 t -82.52 111.32 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -111.26 118.03 34.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.176 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 67' ' ' VAL . 34.2 mm -79.75 115.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -99.71 104.81 30.28 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.555 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.889 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 60.1 Cg_endo -73.62 -21.95 18.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.989 2.46 . . . . 0.0 111.88 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.87 -32.39 23.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.878 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.543 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 21.4 t 65.39 -77.32 0.04 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.804 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.09 -86.16 0.36 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.084 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.88 -3.07 60.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.86 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 64' ' ' GLU . 2.0 mm? -112.92 147.68 37.74 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.279 . . . . 0.0 110.494 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.98 -10.15 11.62 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.124 2.549 . . . . 0.0 111.556 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 4.2 pt-20 -104.27 -147.54 0.39 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.524 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.889 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 19.3 mmt180 -106.53 139.88 40.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.1 p -110.75 108.11 17.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.496 0.665 . . . . 0.0 109.347 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG13 HD13 ' A' ' 55' ' ' ILE . 64.7 t -97.08 108.16 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.249 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -86.88 134.7 33.51 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.954 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.549 HD23 HG22 ' A' ' 53' ' ' VAL . 2.3 mp -123.5 121.87 36.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.163 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 21' ' ' THR . 26.2 m -151.92 121.46 6.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.026 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.772 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.04 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.177 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -160.85 165.45 17.25 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 8.6 Cg_endo -49.93 -47.0 25.27 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 113.284 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.19 -38.94 23.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.431 0.634 . . . . 0.0 110.152 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -65.69 -46.17 80.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.789 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 p -73.06 -23.6 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 0.0 110.332 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.7 tp60 -76.47 -47.84 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.966 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 81' ' ' MET . 17.2 tppt? -60.64 -45.23 94.88 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.778 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.32 79.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.471 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 47.5 mtmt -69.1 -21.04 64.07 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.908 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.1 mmt -61.25 -48.04 83.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.211 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.24 -41.24 97.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.704 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -64.12 -57.33 9.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.361 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.56 -35.89 61.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.317 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.01 -61.44 2.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.013 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.548 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.1 mp -70.41 -38.77 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.052 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 26' ' ' VAL . 77.9 t -61.45 -36.69 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.333 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t -71.17 -22.67 62.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.835 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -59.83 -49.2 78.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.31 -54.9 3.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.385 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 64' ' ' GLU . 39.3 mmt180 . . . . . 0 C--N 1.32 -0.71 0 C-N-CA 123.354 0.662 . . . . 0.0 110.372 178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 8.1 m . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 21' ' ' THR . 60.0 tp60 170.83 -31.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.068 0.855 . . . . 0.0 108.964 171.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 67.55 -90.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.663 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 148.06 94.94 0.15 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.134 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.36 -12.96 30.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.806 2.337 . . . . 0.0 111.854 176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.84 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -99.69 161.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.661 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 31.5 t-80 -92.5 -37.95 0.35 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 51.8 Cg_exo -32.58 144.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.874 3.049 . . . . 0.0 114.387 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 73.1 Cg_exo -40.58 140.76 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.376 2.717 . . . . 0.0 112.29 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 9.5 Cg_endo -51.79 60.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.132 1 C-N-CA 125.652 4.234 . . . . 0.0 116.884 -168.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 11.9 ptp180 -114.84 15.11 17.45 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -178.87 -25.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.513 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.521 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 12.8 m -86.2 10.86 13.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.438 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.655 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 90.1 mmm -147.38 31.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.466 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.578 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 88.4 m -79.88 115.75 19.64 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 9.3 tt0 -123.89 118.04 26.18 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.3 109.29 20.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -92.1 128.22 37.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.003 -170.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 87.8 mtm180 -88.14 101.72 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.518 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -120.4 120.4 29.91 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.079 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.565 ' HD3' ' HG2' ' A' ' 91' ' ' ARG . 85.4 Cg_exo -50.11 145.71 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.878 3.052 . . . . 0.0 112.207 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -60.5 -37.04 79.81 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.587 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.76 -25.3 53.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.791 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.616 ' HG2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 tpp -79.54 -26.67 41.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.203 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 34' ' ' ILE . 7.5 p -75.81 -30.18 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -28.3 62.25 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.16 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -88.87 -24.24 22.57 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.8 tp -70.8 -27.47 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.313 0.578 . . . . 0.0 109.892 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 pt -81.15 -14.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.431 173.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.09 -90.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 O-C-N 124.187 0.929 . . . . 0.0 113.155 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.06 28.15 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.15 0.58 . . . . 0.0 111.991 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.38 67.99 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.271 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -51.87 0.27 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.872 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 5.0 mm-40 -59.12 -22.41 60.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -53.24 52.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.763 0.71 . . . . 0.0 111.34 -172.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.91 -44.44 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.48 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -59.68 -42.95 94.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.0 109.68 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 4.5 ttmm -63.25 -35.73 81.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.569 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.01 -50.67 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.79 84.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.808 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -73.97 -37.49 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.76 -45.03 91.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -73.19 -46.54 49.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.81 8.63 9.63 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.789 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 22.9 t -84.21 139.55 32.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.625 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -94.36 71.82 3.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.742 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.66 120.93 35.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.236 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.5 mm-40 -117.03 119.53 35.57 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.213 0.53 . . . . 0.0 111.032 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.501 HD13 HG13 ' A' ' 67' ' ' VAL . 32.6 mm -85.16 109.06 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.522 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.479 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 10.0 m -91.12 109.76 37.63 Favored Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 120.695 0.283 . . . . 0.0 110.641 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.625 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 32.8 Cg_endo -64.81 -50.96 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.987 2.458 . . . . 0.0 111.941 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.95 94.08 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.884 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.3 p -74.6 -29.74 61.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.329 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.71 -86.56 1.34 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.712 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.98 -12.03 84.29 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.506 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.884 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.9 mp -110.0 144.47 30.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.73 -37.67 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.453 2.102 . . . . 0.0 111.931 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.69 -154.26 0.36 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.322 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.625 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 17.0 tpp180 -85.78 154.97 21.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.642 ' HB3' HD22 ' A' ' 62' ' ' LEU . 73.8 p -120.74 117.36 27.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.537 HG23 HG11 ' A' ' 26' ' ' VAL . 97.1 t -104.51 120.95 55.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.061 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -86.97 128.51 35.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.431 0.634 . . . . 0.0 111.16 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.605 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.2 mm? -104.67 112.18 25.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.231 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.432 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 25.5 m -151.81 155.08 37.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.18 -101.76 0.18 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.415 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -143.78 164.04 32.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 7.8 Cg_endo -49.05 -53.17 7.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.959 2.439 . . . . 0.0 113.54 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -84.54 -30.11 25.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.091 0.472 . . . . 0.0 111.143 -177.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.5 m -72.97 -43.19 62.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.204 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.627 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.6 p -67.74 -24.81 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.963 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.559 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.7 tt0 -74.81 -42.62 57.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.893 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 81' ' ' MET . 21.1 tptp -61.12 -44.64 97.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.461 0.648 . . . . 0.0 110.283 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.38 -48.21 82.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.627 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 8.4 mtmp? -69.22 -20.69 63.96 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.393 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 24.2 mmt -58.35 -46.84 85.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 81.9 mtp -63.68 -49.97 71.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 110.743 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.1 mm? -59.68 -50.88 72.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.629 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.59 -41.66 95.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.842 0.353 . . . . 0.0 110.339 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.33 -56.71 18.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.396 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.86 -35.28 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.123 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 24' ' ' TYR . 55.3 t -72.11 -28.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 121.608 -0.683 . . . . 0.0 111.0 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -69.37 -40.41 77.45 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.652 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 16.9 ptm180 -73.92 -21.54 60.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.879 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.616 ' HA3' ' HG2' ' A' ' 30' ' ' MET . . . -94.02 -58.94 1.2 Allowed Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.139 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.565 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 14.3 mmm180 . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 110.749 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.936 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 20.3 t . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.689 0.28 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.51 156.04 7.88 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.077 0.551 . . . . 0.0 110.864 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' MET . 80.2 mt -137.92 106.43 5.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.27 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.18 61.58 0.64 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.93 -27.42 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.405 2.07 . . . . 0.0 112.76 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.597 HG13 ' HB3' ' A' ' 19' ' ' SER . 15.7 pt -111.11 144.56 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.585 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 41.2 m80 -90.22 -20.48 0.25 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 92.9 Cg_exo -40.58 154.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.216 1.944 . . . . 0.0 112.83 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 17' ' ' ARG . 80.9 Cg_exo -46.58 152.99 1.34 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 123.29 2.66 . . . . 0.0 113.119 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 38.4 Cg_endo -65.51 24.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.294 3.329 . . . . 0.0 114.064 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.791 ' HG3' HG22 ' A' ' 18' ' ' THR . 12.0 ptp180 -71.69 -24.66 61.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.124 0.487 . . . . 0.0 109.942 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.791 HG22 ' HG3' ' A' ' 17' ' ' ARG . 7.2 t -163.25 10.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.916 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.597 ' HB3' HG13 ' A' ' 12' ' ' ILE . 15.2 m -105.22 -86.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.573 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.8 ptp -69.13 85.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.508 0.67 . . . . 0.0 110.949 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 m -88.92 114.03 25.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.223 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.485 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 14.5 tt0 -95.95 118.88 33.43 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.936 ' HB3' ' HB3' ' A' ' 7' ' ' SER . 4.9 tp10 -90.92 106.86 18.81 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.564 ' CD2' HG21 ' A' ' 87' ' ' VAL . 1.9 m-85 -90.54 108.47 19.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.379 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.447 ' HD2' ' CG ' ' A' ' 62' ' ' LEU . 12.4 mtm180 -89.51 99.58 12.55 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -114.71 133.03 22.62 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -170.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.7 Cg_exo -58.55 133.62 55.64 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.018 2.479 . . . . 0.0 110.421 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.8 -32.25 67.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.01 -31.41 79.39 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.712 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.596 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.1 mmm -78.29 -15.86 58.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 34' ' ' ILE . 37.8 t -72.59 -39.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.51 -27.9 70.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.534 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.79 -29.98 23.38 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -72.68 -26.25 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.494 0.664 . . . . 0.0 110.067 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.764 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 20.3 pt -83.2 -13.91 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.829 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.4 -100.54 0.31 Allowed Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.578 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.515 ' HD3' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -60.28 -14.84 20.18 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.748 0.419 . . . . 0.0 111.503 178.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.39 27.84 1.57 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.451 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.764 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.61 -51.61 0.6 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.995 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.403 ' HA ' HD22 ' A' ' 43' ' ' ASN . 5.7 tp10 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' HD3' ' A' ' 37' ' ' ARG . 15.1 tt0 -62.03 -51.71 66.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.122 0.419 . . . . 0.0 111.083 -173.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.525 HD11 HG11 ' A' ' 53' ' ' VAL . 8.1 tp -62.27 -40.92 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 40' ' ' GLU . 95.6 m-20 -52.35 -52.52 52.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 123.628 0.58 . . . . 0.0 110.05 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -56.89 -50.76 71.53 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.5 mm -60.56 -50.8 78.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -39.7 73.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.298 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -75.96 -34.12 59.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.25 -44.75 95.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.688 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.1 p -80.31 -36.75 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.161 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.92 5.03 31.29 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 49.7 t -79.9 141.59 35.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.392 0.615 . . . . 0.0 110.378 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -96.54 74.27 2.79 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.613 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 42' ' ' ILE . 41.7 t -82.22 107.85 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.177 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -103.92 111.12 23.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.759 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.482 HD13 HG13 ' A' ' 67' ' ' VAL . 28.7 mm -79.21 90.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.961 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 66' ' ' SER . 57.7 m -79.78 116.25 59.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 95.1 Cg_endo -84.89 1.8 8.33 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.0 2.467 . . . . 0.0 110.934 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.32 -33.36 49.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.515 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 58.5 p 55.05 -78.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 113.035 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.43 -104.97 2.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.015 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 3.38 86.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.612 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CG ' ' HD2' ' A' ' 25' ' ' ARG . 2.9 mm? -110.08 141.67 24.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.0 0.67 6.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.987 2.458 . . . . 0.0 110.577 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.4 pt-20 -113.54 -170.27 1.66 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.552 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.709 ' HB3' HG13 ' A' ' 26' ' ' VAL . 7.4 tpp180 -85.58 133.67 34.05 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 56' ' ' SER . 52.9 p -108.31 99.62 9.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 0.0 109.896 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 55' ' ' ILE . 57.9 t -101.03 110.36 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -85.73 130.12 34.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.406 0.622 . . . . 0.0 110.956 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.594 HD21 ' HG ' ' A' ' 83' ' ' LEU . 4.4 mm? -105.58 111.3 23.94 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.457 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -150.41 127.53 11.23 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . -155.12 -89.92 0.07 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.653 -1.26 . . . . 0.0 113.583 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -160.96 165.86 16.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 89.9 Cg_exo -44.9 -53.22 5.4 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.521 2.147 . . . . 0.0 112.969 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.56 -40.13 23.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 110.907 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.688 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.1 m -65.59 -44.05 87.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.65 -172.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.6 p -71.64 -30.48 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.037 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.8 tt0 -70.95 -43.62 67.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -52.35 65.79 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.357 0.598 . . . . 0.0 110.102 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.22 74.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.29 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 43.9 mtmt -69.47 -20.9 63.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.605 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.4 mmt -62.73 -42.1 99.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.115 172.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.9 mmt -67.01 -43.11 83.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.99 0.424 . . . . 0.0 111.046 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.1 mm? -64.29 -53.15 53.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.966 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.66 -33.66 66.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.47 . . . . 0.0 110.435 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.6 -60.98 2.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.082 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.697 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.3 mp -75.93 -37.09 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.921 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 24' ' ' TYR . 77.5 t -66.09 -32.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.943 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.697 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.7 ptm180 -75.09 -12.94 60.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.752 0.31 . . . . 0.0 111.129 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.596 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -108.97 -62.15 0.54 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.155 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 91' ' ' ARG . 5.1 tmm_? . . . . . 0 C--N 1.326 -0.446 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.597 0.237 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.56 134.22 56.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.594 0.712 . . . . 0.0 112.508 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' MET . 75.1 mt -120.09 145.55 46.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.923 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.47 66.8 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.361 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.04 -49.72 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.829 2.353 . . . . 0.0 112.101 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.498 HD11 HG23 ' A' ' 18' ' ' THR . 18.7 pt -117.98 163.74 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.66 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 92.0 m-70 -91.25 -29.57 0.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 38.8 Cg_exo -41.27 167.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.168 2.579 . . . . 0.0 114.904 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 17' ' ' ARG . 68.0 Cg_exo -42.3 156.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.62 2.88 . . . . 0.0 113.758 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 28.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 124.031 3.154 . . . . 0.0 114.563 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.49 -11.08 43.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.083 0.468 . . . . 0.0 110.01 173.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 12' ' ' ILE . 6.2 t -163.88 8.18 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.865 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 41.0 t -92.9 -94.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.339 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.7 ptp -70.63 85.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 0.0 110.537 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.7 m -94.24 114.81 26.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.196 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.7 tp10 -95.45 118.38 32.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -96.46 100.68 12.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.538 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -94.07 116.92 29.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.141 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 91' ' ' ARG . 31.5 mtm180 -84.39 113.68 21.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.31 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.505 HG23 HG22 ' A' ' 87' ' ' VAL . 2.2 p -117.71 131.55 24.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 111.048 -176.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.52 ' O ' HG23 ' A' ' 31' ' ' VAL . 26.9 Cg_exo -58.74 139.28 90.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.168 2.579 . . . . 0.0 110.764 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 2.7 p-10 -59.18 -32.17 69.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.136 -172.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -39.55 87.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.246 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.405 ' SD ' HD12 ' A' ' 33' ' ' LEU . 1.5 mpp? -79.5 -7.2 58.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.192 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 35' ' ' ILE . 75.6 t -70.69 -43.18 77.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.99 -31.38 72.32 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.57 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' SD ' ' A' ' 30' ' ' MET . 60.0 mt -83.41 -32.11 26.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 HH22 ' A' ' 65' ' ' ARG . 10.2 tp -70.8 -28.36 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.619 0.723 . . . . 0.0 109.921 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.68 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 14.2 pt -85.4 -13.26 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.59 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.46 -87.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 113.493 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.778 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 2.5 ptm85 -77.26 42.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.074 0.55 . . . . 0.0 110.784 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.43 19.76 69.0 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.03 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.68 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.75 -51.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.311 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 32.0 tt0 -60.42 -21.39 62.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' HD13 ' A' ' 45' ' ' ILE . 29.0 tt0 -63.56 -38.9 92.88 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.341 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -66.03 -36.94 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 1.3 m-20 -59.39 -43.2 92.99 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -59.54 -57.13 14.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.548 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.489 HD13 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -58.81 -53.01 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.484 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -29.72 61.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.252 -172.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.811 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -77.79 -39.92 42.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 178.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -66.08 -32.46 73.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 29.8 p -91.29 -36.01 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.738 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.38 7.25 57.16 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.59 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 49.1 t -78.99 142.75 36.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.624 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -83.6 72.62 10.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 42' ' ' ILE . 49.1 t -86.04 107.47 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.054 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.453 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 6.8 tp60 -98.84 122.66 42.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.5 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.402 HG23 ' HD3' ' A' ' 65' ' ' ARG . 24.7 mm -100.54 117.14 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.954 0.406 . . . . 0.0 111.666 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 44.9 m -112.7 93.97 26.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.772 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 76.6 Cg_exo -51.89 -55.92 3.45 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.434 3.422 . . . . 0.0 114.342 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.3 -2.02 58.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.646 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 p 49.93 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.55 1.14 . . . . 0.0 113.035 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.52 -65.85 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.74 2.44 87.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.206 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.728 HD12 ' HB3' ' A' ' 66' ' ' SER . 58.2 mt -126.02 151.73 72.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.22 -14.11 8.5 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 110.104 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 7.1 pt-20 -105.27 -164.75 1.06 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.305 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.772 ' HG2' ' HA ' ' A' ' 57' ' ' PRO . 6.3 tmm_? -101.1 137.92 38.83 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.728 ' HB3' HD12 ' A' ' 62' ' ' LEU . 77.9 p -105.24 142.6 34.74 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.944 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.0 t -130.31 111.96 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.426 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.7 m -81.15 121.45 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.311 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.999 HD13 ' HG2' ' A' ' 80' ' ' LYS . 96.6 mt -109.72 108.45 18.83 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.14 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 149.79 30.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.65 -95.98 0.11 Allowed Glycine 0 C--O 1.226 -0.362 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.809 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -147.66 163.7 26.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 83.6 Cg_exo -45.44 -55.26 3.64 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.003 2.469 . . . . 0.0 113.432 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.34 -32.81 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 110.912 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.0 m -67.6 -48.06 67.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.899 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.515 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 1.4 p -71.84 -24.32 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.765 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -71.88 -43.34 65.6 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.253 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 81' ' ' MET . 20.9 tptm -66.02 -45.59 80.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.457 0.646 . . . . 0.0 110.128 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.422 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -54.99 -49.33 71.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.072 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.999 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.1 mtmt -71.79 -22.75 61.53 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.755 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 21.9 ptm -69.32 -38.05 78.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.783 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.485 ' HG3' ' CG1' ' A' ' 45' ' ' ILE . 20.9 mmt -75.11 -39.28 60.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.744 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.3 mm? -61.78 -59.57 4.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.56 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.58 -34.11 66.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.736 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 24.6 t70 -69.45 -61.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.857 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.72 -40.27 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 111.282 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 26' ' ' VAL . 58.3 t -70.92 -21.97 22.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.592 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -72.56 -30.25 64.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 15.1 mmm-85 -67.99 -29.94 69.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.12 0.486 . . . . 0.0 110.0 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.21 -41.63 3.68 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.973 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 4.5 ptm180 . . . . . 0 C--N 1.325 -0.481 0 O-C-N 122.557 -0.378 . . . . 0.0 110.755 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.358 0.123 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.476 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 19.1 mm-40 57.78 -161.8 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.955 0.502 . . . . 0.0 111.721 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 2.6 tt 171.66 -72.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 111.24 114.32 3.46 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.615 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.44 -5.08 14.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.746 2.297 . . . . 0.0 112.179 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.56 ' HB ' ' CG2' ' A' ' 18' ' ' THR . 6.8 mt -98.62 121.28 49.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.7 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 m80 -82.55 -26.59 0.41 Allowed Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.3 Cg_exo -31.45 130.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 123.583 2.855 . . . . 0.0 114.07 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.501 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.8 Cg_exo -33.89 127.08 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 125.079 3.853 . . . . 0.0 112.456 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 10.0 Cg_exo -19.62 53.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.571 5.514 . . . . 0.0 117.572 -157.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 76.4 mtp180 -99.06 -4.48 32.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.56 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -178.62 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.41 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -79.15 -23.25 44.08 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.598 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.438 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.6 mtt -117.68 52.69 0.97 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -79.11 112.28 16.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.821 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.5 tp10 -111.27 118.95 37.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.476 ' HB2' ' CG ' ' A' ' 8' ' ' GLN . 36.7 tp10 -98.38 103.53 15.49 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.427 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.83 128.0 37.5 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.043 -169.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HG2' HD21 ' A' ' 62' ' ' LEU . 19.9 mtp180 -87.4 110.14 20.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.997 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.753 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -125.56 127.95 24.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -177.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 31.9 Cg_exo -57.73 147.89 77.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.621 2.214 . . . . 0.0 111.963 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 31' ' ' VAL . 20.0 t70 -53.21 -51.07 63.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.81 76.25 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.193 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.544 ' SD ' HD12 ' A' ' 33' ' ' LEU . 9.5 tpp -79.53 -28.53 41.31 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.699 -0.295 . . . . 0.0 110.373 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 28' ' ' ASP . 13.3 p -74.74 -30.09 24.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.59 67.32 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.795 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.544 HD12 ' SD ' ' A' ' 30' ' ' MET . 95.7 mt -87.55 -25.59 23.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -68.7 -31.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.435 0.636 . . . . 0.0 109.541 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.617 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.1 pt -82.73 -14.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 173.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.37 -88.28 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 124.213 0.945 . . . . 0.0 112.968 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.488 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 8.0 ptp180 -77.7 38.93 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.216 0.606 . . . . 0.0 111.561 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.96 3.27 80.51 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.978 -0.556 . . . . 0.0 114.324 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.617 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 160.33 -50.53 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.158 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 12.6 tp10 -54.08 -25.01 19.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.49 -46.95 77.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.719 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.732 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 10.6 tp -65.94 -38.78 82.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -53.53 -42.88 67.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.33 -48.46 72.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.876 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.501 ' HB ' HD12 ' A' ' 42' ' ' ILE . 95.4 mt -58.91 -57.97 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.732 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 7.9 pt20 -73.24 -20.97 60.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.523 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.879 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -78.36 -38.7 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.434 0.635 . . . . 0.0 110.022 172.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -63.18 -39.59 95.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.811 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' SER . 23.3 p -80.36 -46.78 15.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.349 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.9 56.2 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.583 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 54.1 t -82.44 143.15 31.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.17 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.453 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 33.4 mtmt -80.47 76.78 7.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.442 HG11 HD11 ' A' ' 42' ' ' ILE . 79.9 t -82.74 110.41 17.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.776 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -109.67 115.93 30.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.508 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.574 HD13 HG13 ' A' ' 67' ' ' VAL . 33.3 mm -89.24 106.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.333 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 46.8 m -87.24 107.46 14.83 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.862 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.0 Cg_exo -75.26 -38.28 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.818 3.012 . . . . 0.0 113.289 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.6 116.09 19.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.033 0.444 . . . . 0.0 110.259 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.612 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 16.4 p -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.713 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 -85.22 1.84 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.096 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.27 -13.35 83.4 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 59' ' ' SER . 6.3 mp -112.59 149.73 41.59 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.406 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -87.69 3.39 6.3 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.702 2.268 . . . . 0.0 110.252 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 3.4 pt-20 -125.96 -173.59 2.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.564 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.862 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 8.1 tpp85 -83.83 145.22 28.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.498 ' HB3' HD22 ' A' ' 62' ' ' LEU . 54.6 p -121.5 122.31 39.44 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.096 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.574 HG13 HD13 ' A' ' 55' ' ' ILE . 69.1 t -116.22 131.44 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -94.15 125.41 38.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.045 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 mm? -108.34 104.45 13.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.238 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.6 m -152.28 130.81 12.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -162.57 -82.25 0.04 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.926 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.65 168.33 12.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.586 ' N ' ' HG2' ' A' ' 16' ' ' PRO . 97.4 Cg_exo -45.43 -57.74 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.864 2.376 . . . . 0.0 113.675 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -76.66 -35.64 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.495 0.664 . . . . 0.0 110.067 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' SER . 33.7 m -68.63 -42.37 78.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.981 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.15 -31.77 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.848 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -74.11 -37.72 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 81' ' ' MET . 22.9 tptp -70.8 -36.24 72.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 110.413 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -63.76 -40.81 97.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.681 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.3 mtmt -81.92 -20.55 38.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.246 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.586 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 14.3 tpt -58.7 -55.71 31.57 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.751 175.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mmm -69.74 -38.42 76.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.979 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 87' ' ' VAL . 1.3 mm? -56.69 -58.09 9.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.336 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.04 -41.88 65.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.105 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 37.7 t70 -55.37 -59.2 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.4 mp -72.17 -37.15 58.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.1 0.476 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 83' ' ' LEU . 94.9 t -65.11 -31.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.2 m -71.87 -29.8 64.75 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.678 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 24.4 mmm180 -56.53 -49.38 74.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.966 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.94 -53.02 1.13 Allowed Glycine 0 C--O 1.228 -0.248 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.551 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.761 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 7.4 tpt85 . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 121.152 0.501 . . . . 0.0 110.106 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -145.5 167.34 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.391 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.604 HD12 ' HD3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -155.66 135.68 12.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.993 178.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.71 81.46 0.21 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.593 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD3' HD12 ' A' ' 9' ' ' LEU . 67.3 Cg_endo -75.81 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.454 2.103 . . . . 0.0 112.363 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.783 HD11 HG23 ' A' ' 18' ' ' THR . 27.4 pt -131.14 161.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.537 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.587 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.2 m80 -90.52 -26.81 0.3 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 66.2 Cg_exo -39.37 168.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.23 2.62 . . . . 0.0 114.923 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 14' ' ' PRO . 1.3 Cg_endo -42.56 153.65 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.139 3.226 . . . . 0.0 113.941 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 60.4 Cg_endo -69.51 27.95 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 124.092 3.195 . . . . 0.0 113.765 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' HG3' HG22 ' A' ' 18' ' ' THR . 10.7 ptp180 -81.08 -20.82 40.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.401 0.619 . . . . 0.0 109.649 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.783 HG23 HD11 ' A' ' 12' ' ' ILE . 5.2 t -160.92 18.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.027 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 t -99.5 -98.85 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.7 ptp -64.83 88.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.641 0.734 . . . . 0.0 110.653 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.487 HG23 ' OG1' ' A' ' 70' ' ' THR . 29.2 m -92.66 113.46 25.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.808 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.463 ' CD ' ' HD2' ' A' ' 80' ' ' LYS . 19.2 tt0 -96.06 118.08 31.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -96.37 102.88 14.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -92.01 124.46 36.13 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.482 -169.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' OE2' ' A' ' 64' ' ' GLU . 50.9 mtp180 -81.01 118.93 22.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.679 174.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -137.31 123.77 13.46 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HG2' ' CG ' ' A' ' 30' ' ' MET . 20.5 Cg_endo -61.97 141.67 90.16 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.577 2.185 . . . . 0.0 110.632 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' HG12 ' A' ' 31' ' ' VAL . 30.5 t70 -59.05 -30.56 68.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.975 -167.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.94 -36.97 87.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.286 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.576 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.8 mmm -78.5 -27.91 46.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.66 -0.318 . . . . 0.0 111.002 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.4 p -70.98 -28.63 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.411 174.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.81 71.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.038 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.17 -28.63 23.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.0 tp -68.39 -29.95 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.862 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.664 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.7 pt -83.64 -14.04 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.201 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.66 -93.07 0.03 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 123.921 0.763 . . . . 0.0 113.496 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 12.8 ptp180 -64.15 -1.18 1.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.55 0.74 . . . . 0.0 112.493 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.59 11.1 18.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.276 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.664 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.9 -44.57 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.884 174.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 22.8 tt0 -55.72 -32.31 63.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -61.35 -47.83 84.08 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.436 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 53' ' ' VAL . 8.5 tp -61.59 -42.59 94.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.14 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.87 -38.91 83.51 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.77 -49.07 78.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.12 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 82' ' ' MET . 72.1 mt -63.64 -52.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.708 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -72.59 -43.9 62.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.209 -172.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 47' ' ' GLN . 6.3 tp60 -73.8 -26.02 60.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 110.818 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.21 -53.92 7.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.324 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.709 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 41.8 p -64.5 -40.83 96.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.14 7.72 20.84 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.242 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.659 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 38.6 t -92.81 135.19 34.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.771 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 41.2 mtmt -83.22 88.1 6.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 42' ' ' ILE . 58.4 t -95.34 111.14 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -111.1 116.04 30.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 67' ' ' VAL . 33.1 mm -80.69 100.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.7 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.52 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 17.7 m -85.53 114.45 56.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 6.0 Cg_exo -79.57 -27.02 4.39 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.383 2.722 . . . . 0.0 112.698 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.28 -23.87 30.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.616 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.499 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 74.7 p 53.64 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.841 1.257 . . . . 0.0 113.187 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.93 -100.33 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.51 18.29 50.21 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.066 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 64' ' ' GLU . 2.6 mm? -119.59 136.98 25.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.28 -8.69 11.71 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.905 2.403 . . . . 0.0 110.55 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.57 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 4.9 pt-20 -104.09 -162.01 0.87 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.784 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.711 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -95.81 148.26 22.78 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.499 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 65.4 p -122.38 125.2 45.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 55' ' ' ILE . 64.4 t -111.26 112.14 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.733 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -80.28 126.41 31.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.275 0.559 . . . . 0.0 110.817 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.041 HD13 ' HG2' ' A' ' 80' ' ' LYS . 16.0 mt -118.14 110.91 18.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.487 ' OG1' HG23 ' A' ' 21' ' ' THR . 2.6 m -151.22 121.79 7.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.791 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.57 -90.47 0.08 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.937 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.78 167.09 14.72 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.762 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 73.5 Cg_exo -39.89 -59.48 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.356 2.704 . . . . 0.0 114.276 -176.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -82.65 -37.58 24.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.423 0.63 . . . . 0.0 110.15 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.3 m -61.51 -46.32 90.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.399 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.585 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.8 p -72.33 -32.27 41.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.54 -38.72 74.23 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -63.12 -46.96 84.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.493 0.663 . . . . 0.0 110.317 177.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.07 75.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.856 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.041 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.3 mtmt -74.92 -21.41 59.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.078 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.687 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 19.0 ptm -69.08 -37.35 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.667 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.875 ' HG3' HD13 ' A' ' 45' ' ' ILE . 89.8 mmm -67.89 -43.12 80.06 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.639 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.9 mm? -59.38 -56.89 16.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.69 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.54 -39.48 57.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.27 -57.58 12.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.561 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.723 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.4 mp -73.04 -40.58 58.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.519 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 24' ' ' TYR . 81.7 t -61.43 -40.84 87.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.642 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.3 m -68.36 -36.41 79.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.453 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.723 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.2 ptm180 -79.89 -7.68 58.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.793 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.576 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -131.43 9.63 5.58 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.477 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.52 -179.032 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 8.6 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.752 0.31 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -67.67 109.43 3.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.677 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 53.0 mt -92.42 104.34 16.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.392 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -115.16 58.51 0.44 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.102 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.709 ' HD2' HD13 ' A' ' 12' ' ' ILE . 2.6 Cg_endo -82.28 -43.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.639 2.226 . . . . 0.0 112.12 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.873 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -87.72 138.49 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.298 0.571 . . . . 0.0 110.607 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.639 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 52.2 t-80 -78.31 -29.84 0.67 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 95.5 Cg_exo -35.9 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.751 2.967 . . . . 0.0 115.292 173.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.486 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.69 160.71 3.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.094 2.529 . . . . 0.0 111.58 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 38.5 Cg_endo -63.79 3.91 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.135 2.557 . . . . 0.0 114.021 -172.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD3' ' HG2' ' A' ' 15' ' ' PRO . 2.7 ptt180 -58.31 -29.58 66.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.071 0.462 . . . . 0.0 110.319 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -148.14 3.88 0.71 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.228 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.629 ' HA ' HG12 ' A' ' 12' ' ' ILE . 35.9 t -84.52 -96.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.344 -175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.0 ptp -68.09 80.05 0.23 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.593 0.711 . . . . 0.0 111.277 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -79.49 116.17 19.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -91.8 117.87 30.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 43.0 tt0 -87.62 103.86 15.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -91.22 110.45 21.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.686 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.441 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 64.1 mtp180 -80.26 103.53 10.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.959 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.36 127.52 25.83 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.366 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 52.5 Cg_exo -56.59 139.17 87.29 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.864 2.376 . . . . 0.0 111.831 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.85 -55.56 6.5 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -24.09 72.92 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.557 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.8 tpp -78.81 -18.73 53.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.618 ' HA ' HG22 ' A' ' 34' ' ' ILE . 2.1 t -73.02 -33.13 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.87 -30.07 56.19 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.913 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -88.03 -23.23 23.83 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 31' ' ' VAL . 6.8 tp -71.56 -28.32 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.992 0.814 . . . . 0.0 109.663 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.684 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.0 pt -85.59 -15.3 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.324 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.31 -89.24 0.02 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 124.086 0.866 . . . . 0.0 113.701 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.623 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 13.2 ptp180 -71.96 11.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.07 0.548 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 14.71 30.81 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.098 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.684 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.5 -46.39 0.78 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.412 173.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.623 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 9.4 tp10 -62.31 -22.22 65.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 45' ' ' ILE . 20.5 tt0 -64.63 -48.13 76.01 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.108 -0.37 . . . . 0.0 111.318 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 39' ' ' GLY . 7.1 tp -61.54 -42.44 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.46 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.3 m-20 -52.59 -52.54 54.74 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 123.66 0.6 . . . . 0.0 109.463 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -56.88 -48.8 77.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.104 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 41' ' ' GLN . 25.1 mm -62.27 -49.37 84.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.156 -175.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -79.33 -28.2 42.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.365 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -71.13 -42.09 69.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.79 -47.72 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.485 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.558 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 14.5 p -80.52 -38.29 30.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.896 -175.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.02 9.38 42.6 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.607 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 52.3 t -78.72 139.7 38.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.34 0.59 . . . . 0.0 111.352 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -88.2 79.94 7.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.891 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 69' ' ' LEU . 7.6 p -82.04 131.13 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.4 mm-40 -114.51 107.56 15.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.734 0.778 . . . . 0.0 110.703 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.61 HG23 ' NH1' ' A' ' 65' ' ' ARG . 18.5 mm -80.83 106.14 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.567 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.8 m -109.91 100.17 41.97 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.496 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -86.77 24.64 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.478 2.785 . . . . 0.0 111.05 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.43 -31.04 47.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.094 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 p 45.52 64.9 1.26 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.521 0.677 . . . . 0.0 111.075 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.16 116.24 4.9 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.948 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.83 -47.54 3.33 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -172.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 25' ' ' ARG . 2.6 mp -88.39 128.01 54.71 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.62 -13.35 10.8 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 121.96 1.773 . . . . 0.0 111.117 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.4 pt-20 -99.34 -155.62 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.715 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.61 ' NH1' HG23 ' A' ' 55' ' ' ILE . 5.5 mmm-85 -89.76 138.37 31.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.627 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 p -110.1 129.17 55.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.131 0.491 . . . . 0.0 110.286 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG22 ' NH2' ' A' ' 65' ' ' ARG . 87.7 t -119.22 116.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.138 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 74.2 m -93.67 135.21 35.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.132 0.492 . . . . 0.0 110.597 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.749 HD11 ' HG ' ' A' ' 83' ' ' LEU . 74.2 mt -118.86 127.97 54.0 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.792 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -150.73 157.54 43.07 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.266 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 148.69 -152.73 24.73 Favored Glycine 0 C--O 1.217 -0.911 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.179 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.87 152.42 80.03 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.06 -46.36 19.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.675 2.25 . . . . 0.0 112.717 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.63 -32.29 60.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.972 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -71.15 -49.74 40.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.541 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 9.2 p -67.02 -27.08 38.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.506 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 81' ' ' MET . 28.8 tt0 -72.54 -41.96 65.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.43 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HD2' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -64.82 -40.2 94.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.083 0.468 . . . . 0.0 110.419 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.33 88.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.92 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.674 ' HG2' HD13 ' A' ' 69' ' ' LEU . 55.6 mtmt -64.79 -23.33 67.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.642 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.6 mmm -60.44 -52.46 65.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.603 ' HA ' ' CE ' ' A' ' 82' ' ' MET . 10.1 mmt -70.84 -36.2 72.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.978 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.749 ' HG ' HD11 ' A' ' 69' ' ' LEU . 1.1 mm? -60.87 -60.48 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.29 -29.28 70.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 110.662 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.69 -60.26 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.26 0.553 . . . . 0.0 110.649 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.557 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.02 -37.0 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.07 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.524 HG21 ' HD2' ' A' ' 24' ' ' TYR . 65.6 t -62.53 -32.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.718 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -71.46 -39.99 70.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.253 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.9 ptp180 -72.97 -18.6 61.35 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.605 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.93 -65.07 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.649 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.475 0.655 . . . . 0.0 110.298 -178.008 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.634 ' HB3' ' OE1' ' A' ' 22' ' ' GLU . 39.7 m . . . . . 0 CA--C 1.529 0.162 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.788 ' HB3' ' O ' ' A' ' 21' ' ' THR . 36.7 tt0 -175.4 -143.41 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.727 0.694 . . . . 0.0 110.074 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.645 ' H ' ' HG2' ' A' ' 8' ' ' GLN . 2.0 pt? -167.09 -61.15 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -175.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.633 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . 119.74 149.2 8.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.454 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HD3' ' HA2' ' A' ' 10' ' ' GLY . 6.2 Cg_exo -80.08 -52.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.146 2.564 . . . . 0.0 113.329 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.684 HG22 ' HD2' ' A' ' 14' ' ' PRO . 2.1 mt -93.47 128.59 44.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.699 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 45.5 m80 -92.61 3.57 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -168.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.758 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 19.0 Cg_endo -57.99 -162.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.559 2.173 . . . . 0.0 112.81 169.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 28.2 Cg_exo -38.59 155.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.874 2.383 . . . . 0.0 113.594 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 34.6 Cg_endo -64.68 23.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.231 3.287 . . . . 0.0 115.162 -171.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -78.94 2.13 21.31 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.527 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -179.13 2.27 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.688 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 16' ' ' PRO . 49.2 p -97.59 -8.87 28.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 16' ' ' PRO . 15.8 ptp -146.43 52.9 1.12 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.871 0.844 . . . . 0.0 109.452 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.788 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 94.6 m -78.25 116.77 18.93 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.788 177.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 7' ' ' SER . 2.8 tp10 -101.78 125.16 48.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.343 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -98.57 104.38 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.13 116.79 29.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.635 -169.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.638 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 23.9 mtp180 -81.78 109.52 16.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.883 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -125.05 125.09 25.36 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 110.808 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 51.4 Cg_exo -55.4 136.31 73.13 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.784 2.322 . . . . 0.0 110.885 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.455 ' HA ' HG23 ' A' ' 31' ' ' VAL . 28.1 t70 -58.61 -33.87 70.51 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.561 -168.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.42 -34.64 90.45 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.65 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.535 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 92.1 mmm -78.65 -9.92 59.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 34' ' ' ILE . 44.2 t -75.83 -40.46 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.96 -30.41 69.9 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.284 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.16 -28.97 25.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.3 tp -71.82 -28.94 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.413 0.625 . . . . 0.0 110.114 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.652 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.5 pt -80.46 -13.74 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.677 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.39 -91.82 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.954 0.783 . . . . 0.0 113.302 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.2 ptm85 -77.5 37.89 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.503 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.13 19.75 78.68 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.683 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.652 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.04 -49.33 0.6 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.92 173.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 28.2 tt0 -58.71 -28.7 66.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -169.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -56.42 22.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.818 0.281 . . . . 0.0 111.166 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.57 HD11 HG11 ' A' ' 53' ' ' VAL . 6.1 tp -57.29 -49.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.826 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.21 -38.88 88.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.036 0.446 . . . . 0.0 110.637 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -60.17 -44.29 95.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.71 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.06 -41.85 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.856 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -69.96 -37.38 75.8 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.07 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -71.36 -38.03 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.44 -51.77 66.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.072 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.79 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 32.9 p -70.56 -37.63 74.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.48 12.05 22.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.955 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 35.4 t -84.99 150.03 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.867 0.365 . . . . 0.0 110.149 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 67.2 mmtt -104.99 82.66 1.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.526 0.679 . . . . 0.0 109.693 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.57 HG11 HD11 ' A' ' 42' ' ' ILE . 40.8 t -93.02 113.59 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.165 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 14.3 mm-40 -107.29 129.7 54.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.783 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.485 HD13 HG13 ' A' ' 67' ' ' VAL . 30.1 mm -102.42 89.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.445 -174.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 35.0 t -79.95 114.6 47.69 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.698 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 5.5 Cg_exo -78.88 -32.54 1.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.588 2.859 . . . . 0.0 112.393 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.31 -34.62 42.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.503 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 40.4 t 71.02 -65.52 0.34 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.183 176.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.43 -55.92 0.59 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.098 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.75 -10.12 10.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.638 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.8 mt -112.91 144.59 31.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.798 0.332 . . . . 0.0 110.5 -173.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.42 -16.64 8.05 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.83 2.353 . . . . 0.0 110.336 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 4.3 pt-20 -92.98 -168.74 2.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.11 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.883 ' HB3' HG13 ' A' ' 26' ' ' VAL . 5.5 tpp180 -89.44 140.57 29.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.536 ' HB3' HD12 ' A' ' 62' ' ' LEU . 67.7 p -114.56 105.17 12.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.546 0.689 . . . . 0.0 109.345 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.485 HG13 HD13 ' A' ' 55' ' ' ILE . 95.3 t -98.13 121.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.8 m -89.67 128.16 36.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.412 0.625 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.731 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -106.56 112.33 25.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.9 m -151.32 143.69 24.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.988 -0.096 . . . . 0.0 110.805 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.54 -154.9 25.06 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.402 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -78.92 160.89 70.57 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -47.52 -53.07 6.99 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.796 2.33 . . . . 0.0 113.479 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -72.98 -40.33 65.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.975 0.417 . . . . 0.0 110.336 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.79 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.2 m -60.02 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.436 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.544 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 3.6 p -70.65 -30.01 40.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.01 -37.88 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 109.925 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.739 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.95 -47.06 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 177.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.11 -48.68 79.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.456 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.731 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 46.1 mtmt -68.52 -22.19 64.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.48 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.739 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 17.9 ptm -70.41 -36.47 74.05 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.497 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.62 -39.98 73.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.135 0.493 . . . . 0.0 110.097 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.0 mm? -64.55 -56.57 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.137 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.54 -35.14 67.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 110.557 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.76 -55.89 25.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.515 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.659 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -75.57 -37.19 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.979 0.419 . . . . 0.0 111.425 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 24' ' ' TYR . 72.6 t -68.13 -33.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.875 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.6 t -70.76 -38.63 73.49 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.821 -0.549 . . . . 0.0 110.304 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.659 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -78.39 -13.43 59.85 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.535 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -120.82 -20.58 3.42 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.016 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 117.16 0.48 . . . . 0.0 110.524 -177.705 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' HD22 ' A' ' 9' ' ' LEU . 49.2 m . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 7.6 tt0 -64.45 112.98 3.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.776 0.322 . . . . 0.0 111.781 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 7' ' ' SER . 1.9 mm? -92.15 108.68 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 167.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 73.2 0.29 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.442 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 4.6 Cg_exo -74.99 -57.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.764 2.31 . . . . 0.0 111.874 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.649 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 pp -104.19 151.38 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.416 176.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 7.0 t-160 -90.6 -11.88 0.18 Allowed Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -170.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 72.7 Cg_exo -39.27 161.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.477 2.118 . . . . 0.0 114.337 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.49 148.47 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.703 2.935 . . . . 0.0 113.462 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.35 31.05 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.793 2.995 . . . . 0.0 113.905 -172.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -92.89 -0.36 57.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.874 0.369 . . . . 0.0 110.331 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.579 HG22 ' HD3' ' A' ' 17' ' ' ARG . 12.7 t -174.33 1.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.762 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 p -93.74 -85.09 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.1 ptm -72.56 71.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.596 0.712 . . . . 0.0 111.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.6 m -79.19 120.91 24.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.645 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.904 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 9.0 tp10 -92.58 118.88 31.47 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.82 106.19 18.42 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.556 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -92.26 118.61 31.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.944 -172.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.557 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 95.6 mtt180 -81.98 95.46 7.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.254 174.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -114.73 121.02 36.41 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.028 -176.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.622 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 51.5 Cg_exo -54.93 154.93 19.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.311 2.674 . . . . 0.0 112.442 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.71 -39.06 79.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.4 . . . . 0.0 111.236 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.23 64.11 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.876 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.41 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -78.0 -29.64 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.756 -0.261 . . . . 0.0 111.08 -177.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.67 ' HA ' HG22 ' A' ' 34' ' ' ILE . 5.8 p -73.25 -30.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.758 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -67.66 -22.32 73.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.364 170.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD23 HG23 ' A' ' 86' ' ' ILE . 62.0 tp -89.05 -30.13 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.67 HG22 ' HA ' ' A' ' 31' ' ' VAL . 10.8 tp -72.47 -26.18 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.401 0.619 . . . . 0.0 109.906 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.604 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.3 pt -81.24 -14.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -92.06 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 O-C-N 124.045 0.841 . . . . 0.0 113.281 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 11.1 ptp180 -71.13 3.78 3.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.016 0.526 . . . . 0.0 111.835 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.5 25.72 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.107 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.41 -50.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.45 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 28.9 tt0 -50.65 -36.16 34.19 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 45' ' ' ILE . 15.1 tt0 -59.81 -55.33 35.56 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 53' ' ' VAL . 5.1 tp -58.55 -46.64 89.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.53 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -56.42 -43.66 79.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 123.453 0.471 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.4 -43.25 95.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.646 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 41' ' ' GLN . 24.0 mm -65.19 -50.89 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.769 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -70.54 -27.77 64.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.987 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -72.45 -44.78 61.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.0 -50.02 73.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.436 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.4 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 24.6 p -67.7 -45.31 75.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.319 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.67 10.98 27.79 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.67 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.448 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 53.9 t -94.17 138.64 31.98 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.094 0.473 . . . . 0.0 110.094 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -85.95 79.94 9.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.616 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 42' ' ' ILE . 43.9 t -89.07 107.42 17.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.212 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB3' ' OG ' ' A' ' 68' ' ' SER . 12.1 tp60 -99.06 116.26 30.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -175.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 42' ' ' ILE . 44.5 mm -83.53 89.96 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.111 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 41.1 m -85.49 114.82 58.61 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 121.164 0.507 . . . . 0.0 111.036 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 12.1 Cg_exo -69.61 -36.6 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.324 2.683 . . . . 0.0 111.485 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.11 89.57 5.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.576 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 3.9 m -72.38 -19.31 61.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.155 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 -99.86 1.04 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.296 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.59 -26.87 66.51 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.263 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.557 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.3 mm? -87.25 139.95 32.26 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -85.05 0.71 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.766 2.311 . . . . 0.0 111.421 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -108.45 -110.57 0.31 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.8 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.609 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -133.92 149.57 51.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.576 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 82.7 p -119.77 111.4 17.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.734 0.778 . . . . 0.0 110.35 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.56 132.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.01 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 p -99.38 130.06 45.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.369 0.604 . . . . 0.0 111.485 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.904 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 2.9 mm? -110.49 105.78 14.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.233 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 18' ' ' THR . 6.5 m -150.97 128.01 11.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.939 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -166.81 -97.29 0.11 Allowed Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.924 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.54 163.68 43.61 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.25 -43.41 37.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.441 2.094 . . . . 0.0 112.593 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -79.44 -38.0 35.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.231 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -77.18 -41.76 40.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.087 0.47 . . . . 0.0 110.654 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -23.92 30.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.278 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.2 tp-100 -77.86 -45.6 23.81 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 81' ' ' MET . 4.9 tppp? -60.7 -45.83 92.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.026 0.441 . . . . 0.0 110.561 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.411 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -55.8 -49.73 72.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.393 176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.558 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.3 mtmt -69.54 -21.05 63.67 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.023 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.6 mmt -60.66 -50.18 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.172 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.635 ' HA ' ' CE ' ' A' ' 82' ' ' MET . 6.8 mmt -66.11 -39.5 89.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.067 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.1 mm? -66.27 -54.19 27.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.54 -30.68 67.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.27 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 15.2 t70 -66.03 -61.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.469 HG23 HD23 ' A' ' 33' ' ' LEU . 2.0 mp -68.66 -38.42 78.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.141 0.496 . . . . 0.0 111.295 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.556 HG21 ' HD2' ' A' ' 24' ' ' TYR . 76.9 t -66.62 -29.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -78.15 -22.68 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.345 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 26.7 mmm180 -66.87 -32.51 73.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.069 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.83 -64.38 0.82 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.754 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 . . . . . 0 C--N 1.324 -0.507 0 CA-C-O 121.101 0.477 . . . . 0.0 110.962 -178.248 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 10.5 t . . . . . 0 N--CA 1.465 0.313 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.679 ' HG3' ' H ' ' A' ' 9' ' ' LEU . 23.8 tp60 48.51 -156.47 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 111.667 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.679 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 4.2 pp 174.33 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.261 1.024 . . . . 0.0 108.301 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 9' ' ' LEU . . . 150.98 126.15 1.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.541 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.47 -13.75 22.63 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.542 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.94 HG12 ' HD2' ' A' ' 14' ' ' PRO . 13.1 tt -147.49 148.52 16.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.701 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.5 m-70 -90.38 -10.89 0.16 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.94 ' HD2' HG12 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -38.05 164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.802 2.334 . . . . 0.0 113.226 162.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -26.98 146.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 125.022 3.814 . . . . 0.0 115.871 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 47.5 Cg_endo -65.96 12.9 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.033 3.155 . . . . 0.0 114.213 -171.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -77.52 2.83 15.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 109.474 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 17' ' ' ARG . 8.4 t -159.83 -25.21 0.07 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.651 172.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 15.6 t -79.85 6.36 11.28 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.156 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 mmt -144.52 37.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.1 m -85.9 112.16 20.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 7' ' ' SER . 9.7 tt0 -123.56 119.49 30.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.228 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.74 102.19 14.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.645 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -92.37 136.76 32.93 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.725 -170.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 25' ' ' ARG . 7.5 mtm180 -101.85 129.38 48.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -135.03 124.11 16.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.801 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 91' ' ' ARG . 51.2 Cg_exo -55.8 140.99 85.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 111.731 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.63 -47.03 29.25 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.68 -31.11 79.81 Favored Glycine 0 C--O 1.238 0.349 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.697 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.515 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 84.2 mmm -77.99 -15.05 59.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 65' ' ' ARG . 17.4 t -72.43 -40.11 63.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.94 -29.94 68.85 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.342 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.69 -24.66 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -74.48 -26.34 20.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.507 0.67 . . . . 0.0 109.544 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.72 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 16.4 pt -88.1 -15.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.062 171.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.89 0.02 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.105 0.878 . . . . 0.0 113.72 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.667 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 4.2 ptp180 -81.02 14.07 2.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.014 0.525 . . . . 0.0 111.166 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 16.02 28.15 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.331 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.72 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.48 -49.74 0.58 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.303 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.667 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.0 tt0 -51.4 -33.56 30.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -173.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 45' ' ' ILE . 21.2 tt0 -60.59 -50.78 72.16 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.652 -173.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.547 HD11 HG11 ' A' ' 53' ' ' VAL . 8.1 tp -63.7 -43.59 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.514 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -62.06 -36.36 81.41 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -65.01 -52.62 55.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.141 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -60.08 -48.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.029 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.2 pp0? -73.5 -34.42 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.693 0.282 . . . . 0.0 111.167 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.87 -39.34 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.137 0.494 . . . . 0.0 110.51 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.68 -38.21 89.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.935 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.3 p -81.11 -43.97 18.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.36 8.64 28.68 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 41.5 t -90.0 132.68 35.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.979 0.418 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -79.82 79.25 6.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.288 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.547 HG11 HD11 ' A' ' 42' ' ' ILE . 47.6 t -87.31 107.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.064 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 10.6 mm-40 -97.9 110.05 22.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.613 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 42' ' ' ILE . 49.7 mm -80.2 112.91 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.26 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.9 m -104.15 99.39 16.86 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.624 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 40.0 Cg_endo -68.95 -30.49 26.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.863 2.375 . . . . 0.0 110.943 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.42 79.62 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -72.62 -36.78 68.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.283 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.78 -69.56 3.2 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.844 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.18 -4.38 90.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.203 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.77 HD12 ' HB3' ' A' ' 66' ' ' SER . 56.6 mt -126.63 144.34 49.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.72 -19.54 9.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.687 2.258 . . . . 0.0 109.939 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 3.6 pt-20 -94.2 -161.9 0.89 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.034 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.89 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.7 tpp180 -99.62 146.27 26.65 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.77 ' HB3' HD12 ' A' ' 62' ' ' LEU . 83.8 p -118.43 134.23 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.905 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG13 HD13 ' A' ' 55' ' ' ILE . 57.1 t -128.7 122.68 57.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.633 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 54.3 m -86.04 123.82 31.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.308 0.575 . . . . 0.0 111.27 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.581 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.3 mm? -105.51 114.76 29.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.607 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.9 m -152.87 141.68 21.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.12 -133.53 1.96 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.617 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.732 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -114.59 166.29 11.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.732 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 8.3 Cg_endo -50.04 -41.87 47.35 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.909 2.406 . . . . 0.0 113.39 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -84.28 -44.95 13.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 23.8 p -66.48 -46.91 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -67.5 -32.51 57.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.303 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG3' ' A' ' 81' ' ' MET . 64.5 tt0 -74.55 -42.22 59.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' MET . 1.9 tpmt? -58.42 -51.65 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.935 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.85 72.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.995 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.581 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.5 mtmt -67.24 -22.62 65.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.543 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 61.7 mtt -62.96 -47.74 81.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.406 ' HG2' HG12 ' A' ' 45' ' ' ILE . 2.3 mpt? -65.25 -41.67 94.06 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.19 176.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' A' ' 69' ' ' LEU . 3.6 mm? -60.39 -57.13 14.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.59 -38.76 72.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.466 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' MET . 15.2 t70 -57.12 -51.68 68.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.386 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -80.4 -40.87 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.585 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.645 HG21 ' CD2' ' A' ' 24' ' ' TYR . 70.8 t -61.42 -41.98 92.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.852 0.358 . . . . 0.0 110.455 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -68.04 -40.3 82.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.621 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 8.1 ptp180 -69.9 -28.07 65.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.579 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.515 ' HA3' ' SD ' ' A' ' 30' ' ' MET . . . -118.08 10.6 13.45 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.477 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.488 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 2.0 tmt_? . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.04 0.447 . . . . 0.0 109.996 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 70.6 m . . . . . 0 C--O 1.22 -0.482 0 CA-C-O 119.631 -0.223 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 21' ' ' THR . 77.2 mm-40 -162.53 -36.93 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.773 0.829 . . . . 0.0 109.317 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.16 -126.96 0.09 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.783 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 140.74 119.7 1.61 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.594 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.84 -6.88 17.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.679 . . . . 0.0 112.061 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.731 HG22 ' HD2' ' A' ' 14' ' ' PRO . 13.9 mt -92.03 113.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.596 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 26.8 m-70 -82.19 -11.74 0.18 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -165.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.731 ' HD2' HG22 ' A' ' 12' ' ' ILE . 76.3 Cg_exo -35.01 127.84 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.133 1.889 . . . . 0.0 112.874 169.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' ARG . 45.1 Cg_exo -36.97 132.4 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 124.391 3.394 . . . . 0.0 112.812 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 2.7 Cg_exo -25.23 62.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 127.076 5.184 . . . . 0.0 117.079 -159.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HA ' ' CG2' ' A' ' 70' ' ' THR . 11.8 ptp180 -122.2 10.34 9.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.57 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 7.9 t 174.11 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.147 178.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 18' ' ' THR . 32.7 t -79.58 -24.06 42.31 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.2 0.524 . . . . 0.0 110.221 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.439 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 8.8 ptp -155.26 70.17 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 51.8 m -78.79 120.68 23.77 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.868 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.7 tp10 -102.59 118.5 36.98 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.888 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 5.3 tp10 -94.06 105.85 17.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.613 170.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 115.04 27.73 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.272 -173.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 1.044 ' HG2' HD13 ' A' ' 62' ' ' LEU . 39.0 mtm105 -81.48 98.77 8.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 172.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -108.11 116.71 56.46 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.209 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.551 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 50.2 Cg_exo -50.63 139.08 39.6 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 123.291 2.66 . . . . 0.0 112.518 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -50.34 -48.5 55.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -28.36 73.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.29 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.551 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 91.0 mmm -78.78 -10.28 59.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 65' ' ' ARG . 39.5 t -77.12 -41.24 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.15 64.44 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.396 172.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.5 mt -89.01 -26.12 21.63 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 31' ' ' VAL . 10.5 tp -72.49 -27.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.477 0.656 . . . . 0.0 109.736 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.604 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.4 pt -84.27 -14.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.133 173.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.86 -90.8 0.07 OUTLIER Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.644 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.597 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.04 10.41 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.867 0.467 . . . . 0.0 111.698 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.13 35.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.111 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 154.1 -46.3 0.55 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.467 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.597 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 26.5 tt0 -48.18 -38.18 17.56 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -61.32 -45.57 93.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.521 HD11 HG11 ' A' ' 53' ' ' VAL . 5.7 tp -59.4 -49.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.424 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.11 -43.08 99.62 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.344 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -58.78 -39.25 80.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.364 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -81.27 -42.49 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.769 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -73.46 -26.83 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.61 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.99 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.41 -51.43 69.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.348 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 p -74.43 -37.29 63.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.772 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.53 2.43 60.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.533 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.411 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 51.4 t -79.67 139.98 37.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 110.56 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HE2' ' HA2' ' A' ' 71' ' ' GLY . 12.4 mttm -83.46 75.56 10.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.264 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.521 HG11 HD11 ' A' ' 42' ' ' ILE . 45.4 t -82.18 110.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.638 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.0 mm-40 -102.41 106.44 17.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.675 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 67' ' ' VAL . 44.9 mm -81.04 106.05 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.411 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 15.1 m -98.99 107.49 44.17 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-O 120.753 0.311 . . . . 0.0 110.656 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.718 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 21.6 Cg_endo -62.13 -37.18 65.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.528 2.819 . . . . 0.0 112.249 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.12 97.12 8.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.481 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 4.2 p -70.84 -37.45 73.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.372 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.7 -72.9 2.72 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.312 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.19 70.53 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.714 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.044 HD13 ' HG2' ' A' ' 25' ' ' ARG . 22.2 mt -115.36 153.18 47.53 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.63 -31.28 2.04 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -94.33 -161.66 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.572 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.776 ' HB3' HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -81.35 151.06 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.713 ' HB3' HD12 ' A' ' 62' ' ' LEU . 88.5 p -118.11 114.24 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.036 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 55' ' ' ILE . 91.5 t -106.0 122.63 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.828 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 69.6 m -88.83 125.58 34.97 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.628 0.728 . . . . 0.0 110.78 177.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.868 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.9 mm? -105.04 109.58 21.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.449 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 26.3 m -151.26 144.75 24.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HE2' ' A' ' 52' ' ' LYS . . . 173.28 -107.82 0.26 Allowed Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.935 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -131.61 164.17 44.55 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.3 Cg_endo -47.4 -50.02 12.06 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.193 2.596 . . . . 0.0 112.994 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.53 -30.24 25.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' A' ' 72' ' ' ALA . 18.1 m -71.56 -48.25 49.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.411 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -69.51 -23.9 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -177.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.75 -51.01 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.319 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 81' ' ' MET . 24.4 tptm -62.7 -41.07 98.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.23 90.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.719 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 48.0 mtmt -74.93 -21.35 59.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.37 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 6.1 tpp -60.23 -46.42 89.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.451 ' HG3' HG12 ' A' ' 45' ' ' ILE . 20.4 mmt -71.02 -39.67 72.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.0 mm? -61.43 -48.92 78.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.321 177.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.5 -46.74 83.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.141 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -46.88 -58.13 4.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.385 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -79.57 -44.57 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.388 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.68 -27.49 36.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.747 0.308 . . . . 0.0 111.131 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -77.93 -38.55 45.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.471 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 3.3 ptp180 -72.26 -21.32 61.39 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.38 -83.15 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.379 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.187 0.518 . . . . 0.0 111.256 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -53.24 112.41 0.87 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 16.1 tp -106.83 117.39 33.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.839 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.99 79.75 0.26 Allowed Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.926 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 9' ' ' LEU . 92.4 Cg_endo -87.78 -7.82 6.24 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.761 2.308 . . . . 0.0 112.734 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.812 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.9 tp -140.87 152.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.686 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 71.3 m80 -88.6 -27.08 0.34 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.6 Cg_exo -37.69 165.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.474 2.783 . . . . 0.0 114.16 165.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 17' ' ' ARG . 42.4 Cg_exo -58.3 169.44 2.97 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.139 2.559 . . . . 0.0 112.606 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 37.4 Cg_endo -64.29 21.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.066 3.177 . . . . 0.0 114.064 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 13.5 ptm180 -77.98 -18.12 56.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 70' ' ' THR . 9.9 t -164.5 6.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.366 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.57 ' HA ' HG22 ' A' ' 12' ' ' ILE . 33.6 t -92.36 -99.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.927 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.541 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 17.4 ptm -60.98 84.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.715 0.769 . . . . 0.0 111.407 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -84.89 114.96 22.5 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.613 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.8 tp10 -92.75 116.63 29.2 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.97 109.21 22.01 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.755 0.788 . . . . 0.0 109.25 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.798 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.56 125.14 36.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.664 -169.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 -84.35 99.12 10.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.185 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -119.63 121.93 29.57 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.838 -175.431 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.59 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 46.1 Cg_exo -59.11 150.11 75.6 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.543 2.829 . . . . 0.0 113.025 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.2 t70 -45.82 -59.28 2.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.59 -173.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.44 -24.64 73.76 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.666 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.59 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 78.1 mmm -78.97 -33.35 45.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.697 -0.296 . . . . 0.0 110.598 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.654 HG21 ' HG2' ' A' ' 65' ' ' ARG . 11.7 p -73.14 -28.07 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.868 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.07 72.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.161 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.18 -27.48 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -69.66 -28.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.574 0.702 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.712 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.4 pt -85.75 -15.19 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.515 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 58.31 -93.81 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 123.908 0.755 . . . . 0.0 112.95 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.948 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.07 37.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.115 0.566 . . . . 0.0 111.187 176.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 77.76 9.47 86.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 113.864 174.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.712 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.27 -42.33 0.86 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.185 174.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.948 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 34.0 tt0 -51.67 -30.96 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -66.45 -47.89 71.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 39' ' ' GLY . 10.4 tp -69.37 -36.95 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.857 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.86 -34.32 77.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.339 0.59 . . . . 0.0 110.18 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.149 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.432 HG13 ' HG3' ' A' ' 82' ' ' MET . 30.9 mm -74.14 -38.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.34 -174.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.25 64.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -77.24 -43.29 34.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.472 . . . . 0.0 109.729 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -54.92 -41.64 71.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.449 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.1 p -86.02 -38.04 18.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.289 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.73 2.98 52.76 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 48.2 t -79.51 139.72 37.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.307 0.575 . . . . 0.0 110.771 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -86.24 74.46 10.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.195 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -81.67 109.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.103 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -105.0 112.27 25.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 67' ' ' VAL . 39.2 mm -79.43 97.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 44.1 m -81.17 106.58 5.89 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.568 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.899 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 5.4 Cg_exo -77.86 -33.58 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.105 3.203 . . . . 0.0 113.157 -173.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.2 -25.87 42.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.991 0.425 . . . . 0.0 109.875 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.419 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.0 t 62.33 -154.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.901 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.39 108.16 0.22 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.22 -34.71 4.78 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.493 -177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 66' ' ' SER . 1.4 mm? -100.55 137.09 19.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 1.55 9.2 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.733 2.289 . . . . 0.0 111.912 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -111.11 -115.24 0.31 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.508 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.899 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 4.2 tpp180 -130.16 155.57 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.486 ' HB3' HD23 ' A' ' 62' ' ' LEU . 34.3 p -130.89 129.54 42.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.2 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 55' ' ' ILE . 60.9 t -114.55 130.99 67.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.127 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 p -97.91 128.25 44.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.588 0.709 . . . . 0.0 111.03 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.2 mm? -108.29 112.37 24.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.801 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.467 HG21 ' HA ' ' A' ' 18' ' ' THR . 2.3 m -150.86 155.37 39.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . 162.88 -71.3 0.21 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.382 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.71 161.36 24.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.27 -53.56 6.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.244 1.962 . . . . 0.0 112.558 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -71.23 -37.31 72.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.316 0.579 . . . . 0.0 110.714 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 14.2 m -72.85 -43.55 62.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.591 -171.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.467 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.4 p -70.13 -24.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 81' ' ' MET . 43.5 tp60 -82.01 -35.99 28.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.204 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' MET . 24.4 tptm -64.26 -45.92 86.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.69 0.757 . . . . 0.0 109.584 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.72 -48.21 75.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.284 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.576 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.1 mtmt -69.02 -21.51 64.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.993 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.602 ' HA ' ' CE ' ' A' ' 81' ' ' MET . 13.2 mmt -59.27 -47.56 84.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.9 0.381 . . . . 0.0 110.029 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.432 ' HG3' HG13 ' A' ' 45' ' ' ILE . 92.5 mmm -67.5 -45.77 74.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -59.42 -54.0 51.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.55 -35.13 78.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.483 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.31 -53.44 56.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.491 . . . . 0.0 110.793 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -76.66 -39.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.636 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.798 HG21 ' HD2' ' A' ' 24' ' ' TYR . 78.9 t -65.56 -31.86 55.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.4 t -78.02 -32.63 51.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.69 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.5 ptp180 -74.57 -16.37 60.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.889 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.01 -73.79 1.08 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.339 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.127 -179.47 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 47.9 m . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.908 0.385 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -36.42 117.37 0.48 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.57 1.148 . . . . 0.0 113.525 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' MET . 0.7 OUTLIER -121.27 137.33 54.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.596 170.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.48 71.75 0.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.793 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.77 -37.83 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.951 2.434 . . . . 0.0 112.819 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.664 HG22 ' HD2' ' A' ' 14' ' ' PRO . 8.9 mm -113.87 149.19 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.582 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 10.0 t60 -90.67 -41.72 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 12' ' ' ILE . 25.1 Cg_exo -41.79 171.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.629 2.886 . . . . 0.0 114.397 172.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -33.99 150.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.361 3.374 . . . . 0.0 114.833 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 55.7 Cg_endo -66.26 27.25 0.1 Allowed 'Trans proline' 0 N--CA 1.48 0.729 0 C-N-CA 124.265 3.31 . . . . 0.0 114.899 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -84.54 -8.16 59.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.412 0.625 . . . . 0.0 109.334 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -164.45 12.33 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.003 174.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 47.2 t -92.86 -99.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 15.7 ptp -68.71 78.07 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.644 0.735 . . . . 0.0 110.525 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -79.34 115.71 19.15 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.87 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.6 tp10 -95.16 118.77 32.52 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HB3' ' N ' ' A' ' 7' ' ' SER . 10.0 tp10 -105.1 106.24 16.64 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.539 -0.865 . . . . 0.0 108.861 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.503 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -91.66 124.96 36.21 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.133 -167.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.65 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 19.2 mtp180 -90.3 99.44 12.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.202 174.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -116.1 122.27 32.55 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.559 -175.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.48 145.85 44.93 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.796 2.331 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' HG12 ' A' ' 31' ' ' VAL . 1.4 p-10 -61.95 -28.75 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.306 -169.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -28.95 61.23 Favored Glycine 0 C--O 1.238 0.399 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.507 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.561 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 20.4 mmt -78.67 -31.27 46.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.344 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.674 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -69.99 -34.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.648 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.78 -30.36 69.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.556 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.44 HD12 ' HE2' ' A' ' 30' ' ' MET . 49.9 mt -87.81 -23.86 23.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 31' ' ' VAL . 10.2 tp -71.49 -30.23 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.654 0.74 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.701 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.7 pt -83.13 -14.79 11.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 -91.83 0.11 Allowed Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.214 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 14.3 ptp180 -76.74 -0.02 22.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.0 111.275 -176.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.67 10.39 8.53 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.811 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.701 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 158.01 -55.54 0.37 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.578 173.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 26.4 mm-40 -59.3 -23.92 62.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' A' ' 41' ' ' GLN . 2.9 tt0 -59.99 -52.86 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.081 0.855 . . . . 0.0 110.576 -174.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.596 HD11 HG11 ' A' ' 53' ' ' VAL . 6.3 tp -62.02 -45.33 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.021 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -54.7 -37.13 65.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.439 0.462 . . . . 0.0 110.745 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 40' ' ' GLU . 68.0 mttm -72.28 -41.76 66.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.198 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.21 -48.69 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 111.664 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.32 -31.46 71.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.069 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -74.09 -36.26 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.21 0.528 . . . . 0.0 109.879 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.38 -32.25 73.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.053 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 8.0 p -96.87 -40.35 8.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.839 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.99 27.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.712 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 32.0 t -79.99 136.68 36.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.117 0.484 . . . . 0.0 110.734 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -84.22 72.17 10.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 42' ' ' ILE . 44.6 t -83.14 106.81 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.972 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.21 110.65 22.94 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.136 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.502 HD13 HG13 ' A' ' 67' ' ' VAL . 48.1 mm -79.78 112.62 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.679 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.489 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 2.6 m -94.82 102.05 8.25 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.084 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 86.7 Cg_endo -76.56 -21.36 13.1 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.982 2.455 . . . . 0.0 112.581 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.95 -41.77 25.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.025 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.613 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 9.0 t 73.78 -64.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.746 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 -76.5 2.2 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.143 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.77 -8.25 84.69 Favored Glycine 0 CA--C 1.511 -0.189 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.853 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.65 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.7 mt -121.16 146.82 45.32 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.65 -20.7 10.48 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.61 2.206 . . . . 0.0 110.242 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -93.05 -163.94 1.11 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.752 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.674 ' HG2' HG21 ' A' ' 31' ' ' VAL . 6.0 tpp180 -92.18 147.01 23.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.561 ' HB3' HD12 ' A' ' 62' ' ' LEU . 78.0 p -117.91 141.66 48.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.674 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.502 HG13 HD13 ' A' ' 55' ' ' ILE . 87.7 t -137.68 120.94 20.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.382 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 p -92.46 125.5 37.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.604 0.716 . . . . 0.0 111.497 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.7 mm? -105.23 120.01 40.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.19 155.74 40.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.11 -121.21 1.01 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.198 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.528 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -119.45 164.01 24.01 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 89.3 Cg_exo -47.72 -46.33 21.45 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.573 2.182 . . . . 0.0 112.695 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -75.47 -46.64 31.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.923 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.667 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 1.5 m -61.51 -48.65 80.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.281 -173.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.0 p -70.09 -24.26 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.381 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -74.76 -45.94 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -58.72 -48.69 80.3 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.36 0.6 . . . . 0.0 110.187 176.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.16 -52.09 67.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.886 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.789 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.0 mtmt -68.39 -21.97 64.66 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.253 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 10.6 ptm -72.08 -32.49 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.846 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.6 mmt -66.77 -47.62 71.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 110.011 171.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.29 -52.27 66.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.737 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.98 -38.38 70.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.837 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.52 -60.39 3.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.541 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.598 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.8 mp -72.61 -37.73 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 111.727 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 24' ' ' TYR . 69.7 t -67.68 -26.1 34.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.781 -0.574 . . . . 0.0 111.113 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t -75.67 -34.66 60.48 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.387 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.598 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -77.48 -12.87 60.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.077 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.84 -55.97 0.82 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.546 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 121.043 0.449 . . . . 0.0 110.562 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 110.807 -0.071 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 21' ' ' THR . 26.1 mt-30 -147.92 -93.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp 172.97 -173.4 0.05 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.376 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' C ' ' A' ' 19' ' ' SER . . . -143.52 114.89 0.86 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.076 172.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 -24.79 26.01 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.874 2.383 . . . . 0.0 113.269 -174.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.6 HD12 ' HG2' ' A' ' 14' ' ' PRO . 17.0 pt -121.67 164.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.157 0.503 . . . . 0.0 111.098 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.664 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 63.4 m80 -90.09 -19.11 0.24 Allowed Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 73.2 Cg_exo -39.5 167.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.601 2.2 . . . . 0.0 114.077 168.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 17' ' ' ARG . 7.0 Cg_endo -49.29 165.61 0.22 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.371 2.714 . . . . 0.0 113.057 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' A' ' 73' ' ' PRO . 31.3 Cg_endo -63.75 34.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.061 3.174 . . . . 0.0 114.723 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 15' ' ' PRO . 12.4 ptm180 -86.21 0.3 54.04 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 12' ' ' ILE . 12.7 t -178.92 -12.77 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.011 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.582 ' C ' ' HA3' ' A' ' 10' ' ' GLY . 12.6 t -79.59 1.6 25.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.5 ptm -164.26 72.73 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.591 . . . . 0.0 110.732 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 48.4 m -79.13 122.22 25.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.586 ' HG2' ' HD2' ' A' ' 24' ' ' TYR . 1.6 tt0 -102.28 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.977 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -91.09 103.38 16.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.586 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -92.37 127.3 37.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.399 -172.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 63.9 mtp180 -81.59 111.46 17.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.294 0.568 . . . . 0.0 110.751 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.793 HG11 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -128.65 121.64 21.24 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.855 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 33.9 Cg_endo -68.55 151.38 75.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.932 1.755 . . . . 0.0 110.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -37.75 64.86 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -166.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.42 80.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.478 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.515 ' HB2' HG23 ' A' ' 26' ' ' VAL . 32.0 mmt -78.42 -15.99 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 34' ' ' ILE . 40.3 t -70.01 -44.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.31 -31.73 80.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.089 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.505 HD12 ' CE ' ' A' ' 30' ' ' MET . 45.2 mt -88.37 -23.24 23.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -71.11 -29.75 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.357 0.599 . . . . 0.0 109.508 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -85.37 -15.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.284 170.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.35 -90.6 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.498 0 O-C-N 124.401 1.063 . . . . 0.0 112.429 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 16.2 ptt-85 -76.69 48.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.884 -0.658 . . . . 0.0 111.579 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.83 11.79 61.11 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.902 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.702 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.03 -42.0 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.292 -1.433 . . . . 0.0 113.534 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.59 -32.23 66.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.4 tt0 -61.72 -52.48 64.12 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.439 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.539 HD11 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -62.0 -41.27 90.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.521 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -58.1 -48.17 80.99 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -60.13 -40.49 89.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.909 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.636 HD13 ' HG3' ' A' ' 82' ' ' MET . 87.8 mt -70.89 -50.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.448 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -26.96 62.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -175.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.859 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -78.46 -35.99 45.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.164 0.507 . . . . 0.0 110.218 176.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -42.74 99.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.857 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.768 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 11.9 p -84.88 -38.79 19.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.26 11.35 31.83 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.435 ' N ' ' HB3' ' A' ' 75' ' ' SER . 51.2 t -86.45 154.51 21.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.213 0.53 . . . . 0.0 110.28 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -105.58 71.58 0.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.054 0.93 . . . . 0.0 109.241 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.539 HG11 HD11 ' A' ' 42' ' ' ILE . 37.3 t -81.99 119.34 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.174 -175.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 14.4 mm-40 -113.69 120.4 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.4 mm -83.61 93.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 t -79.71 110.89 17.38 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.1 Cg_exo -80.85 -9.39 13.16 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.654 2.902 . . . . 0.0 111.157 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 -37.91 46.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.902 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.556 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 11.2 m 70.03 -59.64 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.161 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.56 -87.65 1.46 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.775 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -87.66 3.25 86.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 66' ' ' SER . 5.1 mp -124.19 139.55 32.97 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -170.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -87.19 -24.17 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.794 2.329 . . . . 0.0 111.972 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.855 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -88.44 -84.16 0.21 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.677 -175.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 5.4 tpp85 -160.61 153.92 21.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.662 ' HB3' HD22 ' A' ' 62' ' ' LEU . 88.3 p -124.55 130.24 52.08 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.235 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.793 HG23 HG11 ' A' ' 26' ' ' VAL . 85.8 t -105.11 115.7 47.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 72.2 m -79.76 120.32 23.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.366 0.603 . . . . 0.0 109.806 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.9 HD13 ' HG2' ' A' ' 80' ' ' LYS . 27.1 mt -113.27 105.01 12.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -150.12 145.12 26.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.218 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.33 -98.32 0.11 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 119.741 -1.219 . . . . 0.0 113.607 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -138.06 165.04 36.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 93.0 Cg_exo -45.06 -66.12 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.066 2.511 . . . . 0.0 113.46 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.75 -39.99 80.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.458 0.647 . . . . 0.0 110.235 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.768 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 7.1 m -59.64 -46.19 89.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.709 -173.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.638 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.2 p -73.74 -31.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.879 -173.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.79 -42.26 86.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.048 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 81' ' ' MET . 2.4 tmtp? -70.29 -42.26 72.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.688 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.26 93.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.0 111.414 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.9 ' HG2' HD13 ' A' ' 69' ' ' LEU . 5.1 mtmp? -81.19 -21.22 39.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.6 tpt -60.32 -47.49 85.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 173.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.636 ' HG3' HD13 ' A' ' 45' ' ' ILE . 18.9 mmt -68.17 -37.62 81.2 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 176.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.737 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.2 mm? -59.44 -49.84 76.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.28 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.15 -42.63 66.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.735 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.87 -56.5 20.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.661 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.6 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -71.27 -41.15 74.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.045 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 24' ' ' TYR . 60.7 t -63.56 -23.87 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 O-C-N 121.886 -0.509 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.9 m -85.07 -26.01 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 15.4 ptp180 -77.04 -12.94 60.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.148 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.28 -39.92 1.45 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.693 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.611 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 0.0 110.945 -178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 110.662 -0.125 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 21' ' ' THR . 26.8 mt-30 -64.98 109.5 2.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.304 0.573 . . . . 0.0 111.815 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -84.8 133.53 34.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.91 77.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.847 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.96 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.734 2.289 . . . . 0.0 112.207 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -109.03 157.89 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.553 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 54.6 t60 -91.02 -26.98 0.3 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 49.7 Cg_exo -37.12 166.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 123.441 2.76 . . . . 0.0 115.097 170.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.13 153.92 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.776 2.984 . . . . 0.0 113.879 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 38.6 Cg_endo -64.54 12.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.416 3.411 . . . . 0.0 114.3 -174.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 17' ' ' ARG . 3.8 ptp180 -64.9 -24.5 67.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.225 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -154.1 -5.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.947 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.408 ' OG ' ' HA ' ' A' ' 16' ' ' PRO . 27.1 p -79.79 -90.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.061 -0.4 . . . . 0.0 111.433 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.5 ptm -70.45 76.15 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.629 0.728 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 HG23 ' A' ' 70' ' ' THR . 24.8 m -84.53 116.21 23.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.336 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.93 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 5.5 tp10 -92.66 118.2 30.79 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -97.26 101.92 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -95.09 121.08 36.35 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.726 -171.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.422 ' HD3' HD22 ' A' ' 62' ' ' LEU . 82.9 mtt180 -81.94 123.81 29.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.544 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -136.44 124.23 14.74 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.575 -175.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.679 ' HG2' ' HA ' ' A' ' 91' ' ' ARG . 35.8 Cg_exo -59.48 152.93 58.03 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.858 2.372 . . . . 0.0 113.338 -175.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' VAL . 24.2 t70 -50.11 -52.12 37.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.1 70.43 Favored Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.075 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.49 ' SD ' HG23 ' A' ' 86' ' ' ILE . 47.7 tpp -79.26 -27.61 42.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.639 -0.33 . . . . 0.0 110.695 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.2 p -74.59 -25.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.49 -24.98 73.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.874 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.0 mt -87.76 -24.69 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.2 tp -70.92 -32.71 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.596 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.3 pt -82.97 -14.6 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.15 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.16 -94.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.608 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 9.7 ptm180 -63.17 -10.32 14.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.589 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.08 4.96 5.84 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.08 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.79 -53.1 0.4 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.134 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 41.2 tt0 -55.43 -20.73 13.22 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.12 -53.16 61.54 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.865 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.537 HD11 HG11 ' A' ' 53' ' ' VAL . 11.2 tp -65.73 -36.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.918 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.47 -41.25 89.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.155 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -60.67 -56.78 17.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.843 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.459 ' CG1' ' HG2' ' A' ' 82' ' ' MET . 1.5 mp -54.61 -56.63 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.159 -176.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -70.03 -34.61 73.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -170.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.62 -35.49 39.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 110.327 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.99 -26.63 66.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.368 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 p -95.06 -40.58 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.743 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.31 18.23 9.34 Favored Glycine 0 CA--C 1.505 -0.567 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.809 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.95 160.96 14.2 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 0.0 111.978 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 46.3 mtmt -101.3 76.25 1.69 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.16 173.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 42' ' ' ILE . 41.8 t -90.4 109.05 20.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.697 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -113.02 137.8 50.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.65 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.3 116.29 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.291 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -95.01 107.1 29.37 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.227 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 1.002 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 81.9 Cg_endo -78.62 -30.15 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.89 2.393 . . . . 0.0 112.805 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.73 -44.44 23.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.8 t 68.65 -68.33 0.18 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.893 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.9 -86.69 0.46 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.595 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.24 -1.1 90.45 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.132 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 66' ' ' SER . 48.8 mt -119.2 135.81 24.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.96 -17.36 17.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.687 2.258 . . . . 0.0 110.459 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.7 pt-20 -94.26 -162.44 0.94 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.101 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 1.002 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -99.64 156.64 16.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.682 ' HB3' HD12 ' A' ' 62' ' ' LEU . 24.7 p -128.64 135.82 49.82 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.693 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.08 129.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.565 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.1 m -91.72 127.62 37.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.349 0.595 . . . . 0.0 111.146 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 4.2 mm? -108.1 117.63 34.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.325 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.429 HG23 HG23 ' A' ' 21' ' ' THR . 0.6 OUTLIER -150.34 156.6 41.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.021 176.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.17 -152.21 23.65 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.785 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -80.37 159.54 69.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 6.3 Cg_endo -49.08 -50.0 13.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.755 2.303 . . . . 0.0 112.368 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.33 -44.8 82.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.408 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.611 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 9.7 m -62.03 -54.61 39.07 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.034 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -25.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.302 -172.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 81' ' ' MET . 51.1 tt0 -71.45 -50.58 30.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -57.7 -50.73 72.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.754 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . . . -54.17 -48.31 71.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.134 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.735 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 38.3 mtmt -67.09 -21.5 65.87 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.381 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 94.0 mtp -66.85 -41.45 87.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.459 ' HG2' ' CG1' ' A' ' 45' ' ' ILE . 2.6 mpt? -65.91 -47.43 74.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.711 0.291 . . . . 0.0 111.048 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.479 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.3 mm? -57.95 -55.56 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.943 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.7 -44.71 77.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.554 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.24 -53.32 55.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.517 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.751 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 2.0 mp -75.29 -45.25 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.713 -175.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 24' ' ' TYR . 84.7 t -61.82 -40.19 86.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.076 0.465 . . . . 0.0 110.717 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -72.83 -28.5 62.58 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.056 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.751 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -73.28 -21.93 60.49 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.836 -178.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.02 63.27 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.048 -1.549 . . . . 0.0 114.608 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HA ' ' HG2' ' A' ' 27' ' ' PRO . 36.1 ttt180 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 117.697 0.748 . . . . 0.0 109.744 170.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.874 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 40.1 m . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 7' ' ' SER . 26.1 mt-30 -178.77 -103.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.339 1.055 . . . . 0.0 108.668 166.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 38.1 tp 158.83 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.399 1.062 . . . . 0.0 109.082 176.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 152.94 108.11 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.237 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.2 -8.54 23.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.824 2.349 . . . . 0.0 112.013 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.618 HD12 HG21 ' A' ' 18' ' ' THR . 1.0 OUTLIER -114.44 142.62 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.812 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.704 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 18.7 t-80 -92.55 -11.1 0.17 Allowed Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -172.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.4 Cg_endo -56.4 -175.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.515 2.144 . . . . 0.0 113.15 176.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 14' ' ' PRO . 1.8 Cg_endo -44.22 153.7 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.885 2.39 . . . . 0.0 112.962 174.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 36.7 Cg_endo -65.46 33.81 0.11 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 124.286 3.324 . . . . 0.0 115.254 -174.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -84.56 7.2 20.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.626 0.726 . . . . 0.0 109.213 175.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 12' ' ' ILE . 8.9 t -176.02 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.127 175.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.555 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 1.8 m -86.41 9.66 17.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.001 -178.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.672 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 18.5 mmt -146.47 31.23 0.99 Allowed 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.002 177.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 85.7 m -78.92 114.51 17.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.874 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 19.8 tt0 -121.64 118.86 30.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.818 176.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -87.63 110.65 20.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.486 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.34 124.0 34.03 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.81 -166.251 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.839 ' HG2' HD21 ' A' ' 62' ' ' LEU . 48.9 mtm180 -81.86 103.73 11.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.302 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.3 124.59 26.81 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.508 -175.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.0 148.09 78.68 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.424 2.083 . . . . 0.0 111.644 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 31' ' ' VAL . 37.8 t70 -54.47 -51.43 65.07 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.85 -24.52 70.01 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.838 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.457 ' SD ' HD23 ' A' ' 33' ' ' LEU . 30.4 tpp -79.32 -29.64 42.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.477 -0.361 . . . . 0.0 110.828 -175.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 34' ' ' ILE . 13.4 p -70.99 -26.32 27.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -30.12 75.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.421 169.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD23 ' SD ' ' A' ' 30' ' ' MET . 64.3 tp -84.15 -31.01 25.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 177.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.5 tp -70.39 -26.42 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.667 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 8.5 pt -81.42 -14.38 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.557 174.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.7 -92.19 0.1 Allowed Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.316 172.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.762 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -77.34 20.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.86 0.464 . . . . 0.0 111.393 -179.458 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.89 58.88 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.042 177.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.667 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 154.53 -45.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.388 176.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.762 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 49.6 tt0 -56.59 -29.09 61.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' HG12 ' A' ' 45' ' ' ILE . 25.4 tt0 -62.43 -53.24 57.8 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.442 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 53' ' ' VAL . 8.6 tp -62.95 -38.71 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.261 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.97 -42.99 99.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -58.51 -43.2 89.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.602 176.064 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.6 mm -69.96 -50.93 44.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.912 -176.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.24 -31.92 68.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 -174.688 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -76.04 -38.36 57.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 110.17 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 11.9 t70 -62.82 -50.57 70.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.851 178.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 p -70.85 -45.52 64.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.73 -4.36 26.04 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.464 -176.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 41.6 t -79.12 135.16 36.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.11 0.481 . . . . 0.0 110.099 178.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -85.02 74.5 10.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.519 0.676 . . . . 0.0 110.104 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 42' ' ' ILE . 44.9 t -82.49 115.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.789 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.6 mm-40 -119.48 129.95 54.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.856 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.425 HD13 HG13 ' A' ' 67' ' ' VAL . 42.7 mm -83.95 109.12 17.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.754 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.525 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 7.3 m -82.4 111.33 27.43 Favored Pre-proline 0 C--O 1.242 0.662 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.576 -178.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.801 ' HA ' HH11 ' A' ' 65' ' ' ARG . 60.8 Cg_endo -73.01 -27.73 13.76 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.949 2.433 . . . . 0.0 111.858 178.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.46 88.39 2.72 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.855 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 5.3 p -65.6 -39.2 91.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.238 -175.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.01 -61.51 4.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.729 174.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.613 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -93.86 4.88 72.36 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.817 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.855 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.8 mp -127.71 151.38 75.3 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.36 -0.42 . . . . 0.0 109.941 -170.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -90.89 -4.4 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.696 2.264 . . . . 0.0 111.072 171.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 91' ' ' ARG . 1.6 pt-20 -119.52 -153.27 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.962 -177.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.801 HH11 ' HA ' ' A' ' 57' ' ' PRO . 14.6 tpp180 -91.97 157.86 16.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.772 ' HB3' HD22 ' A' ' 62' ' ' LEU . 56.9 p -131.96 153.41 50.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.642 174.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 HD13 ' A' ' 55' ' ' ILE . 57.5 t -135.19 131.75 52.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.2 m -89.87 127.66 36.04 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.284 177.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.751 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -110.57 107.48 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 175.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -152.54 134.64 14.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.61 -147.39 7.84 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.846 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.6 160.2 70.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . 99.9 Cg_exo -45.06 -56.51 2.66 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.033 2.489 . . . . 0.0 114.237 -174.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -84.15 -30.98 25.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.956 -178.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 m -62.38 -43.33 99.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.007 0.432 . . . . 0.0 110.696 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.8 p -66.86 -27.77 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.546 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.4 tp-100 -73.52 -50.28 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.126 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -54.2 -43.89 71.14 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.207 0.527 . . . . 0.0 110.566 178.798 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.71 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.562 176.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.751 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 9.8 mtmp? -66.16 -21.23 66.32 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.854 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.4 mmm -67.7 -43.41 80.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.83 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.0 mmm -66.73 -34.55 78.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 175.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.37 -49.09 65.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -51.3 -44.59 61.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.614 177.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 10.5 t70 -64.08 -61.04 2.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.682 -178.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.455 ' HB ' HD13 ' A' ' 34' ' ' ILE . 1.9 mp -66.68 -40.51 86.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.27 -174.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 24' ' ' TYR . 77.3 t -67.82 -26.86 35.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.502 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.4 t -72.79 -26.25 61.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.815 0.341 . . . . 0.0 110.239 175.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 25.5 mmt180 -63.6 -41.91 98.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.21 0.529 . . . . 0.0 109.671 176.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.45 -59.51 1.72 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.721 178.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.44 HH21 ' CD ' ' A' ' 64' ' ' GLU . 33.2 mmt180 . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.469 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.2 t . . . . . 0 N--CA 1.465 0.281 0 CA-C-O 120.444 0.164 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -155.93 143.49 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.099 0.476 . . . . 0.0 110.889 -177.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -134.65 98.56 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 67.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 172.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.12 -11.86 14.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.917 2.411 . . . . 0.0 111.826 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.541 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 23.2 pt -124.97 154.9 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.692 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 49.4 t-80 -89.45 -22.1 0.27 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 23.8 Cg_exo -42.23 168.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.692 2.262 . . . . 0.0 114.474 174.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 17' ' ' ARG . 65.4 Cg_exo -41.25 157.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.758 2.972 . . . . 0.0 114.36 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 35.1 Cg_endo -66.83 28.6 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.901 3.067 . . . . 0.0 114.357 -175.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 15' ' ' PRO . 88.4 mtt180 -73.19 -26.69 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.496 HG23 HD11 ' A' ' 12' ' ' ILE . 2.7 t -158.36 10.16 0.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.353 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.5 t -101.07 -12.51 18.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.391 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 21.8 mmt -134.33 34.46 3.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 -176.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 87.3 m -79.68 112.19 16.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 14.4 tt0 -111.01 119.09 37.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -96.61 103.21 15.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -91.81 118.68 30.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.973 -166.853 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 32.4 mtm180 -81.78 114.74 20.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.776 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.1 p -135.45 131.87 19.62 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.065 -173.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.614 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 38.2 Cg_exo -61.8 146.28 96.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.905 2.403 . . . . 0.0 111.555 177.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.402 ' HA ' HG12 ' A' ' 31' ' ' VAL . 2.6 p-10 -59.89 -30.32 68.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.405 -172.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.62 -33.24 56.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.177 176.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.736 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 83.7 mmm -78.82 -29.48 44.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.904 -0.174 . . . . 0.0 110.795 -176.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.0 p -69.72 -31.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.358 173.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.58 70.38 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.431 171.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.76 -23.65 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.9 tp -72.37 -27.32 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.457 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.615 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.6 pt -85.18 -14.75 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.155 171.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.42 -97.78 0.1 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.362 173.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 14.2 ptm180 -58.99 -22.39 60.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.097 0.559 . . . . 0.0 111.63 178.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -7.63 1.83 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.785 177.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 167.85 -48.36 0.24 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.256 176.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 28.3 tt0 -59.96 -21.64 61.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -171.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.26 -55.32 35.14 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.316 0.507 . . . . 0.0 110.582 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.84 -38.66 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.76 -36.83 79.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 28.1 tptp -63.04 -58.64 6.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.125 176.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.47 -41.37 87.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.259 -174.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.1 pp0? -71.85 -40.32 69.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.85 -176.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -73.76 -30.29 62.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.347 0.594 . . . . 0.0 110.537 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 13.0 t70 -69.12 -43.99 73.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.716 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 39.4 p -80.03 -35.36 37.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 7.19 30.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.626 -177.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 33.9 t -90.71 141.47 28.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -94.05 89.09 5.9 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.238 0.542 . . . . 0.0 109.657 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.37 106.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.745 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -106.0 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -175.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.452 HD13 HG13 ' A' ' 67' ' ' VAL . 43.1 mm -78.9 116.94 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 t -107.76 112.91 61.81 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 111.133 -177.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 18.6 Cg_exo -66.89 -37.49 19.78 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.357 2.705 . . . . 0.0 111.306 175.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -80.11 83.28 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.4 m -76.31 4.19 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.11 -169.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.16 -92.91 1.07 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.826 169.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.8 -11.26 58.08 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.553 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 59' ' ' SER . 3.0 mm? -103.78 142.87 25.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.1 -18.75 2.18 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.752 2.301 . . . . 0.0 112.502 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -83.41 -86.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.391 -175.253 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HB3' HG13 ' A' ' 26' ' ' VAL . 1.3 tpp180 -160.27 154.31 23.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 176.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 22.1 t -139.35 143.8 37.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 55' ' ' ILE . 46.3 t -129.84 134.95 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.189 -175.305 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.8 m -92.49 128.69 38.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.422 0.63 . . . . 0.0 111.557 177.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.662 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.6 mm? -110.48 112.91 25.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.579 177.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -151.5 148.22 27.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.042 176.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.65 -131.58 2.4 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.601 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.6 162.99 18.53 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.34 -48.58 19.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.823 2.349 . . . . 0.0 113.376 -174.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.48 -41.19 40.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 29.4 p -65.5 -41.56 93.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.454 0.645 . . . . 0.0 110.34 -174.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.15 -26.57 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.773 -176.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 81' ' ' MET . 47.6 mt-30 -82.62 -34.04 27.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.608 177.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -65.84 -43.79 87.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.671 0.748 . . . . 0.0 109.684 176.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.36 78.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.104 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.2 mtmt -77.05 -19.94 56.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.039 -174.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -57.05 -55.04 39.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.879 173.214 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.75 -35.87 82.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.2 mm? -65.99 -56.85 9.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -177.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -52.86 -40.86 63.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.571 179.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.532 ' HB3' HD12 ' A' ' 86' ' ' ILE . 7.4 t70 -53.52 -60.03 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.335 -178.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 89' ' ' ARG . 2.5 mp -76.25 -44.37 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.683 -175.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 26' ' ' VAL . 98.8 t -59.1 -39.8 79.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.52 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 t -70.2 -39.11 75.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.804 -179.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 11.4 ptt180 -77.33 -7.47 56.09 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.526 -176.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.736 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -121.85 0.74 10.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.681 174.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 . . . . . 0 C--N 1.325 -0.47 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.562 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.8 t . . . . . 0 C--O 1.224 -0.283 0 CA-C-O 120.002 -0.047 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -149.01 136.46 20.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.282 0.563 . . . . 0.0 111.599 -177.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.845 ' HG ' ' HD3' ' A' ' 11' ' ' PRO . 57.1 tp -115.28 136.29 53.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.26 63.76 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.653 177.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.845 ' HD3' ' HG ' ' A' ' 9' ' ' LEU . 93.3 Cg_endo -86.47 -19.78 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.306 2.004 . . . . 0.0 112.124 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.605 HG22 ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -127.06 138.66 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.218 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.698 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 t-80 -91.71 -15.68 0.21 Allowed Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 22.6 Cg_endo -56.34 178.99 0.11 Allowed 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.201 1.934 . . . . 0.0 113.031 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 59.5 Cg_exo -40.18 153.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.404 2.736 . . . . 0.0 114.188 179.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 73.8 Cg_endo -71.04 34.88 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.097 3.198 . . . . 0.0 113.283 -175.187 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -84.87 -20.16 31.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -164.56 23.24 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.505 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 34.5 t -101.16 -90.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.749 -176.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptm -79.2 79.79 5.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.157 0.503 . . . . 0.0 110.909 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 9' ' ' LEU . 89.2 m -84.92 114.94 22.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 7' ' ' SER . 13.0 tt0 -94.4 117.95 30.89 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.82 106.25 18.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.529 0.681 . . . . 0.0 109.277 -179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.624 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.88 120.98 33.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.191 -172.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.781 ' HG2' HD21 ' A' ' 62' ' ' LEU . 70.5 mtm180 -86.26 101.31 12.94 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.589 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.773 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.4 p -116.44 129.24 25.4 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.8 Cg_exo -57.23 150.29 58.79 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.536 2.824 . . . . 0.0 112.338 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.35 -44.72 84.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -175.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.76 64.35 Favored Glycine 0 C--O 1.237 0.305 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.875 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.553 ' HG2' ' HA3' ' A' ' 90' ' ' GLY . 31.1 tpp -78.54 -28.65 46.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.828 -175.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.598 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -74.34 -25.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.96 -32.09 69.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.763 168.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.1 mt -82.05 -22.12 36.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 172.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 31' ' ' VAL . 8.7 mm -61.36 -44.96 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 122.05 0.928 . . . . 0.0 108.674 174.223 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 4.8 pt -82.11 -14.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.787 175.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.18 -88.55 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.021 170.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.862 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 3.1 ptm180 -74.05 0.87 12.38 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.746 0.418 . . . . 0.0 110.998 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.18 -5.44 10.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.138 174.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 160.37 -41.46 0.44 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.722 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.862 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 1.5 tm-20 -58.83 -35.57 73.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.378 0.271 . . . . 0.0 111.199 -175.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.12 -47.1 86.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.496 0.189 . . . . 0.0 110.854 -171.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 tp -68.2 -36.32 74.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.224 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -62.46 -37.87 87.61 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -61.61 -54.49 42.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.499 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.53 -45.61 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.245 0.545 . . . . 0.0 111.594 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.899 HE21 ' HB ' ' A' ' 53' ' ' VAL . 97.1 mt-30 -58.33 -45.45 88.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.42 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -69.12 -42.55 75.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.023 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.7 -46.24 84.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.448 177.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.0 p -78.37 -47.48 17.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.583 -177.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.64 6.07 53.16 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 51.1 t -84.72 143.45 29.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.568 . . . . 0.0 110.631 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -89.98 77.66 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.317 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.899 ' HB ' HE21 ' A' ' 46' ' ' GLN . 26.1 t -82.13 107.73 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.123 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.59 HE21 ' CA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.69 106.58 18.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -176.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.467 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.8 mm -88.03 94.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.3 m -91.88 106.07 15.91 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.707 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.679 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 8.3 Cg_exo -72.59 -34.35 7.34 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -176.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.21 -12.14 59.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.695 178.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 11.9 p 47.58 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 176.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.08 -75.41 0.35 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.002 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.545 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -81.63 0.23 88.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.766 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.781 HD21 ' HG2' ' A' ' 25' ' ' ARG . 7.6 mp -127.48 145.7 55.59 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.943 -170.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 43.4 Cg_endo -86.57 -15.17 4.26 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.138 2.559 . . . . 0.0 112.749 176.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.753 ' OE1' ' HB3' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.86 -102.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.947 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.773 ' HB3' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -135.64 131.12 35.37 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.269 -0.27 . . . . 0.0 110.381 -176.253 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.622 ' HB3' HD22 ' A' ' 62' ' ' LEU . 85.8 p -108.72 112.95 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 55' ' ' ILE . 92.9 t -103.16 119.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.112 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.5 m -88.95 126.4 35.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.314 0.578 . . . . 0.0 110.851 176.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.742 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.0 mm? -102.27 104.06 14.57 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.492 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -151.44 148.29 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.25 -93.96 0.1 OUTLIER Glycine 0 C--O 1.226 -0.347 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.134 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -143.02 161.97 45.78 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 84.1 Cg_exo -46.44 -55.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.194 2.596 . . . . 0.0 113.535 -175.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.74 -33.02 25.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 110.272 -178.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -64.68 -45.06 88.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.293 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.7 p -70.06 -26.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.558 -175.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.96 -43.97 67.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 81' ' ' MET . 23.4 tptm -66.15 -44.07 85.18 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -54.18 -48.78 70.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.2 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.742 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 33.0 mtmt -71.13 -25.02 62.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.565 -177.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.694 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 4.2 ppp? -70.18 -30.56 67.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.868 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.7 mmm -77.43 -36.17 53.41 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.755 172.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.6 mm? -63.73 -49.1 74.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.89 -44.05 86.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.886 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.1 -59.36 4.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.458 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.534 HG23 ' SD ' ' A' ' 30' ' ' MET . 1.6 mp -72.45 -45.16 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.119 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.624 HG21 ' HD2' ' A' ' 24' ' ' TYR . 9.1 t -67.2 -28.69 43.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 122.043 -0.411 . . . . 0.0 111.322 -176.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.4 t -69.47 -41.34 76.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.023 174.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 12.2 ptp180 -73.7 -13.23 60.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 110.473 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.553 ' HA3' ' HG2' ' A' ' 30' ' ' MET . . . -95.98 -39.45 4.32 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.987 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 27' ' ' PRO . 8.1 ptp180 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.784 0.326 . . . . 0.0 111.398 -178.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.872 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 20.4 m . . . . . 0 C--O 1.225 -0.204 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.63 96.18 8.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.81 0.338 . . . . 0.0 111.75 -172.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 21' ' ' THR . 91.1 mt -123.38 92.55 3.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.89 73.3 0.39 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.204 178.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.57 -63.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.11 2.54 . . . . 0.0 112.541 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.943 HG12 ' HD2' ' A' ' 14' ' ' PRO . 10.1 tt -99.51 154.92 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.716 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 15.6 m-70 -91.83 -20.78 0.24 Allowed Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -172.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.943 ' HD2' HG12 ' A' ' 12' ' ' ILE . 23.9 Cg_exo -39.94 171.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.319 2.68 . . . . 0.0 114.833 170.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.02 156.6 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.224 2.616 . . . . 0.0 113.538 177.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 36.8 Cg_endo -65.21 11.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.226 3.284 . . . . 0.0 114.371 -175.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -62.51 -24.05 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 110.293 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 19' ' ' SER . 12.7 t -157.75 -11.01 0.08 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.718 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 14.0 m -79.86 -83.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.838 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptp -74.56 73.05 1.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.493 0.663 . . . . 0.0 110.193 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 18.0 m -79.41 131.63 36.15 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.843 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.872 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -94.26 117.37 30.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.309 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' SER . 40.9 tt0 -98.97 96.7 8.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.419 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.14 116.28 28.88 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.429 -167.669 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HG3' HH11 ' A' ' 25' ' ' ARG . 44.1 mtt85 -81.66 103.03 11.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.875 176.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.768 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -121.89 131.87 24.35 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.914 -174.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HG3' HH11 ' A' ' 91' ' ' ARG . 25.7 Cg_exo -62.98 135.99 54.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.761 2.308 . . . . 0.0 110.568 175.424 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.86 -36.84 49.82 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.367 -169.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -34.09 87.64 Favored Glycine 0 C--O 1.236 0.227 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.214 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 87.1 mmm -78.15 -13.36 59.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 34' ' ' ILE . 37.1 t -74.16 -40.9 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.445 173.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -27.78 71.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.226 174.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.26 -24.81 25.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.613 HD13 ' HB ' ' A' ' 86' ' ' ILE . 8.9 tp -74.22 -25.31 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.564 0.697 . . . . 0.0 109.673 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.597 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -89.33 -15.82 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.864 171.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -86.29 0.07 OUTLIER Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.603 174.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.46 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 9.0 ptp180 -79.58 -1.29 37.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.949 0.404 . . . . 0.0 111.07 -177.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.33 2.72 10.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.69 173.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.73 -49.66 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.066 175.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.5 tt0 -44.74 -42.81 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -58.7 -46.62 86.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -167.119 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.605 HD11 HG11 ' A' ' 53' ' ' VAL . 8.0 tp -65.47 -54.31 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.617 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.441 ' N ' HG23 ' A' ' 42' ' ' ILE . 39.5 m-80 -56.19 -42.17 76.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.439 -177.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.45 -47.48 83.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.684 -179.343 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.74 -45.24 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 2.1 pt20 -69.13 -43.18 74.92 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.575 -176.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.96 -36.58 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.407 -178.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.1 -50.07 74.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.958 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 p -72.78 -33.14 66.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.523 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.04 27.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.615 -178.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.641 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 15.2 t -79.73 152.36 29.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.985 0.422 . . . . 0.0 110.133 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -108.84 86.61 2.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 42' ' ' ILE . 44.7 t -103.9 111.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.085 0.469 . . . . 0.0 110.923 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.2 115.58 30.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.426 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.498 HD13 HG13 ' A' ' 67' ' ' VAL . 32.1 mm -81.85 94.47 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.524 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 42.1 m -79.25 114.79 47.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.951 0.405 . . . . 0.0 110.788 -178.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 4.3 Cg_exo -74.41 -40.62 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.668 2.912 . . . . 0.0 111.854 -177.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.43 78.77 2.71 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -61.69 -27.85 68.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.128 -175.73 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.97 -72.53 1.82 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -71.62 -14.03 74.9 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 177.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 2.5 mm? -123.89 138.88 31.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.2 -9.52 10.47 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.045 2.497 . . . . 0.0 111.257 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 2.2 pt-20 -101.16 -94.75 0.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.323 -173.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.768 ' HB3' HG13 ' A' ' 26' ' ' VAL . 3.6 tpp180 -150.03 148.25 28.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 175.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 59' ' ' SER . 68.4 p -122.85 112.47 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.119 0.485 . . . . 0.0 110.082 174.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 55' ' ' ILE . 99.7 t -98.58 115.81 39.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.716 179.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.1 m -86.14 131.51 34.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.141 0.496 . . . . 0.0 110.548 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 1.013 HD13 ' HG2' ' A' ' 80' ' ' LYS . 62.6 mt -120.33 116.91 26.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -179.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.65 156.44 40.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.403 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 151.48 -150.9 22.9 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.493 176.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.12 152.25 76.45 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.45 -49.94 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.104 2.536 . . . . 0.0 113.526 -175.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.1 -33.37 50.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 0.0 110.845 -178.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -70.06 -41.27 74.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.641 -178.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.676 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.5 p -68.47 -32.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -177.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.36 81.7 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -55.91 -45.44 78.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.343 0.592 . . . . 0.0 110.793 178.746 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.74 83.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.376 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 1.013 ' HG2' HD13 ' A' ' 69' ' ' LEU . 44.6 mtmt -82.39 -22.02 35.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -173.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.468 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 17.1 tpt -60.82 -49.59 76.85 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.655 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 93.4 mmm -68.37 -39.61 81.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.751 176.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.859 ' HG ' HD11 ' A' ' 69' ' ' LEU . 1.4 mm? -62.29 -59.63 4.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.02 -40.58 63.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.024 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -55.5 34.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.132 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.613 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.3 mp -80.6 -38.91 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.659 0.266 . . . . 0.0 111.704 -175.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 24' ' ' TYR . 92.2 t -60.02 -50.31 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.703 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -57.83 -48.6 79.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.682 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.2 ptp180 -61.49 -22.35 65.01 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.183 0.302 . . . . 0.0 111.587 -175.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.81 12.76 13.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.117 -1.04 . . . . 0.0 113.472 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.641 HH11 ' HG3' ' A' ' 27' ' ' PRO . 7.3 tpt180 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 117.309 0.554 . . . . 0.0 112.008 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -52.18 113.81 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.73 125.51 52.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.159 170.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.45 75.36 0.42 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.574 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.92 -64.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.684 2.256 . . . . 0.0 111.565 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.794 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 pt -104.77 141.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 177.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.563 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 56.3 m80 -96.26 31.42 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.794 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 18.7 Cg_endo -57.85 -163.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.36 0 C-N-CA 122.47 2.113 . . . . 0.0 112.798 161.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 10.2 Cg_endo -56.44 164.48 5.44 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.219 1.946 . . . . 0.0 112.208 168.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.76 33.69 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.816 3.01 . . . . 0.0 114.393 -175.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 18' ' ' THR . 10.6 ptp180 -92.69 14.59 16.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 9.4 t 171.47 -16.58 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.672 177.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.2 m -78.21 -11.48 59.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.471 ' HE3' HG11 ' A' ' 76' ' ' VAL . 11.7 ptt? -150.56 69.75 0.99 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.836 0.827 . . . . 0.0 109.19 167.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.2 m -78.53 115.3 18.14 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.248 177.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' SER . 8.1 tp10 -94.4 119.76 33.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -172.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -104.87 102.75 12.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -91.43 125.66 36.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.837 -169.536 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 59.7 mtm180 -82.65 102.48 11.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 175.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.737 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -125.14 126.72 25.17 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.778 -177.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 54.6 Cg_exo -54.82 148.24 47.06 Favored 'Trans proline' 0 CA--C 1.521 -0.169 0 C-N-CA 123.537 2.824 . . . . 0.0 111.815 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' HG12 ' A' ' 31' ' ' VAL . 28.8 t70 -59.63 -36.83 77.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.918 -175.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -34.34 61.9 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.384 175.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.6 tpp -78.95 -22.96 44.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.93 -175.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.74 HG21 ' HG2' ' A' ' 65' ' ' ARG . 3.7 p -76.85 -29.96 18.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.78 -26.93 67.6 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.851 169.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.63 -24.26 20.57 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 175.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.3 tp -68.92 -32.23 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.74 0.781 . . . . 0.0 109.693 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.598 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.3 pt -71.95 -12.12 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.367 174.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.84 -8.75 27.59 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.845 163.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.696 ' HD3' ' HB2' ' A' ' 40' ' ' GLU . 11.8 ptm180 -174.75 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.045 -174.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.85 -2.09 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.767 179.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.598 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.08 -37.23 0.61 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.82 -1.181 . . . . 0.0 112.653 174.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.696 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 3.5 mp0 -56.73 -40.93 76.62 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -59.48 -44.81 92.96 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -168.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.653 HD11 HG11 ' A' ' 53' ' ' VAL . 8.5 tp -64.03 -48.08 87.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.445 -177.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.3 m-20 -65.87 -33.39 75.74 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -60.55 -49.65 76.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.161 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.536 HG21 ' HG2' ' A' ' 82' ' ' MET . 1.8 mp -75.95 -40.71 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.798 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.56 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -70.55 -27.21 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.638 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.75 -40.48 40.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.66 -40.11 90.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.889 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 28.6 p -80.86 -42.78 20.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.235 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.99 1.19 36.11 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 44.5 t -79.9 139.25 37.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.242 178.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.21 79.33 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.357 0.599 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.653 HG11 HD11 ' A' ' 42' ' ' ILE . 44.9 t -89.73 123.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.348 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -118.51 133.78 55.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 -176.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 67' ' ' VAL . 43.3 mm -91.98 98.44 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 14.8 m -81.02 108.43 10.25 Favored Pre-proline 0 C--O 1.238 0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 -177.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 2.1 Cg_endo -83.85 -21.42 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.513 2.809 . . . . 0.0 112.693 -176.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.44 -38.3 35.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 t 68.94 -80.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.867 177.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.23 48.3 5.74 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.828 179.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.71 -30.8 0.56 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.569 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.8 mm? -113.47 143.22 28.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.84 8.39 4.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.666 2.244 . . . . 0.0 111.098 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 6.0 pt-20 -126.7 -154.21 0.61 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.435 -175.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.74 ' HG2' HG21 ' A' ' 31' ' ' VAL . 4.6 tpp180 -94.88 140.91 29.27 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 33.5 p -116.64 108.78 16.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 55' ' ' ILE . 94.1 t -96.74 114.69 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.123 -176.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -92.0 134.86 34.42 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.101 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.459 HD13 ' HG2' ' A' ' 80' ' ' LYS . 2.0 mp -125.8 128.73 48.13 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -152.09 146.98 25.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.41 -137.99 4.96 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.024 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.36 161.43 37.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.03 -56.89 2.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.501 2.134 . . . . 0.0 113.041 -175.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.05 -37.71 81.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.486 -178.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.3 m -68.03 -48.42 65.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.414 -176.25 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.561 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 5.5 p -69.12 -33.75 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.138 -174.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.56 -35.41 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.652 0.263 . . . . 0.0 110.442 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -60.49 -45.8 92.43 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.407 0.623 . . . . 0.0 109.846 176.361 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 53' ' ' VAL . . . -64.29 -35.96 82.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.348 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 50.0 mtmt -81.13 -22.91 38.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.246 0.546 . . . . 0.0 109.764 -176.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.2 ttt -65.11 -44.47 88.64 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.459 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.536 ' HG2' HG21 ' A' ' 45' ' ' ILE . 4.0 ppp? -73.2 -28.02 61.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.956 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -66.18 -55.37 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.585 177.396 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.53 -30.35 65.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.465 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.83 -60.79 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.192 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -73.0 -36.61 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -175.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.7 -21.68 28.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.186 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.2 t -72.34 -40.45 67.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 174.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 7.2 ptp180 -72.3 -17.35 61.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.754 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.15 -49.27 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.347 -178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 91' ' ' ARG . 15.6 mtp180 . . . . . 0 C--N 1.322 -0.617 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 -177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.3 mm . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.322 0.582 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.516 ' HB2' ' HD3' ' A' ' 25' ' ' ARG . 12.1 p -153.8 156.52 37.85 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.132 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.3 m 72.9 -35.66 0.33 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.504 0.722 . . . . 0.0 112.229 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 19.3 mm-40 67.58 -68.2 0.16 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.116 0.966 . . . . 0.0 112.854 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 90.0 mt 70.89 -87.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.95 0.9 . . . . 0.0 111.231 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.87 99.41 0.25 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.177 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.2 -17.47 24.46 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 123.017 2.478 . . . . 0.0 112.131 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.84 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.1 tp -100.21 147.29 7.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.73 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 35.9 m-70 -90.77 -19.14 0.24 Allowed Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 115.521 1.674 . . . . 0.0 115.521 -172.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.84 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -36.21 163.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 123.447 2.765 . . . . 0.0 114.397 169.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -42.61 161.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.87 3.047 . . . . 0.0 114.06 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.74 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 18.1 Cg_endo -60.37 3.62 0.24 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.824 3.016 . . . . 0.0 114.523 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -59.32 -19.9 50.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.312 0.577 . . . . 0.0 109.519 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -151.11 -19.81 0.21 Allowed 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.654 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.5 t -80.04 -2.53 44.65 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.067 0.46 . . . . 0.0 111.004 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.575 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.7 mmt -134.1 39.64 3.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.904 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 29.1 m -78.96 112.76 16.48 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.1 tp10 -114.16 117.31 30.86 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.2 tt0 -99.49 104.52 16.35 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -90.19 116.28 28.06 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.841 -168.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HD3' ' HB2' ' A' ' 6' ' ' SER . 65.4 mtm180 -81.0 96.09 7.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.008 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.474 HG11 HG23 ' A' ' 67' ' ' VAL . 0.9 OUTLIER -120.11 126.55 26.78 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.449 -173.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.35 135.74 46.81 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.193 2.595 . . . . 0.0 111.245 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 3.6 p-10 -60.49 -30.68 69.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.663 -170.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.71 -31.06 63.03 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.802 175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.529 ' HE1' ' HG3' ' A' ' 89' ' ' ARG . 95.9 mmm -78.04 -15.16 59.16 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.642 ' HA ' HG22 ' A' ' 34' ' ' ILE . 91.4 t -76.02 -35.88 30.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 171.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.16 -28.73 64.52 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.35 -0.928 . . . . 0.0 111.128 171.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD12 ' SD ' ' A' ' 30' ' ' MET . 82.5 mt -89.17 -27.83 20.42 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.1 tp -69.24 -28.06 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.613 0.72 . . . . 0.0 109.648 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.687 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.9 pt -83.35 -15.0 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.598 174.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.06 -89.87 0.03 OUTLIER Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.818 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 6.4 ptm180 -74.6 9.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.032 0.533 . . . . 0.0 111.623 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.26 9.51 27.45 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.953 174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.687 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.74 -39.47 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.026 174.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.524 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 32.2 tt0 -64.49 -28.88 69.96 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.926 0.714 . . . . 0.0 112.926 -171.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.18 -51.98 67.28 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.274 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.42 -37.65 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.175 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -61.45 -43.97 97.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 66.7 mttm -54.06 -53.39 53.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.433 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.428 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -70.73 -42.92 77.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.102 -173.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -29.28 64.35 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.503 -0.479 . . . . 0.0 111.124 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -81.38 -32.45 32.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.183 0.516 . . . . 0.0 110.116 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.93 -46.82 56.21 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.163 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.408 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 30.7 p -67.56 -38.04 83.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.237 -177.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.92 7.94 55.98 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 43.6 t -85.78 144.81 27.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.369 0.604 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -88.06 70.49 9.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.599 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.408 HG22 HD13 ' A' ' 69' ' ' LEU . 47.3 t -86.72 110.69 20.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.345 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 14.9 tp60 -114.55 123.27 48.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.637 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.5 mm -79.78 124.53 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 37.2 t -112.68 109.85 52.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.975 0.417 . . . . 0.0 111.115 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.642 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 74.1 Cg_endo -75.12 -16.13 20.1 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.983 2.456 . . . . 0.0 111.4 172.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -79.41 -33.25 42.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.623 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.638 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 9.6 t 70.45 -74.47 0.08 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.621 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 120.49 -61.52 0.51 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.409 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.93 -8.59 6.09 Favored Glycine 0 CA--C 1.516 0.15 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.793 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 2.5 mm? -107.53 152.18 41.28 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -79.9 -28.07 3.49 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.292 1.995 . . . . 0.0 111.539 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.42 -169.6 2.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.131 175.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.642 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 24.4 mmt180 -79.81 153.1 29.37 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.638 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 99.1 p -124.28 117.93 25.63 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.474 HG23 HG11 ' A' ' 26' ' ' VAL . 59.1 t -97.75 124.2 50.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -95.63 127.51 41.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.57 0.7 . . . . 0.0 111.408 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.823 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -108.48 124.66 50.77 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.902 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.34 156.28 39.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 172.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 155.88 -128.0 2.15 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 119.838 -1.172 . . . . 0.0 113.121 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.74 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -111.53 165.41 12.87 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 14.1 Cg_endo -55.66 -40.83 83.07 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.182 1.921 . . . . 0.0 113.06 -170.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -85.33 -31.89 22.77 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.462 -177.072 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.402 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 53.6 p -71.03 -46.4 62.16 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.384 0.611 . . . . 0.0 109.617 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.3 OUTLIER -64.99 -23.79 34.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.864 178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -72.61 -55.28 7.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.131 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' CG ' ' HB3' ' A' ' 49' ' ' SER . 4.5 tppp? -55.48 -45.46 76.97 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.12 0.486 . . . . 0.0 110.615 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.41 -51.22 70.74 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.609 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.823 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 51.2 mtmt -75.71 -20.03 58.66 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.53 -174.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 tpt -59.81 -49.89 75.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.522 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.428 ' HG3' HG12 ' A' ' 45' ' ' ILE . 16.0 mmt -66.06 -38.59 88.71 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.06 0.457 . . . . 0.0 110.874 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.34 -44.82 95.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.35 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.53 -46.01 84.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.106 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -53.67 -59.6 4.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.842 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.683 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.69 -41.23 62.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.823 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 24' ' ' TYR . 93.1 t -70.38 -25.32 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.683 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.6 t -72.95 -40.81 65.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.683 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.2 ptp180 -77.9 -6.89 55.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.686 0.279 . . . . 0.0 111.17 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -111.1 -46.81 0.8 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.483 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -103.02 -4.16 25.0 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.518 -0.401 . . . . 0.0 111.291 -176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.77 -68.68 3.46 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.164 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.922 -0.932 . . . . 0.0 111.525 -179.499 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.537 ' HA ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.757 0.313 . . . . 0.0 111.776 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.567 ' HA ' ' HB3' ' A' ' 23' ' ' GLU . 11.2 p -89.28 177.12 6.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.302 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 35.2 t 74.11 -69.71 0.18 Allowed 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.259 0.624 . . . . 0.0 110.122 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -161.42 106.35 1.31 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 0.0 110.093 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.537 HD13 ' HA ' ' A' ' 5' ' ' ILE . 24.4 tp -91.41 96.6 10.6 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.4 70.92 0.33 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.03 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.471 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 6.7 Cg_exo -73.96 -38.37 2.29 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.561 2.174 . . . . 0.0 111.332 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.584 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 12.4 pt -121.81 152.42 25.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.699 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.662 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 72.7 t60 -89.08 -26.22 0.32 Allowed Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.662 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.0 Cg_exo -39.15 159.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.79 2.327 . . . . 0.0 114.049 175.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -38.16 144.38 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.127 3.218 . . . . 0.0 113.828 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.609 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 46.3 Cg_endo -66.77 31.32 0.12 Allowed 'Trans proline' 0 N--CA 1.476 0.489 0 C-N-CA 124.539 3.493 . . . . 0.0 114.493 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.847 ' HD2' HG22 ' A' ' 18' ' ' THR . 4.5 ppt_? -82.63 0.06 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 0.0 110.176 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.847 HG22 ' HD2' ' A' ' 17' ' ' ARG . 11.9 t -179.46 -17.76 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.484 ' HB3' HG13 ' A' ' 12' ' ' ILE . 3.7 m -78.32 -80.92 0.11 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.583 -172.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.609 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.6 ptp -76.24 76.61 3.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.442 0.639 . . . . 0.0 110.811 -178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.9 m -81.82 114.01 20.16 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.2 176.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 15.3 tt0 -94.04 118.01 30.91 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 6' ' ' SER . 6.9 tp10 -99.29 104.98 16.94 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -176.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.673 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -90.82 118.78 30.5 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.684 -168.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -81.86 99.1 8.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.685 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.657 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -116.63 123.52 30.4 Favored Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.763 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.519 ' HG2' ' HG2' ' A' ' 30' ' ' MET . 31.9 Cg_endo -66.36 152.55 80.71 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.482 2.121 . . . . 0.0 111.832 -174.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -52.72 -42.02 64.48 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.32 -37.88 93.21 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.482 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.557 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 88.4 mmm -78.84 -23.49 44.98 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 122.431 -0.452 . . . . 0.0 111.354 -174.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 ' HG2' ' A' ' 65' ' ' ARG . 2.8 p -74.26 -30.55 26.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 119.986 -0.685 . . . . 0.0 109.672 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.03 -28.82 69.48 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 119.86 -1.162 . . . . 0.0 110.925 170.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -89.29 -23.92 22.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.7 tp -70.3 -25.55 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.691 0.758 . . . . 0.0 109.597 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.789 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 9.4 pt -85.33 -14.73 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.434 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.17 -91.18 0.02 OUTLIER Glycine 0 C--N 1.336 0.574 0 O-C-N 124.209 0.943 . . . . 0.0 113.191 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 1.005 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.5 ptm180 -76.99 44.9 0.41 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 123.166 0.587 . . . . 0.0 111.501 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.06 13.78 80.82 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.691 -0.686 . . . . 0.0 114.354 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.789 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 135.51 -36.09 2.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.046 -1.074 . . . . 0.0 112.623 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.005 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 71.8 tt0 -57.75 -33.9 68.96 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -59.91 -52.42 65.51 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.712 0.291 . . . . 0.0 111.361 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.69 HD11 HG11 ' A' ' 53' ' ' VAL . 10.0 tp -63.8 -40.31 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.106 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -58.33 -40.66 82.69 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.467 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 13.7 mmmm -60.32 -59.96 4.58 Favored 'General case' 0 C--O 1.22 -0.496 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.371 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.425 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -62.86 -41.54 93.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.64 -33.2 72.28 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.015 -177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.407 HE21 ' HB3' ' A' ' 47' ' ' GLN . 1.0 OUTLIER -77.95 -37.88 46.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.469 0.652 . . . . 0.0 109.539 176.07 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -64.45 -26.07 68.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 111.198 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 34.1 p -99.65 -44.85 5.98 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.034 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.95 8.96 21.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.06 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.549 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 21.0 t -92.77 136.97 32.77 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.018 0.437 . . . . 0.0 110.855 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.3 mtmt -79.77 79.05 6.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.922 178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.69 HG11 HD11 ' A' ' 42' ' ' ILE . 40.6 t -82.64 109.52 16.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.515 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 14.5 mm-40 -101.03 116.05 31.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.071 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.521 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.5 mm -89.7 96.95 6.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.743 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.3 m -88.36 105.39 9.36 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.812 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.593 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 2.8 Cg_exo -75.43 -22.09 14.42 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.321 2.681 . . . . 0.0 111.641 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -79.62 -38.08 34.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.001 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.632 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.3 t 71.41 -54.09 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 114.708 -1.133 . . . . 0.0 111.556 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.94 -71.79 2.9 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.646 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.78 -9.44 61.13 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.958 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.627 ' HB2' ' OG ' ' A' ' 59' ' ' SER . 2.1 mm? -121.49 154.48 59.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -85.5 -4.3 9.25 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.031 2.487 . . . . 0.0 111.985 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 6.3 pt-20 -111.03 -141.05 0.38 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.817 -174.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.726 ' HG2' HG21 ' A' ' 31' ' ' VAL . 2.0 tpp180 -107.4 140.15 40.78 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.632 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 67.2 p -116.94 111.64 19.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.348 0.594 . . . . 0.0 109.944 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 55' ' ' ILE . 84.7 t -100.83 119.53 49.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.776 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 29.7 m -88.68 128.24 35.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.329 0.585 . . . . 0.0 110.858 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.897 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.9 mm? -107.31 108.09 19.32 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.805 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.492 HG21 ' HA ' ' A' ' 18' ' ' THR . 0.7 OUTLIER -151.2 119.45 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.005 176.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -158.88 -107.34 0.24 Allowed Glycine 0 C--O 1.225 -0.455 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.734 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.565 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -129.35 163.63 44.97 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -45.6 -51.22 8.37 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.463 2.109 . . . . 0.0 112.859 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -72.65 -46.86 51.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.362 0.601 . . . . 0.0 110.698 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.565 ' HB2' ' H ' ' A' ' 72' ' ' ALA . 6.7 m -62.47 -45.5 92.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.818 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.534 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.1 p -71.23 -27.87 30.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.684 -174.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -40.2 49.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.771 0.32 . . . . 0.0 110.385 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.733 ' O ' ' HG3' ' A' ' 81' ' ' MET . 1.8 tpmt? -64.26 -46.59 83.04 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.659 0.742 . . . . 0.0 109.818 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.412 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -55.24 -46.5 76.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.294 176.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.897 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 37.7 mtmt -73.5 -22.45 60.13 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.733 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -70.5 -31.09 68.05 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.458 179.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.425 ' HG3' HG12 ' A' ' 45' ' ' ILE . 15.0 mmt -69.02 -46.7 67.3 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.677 172.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.416 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.4 mm? -61.51 -48.59 80.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -54.87 -40.5 69.78 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.266 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.8 -57.62 12.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.947 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.682 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -72.13 -41.52 67.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.758 -175.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 24' ' ' TYR . 85.8 t -64.57 -32.42 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.336 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 t -73.25 -37.77 66.21 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.019 -0.273 . . . . 0.0 110.455 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.682 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.5 ptp180 -78.41 -7.6 57.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.932 0.396 . . . . 0.0 110.929 -178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -107.41 -64.89 0.6 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.344 175.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 91' ' ' ARG . 22.2 mtp180 -81.79 -33.8 30.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.001 0.429 . . . . 0.0 111.461 -177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.61 -6.39 83.49 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.111 -179.003 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.273 0.559 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.9 m -98.0 91.0 5.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.297 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.572 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 62.6 m -77.52 178.04 7.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.861 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.664 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 68.5 mm-40 53.78 -162.3 0.12 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.48 0.712 . . . . 0.0 111.621 -173.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 28.8 tp 173.05 -69.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.565 0.746 . . . . 0.0 109.41 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 121.76 92.33 1.18 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.952 -177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.09 -26.13 26.32 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.998 2.466 . . . . 0.0 111.385 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.586 HG22 ' HD2' ' A' ' 14' ' ' PRO . 4.1 mt -77.17 108.45 10.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.671 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 23.3 m170 -89.72 7.12 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.85 0 N-CA-C 116.621 2.082 . . . . 0.0 116.621 -168.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 20.5 Cg_exo -46.1 -176.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 121.82 1.68 . . . . 0.0 112.863 158.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' ARG . 67.5 Cg_exo -42.14 158.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.983 2.455 . . . . 0.0 113.557 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 26.8 Cg_endo -64.4 17.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.79 2.993 . . . . 0.0 114.207 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.1 OUTLIER -74.43 -6.55 48.89 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.111 0.481 . . . . 0.0 109.961 172.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.435 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 10.3 t -158.71 -25.96 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.609 175.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.0 t -79.31 8.12 6.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.812 0.339 . . . . 0.0 111.083 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.6 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 1.5 mmt -145.58 32.67 1.06 Allowed 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.397 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 40.1 m -79.51 110.99 15.33 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -116.21 118.97 34.28 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.664 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 25.9 tt0 -84.91 104.12 14.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.85 109.46 20.67 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.259 -174.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.454 ' CZ ' HD11 ' A' ' 62' ' ' LEU . 96.7 mtt180 -87.37 98.83 11.57 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.21 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -112.65 128.87 25.01 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.936 -173.042 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 20.0 Cg_exo -60.7 143.51 99.41 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 123.276 2.651 . . . . 0.0 111.773 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -50.82 -50.62 56.04 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -170.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.87 -29.8 75.24 Favored Glycine 0 C--O 1.237 0.333 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.413 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.779 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 80.3 mmm -77.45 -21.0 53.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 35' ' ' ILE . 41.4 t -66.19 -37.98 80.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 170.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -63.17 -29.38 74.28 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.708 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 75.1 mt -86.81 -25.17 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -75.77 -29.48 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.3 0.572 . . . . 0.0 109.815 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 31' ' ' VAL . 8.8 pt -83.32 -13.51 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.181 172.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.15 -91.02 0.08 OUTLIER Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.087 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.968 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 16.9 ptm180 -71.18 -9.52 58.23 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 122.712 0.405 . . . . 0.0 111.451 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 124.84 3.38 7.66 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.294 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.622 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -58.93 0.25 Allowed Glycine 0 C--N 1.33 0.229 0 C-N-CA 119.979 -1.105 . . . . 0.0 113.314 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.968 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 18.8 tp10 -55.17 -21.96 15.45 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' O ' HD13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.7 -48.45 71.99 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.02 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 39' ' ' GLY . 9.9 tp -63.98 -37.87 80.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -53.78 -49.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.629 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 22.1 mmtm -66.95 -41.76 86.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.299 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.418 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.4 mp -67.19 -41.17 86.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -22.87 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.017 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -78.24 -42.57 30.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.335 0.588 . . . . 0.0 110.047 175.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -59.61 -43.77 93.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.01 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.693 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 23.1 p -83.69 -43.06 15.94 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.291 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.8 10.49 26.54 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.559 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 47.4 t -79.71 141.73 36.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.121 0.486 . . . . 0.0 110.475 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 50.9 mmtt -94.22 67.34 3.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.438 0.637 . . . . 0.0 109.615 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.42 HG23 HD13 ' A' ' 69' ' ' LEU . 2.2 p -82.5 142.88 13.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.127 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -136.53 114.86 11.71 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.518 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.451 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 36.9 mm -79.63 104.65 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.39 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 6.2 t -92.35 105.43 14.14 Favored Pre-proline 0 C--O 1.242 0.665 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.555 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 3.2 Cg_exo -75.93 -30.79 5.57 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.45 2.767 . . . . 0.0 112.724 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -78.53 -29.67 46.59 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.546 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 7.4 t 73.19 -67.53 0.26 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.821 172.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.99 76.83 0.88 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.358 -0.925 . . . . 0.0 111.823 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 125.08 -57.69 0.68 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.067 -0.587 . . . . 0.0 111.815 -178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 25' ' ' ARG . 1.3 mm? -87.57 144.15 35.02 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.05 -23.92 8.73 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.435 2.09 . . . . 0.0 110.225 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 6.6 pt-20 -88.99 -168.67 2.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.556 176.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.754 ' HB3' HG13 ' A' ' 26' ' ' VAL . 4.0 tpp180 -87.08 139.46 30.54 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.146 -175.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.9 p -117.28 111.34 19.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.369 0.604 . . . . 0.0 109.755 176.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.434 HG13 HD13 ' A' ' 55' ' ' ILE . 49.1 t -109.32 131.74 59.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.694 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 57.6 m -91.79 125.59 36.56 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.022 177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 21' ' ' THR . 4.0 mm? -104.57 111.45 24.13 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.025 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 45.2 m -152.29 147.98 26.99 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 117.654 0.206 . . . . 0.0 111.036 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.74 -156.72 28.8 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.018 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -78.3 161.62 69.53 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.8 Cg_endo -48.53 -54.96 4.56 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.008 2.472 . . . . 0.0 113.417 -174.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.48 -37.07 77.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.088 0.47 . . . . 0.0 110.839 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.693 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 9.0 m -66.6 -51.66 53.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.425 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 4.8 p -67.62 -26.48 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.267 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -71.74 -45.26 62.3 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.388 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 81' ' ' MET . 1.3 tmtp? -68.6 -39.23 80.98 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.362 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -62.07 -40.85 97.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.977 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 45.8 mtmt -80.96 -21.32 40.46 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.1 tpt -57.15 -50.7 72.01 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.357 173.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.418 ' HG3' HG12 ' A' ' 45' ' ' ILE . 92.9 mmm -68.96 -39.8 79.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.903 0.383 . . . . 0.0 111.038 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 79' ' ' ALA . 3.7 mm? -62.67 -47.84 81.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.048 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -55.96 -45.67 78.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.042 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -56.0 -54.23 47.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.669 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.7 mp -75.24 -41.55 44.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -175.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' A' ' 26' ' ' VAL . 67.8 t -72.7 -23.65 20.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.291 -174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.9 m -75.2 -41.42 57.88 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.799 172.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.586 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.9 ptm180 -76.74 -6.96 54.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.779 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -105.72 -52.44 0.8 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.982 -0.627 . . . . 0.0 113.597 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' HG2' ' HG3' ' A' ' 27' ' ' PRO . 17.5 mtp180 -84.56 95.28 8.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.311 0.577 . . . . 0.0 112.33 -175.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.68 52.73 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 168.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.519 -1.156 . . . . 0.0 110.917 176.318 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 121.385 0.612 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -73.0 88.82 1.4 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.12 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 23' ' ' GLU . 62.2 m -173.31 -80.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.991 0.917 . . . . 0.0 109.41 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -176.01 163.03 2.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.201 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.461 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 75.1 mt -138.78 107.32 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.669 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -126.32 57.66 0.69 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.627 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 92.0 Cg_endo -93.88 -2.68 3.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.002 2.468 . . . . 0.0 112.387 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 30.9 pt -126.51 149.17 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.813 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.6 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 22.1 m80 -91.18 -19.56 0.24 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 93.2 Cg_exo -38.81 162.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.671 2.247 . . . . 0.0 114.324 172.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.62 152.64 8.95 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.847 2.364 . . . . 0.0 112.077 174.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 42.4 Cg_endo -65.99 7.56 0.34 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.423 2.748 . . . . 0.0 113.788 -173.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.51 -15.87 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.18 0.514 . . . . 0.0 110.284 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -159.29 7.14 0.1 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.14 174.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 30.8 t -93.28 -104.64 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.297 -176.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.468 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptm -63.95 74.22 0.03 OUTLIER 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.045 0.926 . . . . 0.0 111.712 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 62.5 m -90.04 139.02 31.02 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.635 ' HB2' HD23 ' A' ' 69' ' ' LEU . 10.9 mm-40 -95.33 148.87 21.97 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.299 168.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' HB3' ' H ' ' A' ' 7' ' ' SER . 54.5 tp10 -120.34 98.76 6.2 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 160.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.506 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.36 124.57 37.43 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.266 -161.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.955 ' HG2' HD21 ' A' ' 62' ' ' LEU . 32.6 mtm180 -81.78 111.38 17.97 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.067 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.489 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -130.31 126.59 22.25 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.893 -175.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 35.0 Cg_exo -60.07 151.38 72.96 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 123.488 2.792 . . . . 0.0 112.658 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 31' ' ' VAL . 35.5 t70 -55.17 -51.91 65.0 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -172.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.46 -25.03 75.05 Favored Glycine 0 C--O 1.236 0.253 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.935 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.0 tpp -79.53 -32.05 42.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.68 -0.26 . . . . 0.0 110.473 -175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 34' ' ' ILE . 12.7 p -72.69 -24.05 21.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -29.2 74.41 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.06 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.6 mt -87.45 -24.55 24.12 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD13 ' HB ' ' A' ' 86' ' ' ILE . 10.7 tp -72.93 -27.93 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.413 0.625 . . . . 0.0 109.663 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.617 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 11.9 pt -85.05 -13.59 11.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.348 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.33 -93.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.628 0 O-C-N 124.164 0.915 . . . . 0.0 113.066 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.957 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -72.99 48.68 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.179 0.592 . . . . 0.0 111.027 177.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.15 20.8 58.62 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.502 -0.772 . . . . 0.0 114.113 176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.617 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.05 -50.91 0.58 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.809 -1.186 . . . . 0.0 113.602 175.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.957 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 22.2 tt0 -54.62 -33.49 60.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -171.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.52 ' O ' HG12 ' A' ' 45' ' ' ILE . 24.5 tt0 -60.03 -48.4 81.85 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.473 -171.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.76 HD11 HG11 ' A' ' 53' ' ' VAL . 9.8 tp -60.59 -38.48 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.214 -177.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.43 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 60.2 m-20 -65.32 -44.69 87.02 Favored 'General case' 0 C--O 1.208 -1.095 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.58 -31.94 69.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.534 0.207 . . . . 0.0 111.035 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 41' ' ' GLN . 26.4 mm -76.32 -50.95 20.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.989 0.423 . . . . 0.0 111.357 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.43 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -75.72 -24.64 56.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.408 -174.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -82.95 -34.48 26.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.684 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.81 -46.02 76.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.869 175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 25.8 p -73.04 -48.04 39.57 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.209 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.73 13.47 25.7 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.4 t -92.84 143.36 26.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.954 0.407 . . . . 0.0 110.706 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 41.4 mtmt -81.6 72.09 8.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.669 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.76 HG11 HD11 ' A' ' 42' ' ' ILE . 57.9 t -82.4 110.85 18.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.397 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.404 ' HA ' ' NE2' ' A' ' 54' ' ' GLN . 15.7 mm-40 -110.99 122.44 47.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.123 -174.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.582 HD11 HG12 ' A' ' 42' ' ' ILE . 42.7 mm -88.9 99.18 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.79 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.5 t -81.08 115.14 54.18 Favored Pre-proline 0 C--O 1.243 0.715 0 CA-C-O 120.962 0.41 . . . . 0.0 110.859 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.543 ' HA ' HH11 ' A' ' 65' ' ' ARG . 97.4 Cg_endo -79.65 -27.54 4.0 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.367 2.712 . . . . 0.0 112.061 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -79.65 -40.32 29.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.457 178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.554 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 11.0 t 70.72 -69.11 0.19 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.236 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 123.57 -96.54 0.54 Allowed Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.061 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.06 -12.47 79.36 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.654 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.955 HD21 ' HG2' ' A' ' 25' ' ' ARG . 0.6 OUTLIER -94.78 139.93 22.38 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.796 0.332 . . . . 0.0 110.817 -176.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -85.09 -2.46 9.52 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.8 2.333 . . . . 0.0 111.434 174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 91' ' ' ARG . 2.5 pt-20 -110.64 -104.06 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.31 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.543 HH11 ' HA ' ' A' ' 57' ' ' PRO . 6.7 tpp180 -144.57 155.4 43.64 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 78.0 p -136.94 146.97 46.07 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.373 173.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 55' ' ' ILE . 52.2 t -123.3 131.06 73.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.257 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.5 m -91.48 131.23 37.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.2 0.524 . . . . 0.0 110.768 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.635 HD23 ' HB2' ' A' ' 22' ' ' GLU . 3.6 mm? -114.09 104.03 11.72 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.865 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.2 124.19 11.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.389 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.76 -158.03 19.2 Favored Glycine 0 C--O 1.22 -0.732 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.333 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.11 161.88 69.06 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -45.67 -52.24 7.09 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.79 2.326 . . . . 0.0 112.945 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -67.5 -43.33 81.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.455 0.645 . . . . 0.0 110.6 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.635 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.3 m -64.94 -49.62 69.65 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.618 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.55 -23.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.162 -175.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.54 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.2 tt0 -72.55 -52.37 15.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.886 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.413 ' CG ' ' HB3' ' A' ' 49' ' ' SER . 5.4 tppp? -55.04 -43.47 73.8 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 121.191 0.52 . . . . 0.0 110.588 176.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.94 63.34 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.725 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.62 ' HD3' ' CG ' ' A' ' 22' ' ' GLU . 11.2 mtmm -66.91 -23.06 65.94 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.616 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.7 mmt -59.77 -52.72 64.26 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.607 0.241 . . . . 0.0 110.422 177.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 20.4 mmt -68.37 -37.71 80.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.5 178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.473 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.3 mm? -60.48 -54.99 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.183 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 88' ' ' SER . 24.6 t70 -60.3 -34.86 74.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.767 0.318 . . . . 0.0 110.559 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -64.39 -55.98 17.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.262 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.09 -41.48 52.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.365 -175.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 24' ' ' TYR . 87.9 t -64.18 -28.1 44.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.23 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 16.1 t -75.73 -31.63 59.68 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.342 -0.224 . . . . 0.0 110.91 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 17.4 ptp180 -77.74 -12.44 59.97 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.511 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -106.33 -50.07 0.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.957 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 64' ' ' GLU . 26.3 mmt180 -92.22 -77.94 0.42 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 122.293 0.237 . . . . 0.0 111.6 -177.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.73 69.68 3.25 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.652 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.803 -0.998 . . . . 0.0 111.804 -179.346 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.3 p -144.07 134.39 24.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.275 0.56 . . . . 0.0 111.904 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 1.006 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 34.1 m -92.69 163.45 13.76 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -158.2 121.46 3.9 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.022 0.439 . . . . 0.0 110.34 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.26 104.08 15.1 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.085 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.57 69.38 0.44 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.891 171.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -84.95 -27.29 1.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.656 2.238 . . . . 0.0 112.991 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.696 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 6.0 mm -120.49 147.32 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.631 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 24.7 t60 -93.53 12.03 0.04 OUTLIER Pre-proline 0 CA--C 1.57 1.718 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -170.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.696 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 29.8 Cg_endo -61.06 -166.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.362 1.245 0 C-N-CA 122.33 2.02 . . . . 0.0 113.958 171.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 67.3 Cg_exo -56.63 167.08 3.08 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.358 2.039 . . . . 0.0 112.517 168.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.1 33.63 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 124.189 3.259 . . . . 0.0 114.708 -174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' O ' ' HB ' ' A' ' 18' ' ' THR . 4.7 ptp180 -96.92 13.17 29.74 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 0.0 109.908 176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 15.0 t 174.53 -15.25 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.289 177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -79.97 -6.42 57.49 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.134 0.492 . . . . 0.0 111.629 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.42 58.14 0.4 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.22 0.533 . . . . 0.0 110.354 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.3 m -78.21 110.83 13.56 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 172.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 7' ' ' SER . 12.7 tt0 -98.9 119.57 37.9 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -172.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 1.006 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 4.6 tp10 -92.34 102.01 14.49 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -90.96 126.24 36.01 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.112 0.482 . . . . 0.0 110.739 -171.604 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -91.09 98.12 11.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.083 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG11 HH21 ' A' ' 65' ' ' ARG . 1.3 p -120.37 114.33 33.27 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.528 -172.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.644 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 50.3 Cg_exo -57.5 164.25 7.5 Favored 'Trans proline' 0 N--CA 1.474 0.348 0 C-N-CA 124.454 3.436 . . . . 0.0 114.38 -169.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -54.91 -45.34 74.72 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 0.0 111.845 -176.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' HD23 ' A' ' 33' ' ' LEU . . . -63.76 -34.04 88.86 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.136 -1.03 . . . . 0.0 111.806 176.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.419 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 31.4 mmt -80.25 -25.81 39.34 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -175.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -70.77 -33.89 54.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.934 172.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.27 -30.37 77.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.708 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 29' ' ' GLY . 4.2 mm? -87.01 -24.02 24.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.986 HG21 HH22 ' A' ' 65' ' ' ARG . 10.8 tp -71.43 -30.49 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.665 0.745 . . . . 0.0 109.249 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.626 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 16.0 pt -86.99 -14.05 10.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.731 174.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.76 -90.61 0.02 OUTLIER Glycine 0 C--N 1.337 0.605 0 CA-C-N 114.817 -1.083 . . . . 0.0 113.918 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.05 -6.91 9.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.998 -0.601 . . . . 0.0 111.946 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.9 4.42 9.5 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.824 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.626 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.17 -44.91 0.5 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.182 176.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -60.4 -26.31 66.58 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -173.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.59 -45.29 91.06 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.94 -174.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 tp -65.39 -34.0 67.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.973 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 74.3 m-20 -61.47 -38.67 88.11 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -37.63 64.81 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.187 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 41' ' ' GLN . 98.1 mt -64.13 -52.74 52.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 120.979 0.419 . . . . 0.0 111.258 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.97 -21.87 59.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.892 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 6.5 tp-100 -84.14 -35.56 23.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.142 0.496 . . . . 0.0 110.508 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.17 -39.49 78.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.666 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 p -84.07 -39.78 19.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.477 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.57 3.45 59.68 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.814 -0.707 . . . . 0.0 111.687 -176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 54.0 t -80.31 146.15 31.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.949 0.404 . . . . 0.0 110.533 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.724 ' HA ' ' HE2' ' A' ' 52' ' ' LYS . 10.9 mmpt? -84.98 81.01 9.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -81.92 107.16 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.308 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.7 mm-40 -95.93 106.68 18.86 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.933 -173.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.582 HG23 HH11 ' A' ' 65' ' ' ARG . 33.2 mm -81.12 110.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.637 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.8 m -97.38 98.57 5.1 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 39.5 Cg_exo -60.05 -41.36 53.17 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 112.419 -173.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -115.36 102.99 10.35 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 62' ' ' LEU . 34.5 t -68.92 -26.0 64.87 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.751 -172.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.07 -82.01 1.39 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.191 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -66.27 -31.04 77.88 Favored Glycine 0 CA--C 1.508 -0.391 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.782 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 59' ' ' SER . 51.7 mt -98.31 138.52 20.86 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 115.046 -0.577 . . . . 0.0 109.979 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.86 -19.52 23.51 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 122.783 2.322 . . . . 0.0 110.784 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.644 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -96.69 -174.35 2.99 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.183 177.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.986 HH22 HG21 ' A' ' 34' ' ' ILE . 5.7 tmm_? -94.84 141.3 28.79 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -175.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.514 ' N ' ' HD2' ' A' ' 65' ' ' ARG . 79.5 p -115.26 150.82 35.59 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.382 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 82.6 t -129.96 114.34 29.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.701 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.3 m -85.87 129.95 34.69 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.399 173.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.003 HD13 ' HG2' ' A' ' 80' ' ' LYS . 5.4 mt -114.94 121.75 44.14 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.121 -178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 78.8 m -151.33 141.29 22.05 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.247 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.89 -136.94 4.05 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.482 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -96.13 163.11 21.64 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.7 Cg_endo -48.05 -48.35 16.72 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.798 2.332 . . . . 0.0 112.854 -177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.36 -39.67 53.18 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.126 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.2 p -70.94 -47.69 57.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.104 0.478 . . . . 0.0 110.441 -175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.73 -29.2 46.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.228 -177.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -68.68 -50.99 46.59 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 81' ' ' MET . 50.8 tptt -63.13 -40.56 97.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.758 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -58.81 -41.71 87.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.138 0.494 . . . . 0.0 111.082 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.003 ' HG2' HD13 ' A' ' 69' ' ' LEU . 48.5 mtmt -81.18 -21.89 39.32 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.957 -175.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 7.8 tpt -59.1 -50.58 73.53 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.357 174.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.9 mmm -70.25 -37.53 74.96 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.605 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.4 mm? -60.37 -55.09 37.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.418 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -55.18 -34.92 64.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.766 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -60.72 -56.57 19.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.575 -178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.608 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -70.13 -40.21 78.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.336 0.588 . . . . 0.0 110.77 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 74.4 t -62.41 -28.47 44.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.293 0.568 . . . . 0.0 110.106 178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.5 t -75.4 -31.13 60.32 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.164 -0.335 . . . . 0.0 110.759 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.5 ptm180 -78.31 -15.74 58.42 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.616 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' A' ' 27' ' ' PRO . . . -158.21 44.94 0.47 Allowed Glycine 0 CA--C 1.524 0.621 0 C-N-CA 119.213 -1.47 . . . . 0.0 115.009 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.527 ' HD2' ' HG3' ' A' ' 27' ' ' PRO . 7.6 tpm_? -160.44 -50.64 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.551 0.676 . . . . 0.0 110.084 173.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.03 -158.27 34.15 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.938 -0.923 . . . . 0.0 111.588 179.473 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 9' ' ' LEU . 14.4 tt . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.3 m -100.74 141.3 33.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.405 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 20.9 m 70.53 -163.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.663 0.602 . . . . 0.0 111.517 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.3 tp60 -56.84 120.0 7.16 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' MET . 53.2 tp -100.19 102.61 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.791 168.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -132.69 57.33 0.72 Allowed Glycine 0 CA--C 1.521 0.453 0 C-N-CA 119.75 -1.214 . . . . 0.0 113.774 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.702 ' HD2' HD13 ' A' ' 12' ' ' ILE . 5.8 Cg_exo -78.51 -46.15 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.48 2.12 . . . . 0.0 111.368 176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.834 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -82.28 147.76 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.837 179.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.688 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 53.5 m80 -91.12 -19.21 0.24 Allowed Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.6 Cg_endo -53.67 164.8 2.04 Favored 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.31 2.007 . . . . 0.0 113.482 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 17' ' ' ARG . 85.0 Cg_exo -46.65 149.25 3.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.201 2.601 . . . . 0.0 112.791 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 39.7 Cg_endo -65.53 26.83 0.09 OUTLIER 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 124.567 3.511 . . . . 0.0 114.437 -175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.774 ' HG3' HG22 ' A' ' 18' ' ' THR . 13.3 ptp180 -82.23 -20.96 36.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.151 0.5 . . . . 0.0 110.004 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.774 HG22 ' HG3' ' A' ' 17' ' ' ARG . 9.8 t -168.62 34.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.691 0.758 . . . . 0.0 110.458 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.9 p -126.12 -80.66 0.61 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.614 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.1 ptm -74.55 79.13 1.96 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.403 ' HA ' ' OG1' ' A' ' 70' ' ' THR . 99.0 m -79.48 118.78 21.67 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.867 175.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 68' ' ' SER . 6.2 tp10 -92.83 118.24 30.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' HB3' ' N ' ' A' ' 7' ' ' SER . 6.4 tp10 -100.4 103.42 14.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.43 123.62 36.86 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.207 0.527 . . . . 0.0 111.9 -172.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -81.65 110.35 16.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.939 175.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 87' ' ' VAL . 1.3 p -132.76 127.04 20.21 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.294 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 31' ' ' VAL . 52.0 Cg_exo -54.62 136.51 70.94 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.268 2.645 . . . . 0.0 111.038 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -61.4 -29.59 70.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.352 -169.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.34 -28.95 57.03 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.626 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.621 ' SD ' HD12 ' A' ' 33' ' ' LEU . 32.8 tpp -77.5 -20.68 53.93 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.676 ' HA ' HG22 ' A' ' 34' ' ' ILE . 80.1 t -69.15 -39.21 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.377 169.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.54 -28.45 56.05 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.65 172.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.621 HD12 ' SD ' ' A' ' 30' ' ' MET . 81.1 mt -85.78 -29.99 23.39 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.0 tp -72.1 -29.52 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.267 0.556 . . . . 0.0 109.969 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.738 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 17.9 pt -80.38 -13.24 12.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.512 174.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.34 -97.19 0.19 Allowed Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.459 173.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 1.078 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 19.5 ptp180 -60.0 -24.86 64.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.024 0.44 . . . . 0.0 111.003 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.04 30.79 0.61 Allowed Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.486 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.738 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.84 -60.87 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.47 -0.871 . . . . 0.0 113.306 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.078 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 9.5 mp0 -60.86 -21.63 63.45 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -168.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.496 ' O ' HG12 ' A' ' 45' ' ' ILE . 9.1 tt0 -60.1 -50.67 72.8 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.367 0.53 . . . . 0.0 110.765 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.5 HG12 HD11 ' A' ' 55' ' ' ILE . 8.9 tp -64.45 -39.18 84.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -55.29 -46.3 76.21 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.407 0.622 . . . . 0.0 110.037 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -65.57 -37.65 87.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.246 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 41' ' ' GLN . 22.9 mm -68.19 -51.17 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 111.267 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.45 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -72.32 -31.3 65.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.675 -173.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -78.84 -31.48 45.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.933 0.397 . . . . 0.0 110.823 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.14 -45.48 56.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.344 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.5 p -68.12 -45.21 74.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.482 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.76 -0.28 30.45 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.542 -178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.772 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 47.3 t -83.36 135.95 34.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.775 0.321 . . . . 0.0 110.286 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -80.62 72.86 7.57 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.549 HG22 HD23 ' A' ' 69' ' ' LEU . 43.3 t -82.52 111.32 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.008 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -111.26 118.03 34.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.176 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.523 HD13 HG13 ' A' ' 67' ' ' VAL . 34.2 mm -79.75 115.57 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -99.71 104.81 30.28 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-O 120.784 0.326 . . . . 0.0 110.555 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.889 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 60.1 Cg_endo -73.62 -21.95 18.65 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.989 2.46 . . . . 0.0 111.88 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.87 -32.39 23.23 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.878 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.543 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 21.4 t 65.39 -77.32 0.04 OUTLIER 'General case' 0 C--O 1.234 0.252 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.804 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 125.09 -86.16 0.36 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.084 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.88 -3.07 60.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.86 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' HB3' ' HG2' ' A' ' 64' ' ' GLU . 2.0 mm? -112.92 147.68 37.74 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.685 0.279 . . . . 0.0 110.494 -177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.98 -10.15 11.62 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.124 2.549 . . . . 0.0 111.556 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 4.2 pt-20 -104.27 -147.54 0.39 Allowed 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.524 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.889 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 19.3 mmt180 -106.53 139.88 40.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 174.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 15.1 p -110.75 108.11 17.86 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.496 0.665 . . . . 0.0 109.347 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG13 HD13 ' A' ' 55' ' ' ILE . 64.7 t -97.08 108.16 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.249 -176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -86.88 134.7 33.51 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.954 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.549 HD23 HG22 ' A' ' 53' ' ' VAL . 2.3 mp -123.5 121.87 36.77 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.163 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 21' ' ' THR . 26.2 m -151.92 121.46 6.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.026 175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.772 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.04 -76.22 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.646 -1.264 . . . . 0.0 113.177 -177.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -160.85 165.45 17.25 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 8.6 Cg_endo -49.93 -47.0 25.27 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.684 2.256 . . . . 0.0 113.284 -174.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.19 -38.94 23.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.431 0.634 . . . . 0.0 110.152 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 m -65.69 -46.17 80.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.789 -174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.3 p -73.06 -23.6 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 0.0 110.332 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.7 tp60 -76.47 -47.84 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.966 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' O ' ' HB2' ' A' ' 81' ' ' MET . 17.2 tppt? -60.64 -45.23 94.88 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.778 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.6 -48.32 79.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.471 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 47.5 mtmt -69.1 -21.04 64.07 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.908 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.1 mmt -61.25 -48.04 83.28 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.211 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 16.7 mmt -64.24 -41.24 97.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.982 0.42 . . . . 0.0 110.704 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -64.12 -57.33 9.91 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.361 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -53.56 -35.89 61.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.317 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -66.01 -61.44 2.04 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.013 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.548 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.1 mp -70.41 -38.77 75.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.269 0.557 . . . . 0.0 111.052 -176.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 26' ' ' VAL . 77.9 t -61.45 -36.69 74.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.333 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.0 t -71.17 -22.67 62.01 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.835 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -59.83 -49.2 78.63 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 173.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.31 -54.9 3.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.385 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 64' ' ' GLU . 39.3 mmt180 -85.41 95.41 9.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.354 0.662 . . . . 0.0 110.372 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.6 31.95 4.08 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.911 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.796 179.094 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.498 HD11 ' HA3' ' A' ' 61' ' ' GLY . 8.5 tp . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 121.544 0.687 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.7 p -124.97 155.96 38.82 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.299 176.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.524 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 8.1 m 62.91 -153.27 0.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.469 0.481 . . . . 0.0 109.751 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.578 ' HB3' ' O ' ' A' ' 21' ' ' THR . 60.0 tp60 170.83 -31.63 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 O-C-N 124.068 0.855 . . . . 0.0 108.964 171.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 67.55 -90.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.704 -1.134 . . . . 0.0 110.663 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 148.06 94.94 0.15 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.134 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.36 -12.96 30.35 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.806 2.337 . . . . 0.0 111.854 176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.84 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -99.69 161.76 3.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.307 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.661 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 31.5 t-80 -92.5 -37.95 0.35 Allowed Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -176.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 51.8 Cg_exo -32.58 144.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.874 3.049 . . . . 0.0 114.387 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 73.1 Cg_exo -40.58 140.76 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.376 2.717 . . . . 0.0 112.29 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.655 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 9.5 Cg_endo -51.79 60.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.487 1.132 1 C-N-CA 125.652 4.234 . . . . 0.0 116.884 -168.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 15' ' ' PRO . 11.9 ptp180 -114.84 15.11 17.45 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 170.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.2 t -178.87 -25.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.249 -1.341 . . . . 0.0 109.513 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.521 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 12.8 m -86.2 10.86 13.35 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.438 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.655 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 90.1 mmm -147.38 31.1 0.91 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.466 175.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.578 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 88.4 m -79.88 115.75 19.64 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.493 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 9.3 tt0 -123.89 118.04 26.18 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -89.3 109.29 20.2 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -92.1 128.22 37.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.003 -170.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.55 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 87.8 mtm180 -88.14 101.72 14.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.518 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.562 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -120.4 120.4 29.91 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.079 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.565 ' HD3' ' HG2' ' A' ' 91' ' ' ARG . 85.4 Cg_exo -50.11 145.71 19.28 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.878 3.052 . . . . 0.0 112.207 -178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -60.5 -37.04 79.81 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.587 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.76 -25.3 53.61 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.791 176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.616 ' HG2' ' HA3' ' A' ' 90' ' ' GLY . 35.5 tpp -79.54 -26.67 41.39 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.203 -176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 34' ' ' ILE . 7.5 p -75.81 -30.18 20.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 171.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.54 -28.3 62.25 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.16 167.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.3 mt -88.87 -24.24 22.57 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.8 tp -70.8 -27.47 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.313 0.578 . . . . 0.0 109.892 -179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 2.4 pt -81.15 -14.52 12.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.431 173.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 61.09 -90.94 0.05 OUTLIER Glycine 0 C--N 1.334 0.421 0 O-C-N 124.187 0.929 . . . . 0.0 113.155 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -77.06 28.15 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.15 0.58 . . . . 0.0 111.991 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.0 -10.38 67.99 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.271 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 165.26 -51.87 0.27 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.758 -1.21 . . . . 0.0 113.872 177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 5.0 mm-40 -59.12 -22.41 60.82 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -170.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -53.24 52.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 118.763 0.71 . . . . 0.0 111.34 -172.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tp -59.91 -44.44 94.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.48 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -59.68 -42.95 94.09 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.0 109.68 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 4.5 ttmm -63.25 -35.73 81.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.569 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.1 mm -80.01 -50.67 17.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -36.79 84.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.808 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -73.97 -37.49 64.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.76 -45.03 91.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.8 p -73.19 -46.54 49.98 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.81 8.63 9.63 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.789 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 22.9 t -84.21 139.55 32.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.625 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -94.36 71.82 3.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.742 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.5 t -82.66 120.93 35.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.236 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.5 mm-40 -117.03 119.53 35.57 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.213 0.53 . . . . 0.0 111.032 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.501 HD13 HG13 ' A' ' 67' ' ' VAL . 32.6 mm -85.16 109.06 17.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.522 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.479 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 10.0 m -91.12 109.76 37.63 Favored Pre-proline 0 C--O 1.24 0.563 0 CA-C-O 120.695 0.283 . . . . 0.0 110.641 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.625 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 32.8 Cg_endo -64.81 -50.96 1.96 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.987 2.458 . . . . 0.0 111.941 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.95 94.08 7.66 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.884 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 2.3 p -74.6 -29.74 61.43 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.329 -175.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.71 -86.56 1.34 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.712 173.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.498 ' HA3' HD11 ' A' ' 5' ' ' ILE . . . -75.98 -12.03 84.29 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.354 -0.451 . . . . 0.0 112.506 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.884 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.9 mp -110.0 144.47 30.07 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -172.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.73 -37.67 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.453 2.102 . . . . 0.0 111.931 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.69 -154.26 0.36 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.322 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.625 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 17.0 tpp180 -85.78 154.97 21.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.642 ' HB3' HD22 ' A' ' 62' ' ' LEU . 73.8 p -120.74 117.36 27.27 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 176.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.537 HG23 HG11 ' A' ' 26' ' ' VAL . 97.1 t -104.51 120.95 55.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.061 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.3 m -86.97 128.51 35.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.431 0.634 . . . . 0.0 111.16 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.605 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.2 mm? -104.67 112.18 25.16 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.231 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.432 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 25.5 m -151.81 155.08 37.47 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.18 -101.76 0.18 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.12 -1.038 . . . . 0.0 113.415 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -143.78 164.04 32.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 7.8 Cg_endo -49.05 -53.17 7.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.959 2.439 . . . . 0.0 113.54 -172.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -84.54 -30.11 25.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.091 0.472 . . . . 0.0 111.143 -177.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.5 m -72.97 -43.19 62.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.204 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.627 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.6 p -67.74 -24.81 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.963 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.559 ' O ' ' HG2' ' A' ' 81' ' ' MET . 35.7 tt0 -74.81 -42.62 57.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.893 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 81' ' ' MET . 21.1 tptp -61.12 -44.64 97.02 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.461 0.648 . . . . 0.0 110.283 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.38 -48.21 82.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.627 178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 8.4 mtmp? -69.22 -20.69 63.96 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.393 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.559 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 24.2 mmt -58.35 -46.84 85.49 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 171.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 81.9 mtp -63.68 -49.97 71.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.193 0.52 . . . . 0.0 110.743 175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.552 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.1 mm? -59.68 -50.88 72.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.629 -175.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -60.59 -41.66 95.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.842 0.353 . . . . 0.0 110.339 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.33 -56.71 18.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.396 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -74.86 -35.28 35.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.123 -174.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.602 HG21 ' CD1' ' A' ' 24' ' ' TYR . 55.3 t -72.11 -28.26 29.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 O-C-N 121.608 -0.683 . . . . 0.0 111.0 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.4 m -69.37 -40.41 77.45 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.652 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 16.9 ptm180 -73.92 -21.54 60.01 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.879 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.616 ' HA3' ' HG2' ' A' ' 30' ' ' MET . . . -94.02 -58.94 1.2 Allowed Glycine 0 C--O 1.227 -0.287 0 C-N-CA 120.807 -0.711 . . . . 0.0 113.139 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.565 ' HG2' ' HD3' ' A' ' 27' ' ' PRO . 14.3 mmm180 -75.53 -20.71 58.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.969 0.414 . . . . 0.0 110.749 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 -61.4 3.67 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.134 0 CA-C-O 118.369 -1.239 . . . . 0.0 111.44 -179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.3 tt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m 65.74 -145.29 0.2 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.614 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.936 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . 20.3 t -130.59 162.82 28.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.689 0.28 . . . . 0.0 110.283 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.51 156.04 7.88 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.077 0.551 . . . . 0.0 110.864 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' MET . 80.2 mt -137.92 106.43 5.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.27 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.18 61.58 0.64 Allowed Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.485 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -84.93 -27.42 1.22 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.405 2.07 . . . . 0.0 112.76 -177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.597 HG13 ' HB3' ' A' ' 19' ' ' SER . 15.7 pt -111.11 144.56 18.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.585 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 41.2 m80 -90.22 -20.48 0.25 Allowed Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -172.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 92.9 Cg_exo -40.58 154.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.216 1.944 . . . . 0.0 112.83 168.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 17' ' ' ARG . 80.9 Cg_exo -46.58 152.99 1.34 Allowed 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 123.29 2.66 . . . . 0.0 113.119 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 38.4 Cg_endo -65.51 24.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 124.294 3.329 . . . . 0.0 114.064 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.791 ' HG3' HG22 ' A' ' 18' ' ' THR . 12.0 ptp180 -71.69 -24.66 61.86 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.124 0.487 . . . . 0.0 109.942 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.791 HG22 ' HG3' ' A' ' 17' ' ' ARG . 7.2 t -163.25 10.81 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.916 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.597 ' HB3' HG13 ' A' ' 12' ' ' ILE . 15.2 m -105.22 -86.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -173.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.573 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 14.8 ptp -69.13 85.87 0.37 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.508 0.67 . . . . 0.0 110.949 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.1 m -88.92 114.03 25.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.223 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.485 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 14.5 tt0 -95.95 118.88 33.43 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.936 ' HB3' ' HB3' ' A' ' 7' ' ' SER . 4.9 tp10 -90.92 106.86 18.81 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.564 ' CD2' HG21 ' A' ' 87' ' ' VAL . 1.9 m-85 -90.54 108.47 19.81 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.379 -176.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.447 ' HD2' ' CG ' ' A' ' 62' ' ' LEU . 12.4 mtm180 -89.51 99.58 12.55 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -114.71 133.03 22.62 Favored Pre-proline 0 C--N 1.314 -0.956 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.454 -170.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.7 Cg_exo -58.55 133.62 55.64 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.018 2.479 . . . . 0.0 110.421 177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -57.8 -32.25 67.36 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -167.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.01 -31.41 79.39 Favored Glycine 0 C--O 1.239 0.418 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.712 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.596 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.1 mmm -78.29 -15.86 58.34 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 34' ' ' ILE . 37.8 t -72.59 -39.59 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 173.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.51 -27.9 70.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.534 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.79 -29.98 23.38 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -72.68 -26.25 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.494 0.664 . . . . 0.0 110.067 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.764 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 20.3 pt -83.2 -13.91 11.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.829 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.4 -100.54 0.31 Allowed Glycine 0 C--N 1.335 0.526 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.578 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.515 ' HD3' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -60.28 -14.84 20.18 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.748 0.419 . . . . 0.0 111.503 178.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.39 27.84 1.57 Allowed Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.451 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.764 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.61 -51.61 0.6 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.995 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.403 ' HA ' HD22 ' A' ' 43' ' ' ASN . 5.7 tp10 -59.19 -26.2 64.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' N ' ' HD3' ' A' ' 37' ' ' ARG . 15.1 tt0 -62.03 -51.71 66.89 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.122 0.419 . . . . 0.0 111.083 -173.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.525 HD11 HG11 ' A' ' 53' ' ' VAL . 8.1 tp -62.27 -40.92 89.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 40' ' ' GLU . 95.6 m-20 -52.35 -52.52 52.86 Favored 'General case' 0 CA--C 1.517 -0.303 0 O-C-N 123.628 0.58 . . . . 0.0 110.05 176.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -56.89 -50.76 71.53 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.727 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.5 mm -60.56 -50.8 78.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -39.7 73.56 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.298 -175.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -75.96 -34.12 59.81 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.25 -44.75 95.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.668 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.688 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.1 p -80.31 -36.75 33.85 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.161 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.92 5.03 31.29 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.525 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 49.7 t -79.9 141.59 35.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.392 0.615 . . . . 0.0 110.378 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -96.54 74.27 2.79 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.613 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG11 HD11 ' A' ' 42' ' ' ILE . 41.7 t -82.22 107.85 14.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.177 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -103.92 111.12 23.52 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.759 -175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.482 HD13 HG13 ' A' ' 67' ' ' VAL . 28.7 mm -79.21 90.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.961 176.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 66' ' ' SER . 57.7 m -79.78 116.25 59.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-O 121.028 0.442 . . . . 0.0 111.688 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 95.1 Cg_endo -84.89 1.8 8.33 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.0 2.467 . . . . 0.0 110.934 173.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.32 -33.36 49.3 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.515 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 58.5 p 55.05 -78.98 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 113.035 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.43 -104.97 2.08 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.015 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -87.14 3.38 86.85 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.612 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.447 ' CG ' ' HD2' ' A' ' 25' ' ' ARG . 2.9 mm? -110.08 141.67 24.31 Favored Pre-proline 0 C--N 1.32 -0.715 0 N-CA-C 110.202 -0.295 . . . . 0.0 110.202 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -89.0 0.67 6.18 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 122.987 2.458 . . . . 0.0 110.577 175.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.4 pt-20 -113.54 -170.27 1.66 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.552 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.709 ' HB3' HG13 ' A' ' 26' ' ' VAL . 7.4 tpp180 -85.58 133.67 34.05 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 56' ' ' SER . 52.9 p -108.31 99.62 9.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 0.0 109.896 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 55' ' ' ILE . 57.9 t -101.03 110.36 27.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.63 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.8 m -85.73 130.12 34.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.406 0.622 . . . . 0.0 110.956 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.594 HD21 ' HG ' ' A' ' 83' ' ' LEU . 4.4 mm? -105.58 111.3 23.94 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.457 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.413 HG21 ' HA ' ' A' ' 18' ' ' THR . 0.6 OUTLIER -150.41 127.53 11.23 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . -155.12 -89.92 0.07 OUTLIER Glycine 0 C--O 1.226 -0.396 0 C-N-CA 119.653 -1.26 . . . . 0.0 113.583 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -160.96 165.86 16.43 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 89.9 Cg_exo -44.9 -53.22 5.4 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.521 2.147 . . . . 0.0 112.969 -178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.56 -40.13 23.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.152 0.501 . . . . 0.0 110.907 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.688 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.1 m -65.59 -44.05 87.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.65 -172.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.6 p -71.64 -30.48 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.037 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 81' ' ' MET . 25.8 tt0 -70.95 -43.62 67.77 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -52.35 65.79 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.357 0.598 . . . . 0.0 110.102 176.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.77 -50.22 74.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.29 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 43.9 mtmt -69.47 -20.9 63.74 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.605 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.4 mmt -62.73 -42.1 99.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.115 172.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.9 mmt -67.01 -43.11 83.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.99 0.424 . . . . 0.0 111.046 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.594 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.1 mm? -64.29 -53.15 53.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.966 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -56.66 -33.66 66.57 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.086 0.47 . . . . 0.0 110.435 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -63.6 -60.98 2.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.082 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.697 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.3 mp -75.93 -37.09 33.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.921 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 24' ' ' TYR . 77.5 t -66.09 -32.55 58.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.749 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.3 t -76.1 -36.63 58.82 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.943 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.697 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 15.7 ptm180 -75.09 -12.94 60.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.752 0.31 . . . . 0.0 111.129 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.596 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -108.97 -62.15 0.54 Allowed Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.155 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 91' ' ' ARG . 5.1 tmm_? -76.15 92.52 3.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.56 -1.77 24.85 Favored Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -174.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.58 -1.122 . . . . 0.0 111.206 178.226 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -143.74 122.35 12.53 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.889 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.7 m 62.98 -162.58 0.28 Allowed 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.807 0.692 . . . . 0.0 111.637 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -59.56 134.22 56.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.594 0.712 . . . . 0.0 112.508 -176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 20' ' ' MET . 75.1 mt -120.09 145.55 46.77 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.912 -1.04 . . . . 0.0 108.923 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -138.47 66.8 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.361 176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.04 -49.72 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.829 2.353 . . . . 0.0 112.101 -177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.498 HD11 HG23 ' A' ' 18' ' ' THR . 18.7 pt -117.98 163.74 14.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -177.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.66 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 92.0 m-70 -91.25 -29.57 0.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -171.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 38.8 Cg_exo -41.27 167.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 123.168 2.579 . . . . 0.0 114.904 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 17' ' ' ARG . 68.0 Cg_exo -42.3 156.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.62 2.88 . . . . 0.0 113.758 177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.48 28.12 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.636 0 C-N-CA 124.031 3.154 . . . . 0.0 114.563 -176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' A' ' 15' ' ' PRO . 0.4 OUTLIER -89.49 -11.08 43.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.083 0.468 . . . . 0.0 110.01 173.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 12' ' ' ILE . 6.2 t -163.88 8.18 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.865 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 41.0 t -92.9 -94.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.339 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.434 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 14.7 ptp -70.63 85.64 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.604 0.716 . . . . 0.0 110.537 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 30.7 m -94.24 114.81 26.97 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.196 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.7 tp10 -95.45 118.38 32.06 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -96.46 100.68 12.26 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.538 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -94.07 116.92 29.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.141 -167.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 91' ' ' ARG . 31.5 mtm180 -84.39 113.68 21.34 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.31 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.505 HG23 HG22 ' A' ' 87' ' ' VAL . 2.2 p -117.71 131.55 24.05 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.116 0.484 . . . . 0.0 111.048 -176.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.52 ' O ' HG23 ' A' ' 31' ' ' VAL . 26.9 Cg_exo -58.74 139.28 90.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.168 2.579 . . . . 0.0 110.764 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 2.7 p-10 -59.18 -32.17 69.67 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.136 -172.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -39.55 87.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.246 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.405 ' SD ' HD12 ' A' ' 33' ' ' LEU . 1.5 mpp? -79.5 -7.2 58.28 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.051 0.453 . . . . 0.0 110.192 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 35' ' ' ILE . 75.6 t -70.69 -43.18 77.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 167.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.99 -31.38 72.32 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.57 172.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD12 ' SD ' ' A' ' 30' ' ' MET . 60.0 mt -83.41 -32.11 26.29 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.692 HG21 HH22 ' A' ' 65' ' ' ARG . 10.2 tp -70.8 -28.36 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.619 0.723 . . . . 0.0 109.921 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.68 ' HB ' ' CA ' ' A' ' 39' ' ' GLY . 14.2 pt -85.4 -13.26 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.59 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.46 -87.94 0.01 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.144 0.902 . . . . 0.0 113.493 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.778 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 2.5 ptm85 -77.26 42.75 0.35 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 123.074 0.55 . . . . 0.0 110.784 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.43 19.76 69.0 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.528 -0.76 . . . . 0.0 114.03 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.68 ' CA ' ' HB ' ' A' ' 35' ' ' ILE . . . 147.75 -51.15 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 119.999 -1.096 . . . . 0.0 113.311 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 32.0 tt0 -60.42 -21.39 62.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -169.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.489 ' O ' HD13 ' A' ' 45' ' ' ILE . 29.0 tt0 -63.56 -38.9 92.88 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.817 -0.552 . . . . 0.0 111.341 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.586 HD11 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -66.03 -36.94 78.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.857 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 47' ' ' GLN . 1.3 m-20 -59.39 -43.2 92.99 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 175.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -59.54 -57.13 14.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.548 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.489 HD13 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -58.81 -53.01 53.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.484 -172.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -29.72 61.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.252 -172.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.811 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -77.79 -39.92 42.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.814 0.34 . . . . 0.0 110.939 178.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -66.08 -32.46 73.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.262 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 29.8 p -91.29 -36.01 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.738 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.38 7.25 57.16 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.59 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 49.1 t -78.99 142.75 36.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.267 0.556 . . . . 0.0 110.624 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -83.6 72.62 10.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.586 HG11 HD11 ' A' ' 42' ' ' ILE . 49.1 t -86.04 107.47 16.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.054 -178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 6.8 tp60 -98.84 122.66 42.37 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.5 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.402 HG23 ' HD3' ' A' ' 65' ' ' ARG . 24.7 mm -100.54 117.14 45.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.954 0.406 . . . . 0.0 111.666 -177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 44.9 m -112.7 93.97 26.33 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.191 0.52 . . . . 0.0 110.025 175.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.772 ' HA ' ' HG2' ' A' ' 65' ' ' ARG . 76.6 Cg_exo -51.89 -55.92 3.45 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.434 3.422 . . . . 0.0 114.342 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.3 -2.02 58.36 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.646 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 p 49.93 -85.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.55 1.14 . . . . 0.0 113.035 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.52 -65.85 0.51 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.74 2.44 87.23 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.206 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.728 HD12 ' HB3' ' A' ' 66' ' ' SER . 58.2 mt -126.02 151.73 72.01 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.22 -14.11 8.5 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 122.679 2.253 . . . . 0.0 110.104 172.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 7.1 pt-20 -105.27 -164.75 1.06 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.305 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.772 ' HG2' ' HA ' ' A' ' 57' ' ' PRO . 6.3 tmm_? -101.1 137.92 38.83 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.728 ' HB3' HD12 ' A' ' 62' ' ' LEU . 77.9 p -105.24 142.6 34.74 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.944 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.0 t -130.31 111.96 22.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.426 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.7 m -81.15 121.45 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.311 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.999 HD13 ' HG2' ' A' ' 80' ' ' LYS . 96.6 mt -109.72 108.45 18.83 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.14 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 149.79 30.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 171.65 -95.98 0.11 Allowed Glycine 0 C--O 1.226 -0.362 0 C-N-CA 119.632 -1.27 . . . . 0.0 113.809 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -147.66 163.7 26.27 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.439 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 83.6 Cg_exo -45.44 -55.26 3.64 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.003 2.469 . . . . 0.0 113.432 -175.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.34 -32.81 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.776 0.322 . . . . 0.0 110.912 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 13.0 m -67.6 -48.06 67.9 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.899 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.515 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 1.4 p -71.84 -24.32 22.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.765 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -71.88 -43.34 65.6 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.253 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 81' ' ' MET . 20.9 tptm -66.02 -45.59 80.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.457 0.646 . . . . 0.0 110.128 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.422 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -54.99 -49.33 71.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.072 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.999 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.1 mtmt -71.79 -22.75 61.53 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.755 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 21.9 ptm -69.32 -38.05 78.02 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.499 -0.881 . . . . 0.0 109.783 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.485 ' HG3' ' CG1' ' A' ' 45' ' ' ILE . 20.9 mmt -75.11 -39.28 60.71 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.053 0.454 . . . . 0.0 110.354 176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.744 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.3 mm? -61.78 -59.57 4.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.56 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -56.58 -34.11 66.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.736 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 24.6 t70 -69.45 -61.38 1.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.857 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.0 mp -66.72 -40.27 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 0.0 111.282 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 26' ' ' VAL . 58.3 t -70.92 -21.97 22.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.592 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -72.56 -30.25 64.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 171.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 15.1 mmm-85 -67.99 -29.94 69.09 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.12 0.486 . . . . 0.0 110.0 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -96.21 -41.63 3.68 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.973 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 25' ' ' ARG . 4.5 ptm180 -147.05 -161.96 1.44 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 122.557 -0.378 . . . . 0.0 110.755 -177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.41 15.26 76.78 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -173.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.19 0 CA-C-O 118.126 -1.374 . . . . 0.0 111.036 -178.246 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 pt . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.405 ' HB2' HD11 ' A' ' 62' ' ' LEU . 34.4 t 71.56 135.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.808 0.692 . . . . 0.0 110.479 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.1 m 70.75 -61.22 0.48 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.219 0.607 . . . . 0.0 110.703 -174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.476 ' CG ' ' HB2' ' A' ' 23' ' ' GLU . 19.1 mm-40 57.78 -161.8 0.22 Allowed 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.955 0.502 . . . . 0.0 111.721 -178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 2.6 tt 171.66 -72.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -176.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 111.24 114.32 3.46 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.615 -178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.44 -5.08 14.71 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.746 2.297 . . . . 0.0 112.179 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.56 ' HB ' ' CG2' ' A' ' 18' ' ' THR . 6.8 mt -98.62 121.28 49.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.7 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.5 m80 -82.55 -26.59 0.41 Allowed Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -166.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.7 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 52.3 Cg_exo -31.45 130.34 0.07 OUTLIER 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 123.583 2.855 . . . . 0.0 114.07 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.8 Cg_exo -33.89 127.08 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 125.079 3.853 . . . . 0.0 112.456 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.586 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 10.0 Cg_exo -19.62 53.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 127.571 5.514 . . . . 0.0 117.572 -157.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 15' ' ' PRO . 76.4 mtp180 -99.06 -4.48 32.31 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.56 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -178.62 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.41 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 p -79.15 -23.25 44.08 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.598 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.438 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 11.6 mtt -117.68 52.69 0.97 Allowed 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.0 m -79.11 112.28 16.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.821 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.5 tp10 -111.27 118.95 37.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.476 ' HB2' ' CG ' ' A' ' 8' ' ' GLN . 36.7 tp10 -98.38 103.53 15.49 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 173.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.427 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.83 128.0 37.5 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.043 -169.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HG2' HD21 ' A' ' 62' ' ' LEU . 19.9 mtp180 -87.4 110.14 20.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.997 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.753 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -125.56 127.95 24.77 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -177.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.761 ' HD3' ' HB2' ' A' ' 91' ' ' ARG . 31.9 Cg_exo -57.73 147.89 77.63 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.621 2.214 . . . . 0.0 111.963 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.669 ' O ' HG12 ' A' ' 31' ' ' VAL . 20.0 t70 -53.21 -51.07 63.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -171.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.81 76.25 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.193 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.544 ' SD ' HD12 ' A' ' 33' ' ' LEU . 9.5 tpp -79.53 -28.53 41.31 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 122.699 -0.295 . . . . 0.0 110.373 -176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 28' ' ' ASP . 13.3 p -74.74 -30.09 24.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.97 -27.59 67.32 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.976 -1.107 . . . . 0.0 110.795 169.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.544 HD12 ' SD ' ' A' ' 30' ' ' MET . 95.7 mt -87.55 -25.59 23.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -68.7 -31.95 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.435 0.636 . . . . 0.0 109.541 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.617 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.1 pt -82.73 -14.96 11.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.575 173.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 57.37 -88.28 0.01 OUTLIER Glycine 0 C--N 1.336 0.552 0 O-C-N 124.213 0.945 . . . . 0.0 112.968 176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.488 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 8.0 ptp180 -77.7 38.93 0.27 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 123.216 0.606 . . . . 0.0 111.561 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.96 3.27 80.51 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.978 -0.556 . . . . 0.0 114.324 174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.617 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 160.33 -50.53 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.158 175.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 12.6 tp10 -54.08 -25.01 19.51 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -172.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.481 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.0 tt0 -65.49 -46.95 77.72 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.719 -177.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.732 ' O ' ' HG2' ' A' ' 46' ' ' GLN . 10.6 tp -65.94 -38.78 82.89 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.786 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -53.53 -42.88 67.9 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -65.33 -48.46 72.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.876 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.501 ' HB ' HD12 ' A' ' 42' ' ' ILE . 95.4 mt -58.91 -57.97 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.732 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 7.9 pt20 -73.24 -20.97 60.73 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.523 -174.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.879 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -78.36 -38.7 41.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.434 0.635 . . . . 0.0 110.022 172.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -63.18 -39.59 95.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.811 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' SER . 23.3 p -80.36 -46.78 15.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.349 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 99.29 4.9 56.2 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.583 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 54.1 t -82.44 143.15 31.36 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.11 -0.545 . . . . 0.0 110.17 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.453 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 33.4 mtmt -80.47 76.78 7.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 175.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG11 HD11 ' A' ' 42' ' ' ILE . 79.9 t -82.74 110.41 17.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.776 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -109.67 115.93 30.79 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.508 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.574 HD13 HG13 ' A' ' 67' ' ' VAL . 33.3 mm -89.24 106.2 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.333 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 46.8 m -87.24 107.46 14.83 Favored Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 175.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.862 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.0 Cg_exo -75.26 -38.28 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.818 3.012 . . . . 0.0 113.289 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -79.6 116.09 19.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.033 0.444 . . . . 0.0 110.259 -176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.612 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 16.4 p -75.84 116.89 17.01 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.713 -177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -104.01 -85.22 1.84 Allowed Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.096 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.27 -13.35 83.4 Favored Glycine 0 CA--C 1.508 -0.356 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 59' ' ' SER . 6.3 mp -112.59 149.73 41.59 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 114.668 -0.766 . . . . 0.0 109.406 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -87.69 3.39 6.3 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.702 2.268 . . . . 0.0 110.252 172.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 3.4 pt-20 -125.96 -173.59 2.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.564 -175.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.862 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 8.1 tpp85 -83.83 145.22 28.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -176.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.498 ' HB3' HD22 ' A' ' 62' ' ' LEU . 54.6 p -121.5 122.31 39.44 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.096 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.574 HG13 HD13 ' A' ' 55' ' ' ILE . 69.1 t -116.22 131.44 68.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 -177.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -94.15 125.41 38.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.045 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 mm? -108.34 104.45 13.83 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.238 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.6 m -152.28 130.81 12.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -162.57 -82.25 0.04 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 119.641 -1.266 . . . . 0.0 113.926 -177.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.65 168.33 12.39 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.586 ' N ' ' HG2' ' A' ' 16' ' ' PRO . 97.4 Cg_exo -45.43 -57.74 1.98 Allowed 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.864 2.376 . . . . 0.0 113.675 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -76.66 -35.64 57.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.495 0.664 . . . . 0.0 110.067 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 49' ' ' SER . 33.7 m -68.63 -42.37 78.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.981 -172.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.15 -31.77 40.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.848 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -74.11 -37.72 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.26 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 81' ' ' MET . 22.9 tptp -70.8 -36.24 72.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.26 0.552 . . . . 0.0 110.413 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -63.76 -40.81 97.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.847 176.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.681 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.3 mtmt -81.92 -20.55 38.48 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.246 -176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.586 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 14.3 tpt -58.7 -55.71 31.57 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.751 175.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.1 mmm -69.74 -38.42 76.81 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.979 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 87' ' ' VAL . 1.3 mm? -56.69 -58.09 9.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.336 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.04 -41.88 65.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.105 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 37.7 t70 -55.37 -59.2 5.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.4 mp -72.17 -37.15 58.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 121.1 0.476 . . . . 0.0 111.344 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 83' ' ' LEU . 94.9 t -65.11 -31.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 68.2 m -71.87 -29.8 64.75 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.678 176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 24.4 mmm180 -56.53 -49.38 74.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.966 176.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.94 -53.02 1.13 Allowed Glycine 0 C--O 1.228 -0.248 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.551 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.761 ' HB2' ' HD3' ' A' ' 27' ' ' PRO . 7.4 tpt85 -91.58 36.25 0.95 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.152 0.501 . . . . 0.0 110.106 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -130.74 72.11 0.49 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.27 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.439 -1.2 . . . . 0.0 111.457 177.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.7 pt . . . . . 0 C--O 1.236 0.349 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.0 t -155.57 144.66 20.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.82 0.343 . . . . 0.0 110.837 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 m 73.62 -73.16 0.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.84 172.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -145.5 167.34 23.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 111.391 -171.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.604 HD12 ' HD3' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -155.66 135.68 12.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.993 178.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.71 81.46 0.21 Allowed Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.593 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.604 ' HD3' HD12 ' A' ' 9' ' ' LEU . 67.3 Cg_endo -75.81 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.454 2.103 . . . . 0.0 112.363 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.783 HD11 HG23 ' A' ' 18' ' ' THR . 27.4 pt -131.14 161.7 40.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.537 -178.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.587 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.2 m80 -90.52 -26.81 0.3 Allowed Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 66.2 Cg_exo -39.37 168.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 123.23 2.62 . . . . 0.0 114.923 171.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 14' ' ' PRO . 1.3 Cg_endo -42.56 153.65 0.14 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.139 3.226 . . . . 0.0 113.941 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 60.4 Cg_endo -69.51 27.95 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 124.092 3.195 . . . . 0.0 113.765 -175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' HG3' HG22 ' A' ' 18' ' ' THR . 10.7 ptp180 -81.08 -20.82 40.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.401 0.619 . . . . 0.0 109.649 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.783 HG23 HD11 ' A' ' 12' ' ' ILE . 5.2 t -160.92 18.51 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.027 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.2 t -99.5 -98.85 0.23 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.7 ptp -64.83 88.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.641 0.734 . . . . 0.0 110.653 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.487 HG23 ' OG1' ' A' ' 70' ' ' THR . 29.2 m -92.66 113.46 25.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.808 177.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.463 ' CD ' ' HD2' ' A' ' 80' ' ' LYS . 19.2 tt0 -96.06 118.08 31.95 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -96.37 102.88 14.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.476 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -92.01 124.46 36.13 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.482 -169.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' OE2' ' A' ' 64' ' ' GLU . 50.9 mtp180 -81.01 118.93 22.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.679 174.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.711 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -137.31 123.77 13.46 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.611 -177.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.55 ' HG2' ' CG ' ' A' ' 30' ' ' MET . 20.5 Cg_endo -61.97 141.67 90.16 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.577 2.185 . . . . 0.0 110.632 178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' HG12 ' A' ' 31' ' ' VAL . 30.5 t70 -59.05 -30.56 68.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.975 -167.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.94 -36.97 87.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.286 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.576 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 87.8 mmm -78.5 -27.91 46.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.66 -0.318 . . . . 0.0 111.002 -174.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.4 p -70.98 -28.63 33.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.411 174.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.49 -25.81 71.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.028 -1.082 . . . . 0.0 111.038 170.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mp -86.17 -28.63 23.81 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.0 tp -68.39 -29.95 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.624 0.726 . . . . 0.0 109.862 -178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.664 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.7 pt -83.64 -14.04 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.201 176.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.66 -93.07 0.03 OUTLIER Glycine 0 C--N 1.334 0.461 0 O-C-N 123.921 0.763 . . . . 0.0 113.496 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' CD ' ' HB3' ' A' ' 40' ' ' GLU . 12.8 ptp180 -64.15 -1.18 1.45 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.55 0.74 . . . . 0.0 112.493 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.59 11.1 18.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.276 173.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.664 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.9 -44.57 0.71 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.884 174.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.442 ' HB3' ' CD ' ' A' ' 37' ' ' ARG . 22.8 tt0 -55.72 -32.31 63.24 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -175.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -61.35 -47.83 84.08 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.436 -172.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 53' ' ' VAL . 8.5 tp -61.59 -42.59 94.69 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 C-N-CA 120.209 -0.596 . . . . 0.0 110.14 -178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.87 -38.91 83.51 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -60.77 -49.07 78.96 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.12 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 82' ' ' MET . 72.1 mt -63.64 -52.49 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.708 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 0.0 OUTLIER -72.59 -43.9 62.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.209 -172.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 47' ' ' GLN . 6.3 tp60 -73.8 -26.02 60.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 110.818 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.21 -53.92 7.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.324 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.709 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 41.8 p -64.5 -40.83 96.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.973 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.14 7.72 20.84 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.242 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.659 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 38.6 t -92.81 135.19 34.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.169 0.509 . . . . 0.0 110.771 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 41.2 mtmt -83.22 88.1 6.93 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 42' ' ' ILE . 58.4 t -95.34 111.14 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -111.1 116.04 30.45 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.304 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 67' ' ' VAL . 33.1 mm -80.69 100.82 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.7 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.52 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 17.7 m -85.53 114.45 56.61 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.479 . . . . 0.0 111.19 -177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 6.0 Cg_exo -79.57 -27.02 4.39 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.383 2.722 . . . . 0.0 112.698 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -84.28 -23.87 30.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.616 -176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.499 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 74.7 p 53.64 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.841 1.257 . . . . 0.0 113.187 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 139.93 -100.33 0.28 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.51 18.29 50.21 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.066 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.427 ' HB3' ' HG2' ' A' ' 64' ' ' GLU . 2.6 mm? -119.59 136.98 25.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -82.28 -8.69 11.71 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.905 2.403 . . . . 0.0 110.55 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.57 ' OE2' ' HB3' ' A' ' 25' ' ' ARG . 4.9 pt-20 -104.09 -162.01 0.87 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.61 -1.632 . . . . 0.0 109.784 -176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.711 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -95.81 148.26 22.78 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.499 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 65.4 p -122.38 125.2 45.4 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 55' ' ' ILE . 64.4 t -111.26 112.14 39.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.733 -177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.2 m -80.28 126.41 31.1 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.275 0.559 . . . . 0.0 110.817 175.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.041 HD13 ' HG2' ' A' ' 80' ' ' LYS . 16.0 mt -118.14 110.91 18.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.356 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.487 ' OG1' HG23 ' A' ' 21' ' ' THR . 2.6 m -151.22 121.79 7.43 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.791 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -155.57 -90.47 0.08 OUTLIER Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.992 -1.099 . . . . 0.0 113.937 -176.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -159.78 167.09 14.72 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.762 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.585 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 73.5 Cg_exo -39.89 -59.48 0.69 Allowed 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 123.356 2.704 . . . . 0.0 114.276 -176.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -82.65 -37.58 24.7 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.423 0.63 . . . . 0.0 110.15 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.709 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 6.3 m -61.51 -46.32 90.48 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.399 -173.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.585 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.8 p -72.33 -32.27 41.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.25 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -70.54 -38.72 74.23 Favored 'General case' 0 C--O 1.223 -0.321 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.44 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -63.12 -46.96 84.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.493 0.663 . . . . 0.0 110.317 177.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.07 75.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.856 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.041 ' HG2' HD13 ' A' ' 69' ' ' LEU . 43.3 mtmt -74.92 -21.41 59.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.078 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.687 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 19.0 ptm -69.08 -37.35 78.42 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.667 178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.875 ' HG3' HD13 ' A' ' 45' ' ' ILE . 89.8 mmm -67.89 -43.12 80.06 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.973 0.416 . . . . 0.0 110.148 174.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.639 ' HG ' HD11 ' A' ' 69' ' ' LEU . 3.9 mm? -59.38 -56.89 16.3 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.69 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.54 -39.48 57.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.055 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.27 -57.58 12.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.561 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.723 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.4 mp -73.04 -40.58 58.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.519 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.476 HG11 ' CE1' ' A' ' 24' ' ' TYR . 81.7 t -61.43 -40.84 87.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.642 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.471 ' HA ' ' HA2' ' A' ' 92' ' ' GLY . 72.3 m -68.36 -36.41 79.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.453 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.723 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 13.2 ptm180 -79.89 -7.68 58.87 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.793 -176.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.576 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -131.43 9.63 5.58 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.063 -1.065 . . . . 0.0 113.477 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 -162.37 -51.54 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.057 0.456 . . . . 0.0 110.52 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 88' ' ' SER . . . 102.91 -54.79 0.69 Allowed Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.622 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.231 -1.316 . . . . 0.0 111.031 178.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.0 mt . . . . . 0 C--O 1.231 0.116 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p 61.51 137.91 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.692 1.197 . . . . 0.0 112.388 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . 8.6 m -121.62 81.15 1.77 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.102 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -67.67 109.43 3.3 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 0.0 110.537 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.677 ' C ' ' HD3' ' A' ' 11' ' ' PRO . 53.0 mt -92.42 104.34 16.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.392 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' N ' ' HD3' ' A' ' 11' ' ' PRO . . . -115.16 58.51 0.44 Allowed Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.102 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.709 ' HD2' HD13 ' A' ' 12' ' ' ILE . 2.6 Cg_endo -82.28 -43.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.639 2.226 . . . . 0.0 112.12 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.873 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -87.72 138.49 19.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.298 0.571 . . . . 0.0 110.607 179.402 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.639 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 52.2 t-80 -78.31 -29.84 0.67 Allowed Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 95.5 Cg_exo -35.9 164.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 123.751 2.967 . . . . 0.0 115.292 173.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.486 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 10.0 Cg_endo -52.69 160.71 3.6 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.094 2.529 . . . . 0.0 111.58 173.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.551 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 38.5 Cg_endo -63.79 3.91 0.61 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.135 2.557 . . . . 0.0 114.021 -172.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD3' ' HG2' ' A' ' 15' ' ' PRO . 2.7 ptt180 -58.31 -29.58 66.01 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.071 0.462 . . . . 0.0 110.319 178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.5 t -148.14 3.88 0.71 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.228 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.629 ' HA ' HG12 ' A' ' 12' ' ' ILE . 35.9 t -84.52 -96.52 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.344 -175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 13.0 ptp -68.09 80.05 0.23 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.593 0.711 . . . . 0.0 111.277 -176.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -79.49 116.17 19.55 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -91.8 117.87 30.17 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 7' ' ' SER . 43.0 tt0 -87.62 103.86 15.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.524 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -91.22 110.45 21.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.686 -177.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.441 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 64.1 mtp180 -80.26 103.53 10.2 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.959 172.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 31' ' ' VAL . 0.8 OUTLIER -122.36 127.52 25.83 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.366 -177.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 52.5 Cg_exo -56.59 139.17 87.29 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.864 2.376 . . . . 0.0 111.831 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -45.85 -55.56 6.5 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -172.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.94 -24.09 72.92 Favored Glycine 0 C--O 1.238 0.386 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.557 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 27.8 tpp -78.81 -18.73 53.6 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 ' HA ' HG22 ' A' ' 34' ' ' ILE . 2.1 t -73.02 -33.13 42.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 168.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.87 -30.07 56.19 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.913 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.3 mt -88.03 -23.23 23.83 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG22 ' HA ' ' A' ' 31' ' ' VAL . 6.8 tp -71.56 -28.32 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 118.992 0.814 . . . . 0.0 109.663 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.684 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.0 pt -85.59 -15.3 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.324 172.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.31 -89.24 0.02 OUTLIER Glycine 0 C--N 1.337 0.618 0 O-C-N 124.086 0.866 . . . . 0.0 113.701 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.623 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 13.2 ptp180 -71.96 11.92 0.47 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.07 0.548 . . . . 0.0 112.13 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.87 14.71 30.81 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.098 175.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.684 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 145.5 -46.39 0.78 Allowed Glycine 0 C--O 1.227 -0.32 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.412 173.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.623 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 9.4 tp10 -62.31 -22.22 65.88 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 45' ' ' ILE . 20.5 tt0 -64.63 -48.13 76.01 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.108 -0.37 . . . . 0.0 111.318 -174.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 39' ' ' GLY . 7.1 tp -61.54 -42.44 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.46 -177.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.3 m-20 -52.59 -52.54 54.74 Favored 'General case' 0 CA--C 1.515 -0.374 0 O-C-N 123.66 0.6 . . . . 0.0 109.463 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -56.88 -48.8 77.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.104 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 41' ' ' GLN . 25.1 mm -62.27 -49.37 84.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.156 -175.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -79.33 -28.2 42.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.365 -174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -71.13 -42.09 69.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.027 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -58.79 -47.72 83.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.485 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.558 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 14.5 p -80.52 -38.29 30.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.896 -175.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.02 9.38 42.6 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.607 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.541 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 52.3 t -78.72 139.7 38.42 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.34 0.59 . . . . 0.0 111.352 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.3 mmtt -88.2 79.94 7.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.891 176.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.48 HG23 ' CD2' ' A' ' 69' ' ' LEU . 7.6 p -82.04 131.13 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.4 mm-40 -114.51 107.56 15.68 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.734 0.778 . . . . 0.0 110.703 -178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.61 HG23 ' NH1' ' A' ' 65' ' ' ARG . 18.5 mm -80.83 106.14 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.567 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.8 m -109.91 100.17 41.97 Favored Pre-proline 0 C--O 1.238 0.47 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.496 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -86.77 24.64 0.73 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.478 2.785 . . . . 0.0 111.05 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -78.43 -31.04 47.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.094 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.5 p 45.52 64.9 1.26 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.521 0.677 . . . . 0.0 111.075 -177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.16 116.24 4.9 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.948 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.83 -47.54 3.33 Favored Glycine 0 N--CA 1.453 -0.171 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -172.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.441 ' CD2' ' HG2' ' A' ' 25' ' ' ARG . 2.6 mp -88.39 128.01 54.71 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.62 -13.35 10.8 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 121.96 1.773 . . . . 0.0 111.117 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.4 pt-20 -99.34 -155.62 0.51 Allowed 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.715 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.61 ' NH1' HG23 ' A' ' 55' ' ' ILE . 5.5 mmm-85 -89.76 138.37 31.54 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.627 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.8 p -110.1 129.17 55.74 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.131 0.491 . . . . 0.0 110.286 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG22 ' NH2' ' A' ' 65' ' ' ARG . 87.7 t -119.22 116.76 51.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.138 177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 74.2 m -93.67 135.21 35.19 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.132 0.492 . . . . 0.0 110.597 174.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.749 HD11 ' HG ' ' A' ' 83' ' ' LEU . 74.2 mt -118.86 127.97 54.0 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.792 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -150.73 157.54 43.07 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.266 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.465 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 148.69 -152.73 24.73 Favored Glycine 0 C--O 1.217 -0.911 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.179 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.87 152.42 80.03 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -47.06 -46.36 19.2 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.675 2.25 . . . . 0.0 112.717 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.63 -32.29 60.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.972 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -71.15 -49.74 40.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.562 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.541 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 9.2 p -67.02 -27.08 38.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.506 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 81' ' ' MET . 28.8 tt0 -72.54 -41.96 65.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.43 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HD2' ' HB3' ' A' ' 49' ' ' SER . 1.0 OUTLIER -64.82 -40.2 94.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.083 0.468 . . . . 0.0 110.419 -179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.33 88.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.92 175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.674 ' HG2' HD13 ' A' ' 69' ' ' LEU . 55.6 mtmt -64.79 -23.33 67.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.642 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.6 mmm -60.44 -52.46 65.11 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 175.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.603 ' HA ' ' CE ' ' A' ' 82' ' ' MET . 10.1 mmt -70.84 -36.2 72.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.978 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.749 ' HG ' HD11 ' A' ' 69' ' ' LEU . 1.1 mm? -60.87 -60.48 3.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.83 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.29 -29.28 70.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.858 0.361 . . . . 0.0 110.662 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -60.69 -60.26 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.26 0.553 . . . . 0.0 110.649 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.557 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -72.02 -37.0 59.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.07 -177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.524 HG21 ' HD2' ' A' ' 24' ' ' TYR . 65.6 t -62.53 -32.6 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.718 177.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.6 t -71.46 -39.99 70.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.253 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 11.9 ptp180 -72.97 -18.6 61.35 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.605 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -103.93 -65.07 0.69 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.649 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -80.93 -56.26 4.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.475 0.655 . . . . 0.0 110.298 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.2 -158.95 15.27 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 CA-C-O 117.749 -1.584 . . . . 0.0 111.189 178.18 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.725 0.298 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.4 p -87.4 122.77 31.58 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.634 ' HB3' ' OE1' ' A' ' 22' ' ' GLU . 39.7 m 68.39 -147.24 0.13 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -175.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.788 ' HB3' ' O ' ' A' ' 21' ' ' THR . 36.7 tt0 -175.4 -143.41 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.727 0.694 . . . . 0.0 110.074 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.645 ' H ' ' HG2' ' A' ' 8' ' ' GLN . 2.0 pt? -167.09 -61.15 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -175.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.633 ' H ' ' HG ' ' A' ' 9' ' ' LEU . . . 119.74 149.2 8.37 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.454 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.481 ' HD3' ' HA2' ' A' ' 10' ' ' GLY . 6.2 Cg_exo -80.08 -52.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 123.146 2.564 . . . . 0.0 113.329 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.684 HG22 ' HD2' ' A' ' 14' ' ' PRO . 2.1 mt -93.47 128.59 44.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 -173.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.699 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 45.5 m80 -92.61 3.57 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.338 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -168.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.758 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 19.0 Cg_endo -57.99 -162.56 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.559 2.173 . . . . 0.0 112.81 169.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 28.2 Cg_exo -38.59 155.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.874 2.383 . . . . 0.0 113.594 170.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HB3' ' HG2' ' A' ' 20' ' ' MET . 34.6 Cg_endo -64.68 23.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 124.231 3.287 . . . . 0.0 115.162 -171.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -78.94 2.13 21.31 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.527 ' CG2' ' HB ' ' A' ' 12' ' ' ILE . 6.6 t -179.13 2.27 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.688 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 16' ' ' PRO . 49.2 p -97.59 -8.87 28.01 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -174.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 16' ' ' PRO . 15.8 ptp -146.43 52.9 1.12 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.871 0.844 . . . . 0.0 109.452 175.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.788 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 94.6 m -78.25 116.77 18.93 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.788 177.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.634 ' OE1' ' HB3' ' A' ' 7' ' ' SER . 2.8 tp10 -101.78 125.16 48.39 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.343 -177.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -98.57 104.38 16.41 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 173.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.487 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.13 116.79 29.09 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.635 -169.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.638 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 23.9 mtp180 -81.78 109.52 16.25 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.883 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -125.05 125.09 25.36 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-O 120.919 0.39 . . . . 0.0 110.808 -178.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 51.4 Cg_exo -55.4 136.31 73.13 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.784 2.322 . . . . 0.0 110.885 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.455 ' HA ' HG23 ' A' ' 31' ' ' VAL . 28.1 t70 -58.61 -33.87 70.51 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.561 -168.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.42 -34.64 90.45 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.65 174.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.535 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 92.1 mmm -78.65 -9.92 59.56 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.658 ' HA ' HG22 ' A' ' 34' ' ' ILE . 44.2 t -75.83 -40.46 39.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 172.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.96 -30.41 69.9 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.284 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.16 -28.97 25.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.658 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.3 tp -71.82 -28.94 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-O 121.413 0.625 . . . . 0.0 110.114 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.652 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 12.5 pt -80.46 -13.74 12.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.677 174.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.39 -91.82 0.05 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.954 0.783 . . . . 0.0 113.302 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.565 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 3.2 ptm85 -77.5 37.89 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.155 0.503 . . . . 0.0 111.216 178.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.13 19.75 78.68 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.683 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.652 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.04 -49.33 0.6 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 119.682 -1.247 . . . . 0.0 113.92 173.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.565 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 28.2 tt0 -58.71 -28.7 66.05 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -169.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -59.13 -56.42 22.47 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.818 0.281 . . . . 0.0 111.166 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.57 HD11 HG11 ' A' ' 53' ' ' VAL . 6.1 tp -57.29 -49.31 80.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.826 -178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -61.21 -38.88 88.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.036 0.446 . . . . 0.0 110.637 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -60.17 -44.29 95.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.71 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.06 -41.85 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.856 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -69.96 -37.38 75.8 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.07 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -71.36 -38.03 71.62 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.44 -51.77 66.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.072 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.79 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 32.9 p -70.56 -37.63 74.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.06 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.48 12.05 22.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.991 -0.623 . . . . 0.0 111.955 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 35.4 t -84.99 150.03 25.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.867 0.365 . . . . 0.0 110.149 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 52' ' ' LYS . 67.2 mmtt -104.99 82.66 1.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.526 0.679 . . . . 0.0 109.693 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.57 HG11 HD11 ' A' ' 42' ' ' ILE . 40.8 t -93.02 113.59 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.165 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 14.3 mm-40 -107.29 129.7 54.85 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.783 -178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.485 HD13 HG13 ' A' ' 67' ' ' VAL . 30.1 mm -102.42 89.58 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.445 -174.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 35.0 t -79.95 114.6 47.69 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-O 121.007 0.432 . . . . 0.0 110.698 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 5.5 Cg_exo -78.88 -32.54 1.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.588 2.859 . . . . 0.0 112.393 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -79.31 -34.62 42.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.503 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 40.4 t 71.02 -65.52 0.34 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.183 176.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 119.43 -55.92 0.59 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.098 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -116.75 -10.12 10.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.638 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.8 mt -112.91 144.59 31.34 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.798 0.332 . . . . 0.0 110.5 -173.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.42 -16.64 8.05 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.83 2.353 . . . . 0.0 110.336 173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 4.3 pt-20 -92.98 -168.74 2.0 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 113.904 -1.498 . . . . 0.0 109.11 177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.883 ' HB3' HG13 ' A' ' 26' ' ' VAL . 5.5 tpp180 -89.44 140.57 29.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.536 ' HB3' HD12 ' A' ' 62' ' ' LEU . 67.7 p -114.56 105.17 12.77 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.546 0.689 . . . . 0.0 109.345 175.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.485 HG13 HD13 ' A' ' 55' ' ' ILE . 95.3 t -98.13 121.34 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.128 -176.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 52.8 m -89.67 128.16 36.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.412 0.625 . . . . 0.0 111.362 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.731 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -106.56 112.33 25.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.17 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.9 m -151.32 143.69 24.16 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.988 -0.096 . . . . 0.0 110.805 174.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.54 -154.9 25.06 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.402 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -78.92 160.89 70.57 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -47.52 -53.07 6.99 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.796 2.33 . . . . 0.0 113.479 -173.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.0 tp10 -72.98 -40.33 65.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.975 0.417 . . . . 0.0 110.336 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.79 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.2 m -60.02 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.436 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.544 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 3.6 p -70.65 -30.01 40.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 -175.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -74.01 -37.88 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.078 0.466 . . . . 0.0 109.925 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.739 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -62.95 -47.06 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.985 177.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.11 -48.68 79.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.456 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.731 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 46.1 mtmt -68.52 -22.19 64.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.48 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.739 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 17.9 ptm -70.41 -36.47 74.05 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.497 177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.62 -39.98 73.4 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.135 0.493 . . . . 0.0 110.097 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.0 mm? -64.55 -56.57 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.137 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -56.54 -35.14 67.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 0.0 110.557 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.76 -55.89 25.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.515 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.659 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -75.57 -37.19 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.979 0.419 . . . . 0.0 111.425 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 24' ' ' TYR . 72.6 t -68.13 -33.24 59.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.875 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.6 t -70.76 -38.63 73.49 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.821 -0.549 . . . . 0.0 110.304 176.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.659 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -78.39 -13.43 59.85 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -176.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.535 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -120.82 -20.58 3.42 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.156 -1.021 . . . . 0.0 114.016 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -116.11 -25.9 7.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.16 0.48 . . . . 0.0 110.524 -177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 -93.46 1.59 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.226 -1.319 . . . . 0.0 111.278 177.789 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 121.267 0.556 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.9 m -95.94 -166.72 1.48 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.186 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.467 ' O ' HD22 ' A' ' 9' ' ' LEU . 49.2 m 68.78 -166.45 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.527 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 7.6 tt0 -64.45 112.98 3.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.776 0.322 . . . . 0.0 111.781 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 7' ' ' SER . 1.9 mm? -92.15 108.68 20.12 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 167.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.02 73.2 0.29 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.442 175.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 9' ' ' LEU . 4.6 Cg_exo -74.99 -57.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.764 2.31 . . . . 0.0 111.874 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.649 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 1.9 pp -104.19 151.38 6.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.416 176.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.625 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 7.0 t-160 -90.6 -11.88 0.18 Allowed Pre-proline 0 CA--C 1.557 1.219 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -170.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' HD2' ' HB ' ' A' ' 12' ' ' ILE . 72.7 Cg_exo -39.27 161.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.477 2.118 . . . . 0.0 114.337 171.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -42.49 148.47 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.703 2.935 . . . . 0.0 113.462 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -70.35 31.05 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.793 2.995 . . . . 0.0 113.905 -172.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -92.89 -0.36 57.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.874 0.369 . . . . 0.0 110.331 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.579 HG22 ' HD3' ' A' ' 17' ' ' ARG . 12.7 t -174.33 1.37 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.762 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 p -93.74 -85.09 0.29 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.1 ptm -72.56 71.86 0.98 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.596 0.712 . . . . 0.0 111.014 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.6 m -79.19 120.91 24.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.645 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.904 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 9.0 tp10 -92.58 118.88 31.47 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -98.82 106.19 18.42 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.556 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -92.26 118.61 31.06 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.944 -172.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.557 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 95.6 mtt180 -81.98 95.46 7.41 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.254 174.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.609 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -114.73 121.02 36.41 Favored Pre-proline 0 C--N 1.311 -1.065 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.028 -176.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.622 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 51.5 Cg_exo -54.93 154.93 19.83 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.311 2.674 . . . . 0.0 112.442 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.71 -39.06 79.72 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.939 0.4 . . . . 0.0 111.236 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.18 -31.23 64.11 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.876 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.41 ' HB2' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -78.0 -29.64 49.68 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.756 -0.261 . . . . 0.0 111.08 -177.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.67 ' HA ' HG22 ' A' ' 34' ' ' ILE . 5.8 p -73.25 -30.74 31.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.758 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 35' ' ' ILE . . . -67.66 -22.32 73.4 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.364 170.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD23 HG23 ' A' ' 86' ' ' ILE . 62.0 tp -89.05 -30.13 18.92 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.67 HG22 ' HA ' ' A' ' 31' ' ' VAL . 10.8 tp -72.47 -26.18 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.401 0.619 . . . . 0.0 109.906 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.604 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.3 pt -81.24 -14.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 172.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 58.9 -92.06 0.04 OUTLIER Glycine 0 C--N 1.337 0.598 0 O-C-N 124.045 0.841 . . . . 0.0 113.281 175.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 11.1 ptp180 -71.13 3.78 3.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.016 0.526 . . . . 0.0 111.835 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 112.86 0.5 25.72 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.107 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.41 -50.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.45 176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 28.9 tt0 -50.65 -36.16 34.19 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -173.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' O ' HG12 ' A' ' 45' ' ' ILE . 15.1 tt0 -59.81 -55.33 35.56 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -171.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 53' ' ' VAL . 5.1 tp -58.55 -46.64 89.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.53 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -56.42 -43.66 79.59 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 123.453 0.471 . . . . 0.0 109.905 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -64.4 -43.25 95.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.646 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 41' ' ' GLN . 24.0 mm -65.19 -50.89 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.769 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -70.54 -27.77 64.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.987 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -72.45 -44.78 61.87 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.0 -50.02 73.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.436 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.4 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 24.6 p -67.7 -45.31 75.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.319 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.67 10.98 27.79 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.67 -176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.448 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 53.9 t -94.17 138.64 31.98 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.094 0.473 . . . . 0.0 110.094 178.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm -85.95 79.94 9.04 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.616 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 42' ' ' ILE . 43.9 t -89.07 107.42 17.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.212 -177.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.432 ' HB3' ' OG ' ' A' ' 68' ' ' SER . 12.1 tp60 -99.06 116.26 30.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -175.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 42' ' ' ILE . 44.5 mm -83.53 89.96 2.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.111 177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.457 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 41.1 m -85.49 114.82 58.61 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-O 121.164 0.507 . . . . 0.0 111.036 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.54 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 12.1 Cg_exo -69.61 -36.6 10.89 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.324 2.683 . . . . 0.0 111.485 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.11 89.57 5.98 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.576 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 3.9 m -72.38 -19.31 61.64 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.155 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.58 -99.86 1.04 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.296 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.59 -26.87 66.51 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.263 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.557 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.3 mm? -87.25 139.95 32.26 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -85.05 0.71 8.79 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.766 2.311 . . . . 0.0 111.421 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.622 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.7 OUTLIER -108.45 -110.57 0.31 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.8 -177.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.609 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.2 tpp180 -133.92 149.57 51.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.576 ' OG ' ' HA ' ' A' ' 59' ' ' SER . 82.7 p -119.77 111.4 17.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.734 0.778 . . . . 0.0 110.35 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.6 t -106.56 132.54 53.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.01 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 2.1 p -99.38 130.06 45.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.369 0.604 . . . . 0.0 111.485 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.904 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 2.9 mm? -110.49 105.78 14.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.233 178.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 18' ' ' THR . 6.5 m -150.97 128.01 11.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.939 175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 51' ' ' CYS . . . -166.81 -97.29 0.11 Allowed Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.924 -178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -139.54 163.68 43.61 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.25 -43.41 37.51 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.441 2.094 . . . . 0.0 112.593 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -79.44 -38.0 35.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.231 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.4 p -77.18 -41.76 40.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.087 0.47 . . . . 0.0 110.654 -171.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -23.92 30.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.278 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.2 tp-100 -77.86 -45.6 23.81 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 81' ' ' MET . 4.9 tppp? -60.7 -45.83 92.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.026 0.441 . . . . 0.0 110.561 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.411 ' O ' HD23 ' A' ' 83' ' ' LEU . . . -55.8 -49.73 72.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.393 176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.558 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.3 mtmt -69.54 -21.05 63.67 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.023 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.57 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 21.6 mmt -60.66 -50.18 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.887 0.375 . . . . 0.0 110.172 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.635 ' HA ' ' CE ' ' A' ' 82' ' ' MET . 6.8 mmt -66.11 -39.5 89.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.067 177.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 4.1 mm? -66.27 -54.19 27.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.54 -30.68 67.3 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.8 0.333 . . . . 0.0 110.27 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 15.2 t70 -66.03 -61.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.227 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.469 HG23 HD23 ' A' ' 33' ' ' LEU . 2.0 mp -68.66 -38.42 78.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.141 0.496 . . . . 0.0 111.295 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.556 HG21 ' HD2' ' A' ' 24' ' ' TYR . 76.9 t -66.62 -29.37 46.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.8 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.4 t -78.15 -22.68 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.345 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 26.7 mmm180 -66.87 -32.51 73.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.966 0.412 . . . . 0.0 110.069 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.83 -64.38 0.82 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.754 177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -87.91 157.36 18.98 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.101 0.477 . . . . 0.0 110.962 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.31 96.3 1.66 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 172.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.776 -1.014 . . . . 0.0 112.465 -177.51 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.5 tt . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.842 0.353 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.5 m 67.54 178.38 0.24 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.926 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 22' ' ' GLU . 10.5 t 68.49 -69.15 0.16 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.35 0.66 . . . . 0.0 110.176 -177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.679 ' HG3' ' H ' ' A' ' 9' ' ' LEU . 23.8 tp60 48.51 -156.47 0.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.709 0.804 . . . . 0.0 111.667 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.679 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 4.2 pp 174.33 -41.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.261 1.024 . . . . 0.0 108.301 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 9' ' ' LEU . . . 150.98 126.15 1.3 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.541 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.47 -13.75 22.63 Favored 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 122.904 2.403 . . . . 0.0 112.542 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.94 HG12 ' HD2' ' A' ' 14' ' ' PRO . 13.1 tt -147.49 148.52 16.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.701 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 42.5 m-70 -90.38 -10.89 0.16 Allowed Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.94 ' HD2' HG12 ' A' ' 12' ' ' ILE . 31.2 Cg_exo -38.05 164.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.802 2.334 . . . . 0.0 113.226 162.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -26.98 146.04 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 125.022 3.814 . . . . 0.0 115.871 -174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HG2' ' HA ' ' A' ' 72' ' ' ALA . 47.5 Cg_endo -65.96 12.9 0.13 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.033 3.155 . . . . 0.0 114.213 -171.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HD3' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -77.52 2.83 15.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.638 . . . . 0.0 109.474 169.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 17' ' ' ARG . 8.4 t -159.83 -25.21 0.07 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.651 172.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.631 ' HB2' ' O ' ' A' ' 14' ' ' PRO . 15.6 t -79.85 6.36 11.28 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.913 0.387 . . . . 0.0 111.156 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 mmt -144.52 37.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.1 m -85.9 112.16 20.89 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 7' ' ' SER . 9.7 tt0 -123.56 119.49 30.07 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.228 -176.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.74 102.19 14.59 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.645 ' CD2' HG21 ' A' ' 87' ' ' VAL . 0.4 OUTLIER -92.37 136.76 32.93 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.725 -170.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 25' ' ' ARG . 7.5 mtm180 -101.85 129.38 48.07 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.89 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -135.03 124.11 16.27 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.801 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 91' ' ' ARG . 51.2 Cg_exo -55.8 140.99 85.59 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.723 2.282 . . . . 0.0 111.731 178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.63 -47.03 29.25 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.68 -31.11 79.81 Favored Glycine 0 C--O 1.238 0.349 0 C-N-CA 121.062 -0.59 . . . . 0.0 112.697 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.515 ' SD ' ' HA3' ' A' ' 90' ' ' GLY . 84.2 mmm -77.99 -15.05 59.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.634 HG21 ' HB2' ' A' ' 65' ' ' ARG . 17.4 t -72.43 -40.11 63.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 172.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.94 -29.94 68.85 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.405 -0.903 . . . . 0.0 111.342 173.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.1 mt -87.69 -24.66 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 31' ' ' VAL . 11.2 tp -74.48 -26.34 20.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-O 121.507 0.67 . . . . 0.0 109.544 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.72 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 16.4 pt -88.1 -15.22 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.062 171.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.51 -85.89 0.02 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 124.105 0.878 . . . . 0.0 113.72 173.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.667 ' HD2' ' HB3' ' A' ' 40' ' ' GLU . 4.2 ptp180 -81.02 14.07 2.44 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.014 0.525 . . . . 0.0 111.166 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.47 16.02 28.15 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.331 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.72 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.48 -49.74 0.58 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.079 -1.057 . . . . 0.0 113.303 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.667 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.0 tt0 -51.4 -33.56 30.68 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -173.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' O ' HD13 ' A' ' 45' ' ' ILE . 21.2 tt0 -60.59 -50.78 72.16 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.652 -173.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.547 HD11 HG11 ' A' ' 53' ' ' VAL . 8.1 tp -63.7 -43.59 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.514 -177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -62.06 -36.36 81.41 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.6 tptt -65.01 -52.62 55.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.141 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 41' ' ' GLN . 1.4 mp -60.08 -48.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.029 -175.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.2 pp0? -73.5 -34.42 65.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.693 0.282 . . . . 0.0 111.167 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.87 -39.34 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.137 0.494 . . . . 0.0 110.51 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -62.68 -38.21 89.48 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.935 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 27.3 p -81.11 -43.97 18.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.598 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.36 8.64 28.68 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 41.5 t -90.0 132.68 35.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.979 0.418 . . . . 0.0 110.14 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -79.82 79.25 6.35 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.288 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.547 HG11 HD11 ' A' ' 42' ' ' ILE . 47.6 t -87.31 107.92 17.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.064 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 10.6 mm-40 -97.9 110.05 22.7 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.613 -175.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD11 HG12 ' A' ' 42' ' ' ILE . 49.7 mm -80.2 112.91 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.26 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.9 m -104.15 99.39 16.86 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.635 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.624 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 40.0 Cg_endo -68.95 -30.49 26.04 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.863 2.375 . . . . 0.0 110.943 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -93.42 79.62 4.39 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -72.62 -36.78 68.15 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.283 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 80.78 -69.56 3.2 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.844 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.18 -4.38 90.24 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.203 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.77 HD12 ' HB3' ' A' ' 66' ' ' SER . 56.6 mt -126.63 144.34 49.44 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -176.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -79.72 -19.54 9.8 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.687 2.258 . . . . 0.0 109.939 171.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 3.6 pt-20 -94.2 -161.9 0.89 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.034 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.89 ' HB3' HG13 ' A' ' 26' ' ' VAL . 2.7 tpp180 -99.62 146.27 26.65 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.77 ' HB3' HD12 ' A' ' 62' ' ' LEU . 83.8 p -118.43 134.23 55.23 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.905 176.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG13 HD13 ' A' ' 55' ' ' ILE . 57.1 t -128.7 122.68 57.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.633 -176.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 54.3 m -86.04 123.82 31.78 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.308 0.575 . . . . 0.0 111.27 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.581 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.3 mm? -105.51 114.76 29.12 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.607 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.9 m -152.87 141.68 21.08 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -179.12 -133.53 1.96 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.799 -1.191 . . . . 0.0 113.617 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.732 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -114.59 166.29 11.97 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.732 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 8.3 Cg_endo -50.04 -41.87 47.35 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.909 2.406 . . . . 0.0 113.39 -172.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -84.28 -44.95 13.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.872 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 23.8 p -66.48 -46.91 74.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.301 -173.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 p -67.5 -32.51 57.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.303 -173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.574 ' O ' ' HG3' ' A' ' 81' ' ' MET . 64.5 tt0 -74.55 -42.22 59.2 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 81' ' ' MET . 1.9 tpmt? -58.42 -51.65 68.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.935 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.52 -47.85 72.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.995 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.581 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 50.5 mtmt -67.24 -22.62 65.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.543 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 61.7 mtt -62.96 -47.74 81.86 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.406 ' HG2' HG12 ' A' ' 45' ' ' ILE . 2.3 mpt? -65.25 -41.67 94.06 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.19 176.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' A' ' 69' ' ' LEU . 3.6 mm? -60.39 -57.13 14.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.852 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -56.59 -38.76 72.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.466 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' MET . 15.2 t70 -57.12 -51.68 68.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.386 -177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.621 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.0 mp -80.4 -40.87 20.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.585 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.645 HG21 ' CD2' ' A' ' 24' ' ' TYR . 70.8 t -61.42 -41.98 92.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 120.852 0.358 . . . . 0.0 110.455 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.6 t -68.04 -40.3 82.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.621 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 8.1 ptp180 -69.9 -28.07 65.32 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.579 -176.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.515 ' HA3' ' SD ' ' A' ' 30' ' ' MET . . . -118.08 10.6 13.45 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.218 -0.991 . . . . 0.0 113.477 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.488 ' HB2' ' HG2' ' A' ' 27' ' ' PRO . 2.0 tmt_? -156.19 -56.45 0.09 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.04 0.447 . . . . 0.0 109.996 178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.01 -165.27 12.21 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.332 -178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.368 -1.24 . . . . 0.0 111.228 -179.297 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.464 0.275 0 CA-C-O 121.649 0.738 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 m -123.26 162.01 23.46 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.902 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 70.6 m 68.51 -163.46 0.2 Allowed 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.414 0.446 . . . . 0.0 110.582 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 21' ' ' THR . 77.2 mm-40 -162.53 -36.93 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.773 0.829 . . . . 0.0 109.317 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 94.4 mt 70.16 -126.96 0.09 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.783 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 18' ' ' THR . . . 140.74 119.7 1.61 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.594 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.84 -6.88 17.17 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.319 2.679 . . . . 0.0 112.061 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.731 HG22 ' HD2' ' A' ' 14' ' ' PRO . 13.9 mt -92.03 113.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.596 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 26.8 m-70 -82.19 -11.74 0.18 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -165.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.731 ' HD2' HG22 ' A' ' 12' ' ' ILE . 76.3 Cg_exo -35.01 127.84 0.23 Allowed 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.133 1.889 . . . . 0.0 112.874 169.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' ARG . 45.1 Cg_exo -36.97 132.4 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 124.391 3.394 . . . . 0.0 112.812 -174.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.53 ' HG2' ' N ' ' A' ' 73' ' ' PRO . 2.7 Cg_exo -25.23 62.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.841 1 C-N-CA 127.076 5.184 . . . . 0.0 117.079 -159.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.674 ' HA ' ' CG2' ' A' ' 70' ' ' THR . 11.8 ptp180 -122.2 10.34 9.98 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 169.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.57 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 7.9 t 174.11 -8.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.147 178.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.42 ' H ' ' H ' ' A' ' 18' ' ' THR . 32.7 t -79.58 -24.06 42.31 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.2 0.524 . . . . 0.0 110.221 176.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.439 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 8.8 ptp -155.26 70.17 0.73 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.139 176.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 51.8 m -78.79 120.68 23.77 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.868 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.7 tp10 -102.59 118.5 36.98 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.888 -175.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' HB2' ' HG2' ' A' ' 8' ' ' GLN . 5.3 tp10 -94.06 105.85 17.84 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 119.469 -0.892 . . . . 0.0 108.613 170.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.3 115.04 27.73 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.272 -173.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 1.044 ' HG2' HD13 ' A' ' 62' ' ' LEU . 39.0 mtm105 -81.48 98.77 8.42 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 172.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -108.11 116.71 56.46 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.209 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.551 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 50.2 Cg_exo -50.63 139.08 39.6 Favored 'Trans proline' 0 N--CA 1.465 -0.163 0 C-N-CA 123.291 2.66 . . . . 0.0 112.518 -177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -50.34 -48.5 55.48 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -169.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -28.36 73.57 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.29 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.551 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 91.0 mmm -78.78 -10.28 59.73 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 65' ' ' ARG . 39.5 t -77.12 -41.24 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 172.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.15 64.44 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.244 -0.979 . . . . 0.0 111.396 172.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.5 mt -89.01 -26.12 21.63 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.597 HG22 ' O ' ' A' ' 31' ' ' VAL . 10.5 tp -72.49 -27.46 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 121.477 0.656 . . . . 0.0 109.736 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.604 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.4 pt -84.27 -14.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.133 173.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.86 -90.8 0.07 OUTLIER Glycine 0 C--N 1.334 0.445 0 CA-C-N 115.26 -0.882 . . . . 0.0 113.644 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.597 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.04 10.41 1.5 Allowed 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.867 0.467 . . . . 0.0 111.698 -177.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.63 6.13 35.69 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.111 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.604 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 154.1 -46.3 0.55 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.673 -1.251 . . . . 0.0 113.467 175.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.597 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 26.5 tt0 -48.18 -38.18 17.56 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -61.32 -45.57 93.9 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -169.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.521 HD11 HG11 ' A' ' 53' ' ' VAL . 5.7 tp -59.4 -49.7 82.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.424 -177.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.11 -43.08 99.62 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.344 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -58.78 -39.25 80.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.364 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' A' ' 82' ' ' MET . 1.7 mp -81.27 -42.49 19.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.769 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -73.46 -26.83 61.09 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.61 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -73.99 -41.48 61.84 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.41 -51.43 69.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.348 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.9 p -74.43 -37.29 63.35 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.772 -176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.53 2.43 60.12 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.533 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.411 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 51.4 t -79.67 139.98 37.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.261 0.553 . . . . 0.0 110.56 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HE2' ' HA2' ' A' ' 71' ' ' GLY . 12.4 mttm -83.46 75.56 10.0 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.264 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.521 HG11 HD11 ' A' ' 42' ' ' ILE . 45.4 t -82.18 110.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.638 -177.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.445 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 16.0 mm-40 -102.41 106.44 17.2 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.675 -174.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.447 HD13 HG13 ' A' ' 67' ' ' VAL . 44.9 mm -81.04 106.05 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.411 177.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . 15.1 m -98.99 107.49 44.17 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-O 120.753 0.311 . . . . 0.0 110.656 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.718 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 21.6 Cg_endo -62.13 -37.18 65.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.528 2.819 . . . . 0.0 112.249 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -99.12 97.12 8.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.481 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 4.2 p -70.84 -37.45 73.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.372 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.7 -72.9 2.72 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.312 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -88.22 -9.19 70.53 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.714 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.044 HD13 ' HG2' ' A' ' 25' ' ' ARG . 22.2 mt -115.36 153.18 47.53 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -176.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.63 -31.28 2.04 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.396 2.064 . . . . 0.0 111.884 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -94.33 -161.66 0.87 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.572 179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.776 ' HB3' HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -81.35 151.06 28.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.713 ' HB3' HD12 ' A' ' 62' ' ' LEU . 88.5 p -118.11 114.24 22.79 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.036 177.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 55' ' ' ILE . 91.5 t -106.0 122.63 59.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.828 178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 69.6 m -88.83 125.58 34.97 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.628 0.728 . . . . 0.0 110.78 177.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.868 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.9 mm? -105.04 109.58 21.63 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.449 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.674 ' CG2' ' HA ' ' A' ' 17' ' ' ARG . 26.3 m -151.26 144.75 24.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HE2' ' A' ' 52' ' ' LYS . . . 173.28 -107.82 0.26 Allowed Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.935 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -131.61 164.17 44.55 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 5.3 Cg_endo -47.4 -50.02 12.06 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.193 2.596 . . . . 0.0 112.994 -176.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -84.53 -30.24 25.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.84 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.482 ' HB2' ' H ' ' A' ' 72' ' ' ALA . 18.1 m -71.56 -48.25 49.7 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.411 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -69.51 -23.9 26.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.867 -177.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -69.75 -51.01 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.319 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 81' ' ' MET . 24.4 tptm -62.7 -41.07 98.95 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.0 -46.23 90.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.719 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 48.0 mtmt -74.93 -21.35 59.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.37 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 6.1 tpp -60.23 -46.42 89.84 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.241 173.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.451 ' HG3' HG12 ' A' ' 45' ' ' ILE . 20.4 mmt -71.02 -39.67 72.22 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.0 mm? -61.43 -48.92 78.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.321 177.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -57.5 -46.74 83.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.141 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -46.88 -58.13 4.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.385 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -79.57 -44.57 23.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.388 -175.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.0 t -68.68 -27.49 36.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 120.747 0.308 . . . . 0.0 111.131 -175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.2 t -77.93 -38.55 45.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.471 175.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.563 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 3.3 ptp180 -72.26 -21.32 61.39 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.999 0.428 . . . . 0.0 110.012 178.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.38 -83.15 1.19 Allowed Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.379 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.85 60.72 4.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.187 0.518 . . . . 0.0 111.256 -177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.97 120.41 5.14 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.341 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.783 -1.009 . . . . 0.0 111.821 -179.403 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.704 HD11 ' HA3' ' A' ' 61' ' ' GLY . 41.4 pt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.206 0.526 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.3 p -115.94 -160.35 0.75 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.525 -174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 m 68.21 -170.96 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.704 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.458 ' HG2' ' H ' ' A' ' 8' ' ' GLN . 0.5 OUTLIER -53.24 112.41 0.87 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 16.1 tp -106.83 117.39 33.94 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.839 172.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.99 79.75 0.26 Allowed Glycine 0 C--N 1.315 -0.622 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.926 172.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 9' ' ' LEU . 92.4 Cg_endo -87.78 -7.82 6.24 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.761 2.308 . . . . 0.0 112.734 -176.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.812 HG13 ' HD2' ' A' ' 14' ' ' PRO . 6.9 tp -140.87 152.36 20.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.686 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 71.3 m80 -88.6 -27.08 0.34 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.812 ' HD2' HG13 ' A' ' 12' ' ' ILE . 31.6 Cg_exo -37.69 165.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.474 2.783 . . . . 0.0 114.16 165.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.468 ' C ' ' H ' ' A' ' 17' ' ' ARG . 42.4 Cg_exo -58.3 169.44 2.97 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.139 2.559 . . . . 0.0 112.606 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.541 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 37.4 Cg_endo -64.29 21.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 124.066 3.177 . . . . 0.0 114.064 -178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 71' ' ' GLY . 13.5 ptm180 -77.98 -18.12 56.34 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.467 ' HA ' HG21 ' A' ' 70' ' ' THR . 9.9 t -164.5 6.58 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.366 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.57 ' HA ' HG22 ' A' ' 12' ' ' ILE . 33.6 t -92.36 -99.17 0.13 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.927 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.541 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 17.4 ptm -60.98 84.37 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.715 0.769 . . . . 0.0 111.407 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.0 m -84.89 114.96 22.5 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.613 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 3.8 tp10 -92.75 116.63 29.2 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.97 109.21 22.01 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.755 0.788 . . . . 0.0 109.25 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.798 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.56 125.14 36.2 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.664 -169.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.6 mtm-85 -84.35 99.12 10.42 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.185 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -119.63 121.93 29.57 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.838 -175.431 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.59 ' HB2' ' HG2' ' A' ' 30' ' ' MET . 46.1 Cg_exo -59.11 150.11 75.6 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.543 2.829 . . . . 0.0 113.025 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' O ' HG12 ' A' ' 31' ' ' VAL . 10.2 t70 -45.82 -59.28 2.89 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.59 -173.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.44 -24.64 73.76 Favored Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.666 -178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.59 ' HG2' ' HB2' ' A' ' 27' ' ' PRO . 78.1 mmm -78.97 -33.35 45.22 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.697 -0.296 . . . . 0.0 110.598 -174.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.654 HG21 ' HG2' ' A' ' 65' ' ' ARG . 11.7 p -73.14 -28.07 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.868 176.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.42 -26.07 72.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.054 -1.07 . . . . 0.0 111.161 171.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.18 -27.48 21.81 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.616 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -69.66 -28.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.574 0.702 . . . . 0.0 109.503 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.712 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 11.4 pt -85.75 -15.19 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.515 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 38' ' ' GLY . . . 58.31 -93.81 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 O-C-N 123.908 0.755 . . . . 0.0 112.95 176.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.948 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -75.07 37.11 0.12 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.115 0.566 . . . . 0.0 111.187 176.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 36' ' ' GLY . . . 77.76 9.47 86.88 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 113.864 174.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.712 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 148.27 -42.33 0.86 Allowed Glycine 0 C--O 1.227 -0.342 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.185 174.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.948 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 34.0 tt0 -51.67 -30.96 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -66.45 -47.89 71.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.729 0.3 . . . . 0.0 111.05 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 39' ' ' GLY . 10.4 tp -69.37 -36.95 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 120.271 -0.571 . . . . 0.0 109.857 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.86 -34.32 77.12 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.339 0.59 . . . . 0.0 110.18 176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -62.82 -49.48 74.76 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.149 175.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.432 HG13 ' HG3' ' A' ' 82' ' ' MET . 30.9 mm -74.14 -38.94 49.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.34 -174.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.5 -27.25 64.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.835 0.35 . . . . 0.0 110.529 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -77.24 -43.29 34.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.09 0.472 . . . . 0.0 109.729 173.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -54.92 -41.64 71.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.449 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.1 p -86.02 -38.04 18.31 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.289 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.73 2.98 52.76 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 48.2 t -79.51 139.72 37.49 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.307 0.575 . . . . 0.0 110.771 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -86.24 74.46 10.02 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.195 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.2 t -81.67 109.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.103 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -105.0 112.27 25.35 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.478 -177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 67' ' ' VAL . 39.2 mm -79.43 97.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 44.1 m -81.17 106.58 5.89 Favored Pre-proline 0 C--O 1.242 0.697 0 CA-C-O 121.219 0.533 . . . . 0.0 110.568 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.899 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 5.4 Cg_exo -77.86 -33.58 2.14 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 124.105 3.203 . . . . 0.0 113.157 -173.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.2 -25.87 42.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 120.991 0.425 . . . . 0.0 109.875 178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.419 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 8.0 t 62.33 -154.4 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.901 176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 162.39 108.16 0.22 Allowed Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.704 ' HA3' HD11 ' A' ' 5' ' ' ILE . . . 96.22 -34.71 4.78 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.493 -177.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HB3' ' A' ' 66' ' ' SER . 1.4 mm? -100.55 137.09 19.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.52 1.55 9.2 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.733 2.289 . . . . 0.0 111.912 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -111.11 -115.24 0.31 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.508 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.899 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 4.2 tpp180 -130.16 155.57 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.486 ' HB3' HD23 ' A' ' 62' ' ' LEU . 34.3 p -130.89 129.54 42.39 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.2 177.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 55' ' ' ILE . 60.9 t -114.55 130.99 67.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.127 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.1 p -97.91 128.25 44.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.588 0.709 . . . . 0.0 111.03 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.684 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.2 mm? -108.29 112.37 24.8 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.801 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.467 HG21 ' HA ' ' A' ' 18' ' ' THR . 2.3 m -150.86 155.37 39.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 173.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 17' ' ' ARG . . . 162.88 -71.3 0.21 Allowed Glycine 0 C--N 1.331 0.27 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.382 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.71 161.36 24.79 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.27 -53.56 6.71 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.244 1.962 . . . . 0.0 112.558 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -71.23 -37.31 72.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.316 0.579 . . . . 0.0 110.714 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 14.2 m -72.85 -43.55 62.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.591 -171.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.467 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.4 p -70.13 -24.14 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.529 ' O ' ' HG2' ' A' ' 81' ' ' MET . 43.5 tp60 -82.01 -35.99 28.28 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.204 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 81' ' ' MET . 24.4 tptm -64.26 -45.92 86.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.69 0.757 . . . . 0.0 109.584 176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.72 -48.21 75.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.284 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.576 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.1 mtmt -69.02 -21.51 64.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.993 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.602 ' HA ' ' CE ' ' A' ' 81' ' ' MET . 13.2 mmt -59.27 -47.56 84.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.9 0.381 . . . . 0.0 110.029 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.432 ' HG3' HG13 ' A' ' 45' ' ' ILE . 92.5 mmm -67.5 -45.77 74.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 176.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.8 mm? -59.42 -54.0 51.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.47 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.55 -35.13 78.46 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.483 -176.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -55.31 -53.44 56.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.132 0.491 . . . . 0.0 110.793 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.489 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 1.9 mp -76.66 -39.51 32.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.636 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.798 HG21 ' HD2' ' A' ' 24' ' ' TYR . 78.9 t -65.56 -31.86 55.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.498 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 13.4 t -78.02 -32.63 51.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.69 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.5 ptp180 -74.57 -16.37 60.81 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.889 177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.01 -73.79 1.08 Allowed Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.339 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -76.97 -37.16 55.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.127 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 88' ' ' SER . . . 94.19 -77.64 0.99 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.888 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.128 -1.373 . . . . 0.0 111.151 -179.153 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.1 tt . . . . . 0 C--O 1.232 0.133 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.7 p -149.46 -173.7 4.47 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.838 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 23' ' ' GLU . 47.9 m 70.57 -169.78 0.16 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.71 0.631 . . . . 0.0 111.739 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -36.42 117.37 0.48 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.57 1.148 . . . . 0.0 113.525 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' MET . 0.7 OUTLIER -121.27 137.33 54.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.596 170.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.48 71.75 0.42 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.793 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -81.77 -37.83 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.951 2.434 . . . . 0.0 112.819 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.664 HG22 ' HD2' ' A' ' 14' ' ' PRO . 8.9 mm -113.87 149.19 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -176.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.582 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 10.0 t60 -90.67 -41.72 0.4 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -176.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' A' ' 12' ' ' ILE . 25.1 Cg_exo -41.79 171.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 123.629 2.886 . . . . 0.0 114.397 172.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -33.99 150.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.361 3.374 . . . . 0.0 114.833 179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.536 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 55.7 Cg_endo -66.26 27.25 0.1 Allowed 'Trans proline' 0 N--CA 1.48 0.729 0 C-N-CA 124.265 3.31 . . . . 0.0 114.899 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -84.54 -8.16 59.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.412 0.625 . . . . 0.0 109.334 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -164.45 12.33 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.003 174.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 47.2 t -92.86 -99.43 0.13 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.428 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 15.7 ptp -68.71 78.07 0.29 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.644 0.735 . . . . 0.0 110.525 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.7 m -79.34 115.71 19.15 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 176.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.87 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 4.6 tp10 -95.16 118.77 32.52 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.535 ' HB3' ' N ' ' A' ' 7' ' ' SER . 10.0 tp10 -105.1 106.24 16.64 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 119.539 -0.865 . . . . 0.0 108.861 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.503 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -91.66 124.96 36.21 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.459 -0.792 . . . . 0.0 112.133 -167.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.65 ' HG2' ' CD1' ' A' ' 62' ' ' LEU . 19.2 mtp180 -90.3 99.44 12.46 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.202 174.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.0 OUTLIER -116.1 122.27 32.55 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.559 -175.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -53.48 145.85 44.93 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.796 2.331 . . . . 0.0 110.94 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.469 ' HA ' HG12 ' A' ' 31' ' ' VAL . 1.4 p-10 -61.95 -28.75 69.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.306 -169.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.14 -28.95 61.23 Favored Glycine 0 C--O 1.238 0.399 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.507 174.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.561 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 20.4 mmt -78.67 -31.27 46.65 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.162 -0.519 . . . . 0.0 110.344 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.674 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -69.99 -34.19 58.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.648 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.78 -30.36 69.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 119.921 -1.133 . . . . 0.0 111.556 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.44 HD12 ' HE2' ' A' ' 30' ' ' MET . 49.9 mt -87.81 -23.86 23.91 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 31' ' ' VAL . 10.2 tp -71.49 -30.23 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-O 121.654 0.74 . . . . 0.0 109.56 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.701 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 13.7 pt -83.13 -14.79 11.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.061 172.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.52 -91.83 0.11 Allowed Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.165 -0.925 . . . . 0.0 113.214 175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.634 ' HD2' ' HB2' ' A' ' 40' ' ' GLU . 14.3 ptp180 -76.74 -0.02 22.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.027 0.442 . . . . 0.0 111.275 -176.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 118.67 10.39 8.53 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.811 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.701 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 158.01 -55.54 0.37 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 119.583 -1.294 . . . . 0.0 113.578 173.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.634 ' HB2' ' HD2' ' A' ' 37' ' ' ARG . 26.4 mm-40 -59.3 -23.92 62.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -169.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' A' ' 41' ' ' GLN . 2.9 tt0 -59.99 -52.86 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.081 0.855 . . . . 0.0 110.576 -174.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.596 HD11 HG11 ' A' ' 53' ' ' VAL . 6.3 tp -62.02 -45.33 98.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.021 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -54.7 -37.13 65.46 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.439 0.462 . . . . 0.0 110.745 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HE2' ' HB3' ' A' ' 40' ' ' GLU . 68.0 mttm -72.28 -41.76 66.32 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.198 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.21 -48.69 72.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 111.664 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -67.32 -31.46 71.76 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.069 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.45 HE21 ' HB3' ' A' ' 47' ' ' GLN . 0.9 OUTLIER -74.09 -36.26 64.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.21 0.528 . . . . 0.0 109.879 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.38 -32.25 73.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.053 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.667 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 8.0 p -96.87 -40.35 8.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.839 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.6 8.99 27.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.712 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 32.0 t -79.99 136.68 36.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.117 0.484 . . . . 0.0 110.734 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -84.22 72.17 10.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.247 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 42' ' ' ILE . 44.6 t -83.14 106.81 14.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.972 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.21 110.65 22.94 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.136 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.502 HD13 HG13 ' A' ' 67' ' ' VAL . 48.1 mm -79.78 112.62 18.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.679 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.489 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 2.6 m -94.82 102.05 8.25 Favored Pre-proline 0 C--O 1.239 0.506 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.084 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 55' ' ' ILE . 86.7 Cg_endo -76.56 -21.36 13.1 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.982 2.455 . . . . 0.0 112.581 -176.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -79.95 -41.77 25.33 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.025 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.613 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 9.0 t 73.78 -64.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.746 174.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.17 -76.5 2.2 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.143 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.77 -8.25 84.69 Favored Glycine 0 CA--C 1.511 -0.189 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.853 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.65 ' CD1' ' HG2' ' A' ' 25' ' ' ARG . 61.7 mt -121.16 146.82 45.32 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -175.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.65 -20.7 10.48 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 122.61 2.206 . . . . 0.0 110.242 173.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -93.05 -163.94 1.11 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.752 179.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.674 ' HG2' HG21 ' A' ' 31' ' ' VAL . 6.0 tpp180 -92.18 147.01 23.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.561 ' HB3' HD12 ' A' ' 62' ' ' LEU . 78.0 p -117.91 141.66 48.19 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.439 -0.504 . . . . 0.0 109.674 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.502 HG13 HD13 ' A' ' 55' ' ' ILE . 87.7 t -137.68 120.94 20.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.382 -176.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 p -92.46 125.5 37.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.604 0.716 . . . . 0.0 111.497 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.87 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 3.7 mm? -105.23 120.01 40.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.855 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.19 155.74 40.32 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 175.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 161.11 -121.21 1.01 Allowed Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.04 -1.076 . . . . 0.0 113.198 177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.528 ' H ' ' HB2' ' A' ' 75' ' ' SER . . . -119.45 164.01 24.01 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 89.3 Cg_exo -47.72 -46.33 21.45 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.573 2.182 . . . . 0.0 112.695 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -75.47 -46.64 31.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.923 178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.667 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 1.5 m -61.51 -48.65 80.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.281 -173.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 2.0 p -70.09 -24.26 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.381 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -74.76 -45.94 40.46 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 81' ' ' MET . 0.1 OUTLIER -58.72 -48.69 80.3 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.36 0.6 . . . . 0.0 110.187 176.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.16 -52.09 67.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.886 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.789 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.0 mtmt -68.39 -21.97 64.66 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.253 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.574 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 10.6 ptm -72.08 -32.49 67.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.846 178.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 15.6 mmt -66.77 -47.62 71.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 110.011 171.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.29 -52.27 66.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.737 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.98 -38.38 70.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.837 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.52 -60.39 3.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.541 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.598 ' HA ' ' HG2' ' A' ' 89' ' ' ARG . 2.8 mp -72.61 -37.73 57.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.185 0.517 . . . . 0.0 111.727 -176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 24' ' ' TYR . 69.7 t -67.68 -26.1 34.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 O-C-N 121.781 -0.574 . . . . 0.0 111.113 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t -75.67 -34.66 60.48 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.387 177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.598 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 14.3 ptm180 -77.48 -12.87 60.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.077 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.84 -55.97 0.82 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.546 177.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.41 39.26 0.94 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.043 0.449 . . . . 0.0 110.562 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.76 82.96 1.55 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.63 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.865 0 CA-C-O 118.709 -1.051 . . . . 0.0 111.169 -177.367 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.561 0.22 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.4 t -153.19 155.19 36.2 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m 62.26 -161.41 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 O-C-N 123.748 0.655 . . . . 0.0 110.807 176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 21' ' ' THR . 26.1 mt-30 -147.92 -93.13 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 pp 172.97 -173.4 0.05 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.376 -174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.582 ' HA3' ' C ' ' A' ' 19' ' ' SER . . . -143.52 114.89 0.86 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.076 172.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.47 -24.79 26.01 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.874 2.383 . . . . 0.0 113.269 -174.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.6 HD12 ' HG2' ' A' ' 14' ' ' PRO . 17.0 pt -121.67 164.45 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.157 0.503 . . . . 0.0 111.098 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.664 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 63.4 m80 -90.09 -19.11 0.24 Allowed Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 73.2 Cg_exo -39.5 167.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.601 2.2 . . . . 0.0 114.077 168.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 17' ' ' ARG . 7.0 Cg_endo -49.29 165.61 0.22 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.371 2.714 . . . . 0.0 113.057 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HG3' ' HA ' ' A' ' 73' ' ' PRO . 31.3 Cg_endo -63.75 34.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 124.061 3.174 . . . . 0.0 114.723 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 15' ' ' PRO . 12.4 ptm180 -86.21 0.3 54.04 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.593 HG21 HD11 ' A' ' 12' ' ' ILE . 12.7 t -178.92 -12.77 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.011 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.582 ' C ' ' HA3' ' A' ' 10' ' ' GLY . 12.6 t -79.59 1.6 25.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.852 0.358 . . . . 0.0 111.65 -177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.5 ptm -164.26 72.73 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.34 0.591 . . . . 0.0 110.732 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 48.4 m -79.13 122.22 25.98 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 172.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.586 ' HG2' ' HD2' ' A' ' 24' ' ' TYR . 1.6 tt0 -102.28 119.28 38.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.977 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -91.09 103.38 16.08 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.586 ' HD2' ' HG2' ' A' ' 22' ' ' GLU . 0.6 OUTLIER -92.37 127.3 37.8 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.399 -172.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.6 ' HG2' ' CD2' ' A' ' 62' ' ' LEU . 63.9 mtp180 -81.59 111.46 17.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.294 0.568 . . . . 0.0 110.751 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.793 HG11 HG23 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -128.65 121.64 21.24 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.855 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 33.9 Cg_endo -68.55 151.38 75.38 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.932 1.755 . . . . 0.0 110.868 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -37.75 64.86 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -166.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.42 80.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.478 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.515 ' HB2' HG23 ' A' ' 26' ' ' VAL . 32.0 mmt -78.42 -15.99 58.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 34' ' ' ILE . 40.3 t -70.01 -44.68 78.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.31 -31.73 80.28 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.089 176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.505 HD12 ' CE ' ' A' ' 30' ' ' MET . 45.2 mt -88.37 -23.24 23.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.3 tp -71.11 -29.75 37.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.357 0.599 . . . . 0.0 109.508 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -85.37 -15.33 10.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.284 170.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.35 -90.6 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.498 0 O-C-N 124.401 1.063 . . . . 0.0 112.429 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.449 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 16.2 ptt-85 -76.69 48.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.884 -0.658 . . . . 0.0 111.579 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.83 11.79 61.11 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.902 172.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.702 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 149.03 -42.0 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 119.292 -1.433 . . . . 0.0 113.534 173.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -57.59 -32.23 66.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 45' ' ' ILE . 17.4 tt0 -61.72 -52.48 64.12 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.439 -173.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.539 HD11 HG11 ' A' ' 53' ' ' VAL . 9.9 tp -62.0 -41.27 90.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.521 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -58.1 -48.17 80.99 Favored 'General case' 0 C--O 1.225 -0.221 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -60.13 -40.49 89.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.909 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.636 HD13 ' HG3' ' A' ' 82' ' ' MET . 87.8 mt -70.89 -50.82 40.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.448 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 -26.96 62.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.006 -175.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.859 HE21 ' HA ' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -78.46 -35.99 45.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.164 0.507 . . . . 0.0 110.218 176.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -62.42 -42.74 99.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.857 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.768 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 11.9 p -84.88 -38.79 19.01 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.26 11.35 31.83 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.592 -0.603 . . . . 0.0 111.592 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.435 ' N ' ' HB3' ' A' ' 75' ' ' SER . 51.2 t -86.45 154.51 21.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.213 0.53 . . . . 0.0 110.28 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.3 mttt -105.58 71.58 0.93 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 122.054 0.93 . . . . 0.0 109.241 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.539 HG11 HD11 ' A' ' 42' ' ' ILE . 37.3 t -81.99 119.34 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.174 -175.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 68' ' ' SER . 14.4 mm-40 -113.69 120.4 40.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.842 -177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 43.4 mm -83.61 93.31 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 t -79.71 110.89 17.38 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 -172.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.501 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 3.1 Cg_exo -80.85 -9.39 13.16 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.654 2.902 . . . . 0.0 111.157 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 -37.91 46.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.902 178.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.556 ' HA ' ' OG ' ' A' ' 66' ' ' SER . 11.2 m 70.03 -59.64 0.5 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.161 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.56 -87.65 1.46 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.775 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -87.66 3.25 86.28 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.861 -0.496 . . . . 0.0 111.861 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 66' ' ' SER . 5.1 mp -124.19 139.55 32.97 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -170.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -87.19 -24.17 1.34 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.794 2.329 . . . . 0.0 111.972 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.855 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -88.44 -84.16 0.21 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.677 -175.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 5.4 tpp85 -160.61 153.92 21.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.662 ' HB3' HD22 ' A' ' 62' ' ' LEU . 88.3 p -124.55 130.24 52.08 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.235 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.793 HG23 HG11 ' A' ' 26' ' ' VAL . 85.8 t -105.11 115.7 47.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 54' ' ' GLN . 72.2 m -79.76 120.32 23.88 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.366 0.603 . . . . 0.0 109.806 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.9 HD13 ' HG2' ' A' ' 80' ' ' LYS . 27.1 mt -113.27 105.01 12.9 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.593 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.9 m -150.12 145.12 26.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.218 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 179.33 -98.32 0.11 Allowed Glycine 0 C--O 1.227 -0.326 0 C-N-CA 119.741 -1.219 . . . . 0.0 113.607 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HB3' ' OG ' ' A' ' 75' ' ' SER . . . -138.06 165.04 36.46 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.494 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 93.0 Cg_exo -45.06 -66.12 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.066 2.511 . . . . 0.0 113.46 -176.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -68.75 -39.99 80.03 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.458 0.647 . . . . 0.0 110.235 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.768 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 7.1 m -59.64 -46.19 89.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.709 -173.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.638 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 1.2 p -73.74 -31.9 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.879 -173.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -66.79 -42.26 86.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.072 0.463 . . . . 0.0 110.048 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' O ' ' HB3' ' A' ' 81' ' ' MET . 2.4 tmtp? -70.29 -42.26 72.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.688 -177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.26 93.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.104 0.478 . . . . 0.0 111.414 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.9 ' HG2' HD13 ' A' ' 69' ' ' LEU . 5.1 mtmp? -81.19 -21.22 39.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.534 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 10.6 tpt -60.32 -47.49 85.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 173.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.636 ' HG3' HD13 ' A' ' 45' ' ' ILE . 18.9 mmt -68.17 -37.62 81.2 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.911 0.386 . . . . 0.0 110.943 176.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.737 ' HG ' HD11 ' A' ' 69' ' ' LEU . 2.2 mm? -59.44 -49.84 76.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.28 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -53.15 -42.63 66.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.735 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -59.87 -56.5 20.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.661 -176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.6 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -71.27 -41.15 74.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.045 -177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.527 HG21 ' CD1' ' A' ' 24' ' ' TYR . 60.7 t -63.56 -23.87 34.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 O-C-N 121.886 -0.509 . . . . 0.0 110.879 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.9 m -85.07 -26.01 27.23 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 15.4 ptp180 -77.04 -12.94 60.01 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.148 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.28 -39.92 1.45 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.693 174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.611 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -115.74 47.71 1.31 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.957 0.408 . . . . 0.0 110.945 -178.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -95.29 36.82 3.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.319 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.18 -1.345 . . . . 0.0 110.981 -177.569 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p 56.09 -162.37 0.17 Allowed 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.873 0.869 . . . . 0.0 111.586 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m 62.37 -168.66 0.19 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.662 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 21' ' ' THR . 26.8 mt-30 -64.98 109.5 2.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.304 0.573 . . . . 0.0 111.815 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 67.0 mt -84.8 133.53 34.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.897 171.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.91 77.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.847 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.96 -57.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.734 2.289 . . . . 0.0 112.207 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.727 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -109.03 157.89 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.553 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.636 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 54.6 t60 -91.02 -26.98 0.3 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 49.7 Cg_exo -37.12 166.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.366 1.497 0 C-N-CA 123.441 2.76 . . . . 0.0 115.097 170.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.13 153.92 0.46 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.776 2.984 . . . . 0.0 113.879 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HA ' ' OG ' ' A' ' 19' ' ' SER . 38.6 Cg_endo -64.54 12.92 0.1 OUTLIER 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 124.416 3.411 . . . . 0.0 114.3 -174.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 17' ' ' ARG . 3.8 ptp180 -64.9 -24.5 67.55 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.866 0.365 . . . . 0.0 110.225 175.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -154.1 -5.62 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.947 178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.408 ' OG ' ' HA ' ' A' ' 16' ' ' PRO . 27.1 p -79.79 -90.94 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.061 -0.4 . . . . 0.0 111.433 -176.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 14.5 ptm -70.45 76.15 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.629 0.728 . . . . 0.0 110.833 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.429 HG23 HG23 ' A' ' 70' ' ' THR . 24.8 m -84.53 116.21 23.0 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.261 -0.882 . . . . 0.0 109.336 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.93 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 5.5 tp10 -92.66 118.2 30.79 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -97.26 101.92 13.58 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.6 OUTLIER -95.09 121.08 36.35 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.726 -171.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.422 ' HD3' HD22 ' A' ' 62' ' ' LEU . 82.9 mtt180 -81.94 123.81 29.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.544 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG22 ' HB ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -136.44 124.23 14.74 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.575 -175.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.679 ' HG2' ' HA ' ' A' ' 91' ' ' ARG . 35.8 Cg_exo -59.48 152.93 58.03 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.858 2.372 . . . . 0.0 113.338 -175.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 31' ' ' VAL . 24.2 t70 -50.11 -52.12 37.47 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -173.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.1 70.43 Favored Glycine 0 C--N 1.32 -0.33 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.075 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.49 ' SD ' HG23 ' A' ' 86' ' ' ILE . 47.7 tpp -79.26 -27.61 42.36 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 122.639 -0.33 . . . . 0.0 110.695 -175.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.2 p -74.59 -25.37 19.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 172.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.49 -24.98 73.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 110.874 169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.0 mt -87.76 -24.69 23.72 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 31' ' ' VAL . 11.2 tp -70.92 -32.71 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.596 ' O ' ' HB2' ' A' ' 41' ' ' GLN . 11.3 pt -82.97 -14.6 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.15 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 55.16 -94.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.078 -0.965 . . . . 0.0 113.608 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 9.7 ptm180 -63.17 -10.32 14.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.116 -0.542 . . . . 0.0 111.589 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 127.08 4.96 5.84 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.08 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.595 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 157.79 -53.1 0.4 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 119.917 -1.135 . . . . 0.0 113.134 175.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 41.2 tt0 -55.43 -20.73 13.22 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -174.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.596 ' HB2' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -59.12 -53.16 61.54 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.605 0.24 . . . . 0.0 110.865 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.537 HD11 HG11 ' A' ' 53' ' ' VAL . 11.2 tp -65.73 -36.41 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 120.564 -0.454 . . . . 0.0 109.918 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -59.47 -41.25 89.33 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.069 0.461 . . . . 0.0 110.155 175.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -60.67 -56.78 17.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.843 173.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.459 ' CG1' ' HG2' ' A' ' 82' ' ' MET . 1.5 mp -54.61 -56.63 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.159 -176.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -70.03 -34.61 73.49 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -170.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -79.62 -35.49 39.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 110.327 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.99 -26.63 66.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.368 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.5 p -95.06 -40.58 9.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.743 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.31 18.23 9.34 Favored Glycine 0 CA--C 1.505 -0.567 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.809 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -95.95 160.96 14.2 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 0.0 111.978 176.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HB2' ' HE3' ' A' ' 52' ' ' LYS . 46.3 mtmt -101.3 76.25 1.69 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.16 173.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 42' ' ' ILE . 41.8 t -90.4 109.05 20.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.697 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -113.02 137.8 50.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.65 -176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.0 mm -93.3 116.29 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.291 -178.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -95.01 107.1 29.37 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.227 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 1.002 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 81.9 Cg_endo -78.62 -30.15 3.25 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.89 2.393 . . . . 0.0 112.805 -178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.73 -44.44 23.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.8 t 68.65 -68.33 0.18 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.893 173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.9 -86.69 0.46 Allowed Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.595 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.24 -1.1 90.45 Favored Glycine 0 N--CA 1.454 -0.153 0 C-N-CA 121.261 -0.495 . . . . 0.0 113.132 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.682 HD12 ' HB3' ' A' ' 66' ' ' SER . 48.8 mt -119.2 135.81 24.12 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.96 -17.36 17.57 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.687 2.258 . . . . 0.0 110.459 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' H ' ' HG2' ' A' ' 64' ' ' GLU . 5.7 pt-20 -94.26 -162.44 0.94 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.101 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 1.002 ' HD2' ' HA ' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -99.64 156.64 16.97 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.682 ' HB3' HD12 ' A' ' 62' ' ' LEU . 24.7 p -128.64 135.82 49.82 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.693 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.3 t -118.08 129.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.565 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 56.1 m -91.72 127.62 37.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.349 0.595 . . . . 0.0 111.146 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 4.2 mm? -108.1 117.63 34.64 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.325 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.429 HG23 HG23 ' A' ' 21' ' ' THR . 0.6 OUTLIER -150.34 156.6 41.83 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.021 176.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 156.17 -152.21 23.65 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.785 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -80.37 159.54 69.73 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 6.3 Cg_endo -49.08 -50.0 13.91 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.755 2.303 . . . . 0.0 112.368 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.33 -44.8 82.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.408 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.611 ' HB3' ' SG ' ' A' ' 51' ' ' CYS . 9.7 m -62.03 -54.61 39.07 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.034 -175.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -25.93 39.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.302 -172.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 81' ' ' MET . 51.1 tt0 -71.45 -50.58 30.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -57.7 -50.73 72.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.754 -178.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HB2' ' SG ' ' A' ' 51' ' ' CYS . . . -54.17 -48.31 71.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.134 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.735 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 38.3 mtmt -67.09 -21.5 65.87 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.381 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 77' ' ' GLN . 94.0 mtp -66.85 -41.45 87.35 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.235 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.459 ' HG2' ' CG1' ' A' ' 45' ' ' ILE . 2.6 mpt? -65.91 -47.43 74.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.711 0.291 . . . . 0.0 111.048 172.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.479 ' HG ' HD21 ' A' ' 69' ' ' LEU . 4.3 mm? -57.95 -55.56 33.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.943 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.7 -44.71 77.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.554 178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.24 -53.32 55.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.517 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.751 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 2.0 mp -75.29 -45.25 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.713 -175.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 24' ' ' TYR . 84.7 t -61.82 -40.19 86.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.076 0.465 . . . . 0.0 110.717 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -72.83 -28.5 62.58 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.275 -0.421 . . . . 0.0 112.056 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.751 ' HG3' ' O ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -73.28 -21.93 60.49 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.836 -178.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.02 63.27 0.2 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 119.048 -1.549 . . . . 0.0 114.608 175.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.679 ' HA ' ' HG2' ' A' ' 27' ' ' PRO . 36.1 ttt180 -84.68 77.51 10.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.697 0.748 . . . . 0.0 109.744 170.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -161.77 105.28 0.26 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.917 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.51 -1.161 . . . . 0.0 111.862 179.493 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 120.546 0.212 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t 67.9 92.7 0.08 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.762 178.255 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.874 ' HA ' ' HG3' ' A' ' 22' ' ' GLU . 40.1 m 63.19 -152.2 0.33 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.931 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.605 ' HG3' ' O ' ' A' ' 7' ' ' SER . 26.1 mt-30 -178.77 -103.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.339 1.055 . . . . 0.0 108.668 166.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 8' ' ' GLN . 38.1 tp 158.83 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 124.399 1.062 . . . . 0.0 109.082 176.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 19' ' ' SER . . . 152.94 108.11 0.34 Allowed Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.237 -178.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.2 -8.54 23.69 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.824 2.349 . . . . 0.0 112.013 -179.25 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.618 HD12 HG21 ' A' ' 18' ' ' THR . 1.0 OUTLIER -114.44 142.62 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.812 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.704 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 18.7 t-80 -92.55 -11.1 0.17 Allowed Pre-proline 0 CA--C 1.564 1.489 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -172.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 18.4 Cg_endo -56.4 -175.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.515 2.144 . . . . 0.0 113.15 176.582 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 14' ' ' PRO . 1.8 Cg_endo -44.22 153.7 0.32 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.885 2.39 . . . . 0.0 112.962 174.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.672 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 36.7 Cg_endo -65.46 33.81 0.11 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 124.286 3.324 . . . . 0.0 115.254 -174.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -84.56 7.2 20.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.626 0.726 . . . . 0.0 109.213 175.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 12' ' ' ILE . 8.9 t -176.02 -16.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.127 175.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.555 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 1.8 m -86.41 9.66 17.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.001 -178.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.672 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 18.5 mmt -146.47 31.23 0.99 Allowed 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.002 177.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 85.7 m -78.92 114.51 17.92 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.874 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 19.8 tt0 -121.64 118.86 30.22 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.818 176.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -87.63 110.65 20.54 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.486 ' CD1' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -89.34 124.0 34.03 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.81 -166.251 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.839 ' HG2' HD21 ' A' ' 62' ' ' LEU . 48.9 mtm180 -81.86 103.73 11.73 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.302 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER -122.3 124.59 26.81 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.508 -175.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.0 148.09 78.68 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.424 2.083 . . . . 0.0 111.644 -179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.668 ' O ' HG12 ' A' ' 31' ' ' VAL . 37.8 t70 -54.47 -51.43 65.07 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -170.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.85 -24.52 70.01 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.838 177.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.457 ' SD ' HD23 ' A' ' 33' ' ' LEU . 30.4 tpp -79.32 -29.64 42.46 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.477 -0.361 . . . . 0.0 110.828 -175.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 34' ' ' ILE . 13.4 p -70.99 -26.32 27.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -30.12 75.67 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.327 -0.939 . . . . 0.0 111.421 169.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD23 ' SD ' ' A' ' 30' ' ' MET . 64.3 tp -84.15 -31.01 25.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 177.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 31' ' ' VAL . 9.5 tp -70.39 -26.42 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 -178.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.667 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 8.5 pt -81.42 -14.38 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.557 174.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 63.7 -92.19 0.1 Allowed Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.316 172.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.762 ' HG3' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -77.34 20.84 0.27 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 122.86 0.464 . . . . 0.0 111.393 -179.458 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.89 58.88 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.042 177.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.667 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 154.53 -45.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.071 -1.061 . . . . 0.0 113.388 176.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.762 ' HB3' ' HG3' ' A' ' 37' ' ' ARG . 49.6 tt0 -56.59 -29.09 61.71 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' O ' HG12 ' A' ' 45' ' ' ILE . 25.4 tt0 -62.43 -53.24 57.8 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.442 -174.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.611 HD11 HG11 ' A' ' 53' ' ' VAL . 8.6 tp -62.95 -38.71 82.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.261 -177.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -61.97 -42.99 99.75 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 177.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.662 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -58.51 -43.2 89.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.602 176.064 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 41' ' ' GLN . 30.6 mm -69.96 -50.93 44.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.912 -176.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -71.24 -31.92 68.13 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.323 -174.688 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -76.04 -38.36 57.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.872 0.368 . . . . 0.0 110.17 179.717 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 11.9 t70 -62.82 -50.57 70.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.851 178.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.9 p -70.85 -45.52 64.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.73 -4.36 26.04 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.464 -176.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 41.6 t -79.12 135.16 36.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.11 0.481 . . . . 0.0 110.099 178.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -85.02 74.5 10.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.519 0.676 . . . . 0.0 110.104 -176.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 42' ' ' ILE . 44.9 t -82.49 115.53 25.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.789 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 54' ' ' GLN . 15.6 mm-40 -119.48 129.95 54.99 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.856 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.425 HD13 HG13 ' A' ' 67' ' ' VAL . 42.7 mm -83.95 109.12 17.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.754 -178.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.525 ' HB2' ' OG ' ' A' ' 66' ' ' SER . 7.3 m -82.4 111.33 27.43 Favored Pre-proline 0 C--O 1.242 0.662 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.576 -178.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.801 ' HA ' HH11 ' A' ' 65' ' ' ARG . 60.8 Cg_endo -73.01 -27.73 13.76 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.949 2.433 . . . . 0.0 111.858 178.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -108.46 88.39 2.72 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.855 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 5.3 p -65.6 -39.2 91.29 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.238 -175.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.01 -61.51 4.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.729 174.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.613 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -93.86 4.88 72.36 Favored Glycine 0 CA--C 1.508 -0.362 0 C-N-CA 121.205 -0.522 . . . . 0.0 111.817 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.855 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 5.8 mp -127.71 151.38 75.3 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.36 -0.42 . . . . 0.0 109.941 -170.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -90.89 -4.4 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.696 2.264 . . . . 0.0 111.072 171.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' CD ' HH21 ' A' ' 91' ' ' ARG . 1.6 pt-20 -119.52 -153.27 0.53 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.962 -177.335 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.801 HH11 ' HA ' ' A' ' 57' ' ' PRO . 14.6 tpp180 -91.97 157.86 16.58 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.772 ' HB3' HD22 ' A' ' 62' ' ' LEU . 56.9 p -131.96 153.41 50.33 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.642 174.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG13 HD13 ' A' ' 55' ' ' ILE . 57.5 t -135.19 131.75 52.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.2 m -89.87 127.66 36.04 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.284 177.49 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.751 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.7 mm? -110.57 107.48 17.11 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.655 175.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -152.54 134.64 14.93 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 176.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 178.61 -147.39 7.84 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.846 -179.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.6 160.2 70.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 177.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.542 ' HA ' ' HG3' ' A' ' 16' ' ' PRO . 99.9 Cg_exo -45.06 -56.51 2.66 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.033 2.489 . . . . 0.0 114.237 -174.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -84.15 -30.98 25.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.956 -178.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 m -62.38 -43.33 99.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.007 0.432 . . . . 0.0 110.696 179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.8 p -66.86 -27.77 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.841 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.546 ' O ' ' HG2' ' A' ' 81' ' ' MET . 6.4 tp-100 -73.52 -50.28 22.24 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.126 178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 0.4 OUTLIER -54.2 -43.89 71.14 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.207 0.527 . . . . 0.0 110.566 178.798 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -57.01 -54.71 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.562 176.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.751 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 9.8 mtmp? -66.16 -21.23 66.32 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.854 -177.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 93.4 mmm -67.7 -43.41 80.12 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 121.173 -0.211 . . . . 0.0 110.83 177.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 87.0 mmm -66.73 -34.55 78.1 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.422 175.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.37 -49.09 65.43 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.11 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -51.3 -44.59 61.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.614 177.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.458 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 10.5 t70 -64.08 -61.04 2.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.682 -178.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.455 ' HB ' HD13 ' A' ' 34' ' ' ILE . 1.9 mp -66.68 -40.51 86.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.27 -174.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 24' ' ' TYR . 77.3 t -67.82 -26.86 35.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.502 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.4 t -72.79 -26.25 61.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.815 0.341 . . . . 0.0 110.239 175.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 85' ' ' ASP . 25.5 mmt180 -63.6 -41.91 98.28 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.21 0.529 . . . . 0.0 109.671 176.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.45 -59.51 1.72 Allowed Glycine 0 N--CA 1.454 -0.156 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.721 178.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.44 HH21 ' CD ' ' A' ' 64' ' ' GLU . 33.2 mmt180 -88.35 57.85 4.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.265 0.555 . . . . 0.0 110.469 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.14 -126.16 1.15 Allowed Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.644 179.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 118.634 -1.092 . . . . 0.0 111.77 178.989 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.697 0.761 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 p -153.47 -169.7 3.38 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.714 -179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.2 t 73.42 -69.67 0.18 Allowed 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.678 0.611 . . . . 0.0 111.024 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -155.93 143.49 19.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.099 0.476 . . . . 0.0 110.889 -177.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 95.8 mt -134.65 98.56 4.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.126 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.05 67.08 0.43 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 172.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.12 -11.86 14.65 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.917 2.411 . . . . 0.0 111.826 -178.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.541 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 23.2 pt -124.97 154.9 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.381 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.692 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 49.4 t-80 -89.45 -22.1 0.27 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 23.8 Cg_exo -42.23 168.59 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.692 2.262 . . . . 0.0 114.474 174.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 17' ' ' ARG . 65.4 Cg_exo -41.25 157.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.758 2.972 . . . . 0.0 114.36 179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HB3' ' HG3' ' A' ' 20' ' ' MET . 35.1 Cg_endo -66.83 28.6 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.901 3.067 . . . . 0.0 114.357 -175.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' H ' ' C ' ' A' ' 15' ' ' PRO . 88.4 mtt180 -73.19 -26.69 61.26 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 173.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.496 HG23 HD11 ' A' ' 12' ' ' ILE . 2.7 t -158.36 10.16 0.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.353 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.5 t -101.07 -12.51 18.77 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.387 0.613 . . . . 0.0 110.391 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.539 ' HG3' ' HB3' ' A' ' 16' ' ' PRO . 21.8 mmt -134.33 34.46 3.27 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.358 -176.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 87.3 m -79.68 112.19 16.7 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 69' ' ' LEU . 14.4 tt0 -111.01 119.09 37.89 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -96.61 103.21 15.11 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.554 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -91.81 118.68 30.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.973 -166.853 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 32.4 mtm180 -81.78 114.74 20.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.776 175.448 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.1 p -135.45 131.87 19.62 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.065 -173.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.614 ' HA ' ' HB2' ' A' ' 64' ' ' GLU . 38.2 Cg_exo -61.8 146.28 96.66 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.905 2.403 . . . . 0.0 111.555 177.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' HA ' HG12 ' A' ' 31' ' ' VAL . 2.6 p-10 -59.89 -30.32 68.93 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.405 -172.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.62 -33.24 56.28 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.177 176.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.736 ' HG3' ' HA3' ' A' ' 90' ' ' GLY . 83.7 mmm -78.82 -29.48 44.82 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 122.904 -0.174 . . . . 0.0 110.795 -176.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 34' ' ' ILE . 11.0 p -69.72 -31.82 49.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.358 173.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.04 -26.58 70.38 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.431 171.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -88.76 -23.65 22.85 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 177.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.9 tp -72.37 -27.32 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.457 178.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.615 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.6 pt -85.18 -14.75 10.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.155 171.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.42 -97.78 0.1 Allowed Glycine 0 C--N 1.335 0.486 0 CA-C-N 115.208 -0.905 . . . . 0.0 113.362 173.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 14.2 ptm180 -58.99 -22.39 60.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.097 0.559 . . . . 0.0 111.63 178.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.29 -7.63 1.83 Allowed Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.785 177.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 167.85 -48.36 0.24 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 119.815 -1.183 . . . . 0.0 113.256 176.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 28.3 tt0 -59.96 -21.64 61.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -171.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.26 -55.32 35.14 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.316 0.507 . . . . 0.0 110.582 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.84 -38.66 81.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.277 -179.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -60.76 -36.83 79.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.107 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 28.1 tptp -63.04 -58.64 6.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.125 176.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.47 -41.37 87.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.259 -174.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' A' ' 51' ' ' CYS . 1.1 pp0? -71.85 -40.32 69.1 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.85 -176.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -73.76 -30.29 62.7 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.347 0.594 . . . . 0.0 110.537 178.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 13.0 t70 -69.12 -43.99 73.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.716 -178.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 39.4 p -80.03 -35.36 37.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.909 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.24 7.19 30.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.626 -177.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 33.9 t -90.71 141.47 28.77 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -94.05 89.09 5.9 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.238 0.542 . . . . 0.0 109.657 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.37 106.87 18.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.745 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.6 tp60 -106.0 118.94 37.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.475 -175.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.452 HD13 HG13 ' A' ' 67' ' ' VAL . 43.1 mm -78.9 116.94 23.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 16.7 t -107.76 112.91 61.81 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-O 121.255 0.55 . . . . 0.0 111.133 -177.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 18.6 Cg_exo -66.89 -37.49 19.78 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.357 2.705 . . . . 0.0 111.306 175.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -80.11 83.28 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.567 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.4 m -76.31 4.19 9.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.11 -169.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.16 -92.91 1.07 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.826 169.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -93.8 -11.26 58.08 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.553 178.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 59' ' ' SER . 3.0 mm? -103.78 142.87 25.49 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -177.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -88.1 -18.75 2.18 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.752 2.301 . . . . 0.0 112.502 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.614 ' HB2' ' HA ' ' A' ' 27' ' ' PRO . 0.5 OUTLIER -83.41 -86.07 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.391 -175.253 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HB3' HG13 ' A' ' 26' ' ' VAL . 1.3 tpp180 -160.27 154.31 23.1 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 176.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 22.1 t -139.35 143.8 37.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 55' ' ' ILE . 46.3 t -129.84 134.95 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.189 -175.305 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.8 m -92.49 128.69 38.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.422 0.63 . . . . 0.0 111.557 177.81 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.662 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 3.6 mm? -110.48 112.91 25.14 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.579 177.154 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.7 m -151.5 148.22 27.78 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.042 176.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.65 -131.58 2.4 Favored Glycine 0 C--N 1.337 0.604 0 C-N-CA 119.907 -1.139 . . . . 0.0 113.601 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.6 162.99 18.53 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.34 -48.58 19.48 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.823 2.349 . . . . 0.0 113.376 -174.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -77.48 -41.19 40.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 29.4 p -65.5 -41.56 93.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.454 0.645 . . . . 0.0 110.34 -174.208 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.603 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -65.15 -26.57 40.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.773 -176.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 81' ' ' MET . 47.6 mt-30 -82.62 -34.04 27.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.608 177.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -65.84 -43.79 87.44 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.671 0.748 . . . . 0.0 109.684 176.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.36 78.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.104 177.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 47.2 mtmt -77.05 -19.94 56.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.039 -174.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 77' ' ' GLN . 0.0 OUTLIER -57.05 -55.04 39.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.879 173.214 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.75 -35.87 82.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.76 178.388 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.2 mm? -65.99 -56.85 9.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.953 -177.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -52.86 -40.86 63.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.571 179.225 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.532 ' HB3' HD12 ' A' ' 86' ' ' ILE . 7.4 t70 -53.52 -60.03 3.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.335 -178.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.593 HG13 ' CZ ' ' A' ' 89' ' ' ARG . 2.5 mp -76.25 -44.37 36.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.683 -175.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 26' ' ' VAL . 98.8 t -59.1 -39.8 79.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.52 -178.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.3 t -70.2 -39.11 75.37 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.291 . . . . 0.0 110.804 -179.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' CZ ' HG13 ' A' ' 86' ' ' ILE . 11.4 ptt180 -77.33 -7.47 56.09 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.526 -176.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.736 ' HA3' ' HG3' ' A' ' 30' ' ' MET . . . -121.85 0.74 10.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.681 174.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -164.03 100.95 0.87 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.24 68.68 1.43 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.421 -0.895 . . . . 0.0 111.903 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.707 -1.052 . . . . 0.0 111.256 -179.959 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 45.1 mt . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.158 0.504 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 7' ' ' SER . 48.9 m -80.21 166.39 21.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.481 178.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 32.8 t 75.19 -68.61 0.2 Allowed 'General case' 0 C--O 1.224 -0.283 0 O-C-N 123.767 0.667 . . . . 0.0 110.976 179.347 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -149.01 136.46 20.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.282 0.563 . . . . 0.0 111.599 -177.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.845 ' HG ' ' HD3' ' A' ' 11' ' ' PRO . 57.1 tp -115.28 136.29 53.25 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -156.26 63.76 0.32 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.409 -0.901 . . . . 0.0 112.653 177.918 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.845 ' HD3' ' HG ' ' A' ' 9' ' ' LEU . 93.3 Cg_endo -86.47 -19.78 2.81 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.306 2.004 . . . . 0.0 112.124 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.605 HG22 ' HD2' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -127.06 138.66 54.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.218 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.698 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 t-80 -91.71 -15.68 0.21 Allowed Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 -173.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 13' ' ' HIS . 22.6 Cg_endo -56.34 178.99 0.11 Allowed 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 122.201 1.934 . . . . 0.0 113.031 178.272 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 59.5 Cg_exo -40.18 153.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 123.404 2.736 . . . . 0.0 114.188 179.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 19' ' ' SER . 73.8 Cg_endo -71.04 34.88 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.097 3.198 . . . . 0.0 113.283 -175.187 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -84.87 -20.16 31.25 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.4 t -164.56 23.24 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.505 178.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.448 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 34.5 t -101.16 -90.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.749 -176.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 ptm -79.2 79.79 5.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.157 0.503 . . . . 0.0 110.909 -179.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 9' ' ' LEU . 89.2 m -84.92 114.94 22.5 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 175.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 7' ' ' SER . 13.0 tt0 -94.4 117.95 30.89 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.466 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -92.82 106.25 18.25 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.529 0.681 . . . . 0.0 109.277 -179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.624 ' HD2' HG21 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -91.88 120.98 33.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.191 -172.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.781 ' HG2' HD21 ' A' ' 62' ' ' LEU . 70.5 mtm180 -86.26 101.31 12.94 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.589 175.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.773 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.4 p -116.44 129.24 25.4 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 31.8 Cg_exo -57.23 150.29 58.79 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.536 2.824 . . . . 0.0 112.338 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.35 -44.72 84.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 111.678 -175.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.76 64.35 Favored Glycine 0 C--O 1.237 0.305 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.875 177.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.553 ' HG2' ' HA3' ' A' ' 90' ' ' GLY . 31.1 tpp -78.54 -28.65 46.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.613 -0.293 . . . . 0.0 110.828 -175.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.598 HG21 ' HG2' ' A' ' 65' ' ' ARG . 9.0 p -74.34 -25.16 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 172.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.96 -32.09 69.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.286 -0.959 . . . . 0.0 110.763 168.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.1 mt -82.05 -22.12 36.55 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 172.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HB ' ' O ' ' A' ' 31' ' ' VAL . 8.7 mm -61.36 -44.96 99.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 122.05 0.928 . . . . 0.0 108.674 174.223 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.608 ' HB ' ' HA2' ' A' ' 39' ' ' GLY . 4.8 pt -82.11 -14.46 12.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.787 175.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 59.18 -88.55 0.02 OUTLIER Glycine 0 C--N 1.335 0.496 0 CA-C-N 115.146 -0.934 . . . . 0.0 114.021 170.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.862 ' HD3' ' HB3' ' A' ' 40' ' ' GLU . 3.1 ptm180 -74.05 0.87 12.38 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 122.746 0.418 . . . . 0.0 110.998 -178.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 122.18 -5.44 10.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.138 174.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.608 ' HA2' ' HB ' ' A' ' 35' ' ' ILE . . . 160.37 -41.46 0.44 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.722 178.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.862 ' HB3' ' HD3' ' A' ' 37' ' ' ARG . 1.5 tm-20 -58.83 -35.57 73.12 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.378 0.271 . . . . 0.0 111.199 -175.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.12 -47.1 86.51 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.496 0.189 . . . . 0.0 110.854 -171.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 10.3 tp -68.2 -36.32 74.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.224 -178.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.1 m-20 -62.46 -37.87 87.61 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -61.61 -54.49 42.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.499 178.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.53 -45.61 95.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.245 0.545 . . . . 0.0 111.594 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.899 HE21 ' HB ' ' A' ' 53' ' ' VAL . 97.1 mt-30 -58.33 -45.45 88.08 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.42 179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -69.12 -42.55 75.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.023 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -57.7 -46.24 84.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.448 177.509 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.0 p -78.37 -47.48 17.58 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.583 -177.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 100.64 6.07 53.16 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -175.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . 51.1 t -84.72 143.45 29.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.568 . . . . 0.0 110.631 179.484 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -89.98 77.66 6.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.317 -179.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.899 ' HB ' HE21 ' A' ' 46' ' ' GLN . 26.1 t -82.13 107.73 14.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.123 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.59 HE21 ' CA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -89.69 106.58 18.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.616 -176.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 45.8 mm -88.03 94.0 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.3 m -91.88 106.07 15.91 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 120.91 0.386 . . . . 0.0 110.707 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.679 ' HA ' ' CD ' ' A' ' 65' ' ' ARG . 8.3 Cg_exo -72.59 -34.35 7.34 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.275 2.65 . . . . 0.0 112.47 -176.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -80.21 -12.14 59.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.695 178.263 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 11.9 p 47.58 -85.14 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 176.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.08 -75.41 0.35 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.002 -177.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.545 ' C ' HD12 ' A' ' 62' ' ' LEU . . . -81.63 0.23 88.36 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.057 -0.592 . . . . 0.0 111.766 177.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.781 HD21 ' HG2' ' A' ' 25' ' ' ARG . 7.6 mp -127.48 145.7 55.59 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.384 -0.408 . . . . 0.0 110.943 -170.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.459 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 43.4 Cg_endo -86.57 -15.17 4.26 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.138 2.559 . . . . 0.0 112.749 176.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.753 ' OE1' ' HB3' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -110.86 -102.47 0.39 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.947 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.773 ' HB3' HG13 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -135.64 131.12 35.37 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 122.269 -0.27 . . . . 0.0 110.381 -176.253 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.622 ' HB3' HD22 ' A' ' 62' ' ' LEU . 85.8 p -108.72 112.95 25.52 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 55' ' ' ILE . 92.9 t -103.16 119.37 51.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.112 -179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 73.5 m -88.95 126.4 35.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.314 0.578 . . . . 0.0 110.851 176.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.742 ' HG ' ' HG2' ' A' ' 80' ' ' LYS . 4.0 mm? -102.27 104.06 14.57 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.492 177.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 m -151.44 148.29 27.91 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 175.766 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.25 -93.96 0.1 OUTLIER Glycine 0 C--O 1.226 -0.347 0 C-N-CA 120.038 -1.077 . . . . 0.0 113.134 179.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.403 ' HB1' ' HD2' ' A' ' 73' ' ' PRO . . . -143.02 161.97 45.78 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 72' ' ' ALA . 84.1 Cg_exo -46.44 -55.65 3.58 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.194 2.596 . . . . 0.0 113.535 -175.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.74 -33.02 25.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.125 0.488 . . . . 0.0 110.272 -178.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.8 m -64.68 -45.06 88.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.293 -177.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 2.7 p -70.06 -26.26 29.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.558 -175.332 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -70.96 -43.97 67.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.448 179.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.694 ' O ' ' HG3' ' A' ' 81' ' ' MET . 23.4 tptm -66.15 -44.07 85.18 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.078 0.466 . . . . 0.0 110.466 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 51' ' ' CYS . . . -54.18 -48.78 70.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.2 175.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.742 ' HG2' ' HG ' ' A' ' 69' ' ' LEU . 33.0 mtmt -71.13 -25.02 62.4 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.565 -177.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.694 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 4.2 ppp? -70.18 -30.56 67.72 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.868 -177.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 86.7 mmm -77.43 -36.17 53.41 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.755 172.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 3.6 mm? -63.73 -49.1 74.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.786 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -57.89 -44.05 86.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.886 177.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.1 -59.36 4.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.458 -179.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.534 HG23 ' SD ' ' A' ' 30' ' ' MET . 1.6 mp -72.45 -45.16 60.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.119 -175.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.624 HG21 ' HD2' ' A' ' 24' ' ' TYR . 9.1 t -67.2 -28.69 43.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 O-C-N 122.043 -0.411 . . . . 0.0 111.322 -176.397 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.452 ' HA ' ' HA2' ' A' ' 92' ' ' GLY . 21.4 t -69.47 -41.34 76.31 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.023 174.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 12.2 ptp180 -73.7 -13.23 60.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.164 0.507 . . . . 0.0 110.473 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.553 ' HA3' ' HG2' ' A' ' 30' ' ' MET . . . -95.98 -39.45 4.32 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.987 -179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HE ' ' HG3' ' A' ' 27' ' ' PRO . 8.1 ptp180 -157.4 -48.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.784 0.326 . . . . 0.0 111.398 -178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 88' ' ' SER . . . 118.1 -39.15 2.68 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.666 -175.003 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 177.604 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.3 mt . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.638 0.733 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.3 m -133.95 126.78 31.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.584 178.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.872 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 20.4 m 74.03 -4.27 2.32 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 124.088 0.867 . . . . 0.0 111.755 177.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.63 96.18 8.46 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.81 0.338 . . . . 0.0 111.75 -172.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 21' ' ' THR . 91.1 mt -123.38 92.55 3.72 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 171.466 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.89 73.3 0.39 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.204 178.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -83.57 -63.12 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.11 2.54 . . . . 0.0 112.541 -179.045 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.943 HG12 ' HD2' ' A' ' 14' ' ' PRO . 10.1 tt -99.51 154.92 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -176.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.716 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 15.6 m-70 -91.83 -20.78 0.24 Allowed Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -172.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.943 ' HD2' HG12 ' A' ' 12' ' ' ILE . 23.9 Cg_exo -39.94 171.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.319 2.68 . . . . 0.0 114.833 170.235 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.02 156.6 2.09 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.224 2.616 . . . . 0.0 113.538 177.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.537 ' HB3' ' CG ' ' A' ' 20' ' ' MET . 36.8 Cg_endo -65.21 11.36 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 124.226 3.284 . . . . 0.0 114.371 -175.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -62.51 -24.05 67.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 110.293 179.329 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.418 ' H ' ' H ' ' A' ' 19' ' ' SER . 12.7 t -157.75 -11.01 0.08 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.718 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 12' ' ' ILE . 14.0 m -79.86 -83.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.838 -173.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 16' ' ' PRO . 15.5 ptp -74.56 73.05 1.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.493 0.663 . . . . 0.0 110.193 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 18.0 m -79.41 131.63 36.15 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.843 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.872 ' HG3' ' HB3' ' A' ' 7' ' ' SER . 0.4 OUTLIER -94.26 117.37 30.01 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.309 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' SER . 40.9 tt0 -98.97 96.7 8.01 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.419 ' CE1' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -93.14 116.28 28.88 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.429 -167.669 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HG3' HH11 ' A' ' 25' ' ' ARG . 44.1 mtt85 -81.66 103.03 11.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.875 176.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.768 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.3 p -121.89 131.87 24.35 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.914 -174.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.641 ' HG3' HH11 ' A' ' 91' ' ' ARG . 25.7 Cg_exo -62.98 135.99 54.37 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.761 2.308 . . . . 0.0 110.568 175.424 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -51.86 -36.84 49.82 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 114.825 -1.08 . . . . 0.0 113.367 -169.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.86 -34.09 87.64 Favored Glycine 0 C--O 1.236 0.227 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.214 179.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 87.1 mmm -78.15 -13.36 59.89 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 34' ' ' ILE . 37.1 t -74.16 -40.9 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.445 173.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.58 -27.78 71.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.12 -1.038 . . . . 0.0 111.226 174.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.26 -24.81 25.85 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 178.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.613 HD13 ' HB ' ' A' ' 86' ' ' ILE . 8.9 tp -74.22 -25.31 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-O 121.564 0.697 . . . . 0.0 109.673 179.402 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.597 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 7.5 pt -89.33 -15.82 8.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.864 171.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 64.71 -86.29 0.07 OUTLIER Glycine 0 C--N 1.334 0.43 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.603 174.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.46 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 9.0 ptp180 -79.58 -1.29 37.24 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.949 0.404 . . . . 0.0 111.07 -177.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.33 2.72 10.77 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.69 173.759 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.597 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 162.73 -49.66 0.32 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 119.549 -1.31 . . . . 0.0 113.066 175.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 37' ' ' ARG . 25.5 tt0 -44.74 -42.81 8.01 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.052 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -58.7 -46.62 86.9 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -167.119 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.605 HD11 HG11 ' A' ' 53' ' ' VAL . 8.0 tp -65.47 -54.31 29.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.617 -178.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.441 ' N ' HG23 ' A' ' 42' ' ' ILE . 39.5 m-80 -56.19 -42.17 76.72 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.439 -177.264 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.45 -47.48 83.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.684 -179.343 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.74 -45.24 38.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 42' ' ' ILE . 2.1 pt20 -69.13 -43.18 74.92 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.575 -176.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.96 -36.58 75.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 0.0 110.407 -178.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -61.1 -50.07 74.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.958 178.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.0 p -72.78 -33.14 66.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.523 -177.093 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.7 9.04 27.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.615 -178.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.641 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 15.2 t -79.73 152.36 29.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.985 0.422 . . . . 0.0 110.133 179.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -108.84 86.61 2.32 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 42' ' ' ILE . 44.7 t -103.9 111.88 35.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.085 0.469 . . . . 0.0 110.923 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -108.2 115.58 30.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.426 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.498 HD13 HG13 ' A' ' 67' ' ' VAL . 32.1 mm -81.85 94.47 2.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.734 176.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.524 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 42.1 m -79.25 114.79 47.84 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-O 120.951 0.405 . . . . 0.0 110.788 -178.547 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 4.3 Cg_exo -74.41 -40.62 1.09 Allowed 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.668 2.912 . . . . 0.0 111.854 -177.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.43 78.77 2.71 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 174.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.634 ' HB2' ' HB2' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -61.69 -27.85 68.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.128 -175.73 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.97 -72.53 1.82 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.214 178.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.408 ' O ' HD13 ' A' ' 62' ' ' LEU . . . -71.62 -14.03 74.9 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.539 -0.624 . . . . 0.0 111.539 177.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 59' ' ' SER . 2.5 mm? -123.89 138.88 31.27 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.2 -9.52 10.47 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.045 2.497 . . . . 0.0 111.257 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 64' ' ' GLU . 2.2 pt-20 -101.16 -94.75 0.28 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.323 -173.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.768 ' HB3' HG13 ' A' ' 26' ' ' VAL . 3.6 tpp180 -150.03 148.25 28.81 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 175.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 59' ' ' SER . 68.4 p -122.85 112.47 17.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.119 0.485 . . . . 0.0 110.082 174.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 55' ' ' ILE . 99.7 t -98.58 115.81 39.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.716 179.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.1 m -86.14 131.51 34.23 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.141 0.496 . . . . 0.0 110.548 177.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 1.013 HD13 ' HG2' ' A' ' 80' ' ' LYS . 62.6 mt -120.33 116.91 26.47 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.459 -179.331 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.65 156.44 40.4 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.403 -175.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 16' ' ' PRO . . . 151.48 -150.9 22.9 Favored Glycine 0 C--O 1.224 -0.485 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.493 176.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.12 152.25 76.45 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.45 -49.94 8.55 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.104 2.536 . . . . 0.0 113.526 -175.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -78.1 -33.37 50.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.192 0.52 . . . . 0.0 110.845 -178.404 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -70.06 -41.27 74.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.641 -178.047 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.676 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 4.5 p -68.47 -32.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -177.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.36 81.7 Favored 'General case' 0 C--O 1.223 -0.315 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 178.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.468 ' O ' ' HB3' ' A' ' 81' ' ' MET . 0.1 OUTLIER -55.91 -45.44 78.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.343 0.592 . . . . 0.0 110.793 178.746 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.86 -36.74 83.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.376 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 1.013 ' HG2' HD13 ' A' ' 69' ' ' LEU . 44.6 mtmt -82.39 -22.02 35.59 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -173.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.468 ' HB3' ' O ' ' A' ' 78' ' ' LYS . 17.1 tpt -60.82 -49.59 76.85 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.655 172.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 93.4 mmm -68.37 -39.61 81.73 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.751 176.575 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.859 ' HG ' HD11 ' A' ' 69' ' ' LEU . 1.4 mm? -62.29 -59.63 4.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.194 -178.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -53.02 -40.58 63.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.024 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -55.5 34.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.132 -177.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.613 ' HB ' HD13 ' A' ' 34' ' ' ILE . 2.3 mp -80.6 -38.91 17.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.659 0.266 . . . . 0.0 111.704 -175.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 24' ' ' TYR . 92.2 t -60.02 -50.31 80.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.703 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.9 t -57.83 -48.6 79.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.682 -178.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HG2' ' HA ' ' A' ' 86' ' ' ILE . 10.2 ptp180 -61.49 -22.35 65.01 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 123.183 0.302 . . . . 0.0 111.587 -175.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.81 12.76 13.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.117 -1.04 . . . . 0.0 113.472 178.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.641 HH11 ' HG3' ' A' ' 27' ' ' PRO . 7.3 tpt180 -129.0 -47.26 1.23 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.309 0.554 . . . . 0.0 112.008 -178.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.3 -37.67 0.19 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.131 -1.033 . . . . 0.0 113.75 -173.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.77 -1.017 . . . . 0.0 111.473 -177.593 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 5' ' ' ILE . 2.1 pp . . . . . 0 N--CA 1.451 -0.414 0 CA-C-O 120.734 0.302 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.8 p -148.32 -169.98 3.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.344 -177.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.518 ' H ' ' HB3' ' A' ' 23' ' ' GLU . 13.6 m 64.47 -155.26 0.3 Allowed 'General case' 0 C--N 1.332 -0.18 0 O-C-N 123.664 0.602 . . . . 0.0 110.318 -179.083 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -52.18 113.81 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 178.288 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.73 125.51 52.0 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.159 170.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.45 75.36 0.42 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.574 178.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.92 -64.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.684 2.256 . . . . 0.0 111.565 179.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.794 ' C ' ' HD2' ' A' ' 14' ' ' PRO . 12.6 pt -104.77 141.86 19.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 177.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.563 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 56.3 m80 -96.26 31.42 0.03 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 117.373 2.36 . . . . 0.0 117.373 -174.496 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.794 ' HD2' ' C ' ' A' ' 12' ' ' ILE . 18.7 Cg_endo -57.85 -163.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.551 1.36 0 C-N-CA 122.47 2.113 . . . . 0.0 112.798 161.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 14' ' ' PRO . 10.2 Cg_endo -56.44 164.48 5.44 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 122.219 1.946 . . . . 0.0 112.208 168.848 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.76 33.69 0.15 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.816 3.01 . . . . 0.0 114.393 -175.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 18' ' ' THR . 10.6 ptp180 -92.69 14.59 16.68 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 175.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 17' ' ' ARG . 9.4 t 171.47 -16.58 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.672 177.304 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.2 m -78.21 -11.48 59.93 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -174.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.471 ' HE3' HG11 ' A' ' 76' ' ' VAL . 11.7 ptt? -150.56 69.75 0.99 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.836 0.827 . . . . 0.0 109.19 167.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.2 m -78.53 115.3 18.14 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.891 -1.049 . . . . 0.0 108.248 177.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.637 ' O ' ' HA ' ' A' ' 68' ' ' SER . 8.1 tp10 -94.4 119.76 33.62 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -172.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HB3' ' H ' ' A' ' 7' ' ' SER . 6.0 tp10 -104.87 102.75 12.27 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 174.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' SER . 0.2 OUTLIER -91.43 125.66 36.25 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.837 -169.536 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HG2' ' HG ' ' A' ' 62' ' ' LEU . 59.7 mtm180 -82.65 102.48 11.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 175.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.737 HG13 ' HB3' ' A' ' 65' ' ' ARG . 1.2 p -125.14 126.72 25.17 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.778 -177.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 26' ' ' VAL . 54.6 Cg_exo -54.82 148.24 47.06 Favored 'Trans proline' 0 CA--C 1.521 -0.169 0 C-N-CA 123.537 2.824 . . . . 0.0 111.815 -179.175 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.457 ' HA ' HG12 ' A' ' 31' ' ' VAL . 28.8 t70 -59.63 -36.83 77.14 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.918 -175.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -34.34 61.9 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.117 -1.04 . . . . 0.0 111.384 175.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 28.6 tpp -78.95 -22.96 44.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.93 -175.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.74 HG21 ' HG2' ' A' ' 65' ' ' ARG . 3.7 p -76.85 -29.96 18.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 171.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.78 -26.93 67.6 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.939 -1.124 . . . . 0.0 110.851 169.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.4 mt -90.63 -24.26 20.57 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 175.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.3 tp -68.92 -32.23 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.74 0.781 . . . . 0.0 109.693 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.598 ' HB ' ' N ' ' A' ' 39' ' ' GLY . 5.3 pt -71.95 -12.12 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.367 174.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 76.84 -8.75 27.59 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 115.438 -0.801 . . . . 0.0 114.845 163.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.696 ' HD3' ' HB2' ' A' ' 40' ' ' GLU . 11.8 ptm180 -174.75 -32.17 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.072 0.463 . . . . 0.0 110.045 -174.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 160.85 -2.09 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.767 179.04 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.598 ' N ' ' HB ' ' A' ' 35' ' ' ILE . . . 156.08 -37.23 0.61 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 119.82 -1.181 . . . . 0.0 112.653 174.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.696 ' HB2' ' HD3' ' A' ' 37' ' ' ARG . 3.5 mp0 -56.73 -40.93 76.62 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -173.624 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -59.48 -44.81 92.96 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -168.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.653 HD11 HG11 ' A' ' 53' ' ' VAL . 8.5 tp -64.03 -48.08 87.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.295 -0.562 . . . . 0.0 110.445 -177.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 46' ' ' GLN . 71.3 m-20 -65.87 -33.39 75.74 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -60.55 -49.65 76.7 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.161 178.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.536 HG21 ' HG2' ' A' ' 82' ' ' MET . 1.8 mp -75.95 -40.71 38.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.798 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.56 ' HG3' ' HA ' ' A' ' 43' ' ' ASN . 0.0 OUTLIER -70.55 -27.21 63.97 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.638 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -77.75 -40.48 40.87 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -60.66 -40.11 90.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.889 178.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.404 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 28.6 p -80.86 -42.78 20.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.235 -179.433 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.99 1.19 36.11 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.561 ' SG ' ' HA ' ' A' ' 76' ' ' VAL . 44.5 t -79.9 139.25 37.18 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.286 -0.457 . . . . 0.0 110.242 178.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -92.21 79.33 5.09 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.357 0.599 . . . . 0.0 109.433 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.653 HG11 HD11 ' A' ' 42' ' ' ILE . 44.9 t -89.73 123.15 41.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.348 -177.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -118.51 133.78 55.6 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.099 -176.499 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD13 HG13 ' A' ' 67' ' ' VAL . 43.3 mm -91.98 98.44 8.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 14.8 m -81.02 108.43 10.25 Favored Pre-proline 0 C--O 1.238 0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 111.019 -177.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 56' ' ' SER . 2.1 Cg_endo -83.85 -21.42 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.513 2.809 . . . . 0.0 112.693 -176.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.44 -38.3 35.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 t 68.94 -80.48 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.867 177.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.23 48.3 5.74 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.256 -0.973 . . . . 0.0 111.828 179.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.71 -30.8 0.56 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.579 -0.608 . . . . 0.0 111.579 -177.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.569 ' HG ' ' HG2' ' A' ' 25' ' ' ARG . 1.8 mm? -113.47 143.22 28.94 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -82.84 8.39 4.62 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.666 2.244 . . . . 0.0 111.098 178.498 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG2' ' HB3' ' A' ' 62' ' ' LEU . 6.0 pt-20 -126.7 -154.21 0.61 Allowed 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.435 -175.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.74 ' HG2' HG21 ' A' ' 31' ' ' VAL . 4.6 tpp180 -94.88 140.91 29.27 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 24' ' ' TYR . 33.5 p -116.64 108.78 16.36 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 175.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG13 HD13 ' A' ' 55' ' ' ILE . 94.1 t -96.74 114.69 34.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.123 -176.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -92.0 134.86 34.42 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.101 179.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.459 HD13 ' HG2' ' A' ' 80' ' ' LYS . 2.0 mp -125.8 128.73 48.13 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.983 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -152.09 146.98 25.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.661 -179.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.41 -137.99 4.96 Favored Glycine 0 C--O 1.227 -0.294 0 C-N-CA 120.015 -1.088 . . . . 0.0 113.024 177.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.36 161.43 37.18 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.03 -56.89 2.68 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.501 2.134 . . . . 0.0 113.041 -175.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -68.05 -37.71 81.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.486 -178.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.404 ' HA ' ' HB2' ' A' ' 49' ' ' SER . 4.3 m -68.03 -48.42 65.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.414 -176.25 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.561 ' HA ' ' SG ' ' A' ' 51' ' ' CYS . 5.5 p -69.12 -33.75 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.138 -174.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.56 -35.41 65.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.652 0.263 . . . . 0.0 110.442 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -60.49 -45.8 92.43 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.407 0.623 . . . . 0.0 109.846 176.361 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' A' ' 53' ' ' VAL . . . -64.29 -35.96 82.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.348 179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 83' ' ' LEU . 50.0 mtmt -81.13 -22.91 38.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.246 0.546 . . . . 0.0 109.764 -176.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 14.2 ttt -65.11 -44.47 88.64 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.459 176.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.536 ' HG2' HG21 ' A' ' 45' ' ' ILE . 4.0 ppp? -73.2 -28.02 61.95 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 120.374 -0.53 . . . . 0.0 109.956 177.202 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -66.18 -55.37 16.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.585 177.396 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.53 -30.35 65.09 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.465 179.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -61.83 -60.79 3.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.192 -179.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 2.1 mp -73.0 -36.61 51.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.261 -175.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.7 -21.68 28.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.186 177.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.2 t -72.34 -40.45 67.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 174.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 86' ' ' ILE . 7.2 ptp180 -72.3 -17.35 61.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.754 179.81 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -100.15 -49.27 1.48 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.347 -178.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 91' ' ' ARG . 15.6 mtp180 -105.9 29.79 6.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.927 0.394 . . . . 0.0 110.675 -177.183 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -84.14 57.3 5.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.09 178.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.954 0 CA-C-O 118.268 -1.296 . . . . 0.0 110.932 179.031 . . . . . . . . 0 0 . 1 stop_ save_